row;NCIt Code;NCIt PT;NCIt Definition;CTCAE PT;CTCAE 5.0 Definition;MedDRA Term;MedDRA Code;MedDRA TermType;MedDRA Version
0;C143163;CTCAE by Body System;;;;;;;
2;C143164;Blood and Lymphatic System Disorders, CTCAE;;;;;;;
3;C143283;Anemia, CTCAE;A disorder characterized by a reduction in the amount of hemoglobin in 100 ml of blood. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.;Anemia;A disorder characterized by a reduction in the amount of hemoglobin in 100 ml of blood. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.;Anemia;10002272;LLT;20,1
4;C143979;Grade 1 Anemia, CTCAE;"Hemoglobin (Hgb) <LLN-10.0 g/dL; <LLN-6.2 mmol/L; <LLN-100 g/L";Grade 1 Anemia;"Hemoglobin (Hgb) <LLN-10.0 g/dL; <LLN-6.2 mmol/L; <LLN-100 g/L";Anemia;10002272;LLT;20,1
5;C144517;Grade 2 Anemia, CTCAE;"Hgb <10.0-8.0 g/dL; <6.2-4.9 mmol/L; <100-80g/L";Grade 2 Anemia;"Hgb <10.0-8.0 g/dL; <6.2-4.9 mmol/L; <100-80g/L";Anemia;10002272;LLT;20,1
6;C145136;Grade 3 Anemia, CTCAE;"Hgb <8.0 g/dL; <4.9 mmol/L; <80 g/L; transfusion indicated";Grade 3 Anemia;"Hgb <8.0 g/dL; <4.9 mmol/L; <80 g/L; transfusion indicated";Anemia;10002272;LLT;20,1
7;C145745;Grade 4 Anemia, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Anemia;"Life-threatening consequences; urgent intervention indicated";Anemia;10002272;LLT;20,1
8;C146215;Grade 5 Anemia, CTCAE;Death;Grade 5 Anemia;Death;Anemia;10002272;LLT;20,1
9;C143323;Blood and Lymphatic System Disorders - Other, Specify, CTCAE;;Blood and lymphatic system disorders - Other, specify;;Blood and lymphatic system disorders - Other, specify;10005329;LLT;20,1
10;C144000;Grade 1 Blood and Lymphatic System Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Blood and lymphatic system disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Blood and lymphatic system disorders - Other, specify;10005329;LLT;20,1
11;C144544;Grade 2 Blood and Lymphatic System Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Blood and lymphatic system disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Blood and lymphatic system disorders - Other, specify;10005329;LLT;20,1
12;C145162;Grade 3 Blood and Lymphatic System Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Blood and lymphatic system disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Blood and lymphatic system disorders - Other, specify;10005329;LLT;20,1
13;C145766;Grade 4 Blood and Lymphatic System Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Blood and lymphatic system disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Blood and lymphatic system disorders - Other, specify;10005329;LLT;20,1
14;C146235;Grade 5 Blood and Lymphatic System Disorders - Other, Specify, CTCAE;Death;Grade 5 Blood and lymphatic system disorders - Other, specify;Death;Blood and lymphatic system disorders - Other, specify;10005329;LLT;20,1
15;C143332;Bone Marrow Hypocellular, CTCAE;A disorder characterized by the inability of the bone marrow to produce hematopoietic elements.;Bone marrow hypocellular;A disorder characterized by the inability of the bone marrow to produce hematopoietic elements.;Bone marrow hypocellular;10048580;LLT;20,1
16;C144009;Grade 1 Bone Marrow Hypocellular, CTCAE;Mildly hypocellular or <=25% reduction from normal cellularity for age;Grade 1 Bone marrow hypocellular;Mildly hypocellular or <=25% reduction from normal cellularity for age;Bone marrow hypocellular;10048580;LLT;20,1
17;C144552;Grade 2 Bone Marrow Hypocellular, CTCAE;Moderately hypocellular or >25-<50% reduction from normal cellularity for age;Grade 2 Bone marrow hypocellular;Moderately hypocellular or >25-<50% reduction from normal cellularity for age;Bone marrow hypocellular;10048580;LLT;20,1
18;C145168;Grade 3 Bone Marrow Hypocellular, CTCAE;Severely hypocellular or >50-<=75% reduction cellularity from normal for age;Grade 3 Bone marrow hypocellular;Severely hypocellular or >50-<=75% reduction cellularity from normal for age;Bone marrow hypocellular;10048580;LLT;20,1
19;C145769;Grade 4 Bone Marrow Hypocellular, CTCAE;Aplastic persistent for longer than 2 weeks;Grade 4 Bone marrow hypocellular;Aplastic persistent for longer than 2 weeks;Bone marrow hypocellular;10048580;LLT;20,1
20;C146237;Grade 5 Bone Marrow Hypocellular, CTCAE;Death;Grade 5 Bone marrow hypocellular;Death;Bone marrow hypocellular;10048580;LLT;20,1
21;C55273;Disseminated Intravascular Coagulation, CTCAE;A disorder characterized by systemic pathological activation of blood clotting mechanisms which results in clot formation throughout the body. There is an increase in the risk of hemorrhage as the body is depleted of platelets and coagulation factors.;Disseminated intravascular coagulation;A disorder characterized by systemic pathological activation of blood clotting mechanisms which results in clot formation throughout the body. There is an increase in the risk of hemorrhage as the body is depleted of platelets and coagulation factors.;Disseminated intravascular coagulation;10013442;LLT;20,1
22;C55255;Grade 2 Disseminated Intravascular Coagulation, CTCAE;Laboratory findings with no bleeding;Grade 2 Disseminated intravascular coagulation;Laboratory findings with no bleeding;Disseminated intravascular coagulation;10013442;LLT;20,1
23;C55260;Grade 3 Disseminated Intravascular Coagulation, CTCAE;Laboratory findings and bleeding;Grade 3 Disseminated intravascular coagulation;Laboratory findings and bleeding;Disseminated intravascular coagulation;10013442;LLT;20,1
24;C55266;Grade 4 Disseminated Intravascular Coagulation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Disseminated intravascular coagulation;"Life-threatening consequences; urgent intervention indicated";Disseminated intravascular coagulation;10013442;LLT;20,1
25;C55270;Grade 5 Disseminated Intravascular Coagulation, CTCAE;Death;Grade 5 Disseminated intravascular coagulation;Death;Disseminated intravascular coagulation;10013442;LLT;20,1
26;C143190;Eosinophilia, CTCAE;A disorder characterized by laboratory test results that indicate an increased number of eosinophils in the blood.;Eosinophilia;A disorder characterized by laboratory test results that indicate an increased number of eosinophils in the blood.;Eosinophilia;10014950;LLT;20,1
27;C144081;Grade 1 Eosinophilia, CTCAE;>ULN and >Baseline;Grade 1 Eosinophilia;>ULN and >Baseline;Eosinophilia;10014950;LLT;20,1
28;C145256;Grade 3 Eosinophilia, CTCAE;Steroids initiated;Grade 3 Eosinophilia;Steroids initiated;Eosinophilia;10014950;LLT;20,1
29;C143481;Febrile Neutropenia, CTCAE;A disorder characterized by an ANC <1000/mm3 and a single temperature of >38.3 degrees C (101 degrees F) or a sustained temperature of >=38 degrees C (100.4 degrees F) for more than one hour;Febrile neutropenia;A disorder characterized by an ANC <1000/mm3 and a single temperature of >38.3 degrees C (101 degrees F) or a sustained temperature of >=38 degrees C (100.4 degrees F) for more than one hour;Febrile neutropenia;10016288;LLT;20,1
30;C59479;Grade 3 Febrile Neutropenia, CTCAE;ANC <1000/mm3 with a single temperature of >38.3 degrees C (101 degrees F) or a sustained temperature of >=38 degrees C (100.4 degrees F) for more than one hour;Grade 3 Febrile neutropenia;ANC <1000/mm3 with a single temperature of >38.3 degrees C (101 degrees F) or a sustained temperature of >=38 degrees C (100.4 degrees F) for more than one hour;Febrile neutropenia;10016288;LLT;20,1
31;C59715;Grade 4 Febrile Neutropenia, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Febrile neutropenia;"Life-threatening consequences; urgent intervention indicated";Febrile neutropenia;10016288;LLT;20,1
32;C59951;Grade 5 Febrile Neutropenia, CTCAE;Death;Grade 5 Febrile neutropenia;Death;Febrile neutropenia;10016288;LLT;20,1
33;C55992;Hemolysis, CTCAE;A disorder characterized by laboratory test results that indicate widespread erythrocyte cell membrane destruction.;Hemolysis;A disorder characterized by laboratory test results that indicate widespread erythrocyte cell membrane destruction.;Hemolysis;10019491;LLT;20,1
34;C55937;Grade 1 Hemolysis, CTCAE;"Laboratory evidence of hemolysis only (e.g., direct antiglobulin test; DAT; Coombs'; schistocytes; decreased haptoglobin)";Grade 1 Hemolysis;"Laboratory evidence of hemolysis only (e.g., direct antiglobulin test; DAT; Coombs'; schistocytes; decreased haptoglobin)";Hemolysis;10019491;LLT;20,1
35;C55947;Grade 2 Hemolysis, CTCAE;Evidence of hemolysis and >=2 g decrease in hemoglobin;Grade 2 Hemolysis;Evidence of hemolysis and >=2 g decrease in hemoglobin;Hemolysis;10019491;LLT;20,1
36;C55959;Grade 3 Hemolysis, CTCAE;Transfusion or medical intervention indicated (e.g., steroids);Grade 3 Hemolysis;Transfusion or medical intervention indicated (e.g., steroids);Hemolysis;10019491;LLT;20,1
37;C55969;Grade 4 Hemolysis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hemolysis;"Life-threatening consequences; urgent intervention indicated";Hemolysis;10019491;LLT;20,1
38;C55982;Grade 5 Hemolysis, CTCAE;Death;Grade 5 Hemolysis;Death;Hemolysis;10019491;LLT;20,1
39;C143536;Hemolytic Uremic Syndrome, CTCAE;A disorder characterized by a form of thrombotic microangiopathy with renal failure, hemolytic anemia, and severe thrombocytopenia.;Hemolytic uremic syndrome;A disorder characterized by a form of thrombotic microangiopathy with renal failure, hemolytic anemia, and severe thrombocytopenia.;Hemolytic uremic syndrome;10019515;LLT;20,1
40;C145330;Grade 3 Hemolytic Uremic Syndrome, CTCAE;Laboratory findings with clinical consequences (e.g., renal insufficiency, petechiae);Grade 3 Hemolytic uremic syndrome;Laboratory findings with clinical consequences (e.g., renal insufficiency, petechiae);Hemolytic uremic syndrome;10019515;LLT;20,1
41;C145887;Grade 4 Hemolytic Uremic Syndrome, CTCAE;Life-threatening consequences, (e.g., CNS hemorrhage or thrombosis/embolism or renal failure);Grade 4 Hemolytic uremic syndrome;Life-threatening consequences, (e.g., CNS hemorrhage or thrombosis/embolism or renal failure);Hemolytic uremic syndrome;10019515;LLT;20,1
42;C146336;Grade 5 Hemolytic Uremic Syndrome, CTCAE;Death;Grade 5 Hemolytic uremic syndrome;Death;Hemolytic uremic syndrome;10019515;LLT;20,1
43;C143647;Leukocytosis, CTCAE;A disorder characterized by laboratory test results that indicate an increased number of white blood cells in the blood.;Leukocytosis;A disorder characterized by laboratory test results that indicate an increased number of white blood cells in the blood.;Leukocytosis;10024378;LLT;20,1
44;C145438;Grade 3 Leukocytosis, CTCAE;>100,000/mm3;Grade 3 Leukocytosis;>100,000/mm3;Leukocytosis;10024378;LLT;20,1
45;C145981;Grade 4 Leukocytosis, CTCAE;"Clinical manifestations of leucostasis; urgent intervention indicated";Grade 4 Leukocytosis;"Clinical manifestations of leucostasis; urgent intervention indicated";Leukocytosis;10024378;LLT;20,1
46;C146428;Grade 5 Leukocytosis, CTCAE;Death;Grade 5 Leukocytosis;Death;Leukocytosis;10024378;LLT;20,1
47;C146773;Lymph Node Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in a lymph node.;Lymph node pain;A disorder characterized by a sensation of marked discomfort in a lymph node.;Lymph node pain;10025182;LLT;20,1
48;C56121;Grade 1 Lymph Node Pain, CTCAE;Mild pain;Grade 1 Lymph node pain;Mild pain;Lymph node pain;10025182;LLT;20,1
49;C56122;Grade 2 Lymph Node Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Lymph node pain;"Moderate pain; limiting instrumental ADL";Lymph node pain;10025182;LLT;20,1
50;C56123;Grade 3 Lymph Node Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Lymph node pain;"Severe pain; limiting self care ADL";Lymph node pain;10025182;LLT;20,1
51;C143191;Methemoglobinemia, CTCAE;A disorder characterized by laboratory test results that indicate increased methemoglobin in the blood.;Methemoglobinemia;A disorder characterized by laboratory test results that indicate increased methemoglobin in the blood.;Methemoglobinemia;10027506;LLT;20,1
52;C144838;Grade 2 Methemoglobinemia, CTCAE;>ULN;Grade 2 Methemoglobinemia;>ULN;Methemoglobinemia;10027506;LLT;20,1
53;C145460;Grade 3 Methemoglobinemia, CTCAE;Requiring urgent intervention;Grade 3 Methemoglobinemia;Requiring urgent intervention;Methemoglobinemia;10027506;LLT;20,1
54;C145996;Grade 4 Methemoglobinemia, CTCAE;Life-threatening consequences;Grade 4 Methemoglobinemia;Life-threatening consequences;Methemoglobinemia;10027506;LLT;20,1
55;C146441;Grade 5 Methemoglobinemia, CTCAE;Death;Grade 5 Methemoglobinemia;Death;Methemoglobinemia;10027506;LLT;20,1
56;C143874;Thrombotic Thrombocytopenic Purpura, CTCAE;A disorder characterized by the presence of microangiopathic hemolytic anemia, thrombocytopenic purpura, fever, renal abnormalities and neurological abnormalities such as seizures, hemiplegia, and visual disturbances. It is an acute or subacute condition.;Thrombotic thrombocytopenic purpura;A disorder characterized by the presence of microangiopathic hemolytic anemia, thrombocytopenic purpura, fever, renal abnormalities and neurological abnormalities such as seizures, hemiplegia, and visual disturbances. It is an acute or subacute condition.;Thrombotic thrombocytopenic purpura;10043648;LLT;20,1
57;C145658;Grade 3 Thrombotic Thrombocytopenic Purpura, CTCAE;Laboratory findings with clinical consequences (e.g., renal insufficiency, petechiae);Grade 3 Thrombotic thrombocytopenic purpura;Laboratory findings with clinical consequences (e.g., renal insufficiency, petechiae);Thrombotic thrombocytopenic purpura;10043648;LLT;20,1
58;C146146;Grade 4 Thrombotic Thrombocytopenic Purpura, CTCAE;Life-threatening consequences, (e.g., CNS hemorrhage or thrombosis/embolism or renal failure);Grade 4 Thrombotic thrombocytopenic purpura;Life-threatening consequences, (e.g., CNS hemorrhage or thrombosis/embolism or renal failure);Thrombotic thrombocytopenic purpura;10043648;LLT;20,1
59;C146577;Grade 5 Thrombotic Thrombocytopenic Purpura, CTCAE;Death;Grade 5 Thrombotic thrombocytopenic purpura;Death;Thrombotic thrombocytopenic purpura;10043648;LLT;20,1
60;C143165;Cardiac Disorders, CTCAE;;;;;;;
61;C143290;Aortic Valve Disease, CTCAE;A disorder characterized by a defect in aortic valve function or structure.;Aortic valve disease;A disorder characterized by a defect in aortic valve function or structure.;Aortic valve disease;10061589;LLT;20,1
62;C143984;Grade 1 Aortic Valve Disease, CTCAE;Asymptomatic valvular thickening with or without mild valvular regurgitation or stenosis by imaging;Grade 1 Aortic valve disease;Asymptomatic valvular thickening with or without mild valvular regurgitation or stenosis by imaging;Aortic valve disease;10061589;LLT;20,1
63;C144522;Grade 2 Aortic Valve Disease, CTCAE;"Asymptomatic; moderate regurgitation or stenosis by imaging";Grade 2 Aortic valve disease;"Asymptomatic; moderate regurgitation or stenosis by imaging";Aortic valve disease;10061589;LLT;20,1
64;C145140;Grade 3 Aortic Valve Disease, CTCAE;"Symptomatic; severe regurgitation or stenosis by imaging; symptoms controlled with medical intervention";Grade 3 Aortic valve disease;"Symptomatic; severe regurgitation or stenosis by imaging; symptoms controlled with medical intervention";Aortic valve disease;10061589;LLT;20,1
65;C145748;Grade 4 Aortic Valve Disease, CTCAE;"Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)";Grade 4 Aortic valve disease;"Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)";Aortic valve disease;10061589;LLT;20,1
66;C146218;Grade 5 Aortic Valve Disease, CTCAE;Death;Grade 5 Aortic valve disease;Death;Aortic valve disease;10061589;LLT;20,1
67;C146731;Asystole, CTCAE 5.0;A disorder characterized by a dysrhythmia without cardiac electrical activity. Typically, this is accompanied by cessation of the pumping function of the heart.;Asystole;A disorder characterized by a dysrhythmia without cardiac electrical activity. Typically, this is accompanied by cessation of the pumping function of the heart.;Asystole;10003586;LLT;20,1
68;C54777;Grade 1 Asystole, CTCAE;"Periods of asystole; non-urgent medical management indicated";Grade 1 Asystole;"Periods of asystole; non-urgent medical management indicated";Asystole;10003586;LLT;20,1
69;C54871;Grade 4 Asystole, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Asystole;"Life-threatening consequences; urgent intervention indicated";Asystole;10003586;LLT;20,1
70;C54902;Grade 5 Asystole, CTCAE;Death;Grade 5 Asystole;Death;Asystole;10003586;LLT;20,1
71;C54767;Atrial Fibrillation, CTCAE;A disorder characterized by a dysrhythmia without discernible P waves and an irregular ventricular response due to multiple reentry circuits. The rhythm disturbance originates above the ventricles.;Atrial fibrillation;A disorder characterized by a dysrhythmia without discernible P waves and an irregular ventricular response due to multiple reentry circuits. The rhythm disturbance originates above the ventricles.;Atrial fibrillation;10003658;LLT;20,1
72;C54778;Grade 1 Atrial Fibrillation, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Atrial fibrillation;Asymptomatic, intervention not indicated;Atrial fibrillation;10003658;LLT;20,1
73;C54809;Grade 2 Atrial Fibrillation, CTCAE;Non-urgent medical intervention indicated;Grade 2 Atrial fibrillation;Non-urgent medical intervention indicated;Atrial fibrillation;10003658;LLT;20,1
74;C54841;Grade 3 Atrial Fibrillation, CTCAE;"Symptomatic, urgent intervention indicated; device (e.g., pacemaker); ablation; new onset";Grade 3 Atrial fibrillation;"Symptomatic, urgent intervention indicated; device (e.g., pacemaker); ablation; new onset";Atrial fibrillation;10003658;LLT;20,1
75;C54872;Grade 4 Atrial Fibrillation, CTCAE;"Life-threatening consequences; embolus requiring urgent intervention";Grade 4 Atrial fibrillation;"Life-threatening consequences; embolus requiring urgent intervention";Atrial fibrillation;10003658;LLT;20,1
76;C54903;Grade 5 Atrial Fibrillation, CTCAE;Death;Grade 5 Atrial fibrillation;Death;Atrial fibrillation;10003658;LLT;20,1
77;C54768;Atrial Flutter, CTCAE;A disorder characterized by a dysrhythmia with organized rhythmic atrial contractions with a rate of 200-300 beats per minute. The rhythm disturbance originates in the atria.;Atrial flutter;A disorder characterized by a dysrhythmia with organized rhythmic atrial contractions with a rate of 200-300 beats per minute. The rhythm disturbance originates in the atria.;Atrial flutter;10003662;LLT;20,1
78;C54779;Grade 1 Atrial Flutter, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Atrial flutter;Asymptomatic, intervention not indicated;Atrial flutter;10003662;LLT;20,1
79;C54810;Grade 2 Atrial Flutter, CTCAE;Non-urgent medical intervention indicated;Grade 2 Atrial flutter;Non-urgent medical intervention indicated;Atrial flutter;10003662;LLT;20,1
80;C54842;Grade 3 Atrial Flutter, CTCAE;"Symptomatic, urgent intervention indicated; device (e.g., pacemaker); ablation";Grade 3 Atrial flutter;"Symptomatic, urgent intervention indicated; device (e.g., pacemaker); ablation";Atrial flutter;10003662;LLT;20,1
81;C54873;Grade 4 Atrial Flutter, CTCAE;"Life-threatening consequences; embolus requiring urgent intervention";Grade 4 Atrial flutter;"Life-threatening consequences; embolus requiring urgent intervention";Atrial flutter;10003662;LLT;20,1
82;C54904;Grade 5 Atrial Flutter, CTCAE;Death;Grade 5 Atrial flutter;Death;Atrial flutter;10003662;LLT;20,1
83;C143308;Atrioventricular Block Complete, CTCAE;A disorder characterized by a dysrhythmia with complete failure of atrial electrical impulse conduction through the AV node to the ventricles.;Atrioventricular block complete;A disorder characterized by a dysrhythmia with complete failure of atrial electrical impulse conduction through the AV node to the ventricles.;Atrioventricular block complete;10003673;LLT;20,1
84;C144529;Grade 2 Atrioventricular Block Complete, CTCAE;Non-urgent intervention indicated;Grade 2 Atrioventricular block complete;Non-urgent intervention indicated;Atrioventricular block complete;10003673;LLT;20,1
85;C145152;Grade 3 Atrioventricular Block Complete, CTCAE;"Symptomatic and incompletely controlled medically, or controlled with device (e.g., pacemaker); new onset";Grade 3 Atrioventricular block complete;"Symptomatic and incompletely controlled medically, or controlled with device (e.g., pacemaker); new onset";Atrioventricular block complete;10003673;LLT;20,1
86;C145757;Grade 4 Atrioventricular Block Complete, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Atrioventricular block complete;"Life-threatening consequences; urgent intervention indicated";Atrioventricular block complete;10003673;LLT;20,1
87;C146226;Grade 5 Atrioventricular Block Complete, CTCAE;Death;Grade 5 Atrioventricular block complete;Death;Atrioventricular block complete;10003673;LLT;20,1
88;C143309;Atrioventricular Block First Degree, CTCAE;"A disorder characterized by a dysrhythmia with a delay in the time required for the conduction of an electrical impulse through the atrioventricular (AV) node beyond 0.2 seconds; prolongation of the PR interval greater than 200 milliseconds.";Atrioventricular block first degree;"A disorder characterized by a dysrhythmia with a delay in the time required for the conduction of an electrical impulse through the atrioventricular (AV) node beyond 0.2 seconds; prolongation of the PR interval greater than 200 milliseconds.";Atrioventricular block first degree;10003674;LLT;20,1
89;C143991;Grade 1 Atrioventricular Block First Degree, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Atrioventricular block first degree;Asymptomatic, intervention not indicated;Atrioventricular block first degree;10003674;LLT;20,1
90;C144530;Grade 2 Atrioventricular Block First Degree, CTCAE;Non-urgent intervention indicated;Grade 2 Atrioventricular block first degree;Non-urgent intervention indicated;Atrioventricular block first degree;10003674;LLT;20,1
91;C54771;Mobitz Type I, CTCAE;A disorder characterized by a dysrhythmia with a progressively lengthening PR interval prior to the blocking of an atrial impulse. This is the result of intermittent failure of atrial electrical impulse conduction through the atrioventricular (AV) node to the ventricles.;Mobitz type I;A disorder characterized by a dysrhythmia with a progressively lengthening PR interval prior to the blocking of an atrial impulse. This is the result of intermittent failure of atrial electrical impulse conduction through the atrioventricular (AV) node to the ventricles.;Mobitz type I;10027787;LLT;20,1
92;C54782;Grade 1 Mobitz Type I, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Mobitz type I;Asymptomatic, intervention not indicated;Mobitz type I;10027787;LLT;20,1
93;C54813;Grade 2 Mobitz Type I, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Mobitz type I;"Symptomatic; medical intervention indicated";Mobitz type I;10027787;LLT;20,1
94;C54845;Grade 3 Mobitz Type I, CTCAE;Symptomatic and incompletely controlled medically, or controlled with device (e.g., pacemaker);Grade 3 Mobitz type I;Symptomatic and incompletely controlled medically, or controlled with device (e.g., pacemaker);Mobitz type I;10027787;LLT;20,1
95;C54876;Grade 4 Mobitz Type I, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Mobitz type I;"Life-threatening consequences; urgent intervention indicated";Mobitz type I;10027787;LLT;20,1
96;C54907;Grade 5 Mobitz Type I, CTCAE;Death;Grade 5 Mobitz type I;Death;Mobitz type I;10027787;LLT;20,1
97;C54772;Mobitz (Type) II Atrioventricular Block, CTCAE;A disorder characterized by a dysrhythmia with relatively constant PR interval prior to the block of an atrial impulse. This is the result of intermittent failure of atrial electrical impulse conduction through the atrioventricular (AV) node to the ventricles.;Mobitz (type) II atrioventricular block;A disorder characterized by a dysrhythmia with relatively constant PR interval prior to the block of an atrial impulse. This is the result of intermittent failure of atrial electrical impulse conduction through the atrioventricular (AV) node to the ventricles.;Mobitz (type) II atrioventricular block;10027786;LLT;20,1
98;C54783;Grade 1 Mobitz (Type) II Atrioventricular Block, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Mobitz (type) II atrioventricular block;Asymptomatic, intervention not indicated;Mobitz (type) II atrioventricular block;10027786;LLT;20,1
99;C54814;Grade 2 Mobitz (Type) II Atrioventricular Block, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Mobitz (type) II atrioventricular block;"Symptomatic; medical intervention indicated";Mobitz (type) II atrioventricular block;10027786;LLT;20,1
100;C54846;Grade 3 Mobitz (Type) II Atrioventricular Block, CTCAE;"Symptomatic and incompletely controlled medically, or controlled with device (e.g., pacemaker); new onset";Grade 3 Mobitz (type) II atrioventricular block;"Symptomatic and incompletely controlled medically, or controlled with device (e.g., pacemaker); new onset";Mobitz (type) II atrioventricular block;10027786;LLT;20,1
101;C54877;Grade 4 Mobitz (Type) II Atrioventricular Block, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Mobitz (type) II atrioventricular block;"Life-threatening consequences; urgent intervention indicated";Mobitz (type) II atrioventricular block;10027786;LLT;20,1
102;C54908;Grade 5 Mobitz (Type) II Atrioventricular Block, CTCAE;Death;Grade 5 Mobitz (type) II atrioventricular block;Death;Mobitz (type) II atrioventricular block;10027786;LLT;20,1
103;C143351;Cardiac Arrest, CTCAE;A disorder characterized by cessation of the pumping function of the heart.;Cardiac arrest;A disorder characterized by cessation of the pumping function of the heart.;Cardiac arrest;10007515;LLT;20,1
104;C145781;Grade 4 Cardiac Arrest, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Cardiac arrest;"Life-threatening consequences; urgent intervention indicated";Cardiac arrest;10007515;LLT;20,1
105;C146249;Grade 5 Cardiac Arrest, CTCAE;Death;Grade 5 Cardiac arrest;Death;Cardiac arrest;10007515;LLT;20,1
106;C143352;Cardiac Disorders - Other, Specify, CTCAE;;Cardiac disorders - Other, specify;;Cardiac disorders - Other, specify;10007541;LLT;20,1
107;C144021;Grade 1 Cardiac Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Cardiac disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Cardiac disorders - Other, specify;10007541;LLT;20,1
108;C144567;Grade 2 Cardiac Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Cardiac disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Cardiac disorders - Other, specify;10007541;LLT;20,1
109;C145182;Grade 3 Cardiac Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Cardiac disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Cardiac disorders - Other, specify;10007541;LLT;20,1
110;C145782;Grade 4 Cardiac Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Cardiac disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Cardiac disorders - Other, specify;10007541;LLT;20,1
111;C146250;Grade 5 Cardiac Disorders - Other, Specify, CTCAE;Death;Grade 5 Cardiac disorders - Other, specify;Death;Cardiac disorders - Other, specify;10007541;LLT;20,1
112;C143364;Chest Pain - Cardiac, CTCAE;A disorder characterized by substernal discomfort due to insufficient myocardial oxygenation e.g., angina pectoris.;Chest pain - cardiac;A disorder characterized by substernal discomfort due to insufficient myocardial oxygenation e.g., angina pectoris.;Chest pain - cardiac;10008481;LLT;20,1
113;C144028;Grade 1 Chest Pain - Cardiac, CTCAE;Mild pain;Grade 1 Chest pain - cardiac;Mild pain;Chest pain - cardiac;10008481;LLT;20,1
114;C144575;Grade 2 Chest Pain - Cardiac, CTCAE;"Moderate pain; pain on exertion; limiting instrumental ADL; hemodynamically stable";Grade 2 Chest pain - cardiac;"Moderate pain; pain on exertion; limiting instrumental ADL; hemodynamically stable";Chest pain - cardiac;10008481;LLT;20,1
115;C145192;Grade 3 Chest Pain - Cardiac, CTCAE;"Pain at rest; limiting self care ADL; cardiac catheterization; new onset cardiac chest pain; unstable angina";Grade 3 Chest pain - cardiac;"Pain at rest; limiting self care ADL; cardiac catheterization; new onset cardiac chest pain; unstable angina";Chest pain - cardiac;10008481;LLT;20,1
116;C143380;Conduction Disorder, CTCAE;A disorder characterized by pathological irregularities in the cardiac conduction system.;Conduction disorder;A disorder characterized by pathological irregularities in the cardiac conduction system.;Conduction disorder;10010276;LLT;20,1
117;C144039;Grade 1 Conduction Disorder, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Conduction disorder;"Mild symptoms; intervention not indicated";Conduction disorder;10010276;LLT;20,1
118;C144588;Grade 2 Conduction Disorder, CTCAE;Non-urgent medical intervention indicated;Grade 2 Conduction disorder;Non-urgent medical intervention indicated;Conduction disorder;10010276;LLT;20,1
119;C145205;Grade 3 Conduction Disorder, CTCAE;Symptomatic, urgent intervention indicated;Grade 3 Conduction disorder;Symptomatic, urgent intervention indicated;Conduction disorder;10010276;LLT;20,1
120;C145801;Grade 4 Conduction Disorder, CTCAE;Life-threatening consequences;Grade 4 Conduction disorder;Life-threatening consequences;Conduction disorder;10010276;LLT;20,1
121;C146266;Grade 5 Conduction Disorder, CTCAE;Death;Grade 5 Conduction disorder;Death;Conduction disorder;10010276;LLT;20,1
122;C143192;Cyanosis, CTCAE;A disorder characterized by a bluish discoloration of the skin and/or mucous membranes.;Cyanosis;A disorder characterized by a bluish discoloration of the skin and/or mucous membranes.;Cyanosis;10011703;LLT;20,1
123;C144596;Grade 2 Cyanosis, CTCAE;Present;Grade 2 Cyanosis;Present;Cyanosis;10011703;LLT;20,1
124;C143529;Heart Failure, CTCAE;A disorder characterized by the inability of the heart to pump blood at an adequate volume to meet tissue metabolic requirements, or, the ability to do so only at an elevation in the filling pressure.;Heart failure;A disorder characterized by the inability of the heart to pump blood at an adequate volume to meet tissue metabolic requirements, or, the ability to do so only at an elevation in the filling pressure.;Heart failure;10019279;LLT;20,1
125;C144145;Grade 1 Heart Failure, CTCAE;Asymptomatic with laboratory (e.g., BNP [B-Natriuretic Peptide ]) or cardiac imaging abnormalities;Grade 1 Heart failure;Asymptomatic with laboratory (e.g., BNP [B-Natriuretic Peptide ]) or cardiac imaging abnormalities;Heart failure;10019279;LLT;20,1
126;C144706;Grade 2 Heart Failure, CTCAE;Symptoms with moderate activity or exertion;Grade 2 Heart failure;Symptoms with moderate activity or exertion;Heart failure;10019279;LLT;20,1
127;C145326;Grade 3 Heart Failure, CTCAE;"Symptoms at rest or with minimal activity or exertion; hospitalization; new onset of symptoms";Grade 3 Heart failure;"Symptoms at rest or with minimal activity or exertion; hospitalization; new onset of symptoms";Heart failure;10019279;LLT;20,1
128;C145884;Grade 4 Heart Failure, CTCAE;"Life-threatening consequences; urgent intervention indicated (e.g., continuous IV therapy or mechanical hemodynamic support)";Grade 4 Heart failure;"Life-threatening consequences; urgent intervention indicated (e.g., continuous IV therapy or mechanical hemodynamic support)";Heart failure;10019279;LLT;20,1
129;C146333;Grade 5 Heart Failure, CTCAE;Death;Grade 5 Heart failure;Death;Heart failure;10019279;LLT;20,1
130;C146719;Left Ventricular Systolic Dysfunction, CTCAE 5.0;A disorder characterized by failure of the left ventricle to produce adequate output.;Left ventricular systolic dysfunction;A disorder characterized by failure of the left ventricle to produce adequate output.;Left ventricular systolic dysfunction;10069501;LLT;20,1
131;C55023;Grade 3 Left Ventricular Systolic Dysfunction, CTCAE;Symptomatic due to drop in ejection fraction responsive to intervention;Grade 3 Left ventricular systolic dysfunction;Symptomatic due to drop in ejection fraction responsive to intervention;Left ventricular systolic dysfunction;10069501;LLT;20,1
132;C55037;Grade 4 Left Ventricular Systolic Dysfunction, CTCAE;"Refractory or poorly controlled heart failure due to drop in ejection fraction; intervention such as ventricular assist device, intravenous vasopressor support, or heart transplant indicated";Grade 4 Left ventricular systolic dysfunction;"Refractory or poorly controlled heart failure due to drop in ejection fraction; intervention such as ventricular assist device, intravenous vasopressor support, or heart transplant indicated";Left ventricular systolic dysfunction;10069501;LLT;20,1
133;C55051;Grade 5 Left Ventricular Systolic Dysfunction, CTCAE;Death;Grade 5 Left ventricular systolic dysfunction;Death;Left ventricular systolic dysfunction;10069501;LLT;20,1
134;C143674;Mitral Valve Disease, CTCAE;A disorder characterized by a defect in mitral valve function or structure.;Mitral valve disease;A disorder characterized by a defect in mitral valve function or structure.;Mitral valve disease;10061532;LLT;20,1
135;C144263;Grade 1 Mitral Valve Disease, CTCAE;Asymptomatic valvular thickening with or without mild valvular regurgitation or stenosis by imaging;Grade 1 Mitral valve disease;Asymptomatic valvular thickening with or without mild valvular regurgitation or stenosis by imaging;Mitral valve disease;10061532;LLT;20,1
136;C144840;Grade 2 Mitral Valve Disease, CTCAE;"Asymptomatic; moderate regurgitation or stenosis by imaging";Grade 2 Mitral valve disease;"Asymptomatic; moderate regurgitation or stenosis by imaging";Mitral valve disease;10061532;LLT;20,1
137;C145462;Grade 3 Mitral Valve Disease, CTCAE;"Symptomatic; severe regurgitation or stenosis by imaging; symptoms controlled with medical intervention";Grade 3 Mitral valve disease;"Symptomatic; severe regurgitation or stenosis by imaging; symptoms controlled with medical intervention";Mitral valve disease;10061532;LLT;20,1
138;C145998;Grade 4 Mitral Valve Disease, CTCAE;"Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)";Grade 4 Mitral valve disease;"Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)";Mitral valve disease;10061532;LLT;20,1
139;C146443;Grade 5 Mitral Valve Disease, CTCAE;Death;Grade 5 Mitral valve disease;Death;Mitral valve disease;10061532;LLT;20,1
140;C143691;Myocardial Infarction, CTCAE;"A disorder characterized by gross necrosis of the myocardium; this is due to an interruption of blood supply to the area.";Myocardial infarction;"A disorder characterized by gross necrosis of the myocardium; this is due to an interruption of blood supply to the area.";Myocardial infarction;10028596;LLT;20,1
141;C144856;Grade 2 Myocardial Infarction, CTCAE;Asymptomatic and cardiac enzymes minimally abnormal and no evidence of ischemic ECG changes;Grade 2 Myocardial infarction;Asymptomatic and cardiac enzymes minimally abnormal and no evidence of ischemic ECG changes;Myocardial infarction;10028596;LLT;20,1
142;C145479;Grade 3 Myocardial Infarction, CTCAE;"Severe symptoms; cardiac enzymes abnormal; hemodynamically stable; ECG changes consistent with infarction";Grade 3 Myocardial infarction;"Severe symptoms; cardiac enzymes abnormal; hemodynamically stable; ECG changes consistent with infarction";Myocardial infarction;10028596;LLT;20,1
143;C146007;Grade 4 Myocardial Infarction, CTCAE;"Life-threatening consequences; hemodynamically unstable";Grade 4 Myocardial infarction;"Life-threatening consequences; hemodynamically unstable";Myocardial infarction;10028596;LLT;20,1
144;C146452;Grade 5 Myocardial Infarction, CTCAE;Death;Grade 5 Myocardial infarction;Death;Myocardial infarction;10028596;LLT;20,1
145;C146695;Myocarditis, CTCAE 5.0;A disorder characterized by inflammation of the muscle tissue of the heart.;Myocarditis;A disorder characterized by inflammation of the muscle tissue of the heart.;Myocarditis;10028606;LLT;20,1
146;C144857;Grade 2 Myocarditis, CTCAE;Symptoms with moderate activity or exertion;Grade 2 Myocarditis;Symptoms with moderate activity or exertion;Myocarditis;10028606;LLT;20,1
147;C55024;Grade 3 Myocarditis, CTCAE;"Severe with symptoms at rest or with minimal activity or exertion; intervention indicated; new onset of symptoms";Grade 3 Myocarditis;"Severe with symptoms at rest or with minimal activity or exertion; intervention indicated; new onset of symptoms";Myocarditis;10028606;LLT;20,1
148;C55038;Grade 4 Myocarditis, CTCAE;"Life-threatening consequences; urgent intervention indicated (e.g., continuous IV therapy or mechanical hemodynamic support)";Grade 4 Myocarditis;"Life-threatening consequences; urgent intervention indicated (e.g., continuous IV therapy or mechanical hemodynamic support)";Myocarditis;10028606;LLT;20,1
149;C55052;Grade 5 Myocarditis, CTCAE;Death;Grade 5 Myocarditis;Death;Myocarditis;10028606;LLT;20,1
150;C54935;Palpitations, CTCAE;A disorder characterized by an unpleasant sensation of irregular and/or forceful beating of the heart.;Palpitations;A disorder characterized by an unpleasant sensation of irregular and/or forceful beating of the heart.;Palpitations;10033557;LLT;20,1
151;C54790;Grade 1 Palpitations, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Palpitations;"Mild symptoms; intervention not indicated";Palpitations;10033557;LLT;20,1
152;C54821;Grade 2 Palpitations, CTCAE;Intervention indicated;Grade 2 Palpitations;Intervention indicated;Palpitations;10033557;LLT;20,1
153;C143738;Paroxysmal Atrial Tachycardia, CTCAE;A disorder characterized by a dysrhythmia with abrupt onset and sudden termination of atrial contractions with a rate of 150-250 beats per minute. The rhythm disturbance originates in the atria.;Paroxysmal atrial tachycardia;A disorder characterized by a dysrhythmia with abrupt onset and sudden termination of atrial contractions with a rate of 150-250 beats per minute. The rhythm disturbance originates in the atria.;Paroxysmal atrial tachycardia;10034040;LLT;20,1
154;C144320;Grade 1 Paroxysmal Atrial Tachycardia, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Paroxysmal atrial tachycardia;Asymptomatic, intervention not indicated;Paroxysmal atrial tachycardia;10034040;LLT;20,1
155;C144899;Grade 2 Paroxysmal Atrial Tachycardia, CTCAE;Non-urgent medical intervention indicated;Grade 2 Paroxysmal atrial tachycardia;Non-urgent medical intervention indicated;Paroxysmal atrial tachycardia;10034040;LLT;20,1
156;C145521;Grade 3 Paroxysmal Atrial Tachycardia, CTCAE;"Symptomatic, urgent intervention indicated; ablation";Grade 3 Paroxysmal atrial tachycardia;"Symptomatic, urgent intervention indicated; ablation";Paroxysmal atrial tachycardia;10034040;LLT;20,1
157;C146033;Grade 4 Paroxysmal Atrial Tachycardia, CTCAE;"Life-threatening consequences; incompletely controlled medically; cardioversion indicated";Grade 4 Paroxysmal atrial tachycardia;"Life-threatening consequences; incompletely controlled medically; cardioversion indicated";Paroxysmal atrial tachycardia;10034040;LLT;20,1
158;C146473;Grade 5 Paroxysmal Atrial Tachycardia, CTCAE;Death;Grade 5 Paroxysmal atrial tachycardia;Death;Paroxysmal atrial tachycardia;10034040;LLT;20,1
159;C143743;Pericardial Effusion, CTCAE;A disorder characterized by fluid collection within the pericardial sac, usually due to inflammation.;Pericardial effusion;A disorder characterized by fluid collection within the pericardial sac, usually due to inflammation.;Pericardial effusion;10034474;LLT;20,1
160;C144905;Grade 2 Pericardial Effusion, CTCAE;Asymptomatic effusion size small to moderate;Grade 2 Pericardial effusion;Asymptomatic effusion size small to moderate;Pericardial effusion;10034474;LLT;20,1
161;C145528;Grade 3 Pericardial Effusion, CTCAE;Effusion with physiologic consequences;Grade 3 Pericardial effusion;Effusion with physiologic consequences;Pericardial effusion;10034474;LLT;20,1
162;C146037;Grade 4 Pericardial Effusion, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pericardial effusion;"Life-threatening consequences; urgent intervention indicated";Pericardial effusion;10034474;LLT;20,1
163;C146477;Grade 5 Pericardial Effusion, CTCAE;Death;Grade 5 Pericardial effusion;Death;Pericardial effusion;10034474;LLT;20,1
164;C143744;Pericardial Tamponade, CTCAE;A disorder characterized by an increase in intrapericardial pressure due to the collection of blood or fluid in the pericardium.;Pericardial tamponade;A disorder characterized by an increase in intrapericardial pressure due to the collection of blood or fluid in the pericardium.;Pericardial tamponade;10053565;LLT;20,1
165;C146038;Grade 4 Pericardial Tamponade, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pericardial tamponade;"Life-threatening consequences; urgent intervention indicated";Pericardial tamponade;10053565;LLT;20,1
166;C146478;Grade 5 Pericardial Tamponade, CTCAE;Death;Grade 5 Pericardial tamponade;Death;Pericardial tamponade;10053565;LLT;20,1
167;C55067;Pericarditis, CTCAE;A disorder characterized by irritation to the layers of the pericardium (the protective sac around the heart).;Pericarditis;A disorder characterized by irritation to the layers of the pericardium (the protective sac around the heart).;Pericarditis;10034484;LLT;20,1
168;C55001;Grade 1 Pericarditis, CTCAE;Asymptomatic, ECG or physical findings (e.g., rub) consistent with pericarditis;Grade 1 Pericarditis;Asymptomatic, ECG or physical findings (e.g., rub) consistent with pericarditis;Pericarditis;10034484;LLT;20,1
169;C55012;Grade 2 Pericarditis, CTCAE;Symptomatic pericarditis (e.g., chest pain);Grade 2 Pericarditis;Symptomatic pericarditis (e.g., chest pain);Pericarditis;10034484;LLT;20,1
170;C55026;Grade 3 Pericarditis, CTCAE;Pericarditis with physiologic consequences (e.g., pericardial constriction);Grade 3 Pericarditis;Pericarditis with physiologic consequences (e.g., pericardial constriction);Pericarditis;10034484;LLT;20,1
171;C55040;Grade 4 Pericarditis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pericarditis;"Life-threatening consequences; urgent intervention indicated";Pericarditis;10034484;LLT;20,1
172;C55054;Grade 5 Pericarditis, CTCAE;Death;Grade 5 Pericarditis;Death;Pericarditis;10034484;LLT;20,1
173;C143793;Pulmonary Valve Disease, CTCAE;A disorder characterized by a defect in pulmonary valve function or structure.;Pulmonary valve disease;A disorder characterized by a defect in pulmonary valve function or structure.;Pulmonary valve disease;10061541;LLT;20,1
174;C144359;Grade 1 Pulmonary Valve Disease, CTCAE;Asymptomatic valvular thickening with or without mild valvular regurgitation or stenosis by imaging;Grade 1 Pulmonary valve disease;Asymptomatic valvular thickening with or without mild valvular regurgitation or stenosis by imaging;Pulmonary valve disease;10061541;LLT;20,1
175;C144951;Grade 2 Pulmonary Valve Disease, CTCAE;"Asymptomatic; moderate regurgitation or stenosis by imaging";Grade 2 Pulmonary valve disease;"Asymptomatic; moderate regurgitation or stenosis by imaging";Pulmonary valve disease;10061541;LLT;20,1
176;C145573;Grade 3 Pulmonary Valve Disease, CTCAE;"Symptomatic; severe regurgitation or stenosis by imaging; symptoms controlled with medical intervention";Grade 3 Pulmonary valve disease;"Symptomatic; severe regurgitation or stenosis by imaging; symptoms controlled with medical intervention";Pulmonary valve disease;10061541;LLT;20,1
177;C146076;Grade 4 Pulmonary Valve Disease, CTCAE;"Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)";Grade 4 Pulmonary valve disease;"Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)";Pulmonary valve disease;10061541;LLT;20,1
178;C146511;Grade 5 Pulmonary Valve Disease, CTCAE;Death;Grade 5 Pulmonary valve disease;Death;Pulmonary valve disease;10061541;LLT;20,1
179;C55069;Restrictive Cardiomyopathy, CTCAE;A disorder characterized by an inability of the ventricles to fill with blood because the myocardium (heart muscle) stiffens and loses its flexibility.;Restrictive cardiomyopathy;A disorder characterized by an inability of the ventricles to fill with blood because the myocardium (heart muscle) stiffens and loses its flexibility.;Restrictive cardiomyopathy;10038748;LLT;20,1
180;C55003;Grade 1 Restrictive Cardiomyopathy, CTCAE;Imaging findings only;Grade 1 Restrictive cardiomyopathy;Imaging findings only;Restrictive cardiomyopathy;10038748;LLT;20,1
181;C55014;Grade 2 Restrictive Cardiomyopathy, CTCAE;Symptomatic without signs of heart failure;Grade 2 Restrictive cardiomyopathy;Symptomatic without signs of heart failure;Restrictive cardiomyopathy;10038748;LLT;20,1
182;C55028;Grade 3 Restrictive Cardiomyopathy, CTCAE;"Symptomatic heart failure or other cardiac symptoms, responsive to intervention; new onset of symptoms";Grade 3 Restrictive cardiomyopathy;"Symptomatic heart failure or other cardiac symptoms, responsive to intervention; new onset of symptoms";Restrictive cardiomyopathy;10038748;LLT;20,1
183;C55042;Grade 4 Restrictive Cardiomyopathy, CTCAE;Refractory heart failure or other poorly controlled cardiac symptoms;Grade 4 Restrictive cardiomyopathy;Refractory heart failure or other poorly controlled cardiac symptoms;Restrictive cardiomyopathy;10038748;LLT;20,1
184;C55056;Grade 5 Restrictive Cardiomyopathy, CTCAE;Death;Grade 5 Restrictive cardiomyopathy;Death;Restrictive cardiomyopathy;10038748;LLT;20,1
185;C55070;Right Ventricular Dysfunction, CTCAE;A disorder characterized by impairment of right ventricular function associated with low ejection fraction and a decrease in motility of the right ventricular wall.;Right ventricular dysfunction;A disorder characterized by impairment of right ventricular function associated with low ejection fraction and a decrease in motility of the right ventricular wall.;Right ventricular dysfunction;10058597;LLT;20,1
186;C55004;Grade 1 Right Ventricular Dysfunction, CTCAE;Asymptomatic with laboratory (e.g., BNP [B-Natriuretic Peptide ]) or cardiac imaging abnormalities;Grade 1 Right ventricular dysfunction;Asymptomatic with laboratory (e.g., BNP [B-Natriuretic Peptide ]) or cardiac imaging abnormalities;Right ventricular dysfunction;10058597;LLT;20,1
187;C55015;Grade 2 Right Ventricular Dysfunction, CTCAE;Symptoms with moderate activity or exertion;Grade 2 Right ventricular dysfunction;Symptoms with moderate activity or exertion;Right ventricular dysfunction;10058597;LLT;20,1
188;C55029;Grade 3 Right Ventricular Dysfunction, CTCAE;"Severe symptoms, associated with hypoxia, right heart failure; oxygen indicated";Grade 3 Right ventricular dysfunction;"Severe symptoms, associated with hypoxia, right heart failure; oxygen indicated";Right ventricular dysfunction;10058597;LLT;20,1
189;C55043;Grade 4 Right Ventricular Dysfunction, CTCAE;"Life-threatening consequences; urgent intervention indicated (e.g., ventricular assist device); heart transplant indicated";Grade 4 Right ventricular dysfunction;"Life-threatening consequences; urgent intervention indicated (e.g., ventricular assist device); heart transplant indicated";Right ventricular dysfunction;10058597;LLT;20,1
190;C55057;Grade 5 Right Ventricular Dysfunction, CTCAE;Death;Grade 5 Right ventricular dysfunction;Death;Right ventricular dysfunction;10058597;LLT;20,1
191;C54938;Sick Sinus Syndrome, CTCAE;A disorder characterized by a dysrhythmia with alternating periods of bradycardia and atrial tachycardia accompanied by syncope, fatigue and dizziness.;Sick sinus syndrome;A disorder characterized by a dysrhythmia with alternating periods of bradycardia and atrial tachycardia accompanied by syncope, fatigue and dizziness.;Sick sinus syndrome;10040639;LLT;20,1
192;C54793;Grade 1 Sick Sinus Syndrome, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Sick sinus syndrome;Asymptomatic, intervention not indicated;Sick sinus syndrome;10040639;LLT;20,1
193;C54824;Grade 2 Sick Sinus Syndrome, CTCAE;"Symptomatic, intervention not indicated; change in medication initiated";Grade 2 Sick sinus syndrome;"Symptomatic, intervention not indicated; change in medication initiated";Sick sinus syndrome;10040639;LLT;20,1
194;C54855;Grade 3 Sick Sinus Syndrome, CTCAE;Symptomatic, intervention indicated;Grade 3 Sick sinus syndrome;Symptomatic, intervention indicated;Sick sinus syndrome;10040639;LLT;20,1
195;C54886;Grade 4 Sick Sinus Syndrome, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Sick sinus syndrome;"Life-threatening consequences; urgent intervention indicated";Sick sinus syndrome;10040639;LLT;20,1
196;C54917;Grade 5 Sick Sinus Syndrome, CTCAE;Death;Grade 5 Sick sinus syndrome;Death;Sick sinus syndrome;10040639;LLT;20,1
197;C54940;Sinus Bradycardia, CTCAE;A disorder characterized by a dysrhythmia with a heart rate less than 60 beats per minute that originates in the sinus node.;Sinus bradycardia;A disorder characterized by a dysrhythmia with a heart rate less than 60 beats per minute that originates in the sinus node.;Sinus bradycardia;10040741;LLT;20,1
198;C54795;Grade 1 Sinus Bradycardia, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Sinus bradycardia;Asymptomatic, intervention not indicated;Sinus bradycardia;10040741;LLT;20,1
199;C54826;Grade 2 Sinus Bradycardia, CTCAE;"Symptomatic, intervention not indicated; change in medication initiated";Grade 2 Sinus bradycardia;"Symptomatic, intervention not indicated; change in medication initiated";Sinus bradycardia;10040741;LLT;20,1
200;C54857;Grade 3 Sinus Bradycardia, CTCAE;Symptomatic, intervention indicated;Grade 3 Sinus bradycardia;Symptomatic, intervention indicated;Sinus bradycardia;10040741;LLT;20,1
201;C54888;Grade 4 Sinus Bradycardia, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Sinus bradycardia;"Life-threatening consequences; urgent intervention indicated";Sinus bradycardia;10040741;LLT;20,1
202;C54919;Grade 5 Sinus Bradycardia, CTCAE;Death;Grade 5 Sinus bradycardia;Death;Sinus bradycardia;10040741;LLT;20,1
203;C146759;Sinus Tachycardia, CTCAE 5.0;A disorder characterized by a dysrhythmia with a heart rate greater than 100 beats per minute that originates in the sinus node.;Sinus tachycardia;A disorder characterized by a dysrhythmia with a heart rate greater than 100 beats per minute that originates in the sinus node.;Sinus tachycardia;10040752;LLT;20,1
204;C54796;Grade 1 Sinus Tachycardia, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Sinus tachycardia;Asymptomatic, intervention not indicated;Sinus tachycardia;10040752;LLT;20,1
205;C54827;Grade 2 Sinus Tachycardia, CTCAE;"Symptomatic; non-urgent medical intervention indicated";Grade 2 Sinus tachycardia;"Symptomatic; non-urgent medical intervention indicated";Sinus tachycardia;10040752;LLT;20,1
206;C54858;Grade 3 Sinus Tachycardia, CTCAE;Urgent medical intervention indicated;Grade 3 Sinus tachycardia;Urgent medical intervention indicated;Sinus tachycardia;10040752;LLT;20,1
207;C54945;Supraventricular Tachycardia, CTCAE;A disorder characterized by a dysrhythmia with a heart rate greater than 100 beats per minute that originates above the ventricles.;Supraventricular tachycardia;A disorder characterized by a dysrhythmia with a heart rate greater than 100 beats per minute that originates above the ventricles.;Supraventricular tachycardia;10042604;LLT;20,1
208;C54800;Grade 1 Supraventricular Tachycardia, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Supraventricular tachycardia;Asymptomatic, intervention not indicated;Supraventricular tachycardia;10042604;LLT;20,1
209;C54831;Grade 2 Supraventricular Tachycardia, CTCAE;Non-urgent medical intervention indicated;Grade 2 Supraventricular tachycardia;Non-urgent medical intervention indicated;Supraventricular tachycardia;10042604;LLT;20,1
210;C54862;Grade 3 Supraventricular Tachycardia, CTCAE;Symptomatic, urgent intervention indicated;Grade 3 Supraventricular tachycardia;Symptomatic, urgent intervention indicated;Supraventricular tachycardia;10042604;LLT;20,1
211;C54893;Grade 4 Supraventricular Tachycardia, CTCAE;Life-threatening consequences;Grade 4 Supraventricular tachycardia;Life-threatening consequences;Supraventricular tachycardia;10042604;LLT;20,1
212;C54924;Grade 5 Supraventricular Tachycardia, CTCAE;Death;Grade 5 Supraventricular tachycardia;Death;Supraventricular tachycardia;10042604;LLT;20,1
213;C143889;Tricuspid Valve Disease, CTCAE;A disorder characterized by a defect in tricuspid valve function or structure.;Tricuspid valve disease;A disorder characterized by a defect in tricuspid valve function or structure.;Tricuspid valve disease;10061389;LLT;20,1
214;C144444;Grade 1 Tricuspid Valve Disease, CTCAE;Asymptomatic valvular thickening with or without mild valvular regurgitation or stenosis;Grade 1 Tricuspid valve disease;Asymptomatic valvular thickening with or without mild valvular regurgitation or stenosis;Tricuspid valve disease;10061389;LLT;20,1
215;C145049;Grade 2 Tricuspid Valve Disease, CTCAE;"Asymptomatic; moderate regurgitation or stenosis by imaging";Grade 2 Tricuspid valve disease;"Asymptomatic; moderate regurgitation or stenosis by imaging";Tricuspid valve disease;10061389;LLT;20,1
216;C145671;Grade 3 Tricuspid Valve Disease, CTCAE;"Symptomatic; severe regurgitation or stenosis; symptoms controlled with medical intervention";Grade 3 Tricuspid valve disease;"Symptomatic; severe regurgitation or stenosis; symptoms controlled with medical intervention";Tricuspid valve disease;10061389;LLT;20,1
217;C146157;Grade 4 Tricuspid Valve Disease, CTCAE;"Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)";Grade 4 Tricuspid valve disease;"Life-threatening consequences; urgent intervention indicated (e.g., valve replacement, valvuloplasty)";Tricuspid valve disease;10061389;LLT;20,1
218;C146588;Grade 5 Tricuspid Valve Disease, CTCAE;Death;Grade 5 Tricuspid valve disease;Death;Tricuspid valve disease;10061389;LLT;20,1
219;C146629;Ventricular Arrhythmia, CTCAE 5.0;A disorder characterized by a dysrhythmia that originates in the ventricles.;Ventricular arrhythmia;A disorder characterized by a dysrhythmia that originates in the ventricles.;Ventricular arrhythmia;10047281;LLT;20,1
220;C144481;Grade 1 Ventricular Arrhythmia, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Ventricular arrhythmia;Asymptomatic, intervention not indicated;Ventricular arrhythmia;10047281;LLT;20,1
221;C145093;Grade 2 Ventricular Arrhythmia, CTCAE;Non-urgent medical intervention indicated;Grade 2 Ventricular arrhythmia;Non-urgent medical intervention indicated;Ventricular arrhythmia;10047281;LLT;20,1
222;C145714;Grade 3 Ventricular Arrhythmia, CTCAE;Urgent intervention indicated;Grade 3 Ventricular arrhythmia;Urgent intervention indicated;Ventricular arrhythmia;10047281;LLT;20,1
223;C146191;Grade 4 Ventricular Arrhythmia, CTCAE;"Life-threatening consequences; hemodynamic compromise";Grade 4 Ventricular arrhythmia;"Life-threatening consequences; hemodynamic compromise";Ventricular arrhythmia;10047281;LLT;20,1
224;C146619;Grade 5 Ventricular Arrhythmia, CTCAE;Death;Grade 5 Ventricular arrhythmia;Death;Ventricular arrhythmia;10047281;LLT;20,1
225;C146732;Ventricular Fibrillation, CTCAE 5.0;A disorder characterized by a dysrhythmia without discernible QRS complexes due to rapid repetitive excitation of myocardial fibers without coordinated contraction of the ventricles.;Ventricular fibrillation;A disorder characterized by a dysrhythmia without discernible QRS complexes due to rapid repetitive excitation of myocardial fibers without coordinated contraction of the ventricles.;Ventricular fibrillation;10047290;LLT;20,1
226;C54898;Grade 4 Ventricular Fibrillation, CTCAE;"Life-threatening consequences; hemodynamic compromise";Grade 4 Ventricular fibrillation;"Life-threatening consequences; hemodynamic compromise";Ventricular fibrillation;10047290;LLT;20,1
227;C54929;Grade 5 Ventricular Fibrillation, CTCAE;Death;Grade 5 Ventricular fibrillation;Death;Ventricular fibrillation;10047290;LLT;20,1
228;C146733;Ventricular Tachycardia, CTCAE 5.0;A disorder characterized by a dysrhythmia with a heart rate greater than 100 beats per minute that originates distal to the bundle of His.;Ventricular tachycardia;A disorder characterized by a dysrhythmia with a heart rate greater than 100 beats per minute that originates distal to the bundle of His.;Ventricular tachycardia;10047302;LLT;20,1
229;C54838;Grade 2 Ventricular Tachycardia, CTCAE;Non-urgent medical intervention indicated;Grade 2 Ventricular tachycardia;Non-urgent medical intervention indicated;Ventricular tachycardia;10047302;LLT;20,1
230;C54869;Grade 3 Ventricular Tachycardia, CTCAE;Symptomatic, urgent intervention indicated;Grade 3 Ventricular tachycardia;Symptomatic, urgent intervention indicated;Ventricular tachycardia;10047302;LLT;20,1
231;C54900;Grade 4 Ventricular Tachycardia, CTCAE;"Life-threatening consequences; hemodynamic compromise";Grade 4 Ventricular tachycardia;"Life-threatening consequences; hemodynamic compromise";Ventricular tachycardia;10047302;LLT;20,1
232;C54931;Grade 5 Ventricular Tachycardia, CTCAE;Death;Grade 5 Ventricular tachycardia;Death;Ventricular tachycardia;10047302;LLT;20,1
233;C143184;Congenital, Familial and Genetic Disorders, CTCAE;;;;;;;
234;C143382;Congenital, Familial and Genetic Disorders - Other, Specify, CTCAE;;Congenital, familial and genetic disorders - Other, specify;;Congenital, familial and genetic disorders - Other, specify;10010331;LLT;20,1
235;C144040;Grade 1 Congenital, Familial and Genetic Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Congenital, familial and genetic disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Congenital, familial and genetic disorders - Other, specify;10010331;LLT;20,1
236;C144589;Grade 2 Congenital, Familial and Genetic Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Congenital, familial and genetic disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Congenital, familial and genetic disorders - Other, specify;10010331;LLT;20,1
237;C145206;Grade 3 Congenital, Familial and Genetic Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Congenital, familial and genetic disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Congenital, familial and genetic disorders - Other, specify;10010331;LLT;20,1
238;C145802;Grade 4 Congenital, Familial and Genetic Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Congenital, familial and genetic disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Congenital, familial and genetic disorders - Other, specify;10010331;LLT;20,1
239;C146267;Grade 5 Congenital, Familial and Genetic Disorders - Other, Specify, CTCAE;Death;Grade 5 Congenital, familial and genetic disorders - Other, specify;Death;Congenital, familial and genetic disorders - Other, specify;10010331;LLT;20,1
240;C143185;Ear and Labyrinth Disorders, CTCAE;;;;;;;
241;C143429;Ear and Labyrinth Disorders - Other, Specify, CTCAE;;Ear and labyrinth disorders - Other, specify;;Ear and labyrinth disorders - Other, specify;10013993;LLT;20,1
242;C144068;Grade 1 Ear and Labyrinth Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Ear and labyrinth disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Ear and labyrinth disorders - Other, specify;10013993;LLT;20,1
243;C144623;Grade 2 Ear and Labyrinth Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Ear and labyrinth disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Ear and labyrinth disorders - Other, specify;10013993;LLT;20,1
244;C145239;Grade 3 Ear and Labyrinth Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Ear and labyrinth disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Ear and labyrinth disorders - Other, specify;10013993;LLT;20,1
245;C145826;Grade 4 Ear and Labyrinth Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Ear and labyrinth disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Ear and labyrinth disorders - Other, specify;10013993;LLT;20,1
246;C146287;Grade 5 Ear and Labyrinth Disorders - Other, Specify, CTCAE;Death;Grade 5 Ear and labyrinth disorders - Other, specify;Death;Ear and labyrinth disorders - Other, specify;10013993;LLT;20,1
247;C143430;Ear Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the ear.;Ear pain;A disorder characterized by a sensation of marked discomfort in the ear.;Ear pain;10014020;LLT;20,1
248;C144069;Grade 1 Ear Pain, CTCAE;Mild pain;Grade 1 Ear pain;Mild pain;Ear pain;10014020;LLT;20,1
249;C144624;Grade 2 Ear Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Ear pain;"Moderate pain; limiting instrumental ADL";Ear pain;10014020;LLT;20,1
250;C145240;Grade 3 Ear Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Ear pain;"Severe pain; limiting self care ADL";Ear pain;10014020;LLT;20,1
251;C146745;External Ear Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the external ear region.;External ear pain;A disorder characterized by a sensation of marked discomfort in the external ear region.;External ear pain;10065785;LLT;20,1
252;C56061;Grade 1 External Ear Pain, CTCAE;Mild pain;Grade 1 External ear pain;Mild pain;External ear pain;10065785;LLT;20,1
253;C56062;Grade 2 External Ear Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 External ear pain;"Moderate pain; limiting instrumental ADL";External ear pain;10065785;LLT;20,1
254;C56063;Grade 3 External Ear Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 External ear pain;"Severe pain; limiting self care ADL";External ear pain;10065785;LLT;20,1
255;C143528;Hearing Impaired, CTCAE;A disorder characterized by partial or complete loss of the ability to detect or understand sounds resulting from damage to ear structures.;Hearing impaired;A disorder characterized by partial or complete loss of the ability to detect or understand sounds resulting from damage to ear structures.;Hearing impaired;10019245;LLT;20,1
256;C144144;Grade 1 Hearing Impaired, CTCAE;"Adults enrolled on a Monitoring Program (on a 1, 2, 4, 3, 6, and 8 kHz audiogram): Threshold shift of 15-25 dB averaged at 2 contiguous test frequencies in at least one ear; Adults not enrolled on a Monitoring Program: Subjective change in hearing in the absence of documented hearing loss; Pediatric (on a 1, 2, 3, 4, 6, and 8 kHz audiogram): Threshold shift >20 dB hearing loss (HL) (i.e., 25 dB HL or greater); sensorineural hearing loss (SNHL) above 4 kHz (i.e., 6 or 8 kHz) in at least one ear";Grade 1 Hearing impaired;"Adults enrolled on a Monitoring Program (on a 1, 2, 4, 3, 6, and 8 kHz audiogram): Threshold shift of 15-25 dB averaged at 2 contiguous test frequencies in at least one ear; Adults not enrolled on a Monitoring Program: Subjective change in hearing in the absence of documented hearing loss; Pediatric (on a 1, 2, 3, 4, 6, and 8 kHz audiogram): Threshold shift >20 dB hearing loss (HL) (i.e., 25 dB HL or greater); sensorineural hearing loss (SNHL) above 4 kHz (i.e., 6 or 8 kHz) in at least one ear";Hearing impaired;10019245;LLT;20,1
257;C144705;Grade 2 Hearing Impaired, CTCAE;"Adults enrolled on a Monitoring Program (on a 1, 2, 3, 4, 6, and 8 kHz audiogram): Threshold shift of >25 dB averaged at 2 contiguous test frequencies in at least one ear; Adults not enrolled on a Monitoring Program: Hearing loss with hearing aid or intervention not indicated; limiting instrumental ADL; Pediatric (on a 1, 2, 3, 4, 6, and 8 kHz audiogram): Threshold shift >20 dB at 4 kHz in at least one ear";Grade 2 Hearing impaired;"Adults enrolled on a Monitoring Program (on a 1, 2, 3, 4, 6, and 8 kHz audiogram): Threshold shift of >25 dB averaged at 2 contiguous test frequencies in at least one ear; Adults not enrolled on a Monitoring Program: Hearing loss with hearing aid or intervention not indicated; limiting instrumental ADL; Pediatric (on a 1, 2, 3, 4, 6, and 8 kHz audiogram): Threshold shift >20 dB at 4 kHz in at least one ear";Hearing impaired;10019245;LLT;20,1
258;C145325;Grade 3 Hearing Impaired, CTCAE;"Adults enrolled on a Monitoring Program (on a 1, 2, 3, 4, 6, and 8 kHz audiogram): Threshold shift of >25 dB averaged at 3 contiguous test frequencies in at least one ear; therapeutic intervention indicated; Adults not enrolled on a Monitoring Program: Hearing loss with hearing aid or intervention indicated; limiting self care ADL; Pediatric (on a 1, 2, 3, 4, 6, and 8 kHz audiogram): Hearing loss sufficient to indicate therapeutic intervention, including hearing aids; threshold shift >20 dB at 2 to < 4 kHz in at least one ear";Grade 3 Hearing impaired;"Adults enrolled on a Monitoring Program (on a 1, 2, 3, 4, 6, and 8 kHz audiogram): Threshold shift of >25 dB averaged at 3 contiguous test frequencies in at least one ear; therapeutic intervention indicated; Adults not enrolled on a Monitoring Program: Hearing loss with hearing aid or intervention indicated; limiting self care ADL; Pediatric (on a 1, 2, 3, 4, 6, and 8 kHz audiogram): Hearing loss sufficient to indicate therapeutic intervention, including hearing aids; threshold shift >20 dB at 2 to < 4 kHz in at least one ear";Hearing impaired;10019245;LLT;20,1
259;C145883;Grade 4 Hearing Impaired, CTCAE;"Adults: Decrease in hearing to profound bilateral loss (absolute threshold >80 dB HL at 2 kHz and above); nonservicable hearingPediatric: Audiologic indication for cochlear implant; > 40 dB HL (i.e., 45 dB HL or more); SNHL at 2 kHz and above";Grade 4 Hearing impaired;"Adults: Decrease in hearing to profound bilateral loss (absolute threshold >80 dB HL at 2 kHz and above); nonservicable hearingPediatric: Audiologic indication for cochlear implant; > 40 dB HL (i.e., 45 dB HL or more); SNHL at 2 kHz and above";Hearing impaired;10019245;LLT;20,1
260;C143673;Middle Ear Inflammation, CTCAE;A disorder characterized by inflammation (physiologic response to irritation), swelling and redness to the middle ear.;Middle ear inflammation;A disorder characterized by inflammation (physiologic response to irritation), swelling and redness to the middle ear.;Middle ear inflammation;10065838;LLT;20,1
261;C144262;Grade 1 Middle Ear Inflammation, CTCAE;Serous otitis;Grade 1 Middle ear inflammation;Serous otitis;Middle ear inflammation;10065838;LLT;20,1
262;C144839;Grade 2 Middle Ear Inflammation, CTCAE;Serous otitis, medical intervention indicated;Grade 2 Middle ear inflammation;Serous otitis, medical intervention indicated;Middle ear inflammation;10065838;LLT;20,1
263;C145461;Grade 3 Middle Ear Inflammation, CTCAE;"Mastoiditis; necrosis of canal soft tissue or bone";Grade 3 Middle ear inflammation;"Mastoiditis; necrosis of canal soft tissue or bone";Middle ear inflammation;10065838;LLT;20,1
264;C145997;Grade 4 Middle Ear Inflammation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Middle ear inflammation;"Life-threatening consequences; urgent intervention indicated";Middle ear inflammation;10065838;LLT;20,1
265;C146442;Grade 5 Middle Ear Inflammation, CTCAE;Death;Grade 5 Middle ear inflammation;Death;Middle ear inflammation;10065838;LLT;20,1
266;C146690;Tinnitus, CTCAE 5.0;A disorder characterized by noise in the ears, such as ringing, buzzing, roaring or clicking.;Tinnitus;A disorder characterized by noise in the ears, such as ringing, buzzing, roaring or clicking.;Tinnitus;10043882;LLT;20,1
267;C144433;Grade 1 Tinnitus, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Tinnitus;"Mild symptoms; intervention not indicated";Tinnitus;10043882;LLT;20,1
268;C54969;Grade 2 Tinnitus, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Tinnitus;"Moderate symptoms; limiting instrumental ADL";Tinnitus;10043882;LLT;20,1
269;C54975;Grade 3 Tinnitus, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Tinnitus;"Severe symptoms; limiting self care ADL";Tinnitus;10043882;LLT;20,1
270;C143935;Vertigo, CTCAE;A disorder characterized by a sensation as if the external world were revolving around the patient (objective vertigo) or as if he himself were revolving in space (subjective vertigo).;Vertigo;A disorder characterized by a sensation as if the external world were revolving around the patient (objective vertigo) or as if he himself were revolving in space (subjective vertigo).;Vertigo;10047340;LLT;20,1
271;C144482;Grade 1 Vertigo, CTCAE;Mild symptoms;Grade 1 Vertigo;Mild symptoms;Vertigo;10047340;LLT;20,1
272;C145094;Grade 2 Vertigo, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Vertigo;"Moderate symptoms; limiting instrumental ADL";Vertigo;10047340;LLT;20,1
273;C145715;Grade 3 Vertigo, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Vertigo;"Severe symptoms; limiting self care ADL";Vertigo;10047340;LLT;20,1
274;C143936;Vestibular Disorder, CTCAE;A disorder characterized by dizziness, imbalance, nausea, and vision problems.;Vestibular disorder;A disorder characterized by dizziness, imbalance, nausea, and vision problems.;Vestibular disorder;10047386;LLT;20,1
275;C145095;Grade 2 Vestibular Disorder, CTCAE;"Symptomatic; limiting instrumental ADL";Grade 2 Vestibular disorder;"Symptomatic; limiting instrumental ADL";Vestibular disorder;10047386;LLT;20,1
276;C145716;Grade 3 Vestibular Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Vestibular disorder;"Severe symptoms; limiting self care ADL";Vestibular disorder;10047386;LLT;20,1
277;C143166;Endocrine Disorders, CTCAE;;;;;;;
278;C55748;Adrenal Insufficiency, CTCAE;A disorder characterized by the adrenal cortex not producing enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal cortex as in Addison's disease or primary adrenal insufficiency.;Adrenal insufficiency;A disorder characterized by the adrenal cortex not producing enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal cortex as in Addison's disease or primary adrenal insufficiency.;Adrenal insufficiency;10001367;LLT;20,1
279;C55749;Grade 1 Adrenal Insufficiency, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Adrenal insufficiency;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Adrenal insufficiency;10001367;LLT;20,1
280;C55761;Grade 2 Adrenal Insufficiency, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Adrenal insufficiency;"Moderate symptoms; medical intervention indicated";Adrenal insufficiency;10001367;LLT;20,1
281;C55774;Grade 3 Adrenal Insufficiency, CTCAE;"Severe symptoms; hospitalization indicated";Grade 3 Adrenal insufficiency;"Severe symptoms; hospitalization indicated";Adrenal insufficiency;10001367;LLT;20,1
282;C55786;Grade 4 Adrenal Insufficiency, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Adrenal insufficiency;"Life-threatening consequences; urgent intervention indicated";Adrenal insufficiency;10001367;LLT;20,1
283;C55793;Grade 5 Adrenal Insufficiency, CTCAE;Death;Grade 5 Adrenal insufficiency;Death;Adrenal insufficiency;10001367;LLT;20,1
284;C143392;Cushingoid, CTCAE;A disorder characterized by signs and symptoms that resemble Cushing's disease or syndrome: buffalo hump obesity, striations, adiposity, hypertension, diabetes, and osteoporosis, usually due to exogenous corticosteroids.;Cushingoid;A disorder characterized by signs and symptoms that resemble Cushing's disease or syndrome: buffalo hump obesity, striations, adiposity, hypertension, diabetes, and osteoporosis, usually due to exogenous corticosteroids.;Cushingoid;10011655;LLT;20,1
285;C144044;Grade 1 Cushingoid, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Cushingoid;"Mild symptoms; intervention not indicated";Cushingoid;10011655;LLT;20,1
286;C144595;Grade 2 Cushingoid, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Cushingoid;"Moderate symptoms; medical intervention indicated";Cushingoid;10011655;LLT;20,1
287;C145214;Grade 3 Cushingoid, CTCAE;Severe symptoms, medical intervention or hospitalization indicated;Grade 3 Cushingoid;Severe symptoms, medical intervention or hospitalization indicated;Cushingoid;10011655;LLT;20,1
288;C55742;Delayed Puberty, CTCAE;A disorder characterized by unusually late sexual maturity.;Delayed puberty;A disorder characterized by unusually late sexual maturity.;Delayed puberty;10012205;LLT;20,1
289;C55724;Grade 2 Delayed Puberty, CTCAE;"No breast development by age 13 yrs for females; testes volume of <3 cc or no Tanner Stage 2 development by age 14.5 yrs for males";Grade 2 Delayed puberty;"No breast development by age 13 yrs for females; testes volume of <3 cc or no Tanner Stage 2 development by age 14.5 yrs for males";Delayed puberty;10012205;LLT;20,1
290;C55732;Grade 3 Delayed Puberty, CTCAE;"No breast development by age 14 yrs for females; no increase in testes volume or no Tanner Stage 2 by age 16 yrs for males; hormone replacement indicated";Grade 3 Delayed puberty;"No breast development by age 14 yrs for females; no increase in testes volume or no Tanner Stage 2 by age 16 yrs for males; hormone replacement indicated";Delayed puberty;10012205;LLT;20,1
291;C143442;Endocrine Disorders - Other, Specify, CTCAE;;Endocrine disorders - Other, specify;;Endocrine disorders - Other, specify;10014698;LLT;20,1
292;C144078;Grade 1 Endocrine Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Endocrine disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Endocrine disorders - Other, specify;10014698;LLT;20,1
293;C144633;Grade 2 Endocrine Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Endocrine disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Endocrine disorders - Other, specify;10014698;LLT;20,1
294;C145251;Grade 3 Endocrine Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Endocrine disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Endocrine disorders - Other, specify;10014698;LLT;20,1
295;C145833;Grade 4 Endocrine Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Endocrine disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Endocrine disorders - Other, specify;10014698;LLT;20,1
296;C146292;Grade 5 Endocrine Disorders - Other, Specify, CTCAE;Death;Grade 5 Endocrine disorders - Other, specify;Death;Endocrine disorders - Other, specify;10014698;LLT;20,1
297;C143520;Growth Accelerated, CTCAE;A disorder characterized by greater growth than expected for age.;Growth accelerated;A disorder characterized by greater growth than expected for age.;Growth accelerated;10018746;LLT;20,1
298;C144698;Grade 2 Growth Accelerated, CTCAE;>= +2 SD (standard deviation) above mid parental height or target height;Grade 2 Growth accelerated;>= +2 SD (standard deviation) above mid parental height or target height;Growth accelerated;10018746;LLT;20,1
299;C143557;Hyperparathyroidism, CTCAE;A disorder characterized by an increase in production of parathyroid hormone by the parathyroid glands. This results in hypercalcemia (abnormally high levels of calcium in the blood).;Hyperparathyroidism;A disorder characterized by an increase in production of parathyroid hormone by the parathyroid glands. This results in hypercalcemia (abnormally high levels of calcium in the blood).;Hyperparathyroidism;10020705;LLT;20,1
300;C144168;Grade 1 Hyperparathyroidism, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Hyperparathyroidism;"Mild symptoms; intervention not indicated";Hyperparathyroidism;10020705;LLT;20,1
301;C144729;Grade 2 Hyperparathyroidism, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Hyperparathyroidism;"Moderate symptoms; medical intervention indicated";Hyperparathyroidism;10020705;LLT;20,1
302;C143560;Hyperthyroidism, CTCAE;A disorder characterized by excessive levels of thyroid hormone in the body. Common causes include an overactive thyroid gland or thyroid hormone overdose.;Hyperthyroidism;A disorder characterized by excessive levels of thyroid hormone in the body. Common causes include an overactive thyroid gland or thyroid hormone overdose.;Hyperthyroidism;10020850;LLT;20,1
303;C144171;Grade 1 Hyperthyroidism, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hyperthyroidism;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Hyperthyroidism;10020850;LLT;20,1
304;C144732;Grade 2 Hyperthyroidism, CTCAE;"Symptomatic; thyroid suppression therapy indicated; limiting instrumental ADL";Grade 2 Hyperthyroidism;"Symptomatic; thyroid suppression therapy indicated; limiting instrumental ADL";Hyperthyroidism;10020850;LLT;20,1
305;C145354;Grade 3 Hyperthyroidism, CTCAE;"Severe symptoms; limiting self care ADL; hospitalization indicated";Grade 3 Hyperthyroidism;"Severe symptoms; limiting self care ADL; hospitalization indicated";Hyperthyroidism;10020850;LLT;20,1
306;C145904;Grade 4 Hyperthyroidism, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hyperthyroidism;"Life-threatening consequences; urgent intervention indicated";Hyperthyroidism;10020850;LLT;20,1
307;C146351;Grade 5 Hyperthyroidism, CTCAE;Death;Grade 5 Hyperthyroidism;Death;Hyperthyroidism;10020850;LLT;20,1
308;C143572;Hypoparathyroidism, CTCAE;A disorder characterized by a decrease in production of parathyroid hormone by the parathyroid glands.;Hypoparathyroidism;A disorder characterized by a decrease in production of parathyroid hormone by the parathyroid glands.;Hypoparathyroidism;10021041;LLT;20,1
309;C144182;Grade 1 Hypoparathyroidism, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hypoparathyroidism;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Hypoparathyroidism;10021041;LLT;20,1
310;C144743;Grade 2 Hypoparathyroidism, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Hypoparathyroidism;"Moderate symptoms; medical intervention indicated";Hypoparathyroidism;10021041;LLT;20,1
311;C145365;Grade 3 Hypoparathyroidism, CTCAE;"Severe symptoms; medical intervention or hospitalization indicated";Grade 3 Hypoparathyroidism;"Severe symptoms; medical intervention or hospitalization indicated";Hypoparathyroidism;10021041;LLT;20,1
312;C145914;Grade 4 Hypoparathyroidism, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hypoparathyroidism;"Life-threatening consequences; urgent intervention indicated";Hypoparathyroidism;10021041;LLT;20,1
313;C146361;Grade 5 Hypoparathyroidism, CTCAE;Death;Grade 5 Hypoparathyroidism;Death;Hypoparathyroidism;10021041;LLT;20,1
314;C143193;Hypophysitis, CTCAE;A disorder characterized by inflammation and cellular infiltration of the pituitary gland.;Hypophysitis;A disorder characterized by inflammation and cellular infiltration of the pituitary gland.;Hypophysitis;10062767;LLT;20,1
315;C144184;Grade 1 Hypophysitis, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hypophysitis;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Hypophysitis;10062767;LLT;20,1
316;C144745;Grade 2 Hypophysitis, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Hypophysitis;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Hypophysitis;10062767;LLT;20,1
317;C145367;Grade 3 Hypophysitis, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Hypophysitis;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Hypophysitis;10062767;LLT;20,1
318;C145916;Grade 4 Hypophysitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hypophysitis;"Life-threatening consequences; urgent intervention indicated";Hypophysitis;10062767;LLT;20,1
319;C146363;Grade 5 Hypophysitis, CTCAE;Death;Grade 5 Hypophysitis;Death;Hypophysitis;10062767;LLT;20,1
320;C143194;Hypopituitarism, CTCAE;A disorder characterized by a decrease in production of hormones from the pituitary gland.;Hypopituitarism;A disorder characterized by a decrease in production of hormones from the pituitary gland.;Hypopituitarism;10021067;LLT;20,1
321;C144185;Grade 1 Hypopituitarism, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hypopituitarism;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Hypopituitarism;10021067;LLT;20,1
322;C144746;Grade 2 Hypopituitarism, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Hypopituitarism;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Hypopituitarism;10021067;LLT;20,1
323;C145368;Grade 3 Hypopituitarism, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Hypopituitarism;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Hypopituitarism;10021067;LLT;20,1
324;C145917;Grade 4 Hypopituitarism, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hypopituitarism;"Life-threatening consequences; urgent intervention indicated";Hypopituitarism;10021067;LLT;20,1
325;C146364;Grade 5 Hypopituitarism, CTCAE;Death;Grade 5 Hypopituitarism;Death;Hypopituitarism;10021067;LLT;20,1
326;C143576;Hypothyroidism, CTCAE;A disorder characterized by a decrease in production of thyroid hormone by the thyroid gland.;Hypothyroidism;A disorder characterized by a decrease in production of thyroid hormone by the thyroid gland.;Hypothyroidism;10021114;LLT;20,1
327;C144186;Grade 1 Hypothyroidism, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hypothyroidism;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Hypothyroidism;10021114;LLT;20,1
328;C144747;Grade 2 Hypothyroidism, CTCAE;"Symptomatic; thyroid replacement indicated; limiting instrumental ADL";Grade 2 Hypothyroidism;"Symptomatic; thyroid replacement indicated; limiting instrumental ADL";Hypothyroidism;10021114;LLT;20,1
329;C145369;Grade 3 Hypothyroidism, CTCAE;"Severe symptoms; limiting self care ADL; hospitalization indicated";Grade 3 Hypothyroidism;"Severe symptoms; limiting self care ADL; hospitalization indicated";Hypothyroidism;10021114;LLT;20,1
330;C145918;Grade 4 Hypothyroidism, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hypothyroidism;"Life-threatening consequences; urgent intervention indicated";Hypothyroidism;10021114;LLT;20,1
331;C146365;Grade 5 Hypothyroidism, CTCAE;Death;Grade 5 Hypothyroidism;Death;Hypothyroidism;10021114;LLT;20,1
332;C146645;Precocious Puberty, CTCAE 5.0;"A disorder characterized by unusually early development of secondary sexual features; the onset of sexual maturation begins usually before age 8 for girls and before age 9 for boys.";Precocious puberty;"A disorder characterized by unusually early development of secondary sexual features; the onset of sexual maturation begins usually before age 8 for girls and before age 9 for boys.";Precocious puberty;10058084;LLT;20,1
333;C144345;Grade 1 Precocious Puberty, CTCAE;Physical signs of puberty with no biochemical markers for females <8 years and males <9 years;Grade 1 Precocious puberty;Physical signs of puberty with no biochemical markers for females <8 years and males <9 years;Precocious puberty;10058084;LLT;20,1
334;C55725;Grade 2 Precocious Puberty, CTCAE;Physical signs and biochemical markers of puberty for females <8 years and males <9 years;Grade 2 Precocious puberty;Physical signs and biochemical markers of puberty for females <8 years and males <9 years;Precocious puberty;10058084;LLT;20,1
335;C143195;Testosterone Deficiency, CTCAE;A disorder characterized by low testosterone.;Testosterone deficiency;A disorder characterized by low testosterone.;Testosterone deficiency;10067734;LLT;20,1
336;C144429;Grade 1 Testosterone Deficiency, CTCAE;"Asymptomatic; mild symptoms with no intervention indicated";Grade 1 Testosterone deficiency;"Asymptomatic; mild symptoms with no intervention indicated";Testosterone deficiency;10067734;LLT;20,1
337;C145035;Grade 2 Testosterone Deficiency, CTCAE;Replacement therapy initiated;Grade 2 Testosterone deficiency;Replacement therapy initiated;Testosterone deficiency;10067734;LLT;20,1
338;C143937;Virilization, CTCAE;A disorder characterized by inappropriate masculinization occurring in a female or prepubertal male.;Virilization;A disorder characterized by inappropriate masculinization occurring in a female or prepubertal male.;Virilization;10047488;LLT;20,1
339;C144483;Grade 1 Virilization, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Virilization;"Mild symptoms; intervention not indicated";Virilization;10047488;LLT;20,1
340;C145097;Grade 2 Virilization, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Virilization;"Moderate symptoms; medical intervention indicated";Virilization;10047488;LLT;20,1
341;C143167;Eye Disorders, CTCAE;;;;;;;
342;C55906;Blurred Vision, CTCAE;A disorder characterized by visual perception of unclear or fuzzy images.;Blurred vision;A disorder characterized by visual perception of unclear or fuzzy images.;Blurred vision;10005886;LLT;20,1
343;C55907;Grade 1 Blurred Vision, CTCAE;Intervention not indicated;Grade 1 Blurred vision;Intervention not indicated;Blurred vision;10005886;LLT;20,1
344;C55908;Grade 2 Blurred Vision, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL";Grade 2 Blurred vision;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL";Blurred vision;10005886;LLT;20,1
345;C55909;Grade 3 Blurred Vision, CTCAE;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Grade 3 Blurred vision;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Blurred vision;10005886;LLT;20,1
346;C55910;Grade 4 Blurred Vision, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Blurred vision;Best corrected visual acuity of 20/200 or worse in the affected eye;Blurred vision;10005886;LLT;20,1
347;C146674;Cataract, CTCAE 5.0;A disorder characterized by partial or complete opacity of the crystalline lens of one or both eyes. This results in a decrease in visual acuity and eventual blindness if untreated.;Cataract;A disorder characterized by partial or complete opacity of the crystalline lens of one or both eyes. This results in a decrease in visual acuity and eventual blindness if untreated.;Cataract;10007739;LLT;20,1
348;C55831;Grade 1 Cataract, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Cataract;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Cataract;10007739;LLT;20,1
349;C55832;Grade 2 Cataract, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); glare symptoms affecting instrumental ADL";Grade 2 Cataract;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); glare symptoms affecting instrumental ADL";Cataract;10007739;LLT;20,1
350;C55833;Grade 3 Cataract, CTCAE;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Grade 3 Cataract;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Cataract;10007739;LLT;20,1
351;C145783;Grade 4 Cataract, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Cataract;Best corrected visual acuity of 20/200 or worse in the affected eye;Cataract;10007739;LLT;20,1
352;C143387;Corneal Ulcer, CTCAE;A disorder characterized by an area of epithelial tissue loss on the surface of the cornea. It is associated with inflammatory cells in the cornea and anterior chamber.;Corneal ulcer;A disorder characterized by an area of epithelial tissue loss on the surface of the cornea. It is associated with inflammatory cells in the cornea and anterior chamber.;Corneal ulcer;10048492;LLT;20,1
353;C145210;Grade 3 Corneal Ulcer, CTCAE;Corneal ulcer without perforation in the affected eye;Grade 3 Corneal ulcer;Corneal ulcer without perforation in the affected eye;Corneal ulcer;10048492;LLT;20,1
354;C145806;Grade 4 Corneal Ulcer, CTCAE;Perforation in the affected eye;Grade 4 Corneal ulcer;Perforation in the affected eye;Corneal ulcer;10048492;LLT;20,1
355;C143410;Dry Eye, CTCAE;A disorder characterized by dryness of the cornea and conjunctiva.;Dry eye;A disorder characterized by dryness of the cornea and conjunctiva.;Dry eye;10013774;LLT;20,1
356;C144053;Grade 1 Dry Eye, CTCAE;"Asymptomatic; clinical or diagnostic observations only; symptoms relieved by lubricants";Grade 1 Dry eye;"Asymptomatic; clinical or diagnostic observations only; symptoms relieved by lubricants";Dry eye;10013774;LLT;20,1
357;C144607;Grade 2 Dry Eye, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline)";Grade 2 Dry eye;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline)";Dry eye;10013774;LLT;20,1
358;C145224;Grade 3 Dry Eye, CTCAE;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Grade 3 Dry eye;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Dry eye;10013774;LLT;20,1
359;C143466;Extraocular Muscle Paresis, CTCAE;A disorder characterized by incomplete paralysis of an extraocular muscle.;Extraocular muscle paresis;A disorder characterized by incomplete paralysis of an extraocular muscle.;Extraocular muscle paresis;10015829;LLT;20,1
360;C144092;Grade 1 Extraocular Muscle Paresis, CTCAE;"Asymptomatic; clinical or diagnostic observations only";Grade 1 Extraocular muscle paresis;"Asymptomatic; clinical or diagnostic observations only";Extraocular muscle paresis;10015829;LLT;20,1
361;C144651;Grade 2 Extraocular Muscle Paresis, CTCAE;Unilateral paresis without double vision;Grade 2 Extraocular muscle paresis;Unilateral paresis without double vision;Extraocular muscle paresis;10015829;LLT;20,1
362;C145271;Grade 3 Extraocular Muscle Paresis, CTCAE;Bilateral paresis or unilateral paresis causing double vision in peripheral gaze, but not in central gaze;Grade 3 Extraocular muscle paresis;Bilateral paresis or unilateral paresis causing double vision in peripheral gaze, but not in central gaze;Extraocular muscle paresis;10015829;LLT;20,1
363;C145851;Grade 4 Extraocular Muscle Paresis, CTCAE;Bilateral paresis requiring head turning to see beyond central 60 degrees or double vision in central gaze;Grade 4 Extraocular muscle paresis;Bilateral paresis requiring head turning to see beyond central 60 degrees or double vision in central gaze;Extraocular muscle paresis;10015829;LLT;20,1
364;C143468;Eye Disorders - Other, Specify, CTCAE;;Eye disorders - Other, specify;;Eye disorders - Other, specify;10015919;LLT;20,1
365;C144094;Grade 1 Eye Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated; no change in vision";Grade 1 Eye disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated; no change in vision";Eye disorders - Other, specify;10015919;LLT;20,1
366;C144653;Grade 2 Eye Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting instrumental ADL; best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline";Grade 2 Eye disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting instrumental ADL; best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline";Eye disorders - Other, specify;10015919;LLT;20,1
367;C145273;Grade 3 Eye Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately sight-threatening; limiting self care ADL; decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200)";Grade 3 Eye disorders - Other, specify;"Severe or medically significant but not immediately sight-threatening; limiting self care ADL; decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200)";Eye disorders - Other, specify;10015919;LLT;20,1
368;C145853;Grade 4 Eye Disorders - Other, Specify, CTCAE;"Sight-threatening consequences; urgent intervention indicated; best corrected visual acuity of 20/200 or worse in the affected eye";Grade 4 Eye disorders - Other, specify;"Sight-threatening consequences; urgent intervention indicated; best corrected visual acuity of 20/200 or worse in the affected eye";Eye disorders - Other, specify;10015919;LLT;20,1
369;C146751;Eye Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the eye.;Eye pain;A disorder characterized by a sensation of marked discomfort in the eye.;Eye pain;10015958;LLT;20,1
370;C56071;Grade 1 Eye Pain, CTCAE;Mild pain;Grade 1 Eye pain;Mild pain;Eye pain;10015958;LLT;20,1
371;C56072;Grade 2 Eye Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Eye pain;"Moderate pain; limiting instrumental ADL";Eye pain;10015958;LLT;20,1
372;C56073;Grade 3 Eye Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Eye pain;"Severe pain; limiting self care ADL";Eye pain;10015958;LLT;20,1
373;C143471;Eyelid Function Disorder, CTCAE;A disorder characterized by impaired eyelid function.;Eyelid function disorder;A disorder characterized by impaired eyelid function.;Eyelid function disorder;10061145;LLT;20,1
374;C144095;Grade 1 Eyelid Function Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Eyelid function disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Eyelid function disorder;10061145;LLT;20,1
375;C144655;Grade 2 Eyelid Function Disorder, CTCAE;"Symptomatic; nonoperative intervention indicated; limiting instrumental ADL";Grade 2 Eyelid function disorder;"Symptomatic; nonoperative intervention indicated; limiting instrumental ADL";Eyelid function disorder;10061145;LLT;20,1
376;C145275;Grade 3 Eyelid Function Disorder, CTCAE;"Limiting self care ADL; operative intervention indicated";Grade 3 Eyelid function disorder;"Limiting self care ADL; operative intervention indicated";Eyelid function disorder;10061145;LLT;20,1
377;C143489;Flashing Lights, CTCAE;A disorder characterized by a sudden or brief burst of light.;Flashing lights;A disorder characterized by a sudden or brief burst of light.;Flashing lights;10016757;LLT;20,1
378;C144108;Grade 1 Flashing Lights, CTCAE;Symptomatic but not limiting ADL;Grade 1 Flashing lights;Symptomatic but not limiting ADL;Flashing lights;10016757;LLT;20,1
379;C144669;Grade 2 Flashing Lights, CTCAE;Limiting instrumental ADL;Grade 2 Flashing lights;Limiting instrumental ADL;Flashing lights;10016757;LLT;20,1
380;C145289;Grade 3 Flashing Lights, CTCAE;Limiting self care ADL;Grade 3 Flashing lights;Limiting self care ADL;Flashing lights;10016757;LLT;20,1
381;C143491;Floaters, CTCAE;A disorder characterized by an individual seeing spots before their eyes. The spots are shadows of opaque cell fragments in the vitreous humor or lens.;Floaters;A disorder characterized by an individual seeing spots before their eyes. The spots are shadows of opaque cell fragments in the vitreous humor or lens.;Floaters;10016778;LLT;20,1
382;C144109;Grade 1 Floaters, CTCAE;Symptomatic but not limiting ADL;Grade 1 Floaters;Symptomatic but not limiting ADL;Floaters;10016778;LLT;20,1
383;C144670;Grade 2 Floaters, CTCAE;Limiting instrumental ADL;Grade 2 Floaters;Limiting instrumental ADL;Floaters;10016778;LLT;20,1
384;C145290;Grade 3 Floaters, CTCAE;Limiting self care ADL;Grade 3 Floaters;Limiting self care ADL;Floaters;10016778;LLT;20,1
385;C55842;Glaucoma, CTCAE;A disorder characterized by an increase in pressure in the eyeball due to obstruction of the aqueous humor outflow.;Glaucoma;A disorder characterized by an increase in pressure in the eyeball due to obstruction of the aqueous humor outflow.;Glaucoma;10018304;LLT;20,1
386;C55843;Grade 1 Glaucoma, CTCAE;"Less than 8 mmHg of elevated intraocular pressure (EIOP); no visual field deficit";Grade 1 Glaucoma;"Less than 8 mmHg of elevated intraocular pressure (EIOP); no visual field deficit";Glaucoma;10018304;LLT;20,1
387;C55844;Grade 2 Glaucoma, CTCAE;EIOP which can be reduced to 21 mmHg or under with topical medications and no visual field deficit;Grade 2 Glaucoma;EIOP which can be reduced to 21 mmHg or under with topical medications and no visual field deficit;Glaucoma;10018304;LLT;20,1
388;C55845;Grade 3 Glaucoma, CTCAE;EIOP causing visual field deficits;Grade 3 Glaucoma;EIOP causing visual field deficits;Glaucoma;10018304;LLT;20,1
389;C55846;Grade 4 Glaucoma, CTCAE;Visual field deficit within the central 10 degrees of the visual field in the affected eye;Grade 4 Glaucoma;Visual field deficit within the central 10 degrees of the visual field in the affected eye;Glaucoma;10018304;LLT;20,1
390;C55847;Keratitis, CTCAE;A disorder characterized by inflammation to the cornea of the eye.;Keratitis;A disorder characterized by inflammation to the cornea of the eye.;Keratitis;10023332;LLT;20,1
391;C55848;Grade 1 Keratitis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Keratitis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Keratitis;10023332;LLT;20,1
392;C55849;Grade 2 Keratitis, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline)";Grade 2 Keratitis;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline)";Keratitis;10023332;LLT;20,1
393;C55850;Grade 3 Keratitis, CTCAE;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); corneal ulcer; limiting self care ADL";Grade 3 Keratitis;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); corneal ulcer; limiting self care ADL";Keratitis;10023332;LLT;20,1
394;C55851;Grade 4 Keratitis, CTCAE;"Perforation; best corrected visual acuity of 20/200 or worse in the affected eye";Grade 4 Keratitis;"Perforation; best corrected visual acuity of 20/200 or worse in the affected eye";Keratitis;10023332;LLT;20,1
395;C143705;Night Blindness, CTCAE;A disorder characterized by an inability to see clearly in dim light.;Night blindness;A disorder characterized by an inability to see clearly in dim light.;Night blindness;10029404;LLT;20,1
396;C144290;Grade 1 Night Blindness, CTCAE;Symptomatic but not limiting ADL;Grade 1 Night blindness;Symptomatic but not limiting ADL;Night blindness;10029404;LLT;20,1
397;C144866;Grade 2 Night Blindness, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL";Grade 2 Night blindness;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL";Night blindness;10029404;LLT;20,1
398;C145488;Grade 3 Night Blindness, CTCAE;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Grade 3 Night blindness;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Night blindness;10029404;LLT;20,1
399;C146013;Grade 4 Night Blindness, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Night blindness;Best corrected visual acuity of 20/200 or worse in the affected eye;Night blindness;10029404;LLT;20,1
400;C143714;Optic Nerve Disorder, CTCAE;A disorder characterized by involvement of the optic nerve (second cranial nerve).;Optic nerve disorder;A disorder characterized by involvement of the optic nerve (second cranial nerve).;Optic nerve disorder;10061322;LLT;20,1
401;C144296;Grade 1 Optic Nerve Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only";Grade 1 Optic nerve disorder;"Asymptomatic; clinical or diagnostic observations only";Optic nerve disorder;10061322;LLT;20,1
402;C144872;Grade 2 Optic Nerve Disorder, CTCAE;Moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline);Grade 2 Optic nerve disorder;Moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline);Optic nerve disorder;10061322;LLT;20,1
403;C145493;Grade 3 Optic Nerve Disorder, CTCAE;Marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200);Grade 3 Optic nerve disorder;Marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200);Optic nerve disorder;10061322;LLT;20,1
404;C146015;Grade 4 Optic Nerve Disorder, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Optic nerve disorder;Best corrected visual acuity of 20/200 or worse in the affected eye;Optic nerve disorder;10061322;LLT;20,1
405;C143734;Papilledema, CTCAE;A disorder characterized by swelling around the optic disc.;Papilledema;A disorder characterized by swelling around the optic disc.;Papilledema;10033703;LLT;20,1
406;C144316;Grade 1 Papilledema, CTCAE;"Asymptomatic; no visual field deficit";Grade 1 Papilledema;"Asymptomatic; no visual field deficit";Papilledema;10033703;LLT;20,1
407;C144895;Grade 2 Papilledema, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline)";Grade 2 Papilledema;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline)";Papilledema;10033703;LLT;20,1
408;C145517;Grade 3 Papilledema, CTCAE;Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200);Grade 3 Papilledema;Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200);Papilledema;10033703;LLT;20,1
409;C146031;Grade 4 Papilledema, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Papilledema;Best corrected visual acuity of 20/200 or worse in the affected eye;Papilledema;10033703;LLT;20,1
410;C143747;Periorbital Edema, CTCAE;A disorder characterized by swelling due to an excessive accumulation of fluid around the orbits of the face.;Periorbital edema;A disorder characterized by swelling due to an excessive accumulation of fluid around the orbits of the face.;Periorbital edema;10054541;LLT;20,1
411;C144326;Grade 1 Periorbital Edema, CTCAE;Soft or non-pitting;Grade 1 Periorbital edema;Soft or non-pitting;Periorbital edema;10054541;LLT;20,1
412;C144907;Grade 2 Periorbital Edema, CTCAE;"Indurated or pitting edema; topical intervention indicated";Grade 2 Periorbital edema;"Indurated or pitting edema; topical intervention indicated";Periorbital edema;10054541;LLT;20,1
413;C145530;Grade 3 Periorbital Edema, CTCAE;"Edema associated with visual disturbance; increased intraocular pressure, glaucoma or retinal hemorrhage; optic neuritis; diuretics indicated; operative intervention indicated";Grade 3 Periorbital edema;"Edema associated with visual disturbance; increased intraocular pressure, glaucoma or retinal hemorrhage; optic neuritis; diuretics indicated; operative intervention indicated";Periorbital edema;10054541;LLT;20,1
414;C146770;Photophobia, CTCAE 5.0;A disorder characterized by fear and avoidance of light.;Photophobia;A disorder characterized by fear and avoidance of light.;Photophobia;10034960;LLT;20,1
415;C55917;Grade 1 Photophobia, CTCAE;Symptomatic but not limiting ADL;Grade 1 Photophobia;Symptomatic but not limiting ADL;Photophobia;10034960;LLT;20,1
416;C55918;Grade 2 Photophobia, CTCAE;Limiting instrumental ADL;Grade 2 Photophobia;Limiting instrumental ADL;Photophobia;10034960;LLT;20,1
417;C55919;Grade 3 Photophobia, CTCAE;Limiting self care ADL;Grade 3 Photophobia;Limiting self care ADL;Photophobia;10034960;LLT;20,1
418;C146729;Retinal Detachment, CTCAE 5.0;A disorder characterized by the separation of the inner retina layers from the underlying pigment epithelium.;Retinal detachment;A disorder characterized by the separation of the inner retina layers from the underlying pigment epithelium.;Retinal detachment;10038848;LLT;20,1
419;C55889;Grade 3 Retinal Detachment, CTCAE;Macular sparing rhegmatogenous detachment;Grade 3 Retinal detachment;Macular sparing rhegmatogenous detachment;Retinal detachment;10038848;LLT;20,1
420;C55890;Grade 4 Retinal Detachment, CTCAE;Macula-off rhegmatogenous retinal detachment;Grade 4 Retinal detachment;Macula-off rhegmatogenous retinal detachment;Retinal detachment;10038848;LLT;20,1
421;C143814;Retinal Tear, CTCAE;A disorder characterized by a small laceration of the retina, this occurs when the vitreous separates from the retina. Symptoms include flashes and floaters.;Retinal tear;A disorder characterized by a small laceration of the retina, this occurs when the vitreous separates from the retina. Symptoms include flashes and floaters.;Retinal tear;10038897;LLT;20,1
422;C144383;Grade 1 Retinal Tear, CTCAE;No retinal detachment and treatment not indicated;Grade 1 Retinal tear;No retinal detachment and treatment not indicated;Retinal tear;10038897;LLT;20,1
423;C144977;Grade 2 Retinal Tear, CTCAE;No retinal detachment and treatment indicated;Grade 2 Retinal tear;No retinal detachment and treatment indicated;Retinal tear;10038897;LLT;20,1
424;C143815;Retinal Vascular Disorder, CTCAE;A disorder characterized by pathological retinal blood vessels that adversely affects vision.;Retinal vascular disorder;A disorder characterized by pathological retinal blood vessels that adversely affects vision.;Retinal vascular disorder;10038901;LLT;20,1
425;C144978;Grade 2 Retinal Vascular Disorder, CTCAE;Retinal vascular disorder without neovascularization;Grade 2 Retinal vascular disorder;Retinal vascular disorder without neovascularization;Retinal vascular disorder;10038901;LLT;20,1
426;C145600;Grade 3 Retinal Vascular Disorder, CTCAE;Retinal vascular disorder with neovascularization;Grade 3 Retinal vascular disorder;Retinal vascular disorder with neovascularization;Retinal vascular disorder;10038901;LLT;20,1
427;C55891;Retinopathy, CTCAE;A disorder involving the retina.;Retinopathy;A disorder involving the retina.;Retinopathy;10038923;LLT;20,1
428;C55892;Grade 1 Retinopathy, CTCAE;"Asymptomatic; clinical or diagnostic observations only";Grade 1 Retinopathy;"Asymptomatic; clinical or diagnostic observations only";Retinopathy;10038923;LLT;20,1
429;C55893;Grade 2 Retinopathy, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL";Grade 2 Retinopathy;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL";Retinopathy;10038923;LLT;20,1
430;C55894;Grade 3 Retinopathy, CTCAE;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Grade 3 Retinopathy;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Retinopathy;10038923;LLT;20,1
431;C55895;Grade 4 Retinopathy, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Retinopathy;Best corrected visual acuity of 20/200 or worse in the affected eye;Retinopathy;10038923;LLT;20,1
432;C143823;Scleral Disorder, CTCAE;A disorder characterized by involvement of the sclera of the eye.;Scleral disorder;A disorder characterized by involvement of the sclera of the eye.;Scleral disorder;10061510;LLT;20,1
433;C144388;Grade 1 Scleral Disorder, CTCAE;No change in vision from baseline;Grade 1 Scleral disorder;No change in vision from baseline;Scleral disorder;10061510;LLT;20,1
434;C144986;Grade 2 Scleral Disorder, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL";Grade 2 Scleral disorder;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL";Scleral disorder;10061510;LLT;20,1
435;C145607;Grade 3 Scleral Disorder, CTCAE;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Grade 3 Scleral disorder;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Scleral disorder;10061510;LLT;20,1
436;C146102;Grade 4 Scleral Disorder, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Scleral disorder;Best corrected visual acuity of 20/200 or worse in the affected eye;Scleral disorder;10061510;LLT;20,1
437;C55901;Uveitis, CTCAE;A disorder characterized by inflammation to the uvea of the eye.;Uveitis;A disorder characterized by inflammation to the uvea of the eye.;Uveitis;10046851;LLT;20,1
438;C55902;Grade 1 Uveitis, CTCAE;Anterior uveitis with trace cells;Grade 1 Uveitis;Anterior uveitis with trace cells;Uveitis;10046851;LLT;20,1
439;C55903;Grade 2 Uveitis, CTCAE;Anterior uveitis with 1+ or 2+ cells;Grade 2 Uveitis;Anterior uveitis with 1+ or 2+ cells;Uveitis;10046851;LLT;20,1
440;C55904;Grade 3 Uveitis, CTCAE;"Anterior uveitis with 3+ or greater cells; intermediate posterior or pan-uveitis";Grade 3 Uveitis;"Anterior uveitis with 3+ or greater cells; intermediate posterior or pan-uveitis";Uveitis;10046851;LLT;20,1
441;C55905;Grade 4 Uveitis, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Uveitis;Best corrected visual acuity of 20/200 or worse in the affected eye;Uveitis;10046851;LLT;20,1
442;C143196;Vision Decreased, CTCAE;A disorder characterized by a decrease in visual acuity.;Vision decreased;A disorder characterized by a decrease in visual acuity.;Vision decreased;10047516;LLT;20,1
443;C145099;Grade 2 Vision Decreased, CTCAE;Moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline);Grade 2 Vision decreased;Moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline);Vision decreased;10047516;LLT;20,1
444;C145719;Grade 3 Vision Decreased, CTCAE;Marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200);Grade 3 Vision decreased;Marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200);Vision decreased;10047516;LLT;20,1
445;C146193;Grade 4 Vision Decreased, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Vision decreased;Best corrected visual acuity of 20/200 or worse in the affected eye;Vision decreased;10047516;LLT;20,1
446;C146677;Vitreous Hemorrhage, CTCAE 5.0;A disorder characterized by bleeding into the vitreous humor.;Vitreous hemorrhage;A disorder characterized by bleeding into the vitreous humor.;Vitreous hemorrhage;10047656;LLT;20,1
447;C55922;Grade 1 Vitreous Hemorrhage, CTCAE;Intervention not indicated;Grade 1 Vitreous hemorrhage;Intervention not indicated;Vitreous hemorrhage;10047656;LLT;20,1
448;C55923;Grade 2 Vitreous Hemorrhage, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL";Grade 2 Vitreous hemorrhage;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline); limiting instrumental ADL";Vitreous hemorrhage;10047656;LLT;20,1
449;C55924;Grade 3 Vitreous Hemorrhage, CTCAE;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL; vitrectomy indicated";Grade 3 Vitreous hemorrhage;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL; vitrectomy indicated";Vitreous hemorrhage;10047656;LLT;20,1
450;C146194;Grade 4 Vitreous Hemorrhage, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Vitreous hemorrhage;Best corrected visual acuity of 20/200 or worse in the affected eye;Vitreous hemorrhage;10047656;LLT;20,1
451;C143944;Watering Eyes, CTCAE;"A disorder characterized by excessive tearing in the eyes; it can be caused by overproduction of tears or impaired drainage of the tear duct.";Watering eyes;"A disorder characterized by excessive tearing in the eyes; it can be caused by overproduction of tears or impaired drainage of the tear duct.";Watering eyes;10047848;LLT;20,1
452;C144487;Grade 1 Watering Eyes, CTCAE;Intervention not indicated;Grade 1 Watering eyes;Intervention not indicated;Watering eyes;10047848;LLT;20,1
453;C145103;Grade 2 Watering Eyes, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline)";Grade 2 Watering eyes;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline)";Watering eyes;10047848;LLT;20,1
454;C145723;Grade 3 Watering Eyes, CTCAE;Marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200);Grade 3 Watering eyes;Marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200);Watering eyes;10047848;LLT;20,1
455;C146196;Grade 4 Watering Eyes, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Watering eyes;Best corrected visual acuity of 20/200 or worse in the affected eye;Watering eyes;10047848;LLT;20,1
456;C146630;Gastrointestinal Disorders, CTCAE;;;;;;;
457;C143253;Abdominal Distension, CTCAE;A disorder characterized by swelling of the abdomen.;Abdominal distension;A disorder characterized by swelling of the abdomen.;Abdominal distension;10000060;LLT;20,1
458;C143958;Grade 1 Abdominal Distension, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Abdominal distension;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Abdominal distension;10000060;LLT;20,1
459;C144494;Grade 2 Abdominal Distension, CTCAE;"Symptomatic; limiting instrumental ADL";Grade 2 Abdominal distension;"Symptomatic; limiting instrumental ADL";Abdominal distension;10000060;LLT;20,1
460;C145110;Grade 3 Abdominal Distension, CTCAE;"Severe discomfort; limiting self care ADL";Grade 3 Abdominal distension;"Severe discomfort; limiting self care ADL";Abdominal distension;10000060;LLT;20,1
461;C143255;Abdominal Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the abdominal region.;Abdominal pain;A disorder characterized by a sensation of marked discomfort in the abdominal region.;Abdominal pain;10000081;LLT;20,1
462;C143959;Grade 1 Abdominal Pain, CTCAE;Mild pain;Grade 1 Abdominal pain;Mild pain;Abdominal pain;10000081;LLT;20,1
463;C144496;Grade 2 Abdominal Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Abdominal pain;"Moderate pain; limiting instrumental ADL";Abdominal pain;10000081;LLT;20,1
464;C145112;Grade 3 Abdominal Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Abdominal pain;"Severe pain; limiting self care ADL";Abdominal pain;10000081;LLT;20,1
465;C143197;Anal Fissure, CTCAE;A disorder characterized by a tear in the lining of the anus.;Anal fissure;A disorder characterized by a tear in the lining of the anus.;Anal fissure;10002153;LLT;20,1
466;C143972;Grade 1 Anal Fissure, CTCAE;Asymptomatic;Grade 1 Anal fissure;Asymptomatic;Anal fissure;10002153;LLT;20,1
467;C144510;Grade 2 Anal Fissure, CTCAE;Symptomatic;Grade 2 Anal fissure;Symptomatic;Anal fissure;10002153;LLT;20,1
468;C145127;Grade 3 Anal Fissure, CTCAE;Invasive intervention indicated;Grade 3 Anal fissure;Invasive intervention indicated;Anal fissure;10002153;LLT;20,1
469;C143275;Anal Fistula, CTCAE;A disorder characterized by an abnormal communication between the opening in the anal canal to the perianal skin.;Anal fistula;A disorder characterized by an abnormal communication between the opening in the anal canal to the perianal skin.;Anal fistula;10002156;LLT;20,1
470;C143973;Grade 1 Anal Fistula, CTCAE;Asymptomatic;Grade 1 Anal fistula;Asymptomatic;Anal fistula;10002156;LLT;20,1
471;C144511;Grade 2 Anal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Anal fistula;Symptomatic, invasive intervention not indicated;Anal fistula;10002156;LLT;20,1
472;C145128;Grade 3 Anal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Anal fistula;Invasive intervention indicated;Anal fistula;10002156;LLT;20,1
473;C145739;Grade 4 Anal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Anal fistula;"Life-threatening consequences; urgent intervention indicated";Anal fistula;10002156;LLT;20,1
474;C146209;Grade 5 Anal Fistula, CTCAE;Death;Grade 5 Anal fistula;Death;Anal fistula;10002156;LLT;20,1
475;C143276;Anal Hemorrhage, CTCAE;A disorder characterized by bleeding from the anal region.;Anal hemorrhage;A disorder characterized by bleeding from the anal region.;Anal hemorrhage;10055226;LLT;20,1
476;C143974;Grade 1 Anal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Anal hemorrhage;"Mild symptoms; intervention not indicated";Anal hemorrhage;10055226;LLT;20,1
477;C144512;Grade 2 Anal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Anal hemorrhage;"Moderate symptoms; intervention indicated";Anal hemorrhage;10055226;LLT;20,1
478;C145129;Grade 3 Anal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Anal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Anal hemorrhage;10055226;LLT;20,1
479;C145740;Grade 4 Anal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Anal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Anal hemorrhage;10055226;LLT;20,1
480;C146210;Grade 5 Anal Hemorrhage, CTCAE;Death;Grade 5 Anal hemorrhage;Death;Anal hemorrhage;10055226;LLT;20,1
481;C143277;Anal Mucositis, CTCAE;A disorder characterized by ulceration or inflammation of the mucous membrane of the anus.;Anal mucositis;A disorder characterized by ulceration or inflammation of the mucous membrane of the anus.;Anal mucositis;10065721;LLT;20,1
482;C143975;Grade 1 Anal Mucositis, CTCAE;"Asymptomatic or mild symptoms; intervention not indicated";Grade 1 Anal mucositis;"Asymptomatic or mild symptoms; intervention not indicated";Anal mucositis;10065721;LLT;20,1
483;C144513;Grade 2 Anal Mucositis, CTCAE;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Grade 2 Anal mucositis;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Anal mucositis;10065721;LLT;20,1
484;C145130;Grade 3 Anal Mucositis, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Anal mucositis;"Severe symptoms; limiting self care ADL";Anal mucositis;10065721;LLT;20,1
485;C143278;Anal Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the anal region.;Anal necrosis;A disorder characterized by a necrotic process occurring in the anal region.;Anal necrosis;10065722;LLT;20,1
486;C145131;Grade 3 Anal Necrosis, CTCAE;"TPN or hospitalization indicated; invasive intervention indicated";Grade 3 Anal necrosis;"TPN or hospitalization indicated; invasive intervention indicated";Anal necrosis;10065722;LLT;20,1
487;C145741;Grade 4 Anal Necrosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Anal necrosis;"Life-threatening consequences; urgent operative intervention indicated";Anal necrosis;10065722;LLT;20,1
488;C146211;Grade 5 Anal Necrosis, CTCAE;Death;Grade 5 Anal necrosis;Death;Anal necrosis;10065722;LLT;20,1
489;C143279;Anal Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the anal region.;Anal pain;A disorder characterized by a sensation of marked discomfort in the anal region.;Anal pain;10002167;LLT;20,1
490;C143976;Grade 1 Anal Pain, CTCAE;Mild pain;Grade 1 Anal pain;Mild pain;Anal pain;10002167;LLT;20,1
491;C144514;Grade 2 Anal Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Anal pain;"Moderate pain; limiting instrumental ADL";Anal pain;10002167;LLT;20,1
492;C145132;Grade 3 Anal Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Anal pain;"Severe pain; limiting self care ADL";Anal pain;10002167;LLT;20,1
493;C143280;Anal Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the anal canal.;Anal stenosis;A disorder characterized by a narrowing of the lumen of the anal canal.;Anal stenosis;10002176;LLT;20,1
494;C143977;Grade 1 Anal Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Anal stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Anal stenosis;10002176;LLT;20,1
495;C144515;Grade 2 Anal Stenosis, CTCAE;"Symptomatic; altered GI function";Grade 2 Anal stenosis;"Symptomatic; altered GI function";Anal stenosis;10002176;LLT;20,1
496;C145133;Grade 3 Anal Stenosis, CTCAE;"Symptomatic and severely altered GI function; non-emergent operative intervention indicated; TPN or hospitalization indicated";Grade 3 Anal stenosis;"Symptomatic and severely altered GI function; non-emergent operative intervention indicated; TPN or hospitalization indicated";Anal stenosis;10002176;LLT;20,1
497;C145742;Grade 4 Anal Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Anal stenosis;"Life-threatening consequences; urgent operative intervention indicated";Anal stenosis;10002176;LLT;20,1
498;C146212;Grade 5 Anal Stenosis, CTCAE;Death;Grade 5 Anal stenosis;Death;Anal stenosis;10002176;LLT;20,1
499;C143281;Anal Ulcer, CTCAE;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the anal canal.;Anal ulcer;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the anal canal.;Anal ulcer;10002180;LLT;20,1
500;C143978;Grade 1 Anal Ulcer, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Anal ulcer;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Anal ulcer;10002180;LLT;20,1
501;C144516;Grade 2 Anal Ulcer, CTCAE;"Symptomatic; altered GI function";Grade 2 Anal ulcer;"Symptomatic; altered GI function";Anal ulcer;10002180;LLT;20,1
502;C145134;Grade 3 Anal Ulcer, CTCAE;"Severely altered GI function; TPN indicated; elective invasive intervention indicated";Grade 3 Anal ulcer;"Severely altered GI function; TPN indicated; elective invasive intervention indicated";Anal ulcer;10002180;LLT;20,1
503;C145743;Grade 4 Anal Ulcer, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Anal ulcer;"Life-threatening consequences; urgent operative intervention indicated";Anal ulcer;10002180;LLT;20,1
504;C146213;Grade 5 Anal Ulcer, CTCAE;Death;Grade 5 Anal ulcer;Death;Anal ulcer;10002180;LLT;20,1
505;C143300;Ascites, CTCAE;A disorder characterized by accumulation of serous or hemorrhagic fluid in the peritoneal cavity.;Ascites;A disorder characterized by accumulation of serous or hemorrhagic fluid in the peritoneal cavity.;Ascites;10003445;LLT;20,1
506;C143989;Grade 1 Ascites, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Ascites;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Ascites;10003445;LLT;20,1
507;C144527;Grade 2 Ascites, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Ascites;"Symptomatic; medical intervention indicated";Ascites;10003445;LLT;20,1
508;C145150;Grade 3 Ascites, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Ascites;"Severe symptoms; invasive intervention indicated";Ascites;10003445;LLT;20,1
509;C145755;Grade 4 Ascites, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Ascites;"Life-threatening consequences; urgent operative intervention indicated";Ascites;10003445;LLT;20,1
510;C146225;Grade 5 Ascites, CTCAE;Death;Grade 5 Ascites;Death;Ascites;10003445;LLT;20,1
511;C143198;Belching, CTCAE;To expel gas noisily from the mouth.;Belching;To expel gas noisily from the mouth.;Belching;10004222;LLT;20,1
512;C143994;Grade 1 Belching, CTCAE;Increase from baseline;Grade 1 Belching;Increase from baseline;Belching;10004222;LLT;20,1
513;C144535;Grade 2 Belching, CTCAE;Intervention initiated (including over the counter medications);Grade 2 Belching;Intervention initiated (including over the counter medications);Belching;10004222;LLT;20,1
514;C143322;Bloating, CTCAE;A disorder characterized by subject-reported feeling of uncomfortable fullness of the abdomen.;Bloating;A disorder characterized by subject-reported feeling of uncomfortable fullness of the abdomen.;Bloating;10005265;LLT;20,1
515;C143999;Grade 1 Bloating, CTCAE;No change in bowel function or oral intake;Grade 1 Bloating;No change in bowel function or oral intake;Bloating;10005265;LLT;20,1
516;C144543;Grade 2 Bloating, CTCAE;"Symptomatic, decreased oral intake; change in bowel function";Grade 2 Bloating;"Symptomatic, decreased oral intake; change in bowel function";Bloating;10005265;LLT;20,1
517;C143358;Cecal Hemorrhage, CTCAE;A disorder characterized by bleeding from the cecum.;Cecal hemorrhage;A disorder characterized by bleeding from the cecum.;Cecal hemorrhage;10065747;LLT;20,1
518;C144025;Grade 1 Cecal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Cecal hemorrhage;"Mild symptoms; intervention not indicated";Cecal hemorrhage;10065747;LLT;20,1
519;C144570;Grade 2 Cecal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Cecal hemorrhage;"Moderate symptoms; intervention indicated";Cecal hemorrhage;10065747;LLT;20,1
520;C145187;Grade 3 Cecal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Cecal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Cecal hemorrhage;10065747;LLT;20,1
521;C145786;Grade 4 Cecal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Cecal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Cecal hemorrhage;10065747;LLT;20,1
522;C146252;Grade 5 Cecal Hemorrhage, CTCAE;Death;Grade 5 Cecal hemorrhage;Death;Cecal hemorrhage;10065747;LLT;20,1
523;C57901;Cheilitis, CTCAE;A disorder characterized by inflammation of the lip.;Cheilitis;A disorder characterized by inflammation of the lip.;Cheilitis;10008417;LLT;20,1
524;C57905;Grade 1 Cheilitis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Cheilitis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Cheilitis;10008417;LLT;20,1
525;C57930;Grade 2 Cheilitis, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Cheilitis;"Moderate symptoms; limiting instrumental ADL";Cheilitis;10008417;LLT;20,1
526;C57956;Grade 3 Cheilitis, CTCAE;"Severe symptoms; limiting self care ADL; intervention indicated";Grade 3 Cheilitis;"Severe symptoms; limiting self care ADL; intervention indicated";Cheilitis;10008417;LLT;20,1
527;C146788;Cholecystitis, CTCAE 5.0;A disorder characterized by inflammation involving the gallbladder. It may be associated with the presence of gallstones.;Cholecystitis;A disorder characterized by inflammation involving the gallbladder. It may be associated with the presence of gallstones.;Cholecystitis;10008612;LLT;20,1
528;C56579;Grade 2 Cholecystitis, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Cholecystitis;"Symptomatic; medical intervention indicated";Cholecystitis;10008612;LLT;20,1
529;C56584;Grade 3 Cholecystitis, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Cholecystitis;"Severe symptoms; invasive intervention indicated";Cholecystitis;10008612;LLT;20,1
530;C56589;Grade 4 Cholecystitis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Cholecystitis;"Life-threatening consequences; urgent operative intervention indicated";Cholecystitis;10008612;LLT;20,1
531;C56594;Grade 5 Cholecystitis, CTCAE;Death;Grade 5 Cholecystitis;Death;Cholecystitis;10008612;LLT;20,1
532;C143199;Chylous Ascites, CTCAE;A disorder characterized by accumulation of milky fluid in the peritoneal cavity.;Chylous ascites;A disorder characterized by accumulation of milky fluid in the peritoneal cavity.;Chylous ascites;10009167;LLT;20,1
533;C144032;Grade 1 Chylous Ascites, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Chylous ascites;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Chylous ascites;10009167;LLT;20,1
534;C144580;Grade 2 Chylous Ascites, CTCAE;"Symptomatic; medical intervention indicated (e.g., fat-restricted diet); paracentesis or tube drainage indicated";Grade 2 Chylous ascites;"Symptomatic; medical intervention indicated (e.g., fat-restricted diet); paracentesis or tube drainage indicated";Chylous ascites;10009167;LLT;20,1
535;C145197;Grade 3 Chylous Ascites, CTCAE;"Severe symptoms; elective operative intervention indicated";Grade 3 Chylous ascites;"Severe symptoms; elective operative intervention indicated";Chylous ascites;10009167;LLT;20,1
536;C145794;Grade 4 Chylous Ascites, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Chylous ascites;"Life-threatening consequences; urgent operative intervention indicated";Chylous ascites;10009167;LLT;20,1
537;C146259;Grade 5 Chylous Ascites, CTCAE;Death;Grade 5 Chylous ascites;Death;Chylous ascites;10009167;LLT;20,1
538;C57134;Colitis, CTCAE;A disorder characterized by inflammation of the colon.;Colitis;A disorder characterized by inflammation of the colon.;Colitis;10009887;LLT;20,1
539;C57162;Grade 1 Colitis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Colitis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Colitis;10009887;LLT;20,1
540;C57285;Grade 2 Colitis, CTCAE;"Abdominal pain; mucus or blood in stool";Grade 2 Colitis;"Abdominal pain; mucus or blood in stool";Colitis;10009887;LLT;20,1
541;C57409;Grade 3 Colitis, CTCAE;"Severe abdominal pain; peritoneal signs";Grade 3 Colitis;"Severe abdominal pain; peritoneal signs";Colitis;10009887;LLT;20,1
542;C57544;Grade 4 Colitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Colitis;"Life-threatening consequences; urgent intervention indicated";Colitis;10009887;LLT;20,1
543;C57675;Grade 5 Colitis, CTCAE;Death;Grade 5 Colitis;Death;Colitis;10009887;LLT;20,1
544;C143373;Colonic Fistula, CTCAE;A disorder characterized by an abnormal communication between the large intestine and another organ or anatomic site.;Colonic fistula;A disorder characterized by an abnormal communication between the large intestine and another organ or anatomic site.;Colonic fistula;10009995;LLT;20,1
545;C144033;Grade 1 Colonic Fistula, CTCAE;Asymptomatic;Grade 1 Colonic fistula;Asymptomatic;Colonic fistula;10009995;LLT;20,1
546;C144581;Grade 2 Colonic Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Colonic fistula;Symptomatic, invasive intervention not indicated;Colonic fistula;10009995;LLT;20,1
547;C145198;Grade 3 Colonic Fistula, CTCAE;Invasive intervention indicated;Grade 3 Colonic fistula;Invasive intervention indicated;Colonic fistula;10009995;LLT;20,1
548;C145795;Grade 4 Colonic Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Colonic fistula;"Life-threatening consequences; urgent intervention indicated";Colonic fistula;10009995;LLT;20,1
549;C146260;Grade 5 Colonic Fistula, CTCAE;Death;Grade 5 Colonic fistula;Death;Colonic fistula;10009995;LLT;20,1
550;C143374;Colonic Hemorrhage, CTCAE;A disorder characterized by bleeding from the colon.;Colonic hemorrhage;A disorder characterized by bleeding from the colon.;Colonic hemorrhage;10009998;LLT;20,1
551;C144034;Grade 1 Colonic Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Colonic hemorrhage;"Mild symptoms; intervention not indicated";Colonic hemorrhage;10009998;LLT;20,1
552;C144582;Grade 2 Colonic Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Colonic hemorrhage;"Moderate symptoms; intervention indicated";Colonic hemorrhage;10009998;LLT;20,1
553;C145199;Grade 3 Colonic Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Colonic hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Colonic hemorrhage;10009998;LLT;20,1
554;C145796;Grade 4 Colonic Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Colonic hemorrhage;"Life-threatening consequences; urgent intervention indicated";Colonic hemorrhage;10009998;LLT;20,1
555;C146261;Grade 5 Colonic Hemorrhage, CTCAE;Death;Grade 5 Colonic hemorrhage;Death;Colonic hemorrhage;10009998;LLT;20,1
556;C143375;Colonic Obstruction, CTCAE;A disorder characterized by blockage of the normal flow of the intestinal contents in the colon.;Colonic obstruction;A disorder characterized by blockage of the normal flow of the intestinal contents in the colon.;Colonic obstruction;10010000;LLT;20,1
557;C144035;Grade 1 Colonic Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Colonic obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Colonic obstruction;10010000;LLT;20,1
558;C144583;Grade 2 Colonic Obstruction, CTCAE;"Symptomatic; altered GI function";Grade 2 Colonic obstruction;"Symptomatic; altered GI function";Colonic obstruction;10010000;LLT;20,1
559;C145200;Grade 3 Colonic Obstruction, CTCAE;"Hospitalization indicated; invasive intervention indicated";Grade 3 Colonic obstruction;"Hospitalization indicated; invasive intervention indicated";Colonic obstruction;10010000;LLT;20,1
560;C145797;Grade 4 Colonic Obstruction, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Colonic obstruction;"Life-threatening consequences; urgent operative intervention indicated";Colonic obstruction;10010000;LLT;20,1
561;C146262;Grade 5 Colonic Obstruction, CTCAE;Death;Grade 5 Colonic obstruction;Death;Colonic obstruction;10010000;LLT;20,1
562;C143376;Colonic Perforation, CTCAE;A disorder characterized by a rupture in the colonic wall.;Colonic perforation;A disorder characterized by a rupture in the colonic wall.;Colonic perforation;10010001;LLT;20,1
563;C144584;Grade 2 Colonic Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Colonic perforation;Invasive intervention not indicated;Colonic perforation;10010001;LLT;20,1
564;C145201;Grade 3 Colonic Perforation, CTCAE;Invasive intervention indicated;Grade 3 Colonic perforation;Invasive intervention indicated;Colonic perforation;10010001;LLT;20,1
565;C145798;Grade 4 Colonic Perforation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Colonic perforation;"Life-threatening consequences; urgent intervention indicated";Colonic perforation;10010001;LLT;20,1
566;C146263;Grade 5 Colonic Perforation, CTCAE;Death;Grade 5 Colonic perforation;Death;Colonic perforation;10010001;LLT;20,1
567;C143377;Colonic Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the colon.;Colonic stenosis;A disorder characterized by a narrowing of the lumen of the colon.;Colonic stenosis;10010004;LLT;20,1
568;C144036;Grade 1 Colonic Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Colonic stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Colonic stenosis;10010004;LLT;20,1
569;C144585;Grade 2 Colonic Stenosis, CTCAE;"Symptomatic; altered GI function";Grade 2 Colonic stenosis;"Symptomatic; altered GI function";Colonic stenosis;10010004;LLT;20,1
570;C145202;Grade 3 Colonic Stenosis, CTCAE;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Grade 3 Colonic stenosis;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Colonic stenosis;10010004;LLT;20,1
571;C145799;Grade 4 Colonic Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Colonic stenosis;"Life-threatening consequences; urgent operative intervention indicated";Colonic stenosis;10010004;LLT;20,1
572;C146264;Grade 5 Colonic Stenosis, CTCAE;Death;Grade 5 Colonic stenosis;Death;Colonic stenosis;10010004;LLT;20,1
573;C143378;Colonic Ulcer, CTCAE;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the colon.;Colonic ulcer;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the colon.;Colonic ulcer;10010006;LLT;20,1
574;C144037;Grade 1 Colonic Ulcer, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Colonic ulcer;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Colonic ulcer;10010006;LLT;20,1
575;C144586;Grade 2 Colonic Ulcer, CTCAE;"Symptomatic; altered GI function";Grade 2 Colonic ulcer;"Symptomatic; altered GI function";Colonic ulcer;10010006;LLT;20,1
576;C145203;Grade 3 Colonic Ulcer, CTCAE;"Severely altered GI function; TPN indicated; elective invasive intervention indicated";Grade 3 Colonic ulcer;"Severely altered GI function; TPN indicated; elective invasive intervention indicated";Colonic ulcer;10010006;LLT;20,1
577;C145800;Grade 4 Colonic Ulcer, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Colonic ulcer;"Life-threatening consequences; urgent operative intervention indicated";Colonic ulcer;10010006;LLT;20,1
578;C146265;Grade 5 Colonic Ulcer, CTCAE;Death;Grade 5 Colonic ulcer;Death;Colonic ulcer;10010006;LLT;20,1
579;C57141;Constipation, CTCAE;A disorder characterized by irregular and infrequent or difficult evacuation of the bowels.;Constipation;A disorder characterized by irregular and infrequent or difficult evacuation of the bowels.;Constipation;10010774;LLT;20,1
580;C57168;Grade 1 Constipation, CTCAE;"Occasional or intermittent symptoms; occasional use of stool softeners, laxatives, dietary modification, or enema";Grade 1 Constipation;"Occasional or intermittent symptoms; occasional use of stool softeners, laxatives, dietary modification, or enema";Constipation;10010774;LLT;20,1
581;C57291;Grade 2 Constipation, CTCAE;"Persistent symptoms with regular use of laxatives or enemas; limiting instrumental ADL";Grade 2 Constipation;"Persistent symptoms with regular use of laxatives or enemas; limiting instrumental ADL";Constipation;10010774;LLT;20,1
582;C57416;Grade 3 Constipation, CTCAE;"Obstipation with manual evacuation indicated; limiting self care ADL";Grade 3 Constipation;"Obstipation with manual evacuation indicated; limiting self care ADL";Constipation;10010774;LLT;20,1
583;C57551;Grade 4 Constipation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Constipation;"Life-threatening consequences; urgent intervention indicated";Constipation;10010774;LLT;20,1
584;C57682;Grade 5 Constipation, CTCAE;Death;Grade 5 Constipation;Death;Constipation;10010774;LLT;20,1
585;C143402;Dental Caries, CTCAE;A disorder characterized by the decay of a tooth, in which it becomes softened, discolored and/or porous.;Dental caries;A disorder characterized by the decay of a tooth, in which it becomes softened, discolored and/or porous.;Dental caries;10012318;LLT;20,1
586;C144050;Grade 1 Dental Caries, CTCAE;One or more dental caries, not involving the root;Grade 1 Dental caries;One or more dental caries, not involving the root;Dental caries;10012318;LLT;20,1
587;C144603;Grade 2 Dental Caries, CTCAE;Dental caries involving the root;Grade 2 Dental caries;Dental caries involving the root;Dental caries;10012318;LLT;20,1
588;C145220;Grade 3 Dental Caries, CTCAE;Dental caries resulting in pulpitis or periapical abscess or resulting in tooth loss;Grade 3 Dental caries;Dental caries resulting in pulpitis or periapical abscess or resulting in tooth loss;Dental caries;10012318;LLT;20,1
589;C57788;Diarrhea, CTCAE;A disorder characterized by an increase in frequency and/or loose or watery bowel movements.;Diarrhea;A disorder characterized by an increase in frequency and/or loose or watery bowel movements.;Diarrhea;10012727;LLT;20,1
590;C57170;Grade 1 Diarrhea, CTCAE;"Increase of <4 stools per day over baseline; mild increase in ostomy output compared to baseline";Grade 1 Diarrhea;"Increase of <4 stools per day over baseline; mild increase in ostomy output compared to baseline";Diarrhea;10012727;LLT;20,1
591;C57293;Grade 2 Diarrhea, CTCAE;"Increase of 4-6 stools per day over baseline; moderate increase in ostomy output compared to baseline; limiting instrumental ADL";Grade 2 Diarrhea;"Increase of 4-6 stools per day over baseline; moderate increase in ostomy output compared to baseline; limiting instrumental ADL";Diarrhea;10012727;LLT;20,1
592;C57418;Grade 3 Diarrhea, CTCAE;"Increase of >=7 stools per day over baseline; hospitalization indicated; severe increase in ostomy output compared to baseline; limiting self care ADL";Grade 3 Diarrhea;"Increase of >=7 stools per day over baseline; hospitalization indicated; severe increase in ostomy output compared to baseline; limiting self care ADL";Diarrhea;10012727;LLT;20,1
593;C57553;Grade 4 Diarrhea, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Diarrhea;"Life-threatening consequences; urgent intervention indicated";Diarrhea;10012727;LLT;20,1
594;C57684;Grade 5 Diarrhea, CTCAE;Death;Grade 5 Diarrhea;Death;Diarrhea;10012727;LLT;20,1
595;C143411;Dry Mouth, CTCAE;A disorder characterized by reduced salivary flow in the oral cavity.;Dry mouth;A disorder characterized by reduced salivary flow in the oral cavity.;Dry mouth;10013781;LLT;20,1
596;C144054;Grade 1 Dry Mouth, CTCAE;"Symptomatic (e.g., dry or thick saliva) without significant dietary alteration; unstimulated saliva flow >0.2 ml/min";Grade 1 Dry mouth;"Symptomatic (e.g., dry or thick saliva) without significant dietary alteration; unstimulated saliva flow >0.2 ml/min";Dry mouth;10013781;LLT;20,1
597;C144608;Grade 2 Dry Mouth, CTCAE;"Moderate symptoms; oral intake alterations (e.g., copious water, other lubricants, diet limited to purees and/or soft, moist foods); unstimulated saliva 0.1 to 0.2 ml/min";Grade 2 Dry mouth;"Moderate symptoms; oral intake alterations (e.g., copious water, other lubricants, diet limited to purees and/or soft, moist foods); unstimulated saliva 0.1 to 0.2 ml/min";Dry mouth;10013781;LLT;20,1
598;C145225;Grade 3 Dry Mouth, CTCAE;"Inability to adequately aliment orally; tube feeding or TPN indicated; unstimulated saliva <0.1 ml/min";Grade 3 Dry mouth;"Inability to adequately aliment orally; tube feeding or TPN indicated; unstimulated saliva <0.1 ml/min";Dry mouth;10013781;LLT;20,1
599;C143414;Duodenal Hemorrhage, CTCAE;A disorder characterized by bleeding from the duodenum.;Duodenal hemorrhage;A disorder characterized by bleeding from the duodenum.;Duodenal hemorrhage;10055242;LLT;20,1
600;C144056;Grade 1 Duodenal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Duodenal hemorrhage;"Mild symptoms; intervention not indicated";Duodenal hemorrhage;10055242;LLT;20,1
601;C144610;Grade 2 Duodenal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Duodenal hemorrhage;"Moderate symptoms; intervention indicated";Duodenal hemorrhage;10055242;LLT;20,1
602;C145227;Grade 3 Duodenal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Duodenal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Duodenal hemorrhage;10055242;LLT;20,1
603;C145820;Grade 4 Duodenal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Duodenal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Duodenal hemorrhage;10055242;LLT;20,1
604;C146281;Grade 5 Duodenal Hemorrhage, CTCAE;Death;Grade 5 Duodenal hemorrhage;Death;Duodenal hemorrhage;10055242;LLT;20,1
605;C143416;Duodenal Obstruction, CTCAE;A disorder characterized by blockage of the normal flow of stomach contents through the duodenum.;Duodenal obstruction;A disorder characterized by blockage of the normal flow of stomach contents through the duodenum.;Duodenal obstruction;10013830;LLT;20,1
606;C144057;Grade 1 Duodenal Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Duodenal obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Duodenal obstruction;10013830;LLT;20,1
607;C144612;Grade 2 Duodenal Obstruction, CTCAE;"Symptomatic; altered GI function";Grade 2 Duodenal obstruction;"Symptomatic; altered GI function";Duodenal obstruction;10013830;LLT;20,1
608;C145229;Grade 3 Duodenal Obstruction, CTCAE;"Hospitalization indicated; invasive intervention indicated";Grade 3 Duodenal obstruction;"Hospitalization indicated; invasive intervention indicated";Duodenal obstruction;10013830;LLT;20,1
609;C145822;Grade 4 Duodenal Obstruction, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Duodenal obstruction;"Life-threatening consequences; urgent operative intervention indicated";Duodenal obstruction;10013830;LLT;20,1
610;C146283;Grade 5 Duodenal Obstruction, CTCAE;Death;Grade 5 Duodenal obstruction;Death;Duodenal obstruction;10013830;LLT;20,1
611;C143417;Duodenal Perforation, CTCAE;A disorder characterized by a rupture in the duodenal wall.;Duodenal perforation;A disorder characterized by a rupture in the duodenal wall.;Duodenal perforation;10013832;LLT;20,1
612;C144613;Grade 2 Duodenal Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Duodenal perforation;Invasive intervention not indicated;Duodenal perforation;10013832;LLT;20,1
613;C145230;Grade 3 Duodenal Perforation, CTCAE;Invasive intervention indicated;Grade 3 Duodenal perforation;Invasive intervention indicated;Duodenal perforation;10013832;LLT;20,1
614;C145823;Grade 4 Duodenal Perforation, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Duodenal perforation;"Life-threatening consequences; urgent operative intervention indicated";Duodenal perforation;10013832;LLT;20,1
615;C146284;Grade 5 Duodenal Perforation, CTCAE;Death;Grade 5 Duodenal perforation;Death;Duodenal perforation;10013832;LLT;20,1
616;C143418;Duodenal Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the duodenum.;Duodenal stenosis;A disorder characterized by a narrowing of the lumen of the duodenum.;Duodenal stenosis;10050094;LLT;20,1
617;C144058;Grade 1 Duodenal Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Duodenal stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Duodenal stenosis;10050094;LLT;20,1
618;C144614;Grade 2 Duodenal Stenosis, CTCAE;"Symptomatic; altered GI function";Grade 2 Duodenal stenosis;"Symptomatic; altered GI function";Duodenal stenosis;10050094;LLT;20,1
619;C145231;Grade 3 Duodenal Stenosis, CTCAE;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Grade 3 Duodenal stenosis;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Duodenal stenosis;10050094;LLT;20,1
620;C145824;Grade 4 Duodenal Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Duodenal stenosis;"Life-threatening consequences; urgent operative intervention indicated";Duodenal stenosis;10050094;LLT;20,1
621;C146285;Grade 5 Duodenal Stenosis, CTCAE;Death;Grade 5 Duodenal stenosis;Death;Duodenal stenosis;10050094;LLT;20,1
622;C143419;Duodenal Ulcer, CTCAE;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the duodenal wall.;Duodenal ulcer;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the duodenal wall.;Duodenal ulcer;10013836;LLT;20,1
623;C144059;Grade 1 Duodenal Ulcer, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Duodenal ulcer;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Duodenal ulcer;10013836;LLT;20,1
624;C144615;Grade 2 Duodenal Ulcer, CTCAE;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Grade 2 Duodenal ulcer;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Duodenal ulcer;10013836;LLT;20,1
625;C145232;Grade 3 Duodenal Ulcer, CTCAE;"Severely altered GI function; TPN indicated; elective invasive intervention indicated; limiting self care ADL";Grade 3 Duodenal ulcer;"Severely altered GI function; TPN indicated; elective invasive intervention indicated; limiting self care ADL";Duodenal ulcer;10013836;LLT;20,1
626;C145825;Grade 4 Duodenal Ulcer, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Duodenal ulcer;"Life-threatening consequences; urgent operative intervention indicated";Duodenal ulcer;10013836;LLT;20,1
627;C146286;Grade 5 Duodenal Ulcer, CTCAE;Death;Grade 5 Duodenal ulcer;Death;Duodenal ulcer;10013836;LLT;20,1
628;C57789;Duodenal Fistula, CTCAE;A disorder characterized by an abnormal communication between the duodenum and another organ or anatomic site.;Duodenal fistula;A disorder characterized by an abnormal communication between the duodenum and another organ or anatomic site.;Duodenal fistula;10013828;LLT;20,1
629;C57171;Grade 1 Duodenal Fistula, CTCAE;Asymptomatic;Grade 1 Duodenal fistula;Asymptomatic;Duodenal fistula;10013828;LLT;20,1
630;C57294;Grade 2 Duodenal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Duodenal fistula;Symptomatic, invasive intervention not indicated;Duodenal fistula;10013828;LLT;20,1
631;C57419;Grade 3 Duodenal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Duodenal fistula;Invasive intervention indicated;Duodenal fistula;10013828;LLT;20,1
632;C57554;Grade 4 Duodenal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Duodenal fistula;"Life-threatening consequences; urgent intervention indicated";Duodenal fistula;10013828;LLT;20,1
633;C57685;Grade 5 Duodenal Fistula, CTCAE;Death;Grade 5 Duodenal fistula;Death;Duodenal fistula;10013828;LLT;20,1
634;C143425;Dyspepsia, CTCAE;A disorder characterized by an uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach, bloating, heartburn, nausea and vomiting.;Dyspepsia;A disorder characterized by an uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach, bloating, heartburn, nausea and vomiting.;Dyspepsia;10013946;LLT;20,1
635;C144065;Grade 1 Dyspepsia, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Dyspepsia;"Mild symptoms; intervention not indicated";Dyspepsia;10013946;LLT;20,1
636;C144621;Grade 2 Dyspepsia, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Dyspepsia;"Moderate symptoms; medical intervention indicated";Dyspepsia;10013946;LLT;20,1
637;C145237;Grade 3 Dyspepsia, CTCAE;"Severe symptoms; operative intervention indicated";Grade 3 Dyspepsia;"Severe symptoms; operative intervention indicated";Dyspepsia;10013946;LLT;20,1
638;C57795;Dysphagia, CTCAE;A disorder characterized by difficulty in swallowing.;Dysphagia;A disorder characterized by difficulty in swallowing.;Dysphagia;10013950;LLT;20,1
639;C57176;Grade 1 Dysphagia, CTCAE;Symptomatic, able to eat regular diet;Grade 1 Dysphagia;Symptomatic, able to eat regular diet;Dysphagia;10013950;LLT;20,1
640;C57299;Grade 2 Dysphagia, CTCAE;Symptomatic and altered eating/swallowing;Grade 2 Dysphagia;Symptomatic and altered eating/swallowing;Dysphagia;10013950;LLT;20,1
641;C57425;Grade 3 Dysphagia, CTCAE;"Severely altered eating/swallowing; tube feeding, TPN, or hospitalization indicated";Grade 3 Dysphagia;"Severely altered eating/swallowing; tube feeding, TPN, or hospitalization indicated";Dysphagia;10013950;LLT;20,1
642;C57560;Grade 4 Dysphagia, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Dysphagia;"Life-threatening consequences; urgent intervention indicated";Dysphagia;10013950;LLT;20,1
643;C57691;Grade 5 Dysphagia, CTCAE;Death;Grade 5 Dysphagia;Death;Dysphagia;10013950;LLT;20,1
644;C143445;Enterocolitis, CTCAE;A disorder characterized by inflammation of the small and large intestines.;Enterocolitis;A disorder characterized by inflammation of the small and large intestines.;Enterocolitis;10014893;LLT;20,1
645;C144079;Grade 1 Enterocolitis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Enterocolitis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Enterocolitis;10014893;LLT;20,1
646;C144636;Grade 2 Enterocolitis, CTCAE;"Abdominal pain; mucus or blood in stool";Grade 2 Enterocolitis;"Abdominal pain; mucus or blood in stool";Enterocolitis;10014893;LLT;20,1
647;C145254;Grade 3 Enterocolitis, CTCAE;"Severe or persistent abdominal pain; fever; ileus; peritoneal signs";Grade 3 Enterocolitis;"Severe or persistent abdominal pain; fever; ileus; peritoneal signs";Enterocolitis;10014893;LLT;20,1
648;C145836;Grade 4 Enterocolitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Enterocolitis;"Life-threatening consequences; urgent intervention indicated";Enterocolitis;10014893;LLT;20,1
649;C146294;Grade 5 Enterocolitis, CTCAE;Death;Grade 5 Enterocolitis;Death;Enterocolitis;10014893;LLT;20,1
650;C143446;Enterovesical Fistula, CTCAE;A disorder characterized by an abnormal communication between the urinary bladder and the intestine.;Enterovesical fistula;A disorder characterized by an abnormal communication between the urinary bladder and the intestine.;Enterovesical fistula;10062570;LLT;20,1
651;C144080;Grade 1 Enterovesical Fistula, CTCAE;Asymptomatic;Grade 1 Enterovesical fistula;Asymptomatic;Enterovesical fistula;10062570;LLT;20,1
652;C144637;Grade 2 Enterovesical Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Enterovesical fistula;Symptomatic, invasive intervention not indicated;Enterovesical fistula;10062570;LLT;20,1
653;C145255;Grade 3 Enterovesical Fistula, CTCAE;Invasive intervention indicated;Grade 3 Enterovesical fistula;Invasive intervention indicated;Enterovesical fistula;10062570;LLT;20,1
654;C145837;Grade 4 Enterovesical Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Enterovesical fistula;"Life-threatening consequences; urgent intervention indicated";Enterovesical fistula;10062570;LLT;20,1
655;C146295;Grade 5 Enterovesical Fistula, CTCAE;Death;Grade 5 Enterovesical fistula;Death;Enterovesical fistula;10062570;LLT;20,1
656;C143453;Esophageal Hemorrhage, CTCAE;A disorder characterized by bleeding from the esophagus.;Esophageal hemorrhage;A disorder characterized by bleeding from the esophagus.;Esophageal hemorrhage;10015384;LLT;20,1
657;C144087;Grade 1 Esophageal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Esophageal hemorrhage;"Mild symptoms; intervention not indicated";Esophageal hemorrhage;10015384;LLT;20,1
658;C144644;Grade 2 Esophageal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Esophageal hemorrhage;"Moderate symptoms; intervention indicated";Esophageal hemorrhage;10015384;LLT;20,1
659;C145263;Grade 3 Esophageal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Esophageal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Esophageal hemorrhage;10015384;LLT;20,1
660;C145844;Grade 4 Esophageal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Esophageal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Esophageal hemorrhage;10015384;LLT;20,1
661;C146302;Grade 5 Esophageal Hemorrhage, CTCAE;Death;Grade 5 Esophageal hemorrhage;Death;Esophageal hemorrhage;10015384;LLT;20,1
662;C143455;Esophageal Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the esophageal wall.;Esophageal necrosis;A disorder characterized by a necrotic process occurring in the esophageal wall.;Esophageal necrosis;10065727;LLT;20,1
663;C145265;Grade 3 Esophageal Necrosis, CTCAE;"Inability to aliment adequately by GI tract; invasive intervention indicated";Grade 3 Esophageal necrosis;"Inability to aliment adequately by GI tract; invasive intervention indicated";Esophageal necrosis;10065727;LLT;20,1
664;C145846;Grade 4 Esophageal Necrosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Esophageal necrosis;"Life-threatening consequences; urgent operative intervention indicated";Esophageal necrosis;10065727;LLT;20,1
665;C146304;Grade 5 Esophageal Necrosis, CTCAE;Death;Grade 5 Esophageal necrosis;Death;Esophageal necrosis;10065727;LLT;20,1
666;C143456;Esophageal Obstruction, CTCAE;A disorder characterized by blockage of the normal flow of the contents in the esophagus.;Esophageal obstruction;A disorder characterized by blockage of the normal flow of the contents in the esophagus.;Esophageal obstruction;10015387;LLT;20,1
667;C144088;Grade 1 Esophageal Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Esophageal obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Esophageal obstruction;10015387;LLT;20,1
668;C144646;Grade 2 Esophageal Obstruction, CTCAE;"Symptomatic; altered GI function; limiting instrumental ADL";Grade 2 Esophageal obstruction;"Symptomatic; altered GI function; limiting instrumental ADL";Esophageal obstruction;10015387;LLT;20,1
669;C145266;Grade 3 Esophageal Obstruction, CTCAE;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL";Grade 3 Esophageal obstruction;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL";Esophageal obstruction;10015387;LLT;20,1
670;C145847;Grade 4 Esophageal Obstruction, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Esophageal obstruction;"Life-threatening consequences; urgent intervention indicated";Esophageal obstruction;10015387;LLT;20,1
671;C146305;Grade 5 Esophageal Obstruction, CTCAE;Death;Grade 5 Esophageal obstruction;Death;Esophageal obstruction;10015387;LLT;20,1
672;C143457;Esophageal Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the esophageal region.;Esophageal pain;A disorder characterized by a sensation of marked discomfort in the esophageal region.;Esophageal pain;10015388;LLT;20,1
673;C144089;Grade 1 Esophageal Pain, CTCAE;Mild pain;Grade 1 Esophageal pain;Mild pain;Esophageal pain;10015388;LLT;20,1
674;C144647;Grade 2 Esophageal Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Esophageal pain;"Moderate pain; limiting instrumental ADL";Esophageal pain;10015388;LLT;20,1
675;C145267;Grade 3 Esophageal Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Esophageal pain;"Severe pain; limiting self care ADL";Esophageal pain;10015388;LLT;20,1
676;C143458;Esophageal Perforation, CTCAE;A disorder characterized by a rupture in the wall of the esophagus.;Esophageal perforation;A disorder characterized by a rupture in the wall of the esophagus.;Esophageal perforation;10055472;LLT;20,1
677;C144648;Grade 2 Esophageal Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Esophageal perforation;Invasive intervention not indicated;Esophageal perforation;10055472;LLT;20,1
678;C145268;Grade 3 Esophageal Perforation, CTCAE;Invasive intervention indicated;Grade 3 Esophageal perforation;Invasive intervention indicated;Esophageal perforation;10055472;LLT;20,1
679;C145848;Grade 4 Esophageal Perforation, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Esophageal perforation;"Life-threatening consequences; urgent operative intervention indicated";Esophageal perforation;10055472;LLT;20,1
680;C146306;Grade 5 Esophageal Perforation, CTCAE;Death;Grade 5 Esophageal perforation;Death;Esophageal perforation;10055472;LLT;20,1
681;C143459;Esophageal Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the esophagus.;Esophageal stenosis;A disorder characterized by a narrowing of the lumen of the esophagus.;Esophageal stenosis;10015448;LLT;20,1
682;C144090;Grade 1 Esophageal Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Esophageal stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Esophageal stenosis;10015448;LLT;20,1
683;C144649;Grade 2 Esophageal Stenosis, CTCAE;"Symptomatic; altered GI function";Grade 2 Esophageal stenosis;"Symptomatic; altered GI function";Esophageal stenosis;10015448;LLT;20,1
684;C145269;Grade 3 Esophageal Stenosis, CTCAE;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Grade 3 Esophageal stenosis;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Esophageal stenosis;10015448;LLT;20,1
685;C145849;Grade 4 Esophageal Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Esophageal stenosis;"Life-threatening consequences; urgent operative intervention indicated";Esophageal stenosis;10015448;LLT;20,1
686;C146307;Grade 5 Esophageal Stenosis, CTCAE;Death;Grade 5 Esophageal stenosis;Death;Esophageal stenosis;10015448;LLT;20,1
687;C143460;Esophageal Ulcer, CTCAE;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the esophageal wall.;Esophageal ulcer;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the esophageal wall.;Esophageal ulcer;10015451;LLT;20,1
688;C144091;Grade 1 Esophageal Ulcer, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Esophageal ulcer;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Esophageal ulcer;10015451;LLT;20,1
689;C144650;Grade 2 Esophageal Ulcer, CTCAE;"Symptomatic; altered GI function; limiting instrumental ADL";Grade 2 Esophageal ulcer;"Symptomatic; altered GI function; limiting instrumental ADL";Esophageal ulcer;10015451;LLT;20,1
690;C145270;Grade 3 Esophageal Ulcer, CTCAE;"Severely altered GI function; TPN indicated; elective invasive intervention indicated; limiting self care ADL";Grade 3 Esophageal ulcer;"Severely altered GI function; TPN indicated; elective invasive intervention indicated; limiting self care ADL";Esophageal ulcer;10015451;LLT;20,1
691;C145850;Grade 4 Esophageal Ulcer, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Esophageal ulcer;"Life-threatening consequences; urgent operative intervention indicated";Esophageal ulcer;10015451;LLT;20,1
692;C146308;Grade 5 Esophageal Ulcer, CTCAE;Death;Grade 5 Esophageal ulcer;Death;Esophageal ulcer;10015451;LLT;20,1
693;C146710;Esophageal Varices Hemorrhage, CTCAE 5.0;A disorder characterized by bleeding from esophageal varices.;Esophageal varices hemorrhage;A disorder characterized by bleeding from esophageal varices.;Esophageal varices hemorrhage;10015453;LLT;20,1
694;C56342;Grade 2 Esophageal Varices Hemorrhage, CTCAE;"Self-limited; intervention not indicated";Grade 2 Esophageal varices hemorrhage;"Self-limited; intervention not indicated";Esophageal varices hemorrhage;10015453;LLT;20,1
695;C56391;Grade 3 Esophageal Varices Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Esophageal varices hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Esophageal varices hemorrhage;10015453;LLT;20,1
696;C56441;Grade 4 Esophageal Varices Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Esophageal varices hemorrhage;"Life-threatening consequences; urgent intervention indicated";Esophageal varices hemorrhage;10015453;LLT;20,1
697;C56490;Grade 5 Esophageal Varices Hemorrhage, CTCAE;Death;Grade 5 Esophageal varices hemorrhage;Death;Esophageal varices hemorrhage;10015453;LLT;20,1
698;C57797;Esophagitis, CTCAE;A disorder characterized by inflammation of the esophageal wall.;Esophagitis;A disorder characterized by inflammation of the esophageal wall.;Esophagitis;10015461;LLT;20,1
699;C57178;Grade 1 Esophagitis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Esophagitis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Esophagitis;10015461;LLT;20,1
700;C57301;Grade 2 Esophagitis, CTCAE;"Symptomatic; altered eating/swallowing; oral supplements indicated";Grade 2 Esophagitis;"Symptomatic; altered eating/swallowing; oral supplements indicated";Esophagitis;10015461;LLT;20,1
701;C57427;Grade 3 Esophagitis, CTCAE;"Severely altered eating/swallowing; tube feeding, TPN, or hospitalization indicated";Grade 3 Esophagitis;"Severely altered eating/swallowing; tube feeding, TPN, or hospitalization indicated";Esophagitis;10015461;LLT;20,1
702;C57562;Grade 4 Esophagitis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Esophagitis;"Life-threatening consequences; urgent operative intervention indicated";Esophagitis;10015461;LLT;20,1
703;C57693;Grade 5 Esophagitis, CTCAE;Death;Grade 5 Esophagitis;Death;Esophagitis;10015461;LLT;20,1
704;C57798;Esophageal Fistula, CTCAE;A disorder characterized by an abnormal communication between the esophagus and another organ or anatomic site.;Esophageal fistula;A disorder characterized by an abnormal communication between the esophagus and another organ or anatomic site.;Esophageal fistula;10065851;LLT;20,1
705;C57179;Grade 1 Esophageal Fistula, CTCAE;Asymptomatic;Grade 1 Esophageal fistula;Asymptomatic;Esophageal fistula;10065851;LLT;20,1
706;C57302;Grade 2 Esophageal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Esophageal fistula;Symptomatic, invasive intervention not indicated;Esophageal fistula;10065851;LLT;20,1
707;C57428;Grade 3 Esophageal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Esophageal fistula;Invasive intervention indicated;Esophageal fistula;10065851;LLT;20,1
708;C57563;Grade 4 Esophageal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Esophageal fistula;"Life-threatening consequences; urgent intervention indicated";Esophageal fistula;10065851;LLT;20,1
709;C57694;Grade 5 Esophageal Fistula, CTCAE;Death;Grade 5 Esophageal fistula;Death;Esophageal fistula;10065851;LLT;20,1
710;C143482;Fecal Incontinence, CTCAE;A disorder characterized by inability to control the escape of stool from the rectum.;Fecal incontinence;A disorder characterized by inability to control the escape of stool from the rectum.;Fecal incontinence;10016296;LLT;20,1
711;C144102;Grade 1 Fecal Incontinence, CTCAE;Occasional use of pads required;Grade 1 Fecal incontinence;Occasional use of pads required;Fecal incontinence;10016296;LLT;20,1
712;C144662;Grade 2 Fecal Incontinence, CTCAE;Daily use of pads required;Grade 2 Fecal incontinence;Daily use of pads required;Fecal incontinence;10016296;LLT;20,1
713;C145283;Grade 3 Fecal Incontinence, CTCAE;"Severe symptoms; elective operative intervention indicated";Grade 3 Fecal incontinence;"Severe symptoms; elective operative intervention indicated";Fecal incontinence;10016296;LLT;20,1
714;C57807;Flatulence, CTCAE;A disorder characterized by a discharge of excessive gas from the lower GI tract.;Flatulence;A disorder characterized by a discharge of excessive gas from the lower GI tract.;Flatulence;10016766;LLT;20,1
715;C57187;Grade 1 Flatulence, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Flatulence;"Mild symptoms; intervention not indicated";Flatulence;10016766;LLT;20,1
716;C57310;Grade 2 Flatulence, CTCAE;"Moderate; persistent; psychosocial sequelae";Grade 2 Flatulence;"Moderate; persistent; psychosocial sequelae";Flatulence;10016766;LLT;20,1
717;C143499;Gastric Fistula, CTCAE;A disorder characterized by an abnormal communication between the stomach and another organ or anatomic site.;Gastric fistula;A disorder characterized by an abnormal communication between the stomach and another organ or anatomic site.;Gastric fistula;10065713;LLT;20,1
718;C144115;Grade 1 Gastric Fistula, CTCAE;Asymptomatic;Grade 1 Gastric fistula;Asymptomatic;Gastric fistula;10065713;LLT;20,1
719;C144678;Grade 2 Gastric Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Gastric fistula;Symptomatic, invasive intervention not indicated;Gastric fistula;10065713;LLT;20,1
720;C145299;Grade 3 Gastric Fistula, CTCAE;Invasive intervention indicated;Grade 3 Gastric fistula;Invasive intervention indicated;Gastric fistula;10065713;LLT;20,1
721;C145864;Grade 4 Gastric Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Gastric fistula;"Life-threatening consequences; urgent intervention indicated";Gastric fistula;10065713;LLT;20,1
722;C146317;Grade 5 Gastric Fistula, CTCAE;Death;Grade 5 Gastric fistula;Death;Gastric fistula;10065713;LLT;20,1
723;C143500;Gastric Hemorrhage, CTCAE;A disorder characterized by bleeding from the gastric wall.;Gastric hemorrhage;A disorder characterized by bleeding from the gastric wall.;Gastric hemorrhage;10017789;LLT;20,1
724;C144116;Grade 1 Gastric Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Gastric hemorrhage;"Mild symptoms; intervention not indicated";Gastric hemorrhage;10017789;LLT;20,1
725;C144679;Grade 2 Gastric Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Gastric hemorrhage;"Moderate symptoms; intervention indicated";Gastric hemorrhage;10017789;LLT;20,1
726;C145300;Grade 3 Gastric Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Gastric hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Gastric hemorrhage;10017789;LLT;20,1
727;C145865;Grade 4 Gastric Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Gastric hemorrhage;"Life-threatening consequences; urgent intervention indicated";Gastric hemorrhage;10017789;LLT;20,1
728;C146318;Grade 5 Gastric Hemorrhage, CTCAE;Death;Grade 5 Gastric hemorrhage;Death;Gastric hemorrhage;10017789;LLT;20,1
729;C143501;Gastric Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the gastric wall.;Gastric necrosis;A disorder characterized by a necrotic process occurring in the gastric wall.;Gastric necrosis;10051886;LLT;20,1
730;C145301;Grade 3 Gastric Necrosis, CTCAE;"Inability to aliment adequately by GI tract; invasive intervention indicated";Grade 3 Gastric necrosis;"Inability to aliment adequately by GI tract; invasive intervention indicated";Gastric necrosis;10051886;LLT;20,1
731;C145866;Grade 4 Gastric Necrosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Gastric necrosis;"Life-threatening consequences; urgent operative intervention indicated";Gastric necrosis;10051886;LLT;20,1
732;C146319;Grade 5 Gastric Necrosis, CTCAE;Death;Grade 5 Gastric necrosis;Death;Gastric necrosis;10051886;LLT;20,1
733;C143502;Gastric Perforation, CTCAE;A disorder characterized by a rupture in the stomach wall.;Gastric perforation;A disorder characterized by a rupture in the stomach wall.;Gastric perforation;10017815;LLT;20,1
734;C144680;Grade 2 Gastric Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Gastric perforation;Invasive intervention not indicated;Gastric perforation;10017815;LLT;20,1
735;C145302;Grade 3 Gastric Perforation, CTCAE;Invasive intervention indicated;Grade 3 Gastric perforation;Invasive intervention indicated;Gastric perforation;10017815;LLT;20,1
736;C145867;Grade 4 Gastric Perforation, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Gastric perforation;"Life-threatening consequences; urgent operative intervention indicated";Gastric perforation;10017815;LLT;20,1
737;C146320;Grade 5 Gastric Perforation, CTCAE;Death;Grade 5 Gastric perforation;Death;Gastric perforation;10017815;LLT;20,1
738;C143503;Gastric Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the stomach.;Gastric stenosis;A disorder characterized by a narrowing of the lumen of the stomach.;Gastric stenosis;10061970;LLT;20,1
739;C144117;Grade 1 Gastric Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Gastric stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Gastric stenosis;10061970;LLT;20,1
740;C144681;Grade 2 Gastric Stenosis, CTCAE;"Symptomatic; altered GI function";Grade 2 Gastric stenosis;"Symptomatic; altered GI function";Gastric stenosis;10061970;LLT;20,1
741;C145303;Grade 3 Gastric Stenosis, CTCAE;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Grade 3 Gastric stenosis;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Gastric stenosis;10061970;LLT;20,1
742;C145868;Grade 4 Gastric Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Gastric stenosis;"Life-threatening consequences; urgent operative intervention indicated";Gastric stenosis;10061970;LLT;20,1
743;C146321;Grade 5 Gastric Stenosis, CTCAE;Death;Grade 5 Gastric stenosis;Death;Gastric stenosis;10061970;LLT;20,1
744;C143504;Gastric Ulcer, CTCAE;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the stomach.;Gastric ulcer;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the stomach.;Gastric ulcer;10017822;LLT;20,1
745;C144118;Grade 1 Gastric Ulcer, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Gastric ulcer;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Gastric ulcer;10017822;LLT;20,1
746;C144682;Grade 2 Gastric Ulcer, CTCAE;"Symptomatic; altered GI function; medical intervention indicated; limiting instrumental ADL";Grade 2 Gastric ulcer;"Symptomatic; altered GI function; medical intervention indicated; limiting instrumental ADL";Gastric ulcer;10017822;LLT;20,1
747;C145304;Grade 3 Gastric Ulcer, CTCAE;"Severely altered GI function; TPN indicated; elective invasive intervention indicated; limiting self care ADL";Grade 3 Gastric ulcer;"Severely altered GI function; TPN indicated; elective invasive intervention indicated; limiting self care ADL";Gastric ulcer;10017822;LLT;20,1
748;C145869;Grade 4 Gastric Ulcer, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Gastric ulcer;"Life-threatening consequences; urgent operative intervention indicated";Gastric ulcer;10017822;LLT;20,1
749;C146322;Grade 5 Gastric Ulcer, CTCAE;Death;Grade 5 Gastric ulcer;Death;Gastric ulcer;10017822;LLT;20,1
750;C57812;Gastritis, CTCAE;A disorder characterized by inflammation of the stomach.;Gastritis;A disorder characterized by inflammation of the stomach.;Gastritis;10017853;LLT;20,1
751;C57191;Grade 1 Gastritis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Gastritis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Gastritis;10017853;LLT;20,1
752;C57314;Grade 2 Gastritis, CTCAE;"Symptomatic; altered GI function; medical intervention indicated";Grade 2 Gastritis;"Symptomatic; altered GI function; medical intervention indicated";Gastritis;10017853;LLT;20,1
753;C57441;Grade 3 Gastritis, CTCAE;"Severely altered eating or gastric function; TPN or hospitalization indicated";Grade 3 Gastritis;"Severely altered eating or gastric function; TPN or hospitalization indicated";Gastritis;10017853;LLT;20,1
754;C57576;Grade 4 Gastritis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Gastritis;"Life-threatening consequences; urgent operative intervention indicated";Gastritis;10017853;LLT;20,1
755;C57707;Grade 5 Gastritis, CTCAE;Death;Grade 5 Gastritis;Death;Gastritis;10017853;LLT;20,1
756;C143506;Gastroesophageal Reflux Disease, CTCAE;A disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is chronic in nature and usually caused by incompetence of the lower esophageal sphincter, and may result in injury to the esophageal mucosal. Symptoms include heartburn and acid indigestion.;Gastroesophageal reflux disease;A disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is chronic in nature and usually caused by incompetence of the lower esophageal sphincter, and may result in injury to the esophageal mucosal. Symptoms include heartburn and acid indigestion.;Gastroesophageal reflux disease;10066874;LLT;20,1
757;C144119;Grade 1 Gastroesophageal Reflux Disease, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Gastroesophageal reflux disease;"Mild symptoms; intervention not indicated";Gastroesophageal reflux disease;10066874;LLT;20,1
758;C144683;Grade 2 Gastroesophageal Reflux Disease, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Gastroesophageal reflux disease;"Moderate symptoms; medical intervention indicated";Gastroesophageal reflux disease;10066874;LLT;20,1
759;C145305;Grade 3 Gastroesophageal Reflux Disease, CTCAE;"Severe symptoms; operative intervention indicated";Grade 3 Gastroesophageal reflux disease;"Severe symptoms; operative intervention indicated";Gastroesophageal reflux disease;10066874;LLT;20,1
760;C143508;Gastrointestinal Disorders - Other, Specify, CTCAE;;Gastrointestinal disorders - Other, specify;;Gastrointestinal disorders - Other, specify;10017947;LLT;20,1
761;C144121;Grade 1 Gastrointestinal Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Gastrointestinal disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Gastrointestinal disorders - Other, specify;10017947;LLT;20,1
762;C144685;Grade 2 Gastrointestinal Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Gastrointestinal disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Gastrointestinal disorders - Other, specify;10017947;LLT;20,1
763;C145307;Grade 3 Gastrointestinal Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Gastrointestinal disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Gastrointestinal disorders - Other, specify;10017947;LLT;20,1
764;C145871;Grade 4 Gastrointestinal Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Gastrointestinal disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Gastrointestinal disorders - Other, specify;10017947;LLT;20,1
765;C146324;Grade 5 Gastrointestinal Disorders - Other, Specify, CTCAE;Death;Grade 5 Gastrointestinal disorders - Other, specify;Death;Gastrointestinal disorders - Other, specify;10017947;LLT;20,1
766;C146637;Gastrointestinal Fistula, CTCAE 5.0;A disorder characterized by an abnormal communication between any part of the gastrointestinal system and another organ or anatomic site.;Gastrointestinal fistula;A disorder characterized by an abnormal communication between any part of the gastrointestinal system and another organ or anatomic site.;Gastrointestinal fistula;10017877;LLT;20,1
767;C144122;Grade 1 Gastrointestinal Fistula, CTCAE;Asymptomatic;Grade 1 Gastrointestinal fistula;Asymptomatic;Gastrointestinal fistula;10017877;LLT;20,1
768;C144686;Grade 2 Gastrointestinal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Gastrointestinal fistula;Symptomatic, invasive intervention not indicated;Gastrointestinal fistula;10017877;LLT;20,1
769;C145308;Grade 3 Gastrointestinal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Gastrointestinal fistula;Invasive intervention indicated;Gastrointestinal fistula;10017877;LLT;20,1
770;C145872;Grade 4 Gastrointestinal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Gastrointestinal fistula;"Life-threatening consequences; urgent intervention indicated";Gastrointestinal fistula;10017877;LLT;20,1
771;C146325;Grade 5 Gastrointestinal Fistula, CTCAE;Death;Grade 5 Gastrointestinal fistula;Death;Gastrointestinal fistula;10017877;LLT;20,1
772;C57814;Ileus, CTCAE;A disorder characterized by failure of the ileum to transport intestinal contents.;Ileus;A disorder characterized by failure of the ileum to transport intestinal contents.;Ileus;10021328;LLT;20,1
773;C57202;Grade 1 Ileus, CTCAE;Asymptomatic and radiologic observations only;Grade 1 Ileus;Asymptomatic and radiologic observations only;Ileus;10021328;LLT;20,1
774;C57324;Grade 2 Ileus, CTCAE;"Symptomatic; altered GI function; bowel rest indicated";Grade 2 Ileus;"Symptomatic; altered GI function; bowel rest indicated";Ileus;10021328;LLT;20,1
775;C57454;Grade 3 Ileus, CTCAE;"Severely altered GI function; TPN indicated; tube placement indicated";Grade 3 Ileus;"Severely altered GI function; TPN indicated; tube placement indicated";Ileus;10021328;LLT;20,1
776;C57588;Grade 4 Ileus, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Ileus;"Life-threatening consequences; urgent intervention indicated";Ileus;10021328;LLT;20,1
777;C57719;Grade 5 Ileus, CTCAE;Death;Grade 5 Ileus;Death;Ileus;10021328;LLT;20,1
778;C143510;Gastrointestinal Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the gastrointestinal region.;Gastrointestinal pain;A disorder characterized by a sensation of marked discomfort in the gastrointestinal region.;Gastrointestinal pain;10017999;LLT;20,1
779;C144123;Grade 1 Gastrointestinal Pain, CTCAE;Mild pain;Grade 1 Gastrointestinal pain;Mild pain;Gastrointestinal pain;10017999;LLT;20,1
780;C144687;Grade 2 Gastrointestinal Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Gastrointestinal pain;"Moderate pain; limiting instrumental ADL";Gastrointestinal pain;10017999;LLT;20,1
781;C145309;Grade 3 Gastrointestinal Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Gastrointestinal pain;"Severe pain; limiting self care ADL";Gastrointestinal pain;10017999;LLT;20,1
782;C143512;Gastroparesis, CTCAE;A disorder characterized by an incomplete paralysis of the muscles of the stomach wall resulting in delayed emptying of the gastric contents into the small intestine.;Gastroparesis;A disorder characterized by an incomplete paralysis of the muscles of the stomach wall resulting in delayed emptying of the gastric contents into the small intestine.;Gastroparesis;10018043;LLT;20,1
783;C144124;Grade 1 Gastroparesis, CTCAE;Mild nausea, early satiety and bloating, able to maintain caloric intake on regular diet;Grade 1 Gastroparesis;Mild nausea, early satiety and bloating, able to maintain caloric intake on regular diet;Gastroparesis;10018043;LLT;20,1
784;C144689;Grade 2 Gastroparesis, CTCAE;"Moderate symptoms; able to maintain nutrition with dietary and lifestyle modifications; may need pharmacologic intervention";Grade 2 Gastroparesis;"Moderate symptoms; able to maintain nutrition with dietary and lifestyle modifications; may need pharmacologic intervention";Gastroparesis;10018043;LLT;20,1
785;C145311;Grade 3 Gastroparesis, CTCAE;"Weight loss >=20% from baseline; tube feeding or TPN indicated; elective operative intervention indicated";Grade 3 Gastroparesis;"Weight loss >=20% from baseline; tube feeding or TPN indicated; elective operative intervention indicated";Gastroparesis;10018043;LLT;20,1
786;C145874;Grade 4 Gastroparesis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Gastroparesis;"Life-threatening consequences; urgent intervention indicated";Gastroparesis;10018043;LLT;20,1
787;C146626;Gingival Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the gingival region.;Gingival pain;A disorder characterized by a sensation of marked discomfort in the gingival region.;Gingival pain;10018286;LLT;20,1
788;C144130;Grade 1 Gingival Pain, CTCAE;Mild pain;Grade 1 Gingival pain;Mild pain;Gingival pain;10018286;LLT;20,1
789;C144695;Grade 2 Gingival Pain, CTCAE;Moderate pain interfering with oral intake;Grade 2 Gingival pain;Moderate pain interfering with oral intake;Gingival pain;10018286;LLT;20,1
790;C145317;Grade 3 Gingival Pain, CTCAE;"Severe pain; inability to aliment orally";Grade 3 Gingival pain;"Severe pain; inability to aliment orally";Gingival pain;10018286;LLT;20,1
791;C143537;Hemorrhoidal Hemorrhage, CTCAE;A disorder characterized by bleeding from the hemorrhoids.;Hemorrhoidal hemorrhage;A disorder characterized by bleeding from the hemorrhoids.;Hemorrhoidal hemorrhage;10060640;LLT;20,1
792;C144149;Grade 1 Hemorrhoidal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Hemorrhoidal hemorrhage;"Mild symptoms; intervention not indicated";Hemorrhoidal hemorrhage;10060640;LLT;20,1
793;C144710;Grade 2 Hemorrhoidal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Hemorrhoidal hemorrhage;"Moderate symptoms; intervention indicated";Hemorrhoidal hemorrhage;10060640;LLT;20,1
794;C145331;Grade 3 Hemorrhoidal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Hemorrhoidal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Hemorrhoidal hemorrhage;10060640;LLT;20,1
795;C145888;Grade 4 Hemorrhoidal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hemorrhoidal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Hemorrhoidal hemorrhage;10060640;LLT;20,1
796;C146337;Grade 5 Hemorrhoidal Hemorrhage, CTCAE;Death;Grade 5 Hemorrhoidal hemorrhage;Death;Hemorrhoidal hemorrhage;10060640;LLT;20,1
797;C146738;Hemorrhoids, CTCAE 5.0;A disorder characterized by the presence of dilated veins in the rectum and surrounding area.;Hemorrhoids;A disorder characterized by the presence of dilated veins in the rectum and surrounding area.;Hemorrhoids;10019611;LLT;20,1
798;C57196;Grade 1 Hemorrhoids, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hemorrhoids;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Hemorrhoids;10019611;LLT;20,1
799;C57318;Grade 2 Hemorrhoids, CTCAE;"Symptomatic; banding or medical intervention indicated";Grade 2 Hemorrhoids;"Symptomatic; banding or medical intervention indicated";Hemorrhoids;10019611;LLT;20,1
800;C57446;Grade 3 Hemorrhoids, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Hemorrhoids;"Severe symptoms; invasive intervention indicated";Hemorrhoids;10019611;LLT;20,1
801;C146633;Ileal Perforation, CTCAE 5.0;A disorder characterized by a rupture in the ileal wall.;Ileal perforation;A disorder characterized by a rupture in the ileal wall.;Ileal perforation;10021305;LLT;20,1
802;C144751;Grade 2 Ileal Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Ileal perforation;Invasive intervention not indicated;Ileal perforation;10021305;LLT;20,1
803;C145373;Grade 3 Ileal Perforation, CTCAE;Invasive intervention indicated;Grade 3 Ileal perforation;Invasive intervention indicated;Ileal perforation;10021305;LLT;20,1
804;C145922;Grade 4 Ileal Perforation, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Ileal perforation;"Life-threatening consequences; urgent operative intervention indicated";Ileal perforation;10021305;LLT;20,1
805;C146369;Grade 5 Ileal Perforation, CTCAE;Death;Grade 5 Ileal perforation;Death;Ileal perforation;10021305;LLT;20,1
806;C143578;Ileal Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the ileum.;Ileal stenosis;A disorder characterized by a narrowing of the lumen of the ileum.;Ileal stenosis;10021307;LLT;20,1
807;C144190;Grade 1 Ileal Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Ileal stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Ileal stenosis;10021307;LLT;20,1
808;C144752;Grade 2 Ileal Stenosis, CTCAE;"Symptomatic; altered GI function";Grade 2 Ileal stenosis;"Symptomatic; altered GI function";Ileal stenosis;10021307;LLT;20,1
809;C145374;Grade 3 Ileal Stenosis, CTCAE;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Grade 3 Ileal stenosis;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Ileal stenosis;10021307;LLT;20,1
810;C145923;Grade 4 Ileal Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Ileal stenosis;"Life-threatening consequences; urgent operative intervention indicated";Ileal stenosis;10021307;LLT;20,1
811;C146370;Grade 5 Ileal Stenosis, CTCAE;Death;Grade 5 Ileal stenosis;Death;Ileal stenosis;10021307;LLT;20,1
812;C57821;Ileal Fistula, CTCAE;A disorder characterized by an abnormal communication between the ileum and another organ or anatomic site.;Ileal fistula;A disorder characterized by an abnormal communication between the ileum and another organ or anatomic site.;Ileal fistula;10065728;LLT;20,1
813;C57197;Grade 1 Ileal Fistula, CTCAE;Asymptomatic;Grade 1 Ileal fistula;Asymptomatic;Ileal fistula;10065728;LLT;20,1
814;C57319;Grade 2 Ileal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Ileal fistula;Symptomatic, invasive intervention not indicated;Ileal fistula;10065728;LLT;20,1
815;C57448;Grade 3 Ileal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Ileal fistula;Invasive intervention indicated;Ileal fistula;10065728;LLT;20,1
816;C57582;Grade 4 Ileal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Ileal fistula;"Life-threatening consequences; urgent intervention indicated";Ileal fistula;10065728;LLT;20,1
817;C57713;Grade 5 Ileal Fistula, CTCAE;Death;Grade 5 Ileal fistula;Death;Ileal fistula;10065728;LLT;20,1
818;C56542;Ileal Hemorrhage, CTCAE;A disorder characterized by bleeding from the ileal wall.;Ileal hemorrhage;A disorder characterized by bleeding from the ileal wall.;Ileal hemorrhage;10055287;LLT;20,1
819;C56299;Grade 1 Ileal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Ileal hemorrhage;"Mild symptoms; intervention not indicated";Ileal hemorrhage;10055287;LLT;20,1
820;C56348;Grade 2 Ileal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Ileal hemorrhage;"Moderate symptoms; intervention indicated";Ileal hemorrhage;10055287;LLT;20,1
821;C56398;Grade 3 Ileal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Ileal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Ileal hemorrhage;10055287;LLT;20,1
822;C56448;Grade 4 Ileal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Ileal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Ileal hemorrhage;10055287;LLT;20,1
823;C56497;Grade 5 Ileal Hemorrhage, CTCAE;Death;Grade 5 Ileal hemorrhage;Death;Ileal hemorrhage;10055287;LLT;20,1
824;C57823;Ileal Obstruction, CTCAE;A disorder characterized by blockage of the normal flow of the intestinal contents in the ileum.;Ileal obstruction;A disorder characterized by blockage of the normal flow of the intestinal contents in the ileum.;Ileal obstruction;10065730;LLT;20,1
825;C57198;Grade 1 Ileal Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Ileal obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Ileal obstruction;10065730;LLT;20,1
826;C57320;Grade 2 Ileal Obstruction, CTCAE;"Symptomatic; altered GI function; limiting instrumental ADL; naso-gastric tube indicated";Grade 2 Ileal obstruction;"Symptomatic; altered GI function; limiting instrumental ADL; naso-gastric tube indicated";Ileal obstruction;10065730;LLT;20,1
827;C57450;Grade 3 Ileal Obstruction, CTCAE;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL; long intestinal tube indicated";Grade 3 Ileal obstruction;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL; long intestinal tube indicated";Ileal obstruction;10065730;LLT;20,1
828;C57584;Grade 4 Ileal Obstruction, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Ileal obstruction;"Life-threatening consequences; urgent operative intervention indicated";Ileal obstruction;10065730;LLT;20,1
829;C57715;Grade 5 Ileal Obstruction, CTCAE;Death;Grade 5 Ileal obstruction;Death;Ileal obstruction;10065730;LLT;20,1
830;C57826;Ileal Ulcer, CTCAE;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the ileum.;Ileal ulcer;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the ileum.;Ileal ulcer;10021309;LLT;20,1
831;C57201;Grade 1 Ileal Ulcer, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Ileal ulcer;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Ileal ulcer;10021309;LLT;20,1
832;C57323;Grade 2 Ileal Ulcer, CTCAE;"Symptomatic; altered GI function";Grade 2 Ileal ulcer;"Symptomatic; altered GI function";Ileal ulcer;10021309;LLT;20,1
833;C57453;Grade 3 Ileal Ulcer, CTCAE;"Severely altered GI function; TPN indicated; elective invasive intervention indicated";Grade 3 Ileal ulcer;"Severely altered GI function; TPN indicated; elective invasive intervention indicated";Ileal ulcer;10021309;LLT;20,1
834;C57587;Grade 4 Ileal Ulcer, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Ileal ulcer;"Life-threatening consequences; urgent operative intervention indicated";Ileal ulcer;10021309;LLT;20,1
835;C57718;Grade 5 Ileal Ulcer, CTCAE;Death;Grade 5 Ileal ulcer;Death;Ileal ulcer;10021309;LLT;20,1
836;C143595;Intra-Abdominal Hemorrhage, CTCAE;A disorder characterized by bleeding in the abdominal cavity.;Intra-abdominal hemorrhage;A disorder characterized by bleeding in the abdominal cavity.;Intra-abdominal hemorrhage;10055291;LLT;20,1
837;C144770;Grade 2 Intra-Abdominal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Intra-abdominal hemorrhage;"Moderate symptoms; intervention indicated";Intra-abdominal hemorrhage;10055291;LLT;20,1
838;C145392;Grade 3 Intra-Abdominal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Intra-abdominal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Intra-abdominal hemorrhage;10055291;LLT;20,1
839;C145940;Grade 4 Intra-Abdominal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intra-abdominal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Intra-abdominal hemorrhage;10055291;LLT;20,1
840;C146387;Grade 5 Intra-Abdominal Hemorrhage, CTCAE;Death;Grade 5 Intra-abdominal hemorrhage;Death;Intra-abdominal hemorrhage;10055291;LLT;20,1
841;C143622;Jejunal Perforation, CTCAE;A disorder characterized by a rupture in the jejunal wall.;Jejunal perforation;A disorder characterized by a rupture in the jejunal wall.;Jejunal perforation;10023174;LLT;20,1
842;C144795;Grade 2 Jejunal Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Jejunal perforation;Invasive intervention not indicated;Jejunal perforation;10023174;LLT;20,1
843;C145417;Grade 3 Jejunal Perforation, CTCAE;Invasive intervention indicated;Grade 3 Jejunal perforation;Invasive intervention indicated;Jejunal perforation;10023174;LLT;20,1
844;C145964;Grade 4 Jejunal Perforation, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Jejunal perforation;"Life-threatening consequences; urgent operative intervention indicated";Jejunal perforation;10023174;LLT;20,1
845;C146411;Grade 5 Jejunal Perforation, CTCAE;Death;Grade 5 Jejunal perforation;Death;Jejunal perforation;10023174;LLT;20,1
846;C143623;Jejunal Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the jejunum.;Jejunal stenosis;A disorder characterized by a narrowing of the lumen of the jejunum.;Jejunal stenosis;10023176;LLT;20,1
847;C144227;Grade 1 Jejunal Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Jejunal stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Jejunal stenosis;10023176;LLT;20,1
848;C144796;Grade 2 Jejunal Stenosis, CTCAE;"Symptomatic; altered GI function";Grade 2 Jejunal stenosis;"Symptomatic; altered GI function";Jejunal stenosis;10023176;LLT;20,1
849;C145418;Grade 3 Jejunal Stenosis, CTCAE;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Grade 3 Jejunal stenosis;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Jejunal stenosis;10023176;LLT;20,1
850;C145965;Grade 4 Jejunal Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Jejunal stenosis;"Life-threatening consequences; urgent operative intervention indicated";Jejunal stenosis;10023176;LLT;20,1
851;C146412;Grade 5 Jejunal Stenosis, CTCAE;Death;Grade 5 Jejunal stenosis;Death;Jejunal stenosis;10023176;LLT;20,1
852;C57827;Jejunal Fistula, CTCAE;A disorder characterized by an abnormal communication between the jejunum and another organ or anatomic site.;Jejunal fistula;A disorder characterized by an abnormal communication between the jejunum and another organ or anatomic site.;Jejunal fistula;10065719;LLT;20,1
853;C57203;Grade 1 Jejunal Fistula, CTCAE;Asymptomatic;Grade 1 Jejunal fistula;Asymptomatic;Jejunal fistula;10065719;LLT;20,1
854;C57325;Grade 2 Jejunal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Jejunal fistula;Symptomatic, invasive intervention not indicated;Jejunal fistula;10065719;LLT;20,1
855;C57455;Grade 3 Jejunal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Jejunal fistula;Invasive intervention indicated;Jejunal fistula;10065719;LLT;20,1
856;C57589;Grade 4 Jejunal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Jejunal fistula;"Life-threatening consequences; urgent intervention indicated";Jejunal fistula;10065719;LLT;20,1
857;C57720;Grade 5 Jejunal Fistula, CTCAE;Death;Grade 5 Jejunal fistula;Death;Jejunal fistula;10065719;LLT;20,1
858;C56543;Jejunal Hemorrhage, CTCAE;A disorder characterized by bleeding from the jejunal wall.;Jejunal hemorrhage;A disorder characterized by bleeding from the jejunal wall.;Jejunal hemorrhage;10055300;LLT;20,1
859;C56300;Grade 1 Jejunal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Jejunal hemorrhage;"Mild symptoms; intervention not indicated";Jejunal hemorrhage;10055300;LLT;20,1
860;C56349;Grade 2 Jejunal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Jejunal hemorrhage;"Moderate symptoms; intervention indicated";Jejunal hemorrhage;10055300;LLT;20,1
861;C56399;Grade 3 Jejunal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Jejunal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Jejunal hemorrhage;10055300;LLT;20,1
862;C56449;Grade 4 Jejunal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Jejunal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Jejunal hemorrhage;10055300;LLT;20,1
863;C56498;Grade 5 Jejunal Hemorrhage, CTCAE;Death;Grade 5 Jejunal hemorrhage;Death;Jejunal hemorrhage;10055300;LLT;20,1
864;C57829;Jejunal Obstruction, CTCAE;A disorder characterized by blockage of the normal flow of the intestinal contents in the jejunum.;Jejunal obstruction;A disorder characterized by blockage of the normal flow of the intestinal contents in the jejunum.;Jejunal obstruction;10065732;LLT;20,1
865;C57204;Grade 1 Jejunal Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Jejunal obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Jejunal obstruction;10065732;LLT;20,1
866;C57326;Grade 2 Jejunal Obstruction, CTCAE;"Symptomatic; altered GI function; limiting instrumental ADL";Grade 2 Jejunal obstruction;"Symptomatic; altered GI function; limiting instrumental ADL";Jejunal obstruction;10065732;LLT;20,1
867;C57457;Grade 3 Jejunal Obstruction, CTCAE;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL";Grade 3 Jejunal obstruction;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL";Jejunal obstruction;10065732;LLT;20,1
868;C57591;Grade 4 Jejunal Obstruction, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Jejunal obstruction;"Life-threatening consequences; urgent operative intervention indicated";Jejunal obstruction;10065732;LLT;20,1
869;C57722;Grade 5 Jejunal Obstruction, CTCAE;Death;Grade 5 Jejunal obstruction;Death;Jejunal obstruction;10065732;LLT;20,1
870;C57832;Jejunal Ulcer, CTCAE;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the jejunum.;Jejunal ulcer;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the jejunum.;Jejunal ulcer;10023177;LLT;20,1
871;C57207;Grade 1 Jejunal Ulcer, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Jejunal ulcer;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Jejunal ulcer;10023177;LLT;20,1
872;C57329;Grade 2 Jejunal Ulcer, CTCAE;"Symptomatic; altered GI function";Grade 2 Jejunal ulcer;"Symptomatic; altered GI function";Jejunal ulcer;10023177;LLT;20,1
873;C57460;Grade 3 Jejunal Ulcer, CTCAE;"Severely altered GI function; TPN indicated; elective invasive intervention indicated";Grade 3 Jejunal ulcer;"Severely altered GI function; TPN indicated; elective invasive intervention indicated";Jejunal ulcer;10023177;LLT;20,1
874;C57594;Grade 4 Jejunal Ulcer, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Jejunal ulcer;"Life-threatening consequences; urgent operative intervention indicated";Jejunal ulcer;10023177;LLT;20,1
875;C57725;Grade 5 Jejunal Ulcer, CTCAE;Death;Grade 5 Jejunal ulcer;Death;Jejunal ulcer;10023177;LLT;20,1
876;C146761;Lip Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort of the lip.;Lip pain;A disorder characterized by a sensation of marked discomfort of the lip.;Lip pain;10024561;LLT;20,1
877;C56111;Grade 1 Lip Pain, CTCAE;Mild pain;Grade 1 Lip pain;Mild pain;Lip pain;10024561;LLT;20,1
878;C56112;Grade 2 Lip Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Lip pain;"Moderate pain; limiting instrumental ADL";Lip pain;10024561;LLT;20,1
879;C56113;Grade 3 Lip Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Lip pain;"Severe pain; limiting self care ADL";Lip pain;10024561;LLT;20,1
880;C143656;Lower Gastrointestinal Hemorrhage, CTCAE;A disorder characterized by bleeding from the lower gastrointestinal tract (small intestine, large intestine, and anus).;Lower gastrointestinal hemorrhage;A disorder characterized by bleeding from the lower gastrointestinal tract (small intestine, large intestine, and anus).;Lower gastrointestinal hemorrhage;10051746;LLT;20,1
881;C144253;Grade 1 Lower Gastrointestinal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Lower gastrointestinal hemorrhage;"Mild symptoms; intervention not indicated";Lower gastrointestinal hemorrhage;10051746;LLT;20,1
882;C144825;Grade 2 Lower Gastrointestinal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Lower gastrointestinal hemorrhage;"Moderate symptoms; intervention indicated";Lower gastrointestinal hemorrhage;10051746;LLT;20,1
883;C145445;Grade 3 Lower Gastrointestinal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Lower gastrointestinal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Lower gastrointestinal hemorrhage;10051746;LLT;20,1
884;C145984;Grade 4 Lower Gastrointestinal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Lower gastrointestinal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Lower gastrointestinal hemorrhage;10051746;LLT;20,1
885;C146430;Grade 5 Lower Gastrointestinal Hemorrhage, CTCAE;Death;Grade 5 Lower gastrointestinal hemorrhage;Death;Lower gastrointestinal hemorrhage;10051746;LLT;20,1
886;C57838;Malabsorption, CTCAE;A disorder characterized by inadequate absorption of nutrients in the small intestine. Symptoms include abdominal marked discomfort, bloating and diarrhea.;Malabsorption;A disorder characterized by inadequate absorption of nutrients in the small intestine. Symptoms include abdominal marked discomfort, bloating and diarrhea.;Malabsorption;10025476;LLT;20,1
887;C57335;Grade 2 Malabsorption, CTCAE;"Altered diet; oral intervention indicated";Grade 2 Malabsorption;"Altered diet; oral intervention indicated";Malabsorption;10025476;LLT;20,1
888;C57466;Grade 3 Malabsorption, CTCAE;"Inability to aliment adequately; TPN indicated";Grade 3 Malabsorption;"Inability to aliment adequately; TPN indicated";Malabsorption;10025476;LLT;20,1
889;C57600;Grade 4 Malabsorption, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Malabsorption;"Life-threatening consequences; urgent intervention indicated";Malabsorption;10025476;LLT;20,1
890;C57731;Grade 5 Malabsorption, CTCAE;Death;Grade 5 Malabsorption;Death;Malabsorption;10025476;LLT;20,1
891;C143679;Mucositis Oral, CTCAE;A disorder characterized by ulceration or inflammation of the oral mucosal.;Mucositis oral;A disorder characterized by ulceration or inflammation of the oral mucosal.;Mucositis oral;10028130;LLT;20,1
892;C144268;Grade 1 Mucositis Oral, CTCAE;"Asymptomatic or mild symptoms; intervention not indicated";Grade 1 Mucositis oral;"Asymptomatic or mild symptoms; intervention not indicated";Mucositis oral;10028130;LLT;20,1
893;C144845;Grade 2 Mucositis Oral, CTCAE;"Moderate pain or ulcer that does not interfere with oral intake; modified diet indicated";Grade 2 Mucositis oral;"Moderate pain or ulcer that does not interfere with oral intake; modified diet indicated";Mucositis oral;10028130;LLT;20,1
894;C145467;Grade 3 Mucositis Oral, CTCAE;"Severe pain; interfering with oral intake";Grade 3 Mucositis oral;"Severe pain; interfering with oral intake";Mucositis oral;10028130;LLT;20,1
895;C146002;Grade 4 Mucositis Oral, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Mucositis oral;"Life-threatening consequences; urgent intervention indicated";Mucositis oral;10028130;LLT;20,1
896;C146447;Grade 5 Mucositis Oral, CTCAE;Death;Grade 5 Mucositis oral;Death;Mucositis oral;10028130;LLT;20,1
897;C146764;Nausea, CTCAE 5.0;A disorder characterized by a queasy sensation and/or the urge to vomit.;Nausea;A disorder characterized by a queasy sensation and/or the urge to vomit.;Nausea;10028813;LLT;20,1
898;C57213;Grade 1 Nausea, CTCAE;Loss of appetite without alteration in eating habits;Grade 1 Nausea;Loss of appetite without alteration in eating habits;Nausea;10028813;LLT;20,1
899;C57336;Grade 2 Nausea, CTCAE;Oral intake decreased without significant weight loss, dehydration or malnutrition;Grade 2 Nausea;Oral intake decreased without significant weight loss, dehydration or malnutrition;Nausea;10028813;LLT;20,1
900;C57467;Grade 3 Nausea, CTCAE;"Inadequate oral caloric or fluid intake; tube feeding, TPN, or hospitalization indicated";Grade 3 Nausea;"Inadequate oral caloric or fluid intake; tube feeding, TPN, or hospitalization indicated";Nausea;10028813;LLT;20,1
901;C143710;Obstruction Gastric, CTCAE;A disorder characterized by blockage of the normal flow of the contents in the stomach.;Obstruction gastric;A disorder characterized by blockage of the normal flow of the contents in the stomach.;Obstruction gastric;10029957;LLT;20,1
902;C144293;Grade 1 Obstruction Gastric, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Obstruction gastric;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Obstruction gastric;10029957;LLT;20,1
903;C144869;Grade 2 Obstruction Gastric, CTCAE;"Symptomatic; altered GI function; limiting instrumental ADL";Grade 2 Obstruction gastric;"Symptomatic; altered GI function; limiting instrumental ADL";Obstruction gastric;10029957;LLT;20,1
904;C145490;Grade 3 Obstruction Gastric, CTCAE;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL";Grade 3 Obstruction gastric;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL";Obstruction gastric;10029957;LLT;20,1
905;C146014;Grade 4 Obstruction Gastric, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Obstruction gastric;"Life-threatening consequences; urgent operative intervention indicated";Obstruction gastric;10029957;LLT;20,1
906;C146456;Grade 5 Obstruction Gastric, CTCAE;Death;Grade 5 Obstruction gastric;Death;Obstruction gastric;10029957;LLT;20,1
907;C143715;Oral Cavity Fistula, CTCAE;A disorder characterized by an abnormal communication between the oral cavity and another organ or anatomic site.;Oral cavity fistula;A disorder characterized by an abnormal communication between the oral cavity and another organ or anatomic site.;Oral cavity fistula;10065720;LLT;20,1
908;C144297;Grade 1 Oral Cavity Fistula, CTCAE;Asymptomatic;Grade 1 Oral cavity fistula;Asymptomatic;Oral cavity fistula;10065720;LLT;20,1
909;C144873;Grade 2 Oral Cavity Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Oral cavity fistula;Symptomatic, invasive intervention not indicated;Oral cavity fistula;10065720;LLT;20,1
910;C145494;Grade 3 Oral Cavity Fistula, CTCAE;Invasive intervention indicated;Grade 3 Oral cavity fistula;Invasive intervention indicated;Oral cavity fistula;10065720;LLT;20,1
911;C146016;Grade 4 Oral Cavity Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Oral cavity fistula;"Life-threatening consequences; urgent intervention indicated";Oral cavity fistula;10065720;LLT;20,1
912;C146457;Grade 5 Oral Cavity Fistula, CTCAE;Death;Grade 5 Oral cavity fistula;Death;Oral cavity fistula;10065720;LLT;20,1
913;C56551;Oral Hemorrhage, CTCAE;A disorder characterized by bleeding from the mouth.;Oral hemorrhage;A disorder characterized by bleeding from the mouth.;Oral hemorrhage;10030980;LLT;20,1
914;C56308;Grade 1 Oral Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Oral hemorrhage;"Mild symptoms; intervention not indicated";Oral hemorrhage;10030980;LLT;20,1
915;C56357;Grade 2 Oral Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Oral hemorrhage;"Moderate symptoms; intervention indicated";Oral hemorrhage;10030980;LLT;20,1
916;C56407;Grade 3 Oral Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Oral hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Oral hemorrhage;10030980;LLT;20,1
917;C56457;Grade 4 Oral Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Oral hemorrhage;"Life-threatening consequences; urgent intervention indicated";Oral hemorrhage;10030980;LLT;20,1
918;C56506;Grade 5 Oral Hemorrhage, CTCAE;Death;Grade 5 Oral hemorrhage;Death;Oral hemorrhage;10030980;LLT;20,1
919;C143716;Oral Dysesthesia, CTCAE;A disorder characterized by a burning or tingling sensation on the lips, tongue or entire mouth.;Oral dysesthesia;A disorder characterized by a burning or tingling sensation on the lips, tongue or entire mouth.;Oral dysesthesia;10054520;LLT;20,1
920;C144298;Grade 1 Oral Dysesthesia, CTCAE;"Mild discomfort; not interfering with oral intake";Grade 1 Oral dysesthesia;"Mild discomfort; not interfering with oral intake";Oral dysesthesia;10054520;LLT;20,1
921;C144874;Grade 2 Oral Dysesthesia, CTCAE;"Moderate pain; interfering with oral intake";Grade 2 Oral dysesthesia;"Moderate pain; interfering with oral intake";Oral dysesthesia;10054520;LLT;20,1
922;C145495;Grade 3 Oral Dysesthesia, CTCAE;"Disabling pain; tube feeding or TPN indicated";Grade 3 Oral dysesthesia;"Disabling pain; tube feeding or TPN indicated";Oral dysesthesia;10054520;LLT;20,1
923;C146627;Oral Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the mouth, tongue or lips.;Oral pain;A disorder characterized by a sensation of marked discomfort in the mouth, tongue or lips.;Oral pain;10031009;LLT;20,1
924;C56146;Grade 1 Oral Pain, CTCAE;Mild pain;Grade 1 Oral pain;Mild pain;Oral pain;10031009;LLT;20,1
925;C56147;Grade 2 Oral Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Oral pain;"Moderate pain; limiting instrumental ADL";Oral pain;10031009;LLT;20,1
926;C56148;Grade 3 Oral Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Oral pain;"Severe pain; limiting self care ADL";Oral pain;10031009;LLT;20,1
927;C57845;Pancreatic Fistula, CTCAE;A disorder characterized by an abnormal communication between the pancreas and another organ or anatomic site.;Pancreatic fistula;A disorder characterized by an abnormal communication between the pancreas and another organ or anatomic site.;Pancreatic fistula;10049192;LLT;20,1
928;C57218;Grade 1 Pancreatic Fistula, CTCAE;Asymptomatic;Grade 1 Pancreatic fistula;Asymptomatic;Pancreatic fistula;10049192;LLT;20,1
929;C57341;Grade 2 Pancreatic Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Pancreatic fistula;Symptomatic, invasive intervention not indicated;Pancreatic fistula;10049192;LLT;20,1
930;C57473;Grade 3 Pancreatic Fistula, CTCAE;Invasive intervention indicated;Grade 3 Pancreatic fistula;Invasive intervention indicated;Pancreatic fistula;10049192;LLT;20,1
931;C57607;Grade 4 Pancreatic Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pancreatic fistula;"Life-threatening consequences; urgent intervention indicated";Pancreatic fistula;10049192;LLT;20,1
932;C57738;Grade 5 Pancreatic Fistula, CTCAE;Death;Grade 5 Pancreatic fistula;Death;Pancreatic fistula;10049192;LLT;20,1
933;C56554;Pancreatic Hemorrhage, CTCAE;A disorder characterized by bleeding from the pancreas.;Pancreatic hemorrhage;A disorder characterized by bleeding from the pancreas.;Pancreatic hemorrhage;10033626;LLT;20,1
934;C56310;Grade 1 Pancreatic Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Pancreatic hemorrhage;"Mild symptoms; intervention not indicated";Pancreatic hemorrhage;10033626;LLT;20,1
935;C56359;Grade 2 Pancreatic Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Pancreatic hemorrhage;"Moderate symptoms; intervention indicated";Pancreatic hemorrhage;10033626;LLT;20,1
936;C56409;Grade 3 Pancreatic Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Pancreatic hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Pancreatic hemorrhage;10033626;LLT;20,1
937;C56459;Grade 4 Pancreatic Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pancreatic hemorrhage;"Life-threatening consequences; urgent intervention indicated";Pancreatic hemorrhage;10033626;LLT;20,1
938;C56508;Grade 5 Pancreatic Hemorrhage, CTCAE;Death;Grade 5 Pancreatic hemorrhage;Death;Pancreatic hemorrhage;10033626;LLT;20,1
939;C143730;Pancreatic Duct Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the pancreatic duct.;Pancreatic duct stenosis;A disorder characterized by a narrowing of the lumen of the pancreatic duct.;Pancreatic duct stenosis;10065703;LLT;20,1
940;C144312;Grade 1 Pancreatic Duct Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Pancreatic duct stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Pancreatic duct stenosis;10065703;LLT;20,1
941;C144891;Grade 2 Pancreatic Duct Stenosis, CTCAE;"Symptomatic; altered GI function";Grade 2 Pancreatic duct stenosis;"Symptomatic; altered GI function";Pancreatic duct stenosis;10065703;LLT;20,1
942;C145512;Grade 3 Pancreatic Duct Stenosis, CTCAE;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Grade 3 Pancreatic duct stenosis;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Pancreatic duct stenosis;10065703;LLT;20,1
943;C146027;Grade 4 Pancreatic Duct Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Pancreatic duct stenosis;"Life-threatening consequences; urgent operative intervention indicated";Pancreatic duct stenosis;10065703;LLT;20,1
944;C146468;Grade 5 Pancreatic Duct Stenosis, CTCAE;Death;Grade 5 Pancreatic duct stenosis;Death;Pancreatic duct stenosis;10065703;LLT;20,1
945;C143732;Pancreatic Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the pancreas.;Pancreatic necrosis;A disorder characterized by a necrotic process occurring in the pancreas.;Pancreatic necrosis;10058096;LLT;20,1
946;C145516;Grade 3 Pancreatic Necrosis, CTCAE;"Tube feeding or TPN indicated; invasive intervention indicated";Grade 3 Pancreatic necrosis;"Tube feeding or TPN indicated; invasive intervention indicated";Pancreatic necrosis;10058096;LLT;20,1
947;C146030;Grade 4 Pancreatic Necrosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Pancreatic necrosis;"Life-threatening consequences; urgent operative intervention indicated";Pancreatic necrosis;10058096;LLT;20,1
948;C146471;Grade 5 Pancreatic Necrosis, CTCAE;Death;Grade 5 Pancreatic necrosis;Death;Pancreatic necrosis;10058096;LLT;20,1
949;C146789;Pancreatitis, CTCAE 5.0;A disorder characterized by inflammation of the pancreas with no documented pancreas infection.;Pancreatitis;A disorder characterized by inflammation of the pancreas with no documented pancreas infection.;Pancreatitis;10033645;LLT;20,1
950;C56583;Grade 2 Pancreatitis, CTCAE;"Enzyme elevation; radiologic findings only";Grade 2 Pancreatitis;"Enzyme elevation; radiologic findings only";Pancreatitis;10033645;LLT;20,1
951;C56588;Grade 3 Pancreatitis, CTCAE;"Severe pain; vomiting; medical intervention indicated (e.g., analgesia, nutritional support)";Grade 3 Pancreatitis;"Severe pain; vomiting; medical intervention indicated (e.g., analgesia, nutritional support)";Pancreatitis;10033645;LLT;20,1
952;C56593;Grade 4 Pancreatitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pancreatitis;"Life-threatening consequences; urgent intervention indicated";Pancreatitis;10033645;LLT;20,1
953;C56598;Grade 5 Pancreatitis, CTCAE;Death;Grade 5 Pancreatitis;Death;Pancreatitis;10033645;LLT;20,1
954;C57849;Periodontal Disease, CTCAE;A disorder in the gingival tissue around the teeth.;Periodontal disease;A disorder in the gingival tissue around the teeth.;Periodontal disease;10034536;LLT;20,1
955;C57221;Grade 1 Periodontal Disease, CTCAE;"Gingival recession or gingivitis; limited bleeding on probing; mild local bone loss";Grade 1 Periodontal disease;"Gingival recession or gingivitis; limited bleeding on probing; mild local bone loss";Periodontal disease;10034536;LLT;20,1
956;C57344;Grade 2 Periodontal Disease, CTCAE;"Moderate gingival recession or gingivitis; multiple sites of bleeding on probing; moderate bone loss";Grade 2 Periodontal disease;"Moderate gingival recession or gingivitis; multiple sites of bleeding on probing; moderate bone loss";Periodontal disease;10034536;LLT;20,1
957;C57477;Grade 3 Periodontal Disease, CTCAE;"Spontaneous bleeding; severe bone loss with or without tooth loss; osteonecrosis of maxilla or mandible";Grade 3 Periodontal disease;"Spontaneous bleeding; severe bone loss with or without tooth loss; osteonecrosis of maxilla or mandible";Periodontal disease;10034536;LLT;20,1
958;C57850;Peritoneal Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the peritoneum.;Peritoneal necrosis;A disorder characterized by a necrotic process occurring in the peritoneum.;Peritoneal necrosis;10065704;LLT;20,1
959;C57478;Grade 3 Peritoneal Necrosis, CTCAE;"Tube feeding or TPN indicated; invasive intervention indicated";Grade 3 Peritoneal necrosis;"Tube feeding or TPN indicated; invasive intervention indicated";Peritoneal necrosis;10065704;LLT;20,1
960;C57611;Grade 4 Peritoneal Necrosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Peritoneal necrosis;"Life-threatening consequences; urgent operative intervention indicated";Peritoneal necrosis;10065704;LLT;20,1
961;C57742;Grade 5 Peritoneal Necrosis, CTCAE;Death;Grade 5 Peritoneal necrosis;Death;Peritoneal necrosis;10065704;LLT;20,1
962;C57857;Proctitis, CTCAE;A disorder characterized by inflammation of the rectum.;Proctitis;A disorder characterized by inflammation of the rectum.;Proctitis;10036774;LLT;20,1
963;C57227;Grade 1 Proctitis, CTCAE;Rectal discomfort, intervention not indicated;Grade 1 Proctitis;Rectal discomfort, intervention not indicated;Proctitis;10036774;LLT;20,1
964;C57350;Grade 2 Proctitis, CTCAE;"Symptomatic (e.g., rectal discomfort, passing blood or mucus); medical intervention indicated; limiting instrumental ADL";Grade 2 Proctitis;"Symptomatic (e.g., rectal discomfort, passing blood or mucus); medical intervention indicated; limiting instrumental ADL";Proctitis;10036774;LLT;20,1
965;C57485;Grade 3 Proctitis, CTCAE;"Severe symptoms; fecal urgency or stool incontinence; limiting self care ADL";Grade 3 Proctitis;"Severe symptoms; fecal urgency or stool incontinence; limiting self care ADL";Proctitis;10036774;LLT;20,1
966;C57618;Grade 4 Proctitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Proctitis;"Life-threatening consequences; urgent intervention indicated";Proctitis;10036774;LLT;20,1
967;C57749;Grade 5 Proctitis, CTCAE;Death;Grade 5 Proctitis;Death;Proctitis;10036774;LLT;20,1
968;C143200;Rectal Fissure, CTCAE;A disorder characterized by a tear in the lining of the rectum.;Rectal fissure;A disorder characterized by a tear in the lining of the rectum.;Rectal fissure;10064993;LLT;20,1
969;C144367;Grade 1 Rectal Fissure, CTCAE;Asymptomatic;Grade 1 Rectal fissure;Asymptomatic;Rectal fissure;10064993;LLT;20,1
970;C144960;Grade 2 Rectal Fissure, CTCAE;Symptomatic;Grade 2 Rectal fissure;Symptomatic;Rectal fissure;10064993;LLT;20,1
971;C145582;Grade 3 Rectal Fissure, CTCAE;Invasive intervention indicated;Grade 3 Rectal fissure;Invasive intervention indicated;Rectal fissure;10064993;LLT;20,1
972;C143802;Rectal Mucositis, CTCAE;A disorder characterized by ulceration or inflammation of the mucous membrane of the rectum.;Rectal mucositis;A disorder characterized by ulceration or inflammation of the mucous membrane of the rectum.;Rectal mucositis;10063190;LLT;20,1
973;C144370;Grade 1 Rectal Mucositis, CTCAE;"Asymptomatic or mild symptoms; intervention not indicated";Grade 1 Rectal mucositis;"Asymptomatic or mild symptoms; intervention not indicated";Rectal mucositis;10063190;LLT;20,1
974;C144963;Grade 2 Rectal Mucositis, CTCAE;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Grade 2 Rectal mucositis;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Rectal mucositis;10063190;LLT;20,1
975;C145585;Grade 3 Rectal Mucositis, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Rectal mucositis;"Severe symptoms; limiting self care ADL";Rectal mucositis;10063190;LLT;20,1
976;C146084;Grade 4 Rectal Mucositis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Rectal mucositis;"Life-threatening consequences; urgent operative intervention indicated";Rectal mucositis;10063190;LLT;20,1
977;C146519;Grade 5 Rectal Mucositis, CTCAE;Death;Grade 5 Rectal mucositis;Death;Rectal mucositis;10063190;LLT;20,1
978;C146631;Rectal Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the rectal region.;Rectal pain;A disorder characterized by a sensation of marked discomfort in the rectal region.;Rectal pain;10038072;LLT;20,1
979;C144372;Grade 1 Rectal Pain, CTCAE;Mild pain;Grade 1 Rectal pain;Mild pain;Rectal pain;10038072;LLT;20,1
980;C144965;Grade 2 Rectal Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Rectal pain;"Moderate pain; limiting instrumental ADL";Rectal pain;10038072;LLT;20,1
981;C145588;Grade 3 Rectal Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Rectal pain;"Severe pain; limiting self care ADL";Rectal pain;10038072;LLT;20,1
982;C146634;Rectal Perforation, CTCAE 5.0;A disorder characterized by a rupture in the rectal wall.;Rectal perforation;A disorder characterized by a rupture in the rectal wall.;Rectal perforation;10038073;LLT;20,1
983;C57357;Grade 2 Rectal Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Rectal perforation;Invasive intervention not indicated;Rectal perforation;10038073;LLT;20,1
984;C57493;Grade 3 Rectal Perforation, CTCAE;Invasive intervention indicated;Grade 3 Rectal perforation;Invasive intervention indicated;Rectal perforation;10038073;LLT;20,1
985;C57626;Grade 4 Rectal Perforation, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Rectal perforation;"Life-threatening consequences; urgent operative intervention indicated";Rectal perforation;10038073;LLT;20,1
986;C57757;Grade 5 Rectal Perforation, CTCAE;Death;Grade 5 Rectal perforation;Death;Rectal perforation;10038073;LLT;20,1
987;C143803;Rectal Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the rectum.;Rectal stenosis;A disorder characterized by a narrowing of the lumen of the rectum.;Rectal stenosis;10038079;LLT;20,1
988;C144373;Grade 1 Rectal Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Rectal stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Rectal stenosis;10038079;LLT;20,1
989;C144967;Grade 2 Rectal Stenosis, CTCAE;"Symptomatic; altered GI function";Grade 2 Rectal stenosis;"Symptomatic; altered GI function";Rectal stenosis;10038079;LLT;20,1
990;C145590;Grade 3 Rectal Stenosis, CTCAE;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Grade 3 Rectal stenosis;"Severely altered GI function; tube feeding or hospitalization indicated; elective operative intervention indicated";Rectal stenosis;10038079;LLT;20,1
991;C146088;Grade 4 Rectal Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Rectal stenosis;"Life-threatening consequences; urgent operative intervention indicated";Rectal stenosis;10038079;LLT;20,1
992;C146523;Grade 5 Rectal Stenosis, CTCAE;Death;Grade 5 Rectal stenosis;Death;Rectal stenosis;10038079;LLT;20,1
993;C57859;Rectal Fistula, CTCAE;A disorder characterized by an abnormal communication between the rectum and another organ or anatomic site.;Rectal fistula;A disorder characterized by an abnormal communication between the rectum and another organ or anatomic site.;Rectal fistula;10038062;LLT;20,1
994;C57229;Grade 1 Rectal Fistula, CTCAE;Asymptomatic;Grade 1 Rectal fistula;Asymptomatic;Rectal fistula;10038062;LLT;20,1
995;C57352;Grade 2 Rectal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Rectal fistula;Symptomatic, invasive intervention not indicated;Rectal fistula;10038062;LLT;20,1
996;C57487;Grade 3 Rectal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Rectal fistula;Invasive intervention indicated;Rectal fistula;10038062;LLT;20,1
997;C57620;Grade 4 Rectal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Rectal fistula;"Life-threatening consequences; urgent intervention indicated";Rectal fistula;10038062;LLT;20,1
998;C57751;Grade 5 Rectal Fistula, CTCAE;Death;Grade 5 Rectal fistula;Death;Rectal fistula;10038062;LLT;20,1
999;C56560;Rectal Hemorrhage, CTCAE;A disorder characterized by bleeding from the rectal wall and discharged from the anus.;Rectal hemorrhage;A disorder characterized by bleeding from the rectal wall and discharged from the anus.;Rectal hemorrhage;10038064;LLT;20,1
1000;C56317;Grade 1 Rectal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Rectal hemorrhage;"Mild symptoms; intervention not indicated";Rectal hemorrhage;10038064;LLT;20,1
1001;C56366;Grade 2 Rectal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Rectal hemorrhage;"Moderate symptoms; intervention indicated";Rectal hemorrhage;10038064;LLT;20,1
1002;C56416;Grade 3 Rectal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Rectal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Rectal hemorrhage;10038064;LLT;20,1
1003;C56465;Grade 4 Rectal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Rectal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Rectal hemorrhage;10038064;LLT;20,1
1004;C56514;Grade 5 Rectal Hemorrhage, CTCAE;Death;Grade 5 Rectal hemorrhage;Death;Rectal hemorrhage;10038064;LLT;20,1
1005;C57863;Rectal Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the rectal wall.;Rectal necrosis;A disorder characterized by a necrotic process occurring in the rectal wall.;Rectal necrosis;10065709;LLT;20,1
1006;C57491;Grade 3 Rectal Necrosis, CTCAE;"Tube feeding or TPN indicated; invasive intervention indicated";Grade 3 Rectal necrosis;"Tube feeding or TPN indicated; invasive intervention indicated";Rectal necrosis;10065709;LLT;20,1
1007;C57624;Grade 4 Rectal Necrosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Rectal necrosis;"Life-threatening consequences; urgent operative intervention indicated";Rectal necrosis;10065709;LLT;20,1
1008;C57755;Grade 5 Rectal Necrosis, CTCAE;Death;Grade 5 Rectal necrosis;Death;Rectal necrosis;10065709;LLT;20,1
1009;C57864;Rectal Obstruction, CTCAE;A disorder characterized by blockage of the normal flow of the intestinal contents in the rectum.;Rectal obstruction;A disorder characterized by blockage of the normal flow of the intestinal contents in the rectum.;Rectal obstruction;10065707;LLT;20,1
1010;C57233;Grade 1 Rectal Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Rectal obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Rectal obstruction;10065707;LLT;20,1
1011;C57356;Grade 2 Rectal Obstruction, CTCAE;"Symptomatic; altered GI function; limiting instrumental ADL";Grade 2 Rectal obstruction;"Symptomatic; altered GI function; limiting instrumental ADL";Rectal obstruction;10065707;LLT;20,1
1012;C57492;Grade 3 Rectal Obstruction, CTCAE;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL";Grade 3 Rectal obstruction;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL";Rectal obstruction;10065707;LLT;20,1
1013;C57625;Grade 4 Rectal Obstruction, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Rectal obstruction;"Life-threatening consequences; urgent operative intervention indicated";Rectal obstruction;10065707;LLT;20,1
1014;C57756;Grade 5 Rectal Obstruction, CTCAE;Death;Grade 5 Rectal obstruction;Death;Rectal obstruction;10065707;LLT;20,1
1015;C57867;Rectal Ulcer, CTCAE;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the rectum.;Rectal ulcer;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the rectum.;Rectal ulcer;10038080;LLT;20,1
1016;C57236;Grade 1 Rectal Ulcer, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Rectal ulcer;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Rectal ulcer;10038080;LLT;20,1
1017;C57359;Grade 2 Rectal Ulcer, CTCAE;"Symptomatic; altered GI function (e.g., altered dietary habits, vomiting, diarrhea)";Grade 2 Rectal ulcer;"Symptomatic; altered GI function (e.g., altered dietary habits, vomiting, diarrhea)";Rectal ulcer;10038080;LLT;20,1
1018;C57495;Grade 3 Rectal Ulcer, CTCAE;"Severely altered GI function; TPN indicated; elective invasive intervention indicated";Grade 3 Rectal ulcer;"Severely altered GI function; TPN indicated; elective invasive intervention indicated";Rectal ulcer;10038080;LLT;20,1
1019;C57628;Grade 4 Rectal Ulcer, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Rectal ulcer;"Life-threatening consequences; urgent operative intervention indicated";Rectal ulcer;10038080;LLT;20,1
1020;C57759;Grade 5 Rectal Ulcer, CTCAE;Death;Grade 5 Rectal ulcer;Death;Rectal ulcer;10038080;LLT;20,1
1021;C146632;Retroperitoneal Hemorrhage, CTCAE 5.0;A disorder characterized by bleeding from the retroperitoneal area.;Retroperitoneal hemorrhage;A disorder characterized by bleeding from the retroperitoneal area.;Retroperitoneal hemorrhage;10038981;LLT;20,1
1022;C144979;Grade 2 Retroperitoneal Hemorrhage, CTCAE;"Self-limited; intervention indicated";Grade 2 Retroperitoneal hemorrhage;"Self-limited; intervention indicated";Retroperitoneal hemorrhage;10038981;LLT;20,1
1023;C145601;Grade 3 Retroperitoneal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Retroperitoneal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Retroperitoneal hemorrhage;10038981;LLT;20,1
1024;C146097;Grade 4 Retroperitoneal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Retroperitoneal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Retroperitoneal hemorrhage;10038981;LLT;20,1
1025;C146532;Grade 5 Retroperitoneal Hemorrhage, CTCAE;Death;Grade 5 Retroperitoneal hemorrhage;Death;Retroperitoneal hemorrhage;10038981;LLT;20,1
1026;C143821;Salivary Duct Inflammation, CTCAE;A disorder characterized by inflammation of the salivary duct.;Salivary duct inflammation;A disorder characterized by inflammation of the salivary duct.;Salivary duct inflammation;10056681;LLT;20,1
1027;C144387;Grade 1 Salivary Duct Inflammation, CTCAE;"Slightly thickened saliva; slightly altered taste (e.g., metallic)";Grade 1 Salivary duct inflammation;"Slightly thickened saliva; slightly altered taste (e.g., metallic)";Salivary duct inflammation;10056681;LLT;20,1
1028;C144984;Grade 2 Salivary Duct Inflammation, CTCAE;"Thick, ropy, sticky saliva; markedly altered taste; alteration in diet indicated; secretion-induced symptoms; limiting instrumental ADL";Grade 2 Salivary duct inflammation;"Thick, ropy, sticky saliva; markedly altered taste; alteration in diet indicated; secretion-induced symptoms; limiting instrumental ADL";Salivary duct inflammation;10056681;LLT;20,1
1029;C145605;Grade 3 Salivary Duct Inflammation, CTCAE;"Acute salivary gland necrosis; severe secretion-induced symptoms (e.g., thick saliva/oral secretions or gagging); tube feeding or TPN indicated; limiting self care ADL";Grade 3 Salivary duct inflammation;"Acute salivary gland necrosis; severe secretion-induced symptoms (e.g., thick saliva/oral secretions or gagging); tube feeding or TPN indicated; limiting self care ADL";Salivary duct inflammation;10056681;LLT;20,1
1030;C146100;Grade 4 Salivary Duct Inflammation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Salivary duct inflammation;"Life-threatening consequences; urgent intervention indicated";Salivary duct inflammation;10056681;LLT;20,1
1031;C146535;Grade 5 Salivary Duct Inflammation, CTCAE;Death;Grade 5 Salivary duct inflammation;Death;Salivary duct inflammation;10056681;LLT;20,1
1032;C57868;Salivary Gland Fistula, CTCAE;A disorder characterized by an abnormal communication between a salivary gland and another organ or anatomic site.;Salivary gland fistula;A disorder characterized by an abnormal communication between a salivary gland and another organ or anatomic site.;Salivary gland fistula;10039411;LLT;20,1
1033;C57237;Grade 1 Salivary Gland Fistula, CTCAE;Asymptomatic;Grade 1 Salivary gland fistula;Asymptomatic;Salivary gland fistula;10039411;LLT;20,1
1034;C57360;Grade 2 Salivary Gland Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Salivary gland fistula;Symptomatic, invasive intervention not indicated;Salivary gland fistula;10039411;LLT;20,1
1035;C57496;Grade 3 Salivary Gland Fistula, CTCAE;Invasive intervention indicated;Grade 3 Salivary gland fistula;Invasive intervention indicated;Salivary gland fistula;10039411;LLT;20,1
1036;C57629;Grade 4 Salivary Gland Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Salivary gland fistula;"Life-threatening consequences; urgent intervention indicated";Salivary gland fistula;10039411;LLT;20,1
1037;C57760;Grade 5 Salivary Gland Fistula, CTCAE;Death;Grade 5 Salivary gland fistula;Death;Salivary gland fistula;10039411;LLT;20,1
1038;C143842;Small Intestinal Mucositis, CTCAE;A disorder characterized by ulceration or inflammation of the mucous membrane of the small intestine.;Small intestinal mucositis;A disorder characterized by ulceration or inflammation of the mucous membrane of the small intestine.;Small intestinal mucositis;10065710;LLT;20,1
1039;C144406;Grade 1 Small Intestinal Mucositis, CTCAE;"Asymptomatic or mild symptoms; intervention not indicated";Grade 1 Small intestinal mucositis;"Asymptomatic or mild symptoms; intervention not indicated";Small intestinal mucositis;10065710;LLT;20,1
1040;C145005;Grade 2 Small Intestinal Mucositis, CTCAE;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Grade 2 Small intestinal mucositis;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Small intestinal mucositis;10065710;LLT;20,1
1041;C145624;Grade 3 Small Intestinal Mucositis, CTCAE;"Severe pain; interfering with oral intake; tube feeding, TPN or hospitalization indicated; limiting self care ADL";Grade 3 Small intestinal mucositis;"Severe pain; interfering with oral intake; tube feeding, TPN or hospitalization indicated; limiting self care ADL";Small intestinal mucositis;10065710;LLT;20,1
1042;C146117;Grade 4 Small Intestinal Mucositis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Small intestinal mucositis;"Life-threatening consequences; urgent intervention indicated";Small intestinal mucositis;10065710;LLT;20,1
1043;C146549;Grade 5 Small Intestinal Mucositis, CTCAE;Death;Grade 5 Small intestinal mucositis;Death;Small intestinal mucositis;10065710;LLT;20,1
1044;C143843;Small Intestinal Obstruction, CTCAE;A disorder characterized by blockage of the normal flow of the intestinal contents of the small intestine.;Small intestinal obstruction;A disorder characterized by blockage of the normal flow of the intestinal contents of the small intestine.;Small intestinal obstruction;10041101;LLT;20,1
1045;C144407;Grade 1 Small Intestinal Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Small intestinal obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Small intestinal obstruction;10041101;LLT;20,1
1046;C145006;Grade 2 Small Intestinal Obstruction, CTCAE;"Symptomatic; altered GI function; limiting instrumental ADL";Grade 2 Small intestinal obstruction;"Symptomatic; altered GI function; limiting instrumental ADL";Small intestinal obstruction;10041101;LLT;20,1
1047;C145625;Grade 3 Small Intestinal Obstruction, CTCAE;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL";Grade 3 Small intestinal obstruction;"Hospitalization indicated; invasive intervention indicated; limiting self care ADL";Small intestinal obstruction;10041101;LLT;20,1
1048;C146118;Grade 4 Small Intestinal Obstruction, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Small intestinal obstruction;"Life-threatening consequences; urgent operative intervention indicated";Small intestinal obstruction;10041101;LLT;20,1
1049;C146550;Grade 5 Small Intestinal Obstruction, CTCAE;Death;Grade 5 Small intestinal obstruction;Death;Small intestinal obstruction;10041101;LLT;20,1
1050;C146635;Small Intestinal Perforation, CTCAE 5.0;A disorder characterized by a rupture in the small intestine wall.;Small intestinal perforation;A disorder characterized by a rupture in the small intestine wall.;Small intestinal perforation;10041103;LLT;20,1
1051;C145007;Grade 2 Small Intestinal Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Small intestinal perforation;Invasive intervention not indicated;Small intestinal perforation;10041103;LLT;20,1
1052;C145626;Grade 3 Small Intestinal Perforation, CTCAE;Invasive intervention indicated;Grade 3 Small intestinal perforation;Invasive intervention indicated;Small intestinal perforation;10041103;LLT;20,1
1053;C146119;Grade 4 Small Intestinal Perforation, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Small intestinal perforation;"Life-threatening consequences; urgent operative intervention indicated";Small intestinal perforation;10041103;LLT;20,1
1054;C146551;Grade 5 Small Intestinal Perforation, CTCAE;Death;Grade 5 Small intestinal perforation;Death;Small intestinal perforation;10041103;LLT;20,1
1055;C143844;Small Intestinal Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the small intestine.;Small intestinal stenosis;A disorder characterized by a narrowing of the lumen of the small intestine.;Small intestinal stenosis;10062263;LLT;20,1
1056;C144408;Grade 1 Small Intestinal Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Small intestinal stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Small intestinal stenosis;10062263;LLT;20,1
1057;C145008;Grade 2 Small Intestinal Stenosis, CTCAE;"Symptomatic; altered GI function";Grade 2 Small intestinal stenosis;"Symptomatic; altered GI function";Small intestinal stenosis;10062263;LLT;20,1
1058;C145627;Grade 3 Small Intestinal Stenosis, CTCAE;"Symptomatic and severely altered GI function; tube feeding, TPN or hospitalization indicated; non-emergent operative intervention indicated";Grade 3 Small intestinal stenosis;"Symptomatic and severely altered GI function; tube feeding, TPN or hospitalization indicated; non-emergent operative intervention indicated";Small intestinal stenosis;10062263;LLT;20,1
1059;C146120;Grade 4 Small Intestinal Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Small intestinal stenosis;"Life-threatening consequences; urgent operative intervention indicated";Small intestinal stenosis;10062263;LLT;20,1
1060;C146552;Grade 5 Small Intestinal Stenosis, CTCAE;Death;Grade 5 Small intestinal stenosis;Death;Small intestinal stenosis;10062263;LLT;20,1
1061;C143846;Small Intestine Ulcer, CTCAE;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the small intestine.;Small intestine ulcer;A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the small intestine.;Small intestine ulcer;10041133;LLT;20,1
1062;C144409;Grade 1 Small Intestine Ulcer, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Small intestine ulcer;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Small intestine ulcer;10041133;LLT;20,1
1063;C145010;Grade 2 Small Intestine Ulcer, CTCAE;"Symptomatic; altered GI function; limiting instrumental ADL";Grade 2 Small intestine ulcer;"Symptomatic; altered GI function; limiting instrumental ADL";Small intestine ulcer;10041133;LLT;20,1
1064;C145629;Grade 3 Small Intestine Ulcer, CTCAE;"Severely altered GI function; TPN indicated; elective invasive intervention indicated; limiting self care ADL";Grade 3 Small intestine ulcer;"Severely altered GI function; TPN indicated; elective invasive intervention indicated; limiting self care ADL";Small intestine ulcer;10041133;LLT;20,1
1065;C146122;Grade 4 Small Intestine Ulcer, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Small intestine ulcer;"Life-threatening consequences; urgent operative intervention indicated";Small intestine ulcer;10041133;LLT;20,1
1066;C146554;Grade 5 Small Intestine Ulcer, CTCAE;Death;Grade 5 Small intestine ulcer;Death;Small intestine ulcer;10041133;LLT;20,1
1067;C146774;Stomach Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the stomach.;Stomach pain;A disorder characterized by a sensation of marked discomfort in the stomach.;Stomach pain;10042112;LLT;20,1
1068;C56231;Grade 1 Stomach Pain, CTCAE;Mild pain;Grade 1 Stomach pain;Mild pain;Stomach pain;10042112;LLT;20,1
1069;C56232;Grade 2 Stomach Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Stomach pain;"Moderate pain; limiting instrumental ADL";Stomach pain;10042112;LLT;20,1
1070;C56233;Grade 3 Stomach Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Stomach pain;"Severe pain; limiting self care ADL";Stomach pain;10042112;LLT;20,1
1071;C143876;Tooth Development Disorder, CTCAE;A disorder characterized by a pathological process of the teeth occurring during tooth development.;Tooth development disorder;A disorder characterized by a pathological process of the teeth occurring during tooth development.;Tooth development disorder;10044030;LLT;20,1
1072;C144434;Grade 1 Tooth Development Disorder, CTCAE;"Asymptomatic; hypoplasia of tooth or enamel";Grade 1 Tooth development disorder;"Asymptomatic; hypoplasia of tooth or enamel";Tooth development disorder;10044030;LLT;20,1
1073;C145038;Grade 2 Tooth Development Disorder, CTCAE;Impairment correctable with oral surgery;Grade 2 Tooth development disorder;Impairment correctable with oral surgery;Tooth development disorder;10044030;LLT;20,1
1074;C145660;Grade 3 Tooth Development Disorder, CTCAE;"Maldevelopment with impairment not surgically correctable; limiting self care ADL";Grade 3 Tooth development disorder;"Maldevelopment with impairment not surgically correctable; limiting self care ADL";Tooth development disorder;10044030;LLT;20,1
1075;C143877;Tooth Discoloration, CTCAE;A disorder characterized by a change in tooth hue or tint.;Tooth discoloration;A disorder characterized by a change in tooth hue or tint.;Tooth discoloration;10044031;LLT;20,1
1076;C144435;Grade 1 Tooth Discoloration, CTCAE;Surface stains;Grade 1 Tooth discoloration;Surface stains;Tooth discoloration;10044031;LLT;20,1
1077;C143879;Toothache, CTCAE;A disorder characterized by a sensation of marked discomfort in the tooth.;Toothache;A disorder characterized by a sensation of marked discomfort in the tooth.;Toothache;10044055;LLT;20,1
1078;C144436;Grade 1 Toothache, CTCAE;Mild pain;Grade 1 Toothache;Mild pain;Toothache;10044055;LLT;20,1
1079;C145040;Grade 2 Toothache, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Toothache;"Moderate pain; limiting instrumental ADL";Toothache;10044055;LLT;20,1
1080;C145662;Grade 3 Toothache, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Toothache;"Severe pain; limiting self care ADL";Toothache;10044055;LLT;20,1
1081;C146730;Typhlitis, CTCAE 5.0;A disorder characterized by necrotizing enterocolitis in neutropenic patients.;Typhlitis;A disorder characterized by necrotizing enterocolitis in neutropenic patients.;Typhlitis;10045271;LLT;20,1
1082;C57523;Grade 3 Typhlitis, CTCAE;"Symptomatic (e.g., abdominal pain, fever, change in bowel habits with ileus); peritoneal signs";Grade 3 Typhlitis;"Symptomatic (e.g., abdominal pain, fever, change in bowel habits with ileus); peritoneal signs";Typhlitis;10045271;LLT;20,1
1083;C57655;Grade 4 Typhlitis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Typhlitis;"Life-threatening consequences; urgent operative intervention indicated";Typhlitis;10045271;LLT;20,1
1084;C57785;Grade 5 Typhlitis, CTCAE;Death;Grade 5 Typhlitis;Death;Typhlitis;10045271;LLT;20,1
1085;C143895;Upper Gastrointestinal Hemorrhage, CTCAE;A disorder characterized by bleeding from the upper gastrointestinal tract (oral cavity, pharynx, esophagus, and stomach).;Upper gastrointestinal hemorrhage;A disorder characterized by bleeding from the upper gastrointestinal tract (oral cavity, pharynx, esophagus, and stomach).;Upper gastrointestinal hemorrhage;10055356;LLT;20,1
1086;C144449;Grade 1 Upper Gastrointestinal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Upper gastrointestinal hemorrhage;"Mild symptoms; intervention not indicated";Upper gastrointestinal hemorrhage;10055356;LLT;20,1
1087;C145054;Grade 2 Upper Gastrointestinal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Upper gastrointestinal hemorrhage;"Moderate symptoms; intervention indicated";Upper gastrointestinal hemorrhage;10055356;LLT;20,1
1088;C145676;Grade 3 Upper Gastrointestinal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Upper gastrointestinal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Upper gastrointestinal hemorrhage;10055356;LLT;20,1
1089;C146160;Grade 4 Upper Gastrointestinal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Upper gastrointestinal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Upper gastrointestinal hemorrhage;10055356;LLT;20,1
1090;C146590;Grade 5 Upper Gastrointestinal Hemorrhage, CTCAE;Death;Grade 5 Upper gastrointestinal hemorrhage;Death;Upper gastrointestinal hemorrhage;10055356;LLT;20,1
1091;C143938;Visceral Arterial Ischemia, CTCAE;A disorder characterized by a decrease in blood supply due to narrowing or blockage of a visceral (mesenteric) artery.;Visceral arterial ischemia;A disorder characterized by a decrease in blood supply due to narrowing or blockage of a visceral (mesenteric) artery.;Visceral arterial ischemia;10054692;LLT;20,1
1092;C145098;Grade 2 Visceral Arterial Ischemia, CTCAE;Brief (<24 hrs) episode of ischemia managed medically and without permanent deficit;Grade 2 Visceral arterial ischemia;Brief (<24 hrs) episode of ischemia managed medically and without permanent deficit;Visceral arterial ischemia;10054692;LLT;20,1
1093;C145718;Grade 3 Visceral Arterial Ischemia, CTCAE;Prolonged (>=24 hrs) or recurring symptoms and/or invasive intervention indicated;Grade 3 Visceral arterial ischemia;Prolonged (>=24 hrs) or recurring symptoms and/or invasive intervention indicated;Visceral arterial ischemia;10054692;LLT;20,1
1094;C146192;Grade 4 Visceral Arterial Ischemia, CTCAE;"Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated";Grade 4 Visceral arterial ischemia;"Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated";Visceral arterial ischemia;10054692;LLT;20,1
1095;C146620;Grade 5 Visceral Arterial Ischemia, CTCAE;Death;Grade 5 Visceral arterial ischemia;Death;Visceral arterial ischemia;10054692;LLT;20,1
1096;C57896;Vomiting, CTCAE;A disorder characterized by the reflexive act of ejecting the contents of the stomach through the mouth.;Vomiting;A disorder characterized by the reflexive act of ejecting the contents of the stomach through the mouth.;Vomiting;10047700;LLT;20,1
1097;C57263;Grade 1 Vomiting, CTCAE;Intervention not indicated;Grade 1 Vomiting;Intervention not indicated;Vomiting;10047700;LLT;20,1
1098;C57386;Grade 2 Vomiting, CTCAE;"Outpatient IV hydration; medical intervention indicated";Grade 2 Vomiting;"Outpatient IV hydration; medical intervention indicated";Vomiting;10047700;LLT;20,1
1099;C57524;Grade 3 Vomiting, CTCAE;Tube feeding, TPN, or hospitalization indicated;Grade 3 Vomiting;Tube feeding, TPN, or hospitalization indicated;Vomiting;10047700;LLT;20,1
1100;C57656;Grade 4 Vomiting, CTCAE;Life-threatening consequences;Grade 4 Vomiting;Life-threatening consequences;Vomiting;10047700;LLT;20,1
1101;C57786;Grade 5 Vomiting, CTCAE;Death;Grade 5 Vomiting;Death;Vomiting;10047700;LLT;20,1
1102;C143169;General Disorders and Administration Site Conditions, CTCAE;;;;;;;
1103;C143366;Chills, CTCAE;A disorder characterized by a sensation of cold that often marks a physiologic response to sweating after a fever.;Chills;A disorder characterized by a sensation of cold that often marks a physiologic response to sweating after a fever.;Chills;10008531;LLT;20,1
1104;C144029;Grade 1 Chills, CTCAE;"Mild sensation of cold; shivering; chattering of teeth";Grade 1 Chills;"Mild sensation of cold; shivering; chattering of teeth";Chills;10008531;LLT;20,1
1105;C144577;Grade 2 Chills, CTCAE;"Moderate tremor of the entire body; narcotics indicated";Grade 2 Chills;"Moderate tremor of the entire body; narcotics indicated";Chills;10008531;LLT;20,1
1106;C145194;Grade 3 Chills, CTCAE;Severe or prolonged, not responsive to narcotics;Grade 3 Chills;Severe or prolonged, not responsive to narcotics;Chills;10008531;LLT;20,1
1107;C143395;Death Neonatal, CTCAE;Newborn death occurring during the first 28 days after birth.;Death neonatal;Newborn death occurring during the first 28 days after birth.;Death neonatal;10011912;LLT;20,1
1108;C145813;Grade 4 Death Neonatal, CTCAE;Neonatal loss of life;Grade 4 Death neonatal;Neonatal loss of life;Death neonatal;10011912;LLT;20,1
1109;C143396;Death NOS, CTCAE;Death that cannot be attributed to a CTCAE term associated with Grade 5.;Death NOS;Death that cannot be attributed to a CTCAE term associated with Grade 5.;Death NOS;10011914;LLT;20,1
1110;C55278;Grade 5 Death NOS, CTCAE;Death;Grade 5 Death NOS;Death;Death NOS;10011914;LLT;20,1
1111;C143201;Disease Progression, CTCAE;Death due to disease progression that cannot be attributed to a CTCAE term associated with Grade 5.;Disease progression;Death due to disease progression that cannot be attributed to a CTCAE term associated with Grade 5.;Disease progression;10061818;LLT;20,1
1112;C146279;Grade 5 Disease Progression, CTCAE;Death;Grade 5 Disease progression;Death;Disease progression;10061818;LLT;20,1
1113;C143432;Edema Face, CTCAE;A disorder characterized by swelling due to excessive fluid accumulation in facial tissues.;Edema face;A disorder characterized by swelling due to excessive fluid accumulation in facial tissues.;Edema face;10014222;LLT;20,1
1114;C144071;Grade 1 Edema Face, CTCAE;Localized facial edema;Grade 1 Edema face;Localized facial edema;Edema face;10014222;LLT;20,1
1115;C144626;Grade 2 Edema Face, CTCAE;"Moderate localized facial edema; limiting instrumental ADL";Grade 2 Edema face;"Moderate localized facial edema; limiting instrumental ADL";Edema face;10014222;LLT;20,1
1116;C145243;Grade 3 Edema Face, CTCAE;"Severe swelling; limiting self care ADL";Grade 3 Edema face;"Severe swelling; limiting self care ADL";Edema face;10014222;LLT;20,1
1117;C143433;Edema Limbs, CTCAE;A disorder characterized by swelling due to excessive fluid accumulation in the upper or lower extremities.;Edema limbs;A disorder characterized by swelling due to excessive fluid accumulation in the upper or lower extremities.;Edema limbs;10050068;LLT;20,1
1118;C144072;Grade 1 Edema Limbs, CTCAE;"5-10% inter-limb discrepancy in volume or circumference at point of greatest visible difference; swelling or obscuration of anatomic architecture on close inspection";Grade 1 Edema limbs;"5-10% inter-limb discrepancy in volume or circumference at point of greatest visible difference; swelling or obscuration of anatomic architecture on close inspection";Edema limbs;10050068;LLT;20,1
1119;C144627;Grade 2 Edema Limbs, CTCAE;">10-30% inter-limb discrepancy in volume or circumference at point of greatest visible difference; readily apparent obscuration of anatomic architecture; obliteration of skin folds; readily apparent deviation from normal anatomic contour; limiting instrumental ADL";Grade 2 Edema limbs;">10-30% inter-limb discrepancy in volume or circumference at point of greatest visible difference; readily apparent obscuration of anatomic architecture; obliteration of skin folds; readily apparent deviation from normal anatomic contour; limiting instrumental ADL";Edema limbs;10050068;LLT;20,1
1120;C145244;Grade 3 Edema Limbs, CTCAE;">30% inter-limb discrepancy in volume; gross deviation from normal anatomic contour; limiting self care ADL";Grade 3 Edema limbs;">30% inter-limb discrepancy in volume; gross deviation from normal anatomic contour; limiting self care ADL";Edema limbs;10050068;LLT;20,1
1121;C143434;Edema Trunk, CTCAE;A disorder characterized by swelling due to excessive fluid accumulation in the trunk area.;Edema trunk;A disorder characterized by swelling due to excessive fluid accumulation in the trunk area.;Edema trunk;10058720;LLT;20,1
1122;C144073;Grade 1 Edema Trunk, CTCAE;Swelling or obscuration of anatomic architecture on close inspection;Grade 1 Edema trunk;Swelling or obscuration of anatomic architecture on close inspection;Edema trunk;10058720;LLT;20,1
1123;C144628;Grade 2 Edema Trunk, CTCAE;"Readily apparent obscuration of anatomic architecture; obliteration of skin folds; readily apparent deviation from normal anatomic contour; limiting instrumental ADL";Grade 2 Edema trunk;"Readily apparent obscuration of anatomic architecture; obliteration of skin folds; readily apparent deviation from normal anatomic contour; limiting instrumental ADL";Edema trunk;10058720;LLT;20,1
1124;C145245;Grade 3 Edema Trunk, CTCAE;"Gross deviation from normal anatomic contour; limiting self care ADL";Grade 3 Edema trunk;"Gross deviation from normal anatomic contour; limiting self care ADL";Edema trunk;10058720;LLT;20,1
1125;C143474;Facial Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the face.;Facial pain;A disorder characterized by a sensation of marked discomfort in the face.;Facial pain;10016059;LLT;20,1
1126;C144098;Grade 1 Facial Pain, CTCAE;Mild pain;Grade 1 Facial pain;Mild pain;Facial pain;10016059;LLT;20,1
1127;C144658;Grade 2 Facial Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Facial pain;"Moderate pain; limiting instrumental ADL";Facial pain;10016059;LLT;20,1
1128;C145278;Grade 3 Facial Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Facial pain;"Severe pain; limiting self care ADL";Facial pain;10016059;LLT;20,1
1129;C146753;Fatigue, CTCAE 5.0;A disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities.;Fatigue;A disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities.;Fatigue;10016256;LLT;20,1
1130;C55292;Grade 1 Fatigue, CTCAE;Fatigue relieved by rest;Grade 1 Fatigue;Fatigue relieved by rest;Fatigue;10016256;LLT;20,1
1131;C55301;Grade 2 Fatigue, CTCAE;"Fatigue not relieved by rest; limiting instrumental ADL";Grade 2 Fatigue;"Fatigue not relieved by rest; limiting instrumental ADL";Fatigue;10016256;LLT;20,1
1132;C55311;Grade 3 Fatigue, CTCAE;Fatigue not relieved by rest, limiting self care ADL;Grade 3 Fatigue;Fatigue not relieved by rest, limiting self care ADL;Fatigue;10016256;LLT;20,1
1133;C143485;Fever, CTCAE;A disorder characterized by elevation of the body's temperature above the upper limit of normal.;Fever;A disorder characterized by elevation of the body's temperature above the upper limit of normal.;Fever;10016558;LLT;20,1
1134;C144104;Grade 1 Fever, CTCAE;38.0-39.0 degrees C (100.4-102.2 degrees F);Grade 1 Fever;38.0-39.0 degrees C (100.4-102.2 degrees F);Fever;10016558;LLT;20,1
1135;C144665;Grade 2 Fever, CTCAE;>39.0-40.0 degrees C (102.3-104.0 degrees F);Grade 2 Fever;>39.0-40.0 degrees C (102.3-104.0 degrees F);Fever;10016558;LLT;20,1
1136;C145285;Grade 3 Fever, CTCAE;>40.0 degrees C (>104.0 degrees F) for <=24 hrs;Grade 3 Fever;>40.0 degrees C (>104.0 degrees F) for <=24 hrs;Fever;10016558;LLT;20,1
1137;C145858;Grade 4 Fever, CTCAE;>40.0 degrees C (>104.0 degrees F) for >24 hrs;Grade 4 Fever;>40.0 degrees C (>104.0 degrees F) for >24 hrs;Fever;10016558;LLT;20,1
1138;C146313;Grade 5 Fever, CTCAE;Death;Grade 5 Fever;Death;Fever;10016558;LLT;20,1
1139;C143492;Flu Like Symptoms, CTCAE;A disorder characterized by a group of symptoms similar to those observed in patients with the flu. It includes fever, chills, body aches, malaise, loss of appetite and dry cough.;Flu like symptoms;A disorder characterized by a group of symptoms similar to those observed in patients with the flu. It includes fever, chills, body aches, malaise, loss of appetite and dry cough.;Flu like symptoms;10016791;LLT;20,1
1140;C144110;Grade 1 Flu Like Symptoms, CTCAE;Mild flu-like symptoms present;Grade 1 Flu like symptoms;Mild flu-like symptoms present;Flu like symptoms;10016791;LLT;20,1
1141;C144671;Grade 2 Flu Like Symptoms, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Flu like symptoms;"Moderate symptoms; limiting instrumental ADL";Flu like symptoms;10016791;LLT;20,1
1142;C145291;Grade 3 Flu Like Symptoms, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Flu like symptoms;"Severe symptoms; limiting self care ADL";Flu like symptoms;10016791;LLT;20,1
1143;C143496;Gait Disturbance, CTCAE;A disorder characterized by walking difficulties.;Gait disturbance;A disorder characterized by walking difficulties.;Gait disturbance;10017577;LLT;20,1
1144;C144113;Grade 1 Gait Disturbance, CTCAE;Mild change in gait (e.g., wide-based, limping or hobbling);Grade 1 Gait disturbance;Mild change in gait (e.g., wide-based, limping or hobbling);Gait disturbance;10017577;LLT;20,1
1145;C144675;Grade 2 Gait Disturbance, CTCAE;"Moderate change in gait (e.g., wide-based, limping or hobbling); assistive device indicated; limiting instrumental ADL";Grade 2 Gait disturbance;"Moderate change in gait (e.g., wide-based, limping or hobbling); assistive device indicated; limiting instrumental ADL";Gait disturbance;10017577;LLT;20,1
1146;C145296;Grade 3 Gait Disturbance, CTCAE;Limiting self care ADL;Grade 3 Gait disturbance;Limiting self care ADL;Gait disturbance;10017577;LLT;20,1
1147;C143513;General Disorders and Administration Site Conditions - Other, Specify, CTCAE;;General disorders and administration site conditions - Other, specify;;General disorders and administration site conditions - Other, specify;10018065;LLT;20,1
1148;C144125;Grade 1 General Disorders and Administration Site Conditions - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 General disorders and administration site conditions - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";General disorders and administration site conditions - Other, specify;10018065;LLT;20,1
1149;C144690;Grade 2 General Disorders and Administration Site Conditions - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 General disorders and administration site conditions - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";General disorders and administration site conditions - Other, specify;10018065;LLT;20,1
1150;C145312;Grade 3 General Disorders and Administration Site Conditions - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 General disorders and administration site conditions - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";General disorders and administration site conditions - Other, specify;10018065;LLT;20,1
1151;C145875;Grade 4 General Disorders and Administration Site Conditions - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 General disorders and administration site conditions - Other, specify;"Life-threatening consequences; urgent intervention indicated";General disorders and administration site conditions - Other, specify;10018065;LLT;20,1
1152;C146327;Grade 5 General Disorders and Administration Site Conditions - Other, Specify, CTCAE;Death;Grade 5 General disorders and administration site conditions - Other, specify;Death;General disorders and administration site conditions - Other, specify;10018065;LLT;20,1
1153;C143202;Generalized Edema, CTCAE;A disorder characterized by fluid accumulation in the tissues of the body including the skin.;Generalized edema;A disorder characterized by fluid accumulation in the tissues of the body including the skin.;Generalized edema;10018112;LLT;20,1
1154;C144126;Grade 1 Generalized Edema, CTCAE;"Noted on exam; 1+ pitting edema";Grade 1 Generalized edema;"Noted on exam; 1+ pitting edema";Generalized edema;10018112;LLT;20,1
1155;C144691;Grade 2 Generalized Edema, CTCAE;"Interfering with instrumental ADLs; oral therapy initiated";Grade 2 Generalized edema;"Interfering with instrumental ADLs; oral therapy initiated";Generalized edema;10018112;LLT;20,1
1156;C145313;Grade 3 Generalized Edema, CTCAE;"Interferes with self care ADL; intravenous therapy indicated; skin breakdown";Grade 3 Generalized edema;"Interferes with self care ADL; intravenous therapy indicated; skin breakdown";Generalized edema;10018112;LLT;20,1
1157;C145876;Grade 4 Generalized Edema, CTCAE;Life-threatening consequences;Grade 4 Generalized edema;Life-threatening consequences;Generalized edema;10018112;LLT;20,1
1158;C55332;Hypothermia, CTCAE;A disorder characterized by an abnormally low body temperature. Treatment is required when the body temperature is 35C (95F) or below.;Hypothermia;A disorder characterized by an abnormally low body temperature. Treatment is required when the body temperature is 35C (95F) or below.;Hypothermia;10021113;LLT;20,1
1159;C55303;Grade 2 Hypothermia, CTCAE;"35->32 degrees C; 95->89.6 degrees F";Grade 2 Hypothermia;"35->32 degrees C; 95->89.6 degrees F";Hypothermia;10021113;LLT;20,1
1160;C55313;Grade 3 Hypothermia, CTCAE;"32->28 degrees C; 89.6->82.4 degrees F";Grade 3 Hypothermia;"32->28 degrees C; 89.6->82.4 degrees F";Hypothermia;10021113;LLT;20,1
1161;C55322;Grade 4 Hypothermia, CTCAE;"<=28 degrees C; 82.4 degrees F; life-threatening consequences (e.g., coma, hypotension, pulmonary edema, acidemia, ventricular fibrillation)";Grade 4 Hypothermia;"<=28 degrees C; 82.4 degrees F; life-threatening consequences (e.g., coma, hypotension, pulmonary edema, acidemia, ventricular fibrillation)";Hypothermia;10021113;LLT;20,1
1162;C55327;Grade 5 Hypothermia, CTCAE;Death;Grade 5 Hypothermia;Death;Hypothermia;10021113;LLT;20,1
1163;C143584;Infusion Site Extravasation, CTCAE;A disorder characterized by leakage of the infusion into the surrounding tissue. Signs and symptoms may include induration, erythema, swelling, burning sensation and marked discomfort at the infusion site.;Infusion site extravasation;A disorder characterized by leakage of the infusion into the surrounding tissue. Signs and symptoms may include induration, erythema, swelling, burning sensation and marked discomfort at the infusion site.;Infusion site extravasation;10064774;LLT;20,1
1164;C144196;Grade 1 Infusion Site Extravasation, CTCAE;Painless edema;Grade 1 Infusion site extravasation;Painless edema;Infusion site extravasation;10064774;LLT;20,1
1165;C144759;Grade 2 Infusion Site Extravasation, CTCAE;Erythema with associated symptoms (e.g., edema, pain, induration, phlebitis);Grade 2 Infusion site extravasation;Erythema with associated symptoms (e.g., edema, pain, induration, phlebitis);Infusion site extravasation;10064774;LLT;20,1
1166;C145381;Grade 3 Infusion Site Extravasation, CTCAE;"Ulceration or necrosis; severe tissue damage; operative intervention indicated";Grade 3 Infusion site extravasation;"Ulceration or necrosis; severe tissue damage; operative intervention indicated";Infusion site extravasation;10064774;LLT;20,1
1167;C145930;Grade 4 Infusion Site Extravasation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Infusion site extravasation;"Life-threatening consequences; urgent intervention indicated";Infusion site extravasation;10064774;LLT;20,1
1168;C146377;Grade 5 Infusion Site Extravasation, CTCAE;Death;Grade 5 Infusion site extravasation;Death;Infusion site extravasation;10064774;LLT;20,1
1169;C143585;Injection Site Reaction, CTCAE;A disorder characterized by an intense adverse reaction (usually immunologic) developing at the site of an injection.;Injection site reaction;A disorder characterized by an intense adverse reaction (usually immunologic) developing at the site of an injection.;Injection site reaction;10022095;LLT;20,1
1170;C144197;Grade 1 Injection Site Reaction, CTCAE;Tenderness with or without associated symptoms (e.g., warmth, erythema, itching);Grade 1 Injection site reaction;Tenderness with or without associated symptoms (e.g., warmth, erythema, itching);Injection site reaction;10022095;LLT;20,1
1171;C144760;Grade 2 Injection Site Reaction, CTCAE;"Pain; lipodystrophy; edema; phlebitis";Grade 2 Injection site reaction;"Pain; lipodystrophy; edema; phlebitis";Injection site reaction;10022095;LLT;20,1
1172;C145382;Grade 3 Injection Site Reaction, CTCAE;"Ulceration or necrosis; severe tissue damage; operative intervention indicated";Grade 3 Injection site reaction;"Ulceration or necrosis; severe tissue damage; operative intervention indicated";Injection site reaction;10022095;LLT;20,1
1173;C145931;Grade 4 Injection Site Reaction, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Injection site reaction;"Life-threatening consequences; urgent intervention indicated";Injection site reaction;10022095;LLT;20,1
1174;C146378;Grade 5 Injection Site Reaction, CTCAE;Death;Grade 5 Injection site reaction;Death;Injection site reaction;10022095;LLT;20,1
1175;C143654;Localized Edema, CTCAE;A disorder characterized by swelling due to excessive fluid accumulation at a specific anatomic site.;Localized edema;A disorder characterized by swelling due to excessive fluid accumulation at a specific anatomic site.;Localized edema;10062466;LLT;20,1
1176;C144251;Grade 1 Localized Edema, CTCAE;Localized to dependent areas, no disability or functional impairment;Grade 1 Localized edema;Localized to dependent areas, no disability or functional impairment;Localized edema;10062466;LLT;20,1
1177;C144823;Grade 2 Localized Edema, CTCAE;"Moderate localized edema and intervention indicated; limiting instrumental ADL";Grade 2 Localized edema;"Moderate localized edema and intervention indicated; limiting instrumental ADL";Localized edema;10062466;LLT;20,1
1178;C145443;Grade 3 Localized Edema, CTCAE;"Severe localized edema and intervention indicated; limiting self care ADL";Grade 3 Localized edema;"Severe localized edema and intervention indicated; limiting self care ADL";Localized edema;10062466;LLT;20,1
1179;C143665;Malaise, CTCAE;A disorder characterized by a feeling of general discomfort or uneasiness, an out-of-sorts feeling.;Malaise;A disorder characterized by a feeling of general discomfort or uneasiness, an out-of-sorts feeling.;Malaise;10025482;LLT;20,1
1180;C144256;Grade 1 Malaise, CTCAE;Uneasiness or lack of well being;Grade 1 Malaise;Uneasiness or lack of well being;Malaise;10025482;LLT;20,1
1181;C144832;Grade 2 Malaise, CTCAE;Uneasiness or lack of well being limiting instrumental ADL;Grade 2 Malaise;Uneasiness or lack of well being limiting instrumental ADL;Malaise;10025482;LLT;20,1
1182;C145452;Grade 3 Malaise, CTCAE;Uneasiness or lack of well being limiting self-care ADL;Grade 3 Malaise;Uneasiness or lack of well being limiting self-care ADL;Malaise;10025482;LLT;20,1
1183;C143680;Multi-Organ Failure, CTCAE;A disorder characterized by progressive deterioration of the lungs, liver, kidney and clotting mechanisms.;Multi-organ failure;A disorder characterized by progressive deterioration of the lungs, liver, kidney and clotting mechanisms.;Multi-organ failure;10028154;LLT;20,1
1184;C145468;Grade 3 Multi-Organ Failure, CTCAE;"Shock with azotemia and acid-base disturbances; significant coagulation abnormalities";Grade 3 Multi-organ failure;"Shock with azotemia and acid-base disturbances; significant coagulation abnormalities";Multi-organ failure;10028154;LLT;20,1
1185;C146003;Grade 4 Multi-Organ Failure, CTCAE;Life-threatening consequences (e.g., vasopressor dependent and oliguric or anuric or ischemic colitis or lactic acidosis);Grade 4 Multi-organ failure;Life-threatening consequences (e.g., vasopressor dependent and oliguric or anuric or ischemic colitis or lactic acidosis);Multi-organ failure;10028154;LLT;20,1
1186;C55280;Grade 5 Multi-Organ Failure, CTCAE;Death;Grade 5 Multi-organ failure;Death;Multi-organ failure;10028154;LLT;20,1
1187;C143700;Neck Edema, CTCAE;A disorder characterized by swelling due to an accumulation of excessive fluid in the neck.;Neck edema;A disorder characterized by swelling due to an accumulation of excessive fluid in the neck.;Neck edema;10054482;LLT;20,1
1188;C144285;Grade 1 Neck Edema, CTCAE;Asymptomatic localized neck edema;Grade 1 Neck edema;Asymptomatic localized neck edema;Neck edema;10054482;LLT;20,1
1189;C144861;Grade 2 Neck Edema, CTCAE;"Moderate neck edema; slight obliteration of anatomic landmarks; limiting instrumental ADL";Grade 2 Neck edema;"Moderate neck edema; slight obliteration of anatomic landmarks; limiting instrumental ADL";Neck edema;10054482;LLT;20,1
1190;C145482;Grade 3 Neck Edema, CTCAE;"Generalized neck edema (e.g., difficulty in turning neck); limiting self care ADL";Grade 3 Neck edema;"Generalized neck edema (e.g., difficulty in turning neck); limiting self care ADL";Neck edema;10054482;LLT;20,1
1191;C146008;Grade 4 Neck Edema, CTCAE;Vascular or respiratory impairment requiring urgent intervention;Grade 4 Neck edema;Vascular or respiratory impairment requiring urgent intervention;Neck edema;10054482;LLT;20,1
1192;C143707;Non-Cardiac Chest Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the chest unrelated to a heart disorder.;Non-cardiac chest pain;A disorder characterized by a sensation of marked discomfort in the chest unrelated to a heart disorder.;Non-cardiac chest pain;10062501;LLT;20,1
1193;C144292;Grade 1 Non-Cardiac Chest Pain, CTCAE;Mild pain;Grade 1 Non-cardiac chest pain;Mild pain;Non-cardiac chest pain;10062501;LLT;20,1
1194;C144868;Grade 2 Non-Cardiac Chest Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Non-cardiac chest pain;"Moderate pain; limiting instrumental ADL";Non-cardiac chest pain;10062501;LLT;20,1
1195;C145489;Grade 3 Non-Cardiac Chest Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Non-cardiac chest pain;"Severe pain; limiting self care ADL";Non-cardiac chest pain;10062501;LLT;20,1
1196;C143725;Pain, CTCAE;A disorder characterized by the sensation of marked discomfort, distress or agony.;Pain;A disorder characterized by the sensation of marked discomfort, distress or agony.;Pain;10033371;LLT;20,1
1197;C144309;Grade 1 Pain, CTCAE;Mild pain;Grade 1 Pain;Mild pain;Pain;10033371;LLT;20,1
1198;C144888;Grade 2 Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Pain;"Moderate pain; limiting instrumental ADL";Pain;10033371;LLT;20,1
1199;C145508;Grade 3 Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Pain;"Severe pain; limiting self care ADL";Pain;10033371;LLT;20,1
1200;C143863;Sudden Death NOS, CTCAE;An unexpected death that cannot be attributed to a CTCAE term associated with Grade 5.;Sudden death NOS;An unexpected death that cannot be attributed to a CTCAE term associated with Grade 5.;Sudden death NOS;10042435;LLT;20,1
1201;C146570;Grade 5 Sudden Death NOS, CTCAE;Death;Grade 5 Sudden death NOS;Death;Sudden death NOS;10042435;LLT;20,1
1202;C143203;Vaccination Site Lymphadenopathy, CTCAE;A disorder characterized by lymph node enlargement after vaccination;Vaccination site lymphadenopathy;A disorder characterized by lymph node enlargement after vaccination;Vaccination site lymphadenopathy;10069480;LLT;20,1
1203;C144466;Grade 1 Vaccination Site Lymphadenopathy, CTCAE;Local lymph node enlargement;Grade 1 Vaccination site lymphadenopathy;Local lymph node enlargement;Vaccination site lymphadenopathy;10069480;LLT;20,1
1204;C145077;Grade 2 Vaccination Site Lymphadenopathy, CTCAE;"Localized ulceration; generalized lymph node enlargement";Grade 2 Vaccination site lymphadenopathy;"Localized ulceration; generalized lymph node enlargement";Vaccination site lymphadenopathy;10069480;LLT;20,1
1205;C143170;Hepatobiliary Disorders, CTCAE;;;;;;;
1206;C143314;Bile Duct Stenosis, CTCAE;A disorder characterized by a narrowing of the lumen of the bile duct.;Bile duct stenosis;A disorder characterized by a narrowing of the lumen of the bile duct.;Bile duct stenosis;10051341;LLT;20,1
1207;C143995;Grade 1 Bile Duct Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Bile duct stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Bile duct stenosis;10051341;LLT;20,1
1208;C144536;Grade 2 Bile Duct Stenosis, CTCAE;"Symptomatic; altered GI function; IV fluids indicated <24 hrs";Grade 2 Bile duct stenosis;"Symptomatic; altered GI function; IV fluids indicated <24 hrs";Bile duct stenosis;10051341;LLT;20,1
1209;C145155;Grade 3 Bile Duct Stenosis, CTCAE;"Severely altered GI function; invasive intervention indicated";Grade 3 Bile duct stenosis;"Severely altered GI function; invasive intervention indicated";Bile duct stenosis;10051341;LLT;20,1
1210;C145760;Grade 4 Bile Duct Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Bile duct stenosis;"Life-threatening consequences; urgent operative intervention indicated";Bile duct stenosis;10051341;LLT;20,1
1211;C146229;Grade 5 Bile Duct Stenosis, CTCAE;Death;Grade 5 Bile duct stenosis;Death;Bile duct stenosis;10051341;LLT;20,1
1212;C143316;Biliary Fistula, CTCAE;A disorder characterized by an abnormal communication between the bile ducts and another organ or anatomic site.;Biliary fistula;A disorder characterized by an abnormal communication between the bile ducts and another organ or anatomic site.;Biliary fistula;10004665;LLT;20,1
1213;C144538;Grade 2 Biliary Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Biliary fistula;Symptomatic, invasive intervention not indicated;Biliary fistula;10004665;LLT;20,1
1214;C145157;Grade 3 Biliary Fistula, CTCAE;Invasive intervention indicated;Grade 3 Biliary fistula;Invasive intervention indicated;Biliary fistula;10004665;LLT;20,1
1215;C145762;Grade 4 Biliary Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Biliary fistula;"Life-threatening consequences; urgent intervention indicated";Biliary fistula;10004665;LLT;20,1
1216;C146231;Grade 5 Biliary Fistula, CTCAE;Death;Grade 5 Biliary fistula;Death;Biliary fistula;10004665;LLT;20,1
1217;C143204;Budd-Chiari Syndrome, CTCAE;A disorder characterized by occlusion of the hepatic veins and typically presents with abdominal pain, ascites and hepatomegaly.;Budd-Chiari syndrome;A disorder characterized by occlusion of the hepatic veins and typically presents with abdominal pain, ascites and hepatomegaly.;Budd-Chiari syndrome;10006537;LLT;20,1
1218;C144563;Grade 2 Budd-Chiari Syndrome, CTCAE;Medical management indicated;Grade 2 Budd-Chiari syndrome;Medical management indicated;Budd-Chiari syndrome;10006537;LLT;20,1
1219;C145178;Grade 3 Budd-Chiari Syndrome, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; asterixis; mild encephalopathy";Grade 3 Budd-Chiari syndrome;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; asterixis; mild encephalopathy";Budd-Chiari syndrome;10006537;LLT;20,1
1220;C145778;Grade 4 Budd-Chiari Syndrome, CTCAE;"Life-threatening consequences; moderate to severe encephalopathy; coma";Grade 4 Budd-Chiari syndrome;"Life-threatening consequences; moderate to severe encephalopathy; coma";Budd-Chiari syndrome;10006537;LLT;20,1
1221;C146246;Grade 5 Budd-Chiari Syndrome, CTCAE;Death;Grade 5 Budd-Chiari syndrome;Death;Budd-Chiari syndrome;10006537;LLT;20,1
1222;C57808;Gallbladder Fistula, CTCAE;A disorder characterized by an abnormal communication between the gallbladder and another organ or anatomic site.;Gallbladder fistula;A disorder characterized by an abnormal communication between the gallbladder and another organ or anatomic site.;Gallbladder fistula;10017631;LLT;20,1
1223;C57188;Grade 1 Gallbladder Fistula, CTCAE;Asymptomatic;Grade 1 Gallbladder fistula;Asymptomatic;Gallbladder fistula;10017631;LLT;20,1
1224;C57311;Grade 2 Gallbladder Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Gallbladder fistula;Symptomatic, invasive intervention not indicated;Gallbladder fistula;10017631;LLT;20,1
1225;C57437;Grade 3 Gallbladder Fistula, CTCAE;Invasive intervention indicated;Grade 3 Gallbladder fistula;Invasive intervention indicated;Gallbladder fistula;10017631;LLT;20,1
1226;C57572;Grade 4 Gallbladder Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Gallbladder fistula;"Life-threatening consequences; urgent intervention indicated";Gallbladder fistula;10017631;LLT;20,1
1227;C57703;Grade 5 Gallbladder Fistula, CTCAE;Death;Grade 5 Gallbladder fistula;Death;Gallbladder fistula;10017631;LLT;20,1
1228;C146735;Gallbladder Necrosis, CTCAE 5.0;A disorder characterized by a necrotic process occurring in the gallbladder.;Gallbladder necrosis;A disorder characterized by a necrotic process occurring in the gallbladder.;Gallbladder necrosis;10059446;LLT;20,1
1229;C57573;Grade 4 Gallbladder Necrosis, CTCAE;"Life-threatening consequences; urgent invasive intervention indicated";Grade 4 Gallbladder necrosis;"Life-threatening consequences; urgent invasive intervention indicated";Gallbladder necrosis;10059446;LLT;20,1
1230;C57704;Grade 5 Gallbladder Necrosis, CTCAE;Death;Grade 5 Gallbladder necrosis;Death;Gallbladder necrosis;10059446;LLT;20,1
1231;C57810;Gallbladder Obstruction, CTCAE;A disorder characterized by blockage of the normal flow of the contents of the gallbladder.;Gallbladder obstruction;A disorder characterized by blockage of the normal flow of the contents of the gallbladder.;Gallbladder obstruction;10017636;LLT;20,1
1232;C57189;Grade 1 Gallbladder Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Gallbladder obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Gallbladder obstruction;10017636;LLT;20,1
1233;C57312;Grade 2 Gallbladder Obstruction, CTCAE;"Symptomatic; altered GI function; IV fluids indicated <24 hrs";Grade 2 Gallbladder obstruction;"Symptomatic; altered GI function; IV fluids indicated <24 hrs";Gallbladder obstruction;10017636;LLT;20,1
1234;C57439;Grade 3 Gallbladder Obstruction, CTCAE;"Symptomatic and severely altered GI function; tube feeding, TPN or hospitalization indicated; non-emergent operative intervention indicated";Grade 3 Gallbladder obstruction;"Symptomatic and severely altered GI function; tube feeding, TPN or hospitalization indicated; non-emergent operative intervention indicated";Gallbladder obstruction;10017636;LLT;20,1
1235;C57574;Grade 4 Gallbladder Obstruction, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Gallbladder obstruction;"Life-threatening consequences; urgent operative intervention indicated";Gallbladder obstruction;10017636;LLT;20,1
1236;C57705;Grade 5 Gallbladder Obstruction, CTCAE;Death;Grade 5 Gallbladder obstruction;Death;Gallbladder obstruction;10017636;LLT;20,1
1237;C146755;Gallbladder Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the gallbladder region.;Gallbladder pain;A disorder characterized by a sensation of marked discomfort in the gallbladder region.;Gallbladder pain;10017638;LLT;20,1
1238;C56081;Grade 1 Gallbladder Pain, CTCAE;Mild pain;Grade 1 Gallbladder pain;Mild pain;Gallbladder pain;10017638;LLT;20,1
1239;C56082;Grade 2 Gallbladder Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Gallbladder pain;"Moderate pain; limiting instrumental ADL";Gallbladder pain;10017638;LLT;20,1
1240;C56083;Grade 3 Gallbladder Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Gallbladder pain;"Severe pain; limiting self care ADL";Gallbladder pain;10017638;LLT;20,1
1241;C146708;Gallbladder Perforation, CTCAE 5.0;A disorder characterized by a rupture in the gallbladder wall.;Gallbladder perforation;A disorder characterized by a rupture in the gallbladder wall.;Gallbladder perforation;10017639;LLT;20,1
1242;C57575;Grade 4 Gallbladder Perforation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Gallbladder perforation;"Life-threatening consequences; urgent intervention indicated";Gallbladder perforation;10017639;LLT;20,1
1243;C57706;Grade 5 Gallbladder Perforation, CTCAE;Death;Grade 5 Gallbladder perforation;Death;Gallbladder perforation;10017639;LLT;20,1
1244;C143539;Hepatic Failure, CTCAE;A disorder characterized by the inability of the liver to metabolize chemicals in the body. Laboratory test results reveal abnormal plasma levels of ammonia, bilirubin, lactic dehydrogenase, alkaline phosphatase, aminotransferase, and/or prolongation of prothrombin time (INR.) Drug-induced liever injury (DILI) as defined by Hy's Law.;Hepatic failure;A disorder characterized by the inability of the liver to metabolize chemicals in the body. Laboratory test results reveal abnormal plasma levels of ammonia, bilirubin, lactic dehydrogenase, alkaline phosphatase, aminotransferase, and/or prolongation of prothrombin time (INR.) Drug-induced liever injury (DILI) as defined by Hy's Law.;Hepatic failure;10019663;LLT;20,1
1245;C145332;Grade 3 Hepatic Failure, CTCAE;"Asterixis; mild encephalopathy; drug-induced liver injury (DILI); limiting self care ADL";Grade 3 Hepatic failure;"Asterixis; mild encephalopathy; drug-induced liver injury (DILI); limiting self care ADL";Hepatic failure;10019663;LLT;20,1
1246;C145889;Grade 4 Hepatic Failure, CTCAE;"Life-threatening consequences; moderate to severe encephalopathy; coma";Grade 4 Hepatic failure;"Life-threatening consequences; moderate to severe encephalopathy; coma";Hepatic failure;10019663;LLT;20,1
1247;C146338;Grade 5 Hepatic Failure, CTCAE;Death;Grade 5 Hepatic failure;Death;Hepatic failure;10019663;LLT;20,1
1248;C143540;Hepatic Hemorrhage, CTCAE;A disorder characterized by bleeding from the liver.;Hepatic hemorrhage;A disorder characterized by bleeding from the liver.;Hepatic hemorrhage;10019678;LLT;20,1
1249;C144150;Grade 1 Hepatic Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Hepatic hemorrhage;"Mild symptoms; intervention not indicated";Hepatic hemorrhage;10019678;LLT;20,1
1250;C144711;Grade 2 Hepatic Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Hepatic hemorrhage;"Moderate symptoms; intervention indicated";Hepatic hemorrhage;10019678;LLT;20,1
1251;C145333;Grade 3 Hepatic Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Hepatic hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Hepatic hemorrhage;10019678;LLT;20,1
1252;C145890;Grade 4 Hepatic Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hepatic hemorrhage;"Life-threatening consequences; urgent intervention indicated";Hepatic hemorrhage;10019678;LLT;20,1
1253;C146339;Grade 5 Hepatic Hemorrhage, CTCAE;Death;Grade 5 Hepatic hemorrhage;Death;Hepatic hemorrhage;10019678;LLT;20,1
1254;C146736;Hepatic Necrosis, CTCAE 5.0;A disorder characterized by a necrotic process occurring in the hepatic parenchyma.;Hepatic necrosis;A disorder characterized by a necrotic process occurring in the hepatic parenchyma.;Hepatic necrosis;10019692;LLT;20,1
1255;C57581;Grade 4 Hepatic Necrosis, CTCAE;"Life-threatening consequences; urgent invasive intervention indicated";Grade 4 Hepatic necrosis;"Life-threatening consequences; urgent invasive intervention indicated";Hepatic necrosis;10019692;LLT;20,1
1256;C57712;Grade 5 Hepatic Necrosis, CTCAE;Death;Grade 5 Hepatic necrosis;Death;Hepatic necrosis;10019692;LLT;20,1
1257;C143542;Hepatic Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the liver region.;Hepatic pain;A disorder characterized by a sensation of marked discomfort in the liver region.;Hepatic pain;10019705;LLT;20,1
1258;C144151;Grade 1 Hepatic Pain, CTCAE;Mild pain;Grade 1 Hepatic pain;Mild pain;Hepatic pain;10019705;LLT;20,1
1259;C144713;Grade 2 Hepatic Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Hepatic pain;"Moderate pain; limiting instrumental ADL";Hepatic pain;10019705;LLT;20,1
1260;C145335;Grade 3 Hepatic Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Hepatic pain;"Severe pain; limiting self care ADL";Hepatic pain;10019705;LLT;20,1
1261;C143544;Hepatobiliary Disorders - Other, Specify, CTCAE;;Hepatobiliary disorders - Other, specify;;Hepatobiliary disorders - Other, specify;10019805;LLT;20,1
1262;C144154;Grade 1 Hepatobiliary Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hepatobiliary disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Hepatobiliary disorders - Other, specify;10019805;LLT;20,1
1263;C144716;Grade 2 Hepatobiliary Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Hepatobiliary disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Hepatobiliary disorders - Other, specify;10019805;LLT;20,1
1264;C145338;Grade 3 Hepatobiliary Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Hepatobiliary disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Hepatobiliary disorders - Other, specify;10019805;LLT;20,1
1265;C145894;Grade 4 Hepatobiliary Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hepatobiliary disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Hepatobiliary disorders - Other, specify;10019805;LLT;20,1
1266;C146343;Grade 5 Hepatobiliary Disorders - Other, Specify, CTCAE;Death;Grade 5 Hepatobiliary disorders - Other, specify;Death;Hepatobiliary disorders - Other, specify;10019805;LLT;20,1
1267;C143742;Perforation Bile Duct, CTCAE;A disorder characterized by a rupture in the wall of the extrahepatic or intrahepatic bile duct.;Perforation bile duct;A disorder characterized by a rupture in the wall of the extrahepatic or intrahepatic bile duct.;Perforation bile duct;10034405;LLT;20,1
1268;C145527;Grade 3 Perforation Bile Duct, CTCAE;Invasive intervention indicated;Grade 3 Perforation bile duct;Invasive intervention indicated;Perforation bile duct;10034405;LLT;20,1
1269;C146036;Grade 4 Perforation Bile Duct, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Perforation bile duct;"Life-threatening consequences; urgent operative intervention indicated";Perforation bile duct;10034405;LLT;20,1
1270;C146476;Grade 5 Perforation Bile Duct, CTCAE;Death;Grade 5 Perforation bile duct;Death;Perforation bile duct;10034405;LLT;20,1
1271;C143769;Portal Hypertension, CTCAE;A disorder characterized by an increase in blood pressure in the portal venous system.;Portal hypertension;A disorder characterized by an increase in blood pressure in the portal venous system.;Portal hypertension;10036200;LLT;20,1
1272;C144930;Grade 2 Portal Hypertension, CTCAE;Decreased portal vein flow;Grade 2 Portal hypertension;Decreased portal vein flow;Portal hypertension;10036200;LLT;20,1
1273;C145555;Grade 3 Portal Hypertension, CTCAE;"Reversal/retrograde portal vein flow; associated with varices and/or ascites";Grade 3 Portal hypertension;"Reversal/retrograde portal vein flow; associated with varices and/or ascites";Portal hypertension;10036200;LLT;20,1
1274;C146060;Grade 4 Portal Hypertension, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Portal hypertension;"Life-threatening consequences; urgent intervention indicated";Portal hypertension;10036200;LLT;20,1
1275;C146497;Grade 5 Portal Hypertension, CTCAE;Death;Grade 5 Portal hypertension;Death;Portal hypertension;10036200;LLT;20,1
1276;C143770;Portal Vein Thrombosis, CTCAE;A disorder characterized by the formation of a thrombus (blood clot) in the portal vein.;Portal vein thrombosis;A disorder characterized by the formation of a thrombus (blood clot) in the portal vein.;Portal vein thrombosis;10036206;LLT;20,1
1277;C144931;Grade 2 Portal Vein Thrombosis, CTCAE;Intervention not indicated;Grade 2 Portal vein thrombosis;Intervention not indicated;Portal vein thrombosis;10036206;LLT;20,1
1278;C145556;Grade 3 Portal Vein Thrombosis, CTCAE;Medical intervention indicated;Grade 3 Portal vein thrombosis;Medical intervention indicated;Portal vein thrombosis;10036206;LLT;20,1
1279;C146061;Grade 4 Portal Vein Thrombosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Portal vein thrombosis;"Life-threatening consequences; urgent intervention indicated";Portal vein thrombosis;10036206;LLT;20,1
1280;C146498;Grade 5 Portal Vein Thrombosis, CTCAE;Death;Grade 5 Portal vein thrombosis;Death;Portal vein thrombosis;10036206;LLT;20,1
1281;C143205;Sinusoidal Obstruction Syndrome, CTCAE;A disorder characterized by severe hepatic injury as a result of the blood vessels of the liver becoming inflamed and/or blocked.;Sinusoidal obstruction syndrome;A disorder characterized by severe hepatic injury as a result of the blood vessels of the liver becoming inflamed and/or blocked.;Sinusoidal obstruction syndrome;10063675;LLT;20,1
1282;C144995;Grade 2 Sinusoidal Obstruction Syndrome, CTCAE;"Blood bilirubin 2-5 mg/dL; minor interventions required (i.e., blood product, diuretic, oxygen)";Grade 2 Sinusoidal obstruction syndrome;"Blood bilirubin 2-5 mg/dL; minor interventions required (i.e., blood product, diuretic, oxygen)";Sinusoidal obstruction syndrome;10063675;LLT;20,1
1283;C145616;Grade 3 Sinusoidal Obstruction Syndrome, CTCAE;"Blood bilirubin >5 mg/dL; coagulation modifier indicated (e.g., defibrotide); reversal of flow on ultrasound";Grade 3 Sinusoidal obstruction syndrome;"Blood bilirubin >5 mg/dL; coagulation modifier indicated (e.g., defibrotide); reversal of flow on ultrasound";Sinusoidal obstruction syndrome;10063675;LLT;20,1
1284;C146110;Grade 4 Sinusoidal Obstruction Syndrome, CTCAE;Life-threatening consequences (e.g., ventilatory support, dialysis, plasmapheresis, peritoneal drainage);Grade 4 Sinusoidal obstruction syndrome;Life-threatening consequences (e.g., ventilatory support, dialysis, plasmapheresis, peritoneal drainage);Sinusoidal obstruction syndrome;10063675;LLT;20,1
1285;C146542;Grade 5 Sinusoidal Obstruction Syndrome, CTCAE;Death;Grade 5 Sinusoidal obstruction syndrome;Death;Sinusoidal obstruction syndrome;10063675;LLT;20,1
1286;C143186;Immune System Disorders, CTCAE;;;;;;;
1287;C143271;Allergic Reaction, CTCAE;A disorder characterized by an adverse local or general response from exposure to an allergen.;Allergic reaction;A disorder characterized by an adverse local or general response from exposure to an allergen.;Allergic reaction;10001718;LLT;20,1
1288;C143969;Grade 1 Allergic Reaction, CTCAE;Systemic intervention not indicated;Grade 1 Allergic reaction;Systemic intervention not indicated;Allergic reaction;10001718;LLT;20,1
1289;C144506;Grade 2 Allergic Reaction, CTCAE;Oral intervention indicated;Grade 2 Allergic reaction;Oral intervention indicated;Allergic reaction;10001718;LLT;20,1
1290;C145125;Grade 3 Allergic Reaction, CTCAE;"Bronchospasm; hospitalization indicated for clinical sequelae; intravenous intervention indicated";Grade 3 Allergic reaction;"Bronchospasm; hospitalization indicated for clinical sequelae; intravenous intervention indicated";Allergic reaction;10001718;LLT;20,1
1291;C145738;Grade 4 Allergic Reaction, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Allergic reaction;"Life-threatening consequences; urgent intervention indicated";Allergic reaction;10001718;LLT;20,1
1292;C146208;Grade 5 Allergic Reaction, CTCAE;Death;Grade 5 Allergic reaction;Death;Allergic reaction;10001718;LLT;20,1
1293;C143282;Anaphylaxis, CTCAE;A disorder characterized by an acute inflammatory reaction resulting from the release of histamine and histamine-like substances from mast cells, causing a hypersensitivity immune response. Clinically, it presents with breathing difficulty, dizziness, hypotension, cyanosis and loss of consciousness and may lead to death.;Anaphylaxis;A disorder characterized by an acute inflammatory reaction resulting from the release of histamine and histamine-like substances from mast cells, causing a hypersensitivity immune response. Clinically, it presents with breathing difficulty, dizziness, hypotension, cyanosis and loss of consciousness and may lead to death.;Anaphylaxis;10002218;LLT;20,1
1294;C145135;Grade 3 Anaphylaxis, CTCAE;"Symptomatic bronchospasm, with or without urticaria; parenteral intervention indicated; allergy-related edema/angioedema; hypotension";Grade 3 Anaphylaxis;"Symptomatic bronchospasm, with or without urticaria; parenteral intervention indicated; allergy-related edema/angioedema; hypotension";Anaphylaxis;10002218;LLT;20,1
1295;C145744;Grade 4 Anaphylaxis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Anaphylaxis;"Life-threatening consequences; urgent intervention indicated";Anaphylaxis;10002218;LLT;20,1
1296;C146214;Grade 5 Anaphylaxis, CTCAE;Death;Grade 5 Anaphylaxis;Death;Anaphylaxis;10002218;LLT;20,1
1297;C143310;Autoimmune Disorder, CTCAE;A disorder characterized by loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents.;Autoimmune disorder;A disorder characterized by loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents.;Autoimmune disorder;10061664;LLT;20,1
1298;C143992;Grade 1 Autoimmune Disorder, CTCAE;"Asymptomatic; serologic or other evidence of autoimmune reaction, with normal organ function; intervention not indicated";Grade 1 Autoimmune disorder;"Asymptomatic; serologic or other evidence of autoimmune reaction, with normal organ function; intervention not indicated";Autoimmune disorder;10061664;LLT;20,1
1299;C144531;Grade 2 Autoimmune Disorder, CTCAE;Evidence of autoimmune reaction involving a non-essential organ or function (e.g., hypothyroidism);Grade 2 Autoimmune disorder;Evidence of autoimmune reaction involving a non-essential organ or function (e.g., hypothyroidism);Autoimmune disorder;10061664;LLT;20,1
1300;C145153;Grade 3 Autoimmune Disorder, CTCAE;Autoimmune reactions involving major organ (e.g., colitis, anemia, myocarditis, kidney);Grade 3 Autoimmune disorder;Autoimmune reactions involving major organ (e.g., colitis, anemia, myocarditis, kidney);Autoimmune disorder;10061664;LLT;20,1
1301;C145758;Grade 4 Autoimmune Disorder, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Autoimmune disorder;"Life-threatening consequences; urgent intervention indicated";Autoimmune disorder;10061664;LLT;20,1
1302;C146227;Grade 5 Autoimmune Disorder, CTCAE;Death;Grade 5 Autoimmune disorder;Death;Autoimmune disorder;10061664;LLT;20,1
1303;C143394;Cytokine Release Syndrome, CTCAE;A disorder characterized by fever, tachypnea, headache, tachycardia, hypotension, rash, and/or hypoxia caused by the release of cytokines.;Cytokine release syndrome;A disorder characterized by fever, tachypnea, headache, tachycardia, hypotension, rash, and/or hypoxia caused by the release of cytokines.;Cytokine release syndrome;10052015;LLT;20,1
1304;C144046;Grade 1 Cytokine Release Syndrome, CTCAE;Fever with or without constitutional symptoms;Grade 1 Cytokine release syndrome;Fever with or without constitutional symptoms;Cytokine release syndrome;10052015;LLT;20,1
1305;C144598;Grade 2 Cytokine Release Syndrome, CTCAE;"Hypotension responding to fluids; hypoxia responding to <40% O2";Grade 2 Cytokine release syndrome;"Hypotension responding to fluids; hypoxia responding to <40% O2";Cytokine release syndrome;10052015;LLT;20,1
1306;C145216;Grade 3 Cytokine Release Syndrome, CTCAE;"Hypotension managed with one pressor; hypoxia requiring >= 40% O2";Grade 3 Cytokine release syndrome;"Hypotension managed with one pressor; hypoxia requiring >= 40% O2";Cytokine release syndrome;10052015;LLT;20,1
1307;C145811;Grade 4 Cytokine Release Syndrome, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Cytokine release syndrome;"Life-threatening consequences; urgent intervention indicated";Cytokine release syndrome;10052015;LLT;20,1
1308;C146271;Grade 5 Cytokine Release Syndrome, CTCAE;Death;Grade 5 Cytokine release syndrome;Death;Cytokine release syndrome;10052015;LLT;20,1
1309;C143580;Immune System Disorders - Other, Specify, CTCAE;;Immune system disorders - Other, specify;;Immune system disorders - Other, specify;10021428;LLT;20,1
1310;C144193;Grade 1 Immune System Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Immune system disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Immune system disorders - Other, specify;10021428;LLT;20,1
1311;C144755;Grade 2 Immune System Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Immune system disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Immune system disorders - Other, specify;10021428;LLT;20,1
1312;C145377;Grade 3 Immune System Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Immune system disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Immune system disorders - Other, specify;10021428;LLT;20,1
1313;C145926;Grade 4 Immune System Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Immune system disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Immune system disorders - Other, specify;10021428;LLT;20,1
1314;C146373;Grade 5 Immune System Disorders - Other, Specify, CTCAE;Death;Grade 5 Immune system disorders - Other, specify;Death;Immune system disorders - Other, specify;10021428;LLT;20,1
1315;C146642;Serum Sickness, CTCAE 5.0;A disorder characterized by a delayed-type hypersensitivity reaction to foreign proteins derived from an animal serum. It occurs approximately six to twenty-one days following the administration of the foreign antigen. Symptoms include fever, arthralgias, myalgias, skin eruptions, lymphadenopathy, chest marked discomfort and dyspnea.;Serum sickness;A disorder characterized by a delayed-type hypersensitivity reaction to foreign proteins derived from an animal serum. It occurs approximately six to twenty-one days following the administration of the foreign antigen. Symptoms include fever, arthralgias, myalgias, skin eruptions, lymphadenopathy, chest marked discomfort and dyspnea.;Serum sickness;10040400;LLT;20,1
1316;C144394;Grade 1 Serum Sickness, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Serum sickness;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Serum sickness;10040400;LLT;20,1
1317;C144991;Grade 2 Serum Sickness, CTCAE;"Moderate arthralgia; fever, rash, urticaria, antihistamines indicated";Grade 2 Serum sickness;"Moderate arthralgia; fever, rash, urticaria, antihistamines indicated";Serum sickness;10040400;LLT;20,1
1318;C54755;Grade 3 Serum Sickness, CTCAE;"Severe arthralgia or arthritis; extensive rash; steroids or IV fluids indicated";Grade 3 Serum sickness;"Severe arthralgia or arthritis; extensive rash; steroids or IV fluids indicated";Serum sickness;10040400;LLT;20,1
1319;C146106;Grade 4 Serum Sickness, CTCAE;"Life-threatening consequences; pressor or ventilatory support indicated";Grade 4 Serum sickness;"Life-threatening consequences; pressor or ventilatory support indicated";Serum sickness;10040400;LLT;20,1
1320;C54764;Grade 5 Serum Sickness, CTCAE;Death;Grade 5 Serum sickness;Death;Serum sickness;10040400;LLT;20,1
1321;C143171;Infections and Infestations, CTCAE;;;;;;;
1322;C143254;Abdominal Infection, CTCAE;A disorder characterized by an infectious process involving the abdominal cavity.;Abdominal infection;A disorder characterized by an infectious process involving the abdominal cavity.;Abdominal infection;10056519;LLT;20,1
1323;C144495;Grade 2 Abdominal Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Abdominal infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Abdominal infection;10056519;LLT;20,1
1324;C145111;Grade 3 Abdominal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Abdominal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Abdominal infection;10056519;LLT;20,1
1325;C145730;Grade 4 Abdominal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Abdominal infection;"Life-threatening consequences; urgent intervention indicated";Abdominal infection;10056519;LLT;20,1
1326;C146202;Grade 5 Abdominal Infection, CTCAE;Death;Grade 5 Abdominal infection;Death;Abdominal infection;10056519;LLT;20,1
1327;C143285;Anorectal Infection, CTCAE;A disorder characterized by an infectious process involving the anal area and the rectum.;Anorectal infection;A disorder characterized by an infectious process involving the anal area and the rectum.;Anorectal infection;10061640;LLT;20,1
1328;C143981;Grade 1 Anorectal Infection, CTCAE;Localized, local intervention indicated;Grade 1 Anorectal infection;Localized, local intervention indicated;Anorectal infection;10061640;LLT;20,1
1329;C144519;Grade 2 Anorectal Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Anorectal infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Anorectal infection;10061640;LLT;20,1
1330;C145138;Grade 3 Anorectal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Anorectal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Anorectal infection;10061640;LLT;20,1
1331;C145746;Grade 4 Anorectal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Anorectal infection;"Life-threatening consequences; urgent intervention indicated";Anorectal infection;10061640;LLT;20,1
1332;C146216;Grade 5 Anorectal Infection, CTCAE;Death;Grade 5 Anorectal infection;Death;Anorectal infection;10061640;LLT;20,1
1333;C143293;Appendicitis Perforated, CTCAE;A disorder characterized by acute inflammation to the vermiform appendix caused by a pathogenic agent with gangrenous changes resulting in the rupture of the appendiceal wall. The appendiceal wall rupture causes the release of inflammatory and bacterial contents from the appendiceal lumen into the abdominal cavity.;Appendicitis perforated;A disorder characterized by acute inflammation to the vermiform appendix caused by a pathogenic agent with gangrenous changes resulting in the rupture of the appendiceal wall. The appendiceal wall rupture causes the release of inflammatory and bacterial contents from the appendiceal lumen into the abdominal cavity.;Appendicitis perforated;10003012;LLT;20,1
1334;C145142;Grade 3 Appendicitis Perforated, CTCAE;"Medical intervention indicated; operative intervention indicated";Grade 3 Appendicitis perforated;"Medical intervention indicated; operative intervention indicated";Appendicitis perforated;10003012;LLT;20,1
1335;C145749;Grade 4 Appendicitis Perforated, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Appendicitis perforated;"Life-threatening consequences; urgent intervention indicated";Appendicitis perforated;10003012;LLT;20,1
1336;C146219;Grade 5 Appendicitis Perforated, CTCAE;Death;Grade 5 Appendicitis perforated;Death;Appendicitis perforated;10003012;LLT;20,1
1337;C143294;Appendicitis, CTCAE;A disorder characterized by acute inflammation to the vermiform appendix caused by a pathogenic agent.;Appendicitis;A disorder characterized by acute inflammation to the vermiform appendix caused by a pathogenic agent.;Appendicitis;10003011;LLT;20,1
1338;C145143;Grade 3 Appendicitis, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Appendicitis;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Appendicitis;10003011;LLT;20,1
1339;C145750;Grade 4 Appendicitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Appendicitis;"Life-threatening consequences; urgent intervention indicated";Appendicitis;10003011;LLT;20,1
1340;C146220;Grade 5 Appendicitis, CTCAE;Death;Grade 5 Appendicitis;Death;Appendicitis;10003011;LLT;20,1
1341;C143297;Arteritis Infective, CTCAE;A disorder characterized by an infectious process involving an artery.;Arteritis infective;A disorder characterized by an infectious process involving an artery.;Arteritis infective;10065744;LLT;20,1
1342;C145147;Grade 3 Arteritis Infective, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Arteritis infective;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Arteritis infective;10065744;LLT;20,1
1343;C145754;Grade 4 Arteritis Infective, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Arteritis infective;"Life-threatening consequences; urgent intervention indicated";Arteritis infective;10065744;LLT;20,1
1344;C146224;Grade 5 Arteritis Infective, CTCAE;Death;Grade 5 Arteritis infective;Death;Arteritis infective;10065744;LLT;20,1
1345;C143206;Bacteremia, CTCAE;A disorder characterized by the presence of bacteria in the blood stream.;Bacteremia;A disorder characterized by the presence of bacteria in the blood stream.;Bacteremia;10003999;LLT;20,1
1346;C144534;Grade 2 Bacteremia, CTCAE;Blood culture positive with no signs or symptoms;Grade 2 Bacteremia;Blood culture positive with no signs or symptoms;Bacteremia;10003999;LLT;20,1
1347;C143317;Biliary Tract Infection, CTCAE;A disorder characterized by an infectious process involving the biliary tract.;Biliary tract infection;A disorder characterized by an infectious process involving the biliary tract.;Biliary tract infection;10061695;LLT;20,1
1348;C144539;Grade 2 Biliary Tract Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Biliary tract infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Biliary tract infection;10061695;LLT;20,1
1349;C145158;Grade 3 Biliary Tract Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Biliary tract infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Biliary tract infection;10061695;LLT;20,1
1350;C145763;Grade 4 Biliary Tract Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Biliary tract infection;"Life-threatening consequences; urgent intervention indicated";Biliary tract infection;10061695;LLT;20,1
1351;C146232;Grade 5 Biliary Tract Infection, CTCAE;Death;Grade 5 Biliary tract infection;Death;Biliary tract infection;10061695;LLT;20,1
1352;C143319;Bladder Infection, CTCAE;A disorder characterized by an infectious process involving the bladder.;Bladder infection;A disorder characterized by an infectious process involving the bladder.;Bladder infection;10005047;LLT;20,1
1353;C144541;Grade 2 Bladder Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Bladder infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Bladder infection;10005047;LLT;20,1
1354;C145160;Grade 3 Bladder Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Bladder infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Bladder infection;10005047;LLT;20,1
1355;C145765;Grade 4 Bladder Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Bladder infection;"Life-threatening consequences; urgent intervention indicated";Bladder infection;10005047;LLT;20,1
1356;C146234;Grade 5 Bladder Infection, CTCAE;Death;Grade 5 Bladder infection;Death;Bladder infection;10005047;LLT;20,1
1357;C143331;Bone Infection, CTCAE;A disorder characterized by an infectious process involving the bones.;Bone infection;A disorder characterized by an infectious process involving the bones.;Bone infection;10061017;LLT;20,1
1358;C144551;Grade 2 Bone Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Bone infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Bone infection;10061017;LLT;20,1
1359;C145167;Grade 3 Bone Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Bone infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Bone infection;10061017;LLT;20,1
1360;C145768;Grade 4 Bone Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Bone infection;"Life-threatening consequences; urgent intervention indicated";Bone infection;10061017;LLT;20,1
1361;C146236;Grade 5 Bone Infection, CTCAE;Death;Grade 5 Bone infection;Death;Bone infection;10061017;LLT;20,1
1362;C143336;Breast Infection, CTCAE;A disorder characterized by an infectious process involving the breast.;Breast infection;A disorder characterized by an infectious process involving the breast.;Breast infection;10006259;LLT;20,1
1363;C144554;Grade 2 Breast Infection, CTCAE;"Local infection with moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Breast infection;"Local infection with moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Breast infection;10006259;LLT;20,1
1364;C145170;Grade 3 Breast Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; severe infection; axillary adenitis";Grade 3 Breast infection;"IV antibiotic, antifungal, or antiviral intervention indicated; severe infection; axillary adenitis";Breast infection;10006259;LLT;20,1
1365;C145770;Grade 4 Breast Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Breast infection;"Life-threatening consequences; urgent intervention indicated";Breast infection;10006259;LLT;20,1
1366;C146238;Grade 5 Breast Infection, CTCAE;Death;Grade 5 Breast infection;Death;Breast infection;10006259;LLT;20,1
1367;C143339;Bronchial Infection, CTCAE;A disorder characterized by an infectious process involving the bronchi.;Bronchial infection;A disorder characterized by an infectious process involving the bronchi.;Bronchial infection;10055078;LLT;20,1
1368;C144556;Grade 2 Bronchial Infection, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Bronchial infection;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Bronchial infection;10055078;LLT;20,1
1369;C145172;Grade 3 Bronchial Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Bronchial infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Bronchial infection;10055078;LLT;20,1
1370;C145772;Grade 4 Bronchial Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Bronchial infection;"Life-threatening consequences; urgent intervention indicated";Bronchial infection;10055078;LLT;20,1
1371;C146240;Grade 5 Bronchial Infection, CTCAE;Death;Grade 5 Bronchial infection;Death;Bronchial infection;10055078;LLT;20,1
1372;C143356;Catheter Related Infection, CTCAE;A disorder characterized by an infectious process that arises secondary to catheter use.;Catheter related infection;A disorder characterized by an infectious process that arises secondary to catheter use.;Catheter related infection;10007810;LLT;20,1
1373;C144568;Grade 2 Catheter Related Infection, CTCAE;"Localized; local intervention indicated; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Catheter related infection;"Localized; local intervention indicated; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Catheter related infection;10007810;LLT;20,1
1374;C145185;Grade 3 Catheter Related Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Catheter related infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Catheter related infection;10007810;LLT;20,1
1375;C145784;Grade 4 Catheter Related Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Catheter related infection;"Life-threatening consequences; urgent intervention indicated";Catheter related infection;10007810;LLT;20,1
1376;C146251;Grade 5 Catheter Related Infection, CTCAE;Death;Grade 5 Catheter related infection;Death;Catheter related infection;10007810;LLT;20,1
1377;C143359;Cecal Infection, CTCAE;A disorder characterized by an infectious process involving the cecum.;Cecal infection;A disorder characterized by an infectious process involving the cecum.;Cecal infection;10065761;LLT;20,1
1378;C144571;Grade 2 Cecal Infection, CTCAE;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Cecal infection;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Cecal infection;10065761;LLT;20,1
1379;C145188;Grade 3 Cecal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Cecal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Cecal infection;10065761;LLT;20,1
1380;C145787;Grade 4 Cecal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Cecal infection;"Life-threatening consequences; urgent intervention indicated";Cecal infection;10065761;LLT;20,1
1381;C146253;Grade 5 Cecal Infection, CTCAE;Death;Grade 5 Cecal infection;Death;Cecal infection;10065761;LLT;20,1
1382;C143362;Cervicitis Infection, CTCAE;A disorder characterized by an infectious process involving the uterine cervix.;Cervicitis infection;A disorder characterized by an infectious process involving the uterine cervix.;Cervicitis infection;10008330;LLT;20,1
1383;C144574;Grade 2 Cervicitis Infection, CTCAE;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Grade 2 Cervicitis infection;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Cervicitis infection;10008330;LLT;20,1
1384;C145191;Grade 3 Cervicitis Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Cervicitis infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Cervicitis infection;10008330;LLT;20,1
1385;C145790;Grade 4 Cervicitis Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Cervicitis infection;"Life-threatening consequences; urgent intervention indicated";Cervicitis infection;10008330;LLT;20,1
1386;C146256;Grade 5 Cervicitis Infection, CTCAE;Death;Grade 5 Cervicitis infection;Death;Cervicitis infection;10008330;LLT;20,1
1387;C143383;Conjunctivitis Infective, CTCAE;A disorder characterized by an infectious process involving the conjunctiva. Clinical manifestations include pink or red color in the eyes.;Conjunctivitis infective;A disorder characterized by an infectious process involving the conjunctiva. Clinical manifestations include pink or red color in the eyes.;Conjunctivitis infective;10010742;LLT;20,1
1388;C144590;Grade 2 Conjunctivitis Infective, CTCAE;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Grade 2 Conjunctivitis infective;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Conjunctivitis infective;10010742;LLT;20,1
1389;C145207;Grade 3 Conjunctivitis Infective, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Conjunctivitis infective;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Conjunctivitis infective;10010742;LLT;20,1
1390;C145803;Grade 4 Conjunctivitis Infective, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Conjunctivitis infective;"Life-threatening consequences; urgent intervention indicated";Conjunctivitis infective;10010742;LLT;20,1
1391;C143384;Conjunctivitis, CTCAE;A disorder characterized by inflammation, swelling and redness to the conjunctiva of the eye.;Conjunctivitis;A disorder characterized by inflammation, swelling and redness to the conjunctiva of the eye.;Conjunctivitis;10010741;LLT;20,1
1392;C144041;Grade 1 Conjunctivitis, CTCAE;"Asymptomatic or mild symptoms; intervention not indicated";Grade 1 Conjunctivitis;"Asymptomatic or mild symptoms; intervention not indicated";Conjunctivitis;10010741;LLT;20,1
1393;C144591;Grade 2 Conjunctivitis, CTCAE;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline)";Grade 2 Conjunctivitis;"Symptomatic; moderate decrease in visual acuity (best corrected visual acuity 20/40 and better or 3 lines or less decreased vision from known baseline)";Conjunctivitis;10010741;LLT;20,1
1394;C145208;Grade 3 Conjunctivitis, CTCAE;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Grade 3 Conjunctivitis;"Symptomatic with marked decrease in visual acuity (best corrected visual acuity worse than 20/40 or more than 3 lines of decreased vision from known baseline, up to 20/200); limiting self care ADL";Conjunctivitis;10010741;LLT;20,1
1395;C145804;Grade 4 Conjunctivitis, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Conjunctivitis;Best corrected visual acuity of 20/200 or worse in the affected eye;Conjunctivitis;10010741;LLT;20,1
1396;C143386;Corneal Infection, CTCAE;A disorder characterized by an infectious process involving the cornea.;Corneal infection;A disorder characterized by an infectious process involving the cornea.;Corneal infection;10061788;LLT;20,1
1397;C144592;Grade 2 Corneal Infection, CTCAE;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Grade 2 Corneal infection;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Corneal infection;10061788;LLT;20,1
1398;C145209;Grade 3 Corneal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Corneal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Corneal infection;10061788;LLT;20,1
1399;C145805;Grade 4 Corneal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Corneal infection;"Life-threatening consequences; urgent intervention indicated";Corneal infection;10061788;LLT;20,1
1400;C146268;Grade 5 Corneal Infection, CTCAE;Death;Grade 5 Corneal infection;Death;Corneal infection;10061788;LLT;20,1
1401;C143390;Cranial Nerve Infection, CTCAE;A disorder characterized by an infectious process involving a cranial nerve.;Cranial nerve infection;A disorder characterized by an infectious process involving a cranial nerve.;Cranial nerve infection;10065765;LLT;20,1
1402;C145212;Grade 3 Cranial Nerve Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Cranial nerve infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Cranial nerve infection;10065765;LLT;20,1
1403;C145808;Grade 4 Cranial Nerve Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Cranial nerve infection;"Life-threatening consequences; urgent intervention indicated";Cranial nerve infection;10065765;LLT;20,1
1404;C146269;Grade 5 Cranial Nerve Infection, CTCAE;Death;Grade 5 Cranial nerve infection;Death;Cranial nerve infection;10065765;LLT;20,1
1405;C143207;Cytomegalovirus Infection Reactivation, CTCAE;A disorder characterized by the reactivation of cytomegalovirus (CMV).;Cytomegalovirus infection reactivation;A disorder characterized by the reactivation of cytomegalovirus (CMV).;Cytomegalovirus infection reactivation;10058666;LLT;20,1
1406;C144047;Grade 1 Cytomegalovirus Infection Reactivation, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Cytomegalovirus infection reactivation;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Cytomegalovirus infection reactivation;10058666;LLT;20,1
1407;C144599;Grade 2 Cytomegalovirus Infection Reactivation, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Cytomegalovirus infection reactivation;"Moderate symptoms; medical intervention indicated";Cytomegalovirus infection reactivation;10058666;LLT;20,1
1408;C145217;Grade 3 Cytomegalovirus Infection Reactivation, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; IV intervention indicated";Grade 3 Cytomegalovirus infection reactivation;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; IV intervention indicated";Cytomegalovirus infection reactivation;10058666;LLT;20,1
1409;C145812;Grade 4 Cytomegalovirus Infection Reactivation, CTCAE;"Life-threatening consequences; urgent intervention indicated; blindness";Grade 4 Cytomegalovirus infection reactivation;"Life-threatening consequences; urgent intervention indicated; blindness";Cytomegalovirus infection reactivation;10058666;LLT;20,1
1410;C146272;Grade 5 Cytomegalovirus Infection Reactivation, CTCAE;Death;Grade 5 Cytomegalovirus infection reactivation;Death;Cytomegalovirus infection reactivation;10058666;LLT;20,1
1411;C143406;Device Related Infection, CTCAE;A disorder characterized by an infectious process involving the use of a medical device.;Device related infection;A disorder characterized by an infectious process involving the use of a medical device.;Device related infection;10064687;LLT;20,1
1412;C144606;Grade 2 Device Related Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal);Grade 2 Device related infection;Oral intervention indicated (e.g., antibiotic, antifungal);Device related infection;10064687;LLT;20,1
1413;C145223;Grade 3 Device Related Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Device related infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Device related infection;10064687;LLT;20,1
1414;C145818;Grade 4 Device Related Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Device related infection;"Life-threatening consequences; urgent intervention indicated";Device related infection;10064687;LLT;20,1
1415;C146278;Grade 5 Device Related Infection, CTCAE;Death;Grade 5 Device related infection;Death;Device related infection;10064687;LLT;20,1
1416;C143415;Duodenal Infection, CTCAE;A disorder characterized by an infectious process involving the duodenum.;Duodenal infection;A disorder characterized by an infectious process involving the duodenum.;Duodenal infection;10065752;LLT;20,1
1417;C144611;Grade 2 Duodenal Infection, CTCAE;"Moderate symptoms; medical intervention indicated (e.g., oral antibiotics)";Grade 2 Duodenal infection;"Moderate symptoms; medical intervention indicated (e.g., oral antibiotics)";Duodenal infection;10065752;LLT;20,1
1418;C145228;Grade 3 Duodenal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Duodenal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Duodenal infection;10065752;LLT;20,1
1419;C145821;Grade 4 Duodenal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Duodenal infection;"Life-threatening consequences; urgent intervention indicated";Duodenal infection;10065752;LLT;20,1
1420;C146282;Grade 5 Duodenal Infection, CTCAE;Death;Grade 5 Duodenal infection;Death;Duodenal infection;10065752;LLT;20,1
1421;C143438;Encephalitis Infection, CTCAE;A disorder characterized by an infectious process involving the brain tissue.;Encephalitis infection;A disorder characterized by an infectious process involving the brain tissue.;Encephalitis infection;10014594;LLT;20,1
1422;C145248;Grade 3 Encephalitis Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; severe changes in mental status; self-limited seizure activity; focal neurologic abnormalities";Grade 3 Encephalitis infection;"IV antibiotic, antifungal, or antiviral intervention indicated; severe changes in mental status; self-limited seizure activity; focal neurologic abnormalities";Encephalitis infection;10014594;LLT;20,1
1423;C145830;Grade 4 Encephalitis Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Encephalitis infection;"Life-threatening consequences; urgent intervention indicated";Encephalitis infection;10014594;LLT;20,1
1424;C146289;Grade 5 Encephalitis Infection, CTCAE;Death;Grade 5 Encephalitis infection;Death;Encephalitis infection;10014594;LLT;20,1
1425;C143439;Encephalomyelitis Infection, CTCAE;A disorder characterized by an infectious process involving the brain and spinal cord tissues.;Encephalomyelitis infection;A disorder characterized by an infectious process involving the brain and spinal cord tissues.;Encephalomyelitis infection;10014621;LLT;20,1
1426;C145249;Grade 3 Encephalomyelitis Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Encephalomyelitis infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Encephalomyelitis infection;10014621;LLT;20,1
1427;C145831;Grade 4 Encephalomyelitis Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Encephalomyelitis infection;"Life-threatening consequences; urgent intervention indicated";Encephalomyelitis infection;10014621;LLT;20,1
1428;C146290;Grade 5 Encephalomyelitis Infection, CTCAE;Death;Grade 5 Encephalomyelitis infection;Death;Encephalomyelitis infection;10014621;LLT;20,1
1429;C143441;Endocarditis Infective, CTCAE;A disorder characterized by an infectious process involving the endocardial layer of the heart.;Endocarditis infective;A disorder characterized by an infectious process involving the endocardial layer of the heart.;Endocarditis infective;10014678;LLT;20,1
1430;C145250;Grade 3 Endocarditis Infective, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Endocarditis infective;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Endocarditis infective;10014678;LLT;20,1
1431;C145832;Grade 4 Endocarditis Infective, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Endocarditis infective;"Life-threatening consequences; urgent intervention indicated";Endocarditis infective;10014678;LLT;20,1
1432;C146291;Grade 5 Endocarditis Infective, CTCAE;Death;Grade 5 Endocarditis infective;Death;Endocarditis infective;10014678;LLT;20,1
1433;C143443;Endophthalmitis, CTCAE;A disorder characterized by an infectious process involving the internal structures of the eye.;Endophthalmitis;A disorder characterized by an infectious process involving the internal structures of the eye.;Endophthalmitis;10014801;LLT;20,1
1434;C144634;Grade 2 Endophthalmitis, CTCAE;Local intervention indicated;Grade 2 Endophthalmitis;Local intervention indicated;Endophthalmitis;10014801;LLT;20,1
1435;C145252;Grade 3 Endophthalmitis, CTCAE;"Systemic intervention; hospitalization indicated";Grade 3 Endophthalmitis;"Systemic intervention; hospitalization indicated";Endophthalmitis;10014801;LLT;20,1
1436;C145834;Grade 4 Endophthalmitis, CTCAE;Best corrected visual acuity of 20/200 or worse in the affected eye;Grade 4 Endophthalmitis;Best corrected visual acuity of 20/200 or worse in the affected eye;Endophthalmitis;10014801;LLT;20,1
1437;C143444;Enterocolitis Infectious, CTCAE;A disorder characterized by an infectious process involving the small and large intestines.;Enterocolitis infectious;A disorder characterized by an infectious process involving the small and large intestines.;Enterocolitis infectious;10058838;LLT;20,1
1438;C144635;Grade 2 Enterocolitis Infectious, CTCAE;"Passage of >3 unformed stools per 24 hrs or duration of illness >48 hrs; moderate abdominal pain; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Enterocolitis infectious;"Passage of >3 unformed stools per 24 hrs or duration of illness >48 hrs; moderate abdominal pain; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Enterocolitis infectious;10058838;LLT;20,1
1439;C145253;Grade 3 Enterocolitis Infectious, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated; profuse watery diarrhea with signs of hypovolemia; bloody diarrhea; fever; severe abdominal pain; hospitalization indicated";Grade 3 Enterocolitis infectious;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated; profuse watery diarrhea with signs of hypovolemia; bloody diarrhea; fever; severe abdominal pain; hospitalization indicated";Enterocolitis infectious;10058838;LLT;20,1
1440;C145835;Grade 4 Enterocolitis Infectious, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Enterocolitis infectious;"Life-threatening consequences; urgent intervention indicated";Enterocolitis infectious;10058838;LLT;20,1
1441;C146293;Grade 5 Enterocolitis Infectious, CTCAE;Death;Grade 5 Enterocolitis infectious;Death;Enterocolitis infectious;10058838;LLT;20,1
1442;C143208;Epstein-Barr Virus Infection Reactivation, CTCAE;A disorder characterized by the reactivation of Epstein-Barr virus (EBV).;Epstein-Barr virus infection reactivation;A disorder characterized by the reactivation of Epstein-Barr virus (EBV).;Epstein-Barr virus infection reactivation;10015109;LLT;20,1
1443;C144083;Grade 1 Epstein-Barr Virus Infection Reactivation, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Epstein-Barr virus infection reactivation;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Epstein-Barr virus infection reactivation;10015109;LLT;20,1
1444;C144639;Grade 2 Epstein-Barr Virus Infection Reactivation, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Epstein-Barr virus infection reactivation;"Moderate symptoms; medical intervention indicated";Epstein-Barr virus infection reactivation;10015109;LLT;20,1
1445;C145258;Grade 3 Epstein-Barr Virus Infection Reactivation, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; IV intervention indicated";Grade 3 Epstein-Barr virus infection reactivation;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; IV intervention indicated";Epstein-Barr virus infection reactivation;10015109;LLT;20,1
1446;C145839;Grade 4 Epstein-Barr Virus Infection Reactivation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Epstein-Barr virus infection reactivation;"Life-threatening consequences; urgent intervention indicated";Epstein-Barr virus infection reactivation;10015109;LLT;20,1
1447;C146297;Grade 5 Epstein-Barr Virus Infection Reactivation, CTCAE;Death;Grade 5 Epstein-Barr virus infection reactivation;Death;Epstein-Barr virus infection reactivation;10015109;LLT;20,1
1448;C143454;Esophageal Infection, CTCAE;A disorder characterized by an infectious process involving the esophagus.;Esophageal infection;A disorder characterized by an infectious process involving the esophagus.;Esophageal infection;10058804;LLT;20,1
1449;C144645;Grade 2 Esophageal Infection, CTCAE;Local intervention indicated (e.g., oral antibiotic, antifungal, antiviral);Grade 2 Esophageal infection;Local intervention indicated (e.g., oral antibiotic, antifungal, antiviral);Esophageal infection;10058804;LLT;20,1
1450;C145264;Grade 3 Esophageal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Esophageal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Esophageal infection;10058804;LLT;20,1
1451;C145845;Grade 4 Esophageal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Esophageal infection;"Life-threatening consequences; urgent intervention indicated";Esophageal infection;10058804;LLT;20,1
1452;C146303;Grade 5 Esophageal Infection, CTCAE;Death;Grade 5 Esophageal infection;Death;Esophageal infection;10058804;LLT;20,1
1453;C143469;Eye Infection, CTCAE;A disorder characterized by an infectious process involving the eye.;Eye infection;A disorder characterized by an infectious process involving the eye.;Eye infection;10015929;LLT;20,1
1454;C144654;Grade 2 Eye Infection, CTCAE;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Grade 2 Eye infection;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Eye infection;10015929;LLT;20,1
1455;C145274;Grade 3 Eye Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Eye infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Eye infection;10015929;LLT;20,1
1456;C145854;Grade 4 Eye Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated; enucleation";Grade 4 Eye infection;"Life-threatening consequences; urgent intervention indicated; enucleation";Eye infection;10015929;LLT;20,1
1457;C146310;Grade 5 Eye Infection, CTCAE;Death;Grade 5 Eye infection;Death;Eye infection;10015929;LLT;20,1
1458;C143209;Folliculitis, CTCAE;A disorder characterized by inflammation or infection of the hair follicles.;Folliculitis;A disorder characterized by inflammation or infection of the hair follicles.;Folliculitis;10016936;LLT;20,1
1459;C144111;Grade 1 Folliculitis, CTCAE;"Covering <10% of the body surface area; no intervention indicated";Grade 1 Folliculitis;"Covering <10% of the body surface area; no intervention indicated";Folliculitis;10016936;LLT;20,1
1460;C144672;Grade 2 Folliculitis, CTCAE;"Covering 10-30% of the body surface area; topical intervention initiated";Grade 2 Folliculitis;"Covering 10-30% of the body surface area; topical intervention initiated";Folliculitis;10016936;LLT;20,1
1461;C145293;Grade 3 Folliculitis, CTCAE;">30% BSA; systemic intervention indicated";Grade 3 Folliculitis;">30% BSA; systemic intervention indicated";Folliculitis;10016936;LLT;20,1
1462;C143210;Fungemia, CTCAE;A disorder characterized by the presence of fungus in the blood stream.;Fungemia;A disorder characterized by the presence of fungus in the blood stream.;Fungemia;10017544;LLT;20,1
1463;C144674;Grade 2 Fungemia, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Fungemia;"Moderate symptoms; medical intervention indicated";Fungemia;10017544;LLT;20,1
1464;C145295;Grade 3 Fungemia, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated";Grade 3 Fungemia;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated";Fungemia;10017544;LLT;20,1
1465;C143497;Gallbladder Infection, CTCAE;A disorder characterized by an infectious process involving the gallbladder.;Gallbladder infection;A disorder characterized by an infectious process involving the gallbladder.;Gallbladder infection;10062632;LLT;20,1
1466;C144676;Grade 2 Gallbladder Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Gallbladder infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Gallbladder infection;10062632;LLT;20,1
1467;C145297;Grade 3 Gallbladder Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Gallbladder infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Gallbladder infection;10062632;LLT;20,1
1468;C145862;Grade 4 Gallbladder Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Gallbladder infection;"Life-threatening consequences; urgent intervention indicated";Gallbladder infection;10062632;LLT;20,1
1469;C146315;Grade 5 Gallbladder Infection, CTCAE;Death;Grade 5 Gallbladder infection;Death;Gallbladder infection;10062632;LLT;20,1
1470;C143523;Gum Infection, CTCAE;A disorder characterized by an infectious process involving the gums.;Gum infection;A disorder characterized by an infectious process involving the gums.;Gum infection;10018784;LLT;20,1
1471;C144137;Grade 1 Gum Infection, CTCAE;Local therapy indicated (swish and swallow);Grade 1 Gum infection;Local therapy indicated (swish and swallow);Gum infection;10018784;LLT;20,1
1472;C144702;Grade 2 Gum Infection, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Gum infection;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Gum infection;10018784;LLT;20,1
1473;C145322;Grade 3 Gum Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Gum infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Gum infection;10018784;LLT;20,1
1474;C145881;Grade 4 Gum Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Gum infection;"Life-threatening consequences; urgent intervention indicated";Gum infection;10018784;LLT;20,1
1475;C146331;Grade 5 Gum Infection, CTCAE;Death;Grade 5 Gum infection;Death;Gum infection;10018784;LLT;20,1
1476;C143541;Hepatic Infection, CTCAE;A disorder characterized by an infectious process involving the liver.;Hepatic infection;A disorder characterized by an infectious process involving the liver.;Hepatic infection;10056522;LLT;20,1
1477;C144712;Grade 2 Hepatic Infection, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Hepatic infection;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Hepatic infection;10056522;LLT;20,1
1478;C145334;Grade 3 Hepatic Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Hepatic infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Hepatic infection;10056522;LLT;20,1
1479;C145891;Grade 4 Hepatic Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hepatic infection;"Life-threatening consequences; urgent intervention indicated";Hepatic infection;10056522;LLT;20,1
1480;C146340;Grade 5 Hepatic Infection, CTCAE;Death;Grade 5 Hepatic infection;Death;Hepatic infection;10056522;LLT;20,1
1481;C143211;Hepatitis B Reactivation, CTCAE;A disorder characterized by the reactivation of hepatitis B virus.;Hepatitis B reactivation;A disorder characterized by the reactivation of hepatitis B virus.;Hepatitis B reactivation;10058827;LLT;20,1
1482;C144152;Grade 1 Hepatitis B Reactivation, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hepatitis B reactivation;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Hepatitis B reactivation;10058827;LLT;20,1
1483;C144714;Grade 2 Hepatitis B Reactivation, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Hepatitis B reactivation;"Moderate symptoms; medical intervention indicated";Hepatitis B reactivation;10058827;LLT;20,1
1484;C145336;Grade 3 Hepatitis B Reactivation, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; IV intervention indicated";Grade 3 Hepatitis B reactivation;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; IV intervention indicated";Hepatitis B reactivation;10058827;LLT;20,1
1485;C145892;Grade 4 Hepatitis B Reactivation, CTCAE;"Life-threatening consequences; urgent intervention indicated; severe decompensated liver function (e.g., coagulopathy, encephalopathy, coma)";Grade 4 Hepatitis B reactivation;"Life-threatening consequences; urgent intervention indicated; severe decompensated liver function (e.g., coagulopathy, encephalopathy, coma)";Hepatitis B reactivation;10058827;LLT;20,1
1486;C146341;Grade 5 Hepatitis B Reactivation, CTCAE;Death;Grade 5 Hepatitis B reactivation;Death;Hepatitis B reactivation;10058827;LLT;20,1
1487;C143543;Hepatitis Viral, CTCAE;A disorder characterized by a viral pathologic process involving the liver parenchyma.;Hepatitis viral;A disorder characterized by a viral pathologic process involving the liver parenchyma.;Hepatitis viral;10019799;LLT;20,1
1488;C144153;Grade 1 Hepatitis Viral, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Hepatitis viral;Asymptomatic, intervention not indicated;Hepatitis viral;10019799;LLT;20,1
1489;C144715;Grade 2 Hepatitis Viral, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Hepatitis viral;"Moderate symptoms; medical intervention indicated";Hepatitis viral;10019799;LLT;20,1
1490;C145337;Grade 3 Hepatitis Viral, CTCAE;"Symptomatic liver dysfunction; fibrosis by biopsy; compensated cirrhosis; hospitalization or prolongation of existing hospitalization indicated";Grade 3 Hepatitis viral;"Symptomatic liver dysfunction; fibrosis by biopsy; compensated cirrhosis; hospitalization or prolongation of existing hospitalization indicated";Hepatitis viral;10019799;LLT;20,1
1491;C145893;Grade 4 Hepatitis Viral, CTCAE;"Life-threatening consequences; severe decompensated liver function (e.g., coagulopathy, encephalopathy, coma)";Grade 4 Hepatitis viral;"Life-threatening consequences; severe decompensated liver function (e.g., coagulopathy, encephalopathy, coma)";Hepatitis viral;10019799;LLT;20,1
1492;C146342;Grade 5 Hepatitis Viral, CTCAE;Death;Grade 5 Hepatitis viral;Death;Hepatitis viral;10019799;LLT;20,1
1493;C143212;Herpes Simplex Reactivation, CTCAE;A disorder characterized by the reactivation of Herpes simplex virus;Herpes simplex reactivation;A disorder characterized by the reactivation of Herpes simplex virus;Herpes simplex reactivation;10080137;LLT;20,1
1494;C144155;Grade 1 Herpes Simplex Reactivation, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Herpes simplex reactivation;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Herpes simplex reactivation;10080137;LLT;20,1
1495;C144717;Grade 2 Herpes Simplex Reactivation, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Herpes simplex reactivation;"Moderate symptoms; medical intervention indicated";Herpes simplex reactivation;10080137;LLT;20,1
1496;C145339;Grade 3 Herpes Simplex Reactivation, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; IV intervention indicated";Grade 3 Herpes simplex reactivation;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; IV intervention indicated";Herpes simplex reactivation;10080137;LLT;20,1
1497;C145895;Grade 4 Herpes Simplex Reactivation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Herpes simplex reactivation;"Life-threatening consequences; urgent intervention indicated";Herpes simplex reactivation;10080137;LLT;20,1
1498;C146344;Grade 5 Herpes Simplex Reactivation, CTCAE;Death;Grade 5 Herpes simplex reactivation;Death;Herpes simplex reactivation;10080137;LLT;20,1
1499;C143581;Infections and Infestations - Other, Specify, CTCAE;;Infections and infestations - Other, specify;;Infections and infestations - Other, specify;10021881;LLT;20,1
1500;C144194;Grade 1 Infections and Infestations - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Infections and infestations - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Infections and infestations - Other, specify;10021881;LLT;20,1
1501;C144756;Grade 2 Infections and Infestations - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Infections and infestations - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Infections and infestations - Other, specify;10021881;LLT;20,1
1502;C145378;Grade 3 Infections and Infestations - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Infections and infestations - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Infections and infestations - Other, specify;10021881;LLT;20,1
1503;C145927;Grade 4 Infections and Infestations - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Infections and infestations - Other, specify;"Life-threatening consequences; urgent intervention indicated";Infections and infestations - Other, specify;10021881;LLT;20,1
1504;C146374;Grade 5 Infections and Infestations - Other, Specify, CTCAE;Death;Grade 5 Infections and infestations - Other, specify;Death;Infections and infestations - Other, specify;10021881;LLT;20,1
1505;C143582;Infective Myositis, CTCAE;A disorder characterized by an infectious process involving the skeletal muscles.;Infective myositis;A disorder characterized by an infectious process involving the skeletal muscles.;Infective myositis;10021918;LLT;20,1
1506;C144757;Grade 2 Infective Myositis, CTCAE;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Grade 2 Infective myositis;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Infective myositis;10021918;LLT;20,1
1507;C145379;Grade 3 Infective Myositis, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Infective myositis;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Infective myositis;10021918;LLT;20,1
1508;C145928;Grade 4 Infective Myositis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Infective myositis;"Life-threatening consequences; urgent intervention indicated";Infective myositis;10021918;LLT;20,1
1509;C146375;Grade 5 Infective Myositis, CTCAE;Death;Grade 5 Infective myositis;Death;Infective myositis;10021918;LLT;20,1
1510;C143626;Joint Infection, CTCAE;A disorder characterized by an infectious process involving a joint.;Joint infection;A disorder characterized by an infectious process involving a joint.;Joint infection;10023216;LLT;20,1
1511;C144798;Grade 2 Joint Infection, CTCAE;"Localized; local intervention indicated; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral); needle aspiration indicated (single or multiple)";Grade 2 Joint infection;"Localized; local intervention indicated; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral); needle aspiration indicated (single or multiple)";Joint infection;10023216;LLT;20,1
1512;C145420;Grade 3 Joint Infection, CTCAE;Arthroscopic intervention indicated (e.g., drainage) or arthrotomy (e.g., open surgical drainage);Grade 3 Joint infection;Arthroscopic intervention indicated (e.g., drainage) or arthrotomy (e.g., open surgical drainage);Joint infection;10023216;LLT;20,1
1513;C145967;Grade 4 Joint Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Joint infection;"Life-threatening consequences; urgent intervention indicated";Joint infection;10023216;LLT;20,1
1514;C146414;Grade 5 Joint Infection, CTCAE;Death;Grade 5 Joint infection;Death;Joint infection;10023216;LLT;20,1
1515;C143632;Kidney Infection, CTCAE;A disorder characterized by an infectious process involving the kidney.;Kidney infection;A disorder characterized by an infectious process involving the kidney.;Kidney infection;10023424;LLT;20,1
1516;C144803;Grade 2 Kidney Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Kidney infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Kidney infection;10023424;LLT;20,1
1517;C145425;Grade 3 Kidney Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Kidney infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Kidney infection;10023424;LLT;20,1
1518;C145969;Grade 4 Kidney Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Kidney infection;"Life-threatening consequences; urgent intervention indicated";Kidney infection;10023424;LLT;20,1
1519;C146416;Grade 5 Kidney Infection, CTCAE;Death;Grade 5 Kidney infection;Death;Kidney infection;10023424;LLT;20,1
1520;C143641;Laryngitis, CTCAE;A disorder characterized by an inflammatory process involving the larynx.;Laryngitis;A disorder characterized by an inflammatory process involving the larynx.;Laryngitis;10023874;LLT;20,1
1521;C144814;Grade 2 Laryngitis, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Laryngitis;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Laryngitis;10023874;LLT;20,1
1522;C145435;Grade 3 Laryngitis, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Laryngitis;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Laryngitis;10023874;LLT;20,1
1523;C145977;Grade 4 Laryngitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Laryngitis;"Life-threatening consequences; urgent intervention indicated";Laryngitis;10023874;LLT;20,1
1524;C146424;Grade 5 Laryngitis, CTCAE;Death;Grade 5 Laryngitis;Death;Laryngitis;10023874;LLT;20,1
1525;C143651;Lip Infection, CTCAE;A disorder characterized by an infectious process involving the lips.;Lip infection;A disorder characterized by an infectious process involving the lips.;Lip infection;10065755;LLT;20,1
1526;C144248;Grade 1 Lip Infection, CTCAE;Localized, local intervention indicated;Grade 1 Lip infection;Localized, local intervention indicated;Lip infection;10065755;LLT;20,1
1527;C144820;Grade 2 Lip Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Lip infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Lip infection;10065755;LLT;20,1
1528;C145440;Grade 3 Lip Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Lip infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Lip infection;10065755;LLT;20,1
1529;C143657;Lung Infection, CTCAE;A disorder characterized by an infectious process involving the lungs, including pneumonia.;Lung infection;A disorder characterized by an infectious process involving the lungs, including pneumonia.;Lung infection;10061229;LLT;20,1
1530;C144826;Grade 2 Lung Infection, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Lung infection;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Lung infection;10061229;LLT;20,1
1531;C145446;Grade 3 Lung Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Lung infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Lung infection;10061229;LLT;20,1
1532;C145985;Grade 4 Lung Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Lung infection;"Life-threatening consequences; urgent intervention indicated";Lung infection;10061229;LLT;20,1
1533;C146431;Grade 5 Lung Infection, CTCAE;Death;Grade 5 Lung infection;Death;Lung infection;10061229;LLT;20,1
1534;C143658;Lymph Gland Infection, CTCAE;A disorder characterized by an infectious process involving the lymph nodes.;Lymph gland infection;A disorder characterized by an infectious process involving the lymph nodes.;Lymph gland infection;10050823;LLT;20,1
1535;C144827;Grade 2 Lymph Gland Infection, CTCAE;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Lymph gland infection;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Lymph gland infection;10050823;LLT;20,1
1536;C145447;Grade 3 Lymph Gland Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Lymph gland infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Lymph gland infection;10050823;LLT;20,1
1537;C145986;Grade 4 Lymph Gland Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Lymph gland infection;"Life-threatening consequences; urgent intervention indicated";Lymph gland infection;10050823;LLT;20,1
1538;C146432;Grade 5 Lymph Gland Infection, CTCAE;Death;Grade 5 Lymph gland infection;Death;Lymph gland infection;10050823;LLT;20,1
1539;C143667;Mediastinal Infection, CTCAE;A disorder characterized by an infectious process involving the mediastinum.;Mediastinal infection;A disorder characterized by an infectious process involving the mediastinum.;Mediastinal infection;10057483;LLT;20,1
1540;C145455;Grade 3 Mediastinal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Mediastinal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Mediastinal infection;10057483;LLT;20,1
1541;C145991;Grade 4 Mediastinal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Mediastinal infection;"Life-threatening consequences; urgent intervention indicated";Mediastinal infection;10057483;LLT;20,1
1542;C146436;Grade 5 Mediastinal Infection, CTCAE;Death;Grade 5 Mediastinal infection;Death;Mediastinal infection;10057483;LLT;20,1
1543;C143670;Meningitis, CTCAE;A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord.;Meningitis;A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord.;Meningitis;10027199;LLT;20,1
1544;C145457;Grade 3 Meningitis, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated; focal neurologic deficit";Grade 3 Meningitis;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated; focal neurologic deficit";Meningitis;10027199;LLT;20,1
1545;C145993;Grade 4 Meningitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Meningitis;"Life-threatening consequences; urgent intervention indicated";Meningitis;10027199;LLT;20,1
1546;C146438;Grade 5 Meningitis, CTCAE;Death;Grade 5 Meningitis;Death;Meningitis;10027199;LLT;20,1
1547;C143678;Mucosal Infection, CTCAE;A disorder characterized by an infectious process involving a mucosal surface.;Mucosal infection;A disorder characterized by an infectious process involving a mucosal surface.;Mucosal infection;10065764;LLT;20,1
1548;C144267;Grade 1 Mucosal Infection, CTCAE;Localized, local intervention indicated;Grade 1 Mucosal infection;Localized, local intervention indicated;Mucosal infection;10065764;LLT;20,1
1549;C144844;Grade 2 Mucosal Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Mucosal infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Mucosal infection;10065764;LLT;20,1
1550;C145466;Grade 3 Mucosal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Mucosal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Mucosal infection;10065764;LLT;20,1
1551;C146001;Grade 4 Mucosal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Mucosal infection;"Life-threatening consequences; urgent intervention indicated";Mucosal infection;10065764;LLT;20,1
1552;C146446;Grade 5 Mucosal Infection, CTCAE;Death;Grade 5 Mucosal infection;Death;Mucosal infection;10065764;LLT;20,1
1553;C55459;Myelitis, CTCAE;A disorder characterized by inflammation involving the spinal cord. Symptoms include weakness, paresthesia, sensory loss, marked discomfort and incontinence.;Myelitis;A disorder characterized by inflammation involving the spinal cord. Symptoms include weakness, paresthesia, sensory loss, marked discomfort and incontinence.;Myelitis;10028524;LLT;20,1
1554;C55460;Grade 1 Myelitis, CTCAE;"Asymptomatic; mild signs (e.g., Babinski's reflex or Lhermitte's sign)";Grade 1 Myelitis;"Asymptomatic; mild signs (e.g., Babinski's reflex or Lhermitte's sign)";Myelitis;10028524;LLT;20,1
1555;C55461;Grade 2 Myelitis, CTCAE;"Moderate weakness or sensory loss; limiting instrumental ADL";Grade 2 Myelitis;"Moderate weakness or sensory loss; limiting instrumental ADL";Myelitis;10028524;LLT;20,1
1556;C55462;Grade 3 Myelitis, CTCAE;"Severe weakness or sensory loss; limiting self care ADL";Grade 3 Myelitis;"Severe weakness or sensory loss; limiting self care ADL";Myelitis;10028524;LLT;20,1
1557;C55463;Grade 4 Myelitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Myelitis;"Life-threatening consequences; urgent intervention indicated";Myelitis;10028524;LLT;20,1
1558;C55464;Grade 5 Myelitis, CTCAE;Death;Grade 5 Myelitis;Death;Myelitis;10028524;LLT;20,1
1559;C143695;Nail Infection, CTCAE;A disorder characterized by an infectious process involving the nail.;Nail infection;A disorder characterized by an infectious process involving the nail.;Nail infection;10061304;LLT;20,1
1560;C144281;Grade 1 Nail Infection, CTCAE;Localized, local intervention indicated;Grade 1 Nail infection;Localized, local intervention indicated;Nail infection;10061304;LLT;20,1
1561;C144858;Grade 2 Nail Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Nail infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Nail infection;10061304;LLT;20,1
1562;C145480;Grade 3 Nail Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Nail infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Nail infection;10061304;LLT;20,1
1563;C143719;Otitis Externa, CTCAE;A disorder characterized by an infectious process involving the outer ear and ear canal. Contributory factors include excessive water exposure (swimmer's ear infection) and cuts in the ear canal. Symptoms include fullness, itching, swelling and marked discomfort in the ear and ear drainage.;Otitis externa;A disorder characterized by an infectious process involving the outer ear and ear canal. Contributory factors include excessive water exposure (swimmer's ear infection) and cuts in the ear canal. Symptoms include fullness, itching, swelling and marked discomfort in the ear and ear drainage.;Otitis externa;10033072;LLT;20,1
1564;C144304;Grade 1 Otitis Externa, CTCAE;Localized, local intervention indicated;Grade 1 Otitis externa;Localized, local intervention indicated;Otitis externa;10033072;LLT;20,1
1565;C144880;Grade 2 Otitis Externa, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Otitis externa;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Otitis externa;10033072;LLT;20,1
1566;C145501;Grade 3 Otitis Externa, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Otitis externa;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Otitis externa;10033072;LLT;20,1
1567;C146020;Grade 4 Otitis Externa, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Otitis externa;"Life-threatening consequences; urgent intervention indicated";Otitis externa;10033072;LLT;20,1
1568;C146461;Grade 5 Otitis Externa, CTCAE;Death;Grade 5 Otitis externa;Death;Otitis externa;10033072;LLT;20,1
1569;C143720;Otitis Media, CTCAE;A disorder characterized by an infectious process involving the middle ear.;Otitis media;A disorder characterized by an infectious process involving the middle ear.;Otitis media;10033078;LLT;20,1
1570;C144881;Grade 2 Otitis Media, CTCAE;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Otitis media;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Otitis media;10033078;LLT;20,1
1571;C145502;Grade 3 Otitis Media, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Otitis media;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Otitis media;10033078;LLT;20,1
1572;C146021;Grade 4 Otitis Media, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Otitis media;"Life-threatening consequences; urgent intervention indicated";Otitis media;10033078;LLT;20,1
1573;C146462;Grade 5 Otitis Media, CTCAE;Death;Grade 5 Otitis media;Death;Otitis media;10033078;LLT;20,1
1574;C143721;Ovarian Infection, CTCAE;A disorder characterized by an infectious process involving the ovary.;Ovarian infection;A disorder characterized by an infectious process involving the ovary.;Ovarian infection;10055005;LLT;20,1
1575;C144883;Grade 2 Ovarian Infection, CTCAE;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Ovarian infection;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Ovarian infection;10055005;LLT;20,1
1576;C145504;Grade 3 Ovarian Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Ovarian infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Ovarian infection;10055005;LLT;20,1
1577;C146023;Grade 4 Ovarian Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Ovarian infection;"Life-threatening consequences; urgent intervention indicated";Ovarian infection;10055005;LLT;20,1
1578;C146464;Grade 5 Ovarian Infection, CTCAE;Death;Grade 5 Ovarian infection;Death;Ovarian infection;10055005;LLT;20,1
1579;C143728;Pancreas Infection, CTCAE;A disorder characterized by an infectious process involving the pancreas.;Pancreas infection;A disorder characterized by an infectious process involving the pancreas.;Pancreas infection;10051741;LLT;20,1
1580;C145510;Grade 3 Pancreas Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Pancreas infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Pancreas infection;10051741;LLT;20,1
1581;C146025;Grade 4 Pancreas Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pancreas infection;"Life-threatening consequences; urgent intervention indicated";Pancreas infection;10051741;LLT;20,1
1582;C146466;Grade 5 Pancreas Infection, CTCAE;Death;Grade 5 Pancreas infection;Death;Pancreas infection;10051741;LLT;20,1
1583;C143735;Papulopustular Rash, CTCAE;A disorder characterized by an eruption consisting of papules (a small, raised pimple) and pustules (a small pus filled blister), typically appearing in face, scalp, and upper chest and back. Unlike acne, this rash does not present with whiteheads or blackheads, and can be symptomatic, with itchy or tender lesions.;Papulopustular rash;A disorder characterized by an eruption consisting of papules (a small, raised pimple) and pustules (a small pus filled blister), typically appearing in face, scalp, and upper chest and back. Unlike acne, this rash does not present with whiteheads or blackheads, and can be symptomatic, with itchy or tender lesions.;Papulopustular rash;10069138;LLT;20,1
1584;C144317;Grade 1 Papulopustular Rash, CTCAE;Papules and/or pustules covering <10% BSA, which may or may not be associated with symptoms of pruritus or tenderness;Grade 1 Papulopustular rash;Papules and/or pustules covering <10% BSA, which may or may not be associated with symptoms of pruritus or tenderness;Papulopustular rash;10069138;LLT;20,1
1585;C144896;Grade 2 Papulopustular Rash, CTCAE;"Papules and/or pustules covering 10-30% BSA, which may or may not be associated with symptoms of pruritus or tenderness; associated with psychosocial impact; limiting instrumental ADL; papules and/or pustules covering > 30% BSA with or without mild symptoms";Grade 2 Papulopustular rash;"Papules and/or pustules covering 10-30% BSA, which may or may not be associated with symptoms of pruritus or tenderness; associated with psychosocial impact; limiting instrumental ADL; papules and/or pustules covering > 30% BSA with or without mild symptoms";Papulopustular rash;10069138;LLT;20,1
1586;C145518;Grade 3 Papulopustular Rash, CTCAE;"Papules and/or pustules covering >30% BSA with moderate or severe symptoms; limiting self-care ADL; IV antibiotics indicated";Grade 3 Papulopustular rash;"Papules and/or pustules covering >30% BSA with moderate or severe symptoms; limiting self-care ADL; IV antibiotics indicated";Papulopustular rash;10069138;LLT;20,1
1587;C146032;Grade 4 Papulopustular Rash, CTCAE;Life-threatening consequences;Grade 4 Papulopustular rash;Life-threatening consequences;Papulopustular rash;10069138;LLT;20,1
1588;C146472;Grade 5 Papulopustular Rash, CTCAE;Death;Grade 5 Papulopustular rash;Death;Papulopustular rash;10069138;LLT;20,1
1589;C143737;Paronychia, CTCAE;A disorder characterized by an infectious process involving the soft tissues around the nail.;Paronychia;A disorder characterized by an infectious process involving the soft tissues around the nail.;Paronychia;10034016;LLT;20,1
1590;C144319;Grade 1 Paronychia, CTCAE;"Nail fold edema or erythema; disruption of the cuticle";Grade 1 Paronychia;"Nail fold edema or erythema; disruption of the cuticle";Paronychia;10034016;LLT;20,1
1591;C144898;Grade 2 Paronychia, CTCAE;"Local intervention indicated; oral intervention indicated (e.g., antibiotic, antifungal, antiviral); nail fold edema or erythema with pain; associated with discharge or nail plate separation; limiting instrumental ADL";Grade 2 Paronychia;"Local intervention indicated; oral intervention indicated (e.g., antibiotic, antifungal, antiviral); nail fold edema or erythema with pain; associated with discharge or nail plate separation; limiting instrumental ADL";Paronychia;10034016;LLT;20,1
1592;C145520;Grade 3 Paronychia, CTCAE;"Operative intervention indicated; IV antibiotics indicated; limiting self care ADL";Grade 3 Paronychia;"Operative intervention indicated; IV antibiotics indicated; limiting self care ADL";Paronychia;10034016;LLT;20,1
1593;C143740;Pelvic Infection, CTCAE;A disorder characterized by an infectious process involving the pelvic cavity.;Pelvic infection;A disorder characterized by an infectious process involving the pelvic cavity.;Pelvic infection;10058674;LLT;20,1
1594;C144901;Grade 2 Pelvic Infection, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Pelvic infection;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Pelvic infection;10058674;LLT;20,1
1595;C145523;Grade 3 Pelvic Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Pelvic infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Pelvic infection;10058674;LLT;20,1
1596;C146034;Grade 4 Pelvic Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pelvic infection;"Life-threatening consequences; urgent intervention indicated";Pelvic infection;10058674;LLT;20,1
1597;C146474;Grade 5 Pelvic Infection, CTCAE;Death;Grade 5 Pelvic infection;Death;Pelvic infection;10058674;LLT;20,1
1598;C143741;Penile Infection, CTCAE;A disorder characterized by an infectious process involving the penis.;Penile infection;A disorder characterized by an infectious process involving the penis.;Penile infection;10061912;LLT;20,1
1599;C144323;Grade 1 Penile Infection, CTCAE;Localized, local intervention indicated;Grade 1 Penile infection;Localized, local intervention indicated;Penile infection;10061912;LLT;20,1
1600;C144903;Grade 2 Penile Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Penile infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Penile infection;10061912;LLT;20,1
1601;C145525;Grade 3 Penile Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Penile infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Penile infection;10061912;LLT;20,1
1602;C146035;Grade 4 Penile Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Penile infection;"Life-threatening consequences; urgent intervention indicated";Penile infection;10061912;LLT;20,1
1603;C146475;Grade 5 Penile Infection, CTCAE;Death;Grade 5 Penile infection;Death;Penile infection;10061912;LLT;20,1
1604;C143748;Periorbital Infection, CTCAE;A disorder characterized by an infectious process involving the orbit of the eye.;Periorbital infection;A disorder characterized by an infectious process involving the orbit of the eye.;Periorbital infection;10051472;LLT;20,1
1605;C144908;Grade 2 Periorbital Infection, CTCAE;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Grade 2 Periorbital infection;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Periorbital infection;10051472;LLT;20,1
1606;C145531;Grade 3 Periorbital Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Periorbital infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Periorbital infection;10051472;LLT;20,1
1607;C146039;Grade 4 Periorbital Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Periorbital infection;"Life-threatening consequences; urgent intervention indicated";Periorbital infection;10051472;LLT;20,1
1608;C146479;Grade 5 Periorbital Infection, CTCAE;Death;Grade 5 Periorbital infection;Death;Periorbital infection;10051472;LLT;20,1
1609;C143751;Peripheral Nerve Infection, CTCAE;A disorder characterized by an infectious process involving the peripheral nerves.;Peripheral nerve infection;A disorder characterized by an infectious process involving the peripheral nerves.;Peripheral nerve infection;10065766;LLT;20,1
1610;C144911;Grade 2 Peripheral Nerve Infection, CTCAE;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Grade 2 Peripheral nerve infection;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Peripheral nerve infection;10065766;LLT;20,1
1611;C145534;Grade 3 Peripheral Nerve Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Peripheral nerve infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Peripheral nerve infection;10065766;LLT;20,1
1612;C146042;Grade 4 Peripheral Nerve Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Peripheral nerve infection;"Life-threatening consequences; urgent intervention indicated";Peripheral nerve infection;10065766;LLT;20,1
1613;C146482;Grade 5 Peripheral Nerve Infection, CTCAE;Death;Grade 5 Peripheral nerve infection;Death;Peripheral nerve infection;10065766;LLT;20,1
1614;C143753;Peritoneal Infection, CTCAE;A disorder characterized by an infectious process involving the peritoneum.;Peritoneal infection;A disorder characterized by an infectious process involving the peritoneum.;Peritoneal infection;10057262;LLT;20,1
1615;C145536;Grade 3 Peritoneal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Peritoneal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Peritoneal infection;10057262;LLT;20,1
1616;C146044;Grade 4 Peritoneal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Peritoneal infection;"Life-threatening consequences; urgent intervention indicated";Peritoneal infection;10057262;LLT;20,1
1617;C146483;Grade 5 Peritoneal Infection, CTCAE;Death;Grade 5 Peritoneal infection;Death;Peritoneal infection;10057262;LLT;20,1
1618;C143758;Pharyngitis, CTCAE;A disorder characterized by inflammation of the throat.;Pharyngitis;A disorder characterized by inflammation of the throat.;Pharyngitis;10034835;LLT;20,1
1619;C144920;Grade 2 Pharyngitis, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Pharyngitis;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Pharyngitis;10034835;LLT;20,1
1620;C145546;Grade 3 Pharyngitis, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Pharyngitis;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Pharyngitis;10034835;LLT;20,1
1621;C146053;Grade 4 Pharyngitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pharyngitis;"Life-threatening consequences; urgent intervention indicated";Pharyngitis;10034835;LLT;20,1
1622;C146491;Grade 5 Pharyngitis, CTCAE;Death;Grade 5 Pharyngitis;Death;Pharyngitis;10034835;LLT;20,1
1623;C143760;Phlebitis Infective, CTCAE;A disorder characterized by an infectious process involving the vein. Clinical manifestations include erythema, marked discomfort, swelling, and induration along the course of the infected vein.;Phlebitis infective;A disorder characterized by an infectious process involving the vein. Clinical manifestations include erythema, marked discomfort, swelling, and induration along the course of the infected vein.;Phlebitis infective;10056627;LLT;20,1
1624;C144337;Grade 1 Phlebitis Infective, CTCAE;Localized, local intervention indicated;Grade 1 Phlebitis infective;Localized, local intervention indicated;Phlebitis infective;10056627;LLT;20,1
1625;C144922;Grade 2 Phlebitis Infective, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Phlebitis infective;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Phlebitis infective;10056627;LLT;20,1
1626;C145548;Grade 3 Phlebitis Infective, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Phlebitis infective;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Phlebitis infective;10056627;LLT;20,1
1627;C146054;Grade 4 Phlebitis Infective, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Phlebitis infective;"Life-threatening consequences; urgent intervention indicated";Phlebitis infective;10056627;LLT;20,1
1628;C146492;Grade 5 Phlebitis Infective, CTCAE;Death;Grade 5 Phlebitis infective;Death;Phlebitis infective;10056627;LLT;20,1
1629;C143766;Pleural Infection, CTCAE;A disorder characterized by an infectious process involving the pleura.;Pleural infection;A disorder characterized by an infectious process involving the pleura.;Pleural infection;10061351;LLT;20,1
1630;C144927;Grade 2 Pleural Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Pleural infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Pleural infection;10061351;LLT;20,1
1631;C145552;Grade 3 Pleural Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Pleural infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Pleural infection;10061351;LLT;20,1
1632;C146058;Grade 4 Pleural Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pleural infection;"Life-threatening consequences; urgent intervention indicated";Pleural infection;10061351;LLT;20,1
1633;C146495;Grade 5 Pleural Infection, CTCAE;Death;Grade 5 Pleural infection;Death;Pleural infection;10061351;LLT;20,1
1634;C143783;Prostate Infection, CTCAE;A disorder characterized by an infectious process involving the prostate gland.;Prostate infection;A disorder characterized by an infectious process involving the prostate gland.;Prostate infection;10050662;LLT;20,1
1635;C144942;Grade 2 Prostate Infection, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Prostate infection;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Prostate infection;10050662;LLT;20,1
1636;C145564;Grade 3 Prostate Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Prostate infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Prostate infection;10050662;LLT;20,1
1637;C146069;Grade 4 Prostate Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Prostate infection;"Life-threatening consequences; urgent intervention indicated";Prostate infection;10050662;LLT;20,1
1638;C146504;Grade 5 Prostate Infection, CTCAE;Death;Grade 5 Prostate infection;Death;Prostate infection;10050662;LLT;20,1
1639;C143800;Rash Pustular, CTCAE;A disorder characterized by a circumscribed and elevated skin lesion filled with pus.;Rash pustular;A disorder characterized by a circumscribed and elevated skin lesion filled with pus.;Rash pustular;10037888;LLT;20,1
1640;C144958;Grade 2 Rash Pustular, CTCAE;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Grade 2 Rash pustular;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Rash pustular;10037888;LLT;20,1
1641;C145580;Grade 3 Rash Pustular, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Rash pustular;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Rash pustular;10037888;LLT;20,1
1642;C143819;Rhinitis Infective, CTCAE;A disorder characterized by an infectious process involving the nasal mucosal.;Rhinitis infective;A disorder characterized by an infectious process involving the nasal mucosal.;Rhinitis infective;10059827;LLT;20,1
1643;C144982;Grade 2 Rhinitis Infective, CTCAE;"Localized; local intervention indicated";Grade 2 Rhinitis infective;"Localized; local intervention indicated";Rhinitis infective;10059827;LLT;20,1
1644;C143822;Salivary Gland Infection, CTCAE;A disorder characterized by an infectious process involving the salivary gland.;Salivary gland infection;A disorder characterized by an infectious process involving the salivary gland.;Salivary gland infection;10039413;LLT;20,1
1645;C144985;Grade 2 Salivary Gland Infection, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Salivary gland infection;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Salivary gland infection;10039413;LLT;20,1
1646;C145606;Grade 3 Salivary Gland Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Salivary gland infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Salivary gland infection;10039413;LLT;20,1
1647;C146101;Grade 4 Salivary Gland Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Salivary gland infection;"Life-threatening consequences; urgent intervention indicated";Salivary gland infection;10039413;LLT;20,1
1648;C146536;Grade 5 Salivary Gland Infection, CTCAE;Death;Grade 5 Salivary gland infection;Death;Salivary gland infection;10039413;LLT;20,1
1649;C143825;Scrotal Infection, CTCAE;A disorder characterized by an infectious process involving the scrotum.;Scrotal infection;A disorder characterized by an infectious process involving the scrotum.;Scrotal infection;10062156;LLT;20,1
1650;C144390;Grade 1 Scrotal Infection, CTCAE;Localized, local intervention indicated;Grade 1 Scrotal infection;Localized, local intervention indicated;Scrotal infection;10062156;LLT;20,1
1651;C144988;Grade 2 Scrotal Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Scrotal infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Scrotal infection;10062156;LLT;20,1
1652;C145609;Grade 3 Scrotal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Scrotal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Scrotal infection;10062156;LLT;20,1
1653;C146103;Grade 4 Scrotal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Scrotal infection;"Life-threatening consequences; urgent intervention indicated";Scrotal infection;10062156;LLT;20,1
1654;C146537;Grade 5 Scrotal Infection, CTCAE;Death;Grade 5 Scrotal infection;Death;Scrotal infection;10062156;LLT;20,1
1655;C143827;Sepsis, CTCAE;A disorder characterized by the presence of pathogenic microorganisms in the blood stream that cause a rapidly progressing systemic reaction that may lead to shock.;Sepsis;A disorder characterized by the presence of pathogenic microorganisms in the blood stream that cause a rapidly progressing systemic reaction that may lead to shock.;Sepsis;10040047;LLT;20,1
1656;C145611;Grade 3 Sepsis, CTCAE;"Blood culture positive with signs or symptoms; treatment indicated";Grade 3 Sepsis;"Blood culture positive with signs or symptoms; treatment indicated";Sepsis;10040047;LLT;20,1
1657;C146104;Grade 4 Sepsis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Sepsis;"Life-threatening consequences; urgent intervention indicated";Sepsis;10040047;LLT;20,1
1658;C146538;Grade 5 Sepsis, CTCAE;Death;Grade 5 Sepsis;Death;Sepsis;10040047;LLT;20,1
1659;C143213;Shingles, CTCAE;A disorder characterized by the reactivation of herpes zoster virus.;Shingles;A disorder characterized by the reactivation of herpes zoster virus.;Shingles;10040555;LLT;20,1
1660;C144395;Grade 1 Shingles, CTCAE;Localized, local intervention indicated;Grade 1 Shingles;Localized, local intervention indicated;Shingles;10040555;LLT;20,1
1661;C144992;Grade 2 Shingles, CTCAE;"Local infection with moderate symptoms; oral intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Shingles;"Local infection with moderate symptoms; oral intervention indicated; limiting age-appropriate instrumental ADL";Shingles;10040555;LLT;20,1
1662;C145613;Grade 3 Shingles, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; IV intervention indicated; limiting self-care ADL";Grade 3 Shingles;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; IV intervention indicated; limiting self-care ADL";Shingles;10040555;LLT;20,1
1663;C146107;Grade 4 Shingles, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Shingles;"Life-threatening consequences; urgent intervention indicated";Shingles;10040555;LLT;20,1
1664;C146539;Grade 5 Shingles, CTCAE;Death;Grade 5 Shingles;Death;Shingles;10040555;LLT;20,1
1665;C143832;Sinusitis, CTCAE;A disorder characterized by an infectious process involving the mucous membranes of the paranasal sinuses.;Sinusitis;A disorder characterized by an infectious process involving the mucous membranes of the paranasal sinuses.;Sinusitis;10040753;LLT;20,1
1666;C144994;Grade 2 Sinusitis, CTCAE;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Sinusitis;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Sinusitis;10040753;LLT;20,1
1667;C145615;Grade 3 Sinusitis, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Sinusitis;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Sinusitis;10040753;LLT;20,1
1668;C146109;Grade 4 Sinusitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Sinusitis;"Life-threatening consequences; urgent intervention indicated";Sinusitis;10040753;LLT;20,1
1669;C146541;Grade 5 Sinusitis, CTCAE;Death;Grade 5 Sinusitis;Death;Sinusitis;10040753;LLT;20,1
1670;C143838;Skin Infection, CTCAE;A disorder characterized by an infectious process involving the skin such as cellulitis.;Skin infection;A disorder characterized by an infectious process involving the skin such as cellulitis.;Skin infection;10040872;LLT;20,1
1671;C144401;Grade 1 Skin Infection, CTCAE;Localized, local intervention indicated;Grade 1 Skin infection;Localized, local intervention indicated;Skin infection;10040872;LLT;20,1
1672;C145000;Grade 2 Skin Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Skin infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Skin infection;10040872;LLT;20,1
1673;C145620;Grade 3 Skin Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Skin infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Skin infection;10040872;LLT;20,1
1674;C146113;Grade 4 Skin Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Skin infection;"Life-threatening consequences; urgent intervention indicated";Skin infection;10040872;LLT;20,1
1675;C146545;Grade 5 Skin Infection, CTCAE;Death;Grade 5 Skin infection;Death;Skin infection;10040872;LLT;20,1
1676;C143845;Small Intestine Infection, CTCAE;A disorder characterized by an infectious process involving the small intestine.;Small intestine infection;A disorder characterized by an infectious process involving the small intestine.;Small intestine infection;10065771;LLT;20,1
1677;C145009;Grade 2 Small Intestine Infection, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Small intestine infection;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Small intestine infection;10065771;LLT;20,1
1678;C145628;Grade 3 Small Intestine Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Small intestine infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Small intestine infection;10065771;LLT;20,1
1679;C146121;Grade 4 Small Intestine Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Small intestine infection;"Life-threatening consequences; urgent intervention indicated";Small intestine infection;10065771;LLT;20,1
1680;C146553;Grade 5 Small Intestine Infection, CTCAE;Death;Grade 5 Small intestine infection;Death;Small intestine infection;10065771;LLT;20,1
1681;C143849;Soft Tissue Infection, CTCAE;A disorder characterized by an infectious process involving soft tissues.;Soft tissue infection;A disorder characterized by an infectious process involving soft tissues.;Soft tissue infection;10062255;LLT;20,1
1682;C145013;Grade 2 Soft Tissue Infection, CTCAE;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Soft tissue infection;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Soft tissue infection;10062255;LLT;20,1
1683;C145631;Grade 3 Soft Tissue Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Soft tissue infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Soft tissue infection;10062255;LLT;20,1
1684;C146124;Grade 4 Soft Tissue Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Soft tissue infection;"Life-threatening consequences; urgent intervention indicated";Soft tissue infection;10062255;LLT;20,1
1685;C146556;Grade 5 Soft Tissue Infection, CTCAE;Death;Grade 5 Soft tissue infection;Death;Soft tissue infection;10062255;LLT;20,1
1686;C143857;Splenic Infection, CTCAE;A disorder characterized by an infectious process involving the spleen.;Splenic infection;A disorder characterized by an infectious process involving the spleen.;Splenic infection;10062112;LLT;20,1
1687;C145640;Grade 3 Splenic Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Splenic infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Splenic infection;10062112;LLT;20,1
1688;C146132;Grade 4 Splenic Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Splenic infection;"Life-threatening consequences; urgent intervention indicated";Splenic infection;10062112;LLT;20,1
1689;C146564;Grade 5 Splenic Infection, CTCAE;Death;Grade 5 Splenic infection;Death;Splenic infection;10062112;LLT;20,1
1690;C143860;Stoma Site Infection, CTCAE;A disorder characterized by an infectious process involving a stoma (surgically created opening on the surface of the body).;Stoma site infection;A disorder characterized by an infectious process involving a stoma (surgically created opening on the surface of the body).;Stoma site infection;10064505;LLT;20,1
1691;C144417;Grade 1 Stoma Site Infection, CTCAE;Localized, local intervention indicated;Grade 1 Stoma site infection;Localized, local intervention indicated;Stoma site infection;10064505;LLT;20,1
1692;C145022;Grade 2 Stoma Site Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Stoma site infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Stoma site infection;10064505;LLT;20,1
1693;C145643;Grade 3 Stoma Site Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Stoma site infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Stoma site infection;10064505;LLT;20,1
1694;C146135;Grade 4 Stoma Site Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Stoma site infection;"Life-threatening consequences; urgent intervention indicated";Stoma site infection;10064505;LLT;20,1
1695;C146567;Grade 5 Stoma Site Infection, CTCAE;Death;Grade 5 Stoma site infection;Death;Stoma site infection;10064505;LLT;20,1
1696;C143214;Thrush, CTCAE;A disorder characterized by a suspected candidal infection involving an oral mucosal surface.;Thrush;A disorder characterized by a suspected candidal infection involving an oral mucosal surface.;Thrush;10043649;LLT;20,1
1697;C144431;Grade 1 Thrush, CTCAE;"Asymptomatic; local symptomatic management";Grade 1 Thrush;"Asymptomatic; local symptomatic management";Thrush;10043649;LLT;20,1
1698;C145037;Grade 2 Thrush, CTCAE;Oral intervention indicated (e.g., antifungal);Grade 2 Thrush;Oral intervention indicated (e.g., antifungal);Thrush;10043649;LLT;20,1
1699;C145659;Grade 3 Thrush, CTCAE;IV antifungal intervention indicated;Grade 3 Thrush;IV antifungal intervention indicated;Thrush;10043649;LLT;20,1
1700;C143878;Tooth Infection, CTCAE;A disorder characterized by an infectious process involving a tooth.;Tooth infection;A disorder characterized by an infectious process involving a tooth.;Tooth infection;10048762;LLT;20,1
1701;C145039;Grade 2 Tooth Infection, CTCAE;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Grade 2 Tooth infection;"Localized; local intervention indicated (e.g., topical antibiotic, antifungal, or antiviral)";Tooth infection;10048762;LLT;20,1
1702;C145661;Grade 3 Tooth Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Tooth infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Tooth infection;10048762;LLT;20,1
1703;C146147;Grade 4 Tooth Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Tooth infection;"Life-threatening consequences; urgent intervention indicated";Tooth infection;10048762;LLT;20,1
1704;C146578;Grade 5 Tooth Infection, CTCAE;Death;Grade 5 Tooth infection;Death;Tooth infection;10048762;LLT;20,1
1705;C143884;Tracheitis, CTCAE;A disorder characterized by an infectious process involving the trachea.;Tracheitis;A disorder characterized by an infectious process involving the trachea.;Tracheitis;10044302;LLT;20,1
1706;C145046;Grade 2 Tracheitis, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Tracheitis;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Tracheitis;10044302;LLT;20,1
1707;C145668;Grade 3 Tracheitis, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Tracheitis;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Tracheitis;10044302;LLT;20,1
1708;C146154;Grade 4 Tracheitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Tracheitis;"Life-threatening consequences; urgent intervention indicated";Tracheitis;10044302;LLT;20,1
1709;C146585;Grade 5 Tracheitis, CTCAE;Death;Grade 5 Tracheitis;Death;Tracheitis;10044302;LLT;20,1
1710;C143896;Upper Respiratory Infection, CTCAE;A disorder characterized by an infectious process involving the upper respiratory tract (nose, paranasal sinuses, pharynx, larynx, or trachea).;Upper respiratory infection;A disorder characterized by an infectious process involving the upper respiratory tract (nose, paranasal sinuses, pharynx, larynx, or trachea).;Upper respiratory infection;10046300;LLT;20,1
1711;C145055;Grade 2 Upper Respiratory Infection, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Upper respiratory infection;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Upper respiratory infection;10046300;LLT;20,1
1712;C145677;Grade 3 Upper Respiratory Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Upper respiratory infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Upper respiratory infection;10046300;LLT;20,1
1713;C146161;Grade 4 Upper Respiratory Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Upper respiratory infection;"Life-threatening consequences; urgent intervention indicated";Upper respiratory infection;10046300;LLT;20,1
1714;C146591;Grade 5 Upper Respiratory Infection, CTCAE;Death;Grade 5 Upper respiratory infection;Death;Upper respiratory infection;10046300;LLT;20,1
1715;C143899;Urethral Infection, CTCAE;A disorder characterized by an infectious process involving the urethra.;Urethral infection;A disorder characterized by an infectious process involving the urethra.;Urethral infection;10052298;LLT;20,1
1716;C145058;Grade 2 Urethral Infection, CTCAE;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Urethral infection;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Urethral infection;10052298;LLT;20,1
1717;C145680;Grade 3 Urethral Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Urethral infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Urethral infection;10052298;LLT;20,1
1718;C146164;Grade 4 Urethral Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Urethral infection;"Life-threatening consequences; urgent intervention indicated";Urethral infection;10052298;LLT;20,1
1719;C146594;Grade 5 Urethral Infection, CTCAE;Death;Grade 5 Urethral infection;Death;Urethral infection;10052298;LLT;20,1
1720;C143904;Urinary Tract Infection, CTCAE;A disorder characterized by an infectious process involving the urinary tract, most commonly the bladder and the urethra.;Urinary tract infection;A disorder characterized by an infectious process involving the urinary tract, most commonly the bladder and the urethra.;Urinary tract infection;10046571;LLT;20,1
1721;C145061;Grade 2 Urinary Tract Infection, CTCAE;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Urinary tract infection;"Localized; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Urinary tract infection;10046571;LLT;20,1
1722;C145682;Grade 3 Urinary Tract Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Urinary tract infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Urinary tract infection;10046571;LLT;20,1
1723;C146166;Grade 4 Urinary Tract Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Urinary tract infection;"Life-threatening consequences; urgent intervention indicated";Urinary tract infection;10046571;LLT;20,1
1724;C146596;Grade 5 Urinary Tract Infection, CTCAE;Death;Grade 5 Urinary tract infection;Death;Urinary tract infection;10046571;LLT;20,1
1725;C143917;Uterine Infection, CTCAE;A disorder characterized by an infectious process involving the endometrium. It may extend to the myometrium and parametrial tissues.;Uterine infection;A disorder characterized by an infectious process involving the endometrium. It may extend to the myometrium and parametrial tissues.;Uterine infection;10062233;LLT;20,1
1726;C145072;Grade 2 Uterine Infection, CTCAE;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Grade 2 Uterine infection;"Moderate symptoms; oral intervention indicated (e.g., antibiotic, antifungal, or antiviral)";Uterine infection;10062233;LLT;20,1
1727;C145693;Grade 3 Uterine Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Uterine infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Uterine infection;10062233;LLT;20,1
1728;C146176;Grade 4 Uterine Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Uterine infection;"Life-threatening consequences; urgent intervention indicated";Uterine infection;10062233;LLT;20,1
1729;C146605;Grade 5 Uterine Infection, CTCAE;Death;Grade 5 Uterine infection;Death;Uterine infection;10062233;LLT;20,1
1730;C143924;Vaginal Infection, CTCAE;A disorder characterized by an infectious process involving the vagina.;Vaginal infection;A disorder characterized by an infectious process involving the vagina.;Vaginal infection;10046914;LLT;20,1
1731;C144471;Grade 1 Vaginal Infection, CTCAE;Localized, local intervention indicated;Grade 1 Vaginal infection;Localized, local intervention indicated;Vaginal infection;10046914;LLT;20,1
1732;C145082;Grade 2 Vaginal Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Vaginal infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Vaginal infection;10046914;LLT;20,1
1733;C145702;Grade 3 Vaginal Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Vaginal infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Vaginal infection;10046914;LLT;20,1
1734;C146182;Grade 4 Vaginal Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Vaginal infection;"Life-threatening consequences; urgent intervention indicated";Vaginal infection;10046914;LLT;20,1
1735;C146610;Grade 5 Vaginal Infection, CTCAE;Death;Grade 5 Vaginal infection;Death;Vaginal infection;10046914;LLT;20,1
1736;C143215;Viremia, CTCAE;A disorder characterized by the presence of a virus in the blood stream.;Viremia;A disorder characterized by the presence of a virus in the blood stream.;Viremia;10054688;LLT;20,1
1737;C145096;Grade 2 Viremia, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Viremia;"Moderate symptoms; medical intervention indicated";Viremia;10054688;LLT;20,1
1738;C145717;Grade 3 Viremia, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated";Grade 3 Viremia;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated";Viremia;10054688;LLT;20,1
1739;C143943;Vulval Infection, CTCAE;A disorder characterized by an infectious process involving the vulva.;Vulval infection;A disorder characterized by an infectious process involving the vulva.;Vulval infection;10065772;LLT;20,1
1740;C144486;Grade 1 Vulval Infection, CTCAE;Localized, local intervention indicated;Grade 1 Vulval infection;Localized, local intervention indicated;Vulval infection;10065772;LLT;20,1
1741;C145102;Grade 2 Vulval Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Vulval infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Vulval infection;10065772;LLT;20,1
1742;C145722;Grade 3 Vulval Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Vulval infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Vulval infection;10065772;LLT;20,1
1743;C146195;Grade 4 Vulval Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Vulval infection;"Life-threatening consequences; urgent intervention indicated";Vulval infection;10065772;LLT;20,1
1744;C146621;Grade 5 Vulval Infection, CTCAE;Death;Grade 5 Vulval infection;Death;Vulval infection;10065772;LLT;20,1
1745;C143951;Wound Infection, CTCAE;A disorder characterized by an infectious process involving the wound.;Wound infection;A disorder characterized by an infectious process involving the wound.;Wound infection;10048038;LLT;20,1
1746;C144492;Grade 1 Wound Infection, CTCAE;Localized, local intervention indicated;Grade 1 Wound infection;Localized, local intervention indicated;Wound infection;10048038;LLT;20,1
1747;C145108;Grade 2 Wound Infection, CTCAE;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Grade 2 Wound infection;Oral intervention indicated (e.g., antibiotic, antifungal, or antiviral);Wound infection;10048038;LLT;20,1
1748;C145728;Grade 3 Wound Infection, CTCAE;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Grade 3 Wound infection;"IV antibiotic, antifungal, or antiviral intervention indicated; invasive intervention indicated";Wound infection;10048038;LLT;20,1
1749;C146201;Grade 4 Wound Infection, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Wound infection;"Life-threatening consequences; urgent intervention indicated";Wound infection;10048038;LLT;20,1
1750;C146625;Grade 5 Wound Infection, CTCAE;Death;Grade 5 Wound infection;Death;Wound infection;10048038;LLT;20,1
1751;C143172;Injury, Poisoning and Procedural Complications, CTCAE;;;;;;;
1752;C143284;Ankle Fracture, CTCAE;A finding of damage to the ankle joint characterized by a break in the continuity of the ankle bone. Symptoms include marked discomfort, swelling and difficulty moving the affected leg and foot.;Ankle fracture;A finding of damage to the ankle joint characterized by a break in the continuity of the ankle bone. Symptoms include marked discomfort, swelling and difficulty moving the affected leg and foot.;Ankle fracture;10002544;LLT;20,1
1753;C143980;Grade 1 Ankle Fracture, CTCAE;"Mild; non-operative intervention indicated";Grade 1 Ankle fracture;"Mild; non-operative intervention indicated";Ankle fracture;10002544;LLT;20,1
1754;C144518;Grade 2 Ankle Fracture, CTCAE;"Limiting instrumental ADL; outpatient operative intervention indicated";Grade 2 Ankle fracture;"Limiting instrumental ADL; outpatient operative intervention indicated";Ankle fracture;10002544;LLT;20,1
1755;C145137;Grade 3 Ankle Fracture, CTCAE;"Limiting self care ADL; elective operative intervention indicated requiring hospitalization";Grade 3 Ankle fracture;"Limiting self care ADL; elective operative intervention indicated requiring hospitalization";Ankle fracture;10002544;LLT;20,1
1756;C143289;Aortic Injury, CTCAE;A finding of damage to the aorta.;Aortic injury;A finding of damage to the aorta.;Aortic injury;10002899;LLT;20,1
1757;C144521;Grade 2 Aortic Injury, CTCAE;Operative intervention not indicated;Grade 2 Aortic injury;Operative intervention not indicated;Aortic injury;10002899;LLT;20,1
1758;C145139;Grade 3 Aortic Injury, CTCAE;"Severe symptoms; limiting self care ADL; repair or revision indicated";Grade 3 Aortic injury;"Severe symptoms; limiting self care ADL; repair or revision indicated";Aortic injury;10002899;LLT;20,1
1759;C145747;Grade 4 Aortic Injury, CTCAE;"Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated";Grade 4 Aortic injury;"Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated";Aortic injury;10002899;LLT;20,1
1760;C146217;Grade 5 Aortic Injury, CTCAE;Death;Grade 5 Aortic injury;Death;Aortic injury;10002899;LLT;20,1
1761;C143296;Arterial Injury, CTCAE;A finding of damage to an artery.;Arterial injury;A finding of damage to an artery.;Arterial injury;10003162;LLT;20,1
1762;C143986;Grade 1 Arterial Injury, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Arterial injury;"Asymptomatic diagnostic finding; intervention not indicated";Arterial injury;10003162;LLT;20,1
1763;C144524;Grade 2 Arterial Injury, CTCAE;"Symptomatic; repair or revision not indicated";Grade 2 Arterial injury;"Symptomatic; repair or revision not indicated";Arterial injury;10003162;LLT;20,1
1764;C145145;Grade 3 Arterial Injury, CTCAE;"Severe symptoms; limiting self care ADL; repair or revision indicated";Grade 3 Arterial injury;"Severe symptoms; limiting self care ADL; repair or revision indicated";Arterial injury;10003162;LLT;20,1
1765;C145752;Grade 4 Arterial Injury, CTCAE;"Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated";Grade 4 Arterial injury;"Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated";Arterial injury;10003162;LLT;20,1
1766;C146222;Grade 5 Arterial Injury, CTCAE;Death;Grade 5 Arterial injury;Death;Arterial injury;10003162;LLT;20,1
1767;C143315;Biliary Anastomotic Leak, CTCAE;A finding of leakage of bile due to breakdown of a biliary anastomosis (surgical connection of two separate anatomic structures).;Biliary anastomotic leak;A finding of leakage of bile due to breakdown of a biliary anastomosis (surgical connection of two separate anatomic structures).;Biliary anastomotic leak;10050458;LLT;20,1
1768;C143996;Grade 1 Biliary Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Biliary anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Biliary anastomotic leak;10050458;LLT;20,1
1769;C144537;Grade 2 Biliary Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Biliary anastomotic leak;"Symptomatic; medical intervention indicated";Biliary anastomotic leak;10050458;LLT;20,1
1770;C145156;Grade 3 Biliary Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Biliary anastomotic leak;"Severe symptoms; invasive intervention indicated";Biliary anastomotic leak;10050458;LLT;20,1
1771;C145761;Grade 4 Biliary Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Biliary anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Biliary anastomotic leak;10050458;LLT;20,1
1772;C146230;Grade 5 Biliary Anastomotic Leak, CTCAE;Death;Grade 5 Biliary anastomotic leak;Death;Biliary anastomotic leak;10050458;LLT;20,1
1773;C143318;Bladder Anastomotic Leak, CTCAE;A finding of leakage of urine due to breakdown of a bladder anastomosis (surgical connection of two separate anatomic structures).;Bladder anastomotic leak;A finding of leakage of urine due to breakdown of a bladder anastomosis (surgical connection of two separate anatomic structures).;Bladder anastomotic leak;10065802;LLT;20,1
1774;C143997;Grade 1 Bladder Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Bladder anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Bladder anastomotic leak;10065802;LLT;20,1
1775;C144540;Grade 2 Bladder Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Bladder anastomotic leak;"Symptomatic; medical intervention indicated";Bladder anastomotic leak;10065802;LLT;20,1
1776;C145159;Grade 3 Bladder Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Bladder anastomotic leak;"Severe symptoms; invasive intervention indicated";Bladder anastomotic leak;10065802;LLT;20,1
1777;C145764;Grade 4 Bladder Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Bladder anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Bladder anastomotic leak;10065802;LLT;20,1
1778;C146233;Grade 5 Bladder Anastomotic Leak, CTCAE;Death;Grade 5 Bladder anastomotic leak;Death;Bladder anastomotic leak;10065802;LLT;20,1
1779;C143345;Bruising, CTCAE;A finding of injury of the soft tissues or bone characterized by leakage of blood into surrounding tissues.;Bruising;A finding of injury of the soft tissues or bone characterized by leakage of blood into surrounding tissues.;Bruising;10006504;LLT;20,1
1780;C144017;Grade 1 Bruising, CTCAE;Localized or in a dependent area;Grade 1 Bruising;Localized or in a dependent area;Bruising;10006504;LLT;20,1
1781;C144562;Grade 2 Bruising, CTCAE;Generalized;Grade 2 Bruising;Generalized;Bruising;10006504;LLT;20,1
1782;C57900;Burn, CTCAE;A finding of impaired integrity to the anatomic site of an adverse thermal reaction. Burns can be caused by exposure to chemicals, direct heat, electricity, flames and radiation. The extent of damage depends on the length and intensity of exposure and time until provision of treatment.;Burn;A finding of impaired integrity to the anatomic site of an adverse thermal reaction. Burns can be caused by exposure to chemicals, direct heat, electricity, flames and radiation. The extent of damage depends on the length and intensity of exposure and time until provision of treatment.;Burn;10006634;LLT;20,1
1783;C57904;Grade 1 Burn, CTCAE;"Minimal symptoms; intervention not indicated";Grade 1 Burn;"Minimal symptoms; intervention not indicated";Burn;10006634;LLT;20,1
1784;C57929;Grade 2 Burn, CTCAE;"Medical intervention; minimal debridement indicated";Grade 2 Burn;"Medical intervention; minimal debridement indicated";Burn;10006634;LLT;20,1
1785;C57955;Grade 3 Burn, CTCAE;Moderate to major debridement or reconstruction indicated;Grade 3 Burn;Moderate to major debridement or reconstruction indicated;Burn;10006634;LLT;20,1
1786;C57975;Grade 4 Burn, CTCAE;Life-threatening consequences;Grade 4 Burn;Life-threatening consequences;Burn;10006634;LLT;20,1
1787;C57985;Grade 5 Burn, CTCAE;Death;Grade 5 Burn;Death;Burn;10006634;LLT;20,1
1788;C143405;Dermatitis Radiation, CTCAE;A finding of cutaneous inflammatory reaction occurring as a result of exposure to biologically effective levels of ionizing radiation.;Dermatitis radiation;A finding of cutaneous inflammatory reaction occurring as a result of exposure to biologically effective levels of ionizing radiation.;Dermatitis radiation;10061103;LLT;20,1
1789;C144052;Grade 1 Dermatitis Radiation, CTCAE;Faint erythema or dry desquamation;Grade 1 Dermatitis radiation;Faint erythema or dry desquamation;Dermatitis radiation;10061103;LLT;20,1
1790;C144605;Grade 2 Dermatitis Radiation, CTCAE;"Moderate to brisk erythema; patchy moist desquamation, mostly confined to skin folds and creases; moderate edema";Grade 2 Dermatitis radiation;"Moderate to brisk erythema; patchy moist desquamation, mostly confined to skin folds and creases; moderate edema";Dermatitis radiation;10061103;LLT;20,1
1791;C145222;Grade 3 Dermatitis Radiation, CTCAE;"Moist desquamation in areas other than skin folds and creases; bleeding induced by minor trauma or abrasion";Grade 3 Dermatitis radiation;"Moist desquamation in areas other than skin folds and creases; bleeding induced by minor trauma or abrasion";Dermatitis radiation;10061103;LLT;20,1
1792;C145817;Grade 4 Dermatitis Radiation, CTCAE;"Life-threatening consequences; skin necrosis or ulceration of full thickness dermis; spontaneous bleeding from involved site; skin graft indicated";Grade 4 Dermatitis radiation;"Life-threatening consequences; skin necrosis or ulceration of full thickness dermis; spontaneous bleeding from involved site; skin graft indicated";Dermatitis radiation;10061103;LLT;20,1
1793;C146277;Grade 5 Dermatitis Radiation, CTCAE;Death;Grade 5 Dermatitis radiation;Death;Dermatitis radiation;10061103;LLT;20,1
1794;C143451;Esophageal Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of an esophageal anastomosis (surgical connection of two separate anatomic structures).;Esophageal anastomotic leak;A finding of leakage due to breakdown of an esophageal anastomosis (surgical connection of two separate anatomic structures).;Esophageal anastomotic leak;10065961;LLT;20,1
1795;C144085;Grade 1 Esophageal Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Esophageal anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Esophageal anastomotic leak;10065961;LLT;20,1
1796;C144642;Grade 2 Esophageal Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Esophageal anastomotic leak;"Symptomatic; medical intervention indicated";Esophageal anastomotic leak;10065961;LLT;20,1
1797;C145261;Grade 3 Esophageal Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Esophageal anastomotic leak;"Severe symptoms; invasive intervention indicated";Esophageal anastomotic leak;10065961;LLT;20,1
1798;C145842;Grade 4 Esophageal Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Esophageal anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Esophageal anastomotic leak;10065961;LLT;20,1
1799;C146300;Grade 5 Esophageal Anastomotic Leak, CTCAE;Death;Grade 5 Esophageal anastomotic leak;Death;Esophageal anastomotic leak;10065961;LLT;20,1
1800;C143475;Fall, CTCAE;A finding of sudden movement downward, usually resulting in injury.;Fall;A finding of sudden movement downward, usually resulting in injury.;Fall;10016173;LLT;20,1
1801;C144099;Grade 1 Fall, CTCAE;"Minor with no resultant injuries; intervention not indicated";Grade 1 Fall;"Minor with no resultant injuries; intervention not indicated";Fall;10016173;LLT;20,1
1802;C144659;Grade 2 Fall, CTCAE;"Symptomatic; noninvasive intervention indicated";Grade 2 Fall;"Symptomatic; noninvasive intervention indicated";Fall;10016173;LLT;20,1
1803;C145279;Grade 3 Fall, CTCAE;"Hospitalization indicated; invasive intervention indicated";Grade 3 Fall;"Hospitalization indicated; invasive intervention indicated";Fall;10016173;LLT;20,1
1804;C143476;Fallopian Tube Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a fallopian tube anastomosis (surgical connection of two separate anatomic structures).;Fallopian tube anastomotic leak;A finding of leakage due to breakdown of a fallopian tube anastomosis (surgical connection of two separate anatomic structures).;Fallopian tube anastomotic leak;10065788;LLT;20,1
1805;C144100;Grade 1 Fallopian Tube Anastomotic Leak, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Fallopian tube anastomotic leak;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Fallopian tube anastomotic leak;10065788;LLT;20,1
1806;C144660;Grade 2 Fallopian Tube Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Fallopian tube anastomotic leak;"Symptomatic; medical intervention indicated";Fallopian tube anastomotic leak;10065788;LLT;20,1
1807;C145280;Grade 3 Fallopian Tube Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Fallopian tube anastomotic leak;"Severe symptoms; invasive intervention indicated";Fallopian tube anastomotic leak;10065788;LLT;20,1
1808;C145855;Grade 4 Fallopian Tube Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Fallopian tube anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Fallopian tube anastomotic leak;10065788;LLT;20,1
1809;C146311;Grade 5 Fallopian Tube Anastomotic Leak, CTCAE;Death;Grade 5 Fallopian tube anastomotic leak;Death;Fallopian tube anastomotic leak;10065788;LLT;20,1
1810;C146714;Fallopian Tube Perforation, CTCAE 5.0;A disorder characterized by a rupture of the fallopian tube wall.;Fallopian tube perforation;A disorder characterized by a rupture of the fallopian tube wall.;Fallopian tube perforation;10065790;LLT;20,1
1811;C56829;Grade 2 Fallopian Tube Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Fallopian tube perforation;Invasive intervention not indicated;Fallopian tube perforation;10065790;LLT;20,1
1812;C56889;Grade 3 Fallopian Tube Perforation, CTCAE;Invasive intervention indicated;Grade 3 Fallopian tube perforation;Invasive intervention indicated;Fallopian tube perforation;10065790;LLT;20,1
1813;C56950;Grade 4 Fallopian Tube Perforation, CTCAE;"Life-threatening consequences; urgent operative intervention indicated (e.g., organ resection)";Grade 4 Fallopian tube perforation;"Life-threatening consequences; urgent operative intervention indicated (e.g., organ resection)";Fallopian tube perforation;10065790;LLT;20,1
1814;C57008;Grade 5 Fallopian Tube Perforation, CTCAE;Death;Grade 5 Fallopian tube perforation;Death;Fallopian tube perforation;10065790;LLT;20,1
1815;C58382;Fracture, CTCAE;A finding of traumatic injury to the bone in which the continuity of the bone is broken.;Fracture;A finding of traumatic injury to the bone in which the continuity of the bone is broken.;Fracture;10017076;LLT;20,1
1816;C58220;Grade 1 Fracture, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Fracture;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Fracture;10017076;LLT;20,1
1817;C58251;Grade 2 Fracture, CTCAE;"Symptomatic but non-displaced; immobilization indicated";Grade 2 Fracture;"Symptomatic but non-displaced; immobilization indicated";Fracture;10017076;LLT;20,1
1818;C58288;Grade 3 Fracture, CTCAE;"Severe symptoms; displaced or open wound with bone exposure; limiting self care ADL; operative intervention indicated";Grade 3 Fracture;"Severe symptoms; displaced or open wound with bone exposure; limiting self care ADL; operative intervention indicated";Fracture;10017076;LLT;20,1
1819;C58323;Grade 4 Fracture, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Fracture;"Life-threatening consequences; urgent intervention indicated";Fracture;10017076;LLT;20,1
1820;C58355;Grade 5 Fracture, CTCAE;Death;Grade 5 Fracture;Death;Fracture;10017076;LLT;20,1
1821;C143498;Gastric Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a gastric anastomosis (surgical connection of two separate anatomic structures).;Gastric anastomotic leak;A finding of leakage due to breakdown of a gastric anastomosis (surgical connection of two separate anatomic structures).;Gastric anastomotic leak;10065893;LLT;20,1
1822;C144114;Grade 1 Gastric Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Gastric anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Gastric anastomotic leak;10065893;LLT;20,1
1823;C144677;Grade 2 Gastric Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Gastric anastomotic leak;"Symptomatic; medical intervention indicated";Gastric anastomotic leak;10065893;LLT;20,1
1824;C145298;Grade 3 Gastric Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Gastric anastomotic leak;"Severe symptoms; invasive intervention indicated";Gastric anastomotic leak;10065893;LLT;20,1
1825;C145863;Grade 4 Gastric Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Gastric anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Gastric anastomotic leak;10065893;LLT;20,1
1826;C146316;Grade 5 Gastric Anastomotic Leak, CTCAE;Death;Grade 5 Gastric anastomotic leak;Death;Gastric anastomotic leak;10065893;LLT;20,1
1827;C143507;Gastrointestinal Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a gastrointestinal anastomosis (surgical connection of two separate anatomic structures).;Gastrointestinal anastomotic leak;A finding of leakage due to breakdown of a gastrointestinal anastomosis (surgical connection of two separate anatomic structures).;Gastrointestinal anastomotic leak;10065879;LLT;20,1
1828;C144120;Grade 1 Gastrointestinal Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Gastrointestinal anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Gastrointestinal anastomotic leak;10065879;LLT;20,1
1829;C144684;Grade 2 Gastrointestinal Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Gastrointestinal anastomotic leak;"Symptomatic; medical intervention indicated";Gastrointestinal anastomotic leak;10065879;LLT;20,1
1830;C145306;Grade 3 Gastrointestinal Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Gastrointestinal anastomotic leak;"Severe symptoms; invasive intervention indicated";Gastrointestinal anastomotic leak;10065879;LLT;20,1
1831;C145870;Grade 4 Gastrointestinal Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Gastrointestinal anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Gastrointestinal anastomotic leak;10065879;LLT;20,1
1832;C146323;Grade 5 Gastrointestinal Anastomotic Leak, CTCAE;Death;Grade 5 Gastrointestinal anastomotic leak;Death;Gastrointestinal anastomotic leak;10065879;LLT;20,1
1833;C143511;Gastrointestinal Stoma Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the gastrointestinal tract stoma.;Gastrointestinal stoma necrosis;A disorder characterized by a necrotic process occurring in the gastrointestinal tract stoma.;Gastrointestinal stoma necrosis;10065712;LLT;20,1
1834;C144688;Grade 2 Gastrointestinal Stoma Necrosis, CTCAE;"Superficial necrosis; intervention not indicated";Grade 2 Gastrointestinal stoma necrosis;"Superficial necrosis; intervention not indicated";Gastrointestinal stoma necrosis;10065712;LLT;20,1
1835;C145310;Grade 3 Gastrointestinal Stoma Necrosis, CTCAE;"Severe symptoms; hospitalization indicated; elective operative intervention indicated";Grade 3 Gastrointestinal stoma necrosis;"Severe symptoms; hospitalization indicated; elective operative intervention indicated";Gastrointestinal stoma necrosis;10065712;LLT;20,1
1836;C145873;Grade 4 Gastrointestinal Stoma Necrosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Gastrointestinal stoma necrosis;"Life-threatening consequences; urgent intervention indicated";Gastrointestinal stoma necrosis;10065712;LLT;20,1
1837;C146326;Grade 5 Gastrointestinal Stoma Necrosis, CTCAE;Death;Grade 5 Gastrointestinal stoma necrosis;Death;Gastrointestinal stoma necrosis;10065712;LLT;20,1
1838;C143546;Hip Fracture, CTCAE;A finding of traumatic injury to the hip in which the continuity of either the femoral head, femoral neck, intertrochanteric or subtrochanteric regions is broken.;Hip fracture;A finding of traumatic injury to the hip in which the continuity of either the femoral head, femoral neck, intertrochanteric or subtrochanteric regions is broken.;Hip fracture;10020100;LLT;20,1
1839;C144719;Grade 2 Hip Fracture, CTCAE;"Hairline fracture; mild pain; limiting instrumental ADL; non-operative intervention indicated";Grade 2 Hip fracture;"Hairline fracture; mild pain; limiting instrumental ADL; non-operative intervention indicated";Hip fracture;10020100;LLT;20,1
1840;C145341;Grade 3 Hip Fracture, CTCAE;"Severe pain; hospitalization or intervention indicated for pain control (e.g., traction); operative intervention indicated";Grade 3 Hip fracture;"Severe pain; hospitalization or intervention indicated for pain control (e.g., traction); operative intervention indicated";Hip fracture;10020100;LLT;20,1
1841;C145896;Grade 4 Hip Fracture, CTCAE;"Life-threatening consequences; symptoms associated with neurovascular compromise";Grade 4 Hip fracture;"Life-threatening consequences; symptoms associated with neurovascular compromise";Hip fracture;10020100;LLT;20,1
1842;C56735;Injury To Inferior Vena Cava, CTCAE;A finding of damage to the inferior vena cava.;Injury to inferior vena cava;A finding of damage to the inferior vena cava.;Injury to inferior vena cava;10022213;LLT;20,1
1843;C56644;Grade 1 Injury To Inferior Vena Cava, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Injury to inferior vena cava;"Asymptomatic diagnostic finding; intervention not indicated";Injury to inferior vena cava;10022213;LLT;20,1
1844;C56659;Grade 2 Injury To Inferior Vena Cava, CTCAE;"Symptomatic; repair or revision not indicated";Grade 2 Injury to inferior vena cava;"Symptomatic; repair or revision not indicated";Injury to inferior vena cava;10022213;LLT;20,1
1845;C56680;Grade 3 Injury To Inferior Vena Cava, CTCAE;"Severe symptoms; limiting self care ADL; repair or revision indicated";Grade 3 Injury to inferior vena cava;"Severe symptoms; limiting self care ADL; repair or revision indicated";Injury to inferior vena cava;10022213;LLT;20,1
1846;C56700;Grade 4 Injury To Inferior Vena Cava, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Injury to inferior vena cava;"Life-threatening consequences; urgent intervention indicated";Injury to inferior vena cava;10022213;LLT;20,1
1847;C56719;Grade 5 Injury To Inferior Vena Cava, CTCAE;Death;Grade 5 Injury to inferior vena cava;Death;Injury to inferior vena cava;10022213;LLT;20,1
1848;C143583;Infusion Related Reaction, CTCAE;A disorder characterized by adverse reaction to the infusion of pharmacological or biological substances.;Infusion related reaction;A disorder characterized by adverse reaction to the infusion of pharmacological or biological substances.;Infusion related reaction;10051792;LLT;20,1
1849;C144195;Grade 1 Infusion Related Reaction, CTCAE;"Mild transient reaction; infusion interruption not indicated; intervention not indicated";Grade 1 Infusion related reaction;"Mild transient reaction; infusion interruption not indicated; intervention not indicated";Infusion related reaction;10051792;LLT;20,1
1850;C144758;Grade 2 Infusion Related Reaction, CTCAE;"Therapy or infusion interruption indicated but responds promptly to symptomatic treatment (e.g., antihistamines, NSAIDS, narcotics, IV fluids); prophylactic medications indicated for <=24 hrs";Grade 2 Infusion related reaction;"Therapy or infusion interruption indicated but responds promptly to symptomatic treatment (e.g., antihistamines, NSAIDS, narcotics, IV fluids); prophylactic medications indicated for <=24 hrs";Infusion related reaction;10051792;LLT;20,1
1851;C145380;Grade 3 Infusion Related Reaction, CTCAE;"Prolonged (e.g., not rapidly responsive to symptomatic medication and/or brief interruption of infusion); recurrence of symptoms following initial improvement; hospitalization indicated for clinical sequelae";Grade 3 Infusion related reaction;"Prolonged (e.g., not rapidly responsive to symptomatic medication and/or brief interruption of infusion); recurrence of symptoms following initial improvement; hospitalization indicated for clinical sequelae";Infusion related reaction;10051792;LLT;20,1
1852;C145929;Grade 4 Infusion Related Reaction, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Infusion related reaction;"Life-threatening consequences; urgent intervention indicated";Infusion related reaction;10051792;LLT;20,1
1853;C146376;Grade 5 Infusion Related Reaction, CTCAE;Death;Grade 5 Infusion related reaction;Death;Infusion related reaction;10051792;LLT;20,1
1854;C143586;Injury To Carotid Artery, CTCAE;A finding of damage to the carotid artery.;Injury to carotid artery;A finding of damage to the carotid artery.;Injury to carotid artery;10022161;LLT;20,1
1855;C144761;Grade 2 Injury To Carotid Artery, CTCAE;Repair or revision not indicated;Grade 2 Injury to carotid artery;Repair or revision not indicated;Injury to carotid artery;10022161;LLT;20,1
1856;C145383;Grade 3 Injury To Carotid Artery, CTCAE;"Severe symptoms; limiting self care ADL (e.g., transient cerebral ischemia); repair or revision indicated";Grade 3 Injury to carotid artery;"Severe symptoms; limiting self care ADL (e.g., transient cerebral ischemia); repair or revision indicated";Injury to carotid artery;10022161;LLT;20,1
1857;C145932;Grade 4 Injury To Carotid Artery, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Injury to carotid artery;"Life-threatening consequences; urgent intervention indicated";Injury to carotid artery;10022161;LLT;20,1
1858;C146379;Grade 5 Injury To Carotid Artery, CTCAE;Death;Grade 5 Injury to carotid artery;Death;Injury to carotid artery;10022161;LLT;20,1
1859;C143587;Injury To Jugular Vein, CTCAE;A finding of damage to the jugular vein.;Injury to jugular vein;A finding of damage to the jugular vein.;Injury to jugular vein;10065849;LLT;20,1
1860;C144763;Grade 2 Injury To Jugular Vein, CTCAE;Repair or revision not indicated;Grade 2 Injury to jugular vein;Repair or revision not indicated;Injury to jugular vein;10065849;LLT;20,1
1861;C145385;Grade 3 Injury To Jugular Vein, CTCAE;"Symptomatic limiting self care ADL; repair or revision indicated";Grade 3 Injury to jugular vein;"Symptomatic limiting self care ADL; repair or revision indicated";Injury to jugular vein;10065849;LLT;20,1
1862;C145934;Grade 4 Injury To Jugular Vein, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Injury to jugular vein;"Life-threatening consequences; urgent intervention indicated";Injury to jugular vein;10065849;LLT;20,1
1863;C146381;Grade 5 Injury To Jugular Vein, CTCAE;Death;Grade 5 Injury to jugular vein;Death;Injury to jugular vein;10065849;LLT;20,1
1864;C143588;Injury To Superior Vena Cava, CTCAE;A finding of damage to the superior vena cava.;Injury to superior vena cava;A finding of damage to the superior vena cava.;Injury to superior vena cava;10022356;LLT;20,1
1865;C144199;Grade 1 Injury To Superior Vena Cava, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Injury to superior vena cava;"Asymptomatic diagnostic finding; intervention not indicated";Injury to superior vena cava;10022356;LLT;20,1
1866;C144764;Grade 2 Injury To Superior Vena Cava, CTCAE;"Symptomatic; repair or revision not indicated";Grade 2 Injury to superior vena cava;"Symptomatic; repair or revision not indicated";Injury to superior vena cava;10022356;LLT;20,1
1867;C145386;Grade 3 Injury To Superior Vena Cava, CTCAE;"Severe symptoms; limiting self care ADL; repair or revision indicated";Grade 3 Injury to superior vena cava;"Severe symptoms; limiting self care ADL; repair or revision indicated";Injury to superior vena cava;10022356;LLT;20,1
1868;C145935;Grade 4 Injury To Superior Vena Cava, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Injury to superior vena cava;"Life-threatening consequences; urgent intervention indicated";Injury to superior vena cava;10022356;LLT;20,1
1869;C146382;Grade 5 Injury To Superior Vena Cava, CTCAE;Death;Grade 5 Injury to superior vena cava;Death;Injury to superior vena cava;10022356;LLT;20,1
1870;C143589;Injury, Poisoning and Procedural Complications - Other, Specify, CTCAE;;Injury, poisoning and procedural complications - Other, specify;;Injury, poisoning and procedural complications - Other, specify;10022117;LLT;20,1
1871;C144200;Grade 1 Injury, Poisoning and Procedural Complications - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Injury, poisoning and procedural complications - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Injury, poisoning and procedural complications - Other, specify;10022117;LLT;20,1
1872;C144765;Grade 2 Injury, Poisoning and Procedural Complications - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Injury, poisoning and procedural complications - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Injury, poisoning and procedural complications - Other, specify;10022117;LLT;20,1
1873;C145387;Grade 3 Injury, Poisoning and Procedural Complications - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Injury, poisoning and procedural complications - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Injury, poisoning and procedural complications - Other, specify;10022117;LLT;20,1
1874;C145936;Grade 4 Injury, Poisoning and Procedural Complications - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Injury, poisoning and procedural complications - Other, specify;"Life-threatening consequences; urgent intervention indicated";Injury, poisoning and procedural complications - Other, specify;10022117;LLT;20,1
1875;C146383;Grade 5 Injury, Poisoning and Procedural Complications - Other, Specify, CTCAE;Death;Grade 5 Injury, poisoning and procedural complications - Other, specify;Death;Injury, poisoning and procedural complications - Other, specify;10022117;LLT;20,1
1876;C143592;Intestinal Stoma Leak, CTCAE;A finding of leakage of contents from an intestinal stoma (surgically created opening on the surface of the body).;Intestinal stoma leak;A finding of leakage of contents from an intestinal stoma (surgically created opening on the surface of the body).;Intestinal stoma leak;10059095;LLT;20,1
1877;C144202;Grade 1 Intestinal Stoma Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Intestinal stoma leak;"Asymptomatic diagnostic finding; intervention not indicated";Intestinal stoma leak;10059095;LLT;20,1
1878;C144767;Grade 2 Intestinal Stoma Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Intestinal stoma leak;"Symptomatic; medical intervention indicated";Intestinal stoma leak;10059095;LLT;20,1
1879;C145389;Grade 3 Intestinal Stoma Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Intestinal stoma leak;"Severe symptoms; invasive intervention indicated";Intestinal stoma leak;10059095;LLT;20,1
1880;C145937;Grade 4 Intestinal Stoma Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Intestinal stoma leak;"Life-threatening consequences; urgent operative intervention indicated";Intestinal stoma leak;10059095;LLT;20,1
1881;C146384;Grade 5 Intestinal Stoma Leak, CTCAE;Death;Grade 5 Intestinal stoma leak;Death;Intestinal stoma leak;10059095;LLT;20,1
1882;C143593;Intestinal Stoma Obstruction, CTCAE;A disorder characterized by blockage of the normal flow of the contents of the intestinal stoma.;Intestinal stoma obstruction;A disorder characterized by blockage of the normal flow of the contents of the intestinal stoma.;Intestinal stoma obstruction;10059094;LLT;20,1
1883;C144768;Grade 2 Intestinal Stoma Obstruction, CTCAE;"Self-limited; intervention not indicated";Grade 2 Intestinal stoma obstruction;"Self-limited; intervention not indicated";Intestinal stoma obstruction;10059094;LLT;20,1
1884;C145390;Grade 3 Intestinal Stoma Obstruction, CTCAE;"Severe symptoms; IV fluids, tube feeding, or TPN indicated >=24 hrs; elective operative intervention indicated";Grade 3 Intestinal stoma obstruction;"Severe symptoms; IV fluids, tube feeding, or TPN indicated >=24 hrs; elective operative intervention indicated";Intestinal stoma obstruction;10059094;LLT;20,1
1885;C145938;Grade 4 Intestinal Stoma Obstruction, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Intestinal stoma obstruction;"Life-threatening consequences; urgent operative intervention indicated";Intestinal stoma obstruction;10059094;LLT;20,1
1886;C146385;Grade 5 Intestinal Stoma Obstruction, CTCAE;Death;Grade 5 Intestinal stoma obstruction;Death;Intestinal stoma obstruction;10059094;LLT;20,1
1887;C143594;Intestinal Stoma Site Bleeding, CTCAE;A disorder characterized by bleeding from the intestinal stoma.;Intestinal stoma site bleeding;A disorder characterized by bleeding from the intestinal stoma.;Intestinal stoma site bleeding;10049468;LLT;20,1
1888;C144203;Grade 1 Intestinal Stoma Site Bleeding, CTCAE;"Minimal bleeding identified on clinical exam; intervention not indicated";Grade 1 Intestinal stoma site bleeding;"Minimal bleeding identified on clinical exam; intervention not indicated";Intestinal stoma site bleeding;10049468;LLT;20,1
1889;C144769;Grade 2 Intestinal Stoma Site Bleeding, CTCAE;"Moderate bleeding; medical intervention indicated";Grade 2 Intestinal stoma site bleeding;"Moderate bleeding; medical intervention indicated";Intestinal stoma site bleeding;10049468;LLT;20,1
1890;C145391;Grade 3 Intestinal Stoma Site Bleeding, CTCAE;"Transfusion indicated; invasive intervention indicated";Grade 3 Intestinal stoma site bleeding;"Transfusion indicated; invasive intervention indicated";Intestinal stoma site bleeding;10049468;LLT;20,1
1891;C145939;Grade 4 Intestinal Stoma Site Bleeding, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intestinal stoma site bleeding;"Life-threatening consequences; urgent intervention indicated";Intestinal stoma site bleeding;10049468;LLT;20,1
1892;C146386;Grade 5 Intestinal Stoma Site Bleeding, CTCAE;Death;Grade 5 Intestinal stoma site bleeding;Death;Intestinal stoma site bleeding;10049468;LLT;20,1
1893;C143597;Intraoperative Arterial Injury, CTCAE;A finding of damage to an artery during a surgical procedure.;Intraoperative arterial injury;A finding of damage to an artery during a surgical procedure.;Intraoperative arterial injury;10065826;LLT;20,1
1894;C144205;Grade 1 Intraoperative Arterial Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative arterial injury;Primary repair of injured organ/structure indicated;Intraoperative arterial injury;10065826;LLT;20,1
1895;C144772;Grade 2 Intraoperative Arterial Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative arterial injury;Partial resection of injured organ/structure indicated;Intraoperative arterial injury;10065826;LLT;20,1
1896;C145394;Grade 3 Intraoperative Arterial Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative arterial injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative arterial injury;10065826;LLT;20,1
1897;C145942;Grade 4 Intraoperative Arterial Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative arterial injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative arterial injury;10065826;LLT;20,1
1898;C146389;Grade 5 Intraoperative Arterial Injury, CTCAE;Death;Grade 5 Intraoperative arterial injury;Death;Intraoperative arterial injury;10065826;LLT;20,1
1899;C143598;Intraoperative Breast Injury, CTCAE;A finding of damage to the breast parenchyma during a surgical procedure.;Intraoperative breast injury;A finding of damage to the breast parenchyma during a surgical procedure.;Intraoperative breast injury;10065831;LLT;20,1
1900;C144206;Grade 1 Intraoperative Breast Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative breast injury;Primary repair of injured organ/structure indicated;Intraoperative breast injury;10065831;LLT;20,1
1901;C144773;Grade 2 Intraoperative Breast Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative breast injury;Partial resection of injured organ/structure indicated;Intraoperative breast injury;10065831;LLT;20,1
1902;C145395;Grade 3 Intraoperative Breast Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative breast injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative breast injury;10065831;LLT;20,1
1903;C145943;Grade 4 Intraoperative Breast Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative breast injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative breast injury;10065831;LLT;20,1
1904;C146390;Grade 5 Intraoperative Breast Injury, CTCAE;Death;Grade 5 Intraoperative breast injury;Death;Intraoperative breast injury;10065831;LLT;20,1
1905;C143599;Intraoperative Cardiac Injury, CTCAE;A finding of damage to the heart during a surgical procedure.;Intraoperative cardiac injury;A finding of damage to the heart during a surgical procedure.;Intraoperative cardiac injury;10065843;LLT;20,1
1906;C145396;Grade 3 Intraoperative Cardiac Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 3 Intraoperative cardiac injury;Primary repair of injured organ/structure indicated;Intraoperative cardiac injury;10065843;LLT;20,1
1907;C145944;Grade 4 Intraoperative Cardiac Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative cardiac injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative cardiac injury;10065843;LLT;20,1
1908;C146391;Grade 5 Intraoperative Cardiac Injury, CTCAE;Death;Grade 5 Intraoperative cardiac injury;Death;Intraoperative cardiac injury;10065843;LLT;20,1
1909;C143600;Intraoperative Ear Injury, CTCAE;A finding of damage to the ear during a surgical procedure.;Intraoperative ear injury;A finding of damage to the ear during a surgical procedure.;Intraoperative ear injury;10065844;LLT;20,1
1910;C144207;Grade 1 Intraoperative Ear Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative ear injury;Primary repair of injured organ/structure indicated;Intraoperative ear injury;10065844;LLT;20,1
1911;C144774;Grade 2 Intraoperative Ear Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative ear injury;Partial resection of injured organ/structure indicated;Intraoperative ear injury;10065844;LLT;20,1
1912;C145397;Grade 3 Intraoperative Ear Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL (e.g., impaired hearing; impaired balance)";Grade 3 Intraoperative ear injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL (e.g., impaired hearing; impaired balance)";Intraoperative ear injury;10065844;LLT;20,1
1913;C145945;Grade 4 Intraoperative Ear Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative ear injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative ear injury;10065844;LLT;20,1
1914;C146392;Grade 5 Intraoperative Ear Injury, CTCAE;Death;Grade 5 Intraoperative ear injury;Death;Intraoperative ear injury;10065844;LLT;20,1
1915;C143601;Intraoperative Endocrine Injury, CTCAE;A finding of damage to the endocrine gland during a surgical procedure.;Intraoperative endocrine injury;A finding of damage to the endocrine gland during a surgical procedure.;Intraoperative endocrine injury;10065834;LLT;20,1
1916;C144208;Grade 1 Intraoperative Endocrine Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative endocrine injury;Primary repair of injured organ/structure indicated;Intraoperative endocrine injury;10065834;LLT;20,1
1917;C144775;Grade 2 Intraoperative Endocrine Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative endocrine injury;Partial resection of injured organ/structure indicated;Intraoperative endocrine injury;10065834;LLT;20,1
1918;C145398;Grade 3 Intraoperative Endocrine Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative endocrine injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative endocrine injury;10065834;LLT;20,1
1919;C145946;Grade 4 Intraoperative Endocrine Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative endocrine injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative endocrine injury;10065834;LLT;20,1
1920;C146393;Grade 5 Intraoperative Endocrine Injury, CTCAE;Death;Grade 5 Intraoperative endocrine injury;Death;Intraoperative endocrine injury;10065834;LLT;20,1
1921;C143602;Intraoperative Gastrointestinal Injury, CTCAE;A finding of damage to the gastrointestinal system during a surgical procedure.;Intraoperative gastrointestinal injury;A finding of damage to the gastrointestinal system during a surgical procedure.;Intraoperative gastrointestinal injury;10065825;LLT;20,1
1922;C144209;Grade 1 Intraoperative Gastrointestinal Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative gastrointestinal injury;Primary repair of injured organ/structure indicated;Intraoperative gastrointestinal injury;10065825;LLT;20,1
1923;C144776;Grade 2 Intraoperative Gastrointestinal Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative gastrointestinal injury;Partial resection of injured organ/structure indicated;Intraoperative gastrointestinal injury;10065825;LLT;20,1
1924;C145399;Grade 3 Intraoperative Gastrointestinal Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative gastrointestinal injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative gastrointestinal injury;10065825;LLT;20,1
1925;C145947;Grade 4 Intraoperative Gastrointestinal Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative gastrointestinal injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative gastrointestinal injury;10065825;LLT;20,1
1926;C146394;Grade 5 Intraoperative Gastrointestinal Injury, CTCAE;Death;Grade 5 Intraoperative gastrointestinal injury;Death;Intraoperative gastrointestinal injury;10065825;LLT;20,1
1927;C143603;Intraoperative Head and Neck Injury, CTCAE;A finding of damage to the head and neck during a surgical procedure.;Intraoperative head and neck injury;A finding of damage to the head and neck during a surgical procedure.;Intraoperative head and neck injury;10065842;LLT;20,1
1928;C144210;Grade 1 Intraoperative Head and Neck Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative head and neck injury;Primary repair of injured organ/structure indicated;Intraoperative head and neck injury;10065842;LLT;20,1
1929;C144777;Grade 2 Intraoperative Head and Neck Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative head and neck injury;Partial resection of injured organ/structure indicated;Intraoperative head and neck injury;10065842;LLT;20,1
1930;C145400;Grade 3 Intraoperative Head and Neck Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative head and neck injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative head and neck injury;10065842;LLT;20,1
1931;C145948;Grade 4 Intraoperative Head and Neck Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative head and neck injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative head and neck injury;10065842;LLT;20,1
1932;C146395;Grade 5 Intraoperative Head and Neck Injury, CTCAE;Death;Grade 5 Intraoperative head and neck injury;Death;Intraoperative head and neck injury;10065842;LLT;20,1
1933;C143604;Intraoperative Hemorrhage, CTCAE;A finding of uncontrolled bleeding during a surgical procedure.;Intraoperative hemorrhage;A finding of uncontrolled bleeding during a surgical procedure.;Intraoperative hemorrhage;10055298;LLT;20,1
1934;C145401;Grade 3 Intraoperative Hemorrhage, CTCAE;"Postoperative invasive intervention indicated; hospitalization";Grade 3 Intraoperative hemorrhage;"Postoperative invasive intervention indicated; hospitalization";Intraoperative hemorrhage;10055298;LLT;20,1
1935;C145949;Grade 4 Intraoperative Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative hemorrhage;"Life-threatening consequences; urgent intervention indicated";Intraoperative hemorrhage;10055298;LLT;20,1
1936;C146396;Grade 5 Intraoperative Hemorrhage, CTCAE;Death;Grade 5 Intraoperative hemorrhage;Death;Intraoperative hemorrhage;10055298;LLT;20,1
1937;C143605;Intraoperative Hepatobiliary Injury, CTCAE;A finding of damage to the hepatic parenchyma and/or biliary tract during a surgical procedure.;Intraoperative hepatobiliary injury;A finding of damage to the hepatic parenchyma and/or biliary tract during a surgical procedure.;Intraoperative hepatobiliary injury;10065827;LLT;20,1
1938;C144211;Grade 1 Intraoperative Hepatobiliary Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative hepatobiliary injury;Primary repair of injured organ/structure indicated;Intraoperative hepatobiliary injury;10065827;LLT;20,1
1939;C144778;Grade 2 Intraoperative Hepatobiliary Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative hepatobiliary injury;Partial resection of injured organ/structure indicated;Intraoperative hepatobiliary injury;10065827;LLT;20,1
1940;C145402;Grade 3 Intraoperative Hepatobiliary Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative hepatobiliary injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative hepatobiliary injury;10065827;LLT;20,1
1941;C145950;Grade 4 Intraoperative Hepatobiliary Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative hepatobiliary injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative hepatobiliary injury;10065827;LLT;20,1
1942;C146397;Grade 5 Intraoperative Hepatobiliary Injury, CTCAE;Death;Grade 5 Intraoperative hepatobiliary injury;Death;Intraoperative hepatobiliary injury;10065827;LLT;20,1
1943;C143606;Intraoperative Musculoskeletal Injury, CTCAE;A finding of damage to the musculoskeletal system during a surgical procedure.;Intraoperative musculoskeletal injury;A finding of damage to the musculoskeletal system during a surgical procedure.;Intraoperative musculoskeletal injury;10065829;LLT;20,1
1944;C144212;Grade 1 Intraoperative Musculoskeletal Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative musculoskeletal injury;Primary repair of injured organ/structure indicated;Intraoperative musculoskeletal injury;10065829;LLT;20,1
1945;C144779;Grade 2 Intraoperative Musculoskeletal Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative musculoskeletal injury;Partial resection of injured organ/structure indicated;Intraoperative musculoskeletal injury;10065829;LLT;20,1
1946;C145403;Grade 3 Intraoperative Musculoskeletal Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative musculoskeletal injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative musculoskeletal injury;10065829;LLT;20,1
1947;C145951;Grade 4 Intraoperative Musculoskeletal Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative musculoskeletal injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative musculoskeletal injury;10065829;LLT;20,1
1948;C146398;Grade 5 Intraoperative Musculoskeletal Injury, CTCAE;Death;Grade 5 Intraoperative musculoskeletal injury;Death;Intraoperative musculoskeletal injury;10065829;LLT;20,1
1949;C143607;Intraoperative Neurological Injury, CTCAE;A finding of damage to the nervous system during a surgical procedure.;Intraoperative neurological injury;A finding of damage to the nervous system during a surgical procedure.;Intraoperative neurological injury;10065830;LLT;20,1
1950;C144213;Grade 1 Intraoperative Neurological Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative neurological injury;Primary repair of injured organ/structure indicated;Intraoperative neurological injury;10065830;LLT;20,1
1951;C144780;Grade 2 Intraoperative Neurological Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative neurological injury;Partial resection of injured organ/structure indicated;Intraoperative neurological injury;10065830;LLT;20,1
1952;C145404;Grade 3 Intraoperative Neurological Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative neurological injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative neurological injury;10065830;LLT;20,1
1953;C145952;Grade 4 Intraoperative Neurological Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative neurological injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative neurological injury;10065830;LLT;20,1
1954;C146399;Grade 5 Intraoperative Neurological Injury, CTCAE;Death;Grade 5 Intraoperative neurological injury;Death;Intraoperative neurological injury;10065830;LLT;20,1
1955;C143608;Intraoperative Ocular Injury, CTCAE;A finding of damage to the eye during a surgical procedure.;Intraoperative ocular injury;A finding of damage to the eye during a surgical procedure.;Intraoperative ocular injury;10065841;LLT;20,1
1956;C144214;Grade 1 Intraoperative Ocular Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative ocular injury;Primary repair of injured organ/structure indicated;Intraoperative ocular injury;10065841;LLT;20,1
1957;C144781;Grade 2 Intraoperative Ocular Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative ocular injury;Partial resection of injured organ/structure indicated;Intraoperative ocular injury;10065841;LLT;20,1
1958;C145405;Grade 3 Intraoperative Ocular Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative ocular injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative ocular injury;10065841;LLT;20,1
1959;C145953;Grade 4 Intraoperative Ocular Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative ocular injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative ocular injury;10065841;LLT;20,1
1960;C146400;Grade 5 Intraoperative Ocular Injury, CTCAE;Death;Grade 5 Intraoperative ocular injury;Death;Intraoperative ocular injury;10065841;LLT;20,1
1961;C143609;Intraoperative Renal Injury, CTCAE;A finding of damage to the kidney during a surgical procedure.;Intraoperative renal injury;A finding of damage to the kidney during a surgical procedure.;Intraoperative renal injury;10065845;LLT;20,1
1962;C144215;Grade 1 Intraoperative Renal Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative renal injury;Primary repair of injured organ/structure indicated;Intraoperative renal injury;10065845;LLT;20,1
1963;C144782;Grade 2 Intraoperative Renal Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative renal injury;Partial resection of injured organ/structure indicated;Intraoperative renal injury;10065845;LLT;20,1
1964;C145406;Grade 3 Intraoperative Renal Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative renal injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative renal injury;10065845;LLT;20,1
1965;C145954;Grade 4 Intraoperative Renal Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative renal injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative renal injury;10065845;LLT;20,1
1966;C146401;Grade 5 Intraoperative Renal Injury, CTCAE;Death;Grade 5 Intraoperative renal injury;Death;Intraoperative renal injury;10065845;LLT;20,1
1967;C143610;Intraoperative Reproductive Tract Injury, CTCAE;A finding of damage to the reproductive organs during a surgical procedure.;Intraoperative reproductive tract injury;A finding of damage to the reproductive organs during a surgical procedure.;Intraoperative reproductive tract injury;10065840;LLT;20,1
1968;C144216;Grade 1 Intraoperative Reproductive Tract Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative reproductive tract injury;Primary repair of injured organ/structure indicated;Intraoperative reproductive tract injury;10065840;LLT;20,1
1969;C144783;Grade 2 Intraoperative Reproductive Tract Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative reproductive tract injury;Partial resection of injured organ/structure indicated;Intraoperative reproductive tract injury;10065840;LLT;20,1
1970;C145407;Grade 3 Intraoperative Reproductive Tract Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative reproductive tract injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative reproductive tract injury;10065840;LLT;20,1
1971;C145955;Grade 4 Intraoperative Reproductive Tract Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative reproductive tract injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative reproductive tract injury;10065840;LLT;20,1
1972;C146402;Grade 5 Intraoperative Reproductive Tract Injury, CTCAE;Death;Grade 5 Intraoperative reproductive tract injury;Death;Intraoperative reproductive tract injury;10065840;LLT;20,1
1973;C143611;Intraoperative Respiratory Injury, CTCAE;A finding of damage to the respiratory system during a surgical procedure.;Intraoperative respiratory injury;A finding of damage to the respiratory system during a surgical procedure.;Intraoperative respiratory injury;10065832;LLT;20,1
1974;C144217;Grade 1 Intraoperative Respiratory Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative respiratory injury;Primary repair of injured organ/structure indicated;Intraoperative respiratory injury;10065832;LLT;20,1
1975;C144784;Grade 2 Intraoperative Respiratory Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative respiratory injury;Partial resection of injured organ/structure indicated;Intraoperative respiratory injury;10065832;LLT;20,1
1976;C145408;Grade 3 Intraoperative Respiratory Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative respiratory injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative respiratory injury;10065832;LLT;20,1
1977;C145956;Grade 4 Intraoperative Respiratory Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative respiratory injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative respiratory injury;10065832;LLT;20,1
1978;C146403;Grade 5 Intraoperative Respiratory Injury, CTCAE;Death;Grade 5 Intraoperative respiratory injury;Death;Intraoperative respiratory injury;10065832;LLT;20,1
1979;C143612;Intraoperative Splenic Injury, CTCAE;A finding of damage to the spleen during a surgical procedure.;Intraoperative splenic injury;A finding of damage to the spleen during a surgical procedure.;Intraoperative splenic injury;10065847;LLT;20,1
1980;C144785;Grade 2 Intraoperative Splenic Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 2 Intraoperative splenic injury;Primary repair of injured organ/structure indicated;Intraoperative splenic injury;10065847;LLT;20,1
1981;C145409;Grade 3 Intraoperative Splenic Injury, CTCAE;"Resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative splenic injury;"Resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative splenic injury;10065847;LLT;20,1
1982;C145957;Grade 4 Intraoperative Splenic Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative splenic injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative splenic injury;10065847;LLT;20,1
1983;C146404;Grade 5 Intraoperative Splenic Injury, CTCAE;Death;Grade 5 Intraoperative splenic injury;Death;Intraoperative splenic injury;10065847;LLT;20,1
1984;C143613;Intraoperative Urinary Injury, CTCAE;A finding of damage to the urinary system during a surgical procedure.;Intraoperative urinary injury;A finding of damage to the urinary system during a surgical procedure.;Intraoperative urinary injury;10065828;LLT;20,1
1985;C144218;Grade 1 Intraoperative Urinary Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative urinary injury;Primary repair of injured organ/structure indicated;Intraoperative urinary injury;10065828;LLT;20,1
1986;C144786;Grade 2 Intraoperative Urinary Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative urinary injury;Partial resection of injured organ/structure indicated;Intraoperative urinary injury;10065828;LLT;20,1
1987;C145410;Grade 3 Intraoperative Urinary Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative urinary injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative urinary injury;10065828;LLT;20,1
1988;C145958;Grade 4 Intraoperative Urinary Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative urinary injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative urinary injury;10065828;LLT;20,1
1989;C146405;Grade 5 Intraoperative Urinary Injury, CTCAE;Death;Grade 5 Intraoperative urinary injury;Death;Intraoperative urinary injury;10065828;LLT;20,1
1990;C143614;Intraoperative Venous Injury, CTCAE;A finding of damage to a vein during a surgical procedure.;Intraoperative venous injury;A finding of damage to a vein during a surgical procedure.;Intraoperative venous injury;10065848;LLT;20,1
1991;C144219;Grade 1 Intraoperative Venous Injury, CTCAE;Primary repair of injured organ/structure indicated;Grade 1 Intraoperative venous injury;Primary repair of injured organ/structure indicated;Intraoperative venous injury;10065848;LLT;20,1
1992;C144787;Grade 2 Intraoperative Venous Injury, CTCAE;Partial resection of injured organ/structure indicated;Grade 2 Intraoperative venous injury;Partial resection of injured organ/structure indicated;Intraoperative venous injury;10065848;LLT;20,1
1993;C145411;Grade 3 Intraoperative Venous Injury, CTCAE;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Grade 3 Intraoperative venous injury;"Complete resection or reconstruction of injured organ/structure indicated; limiting self care ADL";Intraoperative venous injury;10065848;LLT;20,1
1994;C145959;Grade 4 Intraoperative Venous Injury, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intraoperative venous injury;"Life-threatening consequences; urgent intervention indicated";Intraoperative venous injury;10065848;LLT;20,1
1995;C146406;Grade 5 Intraoperative Venous Injury, CTCAE;Death;Grade 5 Intraoperative venous injury;Death;Intraoperative venous injury;10065848;LLT;20,1
1996;C143631;Kidney Anastomotic Leak, CTCAE;A finding of leakage of urine due to breakdown of a kidney anastomosis (surgical connection of two separate anatomic structures).;Kidney anastomotic leak;A finding of leakage of urine due to breakdown of a kidney anastomosis (surgical connection of two separate anatomic structures).;Kidney anastomotic leak;10065803;LLT;20,1
1997;C144232;Grade 1 Kidney Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Kidney anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Kidney anastomotic leak;10065803;LLT;20,1
1998;C144802;Grade 2 Kidney Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Kidney anastomotic leak;"Symptomatic; medical intervention indicated";Kidney anastomotic leak;10065803;LLT;20,1
1999;C145424;Grade 3 Kidney Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Kidney anastomotic leak;"Severe symptoms; invasive intervention indicated";Kidney anastomotic leak;10065803;LLT;20,1
2000;C145968;Grade 4 Kidney Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Kidney anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Kidney anastomotic leak;10065803;LLT;20,1
2001;C146415;Grade 5 Kidney Anastomotic Leak, CTCAE;Death;Grade 5 Kidney anastomotic leak;Death;Kidney anastomotic leak;10065803;LLT;20,1
2002;C143635;Large Intestinal Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of an anastomosis (surgical connection of two separate anatomic structures) in the large intestine.;Large intestinal anastomotic leak;A finding of leakage due to breakdown of an anastomosis (surgical connection of two separate anatomic structures) in the large intestine.;Large intestinal anastomotic leak;10065891;LLT;20,1
2003;C144235;Grade 1 Large Intestinal Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Large intestinal anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Large intestinal anastomotic leak;10065891;LLT;20,1
2004;C144806;Grade 2 Large Intestinal Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Large intestinal anastomotic leak;"Symptomatic; medical intervention indicated";Large intestinal anastomotic leak;10065891;LLT;20,1
2005;C145427;Grade 3 Large Intestinal Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Large intestinal anastomotic leak;"Severe symptoms; invasive intervention indicated";Large intestinal anastomotic leak;10065891;LLT;20,1
2006;C145970;Grade 4 Large Intestinal Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Large intestinal anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Large intestinal anastomotic leak;10065891;LLT;20,1
2007;C146417;Grade 5 Large Intestinal Anastomotic Leak, CTCAE;Death;Grade 5 Large intestinal anastomotic leak;Death;Large intestinal anastomotic leak;10065891;LLT;20,1
2008;C143729;Pancreatic Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a pancreatic anastomosis (surgical connection of two separate anatomic structures).;Pancreatic anastomotic leak;A finding of leakage due to breakdown of a pancreatic anastomosis (surgical connection of two separate anatomic structures).;Pancreatic anastomotic leak;10050457;LLT;20,1
2009;C144311;Grade 1 Pancreatic Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Pancreatic anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Pancreatic anastomotic leak;10050457;LLT;20,1
2010;C144890;Grade 2 Pancreatic Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Pancreatic anastomotic leak;"Symptomatic; medical intervention indicated";Pancreatic anastomotic leak;10050457;LLT;20,1
2011;C145511;Grade 3 Pancreatic Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Pancreatic anastomotic leak;"Severe symptoms; invasive intervention indicated";Pancreatic anastomotic leak;10050457;LLT;20,1
2012;C146026;Grade 4 Pancreatic Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Pancreatic anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Pancreatic anastomotic leak;10050457;LLT;20,1
2013;C146467;Grade 5 Pancreatic Anastomotic Leak, CTCAE;Death;Grade 5 Pancreatic anastomotic leak;Death;Pancreatic anastomotic leak;10050457;LLT;20,1
2014;C143755;Pharyngeal Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a pharyngeal anastomosis (surgical connection of two separate anatomic structures).;Pharyngeal anastomotic leak;A finding of leakage due to breakdown of a pharyngeal anastomosis (surgical connection of two separate anatomic structures).;Pharyngeal anastomotic leak;10065705;LLT;20,1
2015;C144331;Grade 1 Pharyngeal Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Pharyngeal anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Pharyngeal anastomotic leak;10065705;LLT;20,1
2016;C144915;Grade 2 Pharyngeal Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Pharyngeal anastomotic leak;"Symptomatic; medical intervention indicated";Pharyngeal anastomotic leak;10065705;LLT;20,1
2017;C145540;Grade 3 Pharyngeal Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Pharyngeal anastomotic leak;"Severe symptoms; invasive intervention indicated";Pharyngeal anastomotic leak;10065705;LLT;20,1
2018;C146047;Grade 4 Pharyngeal Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Pharyngeal anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Pharyngeal anastomotic leak;10065705;LLT;20,1
2019;C146485;Grade 5 Pharyngeal Anastomotic Leak, CTCAE;Death;Grade 5 Pharyngeal anastomotic leak;Death;Pharyngeal anastomotic leak;10065705;LLT;20,1
2020;C143772;Postoperative Hemorrhage, CTCAE;A disorder characterized by bleeding occurring after a surgical procedure.;Postoperative hemorrhage;A disorder characterized by bleeding occurring after a surgical procedure.;Postoperative hemorrhage;10055322;LLT;20,1
2021;C144344;Grade 1 Postoperative Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Postoperative hemorrhage;"Mild symptoms; intervention not indicated";Postoperative hemorrhage;10055322;LLT;20,1
2022;C144933;Grade 2 Postoperative Hemorrhage, CTCAE;Moderate bleeding requiring transfusion < 2 units (10 cc/kg for pediatrics) of pRBCs;Grade 2 Postoperative hemorrhage;Moderate bleeding requiring transfusion < 2 units (10 cc/kg for pediatrics) of pRBCs;Postoperative hemorrhage;10055322;LLT;20,1
2023;C145557;Grade 3 Postoperative Hemorrhage, CTCAE;"Transfusion indicated of >=2 units (10 cc/kg for pediatrics) pRBCs; invasive intervention indicated; hospitalization";Grade 3 Postoperative hemorrhage;"Transfusion indicated of >=2 units (10 cc/kg for pediatrics) pRBCs; invasive intervention indicated; hospitalization";Postoperative hemorrhage;10055322;LLT;20,1
2024;C146062;Grade 4 Postoperative Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Postoperative hemorrhage;"Life-threatening consequences; urgent intervention indicated";Postoperative hemorrhage;10055322;LLT;20,1
2025;C146499;Grade 5 Postoperative Hemorrhage, CTCAE;Death;Grade 5 Postoperative hemorrhage;Death;Postoperative hemorrhage;10055322;LLT;20,1
2026;C143773;Postoperative Thoracic Procedure Complication, CTCAE;A finding of a previously undocumented problem that occurs after a thoracic procedure.;Postoperative thoracic procedure complication;A finding of a previously undocumented problem that occurs after a thoracic procedure.;Postoperative thoracic procedure complication;10056745;LLT;20,1
2027;C144934;Grade 2 Postoperative Thoracic Procedure Complication, CTCAE;Extubated within 24-72 hrs postoperatively;Grade 2 Postoperative thoracic procedure complication;Extubated within 24-72 hrs postoperatively;Postoperative thoracic procedure complication;10056745;LLT;20,1
2028;C145558;Grade 3 Postoperative Thoracic Procedure Complication, CTCAE;Extubated >72 hrs postoperatively, but before tracheostomy indicated;Grade 3 Postoperative thoracic procedure complication;Extubated >72 hrs postoperatively, but before tracheostomy indicated;Postoperative thoracic procedure complication;10056745;LLT;20,1
2029;C146063;Grade 4 Postoperative Thoracic Procedure Complication, CTCAE;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Postoperative thoracic procedure complication;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Postoperative thoracic procedure complication;10056745;LLT;20,1
2030;C146500;Grade 5 Postoperative Thoracic Procedure Complication, CTCAE;Death;Grade 5 Postoperative thoracic procedure complication;Death;Postoperative thoracic procedure complication;10056745;LLT;20,1
2031;C143781;Prolapse of Intestinal Stoma, CTCAE;A finding of protrusion of the intestinal stoma (surgically created opening on the surface of the body) above the abdominal surface.;Prolapse of intestinal stoma;A finding of protrusion of the intestinal stoma (surgically created opening on the surface of the body) above the abdominal surface.;Prolapse of intestinal stoma;10065745;LLT;20,1
2032;C144349;Grade 1 Prolapse of Intestinal Stoma, CTCAE;"Asymptomatic; reducible";Grade 1 Prolapse of intestinal stoma;"Asymptomatic; reducible";Prolapse of intestinal stoma;10065745;LLT;20,1
2033;C144940;Grade 2 Prolapse of Intestinal Stoma, CTCAE;"Recurrent after manual reduction; local irritation or stool leakage; difficulty to fit appliance; limiting instrumental ADL";Grade 2 Prolapse of intestinal stoma;"Recurrent after manual reduction; local irritation or stool leakage; difficulty to fit appliance; limiting instrumental ADL";Prolapse of intestinal stoma;10065745;LLT;20,1
2034;C145562;Grade 3 Prolapse of Intestinal Stoma, CTCAE;"Severe symptoms; elective operative intervention indicated; limiting self care ADL";Grade 3 Prolapse of intestinal stoma;"Severe symptoms; elective operative intervention indicated; limiting self care ADL";Prolapse of intestinal stoma;10065745;LLT;20,1
2035;C146067;Grade 4 Prolapse of Intestinal Stoma, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Prolapse of intestinal stoma;"Life-threatening consequences; urgent operative intervention indicated";Prolapse of intestinal stoma;10065745;LLT;20,1
2036;C146502;Grade 5 Prolapse of Intestinal Stoma, CTCAE;Death;Grade 5 Prolapse of intestinal stoma;Death;Prolapse of intestinal stoma;10065745;LLT;20,1
2037;C143782;Prolapse of Urostomy, CTCAE;A finding of displacement of the urostomy.;Prolapse of urostomy;A finding of displacement of the urostomy.;Prolapse of urostomy;10065822;LLT;20,1
2038;C144350;Grade 1 Prolapse of Urostomy, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Prolapse of urostomy;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Prolapse of urostomy;10065822;LLT;20,1
2039;C144941;Grade 2 Prolapse of Urostomy, CTCAE;"Local care or maintenance; minor revision indicated";Grade 2 Prolapse of urostomy;"Local care or maintenance; minor revision indicated";Prolapse of urostomy;10065822;LLT;20,1
2040;C145563;Grade 3 Prolapse of Urostomy, CTCAE;"Dysfunctional stoma; elective operative intervention or major stomal revision indicated";Grade 3 Prolapse of urostomy;"Dysfunctional stoma; elective operative intervention or major stomal revision indicated";Prolapse of urostomy;10065822;LLT;20,1
2041;C146068;Grade 4 Prolapse of Urostomy, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Prolapse of urostomy;"Life-threatening consequences; urgent intervention indicated";Prolapse of urostomy;10065822;LLT;20,1
2042;C146503;Grade 5 Prolapse of Urostomy, CTCAE;Death;Grade 5 Prolapse of urostomy;Death;Prolapse of urostomy;10065822;LLT;20,1
2043;C143796;Radiation Recall Reaction (Dermatologic), CTCAE;A finding of acute skin inflammatory reaction caused by drugs, especially chemotherapeutic agents, for weeks or months following radiotherapy. The inflammatory reaction is confined to the previously irradiated skin and the symptoms disappear after the removal of the pharmaceutical agent.;Radiation recall reaction (dermatologic);A finding of acute skin inflammatory reaction caused by drugs, especially chemotherapeutic agents, for weeks or months following radiotherapy. The inflammatory reaction is confined to the previously irradiated skin and the symptoms disappear after the removal of the pharmaceutical agent.;Radiation recall reaction (dermatologic);10037767;LLT;20,1
2044;C144362;Grade 1 Radiation Recall Reaction (Dermatologic), CTCAE;Faint erythema or dry desquamation;Grade 1 Radiation recall reaction (dermatologic);Faint erythema or dry desquamation;Radiation recall reaction (dermatologic);10037767;LLT;20,1
2045;C144954;Grade 2 Radiation Recall Reaction (Dermatologic), CTCAE;"Moderate to brisk erythema; patchy moist desquamation, mostly confined to skin folds and creases; moderate edema";Grade 2 Radiation recall reaction (dermatologic);"Moderate to brisk erythema; patchy moist desquamation, mostly confined to skin folds and creases; moderate edema";Radiation recall reaction (dermatologic);10037767;LLT;20,1
2046;C145576;Grade 3 Radiation Recall Reaction (Dermatologic), CTCAE;"Moist desquamation in areas other than skin folds and creases; bleeding induced by minor trauma or abrasion";Grade 3 Radiation recall reaction (dermatologic);"Moist desquamation in areas other than skin folds and creases; bleeding induced by minor trauma or abrasion";Radiation recall reaction (dermatologic);10037767;LLT;20,1
2047;C146078;Grade 4 Radiation Recall Reaction (Dermatologic), CTCAE;"Life-threatening consequences; skin necrosis or ulceration of full thickness dermis; spontaneous bleeding from involved site; skin graft indicated";Grade 4 Radiation recall reaction (dermatologic);"Life-threatening consequences; skin necrosis or ulceration of full thickness dermis; spontaneous bleeding from involved site; skin graft indicated";Radiation recall reaction (dermatologic);10037767;LLT;20,1
2048;C146513;Grade 5 Radiation Recall Reaction (Dermatologic), CTCAE;Death;Grade 5 Radiation recall reaction (dermatologic);Death;Radiation recall reaction (dermatologic);10037767;LLT;20,1
2049;C143801;Rectal Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a rectal anastomosis (surgical connection of two separate anatomic structures).;Rectal anastomotic leak;A finding of leakage due to breakdown of a rectal anastomosis (surgical connection of two separate anatomic structures).;Rectal anastomotic leak;10065894;LLT;20,1
2050;C144366;Grade 1 Rectal Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Rectal anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Rectal anastomotic leak;10065894;LLT;20,1
2051;C144959;Grade 2 Rectal Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Rectal anastomotic leak;"Symptomatic; medical intervention indicated";Rectal anastomotic leak;10065894;LLT;20,1
2052;C145581;Grade 3 Rectal Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Rectal anastomotic leak;"Severe symptoms; invasive intervention indicated";Rectal anastomotic leak;10065894;LLT;20,1
2053;C146081;Grade 4 Rectal Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Rectal anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Rectal anastomotic leak;10065894;LLT;20,1
2054;C146516;Grade 5 Rectal Anastomotic Leak, CTCAE;Death;Grade 5 Rectal anastomotic leak;Death;Rectal anastomotic leak;10065894;LLT;20,1
2055;C58401;Seroma, CTCAE;A finding of tumor-like collection of serum in the tissues.;Seroma;A finding of tumor-like collection of serum in the tissues.;Seroma;10040102;LLT;20,1
2056;C58236;Grade 1 Seroma, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Seroma;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Seroma;10040102;LLT;20,1
2057;C58271;Grade 2 Seroma, CTCAE;"Symptomatic; simple aspiration indicated";Grade 2 Seroma;"Symptomatic; simple aspiration indicated";Seroma;10040102;LLT;20,1
2058;C58308;Grade 3 Seroma, CTCAE;Symptomatic, elective invasive intervention indicated;Grade 3 Seroma;Symptomatic, elective invasive intervention indicated;Seroma;10040102;LLT;20,1
2059;C143841;Small Intestinal Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of an anastomosis (surgical connection of two separate anatomic structures) in the small bowel.;Small intestinal anastomotic leak;A finding of leakage due to breakdown of an anastomosis (surgical connection of two separate anatomic structures) in the small bowel.;Small intestinal anastomotic leak;10065892;LLT;20,1
2060;C144405;Grade 1 Small Intestinal Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Small intestinal anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Small intestinal anastomotic leak;10065892;LLT;20,1
2061;C145004;Grade 2 Small Intestinal Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Small intestinal anastomotic leak;"Symptomatic; medical intervention indicated";Small intestinal anastomotic leak;10065892;LLT;20,1
2062;C145623;Grade 3 Small Intestinal Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Small intestinal anastomotic leak;"Severe symptoms; invasive intervention indicated";Small intestinal anastomotic leak;10065892;LLT;20,1
2063;C146116;Grade 4 Small Intestinal Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Small intestinal anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Small intestinal anastomotic leak;10065892;LLT;20,1
2064;C146548;Grade 5 Small Intestinal Anastomotic Leak, CTCAE;Death;Grade 5 Small intestinal anastomotic leak;Death;Small intestinal anastomotic leak;10065892;LLT;20,1
2065;C143855;Spermatic Cord Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a spermatic cord anastomosis (surgical connection of two separate anatomic structures).;Spermatic cord anastomotic leak;A finding of leakage due to breakdown of a spermatic cord anastomosis (surgical connection of two separate anatomic structures).;Spermatic cord anastomotic leak;10065897;LLT;20,1
2066;C144415;Grade 1 Spermatic Cord Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Spermatic cord anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Spermatic cord anastomotic leak;10065897;LLT;20,1
2067;C145019;Grade 2 Spermatic Cord Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Spermatic cord anastomotic leak;"Symptomatic; medical intervention indicated";Spermatic cord anastomotic leak;10065897;LLT;20,1
2068;C145637;Grade 3 Spermatic Cord Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Spermatic cord anastomotic leak;"Severe symptoms; invasive intervention indicated";Spermatic cord anastomotic leak;10065897;LLT;20,1
2069;C146129;Grade 4 Spermatic Cord Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Spermatic cord anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Spermatic cord anastomotic leak;10065897;LLT;20,1
2070;C146561;Grade 5 Spermatic Cord Anastomotic Leak, CTCAE;Death;Grade 5 Spermatic cord anastomotic leak;Death;Spermatic cord anastomotic leak;10065897;LLT;20,1
2071;C143856;Spinal Fracture, CTCAE;A finding of traumatic injury to the spine in which the continuity of a vertebral bone is broken.;Spinal fracture;A finding of traumatic injury to the spine in which the continuity of a vertebral bone is broken.;Spinal fracture;10041569;LLT;20,1
2072;C144416;Grade 1 Spinal Fracture, CTCAE;"Mild back pain; nonprescription analgesics indicated";Grade 1 Spinal fracture;"Mild back pain; nonprescription analgesics indicated";Spinal fracture;10041569;LLT;20,1
2073;C145020;Grade 2 Spinal Fracture, CTCAE;"Moderate back pain; prescription analgesics indicated; limiting instrumental ADL";Grade 2 Spinal fracture;"Moderate back pain; prescription analgesics indicated; limiting instrumental ADL";Spinal fracture;10041569;LLT;20,1
2074;C145639;Grade 3 Spinal Fracture, CTCAE;"Severe back pain; hospitalization or intervention indicated for pain control (e.g., vertebroplasty); limiting self care ADL; disability";Grade 3 Spinal fracture;"Severe back pain; hospitalization or intervention indicated for pain control (e.g., vertebroplasty); limiting self care ADL; disability";Spinal fracture;10041569;LLT;20,1
2075;C146131;Grade 4 Spinal Fracture, CTCAE;"Life-threatening consequences; symptoms associated with neurovascular compromise";Grade 4 Spinal fracture;"Life-threatening consequences; symptoms associated with neurovascular compromise";Spinal fracture;10041569;LLT;20,1
2076;C146563;Grade 5 Spinal Fracture, CTCAE;Death;Grade 5 Spinal fracture;Death;Spinal fracture;10041569;LLT;20,1
2077;C143858;Stenosis of Gastrointestinal Stoma, CTCAE;A finding of narrowing of the gastrointestinal stoma (surgically created opening on the surface of the body).;Stenosis of gastrointestinal stoma;A finding of narrowing of the gastrointestinal stoma (surgically created opening on the surface of the body).;Stenosis of gastrointestinal stoma;10065898;LLT;20,1
2078;C145021;Grade 2 Stenosis of Gastrointestinal Stoma, CTCAE;"Symptomatic; IV fluids indicated <24 hrs; manual dilation at bedside";Grade 2 Stenosis of gastrointestinal stoma;"Symptomatic; IV fluids indicated <24 hrs; manual dilation at bedside";Stenosis of gastrointestinal stoma;10065898;LLT;20,1
2079;C145641;Grade 3 Stenosis of Gastrointestinal Stoma, CTCAE;"Severely altered GI function; tube feeding, TPN or hospitalization indicated; elective operative intervention indicated";Grade 3 Stenosis of gastrointestinal stoma;"Severely altered GI function; tube feeding, TPN or hospitalization indicated; elective operative intervention indicated";Stenosis of gastrointestinal stoma;10065898;LLT;20,1
2080;C146133;Grade 4 Stenosis of Gastrointestinal Stoma, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Stenosis of gastrointestinal stoma;"Life-threatening consequences; urgent operative intervention indicated";Stenosis of gastrointestinal stoma;10065898;LLT;20,1
2081;C146565;Grade 5 Stenosis of Gastrointestinal Stoma, CTCAE;Death;Grade 5 Stenosis of gastrointestinal stoma;Death;Stenosis of gastrointestinal stoma;10065898;LLT;20,1
2082;C146694;Stomal Ulcer, CTCAE 5.0;A disorder characterized by a circumscribed, erosive lesion on the jejunal mucosal surface close to the anastomosis site following a gastroenterostomy procedure.;Stomal ulcer;A disorder characterized by a circumscribed, erosive lesion on the jejunal mucosal surface close to the anastomosis site following a gastroenterostomy procedure.;Stomal ulcer;10042127;LLT;20,1
2083;C144418;Grade 1 Stomal Ulcer, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Stomal ulcer;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Stomal ulcer;10042127;LLT;20,1
2084;C145023;Grade 2 Stomal Ulcer, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Stomal ulcer;"Symptomatic; medical intervention indicated";Stomal ulcer;10042127;LLT;20,1
2085;C145644;Grade 3 Stomal Ulcer, CTCAE;"Severe symptoms; elective operative intervention indicated";Grade 3 Stomal ulcer;"Severe symptoms; elective operative intervention indicated";Stomal ulcer;10042127;LLT;20,1
2086;C56567;Tracheal Hemorrhage, CTCAE;A disorder characterized by bleeding from the trachea.;Tracheal hemorrhage;A disorder characterized by bleeding from the trachea.;Tracheal hemorrhage;10062548;LLT;20,1
2087;C56324;Grade 1 Tracheal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Tracheal hemorrhage;"Mild symptoms; intervention not indicated";Tracheal hemorrhage;10062548;LLT;20,1
2088;C56373;Grade 2 Tracheal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Tracheal hemorrhage;"Moderate symptoms; intervention indicated";Tracheal hemorrhage;10062548;LLT;20,1
2089;C56423;Grade 3 Tracheal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Tracheal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Tracheal hemorrhage;10062548;LLT;20,1
2090;C56472;Grade 4 Tracheal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Tracheal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Tracheal hemorrhage;10062548;LLT;20,1
2091;C56521;Grade 5 Tracheal Hemorrhage, CTCAE;Death;Grade 5 Tracheal hemorrhage;Death;Tracheal hemorrhage;10062548;LLT;20,1
2092;C143882;Tracheal Obstruction, CTCAE;A disorder characterized by blockage of the lumen of the trachea.;Tracheal obstruction;A disorder characterized by blockage of the lumen of the trachea.;Tracheal obstruction;10044291;LLT;20,1
2093;C144440;Grade 1 Tracheal Obstruction, CTCAE;Partial asymptomatic obstruction on examination (e.g., visual, radiologic or endoscopic);Grade 1 Tracheal obstruction;Partial asymptomatic obstruction on examination (e.g., visual, radiologic or endoscopic);Tracheal obstruction;10044291;LLT;20,1
2094;C145044;Grade 2 Tracheal Obstruction, CTCAE;"Symptomatic (e.g., noisy airway breathing), no respiratory distress; medical intervention indicated (e.g., steroids); limiting instrumental ADL";Grade 2 Tracheal obstruction;"Symptomatic (e.g., noisy airway breathing), no respiratory distress; medical intervention indicated (e.g., steroids); limiting instrumental ADL";Tracheal obstruction;10044291;LLT;20,1
2095;C145666;Grade 3 Tracheal Obstruction, CTCAE;"Stridor or respiratory distress limiting self care ADL; invasive intervention indicated (e.g., stent, laser)";Grade 3 Tracheal obstruction;"Stridor or respiratory distress limiting self care ADL; invasive intervention indicated (e.g., stent, laser)";Tracheal obstruction;10044291;LLT;20,1
2096;C146152;Grade 4 Tracheal Obstruction, CTCAE;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Tracheal obstruction;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Tracheal obstruction;10044291;LLT;20,1
2097;C146583;Grade 5 Tracheal Obstruction, CTCAE;Death;Grade 5 Tracheal obstruction;Death;Tracheal obstruction;10044291;LLT;20,1
2098;C143885;Tracheostomy Site Bleeding, CTCAE;A disorder characterized by bleeding from the tracheostomy site.;Tracheostomy site bleeding;A disorder characterized by bleeding from the tracheostomy site.;Tracheostomy site bleeding;10065749;LLT;20,1
2099;C144442;Grade 1 Tracheostomy Site Bleeding, CTCAE;"Minimal bleeding identified on clinical exam; intervention not indicated";Grade 1 Tracheostomy site bleeding;"Minimal bleeding identified on clinical exam; intervention not indicated";Tracheostomy site bleeding;10065749;LLT;20,1
2100;C145047;Grade 2 Tracheostomy Site Bleeding, CTCAE;"Moderate bleeding; medical intervention indicated";Grade 2 Tracheostomy site bleeding;"Moderate bleeding; medical intervention indicated";Tracheostomy site bleeding;10065749;LLT;20,1
2101;C145669;Grade 3 Tracheostomy Site Bleeding, CTCAE;"Transfusion indicated; invasive intervention indicated";Grade 3 Tracheostomy site bleeding;"Transfusion indicated; invasive intervention indicated";Tracheostomy site bleeding;10065749;LLT;20,1
2102;C146155;Grade 4 Tracheostomy Site Bleeding, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Tracheostomy site bleeding;"Life-threatening consequences; urgent intervention indicated";Tracheostomy site bleeding;10065749;LLT;20,1
2103;C146586;Grade 5 Tracheostomy Site Bleeding, CTCAE;Death;Grade 5 Tracheostomy site bleeding;Death;Tracheostomy site bleeding;10065749;LLT;20,1
2104;C143897;Ureteric Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a ureteral anastomosis (surgical connection of two separate anatomic structures).;Ureteric anastomotic leak;A finding of leakage due to breakdown of a ureteral anastomosis (surgical connection of two separate anatomic structures).;Ureteric anastomotic leak;10065814;LLT;20,1
2105;C144450;Grade 1 Ureteric Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Ureteric anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Ureteric anastomotic leak;10065814;LLT;20,1
2106;C145056;Grade 2 Ureteric Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Ureteric anastomotic leak;"Symptomatic; medical intervention indicated";Ureteric anastomotic leak;10065814;LLT;20,1
2107;C145678;Grade 3 Ureteric Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Ureteric anastomotic leak;"Severe symptoms; invasive intervention indicated";Ureteric anastomotic leak;10065814;LLT;20,1
2108;C146162;Grade 4 Ureteric Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Ureteric anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Ureteric anastomotic leak;10065814;LLT;20,1
2109;C146592;Grade 5 Ureteric Anastomotic Leak, CTCAE;Death;Grade 5 Ureteric anastomotic leak;Death;Ureteric anastomotic leak;10065814;LLT;20,1
2110;C143898;Urethral Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a urethral anastomosis (surgical connection of two separate anatomic structures).;Urethral anastomotic leak;A finding of leakage due to breakdown of a urethral anastomosis (surgical connection of two separate anatomic structures).;Urethral anastomotic leak;10065815;LLT;20,1
2111;C144451;Grade 1 Urethral Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Urethral anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Urethral anastomotic leak;10065815;LLT;20,1
2112;C145057;Grade 2 Urethral Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Urethral anastomotic leak;"Symptomatic; medical intervention indicated";Urethral anastomotic leak;10065815;LLT;20,1
2113;C145679;Grade 3 Urethral Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Urethral anastomotic leak;"Severe symptoms; invasive intervention indicated";Urethral anastomotic leak;10065815;LLT;20,1
2114;C146163;Grade 4 Urethral Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Urethral anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Urethral anastomotic leak;10065815;LLT;20,1
2115;C146593;Grade 5 Urethral Anastomotic Leak, CTCAE;Death;Grade 5 Urethral anastomotic leak;Death;Urethral anastomotic leak;10065815;LLT;20,1
2116;C143910;Urostomy Leak, CTCAE;A finding of leakage of contents from a urostomy.;Urostomy leak;A finding of leakage of contents from a urostomy.;Urostomy leak;10065882;LLT;20,1
2117;C144457;Grade 1 Urostomy Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Urostomy leak;"Asymptomatic diagnostic finding; intervention not indicated";Urostomy leak;10065882;LLT;20,1
2118;C145065;Grade 2 Urostomy Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Urostomy leak;"Symptomatic; medical intervention indicated";Urostomy leak;10065882;LLT;20,1
2119;C145686;Grade 3 Urostomy Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Urostomy leak;"Severe symptoms; invasive intervention indicated";Urostomy leak;10065882;LLT;20,1
2120;C146169;Grade 4 Urostomy Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Urostomy leak;"Life-threatening consequences; urgent operative intervention indicated";Urostomy leak;10065882;LLT;20,1
2121;C146598;Grade 5 Urostomy Leak, CTCAE;Death;Grade 5 Urostomy leak;Death;Urostomy leak;10065882;LLT;20,1
2122;C143911;Urostomy Obstruction, CTCAE;A disorder characterized by blockage of the urostomy.;Urostomy obstruction;A disorder characterized by blockage of the urostomy.;Urostomy obstruction;10065883;LLT;20,1
2123;C144458;Grade 1 Urostomy Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Urostomy obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Urostomy obstruction;10065883;LLT;20,1
2124;C145066;Grade 2 Urostomy Obstruction, CTCAE;"Symptomatic; dilation or endoscopic repair or stent placement indicated";Grade 2 Urostomy obstruction;"Symptomatic; dilation or endoscopic repair or stent placement indicated";Urostomy obstruction;10065883;LLT;20,1
2125;C145687;Grade 3 Urostomy Obstruction, CTCAE;"Altered organ function (e.g., sepsis or hydronephrosis, or renal dysfunction); elective operative intervention indicated";Grade 3 Urostomy obstruction;"Altered organ function (e.g., sepsis or hydronephrosis, or renal dysfunction); elective operative intervention indicated";Urostomy obstruction;10065883;LLT;20,1
2126;C146170;Grade 4 Urostomy Obstruction, CTCAE;"Life-threatening consequences; organ failure; urgent operative intervention indicated";Grade 4 Urostomy obstruction;"Life-threatening consequences; organ failure; urgent operative intervention indicated";Urostomy obstruction;10065883;LLT;20,1
2127;C146599;Grade 5 Urostomy Obstruction, CTCAE;Death;Grade 5 Urostomy obstruction;Death;Urostomy obstruction;10065883;LLT;20,1
2128;C143912;Urostomy Site Bleeding, CTCAE;A disorder characterized by bleeding from the urostomy site.;Urostomy site bleeding;A disorder characterized by bleeding from the urostomy site.;Urostomy site bleeding;10065748;LLT;20,1
2129;C144459;Grade 1 Urostomy Site Bleeding, CTCAE;"Minimal bleeding identified on clinical exam; intervention not indicated";Grade 1 Urostomy site bleeding;"Minimal bleeding identified on clinical exam; intervention not indicated";Urostomy site bleeding;10065748;LLT;20,1
2130;C145067;Grade 2 Urostomy Site Bleeding, CTCAE;"Moderate bleeding; medical intervention indicated";Grade 2 Urostomy site bleeding;"Moderate bleeding; medical intervention indicated";Urostomy site bleeding;10065748;LLT;20,1
2131;C145688;Grade 3 Urostomy Site Bleeding, CTCAE;"Transfusion indicated; invasive intervention indicated";Grade 3 Urostomy site bleeding;"Transfusion indicated; invasive intervention indicated";Urostomy site bleeding;10065748;LLT;20,1
2132;C146171;Grade 4 Urostomy Site Bleeding, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Urostomy site bleeding;"Life-threatening consequences; urgent intervention indicated";Urostomy site bleeding;10065748;LLT;20,1
2133;C146600;Grade 5 Urostomy Site Bleeding, CTCAE;Death;Grade 5 Urostomy site bleeding;Death;Urostomy site bleeding;10065748;LLT;20,1
2134;C143913;Urostomy Stenosis, CTCAE;A finding of narrowing of the opening of a urostomy.;Urostomy stenosis;A finding of narrowing of the opening of a urostomy.;Urostomy stenosis;10065885;LLT;20,1
2135;C145068;Grade 2 Urostomy Stenosis, CTCAE;"Symptomatic but no hydronephrosis, sepsis, or renal dysfunction; dilation or endoscopic repair or stent placement indicated";Grade 2 Urostomy stenosis;"Symptomatic but no hydronephrosis, sepsis, or renal dysfunction; dilation or endoscopic repair or stent placement indicated";Urostomy stenosis;10065885;LLT;20,1
2136;C145689;Grade 3 Urostomy Stenosis, CTCAE;"Symptomatic (e.g., hydronephrosis, or renal dysfunction); elective operative intervention indicated";Grade 3 Urostomy stenosis;"Symptomatic (e.g., hydronephrosis, or renal dysfunction); elective operative intervention indicated";Urostomy stenosis;10065885;LLT;20,1
2137;C146172;Grade 4 Urostomy Stenosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Urostomy stenosis;"Life-threatening consequences; urgent operative intervention indicated";Urostomy stenosis;10065885;LLT;20,1
2138;C146601;Grade 5 Urostomy Stenosis, CTCAE;Death;Grade 5 Urostomy stenosis;Death;Urostomy stenosis;10065885;LLT;20,1
2139;C143915;Uterine Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a uterine anastomosis (surgical connection of two separate anatomic structures).;Uterine anastomotic leak;A finding of leakage due to breakdown of a uterine anastomosis (surgical connection of two separate anatomic structures).;Uterine anastomotic leak;10065886;LLT;20,1
2140;C144460;Grade 1 Uterine Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Uterine anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Uterine anastomotic leak;10065886;LLT;20,1
2141;C145069;Grade 2 Uterine Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Uterine anastomotic leak;"Symptomatic; medical intervention indicated";Uterine anastomotic leak;10065886;LLT;20,1
2142;C145690;Grade 3 Uterine Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Uterine anastomotic leak;"Severe symptoms; invasive intervention indicated";Uterine anastomotic leak;10065886;LLT;20,1
2143;C146173;Grade 4 Uterine Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Uterine anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Uterine anastomotic leak;10065886;LLT;20,1
2144;C146602;Grade 5 Uterine Anastomotic Leak, CTCAE;Death;Grade 5 Uterine anastomotic leak;Death;Uterine anastomotic leak;10065886;LLT;20,1
2145;C143919;Uterine Perforation, CTCAE;A disorder characterized by a rupture in the uterine wall.;Uterine perforation;A disorder characterized by a rupture in the uterine wall.;Uterine perforation;10046810;LLT;20,1
2146;C145075;Grade 2 Uterine Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Uterine perforation;Invasive intervention not indicated;Uterine perforation;10046810;LLT;20,1
2147;C145696;Grade 3 Uterine Perforation, CTCAE;Invasive intervention indicated;Grade 3 Uterine perforation;Invasive intervention indicated;Uterine perforation;10046810;LLT;20,1
2148;C146177;Grade 4 Uterine Perforation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Uterine perforation;"Life-threatening consequences; urgent intervention indicated";Uterine perforation;10046810;LLT;20,1
2149;C146606;Grade 5 Uterine Perforation, CTCAE;Death;Grade 5 Uterine perforation;Death;Uterine perforation;10046810;LLT;20,1
2150;C143216;Vaccination Complication, CTCAE;A disorder that occurs after the injection of a substance with antigenic properties, administered to activate the immune system.;Vaccination complication;A disorder that occurs after the injection of a substance with antigenic properties, administered to activate the immune system.;Vaccination complication;10046861;LLT;20,1
2151;C144465;Grade 1 Vaccination Complication, CTCAE;"Mild pain; erythema 2.5-5cm; induration/swelling 2.5-5cm; does not interfere with activity";Grade 1 Vaccination complication;"Mild pain; erythema 2.5-5cm; induration/swelling 2.5-5cm; does not interfere with activity";Vaccination complication;10046861;LLT;20,1
2152;C145076;Grade 2 Vaccination Complication, CTCAE;"Moderate pain; Erythema 5.1-10 cm; Induration/swelling 5.1-10 cm; lipodystrophy; limiting instrumental ADL";Grade 2 Vaccination complication;"Moderate pain; Erythema 5.1-10 cm; Induration/swelling 5.1-10 cm; lipodystrophy; limiting instrumental ADL";Vaccination complication;10046861;LLT;20,1
2153;C145697;Grade 3 Vaccination Complication, CTCAE;"Severe pain; Erythema > 10 cm; Induration/swelling > 10 cm; necrosis; limiting self care ADL";Grade 3 Vaccination complication;"Severe pain; Erythema > 10 cm; Induration/swelling > 10 cm; necrosis; limiting self care ADL";Vaccination complication;10046861;LLT;20,1
2154;C146178;Grade 4 Vaccination Complication, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Vaccination complication;"Life-threatening consequences; urgent intervention indicated";Vaccination complication;10046861;LLT;20,1
2155;C143921;Vaginal Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a vaginal anastomosis (surgical connection of two separate anatomic structures).;Vaginal anastomotic leak;A finding of leakage due to breakdown of a vaginal anastomosis (surgical connection of two separate anatomic structures).;Vaginal anastomotic leak;10065887;LLT;20,1
2156;C144467;Grade 1 Vaginal Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Vaginal anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Vaginal anastomotic leak;10065887;LLT;20,1
2157;C145078;Grade 2 Vaginal Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Vaginal anastomotic leak;"Symptomatic; medical intervention indicated";Vaginal anastomotic leak;10065887;LLT;20,1
2158;C145698;Grade 3 Vaginal Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Vaginal anastomotic leak;"Severe symptoms; invasive intervention indicated";Vaginal anastomotic leak;10065887;LLT;20,1
2159;C146179;Grade 4 Vaginal Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Vaginal anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Vaginal anastomotic leak;10065887;LLT;20,1
2160;C146607;Grade 5 Vaginal Anastomotic Leak, CTCAE;Death;Grade 5 Vaginal anastomotic leak;Death;Vaginal anastomotic leak;10065887;LLT;20,1
2161;C143928;Vas Deferens Anastomotic Leak, CTCAE;A finding of leakage due to breakdown of a vas deferens anastomosis (surgical connection of two separate anatomic structures).;Vas deferens anastomotic leak;A finding of leakage due to breakdown of a vas deferens anastomosis (surgical connection of two separate anatomic structures).;Vas deferens anastomotic leak;10065888;LLT;20,1
2162;C144477;Grade 1 Vas Deferens Anastomotic Leak, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Vas deferens anastomotic leak;"Asymptomatic diagnostic finding; intervention not indicated";Vas deferens anastomotic leak;10065888;LLT;20,1
2163;C145089;Grade 2 Vas Deferens Anastomotic Leak, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Vas deferens anastomotic leak;"Symptomatic; medical intervention indicated";Vas deferens anastomotic leak;10065888;LLT;20,1
2164;C145709;Grade 3 Vas Deferens Anastomotic Leak, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Vas deferens anastomotic leak;"Severe symptoms; invasive intervention indicated";Vas deferens anastomotic leak;10065888;LLT;20,1
2165;C146186;Grade 4 Vas Deferens Anastomotic Leak, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Vas deferens anastomotic leak;"Life-threatening consequences; urgent operative intervention indicated";Vas deferens anastomotic leak;10065888;LLT;20,1
2166;C146614;Grade 5 Vas Deferens Anastomotic Leak, CTCAE;Death;Grade 5 Vas deferens anastomotic leak;Death;Vas deferens anastomotic leak;10065888;LLT;20,1
2167;C143929;Vascular Access Complication, CTCAE;A finding of a previously undocumented problem related to the vascular access site.;Vascular access complication;A finding of a previously undocumented problem related to the vascular access site.;Vascular access complication;10062169;LLT;20,1
2168;C144478;Grade 1 Vascular Access Complication, CTCAE;TPA administration into line with no intent for systemic therapy indicated;Grade 1 Vascular access complication;TPA administration into line with no intent for systemic therapy indicated;Vascular access complication;10062169;LLT;20,1
2169;C145090;Grade 2 Vascular Access Complication, CTCAE;"Device dislodgement, blockage, leak, or malposition; device replacement indicated";Grade 2 Vascular access complication;"Device dislodgement, blockage, leak, or malposition; device replacement indicated";Vascular access complication;10062169;LLT;20,1
2170;C145710;Grade 3 Vascular Access Complication, CTCAE;"Pulmonary embolism, deep vein or cardiac thrombosis; intervention indicated (e.g., anticoagulation, lysis, filter, invasive procedure)";Grade 3 Vascular access complication;"Pulmonary embolism, deep vein or cardiac thrombosis; intervention indicated (e.g., anticoagulation, lysis, filter, invasive procedure)";Vascular access complication;10062169;LLT;20,1
2171;C146187;Grade 4 Vascular Access Complication, CTCAE;Life-threatening consequences with hemodynamic or neurologic instability;Grade 4 Vascular access complication;Life-threatening consequences with hemodynamic or neurologic instability;Vascular access complication;10062169;LLT;20,1
2172;C146615;Grade 5 Vascular Access Complication, CTCAE;Death;Grade 5 Vascular access complication;Death;Vascular access complication;10062169;LLT;20,1
2173;C143933;Venous Injury, CTCAE;A finding of damage to a vein.;Venous injury;A finding of damage to a vein.;Venous injury;10047228;LLT;20,1
2174;C144480;Grade 1 Venous Injury, CTCAE;"Asymptomatic diagnostic finding; intervention not indicated";Grade 1 Venous injury;"Asymptomatic diagnostic finding; intervention not indicated";Venous injury;10047228;LLT;20,1
2175;C145092;Grade 2 Venous Injury, CTCAE;"Symptomatic (e.g., claudication); repair or revision not indicated";Grade 2 Venous injury;"Symptomatic (e.g., claudication); repair or revision not indicated";Venous injury;10047228;LLT;20,1
2176;C145713;Grade 3 Venous Injury, CTCAE;"Severe symptoms; limiting self care ADL; repair or revision indicated";Grade 3 Venous injury;"Severe symptoms; limiting self care ADL; repair or revision indicated";Venous injury;10047228;LLT;20,1
2177;C146190;Grade 4 Venous Injury, CTCAE;"Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated";Grade 4 Venous injury;"Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated";Venous injury;10047228;LLT;20,1
2178;C146618;Grade 5 Venous Injury, CTCAE;Death;Grade 5 Venous injury;Death;Venous injury;10047228;LLT;20,1
2179;C143949;Wound Complication, CTCAE;A finding of development of a new problem at the site of an existing wound.;Wound complication;A finding of development of a new problem at the site of an existing wound.;Wound complication;10053692;LLT;20,1
2180;C144490;Grade 1 Wound Complication, CTCAE;"Observation only; topical intervention indicated";Grade 1 Wound complication;"Observation only; topical intervention indicated";Wound complication;10053692;LLT;20,1
2181;C145106;Grade 2 Wound Complication, CTCAE;Bedside local care indicated;Grade 2 Wound complication;Bedside local care indicated;Wound complication;10053692;LLT;20,1
2182;C145726;Grade 3 Wound Complication, CTCAE;Operative intervention indicated;Grade 3 Wound complication;Operative intervention indicated;Wound complication;10053692;LLT;20,1
2183;C146199;Grade 4 Wound Complication, CTCAE;Life-threatening consequences;Grade 4 Wound complication;Life-threatening consequences;Wound complication;10053692;LLT;20,1
2184;C146623;Grade 5 Wound Complication, CTCAE;Death;Grade 5 Wound complication;Death;Wound complication;10053692;LLT;20,1
2185;C143950;Wound Dehiscence, CTCAE;A finding of separation of the approximated margins of a surgical wound.;Wound dehiscence;A finding of separation of the approximated margins of a surgical wound.;Wound dehiscence;10048031;LLT;20,1
2186;C144491;Grade 1 Wound Dehiscence, CTCAE;Incisional separation, intervention not indicated;Grade 1 Wound dehiscence;Incisional separation, intervention not indicated;Wound dehiscence;10048031;LLT;20,1
2187;C145107;Grade 2 Wound Dehiscence, CTCAE;Incisional separation, local care (e.g., suturing) or medical intervention indicated (e.g., analgesic);Grade 2 Wound dehiscence;Incisional separation, local care (e.g., suturing) or medical intervention indicated (e.g., analgesic);Wound dehiscence;10048031;LLT;20,1
2188;C145727;Grade 3 Wound Dehiscence, CTCAE;"Fascial disruption or dehiscence without evisceration; revision by operative intervention indicated";Grade 3 Wound dehiscence;"Fascial disruption or dehiscence without evisceration; revision by operative intervention indicated";Wound dehiscence;10048031;LLT;20,1
2189;C146200;Grade 4 Wound Dehiscence, CTCAE;"Life-threatening consequences; symptomatic hernia with evidence of strangulation; fascial disruption with evisceration; major reconstruction flap, grafting, resection, or amputation indicated";Grade 4 Wound dehiscence;"Life-threatening consequences; symptomatic hernia with evidence of strangulation; fascial disruption with evisceration; major reconstruction flap, grafting, resection, or amputation indicated";Wound dehiscence;10048031;LLT;20,1
2190;C146624;Grade 5 Wound Dehiscence, CTCAE;Death;Grade 5 Wound dehiscence;Death;Wound dehiscence;10048031;LLT;20,1
2191;C143952;Wrist Fracture, CTCAE;A finding of traumatic injury to the wrist joint in which the continuity of a wrist bone is broken.;Wrist fracture;A finding of traumatic injury to the wrist joint in which the continuity of a wrist bone is broken.;Wrist fracture;10048049;LLT;20,1
2192;C144493;Grade 1 Wrist Fracture, CTCAE;"Mild; non-operative intervention indicated";Grade 1 Wrist fracture;"Mild; non-operative intervention indicated";Wrist fracture;10048049;LLT;20,1
2193;C145109;Grade 2 Wrist Fracture, CTCAE;"Limiting instrumental ADL; outpatient operative intervention indicated";Grade 2 Wrist fracture;"Limiting instrumental ADL; outpatient operative intervention indicated";Wrist fracture;10048049;LLT;20,1
2194;C145729;Grade 3 Wrist Fracture, CTCAE;"Limiting self care ADL; elective operative intervention indicated requiring hospitalization";Grade 3 Wrist fracture;"Limiting self care ADL; elective operative intervention indicated requiring hospitalization";Wrist fracture;10048049;LLT;20,1
2195;C143173;Investigations, CTCAE;;;;;;;
2196;C143261;Activated Partial Thromboplastin Time Prolonged, CTCAE;A finding based on laboratory test results in which the partial thromboplastin time is found to be greater than the control value. As a possible indicator of coagulopathy, a prolonged partial thromboplastin time (PTT) may occur in a variety of diseases and disorders, both primary and related to treatment.;Activated partial thromboplastin time prolonged;A finding based on laboratory test results in which the partial thromboplastin time is found to be greater than the control value. As a possible indicator of coagulopathy, a prolonged partial thromboplastin time (PTT) may occur in a variety of diseases and disorders, both primary and related to treatment.;Activated partial thromboplastin time prolonged;10000636;LLT;20,1
2197;C143964;Grade 1 Activated Partial Thromboplastin Time Prolonged, CTCAE;>ULN-1.5 x ULN;Grade 1 Activated partial thromboplastin time prolonged;>ULN-1.5 x ULN;Activated partial thromboplastin time prolonged;10000636;LLT;20,1
2198;C144501;Grade 2 Activated Partial Thromboplastin Time Prolonged, CTCAE;>1.5-2.5 x ULN;Grade 2 Activated partial thromboplastin time prolonged;>1.5-2.5 x ULN;Activated partial thromboplastin time prolonged;10000636;LLT;20,1
2199;C145118;Grade 3 Activated Partial Thromboplastin Time Prolonged, CTCAE;">2.5 x ULN; bleeding";Grade 3 Activated partial thromboplastin time prolonged;">2.5 x ULN; bleeding";Activated partial thromboplastin time prolonged;10000636;LLT;20,1
2200;C143267;Alanine Aminotransferase Increased, CTCAE;A finding based on laboratory test results that indicate an increase in the level of alanine aminotransferase (ALT or SGPT) in the blood specimen.;Alanine aminotransferase increased;A finding based on laboratory test results that indicate an increase in the level of alanine aminotransferase (ALT or SGPT) in the blood specimen.;Alanine aminotransferase increased;10001551;LLT;20,1
2201;C143966;Grade 1 Alanine Aminotransferase Increased, CTCAE;">ULN-3.0 x ULN if baseline was normal; 1.5-3.0 x baseline if baseline was abnormal";Grade 1 Alanine aminotransferase increased;">ULN-3.0 x ULN if baseline was normal; 1.5-3.0 x baseline if baseline was abnormal";Alanine aminotransferase increased;10001551;LLT;20,1
2202;C144503;Grade 2 Alanine Aminotransferase Increased, CTCAE;">3.0-5.0 x ULN if baseline was normal; >3.0-5.0 x baseline if baseline was abnormal";Grade 2 Alanine aminotransferase increased;">3.0-5.0 x ULN if baseline was normal; >3.0-5.0 x baseline if baseline was abnormal";Alanine aminotransferase increased;10001551;LLT;20,1
2203;C145121;Grade 3 Alanine Aminotransferase Increased, CTCAE;">5.0-20.0 x ULN if baseline was normal; >5.0-20.0 x baseline if baseline was abnormal";Grade 3 Alanine aminotransferase increased;">5.0-20.0 x ULN if baseline was normal; >5.0-20.0 x baseline if baseline was abnormal";Alanine aminotransferase increased;10001551;LLT;20,1
2204;C145734;Grade 4 Alanine Aminotransferase Increased, CTCAE;">20.0 x ULN if baseline was normal; >20.0 x baseline if baseline was abnormal";Grade 4 Alanine aminotransferase increased;">20.0 x ULN if baseline was normal; >20.0 x baseline if baseline was abnormal";Alanine aminotransferase increased;10001551;LLT;20,1
2205;C143269;Alkaline Phosphatase Increased, CTCAE;A finding based on laboratory test results that indicate an increase in the level of alkaline phosphatase in a blood specimen.;Alkaline phosphatase increased;A finding based on laboratory test results that indicate an increase in the level of alkaline phosphatase in a blood specimen.;Alkaline phosphatase increased;10001675;LLT;20,1
2206;C143967;Grade 1 Alkaline Phosphatase Increased, CTCAE;">ULN-2.5 x ULN if baseline was normal; 2.0-2.5 x baseline if baseline was abnormal";Grade 1 Alkaline phosphatase increased;">ULN-2.5 x ULN if baseline was normal; 2.0-2.5 x baseline if baseline was abnormal";Alkaline phosphatase increased;10001675;LLT;20,1
2207;C144505;Grade 2 Alkaline Phosphatase Increased, CTCAE;">2.5-5.0 x ULN if baseline was normal; >2.5-5.0 x baseline if baseline was abnormal";Grade 2 Alkaline phosphatase increased;">2.5-5.0 x ULN if baseline was normal; >2.5-5.0 x baseline if baseline was abnormal";Alkaline phosphatase increased;10001675;LLT;20,1
2208;C145123;Grade 3 Alkaline Phosphatase Increased, CTCAE;">5.0-20.0 x ULN if baseline was normal; >5.0-20.0 x baseline if baseline was abnormal";Grade 3 Alkaline phosphatase increased;">5.0-20.0 x ULN if baseline was normal; >5.0-20.0 x baseline if baseline was abnormal";Alkaline phosphatase increased;10001675;LLT;20,1
2209;C145736;Grade 4 Alkaline Phosphatase Increased, CTCAE;">20.0 x ULN if baseline was normal; >20.0 x baseline if baseline was abnormal";Grade 4 Alkaline phosphatase increased;">20.0 x ULN if baseline was normal; >20.0 x baseline if baseline was abnormal";Alkaline phosphatase increased;10001675;LLT;20,1
2210;C143301;Aspartate Aminotransferase Increased, CTCAE;A finding based on laboratory test results that indicate an increase in the level of aspartate aminotransferase (AST or SGOT) in a blood specimen.;Aspartate aminotransferase increased;A finding based on laboratory test results that indicate an increase in the level of aspartate aminotransferase (AST or SGOT) in a blood specimen.;Aspartate aminotransferase increased;10003481;LLT;20,1
2211;C143990;Grade 1 Aspartate Aminotransferase Increased, CTCAE;">ULN-3.0 x ULN if baseline was normal; 1.5-3.0 x baseline if baseline was abnormal";Grade 1 Aspartate aminotransferase increased;">ULN-3.0 x ULN if baseline was normal; 1.5-3.0 x baseline if baseline was abnormal";Aspartate aminotransferase increased;10003481;LLT;20,1
2212;C144528;Grade 2 Aspartate Aminotransferase Increased, CTCAE;">3.0-5.0 x ULN if baseline was normal; >3.0-5.0 x baseline if baseline was abnormal";Grade 2 Aspartate aminotransferase increased;">3.0-5.0 x ULN if baseline was normal; >3.0-5.0 x baseline if baseline was abnormal";Aspartate aminotransferase increased;10003481;LLT;20,1
2213;C145151;Grade 3 Aspartate Aminotransferase Increased, CTCAE;">5.0-20.0 x ULN if baseline was normal; >5.0-20.0 x baseline if baseline was abnormal";Grade 3 Aspartate aminotransferase increased;">5.0-20.0 x ULN if baseline was normal; >5.0-20.0 x baseline if baseline was abnormal";Aspartate aminotransferase increased;10003481;LLT;20,1
2214;C145756;Grade 4 Aspartate Aminotransferase Increased, CTCAE;">20.0 x ULN if baseline was normal; >20.0 x baseline if baseline was abnormal";Grade 4 Aspartate aminotransferase increased;">20.0 x ULN if baseline was normal; >20.0 x baseline if baseline was abnormal";Aspartate aminotransferase increased;10003481;LLT;20,1
2215;C143324;Blood Antidiuretic Hormone Abnormal, CTCAE;A finding based on laboratory test results that indicate abnormal levels of antidiuretic hormone in the blood specimen.;Blood antidiuretic hormone abnormal;A finding based on laboratory test results that indicate abnormal levels of antidiuretic hormone in the blood specimen.;Blood antidiuretic hormone abnormal;10005332;LLT;20,1
2216;C144001;Grade 1 Blood Antidiuretic Hormone Abnormal, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Blood antidiuretic hormone abnormal;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Blood antidiuretic hormone abnormal;10005332;LLT;20,1
2217;C144545;Grade 2 Blood Antidiuretic Hormone Abnormal, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Blood antidiuretic hormone abnormal;"Symptomatic; medical intervention indicated";Blood antidiuretic hormone abnormal;10005332;LLT;20,1
2218;C145163;Grade 3 Blood Antidiuretic Hormone Abnormal, CTCAE;Hospitalization indicated;Grade 3 Blood antidiuretic hormone abnormal;Hospitalization indicated;Blood antidiuretic hormone abnormal;10005332;LLT;20,1
2219;C143217;Blood Bicarbonate Decreased, CTCAE;A finding based on laboratory test results that indicate a decrease in levels of bicarbonate in a venous blood specimen.;Blood bicarbonate decreased;A finding based on laboratory test results that indicate a decrease in levels of bicarbonate in a venous blood specimen.;Blood bicarbonate decreased;10005359;LLT;20,1
2220;C144002;Grade 1 Blood Bicarbonate Decreased, CTCAE;<LLN and no intervention initiated;Grade 1 Blood bicarbonate decreased;<LLN and no intervention initiated;Blood bicarbonate decreased;10005359;LLT;20,1
2221;C143325;Blood Bilirubin Increased, CTCAE;A finding based on laboratory test results that indicate an abnormally high level of bilirubin in the blood. Excess bilirubin is associated with jaundice.;Blood bilirubin increased;A finding based on laboratory test results that indicate an abnormally high level of bilirubin in the blood. Excess bilirubin is associated with jaundice.;Blood bilirubin increased;10005364;LLT;20,1
2222;C144003;Grade 1 Blood Bilirubin Increased, CTCAE;">ULN-1.5 x ULN if baseline was normal; > 1.0-1.5 x baseline if baseline was abnormal";Grade 1 Blood bilirubin increased;">ULN-1.5 x ULN if baseline was normal; > 1.0-1.5 x baseline if baseline was abnormal";Blood bilirubin increased;10005364;LLT;20,1
2223;C144546;Grade 2 Blood Bilirubin Increased, CTCAE;">1.5-3.0 x ULN if baseline was normal; >1.5-3.0 x baseline if baseline was abnormal";Grade 2 Blood bilirubin increased;">1.5-3.0 x ULN if baseline was normal; >1.5-3.0 x baseline if baseline was abnormal";Blood bilirubin increased;10005364;LLT;20,1
2224;C145164;Grade 3 Blood Bilirubin Increased, CTCAE;">3.0-10.0 x ULN if baseline was normal; >3.0-10.0 x baseline if baseline was abnormal";Grade 3 Blood bilirubin increased;">3.0-10.0 x ULN if baseline was normal; >3.0-10.0 x baseline if baseline was abnormal";Blood bilirubin increased;10005364;LLT;20,1
2225;C145767;Grade 4 Blood Bilirubin Increased, CTCAE;">10.0 x ULN if baseline was normal; >10.0 x baseline if baseline was abnormal";Grade 4 Blood bilirubin increased;">10.0 x ULN if baseline was normal; >10.0 x baseline if baseline was abnormal";Blood bilirubin increased;10005364;LLT;20,1
2226;C143326;Blood Corticotrophin Decreased, CTCAE;A finding based on laboratory test results that indicate an decrease in levels of corticotrophin in a blood specimen.;Blood corticotrophin decreased;A finding based on laboratory test results that indicate an decrease in levels of corticotrophin in a blood specimen.;Blood corticotrophin decreased;10005452;LLT;20,1
2227;C144004;Grade 1 Blood Corticotrophin Decreased, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Blood corticotrophin decreased;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Blood corticotrophin decreased;10005452;LLT;20,1
2228;C144547;Grade 2 Blood Corticotrophin Decreased, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Blood corticotrophin decreased;"Symptomatic; medical intervention indicated";Blood corticotrophin decreased;10005452;LLT;20,1
2229;C145165;Grade 3 Blood Corticotrophin Decreased, CTCAE;Hospitalization indicated;Grade 3 Blood corticotrophin decreased;Hospitalization indicated;Blood corticotrophin decreased;10005452;LLT;20,1
2230;C143327;Blood Gonadotrophin Abnormal, CTCAE;A finding based on laboratory test results that indicate abnormal levels of gonadotrophin hormone in a blood specimen.;Blood gonadotrophin abnormal;A finding based on laboratory test results that indicate abnormal levels of gonadotrophin hormone in a blood specimen.;Blood gonadotrophin abnormal;10005561;LLT;20,1
2231;C144005;Grade 1 Blood Gonadotrophin Abnormal, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Blood gonadotrophin abnormal;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Blood gonadotrophin abnormal;10005561;LLT;20,1
2232;C144548;Grade 2 Blood Gonadotrophin Abnormal, CTCAE;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Grade 2 Blood gonadotrophin abnormal;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Blood gonadotrophin abnormal;10005561;LLT;20,1
2233;C145166;Grade 3 Blood Gonadotrophin Abnormal, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Blood gonadotrophin abnormal;"Severe symptoms; limiting self care ADL";Blood gonadotrophin abnormal;10005561;LLT;20,1
2234;C143218;Blood Lactate Dehydrogenase Increased, CTCAE;A finding based on laboratory test results that indicate increased levels of lactate dehydrogenase in the blood specimen.;Blood lactate dehydrogenase increased;A finding based on laboratory test results that indicate increased levels of lactate dehydrogenase in the blood specimen.;Blood lactate dehydrogenase increased;10005630;LLT;20,1
2235;C144006;Grade 1 Blood Lactate Dehydrogenase Increased, CTCAE;>ULN;Grade 1 Blood lactate dehydrogenase increased;>ULN;Blood lactate dehydrogenase increased;10005630;LLT;20,1
2236;C143328;Blood Prolactin Abnormal, CTCAE;A finding based on laboratory test results that indicate abnormal levels of prolactin hormone in a blood specimen.;Blood prolactin abnormal;A finding based on laboratory test results that indicate abnormal levels of prolactin hormone in a blood specimen.;Blood prolactin abnormal;10005778;LLT;20,1
2237;C144007;Grade 1 Blood Prolactin Abnormal, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Blood prolactin abnormal;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Blood prolactin abnormal;10005778;LLT;20,1
2238;C144549;Grade 2 Blood Prolactin Abnormal, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Blood prolactin abnormal;"Moderate symptoms; limiting instrumental ADL";Blood prolactin abnormal;10005778;LLT;20,1
2239;C143350;Carbon Monoxide Diffusing Capacity Decreased, CTCAE;A finding based on lung function test results that indicate a decrease in the lung capacity to absorb carbon monoxide.;Carbon monoxide diffusing capacity decreased;A finding based on lung function test results that indicate a decrease in the lung capacity to absorb carbon monoxide.;Carbon monoxide diffusing capacity decreased;10065906;LLT;20,1
2240;C144020;Grade 1 Carbon Monoxide Diffusing Capacity Decreased, CTCAE;"3-5 units below LLN; for follow-up, a decrease of 3-5 units (ml/min/mm Hg) below the baseline value; asymptomatic and intervention not indicated";Grade 1 Carbon monoxide diffusing capacity decreased;"3-5 units below LLN; for follow-up, a decrease of 3-5 units (ml/min/mm Hg) below the baseline value; asymptomatic and intervention not indicated";Carbon monoxide diffusing capacity decreased;10065906;LLT;20,1
2241;C144566;Grade 2 Carbon Monoxide Diffusing Capacity Decreased, CTCAE;"6-8 units below LLN; for follow-up, an asymptomatic decrease of >5-8 units (ml/min/mm Hg) below the baseline value; symptomatic and intervention not indicated";Grade 2 Carbon monoxide diffusing capacity decreased;"6-8 units below LLN; for follow-up, an asymptomatic decrease of >5-8 units (ml/min/mm Hg) below the baseline value; symptomatic and intervention not indicated";Carbon monoxide diffusing capacity decreased;10065906;LLT;20,1
2242;C145181;Grade 3 Carbon Monoxide Diffusing Capacity Decreased, CTCAE;"Asymptomatic decrease of >8 units drop; >5 units drop along with the presence of pulmonary symptoms (e.g., >Grade 2 hypoxia or >Grade 2 dyspnea); intervention indicated";Grade 3 Carbon monoxide diffusing capacity decreased;"Asymptomatic decrease of >8 units drop; >5 units drop along with the presence of pulmonary symptoms (e.g., >Grade 2 hypoxia or >Grade 2 dyspnea); intervention indicated";Carbon monoxide diffusing capacity decreased;10065906;LLT;20,1
2243;C143353;Cardiac Troponin I Increased, CTCAE;A finding based on laboratory test results that indicate increased levels of cardiac troponin I in a biological specimen.;Cardiac troponin I increased;A finding based on laboratory test results that indicate increased levels of cardiac troponin I in a biological specimen.;Cardiac troponin I increased;10007612;LLT;20,1
2244;C144022;Grade 1 Cardiac Troponin I Increased, CTCAE;Levels above the upper limit of normal and below the level of myocardial infarction as defined by the manufacturer;Grade 1 Cardiac troponin I increased;Levels above the upper limit of normal and below the level of myocardial infarction as defined by the manufacturer;Cardiac troponin I increased;10007612;LLT;20,1
2245;C145183;Grade 3 Cardiac Troponin I Increased, CTCAE;Levels consistent with myocardial infarction as defined by the manufacturer;Grade 3 Cardiac troponin I increased;Levels consistent with myocardial infarction as defined by the manufacturer;Cardiac troponin I increased;10007612;LLT;20,1
2246;C143354;Cardiac Troponin T Increased, CTCAE;A finding based on laboratory test results that indicate increased levels of cardiac troponin T in a biological specimen.;Cardiac troponin T increased;A finding based on laboratory test results that indicate increased levels of cardiac troponin T in a biological specimen.;Cardiac troponin T increased;10007613;LLT;20,1
2247;C144023;Grade 1 Cardiac Troponin T Increased, CTCAE;Levels above the upper limit of normal and below the level of myocardial infarction as defined by the manufacturer;Grade 1 Cardiac troponin T increased;Levels above the upper limit of normal and below the level of myocardial infarction as defined by the manufacturer;Cardiac troponin T increased;10007613;LLT;20,1
2248;C145184;Grade 3 Cardiac Troponin T Increased, CTCAE;Levels consistent with myocardial infarction as defined by the manufacturer;Grade 3 Cardiac troponin T increased;Levels consistent with myocardial infarction as defined by the manufacturer;Cardiac troponin T increased;10007613;LLT;20,1
2249;C143357;CD4 Lymphocytes Decreased, CTCAE;A finding based on laboratory test results that indicate an decrease in levels of CD4 lymphocytes in a blood specimen.;CD4 lymphocytes decreased;A finding based on laboratory test results that indicate an decrease in levels of CD4 lymphocytes in a blood specimen.;CD4 lymphocytes decreased;10007839;LLT;20,1
2250;C144024;Grade 1 CD4 Lymphocytes Decreased, CTCAE;"<LLN-500/mm3; <LLN-0.5 x 10e9/L";Grade 1 CD4 lymphocytes decreased;"<LLN-500/mm3; <LLN-0.5 x 10e9/L";CD4 lymphocytes decreased;10007839;LLT;20,1
2251;C144569;Grade 2 CD4 Lymphocytes Decreased, CTCAE;"<500-200/mm3; <0.5-0.2 x 10e9/L";Grade 2 CD4 lymphocytes decreased;"<500-200/mm3; <0.5-0.2 x 10e9/L";CD4 lymphocytes decreased;10007839;LLT;20,1
2252;C145186;Grade 3 CD4 Lymphocytes Decreased, CTCAE;"<200-50/mm3; <0.2 x 0.05-10e9/L";Grade 3 CD4 lymphocytes decreased;"<200-50/mm3; <0.2 x 0.05-10e9/L";CD4 lymphocytes decreased;10007839;LLT;20,1
2253;C145785;Grade 4 CD4 Lymphocytes Decreased, CTCAE;"<50/mm3; <0.05 x 10e9/L";Grade 4 CD4 lymphocytes decreased;"<50/mm3; <0.05 x 10e9/L";CD4 lymphocytes decreased;10007839;LLT;20,1
2254;C143368;Cholesterol High, CTCAE;A finding based on laboratory test results that indicate higher than normal levels of cholesterol in a blood specimen.;Cholesterol high;A finding based on laboratory test results that indicate higher than normal levels of cholesterol in a blood specimen.;Cholesterol high;10008661;LLT;20,1
2255;C144030;Grade 1 Cholesterol High, CTCAE;">ULN-300 mg/dL; >ULN-7.75 mmol/L";Grade 1 Cholesterol high;">ULN-300 mg/dL; >ULN-7.75 mmol/L";Cholesterol high;10008661;LLT;20,1
2256;C144578;Grade 2 Cholesterol High, CTCAE;">300-400 mg/dL; >7.75-10.34 mmol/L";Grade 2 Cholesterol high;">300-400 mg/dL; >7.75-10.34 mmol/L";Cholesterol high;10008661;LLT;20,1
2257;C145195;Grade 3 Cholesterol High, CTCAE;">400-500 mg/dL; >10.34-12.92 mmol/L";Grade 3 Cholesterol high;">400-500 mg/dL; >10.34-12.92 mmol/L";Cholesterol high;10008661;LLT;20,1
2258;C145792;Grade 4 Cholesterol High, CTCAE;">500 mg/dL; >12.92 mmol/L";Grade 4 Cholesterol high;">500 mg/dL; >12.92 mmol/L";Cholesterol high;10008661;LLT;20,1
2259;C143389;CPK Increased, CTCAE;A finding based on laboratory test results that indicate an increase in levels of creatine phosphokinase in a blood specimen.;CPK increased;A finding based on laboratory test results that indicate an increase in levels of creatine phosphokinase in a blood specimen.;CPK increased;10011268;LLT;20,1
2260;C144042;Grade 1 CPK Increased, CTCAE;>ULN-2.5 x ULN;Grade 1 CPK increased;>ULN-2.5 x ULN;CPK increased;10011268;LLT;20,1
2261;C144593;Grade 2 CPK Increased, CTCAE;>2.5 x ULN-5 x ULN;Grade 2 CPK increased;>2.5 x ULN-5 x ULN;CPK increased;10011268;LLT;20,1
2262;C145211;Grade 3 CPK Increased, CTCAE;>5 x ULN-10 x ULN;Grade 3 CPK increased;>5 x ULN-10 x ULN;CPK increased;10011268;LLT;20,1
2263;C145807;Grade 4 CPK Increased, CTCAE;>10 x ULN;Grade 4 CPK increased;>10 x ULN;CPK increased;10011268;LLT;20,1
2264;C143391;Creatinine Increased, CTCAE;A finding based on laboratory test results that indicate increased levels of creatinine in a biological specimen.;Creatinine increased;A finding based on laboratory test results that indicate increased levels of creatinine in a biological specimen.;Creatinine increased;10011368;LLT;20,1
2265;C144043;Grade 1 Creatinine Increased, CTCAE;>ULN-1.5 x ULN;Grade 1 Creatinine increased;>ULN-1.5 x ULN;Creatinine increased;10011368;LLT;20,1
2266;C144594;Grade 2 Creatinine Increased, CTCAE;">1.5-3.0 x baseline; >1.5-3.0 x ULN";Grade 2 Creatinine increased;">1.5-3.0 x baseline; >1.5-3.0 x ULN";Creatinine increased;10011368;LLT;20,1
2267;C145213;Grade 3 Creatinine Increased, CTCAE;">3.0 x baseline; >3.0-6.0 x ULN";Grade 3 Creatinine increased;">3.0 x baseline; >3.0-6.0 x ULN";Creatinine increased;10011368;LLT;20,1
2268;C145809;Grade 4 Creatinine Increased, CTCAE;>6.0 x ULN;Grade 4 Creatinine increased;>6.0 x ULN;Creatinine increased;10011368;LLT;20,1
2269;C143436;Ejection Fraction Decreased, CTCAE;The percentage computed when the amount of blood ejected during a ventricular contraction of the heart is compared to the amount that was present prior to the contraction.;Ejection fraction decreased;The percentage computed when the amount of blood ejected during a ventricular contraction of the heart is compared to the amount that was present prior to the contraction.;Ejection fraction decreased;10050528;LLT;20,1
2270;C144630;Grade 2 Ejection Fraction Decreased, CTCAE;"Resting ejection fraction (EF) 50-40%; 10-19% drop from baseline";Grade 2 Ejection fraction decreased;"Resting ejection fraction (EF) 50-40%; 10-19% drop from baseline";Ejection fraction decreased;10050528;LLT;20,1
2271;C145246;Grade 3 Ejection Fraction Decreased, CTCAE;"Resting ejection fraction (EF) 39-20%; >=20% drop from baseline";Grade 3 Ejection fraction decreased;"Resting ejection fraction (EF) 39-20%; >=20% drop from baseline";Ejection fraction decreased;10050528;LLT;20,1
2272;C145828;Grade 4 Ejection Fraction Decreased, CTCAE;Resting ejection fraction (EF) <20%;Grade 4 Ejection fraction decreased;Resting ejection fraction (EF) <20%;Ejection fraction decreased;10050528;LLT;20,1
2273;C143437;Electrocardiogram QT Corrected Interval Prolonged, CTCAE;A finding of a cardiac dysrhythmia characterized by an abnormally long corrected QT interval.;Electrocardiogram QT corrected interval prolonged;A finding of a cardiac dysrhythmia characterized by an abnormally long corrected QT interval.;Electrocardiogram QT corrected interval prolonged;10014383;LLT;20,1
2274;C144075;Grade 1 Electrocardiogram QT Corrected Interval Prolonged, CTCAE;Average QTc 450-480 ms;Grade 1 Electrocardiogram QT corrected interval prolonged;Average QTc 450-480 ms;Electrocardiogram QT corrected interval prolonged;10014383;LLT;20,1
2275;C144631;Grade 2 Electrocardiogram QT Corrected Interval Prolonged, CTCAE;Average QTc 481-500 ms;Grade 2 Electrocardiogram QT corrected interval prolonged;Average QTc 481-500 ms;Electrocardiogram QT corrected interval prolonged;10014383;LLT;20,1
2276;C145247;Grade 3 Electrocardiogram QT Corrected Interval Prolonged, CTCAE;"Average QTc >= 501 ms; >60 ms change from baseline";Grade 3 Electrocardiogram QT corrected interval prolonged;"Average QTc >= 501 ms; >60 ms change from baseline";Electrocardiogram QT corrected interval prolonged;10014383;LLT;20,1
2277;C145829;Grade 4 Electrocardiogram QT Corrected Interval Prolonged, CTCAE;"Torsade de pointes; polymorphic ventricular tachycardia; signs/symptoms of serious arrhythmia";Grade 4 Electrocardiogram QT corrected interval prolonged;"Torsade de pointes; polymorphic ventricular tachycardia; signs/symptoms of serious arrhythmia";Electrocardiogram QT corrected interval prolonged;10014383;LLT;20,1
2278;C143219;Electrocardiogram T Wave Abnormal, CTCAE;A disorder characterized by Electrocardiogram T wave amplitude changes.;Electrocardiogram T wave abnormal;A disorder characterized by Electrocardiogram T wave amplitude changes.;Electrocardiogram T wave abnormal;10050380;LLT;20,1
2279;C144076;Grade 1 Electrocardiogram T Wave Abnormal, CTCAE;T wave flattening;Grade 1 Electrocardiogram T wave abnormal;T wave flattening;Electrocardiogram T wave abnormal;10050380;LLT;20,1
2280;C144632;Grade 2 Electrocardiogram T Wave Abnormal, CTCAE;Nonspecific ST segment change;Grade 2 Electrocardiogram T wave abnormal;Nonspecific ST segment change;Electrocardiogram T wave abnormal;10050380;LLT;20,1
2281;C143486;Fibrinogen Decreased, CTCAE;A finding based on laboratory test results that indicate an decrease in levels of fibrinogen in a blood specimen.;Fibrinogen decreased;A finding based on laboratory test results that indicate an decrease in levels of fibrinogen in a blood specimen.;Fibrinogen decreased;10016596;LLT;20,1
2282;C144105;Grade 1 Fibrinogen Decreased, CTCAE;"<1.0-0.75 x LLN; if abnormal, <25% decrease from baseline";Grade 1 Fibrinogen decreased;"<1.0-0.75 x LLN; if abnormal, <25% decrease from baseline";Fibrinogen decreased;10016596;LLT;20,1
2283;C144666;Grade 2 Fibrinogen Decreased, CTCAE;"<0.75-0.5 x LLN; if abnormal, 25-<50% decrease from baseline";Grade 2 Fibrinogen decreased;"<0.75-0.5 x LLN; if abnormal, 25-<50% decrease from baseline";Fibrinogen decreased;10016596;LLT;20,1
2284;C145286;Grade 3 Fibrinogen Decreased, CTCAE;"<0.5-0.25 x LLN; if abnormal, 50-<75% decrease from baseline";Grade 3 Fibrinogen decreased;"<0.5-0.25 x LLN; if abnormal, 50-<75% decrease from baseline";Fibrinogen decreased;10016596;LLT;20,1
2285;C145859;Grade 4 Fibrinogen Decreased, CTCAE;"<0.25 x LLN; if abnormal, 75% decrease from baseline; absolute value <50 mg/dL";Grade 4 Fibrinogen decreased;"<0.25 x LLN; if abnormal, 75% decrease from baseline; absolute value <50 mg/dL";Fibrinogen decreased;10016596;LLT;20,1
2286;C143494;Forced Expiratory Volume Decreased, CTCAE;A finding based on test results that indicate a relative decrease in the fraction of the forced vital capacity that is exhaled in a specific number of seconds.;Forced expiratory volume decreased;A finding based on test results that indicate a relative decrease in the fraction of the forced vital capacity that is exhaled in a specific number of seconds.;Forced expiratory volume decreased;10016987;LLT;20,1
2287;C144112;Grade 1 Forced Expiratory Volume Decreased, CTCAE;FEV1% (percentages of observed FEV1 and FVC related to their respective predicted values) 99-70% predicted;Grade 1 Forced expiratory volume decreased;FEV1% (percentages of observed FEV1 and FVC related to their respective predicted values) 99-70% predicted;Forced expiratory volume decreased;10016987;LLT;20,1
2288;C144673;Grade 2 Forced Expiratory Volume Decreased, CTCAE;FEV1 60-69%;Grade 2 Forced expiratory volume decreased;FEV1 60-69%;Forced expiratory volume decreased;10016987;LLT;20,1
2289;C145294;Grade 3 Forced Expiratory Volume Decreased, CTCAE;50-59%;Grade 3 Forced expiratory volume decreased;50-59%;Forced expiratory volume decreased;10016987;LLT;20,1
2290;C145861;Grade 4 Forced Expiratory Volume Decreased, CTCAE;<=49%;Grade 4 Forced expiratory volume decreased;<=49%;Forced expiratory volume decreased;10016987;LLT;20,1
2291;C143516;GGT Increased, CTCAE;A finding based on laboratory test results that indicate higher than normal levels of the enzyme gamma-glutamyltransferase in the blood specimen. GGT (gamma-glutamyltransferase ) catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, amino acids or water.;GGT increased;A finding based on laboratory test results that indicate higher than normal levels of the enzyme gamma-glutamyltransferase in the blood specimen. GGT (gamma-glutamyltransferase ) catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, amino acids or water.;GGT increased;10056910;LLT;20,1
2292;C144129;Grade 1 GGT Increased, CTCAE;">ULN-2.5 x ULN if baseline was normal; 2.0-2.5 x baseline if baseline was abnormal";Grade 1 GGT increased;">ULN-2.5 x ULN if baseline was normal; 2.0-2.5 x baseline if baseline was abnormal";GGT increased;10056910;LLT;20,1
2293;C144694;Grade 2 GGT Increased, CTCAE;">2.5-5.0 x ULN if baseline was normal; >2.5-5.0 x baseline if baseline was abnormal";Grade 2 GGT increased;">2.5-5.0 x ULN if baseline was normal; >2.5-5.0 x baseline if baseline was abnormal";GGT increased;10056910;LLT;20,1
2294;C145316;Grade 3 GGT Increased, CTCAE;">5.0-20.0 x ULN if baseline was normal; >5.0-20.0 x baseline if baseline was abnormal";Grade 3 GGT increased;">5.0-20.0 x ULN if baseline was normal; >5.0-20.0 x baseline if baseline was abnormal";GGT increased;10056910;LLT;20,1
2295;C145877;Grade 4 GGT Increased, CTCAE;">20.0 x ULN if baseline was normal; >20.0 x baseline if baseline was abnormal";Grade 4 GGT increased;">20.0 x ULN if baseline was normal; >20.0 x baseline if baseline was abnormal";GGT increased;10056910;LLT;20,1
2296;C143521;Growth Hormone Abnormal, CTCAE;A finding based on laboratory test results that indicate abnormal levels of growth hormone in a biological specimen.;Growth hormone abnormal;A finding based on laboratory test results that indicate abnormal levels of growth hormone in a biological specimen.;Growth hormone abnormal;10018748;LLT;20,1
2297;C144134;Grade 1 Growth Hormone Abnormal, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Growth hormone abnormal;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Growth hormone abnormal;10018748;LLT;20,1
2298;C144699;Grade 2 Growth Hormone Abnormal, CTCAE;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Grade 2 Growth hormone abnormal;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Growth hormone abnormal;10018748;LLT;20,1
2299;C143526;Haptoglobin Decreased, CTCAE;A finding based on laboratory test results that indicate an decrease in levels of haptoglobin in a blood specimen.;Haptoglobin decreased;A finding based on laboratory test results that indicate an decrease in levels of haptoglobin in a blood specimen.;Haptoglobin decreased;10019150;LLT;20,1
2300;C144142;Grade 1 Haptoglobin Decreased, CTCAE;<LLN;Grade 1 Haptoglobin decreased;<LLN;Haptoglobin decreased;10019150;LLT;20,1
2301;C143533;Hemoglobin Increased, CTCAE;A finding based on laboratory test results that indicate increased levels of hemoglobin above normal.;Hemoglobin increased;A finding based on laboratory test results that indicate increased levels of hemoglobin above normal.;Hemoglobin increased;10055599;LLT;20,1
2302;C144148;Grade 1 Hemoglobin Increased, CTCAE;Increase in >0-2 g/dL;Grade 1 Hemoglobin increased;Increase in >0-2 g/dL;Hemoglobin increased;10055599;LLT;20,1
2303;C144709;Grade 2 Hemoglobin Increased, CTCAE;Increase in >2-4 g/dL;Grade 2 Hemoglobin increased;Increase in >2-4 g/dL;Hemoglobin increased;10055599;LLT;20,1
2304;C145329;Grade 3 Hemoglobin Increased, CTCAE;Increase in >4 g/dL;Grade 3 Hemoglobin increased;Increase in >4 g/dL;Hemoglobin increased;10055599;LLT;20,1
2305;C143590;INR Increased, CTCAE;A finding based on laboratory test results that indicate an increase in the ratio of the patient's prothrombin time to a control sample in the blood.;INR increased;A finding based on laboratory test results that indicate an increase in the ratio of the patient's prothrombin time to a control sample in the blood.;INR increased;10022402;LLT;20,1
2306;C144201;Grade 1 INR Increased, CTCAE;">1.2-1.5; >1-1.5 x baseline if on anticoagulation; monitoring only indicated";Grade 1 INR increased;">1.2-1.5; >1-1.5 x baseline if on anticoagulation; monitoring only indicated";INR increased;10022402;LLT;20,1
2307;C144766;Grade 2 INR Increased, CTCAE;">1.5-2.5; >1.5-2.5 x baseline if on anticoagulation; dose adjustment indicated";Grade 2 INR increased;">1.5-2.5; >1.5-2.5 x baseline if on anticoagulation; dose adjustment indicated";INR increased;10022402;LLT;20,1
2308;C145388;Grade 3 INR Increased, CTCAE;">2.5; >2.5 x baseline if on anticoagulation; bleeding";Grade 3 INR increased;">2.5; >2.5 x baseline if on anticoagulation; bleeding";INR increased;10022402;LLT;20,1
2309;C143615;Investigations - Other, Specify, CTCAE;;Investigations - Other, specify;;Investigations - Other, specify;10022891;LLT;20,1
2310;C144220;Grade 1 Investigations - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Investigations - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Investigations - Other, specify;10022891;LLT;20,1
2311;C144788;Grade 2 Investigations - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Investigations - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Investigations - Other, specify;10022891;LLT;20,1
2312;C145412;Grade 3 Investigations - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Investigations - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Investigations - Other, specify;10022891;LLT;20,1
2313;C145960;Grade 4 Investigations - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Investigations - Other, specify;"Life-threatening consequences; urgent intervention indicated";Investigations - Other, specify;10022891;LLT;20,1
2314;C146407;Grade 5 Investigations - Other, Specify, CTCAE;Death;Grade 5 Investigations - Other, specify;Death;Investigations - Other, specify;10022891;LLT;20,1
2315;C143652;Lipase Increased, CTCAE;A finding based on laboratory test results that indicate an increase in the level of lipase in a biological specimen.;Lipase increased;A finding based on laboratory test results that indicate an increase in the level of lipase in a biological specimen.;Lipase increased;10024574;LLT;20,1
2316;C144249;Grade 1 Lipase Increased, CTCAE;>ULN-1.5 x ULN;Grade 1 Lipase increased;>ULN-1.5 x ULN;Lipase increased;10024574;LLT;20,1
2317;C144821;Grade 2 Lipase Increased, CTCAE;">1.5-2.0 x ULN; >2.0-5.0 x ULN and asymptomatic";Grade 2 Lipase increased;">1.5-2.0 x ULN; >2.0-5.0 x ULN and asymptomatic";Lipase increased;10024574;LLT;20,1
2318;C145441;Grade 3 Lipase Increased, CTCAE;">2.0-5.0 x ULN with signs or symptoms; >5.0 x ULN and asymptomatic";Grade 3 Lipase increased;">2.0-5.0 x ULN with signs or symptoms; >5.0 x ULN and asymptomatic";Lipase increased;10024574;LLT;20,1
2319;C145983;Grade 4 Lipase Increased, CTCAE;>5.0 x ULN and with signs or symptoms;Grade 4 Lipase increased;>5.0 x ULN and with signs or symptoms;Lipase increased;10024574;LLT;20,1
2320;C143662;Lymphocyte Count Decreased, CTCAE;A finding based on laboratory test results that indicate a decrease in number of lymphocytes in a blood specimen.;Lymphocyte count decreased;A finding based on laboratory test results that indicate a decrease in number of lymphocytes in a blood specimen.;Lymphocyte count decreased;10025256;LLT;20,1
2321;C144255;Grade 1 Lymphocyte Count Decreased, CTCAE;"<LLN-800/mm3; <LLN-0.8 x 10e9/L";Grade 1 Lymphocyte count decreased;"<LLN-800/mm3; <LLN-0.8 x 10e9/L";Lymphocyte count decreased;10025256;LLT;20,1
2322;C144830;Grade 2 Lymphocyte Count Decreased, CTCAE;"<800-500/mm3; <0.8-0.5 x 10e9/L";Grade 2 Lymphocyte count decreased;"<800-500/mm3; <0.8-0.5 x 10e9/L";Lymphocyte count decreased;10025256;LLT;20,1
2323;C145450;Grade 3 Lymphocyte Count Decreased, CTCAE;"<500-200/mm3; <0.5-0.2 x 10e9/L";Grade 3 Lymphocyte count decreased;"<500-200/mm3; <0.5-0.2 x 10e9/L";Lymphocyte count decreased;10025256;LLT;20,1
2324;C145988;Grade 4 Lymphocyte Count Decreased, CTCAE;"<200/mm3; <0.2 x 10e9/L";Grade 4 Lymphocyte count decreased;"<200/mm3; <0.2 x 10e9/L";Lymphocyte count decreased;10025256;LLT;20,1
2325;C143663;Lymphocyte Count Increased, CTCAE;A finding based on laboratory test results that indicate an abnormal increase in the number of lymphocytes in the blood, effusions or bone marrow.;Lymphocyte count increased;A finding based on laboratory test results that indicate an abnormal increase in the number of lymphocytes in the blood, effusions or bone marrow.;Lymphocyte count increased;10025258;LLT;20,1
2326;C144831;Grade 2 Lymphocyte Count Increased, CTCAE;>4000/mm3-20,000/mm3;Grade 2 Lymphocyte count increased;>4000/mm3-20,000/mm3;Lymphocyte count increased;10025258;LLT;20,1
2327;C145451;Grade 3 Lymphocyte Count Increased, CTCAE;>20,000/mm3;Grade 3 Lymphocyte count increased;>20,000/mm3;Lymphocyte count increased;10025258;LLT;20,1
2328;C143704;Neutrophil Count Decreased, CTCAE;A finding based on laboratory test results that indicate a decrease in number of neutrophils in a blood specimen.;Neutrophil count decreased;A finding based on laboratory test results that indicate a decrease in number of neutrophils in a blood specimen.;Neutrophil count decreased;10029366;LLT;20,1
2329;C144289;Grade 1 Neutrophil Count Decreased, CTCAE;"<LLN-1500/mm3; <LLN-1.5 x 10e9/L";Grade 1 Neutrophil count decreased;"<LLN-1500/mm3; <LLN-1.5 x 10e9/L";Neutrophil count decreased;10029366;LLT;20,1
2330;C144865;Grade 2 Neutrophil Count Decreased, CTCAE;"<1500-1000/mm3; <1.5-1.0 x 10e9/L";Grade 2 Neutrophil count decreased;"<1500-1000/mm3; <1.5-1.0 x 10e9/L";Neutrophil count decreased;10029366;LLT;20,1
2331;C145487;Grade 3 Neutrophil Count Decreased, CTCAE;"<1000-500/mm3; <1.0-0.5 x 10e9/L";Grade 3 Neutrophil count decreased;"<1000-500/mm3; <1.0-0.5 x 10e9/L";Neutrophil count decreased;10029366;LLT;20,1
2332;C146012;Grade 4 Neutrophil Count Decreased, CTCAE;"<500/mm3; <0.5 x 10e9/L";Grade 4 Neutrophil count decreased;"<500/mm3; <0.5 x 10e9/L";Neutrophil count decreased;10029366;LLT;20,1
2333;C143731;Pancreatic Enzymes Decreased, CTCAE;A finding based on laboratory test results that indicate an decrease in levels of pancreatic enzymes in a biological specimen.;Pancreatic enzymes decreased;A finding based on laboratory test results that indicate an decrease in levels of pancreatic enzymes in a biological specimen.;Pancreatic enzymes decreased;10062646;LLT;20,1
2334;C144313;Grade 1 Pancreatic Enzymes Decreased, CTCAE;<LLN and asymptomatic;Grade 1 Pancreatic enzymes decreased;<LLN and asymptomatic;Pancreatic enzymes decreased;10062646;LLT;20,1
2335;C144892;Grade 2 Pancreatic Enzymes Decreased, CTCAE;"Increase in stool frequency, bulk, or odor; steatorrhea";Grade 2 Pancreatic enzymes decreased;"Increase in stool frequency, bulk, or odor; steatorrhea";Pancreatic enzymes decreased;10062646;LLT;20,1
2336;C145513;Grade 3 Pancreatic Enzymes Decreased, CTCAE;Sequelae of absorption deficiency;Grade 3 Pancreatic enzymes decreased;Sequelae of absorption deficiency;Pancreatic enzymes decreased;10062646;LLT;20,1
2337;C143764;Platelet Count Decreased, CTCAE;A finding based on laboratory test results that indicate a decrease in number of platelets in a blood specimen.;Platelet count decreased;A finding based on laboratory test results that indicate a decrease in number of platelets in a blood specimen.;Platelet count decreased;10035528;LLT;20,1
2338;C144338;Grade 1 Platelet Count Decreased, CTCAE;"<LLN-75,000/mm3; <LLN-75.0 x 10e9/L";Grade 1 Platelet count decreased;"<LLN-75,000/mm3; <LLN-75.0 x 10e9/L";Platelet count decreased;10035528;LLT;20,1
2339;C144924;Grade 2 Platelet Count Decreased, CTCAE;"<75,000-50,000/mm3; <75.0-50.0 x 10e9/L";Grade 2 Platelet count decreased;"<75,000-50,000/mm3; <75.0-50.0 x 10e9/L";Platelet count decreased;10035528;LLT;20,1
2340;C145549;Grade 3 Platelet Count Decreased, CTCAE;"<50,000-25,000/mm3; <50.0-25.0 x 10e9/L";Grade 3 Platelet count decreased;"<50,000-25,000/mm3; <50.0-25.0 x 10e9/L";Platelet count decreased;10035528;LLT;20,1
2341;C146055;Grade 4 Platelet Count Decreased, CTCAE;"<25,000/mm3; <25.0 x 10e9/L";Grade 4 Platelet count decreased;"<25,000/mm3; <25.0 x 10e9/L";Platelet count decreased;10035528;LLT;20,1
2342;C143829;Serum Amylase Increased, CTCAE;A finding based on laboratory test results that indicate an increase in the levels of amylase in a serum specimen.;Serum amylase increased;A finding based on laboratory test results that indicate an increase in the levels of amylase in a serum specimen.;Serum amylase increased;10040139;LLT;20,1
2343;C144393;Grade 1 Serum Amylase Increased, CTCAE;>ULN-1.5 x ULN;Grade 1 Serum amylase increased;>ULN-1.5 x ULN;Serum amylase increased;10040139;LLT;20,1
2344;C144990;Grade 2 Serum Amylase Increased, CTCAE;">1.5-2.0 x ULN; >2.0-5.0 x ULN and asymptomatic";Grade 2 Serum amylase increased;">1.5-2.0 x ULN; >2.0-5.0 x ULN and asymptomatic";Serum amylase increased;10040139;LLT;20,1
2345;C145612;Grade 3 Serum Amylase Increased, CTCAE;">2.0-5.0 x ULN with signs or symptoms; >5.0 x ULN and asymptomatic";Grade 3 Serum amylase increased;">2.0-5.0 x ULN with signs or symptoms; >5.0 x ULN and asymptomatic";Serum amylase increased;10040139;LLT;20,1
2346;C146105;Grade 4 Serum Amylase Increased, CTCAE;>5.0 x ULN and with signs or symptoms;Grade 4 Serum amylase increased;>5.0 x ULN and with signs or symptoms;Serum amylase increased;10040139;LLT;20,1
2347;C143220;Thyroid Stimulating Hormone Increased, CTCAE;A disorder characterized by an increase in thyroid stimulating hormone.;Thyroid stimulating hormone increased;A disorder characterized by an increase in thyroid stimulating hormone.;Thyroid stimulating hormone increased;10043770;LLT;20,1
2348;C144432;Grade 1 Thyroid Stimulating Hormone Increased, CTCAE;TSH increased and no intervention initiated;Grade 1 Thyroid stimulating hormone increased;TSH increased and no intervention initiated;Thyroid stimulating hormone increased;10043770;LLT;20,1
2349;C143909;Urine Output Decreased, CTCAE;A finding based on test results that indicate urine production is less relative to previous output.;Urine output decreased;A finding based on test results that indicate urine production is less relative to previous output.;Urine output decreased;10059895;LLT;20,1
2350;C145685;Grade 3 Urine Output Decreased, CTCAE;"Adult: Oliguria (<80 ml in 8 hr); Infants: < 0.5 mL/kg per hour for 24 hours; Children: < 500 mL/1.73 m2 body surface area per day";Grade 3 Urine output decreased;"Adult: Oliguria (<80 ml in 8 hr); Infants: < 0.5 mL/kg per hour for 24 hours; Children: < 500 mL/1.73 m2 body surface area per day";Urine output decreased;10059895;LLT;20,1
2351;C146168;Grade 4 Urine Output Decreased, CTCAE;"Adult: Anuria (<240 ml in 24 hr); Pediatric: No urine output over 12 hours";Grade 4 Urine output decreased;"Adult: Anuria (<240 ml in 24 hr); Pediatric: No urine output over 12 hours";Urine output decreased;10059895;LLT;20,1
2352;C143939;Vital Capacity Abnormal, CTCAE;A finding based on pulmonary function test results that indicate an abnormal vital capacity (amount of exhaled after a maximum inhalation) when compared to the predicted value.;Vital capacity abnormal;A finding based on pulmonary function test results that indicate an abnormal vital capacity (amount of exhaled after a maximum inhalation) when compared to the predicted value.;Vital capacity abnormal;10047580;LLT;20,1
2353;C144484;Grade 1 Vital Capacity Abnormal, CTCAE;90-75% of predicted value;Grade 1 Vital capacity abnormal;90-75% of predicted value;Vital capacity abnormal;10047580;LLT;20,1
2354;C145100;Grade 2 Vital Capacity Abnormal, CTCAE;"<75-50% of predicted value; limiting instrumental ADL";Grade 2 Vital capacity abnormal;"<75-50% of predicted value; limiting instrumental ADL";Vital capacity abnormal;10047580;LLT;20,1
2355;C145720;Grade 3 Vital Capacity Abnormal, CTCAE;"<50% of predicted value; limiting self care ADL";Grade 3 Vital capacity abnormal;"<50% of predicted value; limiting self care ADL";Vital capacity abnormal;10047580;LLT;20,1
2356;C55338;Weight Gain, CTCAE;"A finding characterized by an unexpected or abnormal increase in overall body weight; for pediatrics, greater than the baseline growth curve.";Weight gain;"A finding characterized by an unexpected or abnormal increase in overall body weight; for pediatrics, greater than the baseline growth curve.";Weight gain;10047896;LLT;20,1
2357;C55298;Grade 1 Weight Gain, CTCAE;5-<10% from baseline;Grade 1 Weight gain;5-<10% from baseline;Weight gain;10047896;LLT;20,1
2358;C55309;Grade 2 Weight Gain, CTCAE;10-<20% from baseline;Grade 2 Weight gain;10-<20% from baseline;Weight gain;10047896;LLT;20,1
2359;C55318;Grade 3 Weight Gain, CTCAE;>=20% from baseline;Grade 3 Weight gain;>=20% from baseline;Weight gain;10047896;LLT;20,1
2360;C55339;Weight Loss, CTCAE;"A finding characterized by a decrease in overall body weight; for pediatrics, less than the baseline growth curve.";Weight loss;"A finding characterized by a decrease in overall body weight; for pediatrics, less than the baseline growth curve.";Weight loss;10047900;LLT;20,1
2361;C55299;Grade 1 Weight Loss, CTCAE;"5 to <10% from baseline; intervention not indicated";Grade 1 Weight loss;"5 to <10% from baseline; intervention not indicated";Weight loss;10047900;LLT;20,1
2362;C55310;Grade 2 Weight Loss, CTCAE;"10-<20% from baseline; nutritional support indicated";Grade 2 Weight loss;"10-<20% from baseline; nutritional support indicated";Weight loss;10047900;LLT;20,1
2363;C55319;Grade 3 Weight Loss, CTCAE;">=20% from baseline; tube feeding or TPN indicated";Grade 3 Weight loss;">=20% from baseline; tube feeding or TPN indicated";Weight loss;10047900;LLT;20,1
2364;C143948;White Blood Cell Decreased, CTCAE;A finding based on laboratory test results that indicate an decrease in number of white blood cells in a blood specimen.;White blood cell decreased;A finding based on laboratory test results that indicate an decrease in number of white blood cells in a blood specimen.;White blood cell decreased;10049182;LLT;20,1
2365;C144489;Grade 1 White Blood Cell Decreased, CTCAE;"<LLN-3000/mm3; <LLN-3.0 x 10e9/L";Grade 1 White blood cell decreased;"<LLN-3000/mm3; <LLN-3.0 x 10e9/L";White blood cell decreased;10049182;LLT;20,1
2366;C145105;Grade 2 White Blood Cell Decreased, CTCAE;"<3000-2000/mm3; <3.0-2.0 x 10e9/L";Grade 2 White blood cell decreased;"<3000-2000/mm3; <3.0-2.0 x 10e9/L";White blood cell decreased;10049182;LLT;20,1
2367;C145725;Grade 3 White Blood Cell Decreased, CTCAE;"<2000-1000/mm3; <2.0-1.0 x 10e9/L";Grade 3 White blood cell decreased;"<2000-1000/mm3; <2.0-1.0 x 10e9/L";White blood cell decreased;10049182;LLT;20,1
2368;C146198;Grade 4 White Blood Cell Decreased, CTCAE;"<1000/mm3; <1.0 x 10e9/L";Grade 4 White blood cell decreased;"<1000/mm3; <1.0 x 10e9/L";White blood cell decreased;10049182;LLT;20,1
2369;C143174;Metabolism and Nutrition Disorders, CTCAE;;;;;;;
2370;C143259;Acidosis, CTCAE;A disorder characterized by abnormally high acidity (high hydrogen-ion concentration) of the blood and other body tissues.;Acidosis;A disorder characterized by abnormally high acidity (high hydrogen-ion concentration) of the blood and other body tissues.;Acidosis;10000486;LLT;20,1
2371;C143962;Grade 1 Acidosis, CTCAE;pH <normal, but >=7.3;Grade 1 Acidosis;pH <normal, but >=7.3;Acidosis;10000486;LLT;20,1
2372;C145116;Grade 3 Acidosis, CTCAE;pH <7.3;Grade 3 Acidosis;pH <7.3;Acidosis;10000486;LLT;20,1
2373;C145732;Grade 4 Acidosis, CTCAE;Life-threatening consequences;Grade 4 Acidosis;Life-threatening consequences;Acidosis;10000486;LLT;20,1
2374;C146204;Grade 5 Acidosis, CTCAE;Death;Grade 5 Acidosis;Death;Acidosis;10000486;LLT;20,1
2375;C143268;Alcohol Intolerance, CTCAE;A disorder characterized by an increase in sensitivity to the adverse effects of alcohol, which can include nasal congestion, skin flushes, heart dysrhythmias, nausea, vomiting, indigestion and headaches.;Alcohol intolerance;A disorder characterized by an increase in sensitivity to the adverse effects of alcohol, which can include nasal congestion, skin flushes, heart dysrhythmias, nausea, vomiting, indigestion and headaches.;Alcohol intolerance;10001598;LLT;20,1
2376;C144504;Grade 2 Alcohol Intolerance, CTCAE;Present;Grade 2 Alcohol intolerance;Present;Alcohol intolerance;10001598;LLT;20,1
2377;C145122;Grade 3 Alcohol Intolerance, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Alcohol intolerance;"Severe symptoms; limiting self care ADL";Alcohol intolerance;10001598;LLT;20,1
2378;C145735;Grade 4 Alcohol Intolerance, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Alcohol intolerance;"Life-threatening consequences; urgent intervention indicated";Alcohol intolerance;10001598;LLT;20,1
2379;C146206;Grade 5 Alcohol Intolerance, CTCAE;Death;Grade 5 Alcohol intolerance;Death;Alcohol intolerance;10001598;LLT;20,1
2380;C143270;Alkalosis, CTCAE;A disorder characterized by abnormally high alkalinity (low hydrogen-ion concentration) of the blood and other body tissues.;Alkalosis;A disorder characterized by abnormally high alkalinity (low hydrogen-ion concentration) of the blood and other body tissues.;Alkalosis;10001680;LLT;20,1
2381;C143968;Grade 1 Alkalosis, CTCAE;pH >normal, but <=7.5;Grade 1 Alkalosis;pH >normal, but <=7.5;Alkalosis;10001680;LLT;20,1
2382;C145124;Grade 3 Alkalosis, CTCAE;pH >7.5;Grade 3 Alkalosis;pH >7.5;Alkalosis;10001680;LLT;20,1
2383;C145737;Grade 4 Alkalosis, CTCAE;Life-threatening consequences;Grade 4 Alkalosis;Life-threatening consequences;Alkalosis;10001680;LLT;20,1
2384;C146207;Grade 5 Alkalosis, CTCAE;Death;Grade 5 Alkalosis;Death;Alkalosis;10001680;LLT;20,1
2385;C57118;Anorexia, CTCAE;A disorder characterized by a loss of appetite.;Anorexia;A disorder characterized by a loss of appetite.;Anorexia;10002646;LLT;20,1
2386;C57145;Grade 1 Anorexia, CTCAE;Loss of appetite without alteration in eating habits;Grade 1 Anorexia;Loss of appetite without alteration in eating habits;Anorexia;10002646;LLT;20,1
2387;C57268;Grade 2 Anorexia, CTCAE;"Oral intake altered without significant weight loss or malnutrition; oral nutritional supplements indicated";Grade 2 Anorexia;"Oral intake altered without significant weight loss or malnutrition; oral nutritional supplements indicated";Anorexia;10002646;LLT;20,1
2388;C57391;Grade 3 Anorexia, CTCAE;"Associated with significant weight loss or malnutrition (e.g., inadequate oral caloric and/or fluid intake); tube feeding or TPN indicated";Grade 3 Anorexia;"Associated with significant weight loss or malnutrition (e.g., inadequate oral caloric and/or fluid intake); tube feeding or TPN indicated";Anorexia;10002646;LLT;20,1
2389;C57528;Grade 4 Anorexia, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Anorexia;"Life-threatening consequences; urgent intervention indicated";Anorexia;10002646;LLT;20,1
2390;C57659;Grade 5 Anorexia, CTCAE;Death;Grade 5 Anorexia;Death;Anorexia;10002646;LLT;20,1
2391;C57787;Dehydration, CTCAE;A disorder characterized by excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.;Dehydration;A disorder characterized by excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.;Dehydration;10012174;LLT;20,1
2392;C57169;Grade 1 Dehydration, CTCAE;"Increased oral fluids indicated; dry mucous membranes; diminished skin turgor";Grade 1 Dehydration;"Increased oral fluids indicated; dry mucous membranes; diminished skin turgor";Dehydration;10012174;LLT;20,1
2393;C57292;Grade 2 Dehydration, CTCAE;IV fluids indicated;Grade 2 Dehydration;IV fluids indicated;Dehydration;10012174;LLT;20,1
2394;C57417;Grade 3 Dehydration, CTCAE;Hospitalization indicated;Grade 3 Dehydration;Hospitalization indicated;Dehydration;10012174;LLT;20,1
2395;C57552;Grade 4 Dehydration, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Dehydration;"Life-threatening consequences; urgent intervention indicated";Dehydration;10012174;LLT;20,1
2396;C57683;Grade 5 Dehydration, CTCAE;Death;Grade 5 Dehydration;Death;Dehydration;10012174;LLT;20,1
2397;C143519;Glucose Intolerance, CTCAE;A disorder characterized by an inability to properly metabolize glucose.;Glucose intolerance;A disorder characterized by an inability to properly metabolize glucose.;Glucose intolerance;10052426;LLT;20,1
2398;C144132;Grade 1 Glucose Intolerance, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Glucose intolerance;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Glucose intolerance;10052426;LLT;20,1
2399;C144697;Grade 2 Glucose Intolerance, CTCAE;"Symptomatic; dietary modification or oral agent indicated";Grade 2 Glucose intolerance;"Symptomatic; dietary modification or oral agent indicated";Glucose intolerance;10052426;LLT;20,1
2400;C145319;Grade 3 Glucose Intolerance, CTCAE;"Severe symptoms; insulin indicated";Grade 3 Glucose intolerance;"Severe symptoms; insulin indicated";Glucose intolerance;10052426;LLT;20,1
2401;C145879;Grade 4 Glucose Intolerance, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Glucose intolerance;"Life-threatening consequences; urgent intervention indicated";Glucose intolerance;10052426;LLT;20,1
2402;C146329;Grade 5 Glucose Intolerance, CTCAE;Death;Grade 5 Glucose intolerance;Death;Glucose intolerance;10052426;LLT;20,1
2403;C143551;Hypercalcemia, CTCAE;A disorder characterized by laboratory test results that indicate an elevation in the concentration of calcium (corrected for albumin) in blood.;Hypercalcemia;A disorder characterized by laboratory test results that indicate an elevation in the concentration of calcium (corrected for albumin) in blood.;Hypercalcemia;10020587;LLT;20,1
2404;C144160;Grade 1 Hypercalcemia, CTCAE;"Corrected serum calcium of >ULN-11.5 mg/dL; >ULN-2.9 mmol/L; Ionized calcium >ULN-1.5 mmol/L";Grade 1 Hypercalcemia;"Corrected serum calcium of >ULN-11.5 mg/dL; >ULN-2.9 mmol/L; Ionized calcium >ULN-1.5 mmol/L";Hypercalcemia;10020587;LLT;20,1
2405;C144723;Grade 2 Hypercalcemia, CTCAE;"Corrected serum calcium of >11.5-12.5 mg/dL; >2.9-3.1 mmol/L; Ionized calcium >1.5-1.6 mmol/L; symptomatic";Grade 2 Hypercalcemia;"Corrected serum calcium of >11.5-12.5 mg/dL; >2.9-3.1 mmol/L; Ionized calcium >1.5-1.6 mmol/L; symptomatic";Hypercalcemia;10020587;LLT;20,1
2406;C145344;Grade 3 Hypercalcemia, CTCAE;"Corrected serum calcium of >12.5-13.5 mg/dL; >3.1-3.4 mmol/L; Ionized calcium >1.6-1.8 mmol/L; hospitalization indicated";Grade 3 Hypercalcemia;"Corrected serum calcium of >12.5-13.5 mg/dL; >3.1-3.4 mmol/L; Ionized calcium >1.6-1.8 mmol/L; hospitalization indicated";Hypercalcemia;10020587;LLT;20,1
2407;C145897;Grade 4 Hypercalcemia, CTCAE;"Corrected serum calcium of >13.5 mg/dL; >3.4 mmol/L; Ionized calcium >1.8 mmol/L; life-threatening consequences";Grade 4 Hypercalcemia;"Corrected serum calcium of >13.5 mg/dL; >3.4 mmol/L; Ionized calcium >1.8 mmol/L; life-threatening consequences";Hypercalcemia;10020587;LLT;20,1
2408;C146345;Grade 5 Hypercalcemia, CTCAE;Death;Grade 5 Hypercalcemia;Death;Hypercalcemia;10020587;LLT;20,1
2409;C143552;Hyperglycemia, CTCAE;A disorder characterized by laboratory test results that indicate an elevation in the concentration of blood sugar. It is usually an indication of diabetes mellitus or glucose intolerance.;Hyperglycemia;A disorder characterized by laboratory test results that indicate an elevation in the concentration of blood sugar. It is usually an indication of diabetes mellitus or glucose intolerance.;Hyperglycemia;10020639;LLT;20,1
2410;C144161;Grade 1 Hyperglycemia, CTCAE;Abnormal glucose above baseline with no medical intervention;Grade 1 Hyperglycemia;Abnormal glucose above baseline with no medical intervention;Hyperglycemia;10020639;LLT;20,1
2411;C144724;Grade 2 Hyperglycemia, CTCAE;"Change in daily management from baseline for a diabetic; oral antiglycemic agent initiated; workup for diabetes";Grade 2 Hyperglycemia;"Change in daily management from baseline for a diabetic; oral antiglycemic agent initiated; workup for diabetes";Hyperglycemia;10020639;LLT;20,1
2412;C145345;Grade 3 Hyperglycemia, CTCAE;"Insulin therapy initiated; hospitalization indicated";Grade 3 Hyperglycemia;"Insulin therapy initiated; hospitalization indicated";Hyperglycemia;10020639;LLT;20,1
2413;C145898;Grade 4 Hyperglycemia, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hyperglycemia;"Life-threatening consequences; urgent intervention indicated";Hyperglycemia;10020639;LLT;20,1
2414;C146346;Grade 5 Hyperglycemia, CTCAE;Death;Grade 5 Hyperglycemia;Death;Hyperglycemia;10020639;LLT;20,1
2415;C143554;Hyperkalemia, CTCAE;"A disorder characterized by laboratory test results that indicate an elevation in the concentration of potassium in the blood; associated with kidney failure or sometimes with the use of diuretic drugs.";Hyperkalemia;"A disorder characterized by laboratory test results that indicate an elevation in the concentration of potassium in the blood; associated with kidney failure or sometimes with the use of diuretic drugs.";Hyperkalemia;10020647;LLT;20,1
2416;C144163;Grade 1 Hyperkalemia, CTCAE;>ULN-5.5 mmol/L;Grade 1 Hyperkalemia;>ULN-5.5 mmol/L;Hyperkalemia;10020647;LLT;20,1
2417;C144726;Grade 2 Hyperkalemia, CTCAE;">5.5-6.0 mmol/L; intervention initiated";Grade 2 Hyperkalemia;">5.5-6.0 mmol/L; intervention initiated";Hyperkalemia;10020647;LLT;20,1
2418;C145347;Grade 3 Hyperkalemia, CTCAE;">6.0-7.0 mmol/L; hospitalization indicated";Grade 3 Hyperkalemia;">6.0-7.0 mmol/L; hospitalization indicated";Hyperkalemia;10020647;LLT;20,1
2419;C145899;Grade 4 Hyperkalemia, CTCAE;">7.0 mmol/L; life-threatening consequences";Grade 4 Hyperkalemia;">7.0 mmol/L; life-threatening consequences";Hyperkalemia;10020647;LLT;20,1
2420;C146347;Grade 5 Hyperkalemia, CTCAE;Death;Grade 5 Hyperkalemia;Death;Hyperkalemia;10020647;LLT;20,1
2421;C143221;Hyperlipidemia, CTCAE;A disorder characterized by laboratory test results that indicate an elevation in the concentration of lipids in blood.;Hyperlipidemia;A disorder characterized by laboratory test results that indicate an elevation in the concentration of lipids in blood.;Hyperlipidemia;10020667;LLT;20,1
2422;C144165;Grade 1 Hyperlipidemia, CTCAE;Requiring diet changes;Grade 1 Hyperlipidemia;Requiring diet changes;Hyperlipidemia;10020667;LLT;20,1
2423;C144727;Grade 2 Hyperlipidemia, CTCAE;Requiring pharmaceutical intervention;Grade 2 Hyperlipidemia;Requiring pharmaceutical intervention;Hyperlipidemia;10020667;LLT;20,1
2424;C145349;Grade 3 Hyperlipidemia, CTCAE;"Hospitalization; pancreatitis";Grade 3 Hyperlipidemia;"Hospitalization; pancreatitis";Hyperlipidemia;10020667;LLT;20,1
2425;C145900;Grade 4 Hyperlipidemia, CTCAE;Life-threatening consequences;Grade 4 Hyperlipidemia;Life-threatening consequences;Hyperlipidemia;10020667;LLT;20,1
2426;C143555;Hypermagnesemia, CTCAE;A disorder characterized by laboratory test results that indicate an elevation in the concentration of magnesium in the blood.;Hypermagnesemia;A disorder characterized by laboratory test results that indicate an elevation in the concentration of magnesium in the blood.;Hypermagnesemia;10020670;LLT;20,1
2427;C144166;Grade 1 Hypermagnesemia, CTCAE;">ULN-3.0 mg/dL; >ULN-1.23 mmol/L";Grade 1 Hypermagnesemia;">ULN-3.0 mg/dL; >ULN-1.23 mmol/L";Hypermagnesemia;10020670;LLT;20,1
2428;C145350;Grade 3 Hypermagnesemia, CTCAE;">3.0-8.0 mg/dL; >1.23-3.30 mmol/L";Grade 3 Hypermagnesemia;">3.0-8.0 mg/dL; >1.23-3.30 mmol/L";Hypermagnesemia;10020670;LLT;20,1
2429;C145901;Grade 4 Hypermagnesemia, CTCAE;">8.0 mg/dL; >3.30 mmol/L; life-threatening consequences";Grade 4 Hypermagnesemia;">8.0 mg/dL; >3.30 mmol/L; life-threatening consequences";Hypermagnesemia;10020670;LLT;20,1
2430;C146348;Grade 5 Hypermagnesemia, CTCAE;Death;Grade 5 Hypermagnesemia;Death;Hypermagnesemia;10020670;LLT;20,1
2431;C143556;Hypernatremia, CTCAE;A disorder characterized by laboratory test results that indicate an elevation in the concentration of sodium in the blood.;Hypernatremia;A disorder characterized by laboratory test results that indicate an elevation in the concentration of sodium in the blood.;Hypernatremia;10020680;LLT;20,1
2432;C144167;Grade 1 Hypernatremia, CTCAE;>ULN-150 mmol/L;Grade 1 Hypernatremia;>ULN-150 mmol/L;Hypernatremia;10020680;LLT;20,1
2433;C144728;Grade 2 Hypernatremia, CTCAE;">150-155 mmol/L; intervention initiated";Grade 2 Hypernatremia;">150-155 mmol/L; intervention initiated";Hypernatremia;10020680;LLT;20,1
2434;C145351;Grade 3 Hypernatremia, CTCAE;">155-160 mmol/L; hospitalization indicated";Grade 3 Hypernatremia;">155-160 mmol/L; hospitalization indicated";Hypernatremia;10020680;LLT;20,1
2435;C145902;Grade 4 Hypernatremia, CTCAE;">160 mmol/L; life-threatening consequences";Grade 4 Hypernatremia;">160 mmol/L; life-threatening consequences";Hypernatremia;10020680;LLT;20,1
2436;C146349;Grade 5 Hypernatremia, CTCAE;Death;Grade 5 Hypernatremia;Death;Hypernatremia;10020680;LLT;20,1
2437;C143222;Hyperphosphatemia, CTCAE;A disorder characterized by laboratory test results that indicate an elevation in the concentration of phosphate in a blood.;Hyperphosphatemia;A disorder characterized by laboratory test results that indicate an elevation in the concentration of phosphate in a blood.;Hyperphosphatemia;10020712;LLT;20,1
2438;C144169;Grade 1 Hyperphosphatemia, CTCAE;Laboratory finding only and intervention not indicated;Grade 1 Hyperphosphatemia;Laboratory finding only and intervention not indicated;Hyperphosphatemia;10020712;LLT;20,1
2439;C144730;Grade 2 Hyperphosphatemia, CTCAE;Noninvasive intervention indicated;Grade 2 Hyperphosphatemia;Noninvasive intervention indicated;Hyperphosphatemia;10020712;LLT;20,1
2440;C145352;Grade 3 Hyperphosphatemia, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated";Grade 3 Hyperphosphatemia;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated";Hyperphosphatemia;10020712;LLT;20,1
2441;C145903;Grade 4 Hyperphosphatemia, CTCAE;"Life-threatening consequences; urgent intervention indicated (e.g., dialysis)";Grade 4 Hyperphosphatemia;"Life-threatening consequences; urgent intervention indicated (e.g., dialysis)";Hyperphosphatemia;10020712;LLT;20,1
2442;C146350;Grade 5 Hyperphosphatemia, CTCAE;Death;Grade 5 Hyperphosphatemia;Death;Hyperphosphatemia;10020712;LLT;20,1
2443;C143562;Hypertriglyceridemia, CTCAE;A disorder characterized by laboratory test results that indicate an elevation in the concentration of triglyceride concentration in the blood.;Hypertriglyceridemia;A disorder characterized by laboratory test results that indicate an elevation in the concentration of triglyceride concentration in the blood.;Hypertriglyceridemia;10020870;LLT;20,1
2444;C144173;Grade 1 Hypertriglyceridemia, CTCAE;"150 mg/dL-300 mg/dL; 1.71 mmol/L-3.42 mmol/L";Grade 1 Hypertriglyceridemia;"150 mg/dL-300 mg/dL; 1.71 mmol/L-3.42 mmol/L";Hypertriglyceridemia;10020870;LLT;20,1
2445;C144734;Grade 2 Hypertriglyceridemia, CTCAE;">300 mg/dL-500 mg/dL; >3.42 mmol/L-5.7 mmol/L";Grade 2 Hypertriglyceridemia;">300 mg/dL-500 mg/dL; >3.42 mmol/L-5.7 mmol/L";Hypertriglyceridemia;10020870;LLT;20,1
2446;C145355;Grade 3 Hypertriglyceridemia, CTCAE;">500 mg/dL-1000 mg/dL; >5.7 mmol/L-11.4 mmol/L";Grade 3 Hypertriglyceridemia;">500 mg/dL-1000 mg/dL; >5.7 mmol/L-11.4 mmol/L";Hypertriglyceridemia;10020870;LLT;20,1
2447;C145905;Grade 4 Hypertriglyceridemia, CTCAE;">1000 mg/dL; >11.4 mmol/L; life-threatening consequences";Grade 4 Hypertriglyceridemia;">1000 mg/dL; >11.4 mmol/L; life-threatening consequences";Hypertriglyceridemia;10020870;LLT;20,1
2448;C146352;Grade 5 Hypertriglyceridemia, CTCAE;Death;Grade 5 Hypertriglyceridemia;Death;Hypertriglyceridemia;10020870;LLT;20,1
2449;C143563;Hyperuricemia, CTCAE;A disorder characterized by laboratory test results that indicate an elevation in the concentration of uric acid.;Hyperuricemia;A disorder characterized by laboratory test results that indicate an elevation in the concentration of uric acid.;Hyperuricemia;10020907;LLT;20,1
2450;C144174;Grade 1 Hyperuricemia, CTCAE;>ULN without physiologic consequences;Grade 1 Hyperuricemia;>ULN without physiologic consequences;Hyperuricemia;10020907;LLT;20,1
2451;C145356;Grade 3 Hyperuricemia, CTCAE;>ULN with physiologic consequences;Grade 3 Hyperuricemia;>ULN with physiologic consequences;Hyperuricemia;10020907;LLT;20,1
2452;C145906;Grade 4 Hyperuricemia, CTCAE;Life-threatening consequences;Grade 4 Hyperuricemia;Life-threatening consequences;Hyperuricemia;10020907;LLT;20,1
2453;C146353;Grade 5 Hyperuricemia, CTCAE;Death;Grade 5 Hyperuricemia;Death;Hyperuricemia;10020907;LLT;20,1
2454;C143564;Hypoalbuminemia, CTCAE;A disorder characterized by laboratory test results that indicate a low concentration of albumin in the blood.;Hypoalbuminemia;A disorder characterized by laboratory test results that indicate a low concentration of albumin in the blood.;Hypoalbuminemia;10020943;LLT;20,1
2455;C144175;Grade 1 Hypoalbuminemia, CTCAE;"<LLN-3 g/dL; <LLN-30 g/L";Grade 1 Hypoalbuminemia;"<LLN-3 g/dL; <LLN-30 g/L";Hypoalbuminemia;10020943;LLT;20,1
2456;C144735;Grade 2 Hypoalbuminemia, CTCAE;"<3-2 g/dL; <30-20 g/L";Grade 2 Hypoalbuminemia;"<3-2 g/dL; <30-20 g/L";Hypoalbuminemia;10020943;LLT;20,1
2457;C145357;Grade 3 Hypoalbuminemia, CTCAE;"<2 g/dL; <20 g/L";Grade 3 Hypoalbuminemia;"<2 g/dL; <20 g/L";Hypoalbuminemia;10020943;LLT;20,1
2458;C145907;Grade 4 Hypoalbuminemia, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hypoalbuminemia;"Life-threatening consequences; urgent intervention indicated";Hypoalbuminemia;10020943;LLT;20,1
2459;C146354;Grade 5 Hypoalbuminemia, CTCAE;Death;Grade 5 Hypoalbuminemia;Death;Hypoalbuminemia;10020943;LLT;20,1
2460;C143565;Hypocalcemia, CTCAE;A disorder characterized by laboratory test results that indicate a low concentration of calcium (corrected for albumin) in the blood.;Hypocalcemia;A disorder characterized by laboratory test results that indicate a low concentration of calcium (corrected for albumin) in the blood.;Hypocalcemia;10020949;LLT;20,1
2461;C144176;Grade 1 Hypocalcemia, CTCAE;"Corrected serum calcium of <LLN-8.0 mg/dL; <LLN-2.0 mmol/L; Ionized calcium <LLN-1.0 mmol/L";Grade 1 Hypocalcemia;"Corrected serum calcium of <LLN-8.0 mg/dL; <LLN-2.0 mmol/L; Ionized calcium <LLN-1.0 mmol/L";Hypocalcemia;10020949;LLT;20,1
2462;C144736;Grade 2 Hypocalcemia, CTCAE;"Corrected serum calcium of <8.0-7.0 mg/dL; <2.0-1.75 mmol/L; Ionized calcium <1.0-0.9 mmol/L; symptomatic";Grade 2 Hypocalcemia;"Corrected serum calcium of <8.0-7.0 mg/dL; <2.0-1.75 mmol/L; Ionized calcium <1.0-0.9 mmol/L; symptomatic";Hypocalcemia;10020949;LLT;20,1
2463;C145358;Grade 3 Hypocalcemia, CTCAE;"Corrected serum calcium of <7.0-6.0 mg/dL; <1.75-1.5 mmol/L; Ionized calcium <0.9-0.8 mmol/L; hospitalization indicated";Grade 3 Hypocalcemia;"Corrected serum calcium of <7.0-6.0 mg/dL; <1.75-1.5 mmol/L; Ionized calcium <0.9-0.8 mmol/L; hospitalization indicated";Hypocalcemia;10020949;LLT;20,1
2464;C145908;Grade 4 Hypocalcemia, CTCAE;"Corrected serum calcium of <6.0 mg/dL; <1.5 mmol/L; Ionized calcium <0.8 mmol/L; life-threatening consequences";Grade 4 Hypocalcemia;"Corrected serum calcium of <6.0 mg/dL; <1.5 mmol/L; Ionized calcium <0.8 mmol/L; life-threatening consequences";Hypocalcemia;10020949;LLT;20,1
2465;C146355;Grade 5 Hypocalcemia, CTCAE;Death;Grade 5 Hypocalcemia;Death;Hypocalcemia;10020949;LLT;20,1
2466;C143567;Hypoglycemia, CTCAE;A disorder characterized by laboratory test results that indicate a low concentration of glucose in the blood.;Hypoglycemia;A disorder characterized by laboratory test results that indicate a low concentration of glucose in the blood.;Hypoglycemia;10021005;LLT;20,1
2467;C144178;Grade 1 Hypoglycemia, CTCAE;"<LLN-55 mg/dL; <LLN-3.0 mmol/L";Grade 1 Hypoglycemia;"<LLN-55 mg/dL; <LLN-3.0 mmol/L";Hypoglycemia;10021005;LLT;20,1
2468;C144738;Grade 2 Hypoglycemia, CTCAE;"<55-40 mg/dL; <3.0-2.2 mmol/L";Grade 2 Hypoglycemia;"<55-40 mg/dL; <3.0-2.2 mmol/L";Hypoglycemia;10021005;LLT;20,1
2469;C145360;Grade 3 Hypoglycemia, CTCAE;"<40-30 mg/dL; <2.2-1.7 mmol/L";Grade 3 Hypoglycemia;"<40-30 mg/dL; <2.2-1.7 mmol/L";Hypoglycemia;10021005;LLT;20,1
2470;C145909;Grade 4 Hypoglycemia, CTCAE;"<30 mg/dL; <1.7 mmol/L; life-threatening consequences; seizures";Grade 4 Hypoglycemia;"<30 mg/dL; <1.7 mmol/L; life-threatening consequences; seizures";Hypoglycemia;10021005;LLT;20,1
2471;C146356;Grade 5 Hypoglycemia, CTCAE;Death;Grade 5 Hypoglycemia;Death;Hypoglycemia;10021005;LLT;20,1
2472;C143569;Hypokalemia, CTCAE;A disorder characterized by laboratory test results that indicate a low concentration of potassium in the blood.;Hypokalemia;A disorder characterized by laboratory test results that indicate a low concentration of potassium in the blood.;Hypokalemia;10021018;LLT;20,1
2473;C144179;Grade 1 Hypokalemia, CTCAE;<LLN-3.0 mmol/L;Grade 1 Hypokalemia;<LLN-3.0 mmol/L;Hypokalemia;10021018;LLT;20,1
2474;C144740;Grade 2 Hypokalemia, CTCAE;"Symptomatic with <LLN-3.0 mmol/L; intervention indicated";Grade 2 Hypokalemia;"Symptomatic with <LLN-3.0 mmol/L; intervention indicated";Hypokalemia;10021018;LLT;20,1
2475;C145362;Grade 3 Hypokalemia, CTCAE;"<3.0-2.5 mmol/L; hospitalization indicated";Grade 3 Hypokalemia;"<3.0-2.5 mmol/L; hospitalization indicated";Hypokalemia;10021018;LLT;20,1
2476;C145911;Grade 4 Hypokalemia, CTCAE;"<2.5 mmol/L; life-threatening consequences";Grade 4 Hypokalemia;"<2.5 mmol/L; life-threatening consequences";Hypokalemia;10021018;LLT;20,1
2477;C146358;Grade 5 Hypokalemia, CTCAE;Death;Grade 5 Hypokalemia;Death;Hypokalemia;10021018;LLT;20,1
2478;C143570;Hypomagnesemia, CTCAE;A disorder characterized by laboratory test results that indicate a low concentration of magnesium in the blood.;Hypomagnesemia;A disorder characterized by laboratory test results that indicate a low concentration of magnesium in the blood.;Hypomagnesemia;10021028;LLT;20,1
2479;C144180;Grade 1 Hypomagnesemia, CTCAE;"<LLN-1.2 mg/dL; <LLN-0.5 mmol/L";Grade 1 Hypomagnesemia;"<LLN-1.2 mg/dL; <LLN-0.5 mmol/L";Hypomagnesemia;10021028;LLT;20,1
2480;C144741;Grade 2 Hypomagnesemia, CTCAE;"<1.2-0.9 mg/dL; <0.5-0.4 mmol/L";Grade 2 Hypomagnesemia;"<1.2-0.9 mg/dL; <0.5-0.4 mmol/L";Hypomagnesemia;10021028;LLT;20,1
2481;C145363;Grade 3 Hypomagnesemia, CTCAE;"<0.9-0.7 mg/dL; <0.4-0.3 mmol/L";Grade 3 Hypomagnesemia;"<0.9-0.7 mg/dL; <0.4-0.3 mmol/L";Hypomagnesemia;10021028;LLT;20,1
2482;C145912;Grade 4 Hypomagnesemia, CTCAE;"<0.7 mg/dL; <0.3 mmol/L; life-threatening consequences";Grade 4 Hypomagnesemia;"<0.7 mg/dL; <0.3 mmol/L; life-threatening consequences";Hypomagnesemia;10021028;LLT;20,1
2483;C146359;Grade 5 Hypomagnesemia, CTCAE;Death;Grade 5 Hypomagnesemia;Death;Hypomagnesemia;10021028;LLT;20,1
2484;C143571;Hyponatremia, CTCAE;A disorder characterized by laboratory test results that indicate a low concentration of sodium in the blood.;Hyponatremia;A disorder characterized by laboratory test results that indicate a low concentration of sodium in the blood.;Hyponatremia;10021038;LLT;20,1
2485;C144181;Grade 1 Hyponatremia, CTCAE;<LLN-130 mmol/L;Grade 1 Hyponatremia;<LLN-130 mmol/L;Hyponatremia;10021038;LLT;20,1
2486;C144742;Grade 2 Hyponatremia, CTCAE;125-129 mmol/L and asymptomatic;Grade 2 Hyponatremia;125-129 mmol/L and asymptomatic;Hyponatremia;10021038;LLT;20,1
2487;C145364;Grade 3 Hyponatremia, CTCAE;"125-129 mmol/L symptomatic; 120-124 mmol/L regardless of symptoms";Grade 3 Hyponatremia;"125-129 mmol/L symptomatic; 120-124 mmol/L regardless of symptoms";Hyponatremia;10021038;LLT;20,1
2488;C145913;Grade 4 Hyponatremia, CTCAE;"<120 mmol/L; life-threatening consequences";Grade 4 Hyponatremia;"<120 mmol/L; life-threatening consequences";Hyponatremia;10021038;LLT;20,1
2489;C146360;Grade 5 Hyponatremia, CTCAE;Death;Grade 5 Hyponatremia;Death;Hyponatremia;10021038;LLT;20,1
2490;C143573;Hypophosphatemia, CTCAE;A disorder characterized by laboratory test results that indicate a low concentration of phosphates in the blood.;Hypophosphatemia;A disorder characterized by laboratory test results that indicate a low concentration of phosphates in the blood.;Hypophosphatemia;10021059;LLT;20,1
2491;C144183;Grade 1 Hypophosphatemia, CTCAE;Laboratory finding only and intervention not indicated;Grade 1 Hypophosphatemia;Laboratory finding only and intervention not indicated;Hypophosphatemia;10021059;LLT;20,1
2492;C144744;Grade 2 Hypophosphatemia, CTCAE;Oral replacement therapy indicated;Grade 2 Hypophosphatemia;Oral replacement therapy indicated;Hypophosphatemia;10021059;LLT;20,1
2493;C145366;Grade 3 Hypophosphatemia, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated";Grade 3 Hypophosphatemia;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated";Hypophosphatemia;10021059;LLT;20,1
2494;C145915;Grade 4 Hypophosphatemia, CTCAE;Life-threatening consequences;Grade 4 Hypophosphatemia;Life-threatening consequences;Hypophosphatemia;10021059;LLT;20,1
2495;C146362;Grade 5 Hypophosphatemia, CTCAE;Death;Grade 5 Hypophosphatemia;Death;Hypophosphatemia;10021059;LLT;20,1
2496;C55993;Iron Overload, CTCAE;A disorder characterized by accumulation of iron in the tissues.;Iron overload;A disorder characterized by accumulation of iron in the tissues.;Iron overload;10065973;LLT;20,1
2497;C55948;Grade 2 Iron Overload, CTCAE;"Moderate symptoms; intervention not indicated";Grade 2 Iron overload;"Moderate symptoms; intervention not indicated";Iron overload;10065973;LLT;20,1
2498;C55960;Grade 3 Iron Overload, CTCAE;"Severe symptoms; intervention indicated";Grade 3 Iron overload;"Severe symptoms; intervention indicated";Iron overload;10065973;LLT;20,1
2499;C55970;Grade 4 Iron Overload, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Iron overload;"Life-threatening consequences; urgent intervention indicated";Iron overload;10065973;LLT;20,1
2500;C55983;Grade 5 Iron Overload, CTCAE;Death;Grade 5 Iron overload;Death;Iron overload;10065973;LLT;20,1
2501;C143672;Metabolism and Nutrition Disorders - Other, Specify, CTCAE;;Metabolism and nutrition disorders - Other, specify;;Metabolism and nutrition disorders - Other, specify;10027433;LLT;20,1
2502;C144261;Grade 1 Metabolism and Nutrition Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Metabolism and nutrition disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Metabolism and nutrition disorders - Other, specify;10027433;LLT;20,1
2503;C144837;Grade 2 Metabolism and Nutrition Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Metabolism and nutrition disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Metabolism and nutrition disorders - Other, specify;10027433;LLT;20,1
2504;C145459;Grade 3 Metabolism and Nutrition Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Metabolism and nutrition disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Metabolism and nutrition disorders - Other, specify;10027433;LLT;20,1
2505;C145995;Grade 4 Metabolism and Nutrition Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Metabolism and nutrition disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Metabolism and nutrition disorders - Other, specify;10027433;LLT;20,1
2506;C146440;Grade 5 Metabolism and Nutrition Disorders - Other, Specify, CTCAE;Death;Grade 5 Metabolism and nutrition disorders - Other, specify;Death;Metabolism and nutrition disorders - Other, specify;10027433;LLT;20,1
2507;C55334;Obesity, CTCAE;A disorder characterized by having a high amount of body fat.;Obesity;A disorder characterized by having a high amount of body fat.;Obesity;10029883;LLT;20,1
2508;C55305;Grade 2 Obesity, CTCAE;BMI 25-29.9 kg/m2;Grade 2 Obesity;BMI 25-29.9 kg/m2;Obesity;10029883;LLT;20,1
2509;C55315;Grade 3 Obesity, CTCAE;BMI 30-39.9 kg/m2;Grade 3 Obesity;BMI 30-39.9 kg/m2;Obesity;10029883;LLT;20,1
2510;C55324;Grade 4 Obesity, CTCAE;BMI >=40 kg/m2;Grade 4 Obesity;BMI >=40 kg/m2;Obesity;10029883;LLT;20,1
2511;C146688;Tumor Lysis Syndrome, CTCAE 5.0;A disorder characterized by metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells.;Tumor lysis syndrome;A disorder characterized by metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells.;Tumor lysis syndrome;10045152;LLT;20,1
2512;C56620;Grade 3 Tumor Lysis Syndrome, CTCAE;Present;Grade 3 Tumor lysis syndrome;Present;Tumor lysis syndrome;10045152;LLT;20,1
2513;C146159;Grade 4 Tumor Lysis Syndrome, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Tumor lysis syndrome;"Life-threatening consequences; urgent intervention indicated";Tumor lysis syndrome;10045152;LLT;20,1
2514;C56632;Grade 5 Tumor Lysis Syndrome, CTCAE;Death;Grade 5 Tumor lysis syndrome;Death;Tumor lysis syndrome;10045152;LLT;20,1
2515;C143175;Musculoskeletal and Connective Tissue Disorders, CTCAE;;;;;;;
2516;C143256;Abdominal Soft Tissue Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the soft tissues of the abdominal wall.;Abdominal soft tissue necrosis;A disorder characterized by a necrotic process occurring in the soft tissues of the abdominal wall.;Abdominal soft tissue necrosis;10065775;LLT;20,1
2517;C144497;Grade 2 Abdominal Soft Tissue Necrosis, CTCAE;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Grade 2 Abdominal soft tissue necrosis;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Abdominal soft tissue necrosis;10065775;LLT;20,1
2518;C145113;Grade 3 Abdominal Soft Tissue Necrosis, CTCAE;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Grade 3 Abdominal soft tissue necrosis;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Abdominal soft tissue necrosis;10065775;LLT;20,1
2519;C145731;Grade 4 Abdominal Soft Tissue Necrosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Abdominal soft tissue necrosis;"Life-threatening consequences; urgent intervention indicated";Abdominal soft tissue necrosis;10065775;LLT;20,1
2520;C146203;Grade 5 Abdominal Soft Tissue Necrosis, CTCAE;Death;Grade 5 Abdominal soft tissue necrosis;Death;Abdominal soft tissue necrosis;10065775;LLT;20,1
2521;C143298;Arthralgia, CTCAE;A disorder characterized by a sensation of marked discomfort in a joint.;Arthralgia;A disorder characterized by a sensation of marked discomfort in a joint.;Arthralgia;10003239;LLT;20,1
2522;C143987;Grade 1 Arthralgia, CTCAE;Mild pain;Grade 1 Arthralgia;Mild pain;Arthralgia;10003239;LLT;20,1
2523;C144525;Grade 2 Arthralgia, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Arthralgia;"Moderate pain; limiting instrumental ADL";Arthralgia;10003239;LLT;20,1
2524;C145148;Grade 3 Arthralgia, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Arthralgia;"Severe pain; limiting self care ADL";Arthralgia;10003239;LLT;20,1
2525;C143299;Arthritis, CTCAE;A disorder characterized by inflammation involving a joint.;Arthritis;A disorder characterized by inflammation involving a joint.;Arthritis;10003246;LLT;20,1
2526;C143988;Grade 1 Arthritis, CTCAE;Mild pain with inflammation, erythema, or joint swelling;Grade 1 Arthritis;Mild pain with inflammation, erythema, or joint swelling;Arthritis;10003246;LLT;20,1
2527;C144526;Grade 2 Arthritis, CTCAE;"Moderate pain associated with signs of inflammation, erythema, or joint swelling; limiting instrumental ADL";Grade 2 Arthritis;"Moderate pain associated with signs of inflammation, erythema, or joint swelling; limiting instrumental ADL";Arthritis;10003246;LLT;20,1
2528;C145149;Grade 3 Arthritis, CTCAE;"Severe pain associated with signs of inflammation, erythema, or joint swelling; irreversible joint damage; limiting self care ADL";Grade 3 Arthritis;"Severe pain associated with signs of inflammation, erythema, or joint swelling; irreversible joint damage; limiting self care ADL";Arthritis;10003246;LLT;20,1
2529;C143311;Avascular Necrosis, CTCAE;A disorder characterized by necrotic changes in the bone tissue due to interruption of blood supply. Most often affecting the epiphysis of the long bones, the necrotic changes result in the collapse and the destruction of the bone structure.;Avascular necrosis;A disorder characterized by necrotic changes in the bone tissue due to interruption of blood supply. Most often affecting the epiphysis of the long bones, the necrotic changes result in the collapse and the destruction of the bone structure.;Avascular necrosis;10066480;LLT;20,1
2530;C143993;Grade 1 Avascular Necrosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Avascular necrosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Avascular necrosis;10066480;LLT;20,1
2531;C144532;Grade 2 Avascular Necrosis, CTCAE;"Symptomatic; limiting instrumental ADL";Grade 2 Avascular necrosis;"Symptomatic; limiting instrumental ADL";Avascular necrosis;10066480;LLT;20,1
2532;C145154;Grade 3 Avascular Necrosis, CTCAE;"Severe symptoms; limiting self care ADL; elective operative intervention indicated";Grade 3 Avascular necrosis;"Severe symptoms; limiting self care ADL; elective operative intervention indicated";Avascular necrosis;10066480;LLT;20,1
2533;C145759;Grade 4 Avascular Necrosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Avascular necrosis;"Life-threatening consequences; urgent intervention indicated";Avascular necrosis;10066480;LLT;20,1
2534;C146228;Grade 5 Avascular Necrosis, CTCAE;Death;Grade 5 Avascular necrosis;Death;Avascular necrosis;10066480;LLT;20,1
2535;C146739;Back Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the back region.;Back pain;A disorder characterized by a sensation of marked discomfort in the back region.;Back pain;10003988;LLT;20,1
2536;C56011;Grade 1 Back Pain, CTCAE;Mild pain;Grade 1 Back pain;Mild pain;Back pain;10003988;LLT;20,1
2537;C56012;Grade 2 Back Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Back pain;"Moderate pain; limiting instrumental ADL";Back pain;10003988;LLT;20,1
2538;C56013;Grade 3 Back Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Back pain;"Severe pain; limiting self care ADL";Back pain;10003988;LLT;20,1
2539;C146741;Bone Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the bones.;Bone pain;A disorder characterized by a sensation of marked discomfort in the bones.;Bone pain;10006002;LLT;20,1
2540;C56021;Grade 1 Bone Pain, CTCAE;Mild pain;Grade 1 Bone pain;Mild pain;Bone pain;10006002;LLT;20,1
2541;C56022;Grade 2 Bone Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Bone pain;"Moderate pain; limiting instrumental ADL";Bone pain;10006002;LLT;20,1
2542;C56023;Grade 3 Bone Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Bone pain;"Severe pain; limiting self care ADL";Bone pain;10006002;LLT;20,1
2543;C146744;Buttock Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the buttocks.;Buttock pain;A disorder characterized by a sensation of marked discomfort in the buttocks.;Buttock pain;10048677;LLT;20,1
2544;C56031;Grade 1 Buttock Pain, CTCAE;Mild pain;Grade 1 Buttock pain;Mild pain;Buttock pain;10048677;LLT;20,1
2545;C56032;Grade 2 Buttock Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Buttock pain;"Moderate pain; limiting instrumental ADL";Buttock pain;10048677;LLT;20,1
2546;C56033;Grade 3 Buttock Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Buttock pain;"Severe pain; limiting self care ADL";Buttock pain;10048677;LLT;20,1
2547;C143223;Chest Wall Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the soft tissues of the chest wall including breast.;Chest wall necrosis;A disorder characterized by a necrotic process occurring in the soft tissues of the chest wall including breast.;Chest wall necrosis;10048831;LLT;20,1
2548;C144576;Grade 2 Chest Wall Necrosis, CTCAE;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Grade 2 Chest wall necrosis;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Chest wall necrosis;10048831;LLT;20,1
2549;C145193;Grade 3 Chest Wall Necrosis, CTCAE;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Grade 3 Chest wall necrosis;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Chest wall necrosis;10048831;LLT;20,1
2550;C145791;Grade 4 Chest Wall Necrosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Chest wall necrosis;"Life-threatening consequences; urgent intervention indicated";Chest wall necrosis;10048831;LLT;20,1
2551;C146257;Grade 5 Chest Wall Necrosis, CTCAE;Death;Grade 5 Chest wall necrosis;Death;Chest wall necrosis;10048831;LLT;20,1
2552;C146743;Chest Wall Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the chest wall.;Chest wall pain;A disorder characterized by a sensation of marked discomfort in the chest wall.;Chest wall pain;10008496;LLT;20,1
2553;C56041;Grade 1 Chest Wall Pain, CTCAE;Mild pain;Grade 1 Chest wall pain;Mild pain;Chest wall pain;10008496;LLT;20,1
2554;C56042;Grade 2 Chest Wall Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Chest wall pain;"Moderate pain; limiting instrumental ADL";Chest wall pain;10008496;LLT;20,1
2555;C56043;Grade 3 Chest Wall Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Chest wall pain;"Severe pain; limiting self care ADL";Chest wall pain;10008496;LLT;20,1
2556;C146749;Exostosis, CTCAE 5.0;A disorder characterized by non-neoplastic overgrowth of bone.;Exostosis;A disorder characterized by non-neoplastic overgrowth of bone.;Exostosis;10015688;LLT;20,1
2557;C58215;Grade 1 Exostosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Exostosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Exostosis;10015688;LLT;20,1
2558;C58246;Grade 2 Exostosis, CTCAE;"Symptomatic; limiting instrumental ADL";Grade 2 Exostosis;"Symptomatic; limiting instrumental ADL";Exostosis;10015688;LLT;20,1
2559;C58283;Grade 3 Exostosis, CTCAE;"Severe symptoms; limiting self care ADL; elective operative intervention indicated";Grade 3 Exostosis;"Severe symptoms; limiting self care ADL; elective operative intervention indicated";Exostosis;10015688;LLT;20,1
2560;C143487;Fibrosis Deep Connective Tissue, CTCAE;A disorder characterized by fibrotic degeneration of the deep connective tissues.;Fibrosis deep connective tissue;A disorder characterized by fibrotic degeneration of the deep connective tissues.;Fibrosis deep connective tissue;10065799;LLT;20,1
2561;C144106;Grade 1 Fibrosis Deep Connective Tissue, CTCAE;Mild induration, able to move skin parallel to plane (sliding) and perpendicular to skin (pinching up);Grade 1 Fibrosis deep connective tissue;Mild induration, able to move skin parallel to plane (sliding) and perpendicular to skin (pinching up);Fibrosis deep connective tissue;10065799;LLT;20,1
2562;C144667;Grade 2 Fibrosis Deep Connective Tissue, CTCAE;"Moderate induration, able to slide skin, unable to pinch skin; limiting instrumental ADL";Grade 2 Fibrosis deep connective tissue;"Moderate induration, able to slide skin, unable to pinch skin; limiting instrumental ADL";Fibrosis deep connective tissue;10065799;LLT;20,1
2563;C145287;Grade 3 Fibrosis Deep Connective Tissue, CTCAE;"Severe induration; unable to slide or pinch skin; limiting joint or orifice movement (e.g., mouth, anus); limiting self care ADL";Grade 3 Fibrosis deep connective tissue;"Severe induration; unable to slide or pinch skin; limiting joint or orifice movement (e.g., mouth, anus); limiting self care ADL";Fibrosis deep connective tissue;10065799;LLT;20,1
2564;C145860;Grade 4 Fibrosis Deep Connective Tissue, CTCAE;"Generalized; associated with signs or symptoms of impaired breathing or feeding";Grade 4 Fibrosis deep connective tissue;"Generalized; associated with signs or symptoms of impaired breathing or feeding";Fibrosis deep connective tissue;10065799;LLT;20,1
2565;C146314;Grade 5 Fibrosis Deep Connective Tissue, CTCAE;Death;Grade 5 Fibrosis deep connective tissue;Death;Fibrosis deep connective tissue;10065799;LLT;20,1
2566;C143488;Flank Pain, CTCAE;A disorder characterized by a sensation of marked discomfort on the lateral side of the body in the region below the ribs and above the hip.;Flank pain;A disorder characterized by a sensation of marked discomfort on the lateral side of the body in the region below the ribs and above the hip.;Flank pain;10016750;LLT;20,1
2567;C144107;Grade 1 Flank Pain, CTCAE;Mild pain;Grade 1 Flank pain;Mild pain;Flank pain;10016750;LLT;20,1
2568;C144668;Grade 2 Flank Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Flank pain;"Moderate pain; limiting instrumental ADL";Flank pain;10016750;LLT;20,1
2569;C145288;Grade 3 Flank Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Flank pain;"Severe pain; limiting self care ADL";Flank pain;10016750;LLT;20,1
2570;C143514;Generalized Muscle Weakness, CTCAE;A disorder characterized by a reduction in the strength of muscles in multiple anatomic sites.;Generalized muscle weakness;A disorder characterized by a reduction in the strength of muscles in multiple anatomic sites.;Generalized muscle weakness;10062572;LLT;20,1
2571;C144127;Grade 1 Generalized Muscle Weakness, CTCAE;"Symptomatic; perceived by patient but not evident on physical exam";Grade 1 Generalized muscle weakness;"Symptomatic; perceived by patient but not evident on physical exam";Generalized muscle weakness;10062572;LLT;20,1
2572;C144692;Grade 2 Generalized Muscle Weakness, CTCAE;"Symptomatic; evident on physical exam; limiting instrumental ADL";Grade 2 Generalized muscle weakness;"Symptomatic; evident on physical exam; limiting instrumental ADL";Generalized muscle weakness;10062572;LLT;20,1
2573;C145314;Grade 3 Generalized Muscle Weakness, CTCAE;Limiting self care ADL;Grade 3 Generalized muscle weakness;Limiting self care ADL;Generalized muscle weakness;10062572;LLT;20,1
2574;C143522;Growth Suppression, CTCAE;A disorder characterized by stature that is smaller than normal as expected for age.;Growth suppression;A disorder characterized by stature that is smaller than normal as expected for age.;Growth suppression;10018761;LLT;20,1
2575;C144135;Grade 1 Growth Suppression, CTCAE;Reduction in growth velocity by 10-29% ideally measured over the period of a year;Grade 1 Growth suppression;Reduction in growth velocity by 10-29% ideally measured over the period of a year;Growth suppression;10018761;LLT;20,1
2576;C144700;Grade 2 Growth Suppression, CTCAE;Reduction in growth velocity by 30-49% ideally measured over the period of a year or 0-49% reduction in growth from the baseline growth curve;Grade 2 Growth suppression;Reduction in growth velocity by 30-49% ideally measured over the period of a year or 0-49% reduction in growth from the baseline growth curve;Growth suppression;10018761;LLT;20,1
2577;C145320;Grade 3 Growth Suppression, CTCAE;Reduction in growth velocity of >=50% ideally measured over the period of a year;Grade 3 Growth suppression;Reduction in growth velocity of >=50% ideally measured over the period of a year;Growth suppression;10018761;LLT;20,1
2578;C58383;Head Soft Tissue Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the soft tissues of the head.;Head soft tissue necrosis;A disorder characterized by a necrotic process occurring in the soft tissues of the head.;Head soft tissue necrosis;10065779;LLT;20,1
2579;C58252;Grade 2 Head Soft Tissue Necrosis, CTCAE;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Grade 2 Head soft tissue necrosis;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Head soft tissue necrosis;10065779;LLT;20,1
2580;C58289;Grade 3 Head Soft Tissue Necrosis, CTCAE;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Grade 3 Head soft tissue necrosis;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Head soft tissue necrosis;10065779;LLT;20,1
2581;C58324;Grade 4 Head Soft Tissue Necrosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Head soft tissue necrosis;"Life-threatening consequences; urgent intervention indicated";Head soft tissue necrosis;10065779;LLT;20,1
2582;C58356;Grade 5 Head Soft Tissue Necrosis, CTCAE;Death;Grade 5 Head soft tissue necrosis;Death;Head soft tissue necrosis;10065779;LLT;20,1
2583;C146760;Joint Effusion, CTCAE 5.0;A disorder characterized by excessive fluid in a joint, usually as a result of joint inflammation.;Joint effusion;A disorder characterized by excessive fluid in a joint, usually as a result of joint inflammation.;Joint effusion;10023215;LLT;20,1
2584;C58221;Grade 1 Joint Effusion, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Joint effusion;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Joint effusion;10023215;LLT;20,1
2585;C58253;Grade 2 Joint Effusion, CTCAE;"Symptomatic; limiting instrumental ADL";Grade 2 Joint effusion;"Symptomatic; limiting instrumental ADL";Joint effusion;10023215;LLT;20,1
2586;C58290;Grade 3 Joint Effusion, CTCAE;"Severe symptoms; limiting self care ADL; invasive intervention indicated";Grade 3 Joint effusion;"Severe symptoms; limiting self care ADL; invasive intervention indicated";Joint effusion;10023215;LLT;20,1
2587;C143627;Joint Range of Motion Decreased Cervical Spine, CTCAE;A disorder characterized by a decrease in flexibility of a cervical spine joint.;Joint range of motion decreased cervical spine;A disorder characterized by a decrease in flexibility of a cervical spine joint.;Joint range of motion decreased cervical spine;10065796;LLT;20,1
2588;C144229;Grade 1 Joint Range of Motion Decreased Cervical Spine, CTCAE;Mild restriction of rotation or flexion between 60-70 degrees;Grade 1 Joint range of motion decreased cervical spine;Mild restriction of rotation or flexion between 60-70 degrees;Joint range of motion decreased cervical spine;10065796;LLT;20,1
2589;C144799;Grade 2 Joint Range of Motion Decreased Cervical Spine, CTCAE;"Rotation <60 degrees to right or left; <60 degrees of flexion";Grade 2 Joint range of motion decreased cervical spine;"Rotation <60 degrees to right or left; <60 degrees of flexion";Joint range of motion decreased cervical spine;10065796;LLT;20,1
2590;C145421;Grade 3 Joint Range of Motion Decreased Cervical Spine, CTCAE;Ankylosed/fused over multiple segments with no C-spine rotation;Grade 3 Joint range of motion decreased cervical spine;Ankylosed/fused over multiple segments with no C-spine rotation;Joint range of motion decreased cervical spine;10065796;LLT;20,1
2591;C143628;Joint Range of Motion Decreased Lumbar Spine, CTCAE;A disorder characterized by a decrease in flexibility of a lumbar spine joint.;Joint range of motion decreased lumbar spine;A disorder characterized by a decrease in flexibility of a lumbar spine joint.;Joint range of motion decreased lumbar spine;10065800;LLT;20,1
2592;C144230;Grade 1 Joint Range of Motion Decreased Lumbar Spine, CTCAE;"Stiffness; difficulty bending to the floor to pick up a very light object but able to do athletic activity";Grade 1 Joint range of motion decreased lumbar spine;"Stiffness; difficulty bending to the floor to pick up a very light object but able to do athletic activity";Joint range of motion decreased lumbar spine;10065800;LLT;20,1
2593;C144800;Grade 2 Joint Range of Motion Decreased Lumbar Spine, CTCAE;"Pain with range of motion (ROM) in lumbar spine; requires a reaching aid to pick up a very light object from the floor";Grade 2 Joint range of motion decreased lumbar spine;"Pain with range of motion (ROM) in lumbar spine; requires a reaching aid to pick up a very light object from the floor";Joint range of motion decreased lumbar spine;10065800;LLT;20,1
2594;C145422;Grade 3 Joint Range of Motion Decreased Lumbar Spine, CTCAE;"<50% lumbar spine flexion; associated with symptoms of ankylosis or fused over multiple segments with no L-spine flexion (e.g., unable to reach to floor to pick up a very light object)";Grade 3 Joint range of motion decreased lumbar spine;"<50% lumbar spine flexion; associated with symptoms of ankylosis or fused over multiple segments with no L-spine flexion (e.g., unable to reach to floor to pick up a very light object)";Joint range of motion decreased lumbar spine;10065800;LLT;20,1
2595;C143629;Joint Range of Motion Decreased, CTCAE;A disorder characterized by a decrease in joint flexibility of any joint.;Joint range of motion decreased;A disorder characterized by a decrease in joint flexibility of any joint.;Joint range of motion decreased;10048706;LLT;20,1
2596;C144231;Grade 1 Joint Range of Motion Decreased, CTCAE;"<=25% loss of ROM (range of motion); decreased ROM limiting athletic activity";Grade 1 Joint range of motion decreased;"<=25% loss of ROM (range of motion); decreased ROM limiting athletic activity";Joint range of motion decreased;10048706;LLT;20,1
2597;C144801;Grade 2 Joint Range of Motion Decreased, CTCAE;">25-50% decrease in ROM; limiting instrumental ADL";Grade 2 Joint range of motion decreased;">25-50% decrease in ROM; limiting instrumental ADL";Joint range of motion decreased;10048706;LLT;20,1
2598;C145423;Grade 3 Joint Range of Motion Decreased, CTCAE;">50% decrease in ROM; limiting self care ADL";Grade 3 Joint range of motion decreased;">50% decrease in ROM; limiting self care ADL";Joint range of motion decreased;10048706;LLT;20,1
2599;C143633;Kyphosis, CTCAE;A disorder characterized by an abnormal increase in the curvature of the thoracic portion of the spine.;Kyphosis;A disorder characterized by an abnormal increase in the curvature of the thoracic portion of the spine.;Kyphosis;10023509;LLT;20,1
2600;C144233;Grade 1 Kyphosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Kyphosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Kyphosis;10023509;LLT;20,1
2601;C144804;Grade 2 Kyphosis, CTCAE;"Moderate accentuation; limiting instrumental ADL";Grade 2 Kyphosis;"Moderate accentuation; limiting instrumental ADL";Kyphosis;10023509;LLT;20,1
2602;C145426;Grade 3 Kyphosis, CTCAE;"Severe accentuation; operative intervention indicated; limiting self care ADL";Grade 3 Kyphosis;"Severe accentuation; operative intervention indicated; limiting self care ADL";Kyphosis;10023509;LLT;20,1
2603;C143655;Lordosis, CTCAE;A disorder characterized by an abnormal increase in the curvature of the lumbar portion of the spine.;Lordosis;A disorder characterized by an abnormal increase in the curvature of the lumbar portion of the spine.;Lordosis;10024842;LLT;20,1
2604;C144252;Grade 1 Lordosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Lordosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Lordosis;10024842;LLT;20,1
2605;C144824;Grade 2 Lordosis, CTCAE;"Moderate accentuation; limiting instrumental ADL";Grade 2 Lordosis;"Moderate accentuation; limiting instrumental ADL";Lordosis;10024842;LLT;20,1
2606;C145444;Grade 3 Lordosis, CTCAE;"Severe accentuation; operative intervention indicated; limiting self care ADL";Grade 3 Lordosis;"Severe accentuation; operative intervention indicated; limiting self care ADL";Lordosis;10024842;LLT;20,1
2607;C143224;Muscle Cramp, CTCAE;A disorder characterized by marked cramping sensation originating from a muscle or group of muscles.;Muscle cramp;A disorder characterized by marked cramping sensation originating from a muscle or group of muscles.;Muscle cramp;10028294;LLT;20,1
2608;C144269;Grade 1 Muscle Cramp, CTCAE;Mild pain;Grade 1 Muscle cramp;Mild pain;Muscle cramp;10028294;LLT;20,1
2609;C144846;Grade 2 Muscle Cramp, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Muscle cramp;"Moderate pain; limiting instrumental ADL";Muscle cramp;10028294;LLT;20,1
2610;C145469;Grade 3 Muscle Cramp, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Muscle cramp;"Severe pain; limiting self care ADL";Muscle cramp;10028294;LLT;20,1
2611;C143682;Muscle Weakness Lower Limb, CTCAE;A disorder characterized by a reduction in the strength of the lower limb muscles.;Muscle weakness lower limb;A disorder characterized by a reduction in the strength of the lower limb muscles.;Muscle weakness lower limb;10065776;LLT;20,1
2612;C144271;Grade 1 Muscle Weakness Lower Limb, CTCAE;"Symptomatic; perceived by patient but not evident on physical exam";Grade 1 Muscle weakness lower limb;"Symptomatic; perceived by patient but not evident on physical exam";Muscle weakness lower limb;10065776;LLT;20,1
2613;C144848;Grade 2 Muscle Weakness Lower Limb, CTCAE;"Symptomatic; evident on physical exam; limiting instrumental ADL";Grade 2 Muscle weakness lower limb;"Symptomatic; evident on physical exam; limiting instrumental ADL";Muscle weakness lower limb;10065776;LLT;20,1
2614;C145471;Grade 3 Muscle Weakness Lower Limb, CTCAE;Limiting self care ADL;Grade 3 Muscle weakness lower limb;Limiting self care ADL;Muscle weakness lower limb;10065776;LLT;20,1
2615;C143684;Muscle Weakness Trunk, CTCAE;A disorder characterized by a reduction in the strength of the trunk muscles.;Muscle weakness trunk;A disorder characterized by a reduction in the strength of the trunk muscles.;Muscle weakness trunk;10065795;LLT;20,1
2616;C144273;Grade 1 Muscle Weakness Trunk, CTCAE;"Symptomatic; perceived by patient but not evident on physical exam";Grade 1 Muscle weakness trunk;"Symptomatic; perceived by patient but not evident on physical exam";Muscle weakness trunk;10065795;LLT;20,1
2617;C144850;Grade 2 Muscle Weakness Trunk, CTCAE;"Symptomatic; evident on physical exam; limiting instrumental ADL";Grade 2 Muscle weakness trunk;"Symptomatic; evident on physical exam; limiting instrumental ADL";Muscle weakness trunk;10065795;LLT;20,1
2618;C145473;Grade 3 Muscle Weakness Trunk, CTCAE;Limiting self care ADL;Grade 3 Muscle weakness trunk;Limiting self care ADL;Muscle weakness trunk;10065795;LLT;20,1
2619;C143685;Muscle Weakness Upper Limb, CTCAE;A disorder characterized by a reduction in the strength of the upper limb muscles.;Muscle weakness upper limb;A disorder characterized by a reduction in the strength of the upper limb muscles.;Muscle weakness upper limb;10065895;LLT;20,1
2620;C144274;Grade 1 Muscle Weakness Upper Limb, CTCAE;"Symptomatic; perceived by patient but not evident on physical exam";Grade 1 Muscle weakness upper limb;"Symptomatic; perceived by patient but not evident on physical exam";Muscle weakness upper limb;10065895;LLT;20,1
2621;C144851;Grade 2 Muscle Weakness Upper Limb, CTCAE;"Symptomatic; evident on physical exam; limiting instrumental ADL";Grade 2 Muscle weakness upper limb;"Symptomatic; evident on physical exam; limiting instrumental ADL";Muscle weakness upper limb;10065895;LLT;20,1
2622;C145474;Grade 3 Muscle Weakness Upper Limb, CTCAE;Limiting self care ADL;Grade 3 Muscle weakness upper limb;Limiting self care ADL;Muscle weakness upper limb;10065895;LLT;20,1
2623;C143686;Musculoskeletal and Connective Tissue Disorder - Other, Specify, CTCAE;;Musculoskeletal and connective tissue disorder - Other, specify;;Musculoskeletal and connective tissue disorder - Other, specify;10028395;LLT;20,1
2624;C144275;Grade 1 Musculoskeletal and Connective Tissue Disorder - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Musculoskeletal and connective tissue disorder - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Musculoskeletal and connective tissue disorder - Other, specify;10028395;LLT;20,1
2625;C144852;Grade 2 Musculoskeletal and Connective Tissue Disorder - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Musculoskeletal and connective tissue disorder - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Musculoskeletal and connective tissue disorder - Other, specify;10028395;LLT;20,1
2626;C145475;Grade 3 Musculoskeletal and Connective Tissue Disorder - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Musculoskeletal and connective tissue disorder - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Musculoskeletal and connective tissue disorder - Other, specify;10028395;LLT;20,1
2627;C146004;Grade 4 Musculoskeletal and Connective Tissue Disorder - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Musculoskeletal and connective tissue disorder - Other, specify;"Life-threatening consequences; urgent intervention indicated";Musculoskeletal and connective tissue disorder - Other, specify;10028395;LLT;20,1
2628;C146449;Grade 5 Musculoskeletal and Connective Tissue Disorder - Other, Specify, CTCAE;Death;Grade 5 Musculoskeletal and connective tissue disorder - Other, specify;Death;Musculoskeletal and connective tissue disorder - Other, specify;10028395;LLT;20,1
2629;C143687;Musculoskeletal Deformity, CTCAE;A disorder characterized by a malformation of the musculoskeletal system.;Musculoskeletal deformity;A disorder characterized by a malformation of the musculoskeletal system.;Musculoskeletal deformity;10065783;LLT;20,1
2630;C144276;Grade 1 Musculoskeletal Deformity, CTCAE;Cosmetically and functionally insignificant hypoplasia;Grade 1 Musculoskeletal deformity;Cosmetically and functionally insignificant hypoplasia;Musculoskeletal deformity;10065783;LLT;20,1
2631;C144853;Grade 2 Musculoskeletal Deformity, CTCAE;Deformity, hypoplasia, or asymmetry able to be remediated by prosthesis (e.g., shoe insert) or covered by clothing;Grade 2 Musculoskeletal deformity;Deformity, hypoplasia, or asymmetry able to be remediated by prosthesis (e.g., shoe insert) or covered by clothing;Musculoskeletal deformity;10065783;LLT;20,1
2632;C145476;Grade 3 Musculoskeletal Deformity, CTCAE;"Significant deformity, hypoplasia, or asymmetry, unable to be remediated by prosthesis or covered by clothing; limiting self care ADL";Grade 3 Musculoskeletal deformity;"Significant deformity, hypoplasia, or asymmetry, unable to be remediated by prosthesis or covered by clothing; limiting self care ADL";Musculoskeletal deformity;10065783;LLT;20,1
2633;C143688;Myalgia, CTCAE;A disorder characterized by marked discomfort sensation originating from a muscle or group of muscles.;Myalgia;A disorder characterized by marked discomfort sensation originating from a muscle or group of muscles.;Myalgia;10028411;LLT;20,1
2634;C144277;Grade 1 Myalgia, CTCAE;Mild pain;Grade 1 Myalgia;Mild pain;Myalgia;10028411;LLT;20,1
2635;C144854;Grade 2 Myalgia, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Myalgia;"Moderate pain; limiting instrumental ADL";Myalgia;10028411;LLT;20,1
2636;C145477;Grade 3 Myalgia, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Myalgia;"Severe pain; limiting self care ADL";Myalgia;10028411;LLT;20,1
2637;C146787;Myositis, CTCAE 5.0;A disorder characterized by inflammation involving the skeletal muscles.;Myositis;A disorder characterized by inflammation involving the skeletal muscles.;Myositis;10028653;LLT;20,1
2638;C58230;Grade 1 Myositis, CTCAE;Mild pain;Grade 1 Myositis;Mild pain;Myositis;10028653;LLT;20,1
2639;C58262;Grade 2 Myositis, CTCAE;"Moderate pain associated with weakness; pain limiting instrumental ADL";Grade 2 Myositis;"Moderate pain associated with weakness; pain limiting instrumental ADL";Myositis;10028653;LLT;20,1
2640;C58299;Grade 3 Myositis, CTCAE;"Pain associated with severe weakness; limiting self care ADL";Grade 3 Myositis;"Pain associated with severe weakness; limiting self care ADL";Myositis;10028653;LLT;20,1
2641;C58333;Grade 4 Myositis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Myositis;"Life-threatening consequences; urgent intervention indicated";Myositis;10028653;LLT;20,1
2642;C146766;Neck Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the neck area.;Neck pain;A disorder characterized by a sensation of marked discomfort in the neck area.;Neck pain;10028836;LLT;20,1
2643;C56136;Grade 1 Neck Pain, CTCAE;Mild pain;Grade 1 Neck pain;Mild pain;Neck pain;10028836;LLT;20,1
2644;C56137;Grade 2 Neck Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Neck pain;"Moderate pain; limiting instrumental ADL";Neck pain;10028836;LLT;20,1
2645;C56138;Grade 3 Neck Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Neck pain;"Severe pain; limiting self care ADL";Neck pain;10028836;LLT;20,1
2646;C58394;Neck Soft Tissue Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the soft tissues of the neck.;Neck soft tissue necrosis;A disorder characterized by a necrotic process occurring in the soft tissues of the neck.;Neck soft tissue necrosis;10065781;LLT;20,1
2647;C58263;Grade 2 Neck Soft Tissue Necrosis, CTCAE;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Grade 2 Neck soft tissue necrosis;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Neck soft tissue necrosis;10065781;LLT;20,1
2648;C58300;Grade 3 Neck Soft Tissue Necrosis, CTCAE;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Grade 3 Neck soft tissue necrosis;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Neck soft tissue necrosis;10065781;LLT;20,1
2649;C58334;Grade 4 Neck Soft Tissue Necrosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Neck soft tissue necrosis;"Life-threatening consequences; urgent intervention indicated";Neck soft tissue necrosis;10065781;LLT;20,1
2650;C58363;Grade 5 Neck Soft Tissue Necrosis, CTCAE;Death;Grade 5 Neck soft tissue necrosis;Death;Neck soft tissue necrosis;10065781;LLT;20,1
2651;C143717;Osteonecrosis of Jaw, CTCAE;A disorder characterized by a necrotic process occurring in the bone of the mandible.;Osteonecrosis of jaw;A disorder characterized by a necrotic process occurring in the bone of the mandible.;Osteonecrosis of jaw;10064658;LLT;20,1
2652;C144302;Grade 1 Osteonecrosis of Jaw, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Osteonecrosis of jaw;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Osteonecrosis of jaw;10064658;LLT;20,1
2653;C144878;Grade 2 Osteonecrosis of Jaw, CTCAE;"Symptomatic; medical intervention indicated (e.g., topical agents); limiting instrumental ADL";Grade 2 Osteonecrosis of jaw;"Symptomatic; medical intervention indicated (e.g., topical agents); limiting instrumental ADL";Osteonecrosis of jaw;10064658;LLT;20,1
2654;C145499;Grade 3 Osteonecrosis of Jaw, CTCAE;"Severe symptoms; limiting self care ADL; elective operative intervention indicated";Grade 3 Osteonecrosis of jaw;"Severe symptoms; limiting self care ADL; elective operative intervention indicated";Osteonecrosis of jaw;10064658;LLT;20,1
2655;C146018;Grade 4 Osteonecrosis of Jaw, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Osteonecrosis of jaw;"Life-threatening consequences; urgent intervention indicated";Osteonecrosis of jaw;10064658;LLT;20,1
2656;C146459;Grade 5 Osteonecrosis of Jaw, CTCAE;Death;Grade 5 Osteonecrosis of jaw;Death;Osteonecrosis of jaw;10064658;LLT;20,1
2657;C143225;Osteonecrosis, CTCAE;A disorder characterized by necrotic changes in the bone tissue due to interruption of blood supply. Most often affecting the epiphysis of the long bones, the necrotic changes result in the collapse and the destruction of the bone structure.;Osteonecrosis;A disorder characterized by necrotic changes in the bone tissue due to interruption of blood supply. Most often affecting the epiphysis of the long bones, the necrotic changes result in the collapse and the destruction of the bone structure.;Osteonecrosis;10031264;LLT;20,1
2658;C144303;Grade 1 Osteonecrosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Osteonecrosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Osteonecrosis;10031264;LLT;20,1
2659;C144879;Grade 2 Osteonecrosis, CTCAE;"Symptomatic; medical intervention indicated (e.g., analgesics or bisphosphonates); limiting instrumental ADL";Grade 2 Osteonecrosis;"Symptomatic; medical intervention indicated (e.g., analgesics or bisphosphonates); limiting instrumental ADL";Osteonecrosis;10031264;LLT;20,1
2660;C145500;Grade 3 Osteonecrosis, CTCAE;"Severe symptoms; limiting self care ADL; elective operative intervention indicated";Grade 3 Osteonecrosis;"Severe symptoms; limiting self care ADL; elective operative intervention indicated";Osteonecrosis;10031264;LLT;20,1
2661;C146019;Grade 4 Osteonecrosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Osteonecrosis;"Life-threatening consequences; urgent intervention indicated";Osteonecrosis;10031264;LLT;20,1
2662;C146460;Grade 5 Osteonecrosis, CTCAE;Death;Grade 5 Osteonecrosis;Death;Osteonecrosis;10031264;LLT;20,1
2663;C146767;Osteoporosis, CTCAE 5.0;A disorder characterized by reduced bone mass, with a decrease in cortical thickness and in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence.;Osteoporosis;A disorder characterized by reduced bone mass, with a decrease in cortical thickness and in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence.;Osteoporosis;10031282;LLT;20,1
2664;C58233;Grade 1 Osteoporosis, CTCAE;"Adult: Radiologic evidence of osteoporosis or Bone Mineral Density (BMD) t-score -1 to -2.5 (osteopenia); Pediatric: Radiologic evidence of low BMD with z score of <= -2.0 and no history of significant fractures";Grade 1 Osteoporosis;"Adult: Radiologic evidence of osteoporosis or Bone Mineral Density (BMD) t-score -1 to -2.5 (osteopenia); Pediatric: Radiologic evidence of low BMD with z score of <= -2.0 and no history of significant fractures";Osteoporosis;10031282;LLT;20,1
2665;C58266;Grade 2 Osteoporosis, CTCAE;"Adult: BMD t-score < -2.5; loss of height <2 cm; therapy to improve BMD indicated; limiting instrumental ADL; Pediatric: Low BMD (z-score <= -2.0) and significant fracture history (defined as a long bone fracture of the lower extremity, vertebral compression, 2 or more long bone fractures of the upper extremities); therapy to improve BMD indicated";Grade 2 Osteoporosis;"Adult: BMD t-score < -2.5; loss of height <2 cm; therapy to improve BMD indicated; limiting instrumental ADL; Pediatric: Low BMD (z-score <= -2.0) and significant fracture history (defined as a long bone fracture of the lower extremity, vertebral compression, 2 or more long bone fractures of the upper extremities); therapy to improve BMD indicated";Osteoporosis;10031282;LLT;20,1
2666;C58303;Grade 3 Osteoporosis, CTCAE;"Adult: Loss of height >=2 cm; hospitalization indicated; limiting self care ADL; Pediatric: Limiting self care ADL";Grade 3 Osteoporosis;"Adult: Loss of height >=2 cm; hospitalization indicated; limiting self care ADL; Pediatric: Limiting self care ADL";Osteoporosis;10031282;LLT;20,1
2667;C143723;Pain In Extremity, CTCAE;A disorder characterized by a sensation of marked discomfort in the upper or lower extremities.;Pain in extremity;A disorder characterized by a sensation of marked discomfort in the upper or lower extremities.;Pain in extremity;10033425;LLT;20,1
2668;C144307;Grade 1 Pain In Extremity, CTCAE;Mild pain;Grade 1 Pain in extremity;Mild pain;Pain in extremity;10033425;LLT;20,1
2669;C144886;Grade 2 Pain In Extremity, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Pain in extremity;"Moderate pain; limiting instrumental ADL";Pain in extremity;10033425;LLT;20,1
2670;C145506;Grade 3 Pain In Extremity, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Pain in extremity;"Severe pain; limiting self care ADL";Pain in extremity;10033425;LLT;20,1
2671;C58399;Pelvic Soft Tissue Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the soft tissues of the pelvis.;Pelvic soft tissue necrosis;A disorder characterized by a necrotic process occurring in the soft tissues of the pelvis.;Pelvic soft tissue necrosis;10065793;LLT;20,1
2672;C58269;Grade 2 Pelvic Soft Tissue Necrosis, CTCAE;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Grade 2 Pelvic soft tissue necrosis;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Pelvic soft tissue necrosis;10065793;LLT;20,1
2673;C58306;Grade 3 Pelvic Soft Tissue Necrosis, CTCAE;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Grade 3 Pelvic soft tissue necrosis;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Pelvic soft tissue necrosis;10065793;LLT;20,1
2674;C58340;Grade 4 Pelvic Soft Tissue Necrosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pelvic soft tissue necrosis;"Life-threatening consequences; urgent intervention indicated";Pelvic soft tissue necrosis;10065793;LLT;20,1
2675;C58369;Grade 5 Pelvic Soft Tissue Necrosis, CTCAE;Death;Grade 5 Pelvic soft tissue necrosis;Death;Pelvic soft tissue necrosis;10065793;LLT;20,1
2676;C143226;Rhabdomyolysis, CTCAE;A disorder characterized by the breakdown of muscle tissue resulting in the release of muscle fiber contents into the bloodstream.;Rhabdomyolysis;A disorder characterized by the breakdown of muscle tissue resulting in the release of muscle fiber contents into the bloodstream.;Rhabdomyolysis;10039020;LLT;20,1
2677;C144384;Grade 1 Rhabdomyolysis, CTCAE;"Asymptomatic, intervention not indicated; laboratory findings only";Grade 1 Rhabdomyolysis;"Asymptomatic, intervention not indicated; laboratory findings only";Rhabdomyolysis;10039020;LLT;20,1
2678;C144981;Grade 2 Rhabdomyolysis, CTCAE;Non-urgent intervention indicated;Grade 2 Rhabdomyolysis;Non-urgent intervention indicated;Rhabdomyolysis;10039020;LLT;20,1
2679;C145603;Grade 3 Rhabdomyolysis, CTCAE;Symptomatic, urgent intervention indicated;Grade 3 Rhabdomyolysis;Symptomatic, urgent intervention indicated;Rhabdomyolysis;10039020;LLT;20,1
2680;C146099;Grade 4 Rhabdomyolysis, CTCAE;"Life-threatening consequences; dialysis";Grade 4 Rhabdomyolysis;"Life-threatening consequences; dialysis";Rhabdomyolysis;10039020;LLT;20,1
2681;C146534;Grade 5 Rhabdomyolysis, CTCAE;Death;Grade 5 Rhabdomyolysis;Death;Rhabdomyolysis;10039020;LLT;20,1
2682;C143227;Rotator Cuff Injury, CTCAE;A disorder characterized by an injury of the rotator cuff.;Rotator cuff injury;A disorder characterized by an injury of the rotator cuff.;Rotator cuff injury;10039226;LLT;20,1
2683;C144386;Grade 1 Rotator Cuff Injury, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Rotator cuff injury;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Rotator cuff injury;10039226;LLT;20,1
2684;C144983;Grade 2 Rotator Cuff Injury, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting instrumental ADL";Grade 2 Rotator cuff injury;"Moderate; minimal, local or noninvasive intervention indicated; limiting instrumental ADL";Rotator cuff injury;10039226;LLT;20,1
2685;C145604;Grade 3 Rotator Cuff Injury, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Rotator cuff injury;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Rotator cuff injury;10039226;LLT;20,1
2686;C143824;Scoliosis, CTCAE;A disorder characterized by a malformed, lateral curvature of the spine.;Scoliosis;A disorder characterized by a malformed, lateral curvature of the spine.;Scoliosis;10039722;LLT;20,1
2687;C144389;Grade 1 Scoliosis, CTCAE;"<20 degrees; clinically undetectable";Grade 1 Scoliosis;"<20 degrees; clinically undetectable";Scoliosis;10039722;LLT;20,1
2688;C144987;Grade 2 Scoliosis, CTCAE;">20-45 degrees; visible by forward flexion; limiting instrumental ADL";Grade 2 Scoliosis;">20-45 degrees; visible by forward flexion; limiting instrumental ADL";Scoliosis;10039722;LLT;20,1
2689;C145608;Grade 3 Scoliosis, CTCAE;">45 degrees; scapular prominence in forward flexion; operative intervention indicated; limiting self care ADL";Grade 3 Scoliosis;">45 degrees; scapular prominence in forward flexion; operative intervention indicated; limiting self care ADL";Scoliosis;10039722;LLT;20,1
2690;C143850;Soft Tissue Necrosis Lower Limb, CTCAE;A disorder characterized by a necrotic process occurring in the soft tissues of the lower extremity.;Soft tissue necrosis lower limb;A disorder characterized by a necrotic process occurring in the soft tissues of the lower extremity.;Soft tissue necrosis lower limb;10065777;LLT;20,1
2691;C145014;Grade 2 Soft Tissue Necrosis Lower Limb, CTCAE;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Grade 2 Soft tissue necrosis lower limb;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Soft tissue necrosis lower limb;10065777;LLT;20,1
2692;C145632;Grade 3 Soft Tissue Necrosis Lower Limb, CTCAE;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Grade 3 Soft tissue necrosis lower limb;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Soft tissue necrosis lower limb;10065777;LLT;20,1
2693;C146125;Grade 4 Soft Tissue Necrosis Lower Limb, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Soft tissue necrosis lower limb;"Life-threatening consequences; urgent intervention indicated";Soft tissue necrosis lower limb;10065777;LLT;20,1
2694;C146557;Grade 5 Soft Tissue Necrosis Lower Limb, CTCAE;Death;Grade 5 Soft tissue necrosis lower limb;Death;Soft tissue necrosis lower limb;10065777;LLT;20,1
2695;C143851;Soft Tissue Necrosis Upper Limb, CTCAE;A disorder characterized by a necrotic process occurring in the soft tissues of the upper extremity.;Soft tissue necrosis upper limb;A disorder characterized by a necrotic process occurring in the soft tissues of the upper extremity.;Soft tissue necrosis upper limb;10065778;LLT;20,1
2696;C145015;Grade 2 Soft Tissue Necrosis Upper Limb, CTCAE;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Grade 2 Soft tissue necrosis upper limb;"Local wound care; medical intervention indicated (e.g., dressings or topical medications)";Soft tissue necrosis upper limb;10065778;LLT;20,1
2697;C145633;Grade 3 Soft Tissue Necrosis Upper Limb, CTCAE;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Grade 3 Soft tissue necrosis upper limb;Operative debridement or other invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting);Soft tissue necrosis upper limb;10065778;LLT;20,1
2698;C146126;Grade 4 Soft Tissue Necrosis Upper Limb, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Soft tissue necrosis upper limb;"Life-threatening consequences; urgent intervention indicated";Soft tissue necrosis upper limb;10065778;LLT;20,1
2699;C146558;Grade 5 Soft Tissue Necrosis Upper Limb, CTCAE;Death;Grade 5 Soft tissue necrosis upper limb;Death;Soft tissue necrosis upper limb;10065778;LLT;20,1
2700;C143866;Superficial Soft Tissue Fibrosis, CTCAE;A disorder characterized by fibrotic degeneration of the superficial soft tissues.;Superficial soft tissue fibrosis;A disorder characterized by fibrotic degeneration of the superficial soft tissues.;Superficial soft tissue fibrosis;10065798;LLT;20,1
2701;C144422;Grade 1 Superficial Soft Tissue Fibrosis, CTCAE;Mild induration, able to move skin parallel to plane (sliding) and perpendicular to skin (pinching up);Grade 1 Superficial soft tissue fibrosis;Mild induration, able to move skin parallel to plane (sliding) and perpendicular to skin (pinching up);Superficial soft tissue fibrosis;10065798;LLT;20,1
2702;C145027;Grade 2 Superficial Soft Tissue Fibrosis, CTCAE;"Moderate induration, able to slide skin, unable to pinch skin; limiting instrumental ADL";Grade 2 Superficial soft tissue fibrosis;"Moderate induration, able to slide skin, unable to pinch skin; limiting instrumental ADL";Superficial soft tissue fibrosis;10065798;LLT;20,1
2703;C145650;Grade 3 Superficial Soft Tissue Fibrosis, CTCAE;"Severe induration; unable to slide or pinch skin; limiting joint or orifice movement (e.g., mouth, anus); limiting self care ADL";Grade 3 Superficial soft tissue fibrosis;"Severe induration; unable to slide or pinch skin; limiting joint or orifice movement (e.g., mouth, anus); limiting self care ADL";Superficial soft tissue fibrosis;10065798;LLT;20,1
2704;C146140;Grade 4 Superficial Soft Tissue Fibrosis, CTCAE;"Generalized; associated with signs or symptoms of impaired breathing or feeding";Grade 4 Superficial soft tissue fibrosis;"Generalized; associated with signs or symptoms of impaired breathing or feeding";Superficial soft tissue fibrosis;10065798;LLT;20,1
2705;C146572;Grade 5 Superficial Soft Tissue Fibrosis, CTCAE;Death;Grade 5 Superficial soft tissue fibrosis;Death;Superficial soft tissue fibrosis;10065798;LLT;20,1
2706;C58404;Trismus, CTCAE;A disorder characterized by lack of ability to open the mouth fully due to a decrease in the range of motion of the muscles of mastication.;Trismus;A disorder characterized by lack of ability to open the mouth fully due to a decrease in the range of motion of the muscles of mastication.;Trismus;10044684;LLT;20,1
2707;C58238;Grade 1 Trismus, CTCAE;Decreased ROM (range of motion) without impaired eating;Grade 1 Trismus;Decreased ROM (range of motion) without impaired eating;Trismus;10044684;LLT;20,1
2708;C58274;Grade 2 Trismus, CTCAE;Decreased ROM requiring small bites, soft foods or purees;Grade 2 Trismus;Decreased ROM requiring small bites, soft foods or purees;Trismus;10044684;LLT;20,1
2709;C58311;Grade 3 Trismus, CTCAE;Decreased ROM with inability to adequately aliment or hydrate orally;Grade 3 Trismus;Decreased ROM with inability to adequately aliment or hydrate orally;Trismus;10044684;LLT;20,1
2710;C143894;Unequal Limb Length, CTCAE;A disorder characterized by a discrepancy between the lengths of the lower or upper extremities.;Unequal limb length;A disorder characterized by a discrepancy between the lengths of the lower or upper extremities.;Unequal limb length;10065738;LLT;20,1
2711;C144448;Grade 1 Unequal Limb Length, CTCAE;Mild length discrepancy <2 cm;Grade 1 Unequal limb length;Mild length discrepancy <2 cm;Unequal limb length;10065738;LLT;20,1
2712;C145053;Grade 2 Unequal Limb Length, CTCAE;"Moderate length discrepancy 2-5 cm; shoe lift indicated; limiting instrumental ADL";Grade 2 Unequal limb length;"Moderate length discrepancy 2-5 cm; shoe lift indicated; limiting instrumental ADL";Unequal limb length;10065738;LLT;20,1
2713;C145675;Grade 3 Unequal Limb Length, CTCAE;"Severe length discrepancy >5 cm; limiting self care ADL; operative intervention indicated";Grade 3 Unequal limb length;"Severe length discrepancy >5 cm; limiting self care ADL; operative intervention indicated";Unequal limb length;10065738;LLT;20,1
2714;C143176;Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps), CTCAE;;;;;;;
2715;C144286;Grade 1 Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps) - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;10029104;LLT;20,1
2716;C144862;Grade 2 Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps) - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;10029104;LLT;20,1
2717;C145483;Grade 3 Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps) - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;10029104;LLT;20,1
2718;C146009;Grade 4 Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps) - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;"Life-threatening consequences; urgent intervention indicated";Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;10029104;LLT;20,1
2719;C146453;Grade 5 Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps) - Other, Specify, CTCAE;Death;Grade 5 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;Death;Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;10029104;LLT;20,1
2720;C143646;Leukemia Secondary To Oncology Chemotherapy, CTCAE;A disorder characterized by leukemia arising as a result of the mutagenic effect of chemotherapy agents.;Leukemia secondary to oncology chemotherapy;A disorder characterized by leukemia arising as a result of the mutagenic effect of chemotherapy agents.;Leukemia secondary to oncology chemotherapy;10048293;LLT;20,1
2721;C145980;Grade 4 Leukemia Secondary To Oncology Chemotherapy, CTCAE;Present;Grade 4 Leukemia secondary to oncology chemotherapy;Present;Leukemia secondary to oncology chemotherapy;10048293;LLT;20,1
2722;C146427;Grade 5 Leukemia Secondary To Oncology Chemotherapy, CTCAE;Death;Grade 5 Leukemia secondary to oncology chemotherapy;Death;Leukemia secondary to oncology chemotherapy;10048293;LLT;20,1
2723;C143690;Myelodysplastic Syndrome, CTCAE;A disorder characterized by insufficiently healthy hematapoietic cell production by the bone marrow.;Myelodysplastic syndrome;A disorder characterized by insufficiently healthy hematapoietic cell production by the bone marrow.;Myelodysplastic syndrome;10028533;LLT;20,1
2724;C146006;Grade 4 Myelodysplastic Syndrome, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Myelodysplastic syndrome;"Life-threatening consequences; urgent intervention indicated";Myelodysplastic syndrome;10028533;LLT;20,1
2725;C146451;Grade 5 Myelodysplastic Syndrome, CTCAE;Death;Grade 5 Myelodysplastic syndrome;Death;Myelodysplastic syndrome;10028533;LLT;20,1
2726;C143701;Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps) - Other, Specify, CTCAE;;Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;;Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify;10029104;LLT;20,1
2727;C143228;Skin Papilloma, CTCAE;A disorder characterized by the presence of one or more warts.;Skin papilloma;A disorder characterized by the presence of one or more warts.;Skin papilloma;10040907;LLT;20,1
2728;C144402;Grade 1 Skin Papilloma, CTCAE;"Asymptomatic; intervention not indicated";Grade 1 Skin papilloma;"Asymptomatic; intervention not indicated";Skin papilloma;10040907;LLT;20,1
2729;C145001;Grade 2 Skin Papilloma, CTCAE;Intervention initiated;Grade 2 Skin papilloma;Intervention initiated;Skin papilloma;10040907;LLT;20,1
2730;C143887;Treatment Related Secondary Malignancy, CTCAE;A disorder characterized by development of a malignancy most probably as a result of treatment for a previously existing malignancy.;Treatment related secondary malignancy;A disorder characterized by development of a malignancy most probably as a result of treatment for a previously existing malignancy.;Treatment related secondary malignancy;10049737;LLT;20,1
2731;C145670;Grade 3 Treatment Related Secondary Malignancy, CTCAE;Non life-threatening secondary malignancy;Grade 3 Treatment related secondary malignancy;Non life-threatening secondary malignancy;Treatment related secondary malignancy;10049737;LLT;20,1
2732;C146156;Grade 4 Treatment Related Secondary Malignancy, CTCAE;"Acute life-threatening secondary malignancy; blast crisis in leukemia";Grade 4 Treatment related secondary malignancy;"Acute life-threatening secondary malignancy; blast crisis in leukemia";Treatment related secondary malignancy;10049737;LLT;20,1
2733;C146587;Grade 5 Treatment Related Secondary Malignancy, CTCAE;Death;Grade 5 Treatment related secondary malignancy;Death;Treatment related secondary malignancy;10049737;LLT;20,1
2734;C143229;Tumor Hemorrhage, CTCAE;A disorder characterized by bleeding in a tumor.;Tumor hemorrhage;A disorder characterized by bleeding in a tumor.;Tumor hemorrhage;10055351;LLT;20,1
2735;C144447;Grade 1 Tumor Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Tumor hemorrhage;"Mild symptoms; intervention not indicated";Tumor hemorrhage;10055351;LLT;20,1
2736;C145052;Grade 2 Tumor Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Tumor hemorrhage;"Moderate symptoms; intervention indicated";Tumor hemorrhage;10055351;LLT;20,1
2737;C145674;Grade 3 Tumor Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Tumor hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Tumor hemorrhage;10055351;LLT;20,1
2738;C146158;Grade 4 Tumor Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Tumor hemorrhage;"Life-threatening consequences; urgent intervention indicated";Tumor hemorrhage;10055351;LLT;20,1
2739;C146589;Grade 5 Tumor Hemorrhage, CTCAE;Death;Grade 5 Tumor hemorrhage;Death;Tumor hemorrhage;10055351;LLT;20,1
2740;C146782;Tumor Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort from a neoplasm that may be pressing on a nerve, blocking blood vessels, inflamed or fractured from metastasis.;Tumor pain;A disorder characterized by a sensation of marked discomfort from a neoplasm that may be pressing on a nerve, blocking blood vessels, inflamed or fractured from metastasis.;Tumor pain;10045158;LLT;20,1
2741;C56246;Grade 1 Tumor Pain, CTCAE;Mild pain;Grade 1 Tumor pain;Mild pain;Tumor pain;10045158;LLT;20,1
2742;C56247;Grade 2 Tumor Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Tumor pain;"Moderate pain; limiting instrumental ADL";Tumor pain;10045158;LLT;20,1
2743;C56248;Grade 3 Tumor Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Tumor pain;"Severe pain; limiting self care ADL";Tumor pain;10045158;LLT;20,1
2744;C143177;Nervous System Disorders, CTCAE;;;;;;;
2745;C143257;Abducens Nerve Disorder, CTCAE;A disorder characterized by dysfunction of the abducens nerve (sixth cranial nerve).;Abducens nerve disorder;A disorder characterized by dysfunction of the abducens nerve (sixth cranial nerve).;Abducens nerve disorder;10053662;LLT;20,1
2746;C143960;Grade 1 Abducens Nerve Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Abducens nerve disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Abducens nerve disorder;10053662;LLT;20,1
2747;C144498;Grade 2 Abducens Nerve Disorder, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Abducens nerve disorder;"Moderate symptoms; limiting instrumental ADL";Abducens nerve disorder;10053662;LLT;20,1
2748;C145114;Grade 3 Abducens Nerve Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Abducens nerve disorder;"Severe symptoms; limiting self care ADL";Abducens nerve disorder;10053662;LLT;20,1
2749;C143258;Accessory Nerve Disorder, CTCAE;A disorder characterized by dysfunction of the accessory nerve (eleventh cranial nerve).;Accessory nerve disorder;A disorder characterized by dysfunction of the accessory nerve (eleventh cranial nerve).;Accessory nerve disorder;10060929;LLT;20,1
2750;C143961;Grade 1 Accessory Nerve Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Accessory nerve disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Accessory nerve disorder;10060929;LLT;20,1
2751;C144499;Grade 2 Accessory Nerve Disorder, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Accessory nerve disorder;"Moderate symptoms; limiting instrumental ADL";Accessory nerve disorder;10060929;LLT;20,1
2752;C145115;Grade 3 Accessory Nerve Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Accessory nerve disorder;"Severe symptoms; limiting self care ADL";Accessory nerve disorder;10060929;LLT;20,1
2753;C143260;Acoustic Nerve Disorder NOS, CTCAE;A disorder characterized by dysfunction of the acoustic nerve (eighth cranial nerve).;Acoustic nerve disorder NOS;A disorder characterized by dysfunction of the acoustic nerve (eighth cranial nerve).;Acoustic nerve disorder NOS;10000521;LLT;20,1
2754;C143963;Grade 1 Acoustic Nerve Disorder NOS, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Acoustic nerve disorder NOS;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Acoustic nerve disorder NOS;10000521;LLT;20,1
2755;C144500;Grade 2 Acoustic Nerve Disorder NOS, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Acoustic nerve disorder NOS;"Moderate symptoms; limiting instrumental ADL";Acoustic nerve disorder NOS;10000521;LLT;20,1
2756;C145117;Grade 3 Acoustic Nerve Disorder NOS, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Acoustic nerve disorder NOS;"Severe symptoms; limiting self care ADL";Acoustic nerve disorder NOS;10000521;LLT;20,1
2757;C143266;Akathisia, CTCAE;"A disorder characterized by an uncomfortable feeling of inner restlessness and inability to stay still; this is a side effect of some psychotropic drugs.";Akathisia;"A disorder characterized by an uncomfortable feeling of inner restlessness and inability to stay still; this is a side effect of some psychotropic drugs.";Akathisia;10001540;LLT;20,1
2758;C143965;Grade 1 Akathisia, CTCAE;Mild restlessness or increased motor activity;Grade 1 Akathisia;Mild restlessness or increased motor activity;Akathisia;10001540;LLT;20,1
2759;C144502;Grade 2 Akathisia, CTCAE;"Moderate restlessness or increased motor activity; limiting instrumental ADL";Grade 2 Akathisia;"Moderate restlessness or increased motor activity; limiting instrumental ADL";Akathisia;10001540;LLT;20,1
2760;C145120;Grade 3 Akathisia, CTCAE;"Severe restlessness or increased motor activity; limiting self care ADL";Grade 3 Akathisia;"Severe restlessness or increased motor activity; limiting self care ADL";Akathisia;10001540;LLT;20,1
2761;C143274;Amnesia, CTCAE;A disorder characterized by systematic and extensive loss of memory.;Amnesia;A disorder characterized by systematic and extensive loss of memory.;Amnesia;10001949;LLT;20,1
2762;C143971;Grade 1 Amnesia, CTCAE;"Mild; transient memory loss";Grade 1 Amnesia;"Mild; transient memory loss";Amnesia;10001949;LLT;20,1
2763;C144509;Grade 2 Amnesia, CTCAE;"Moderate; short term memory loss; limiting instrumental ADL";Grade 2 Amnesia;"Moderate; short term memory loss; limiting instrumental ADL";Amnesia;10001949;LLT;20,1
2764;C145126;Grade 3 Amnesia, CTCAE;"Severe; long term memory loss; limiting self care ADL";Grade 3 Amnesia;"Severe; long term memory loss; limiting self care ADL";Amnesia;10001949;LLT;20,1
2765;C143230;Anosmia, CTCAE;A disorder characterized by a change in the sense of smell.;Anosmia;A disorder characterized by a change in the sense of smell.;Anosmia;10002653;LLT;20,1
2766;C143983;Grade 1 Anosmia, CTCAE;Present;Grade 1 Anosmia;Present;Anosmia;10002653;LLT;20,1
2767;C143291;Aphonia, CTCAE;A disorder characterized by the inability to speak. It may result from injuries to the vocal cords or may be functional (psychogenic).;Aphonia;A disorder characterized by the inability to speak. It may result from injuries to the vocal cords or may be functional (psychogenic).;Aphonia;10002953;LLT;20,1
2768;C145141;Grade 3 Aphonia, CTCAE;"Voicelessness; unable to speak";Grade 3 Aphonia;"Voicelessness; unable to speak";Aphonia;10002953;LLT;20,1
2769;C143295;Arachnoiditis, CTCAE;A disorder characterized by inflammation of the arachnoid membrane and adjacent subarachnoid space.;Arachnoiditis;A disorder characterized by inflammation of the arachnoid membrane and adjacent subarachnoid space.;Arachnoiditis;10003074;LLT;20,1
2770;C143985;Grade 1 Arachnoiditis, CTCAE;Mild symptoms;Grade 1 Arachnoiditis;Mild symptoms;Arachnoiditis;10003074;LLT;20,1
2771;C144523;Grade 2 Arachnoiditis, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Arachnoiditis;"Moderate symptoms; limiting instrumental ADL";Arachnoiditis;10003074;LLT;20,1
2772;C145144;Grade 3 Arachnoiditis, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Arachnoiditis;"Severe symptoms; limiting self care ADL";Arachnoiditis;10003074;LLT;20,1
2773;C145751;Grade 4 Arachnoiditis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Arachnoiditis;"Life-threatening consequences; urgent intervention indicated";Arachnoiditis;10003074;LLT;20,1
2774;C146221;Grade 5 Arachnoiditis, CTCAE;Death;Grade 5 Arachnoiditis;Death;Arachnoiditis;10003074;LLT;20,1
2775;C146737;Ataxia, CTCAE 5.0;A disorder characterized by lack of coordination of muscle movements resulting in the impairment or inability to perform voluntary activities.;Ataxia;A disorder characterized by lack of coordination of muscle movements resulting in the impairment or inability to perform voluntary activities.;Ataxia;10003591;LLT;20,1
2776;C55351;Grade 1 Ataxia, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Ataxia;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Ataxia;10003591;LLT;20,1
2777;C55352;Grade 2 Ataxia, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Ataxia;"Moderate symptoms; limiting instrumental ADL";Ataxia;10003591;LLT;20,1
2778;C55353;Grade 3 Ataxia, CTCAE;"Severe symptoms; limiting self care ADL; mechanical assistance indicated";Grade 3 Ataxia;"Severe symptoms; limiting self care ADL; mechanical assistance indicated";Ataxia;10003591;LLT;20,1
2779;C146754;Brachial Plexopathy, CTCAE 5.0;A disorder characterized by regional paresthesia of the brachial plexus, marked discomfort and muscle weakness, and limited movement in the arm or hand.;Brachial plexopathy;A disorder characterized by regional paresthesia of the brachial plexus, marked discomfort and muscle weakness, and limited movement in the arm or hand.;Brachial plexopathy;10065417;LLT;20,1
2780;C55357;Grade 1 Brachial Plexopathy, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Brachial plexopathy;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Brachial plexopathy;10065417;LLT;20,1
2781;C55358;Grade 2 Brachial Plexopathy, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Brachial plexopathy;"Moderate symptoms; limiting instrumental ADL";Brachial plexopathy;10065417;LLT;20,1
2782;C55359;Grade 3 Brachial Plexopathy, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Brachial plexopathy;"Severe symptoms; limiting self care ADL";Brachial plexopathy;10065417;LLT;20,1
2783;C143360;Central Nervous System Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the brain and/or spinal cord.;Central nervous system necrosis;A disorder characterized by a necrotic process occurring in the brain and/or spinal cord.;Central nervous system necrosis;10065784;LLT;20,1
2784;C144026;Grade 1 Central Nervous System Necrosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Central nervous system necrosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Central nervous system necrosis;10065784;LLT;20,1
2785;C144572;Grade 2 Central Nervous System Necrosis, CTCAE;"Moderate symptoms; corticosteroids indicated";Grade 2 Central nervous system necrosis;"Moderate symptoms; corticosteroids indicated";Central nervous system necrosis;10065784;LLT;20,1
2786;C145189;Grade 3 Central Nervous System Necrosis, CTCAE;"Severe symptoms; medical intervention indicated";Grade 3 Central nervous system necrosis;"Severe symptoms; medical intervention indicated";Central nervous system necrosis;10065784;LLT;20,1
2787;C145788;Grade 4 Central Nervous System Necrosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Central nervous system necrosis;"Life-threatening consequences; urgent intervention indicated";Central nervous system necrosis;10065784;LLT;20,1
2788;C146254;Grade 5 Central Nervous System Necrosis, CTCAE;Death;Grade 5 Central nervous system necrosis;Death;Central nervous system necrosis;10065784;LLT;20,1
2789;C143361;Cerebrospinal Fluid Leakage, CTCAE;A disorder characterized by loss of cerebrospinal fluid into the surrounding tissues.;Cerebrospinal fluid leakage;A disorder characterized by loss of cerebrospinal fluid into the surrounding tissues.;Cerebrospinal fluid leakage;10008164;LLT;20,1
2790;C144027;Grade 1 Cerebrospinal Fluid Leakage, CTCAE;"Post-craniotomy: asymptomatic; Post-lumbar puncture: transient headache; postural care indicated";Grade 1 Cerebrospinal fluid leakage;"Post-craniotomy: asymptomatic; Post-lumbar puncture: transient headache; postural care indicated";Cerebrospinal fluid leakage;10008164;LLT;20,1
2791;C144573;Grade 2 Cerebrospinal Fluid Leakage, CTCAE;"Post-craniotomy: moderate symptoms; medical intervention indicated; Post-lumbar puncture: persistent moderate symptoms; blood patch indicated";Grade 2 Cerebrospinal fluid leakage;"Post-craniotomy: moderate symptoms; medical intervention indicated; Post-lumbar puncture: persistent moderate symptoms; blood patch indicated";Cerebrospinal fluid leakage;10008164;LLT;20,1
2792;C145190;Grade 3 Cerebrospinal Fluid Leakage, CTCAE;"Severe symptoms; medical intervention indicated";Grade 3 Cerebrospinal fluid leakage;"Severe symptoms; medical intervention indicated";Cerebrospinal fluid leakage;10008164;LLT;20,1
2793;C145789;Grade 4 Cerebrospinal Fluid Leakage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Cerebrospinal fluid leakage;"Life-threatening consequences; urgent intervention indicated";Cerebrospinal fluid leakage;10008164;LLT;20,1
2794;C146255;Grade 5 Cerebrospinal Fluid Leakage, CTCAE;Death;Grade 5 Cerebrospinal fluid leakage;Death;Cerebrospinal fluid leakage;10008164;LLT;20,1
2795;C146746;Cognitive Disturbance, CTCAE 5.0;A disorder characterized by a conspicuous change in cognitive function.;Cognitive disturbance;A disorder characterized by a conspicuous change in cognitive function.;Cognitive disturbance;10009845;LLT;20,1
2796;C55374;Grade 1 Cognitive Disturbance, CTCAE;"Mild cognitive disability; not interfering with work/school/life performance; specialized educational services/devices not indicated";Grade 1 Cognitive disturbance;"Mild cognitive disability; not interfering with work/school/life performance; specialized educational services/devices not indicated";Cognitive disturbance;10009845;LLT;20,1
2797;C55375;Grade 2 Cognitive Disturbance, CTCAE;"Moderate cognitive disability; interfering with work/school/life performance but capable of independent living; specialized resources on part time basis indicated";Grade 2 Cognitive disturbance;"Moderate cognitive disability; interfering with work/school/life performance but capable of independent living; specialized resources on part time basis indicated";Cognitive disturbance;10009845;LLT;20,1
2798;C55376;Grade 3 Cognitive Disturbance, CTCAE;"Severe cognitive disability; significant impairment of work/school/life performance";Grade 3 Cognitive disturbance;"Severe cognitive disability; significant impairment of work/school/life performance";Cognitive disturbance;10009845;LLT;20,1
2799;C143379;Concentration Impairment, CTCAE;A disorder characterized by a deterioration in the ability to concentrate.;Concentration impairment;A disorder characterized by a deterioration in the ability to concentrate.;Concentration impairment;10010250;LLT;20,1
2800;C144038;Grade 1 Concentration Impairment, CTCAE;Mild inattention or decreased level of concentration;Grade 1 Concentration impairment;Mild inattention or decreased level of concentration;Concentration impairment;10010250;LLT;20,1
2801;C144587;Grade 2 Concentration Impairment, CTCAE;"Moderate impairment in attention or decreased level of concentration; limiting instrumental ADL";Grade 2 Concentration impairment;"Moderate impairment in attention or decreased level of concentration; limiting instrumental ADL";Concentration impairment;10010250;LLT;20,1
2802;C145204;Grade 3 Concentration Impairment, CTCAE;"Severe impairment in attention or decreased level of concentration; limiting self care ADL";Grade 3 Concentration impairment;"Severe impairment in attention or decreased level of concentration; limiting self care ADL";Concentration impairment;10010250;LLT;20,1
2803;C143403;Depressed Level of Consciousness, CTCAE;A disorder characterized by a decrease in ability to perceive and respond.;Depressed level of consciousness;A disorder characterized by a decrease in ability to perceive and respond.;Depressed level of consciousness;10012373;LLT;20,1
2804;C144051;Grade 1 Depressed Level of Consciousness, CTCAE;Decreased level of alertness;Grade 1 Depressed level of consciousness;Decreased level of alertness;Depressed level of consciousness;10012373;LLT;20,1
2805;C144604;Grade 2 Depressed Level of Consciousness, CTCAE;"Sedation; slow response to stimuli; limiting instrumental ADL";Grade 2 Depressed level of consciousness;"Sedation; slow response to stimuli; limiting instrumental ADL";Depressed level of consciousness;10012373;LLT;20,1
2806;C145221;Grade 3 Depressed Level of Consciousness, CTCAE;Difficult to arouse;Grade 3 Depressed level of consciousness;Difficult to arouse;Depressed level of consciousness;10012373;LLT;20,1
2807;C145816;Grade 4 Depressed Level of Consciousness, CTCAE;"Life-threatening consequences; coma; urgent intervention indicated";Grade 4 Depressed level of consciousness;"Life-threatening consequences; coma; urgent intervention indicated";Depressed level of consciousness;10012373;LLT;20,1
2808;C146276;Grade 5 Depressed Level of Consciousness, CTCAE;Death;Grade 5 Depressed level of consciousness;Death;Depressed level of consciousness;10012373;LLT;20,1
2809;C146747;Dizziness, CTCAE 5.0;A disorder characterized by a disturbing sensation of lightheadedness, unsteadiness, giddiness, spinning or rocking.;Dizziness;A disorder characterized by a disturbing sensation of lightheadedness, unsteadiness, giddiness, spinning or rocking.;Dizziness;10013573;LLT;20,1
2810;C55386;Grade 1 Dizziness, CTCAE;Mild unsteadiness or sensation of movement;Grade 1 Dizziness;Mild unsteadiness or sensation of movement;Dizziness;10013573;LLT;20,1
2811;C55387;Grade 2 Dizziness, CTCAE;"Moderate unsteadiness or sensation of movement; limiting instrumental ADL";Grade 2 Dizziness;"Moderate unsteadiness or sensation of movement; limiting instrumental ADL";Dizziness;10013573;LLT;20,1
2812;C55388;Grade 3 Dizziness, CTCAE;"Severe unsteadiness or sensation of movement; limiting self care ADL";Grade 3 Dizziness;"Severe unsteadiness or sensation of movement; limiting self care ADL";Dizziness;10013573;LLT;20,1
2813;C143420;Dysarthria, CTCAE;A disorder characterized by slow and slurred speech resulting from an inability to coordinate the muscles used in speech.;Dysarthria;A disorder characterized by slow and slurred speech resulting from an inability to coordinate the muscles used in speech.;Dysarthria;10013887;LLT;20,1
2814;C144060;Grade 1 Dysarthria, CTCAE;Mild slurred speech;Grade 1 Dysarthria;Mild slurred speech;Dysarthria;10013887;LLT;20,1
2815;C144616;Grade 2 Dysarthria, CTCAE;Moderate impairment of articulation or slurred speech;Grade 2 Dysarthria;Moderate impairment of articulation or slurred speech;Dysarthria;10013887;LLT;20,1
2816;C145233;Grade 3 Dysarthria, CTCAE;Severe impairment of articulation or slurred speech;Grade 3 Dysarthria;Severe impairment of articulation or slurred speech;Dysarthria;10013887;LLT;20,1
2817;C143421;Dysesthesia, CTCAE;A disorder characterized by distortion of sensory perception, resulting in an abnormal and unpleasant sensation.;Dysesthesia;A disorder characterized by distortion of sensory perception, resulting in an abnormal and unpleasant sensation.;Dysesthesia;10062872;LLT;20,1
2818;C144061;Grade 1 Dysesthesia, CTCAE;Mild sensory alteration;Grade 1 Dysesthesia;Mild sensory alteration;Dysesthesia;10062872;LLT;20,1
2819;C144617;Grade 2 Dysesthesia, CTCAE;"Moderate sensory alteration; limiting instrumental ADL";Grade 2 Dysesthesia;"Moderate sensory alteration; limiting instrumental ADL";Dysesthesia;10062872;LLT;20,1
2820;C145234;Grade 3 Dysesthesia, CTCAE;"Severe sensory alteration; limiting self care ADL";Grade 3 Dysesthesia;"Severe sensory alteration; limiting self care ADL";Dysesthesia;10062872;LLT;20,1
2821;C143422;Dysgeusia, CTCAE;"A disorder characterized by abnormal sensual experience with the taste of foodstuffs; it can be related to a decrease in the sense of smell.";Dysgeusia;"A disorder characterized by abnormal sensual experience with the taste of foodstuffs; it can be related to a decrease in the sense of smell.";Dysgeusia;10013911;LLT;20,1
2822;C144062;Grade 1 Dysgeusia, CTCAE;Altered taste but no change in diet;Grade 1 Dysgeusia;Altered taste but no change in diet;Dysgeusia;10013911;LLT;20,1
2823;C144618;Grade 2 Dysgeusia, CTCAE;"Altered taste with change in diet (e.g., oral supplements); noxious or unpleasant taste; loss of taste";Grade 2 Dysgeusia;"Altered taste with change in diet (e.g., oral supplements); noxious or unpleasant taste; loss of taste";Dysgeusia;10013911;LLT;20,1
2824;C143427;Dysphasia, CTCAE;A disorder characterized by impairment of verbal communication skills, often resulting from brain damage.;Dysphasia;A disorder characterized by impairment of verbal communication skills, often resulting from brain damage.;Dysphasia;10013951;LLT;20,1
2825;C144066;Grade 1 Dysphasia, CTCAE;"Awareness of receptive or expressive characteristics; not impairing ability to communicate";Grade 1 Dysphasia;"Awareness of receptive or expressive characteristics; not impairing ability to communicate";Dysphasia;10013951;LLT;20,1
2826;C144622;Grade 2 Dysphasia, CTCAE;"Moderate receptive or expressive characteristics; impairing ability to communicate spontaneously";Grade 2 Dysphasia;"Moderate receptive or expressive characteristics; impairing ability to communicate spontaneously";Dysphasia;10013951;LLT;20,1
2827;C145238;Grade 3 Dysphasia, CTCAE;"Severe receptive or expressive characteristics; impairing ability to read, write or communicate intelligibly";Grade 3 Dysphasia;"Severe receptive or expressive characteristics; impairing ability to read, write or communicate intelligibly";Dysphasia;10013951;LLT;20,1
2828;C143431;Edema Cerebral, CTCAE;A disorder characterized by swelling due to an excessive accumulation of fluid in the brain.;Edema cerebral;A disorder characterized by swelling due to an excessive accumulation of fluid in the brain.;Edema cerebral;10014217;LLT;20,1
2829;C145242;Grade 3 Edema Cerebral, CTCAE;"New onset; worsening from baseline";Grade 3 Edema cerebral;"New onset; worsening from baseline";Edema cerebral;10014217;LLT;20,1
2830;C145827;Grade 4 Edema Cerebral, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Edema cerebral;"Life-threatening consequences; urgent intervention indicated";Edema cerebral;10014217;LLT;20,1
2831;C146288;Grade 5 Edema Cerebral, CTCAE;Death;Grade 5 Edema cerebral;Death;Edema cerebral;10014217;LLT;20,1
2832;C146699;Encephalopathy, CTCAE 5.0;A disorder characterized by a pathologic process involving the brain.;Encephalopathy;A disorder characterized by a pathologic process involving the brain.;Encephalopathy;10014625;LLT;20,1
2833;C144077;Grade 1 Encephalopathy, CTCAE;Mild symptoms;Grade 1 Encephalopathy;Mild symptoms;Encephalopathy;10014625;LLT;20,1
2834;C55391;Grade 2 Encephalopathy, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Encephalopathy;"Moderate symptoms; limiting instrumental ADL";Encephalopathy;10014625;LLT;20,1
2835;C55392;Grade 3 Encephalopathy, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Encephalopathy;"Severe symptoms; limiting self care ADL";Encephalopathy;10014625;LLT;20,1
2836;C55393;Grade 4 Encephalopathy, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Encephalopathy;"Life-threatening consequences; urgent intervention indicated";Encephalopathy;10014625;LLT;20,1
2837;C55394;Grade 5 Encephalopathy, CTCAE;Death;Grade 5 Encephalopathy;Death;Encephalopathy;10014625;LLT;20,1
2838;C143467;Extrapyramidal Disorder, CTCAE;A disorder characterized by abnormal, repetitive, involuntary muscle movements, frenzied speech and extreme restlessness.;Extrapyramidal disorder;A disorder characterized by abnormal, repetitive, involuntary muscle movements, frenzied speech and extreme restlessness.;Extrapyramidal disorder;10015832;LLT;20,1
2839;C144093;Grade 1 Extrapyramidal Disorder, CTCAE;Mild involuntary movements;Grade 1 Extrapyramidal disorder;Mild involuntary movements;Extrapyramidal disorder;10015832;LLT;20,1
2840;C144652;Grade 2 Extrapyramidal Disorder, CTCAE;"Moderate involuntary movements; limiting instrumental ADL";Grade 2 Extrapyramidal disorder;"Moderate involuntary movements; limiting instrumental ADL";Extrapyramidal disorder;10015832;LLT;20,1
2841;C145272;Grade 3 Extrapyramidal Disorder, CTCAE;"Severe involuntary movements or torticollis; limiting self care ADL";Grade 3 Extrapyramidal disorder;"Severe involuntary movements or torticollis; limiting self care ADL";Extrapyramidal disorder;10015832;LLT;20,1
2842;C145852;Grade 4 Extrapyramidal Disorder, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Extrapyramidal disorder;"Life-threatening consequences; urgent intervention indicated";Extrapyramidal disorder;10015832;LLT;20,1
2843;C146309;Grade 5 Extrapyramidal Disorder, CTCAE;Death;Grade 5 Extrapyramidal disorder;Death;Extrapyramidal disorder;10015832;LLT;20,1
2844;C143472;Facial Muscle Weakness, CTCAE;A disorder characterized by a reduction in the strength of the facial muscles.;Facial muscle weakness;A disorder characterized by a reduction in the strength of the facial muscles.;Facial muscle weakness;10051272;LLT;20,1
2845;C144096;Grade 1 Facial Muscle Weakness, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Facial muscle weakness;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Facial muscle weakness;10051272;LLT;20,1
2846;C144656;Grade 2 Facial Muscle Weakness, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Facial muscle weakness;"Moderate symptoms; limiting instrumental ADL";Facial muscle weakness;10051272;LLT;20,1
2847;C145276;Grade 3 Facial Muscle Weakness, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Facial muscle weakness;"Severe symptoms; limiting self care ADL";Facial muscle weakness;10051272;LLT;20,1
2848;C143473;Facial Nerve Disorder, CTCAE;A disorder characterized by dysfunction of the facial nerve (seventh cranial nerve).;Facial nerve disorder;A disorder characterized by dysfunction of the facial nerve (seventh cranial nerve).;Facial nerve disorder;10061457;LLT;20,1
2849;C144097;Grade 1 Facial Nerve Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Facial nerve disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Facial nerve disorder;10061457;LLT;20,1
2850;C144657;Grade 2 Facial Nerve Disorder, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Facial nerve disorder;"Moderate symptoms; limiting instrumental ADL";Facial nerve disorder;10061457;LLT;20,1
2851;C145277;Grade 3 Facial Nerve Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Facial nerve disorder;"Severe symptoms; limiting self care ADL";Facial nerve disorder;10061457;LLT;20,1
2852;C143518;Glossopharyngeal Nerve Disorder, CTCAE;A disorder characterized by dysfunction of the glossopharyngeal nerve (ninth cranial nerve).;Glossopharyngeal nerve disorder;A disorder characterized by dysfunction of the glossopharyngeal nerve (ninth cranial nerve).;Glossopharyngeal nerve disorder;10061185;LLT;20,1
2853;C144131;Grade 1 Glossopharyngeal Nerve Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Glossopharyngeal nerve disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Glossopharyngeal nerve disorder;10061185;LLT;20,1
2854;C144696;Grade 2 Glossopharyngeal Nerve Disorder, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Glossopharyngeal nerve disorder;"Moderate symptoms; limiting instrumental ADL";Glossopharyngeal nerve disorder;10061185;LLT;20,1
2855;C145318;Grade 3 Glossopharyngeal Nerve Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Glossopharyngeal nerve disorder;"Severe symptoms; limiting self care ADL";Glossopharyngeal nerve disorder;10061185;LLT;20,1
2856;C145878;Grade 4 Glossopharyngeal Nerve Disorder, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Glossopharyngeal nerve disorder;"Life-threatening consequences; urgent intervention indicated";Glossopharyngeal nerve disorder;10061185;LLT;20,1
2857;C146328;Grade 5 Glossopharyngeal Nerve Disorder, CTCAE;Death;Grade 5 Glossopharyngeal nerve disorder;Death;Glossopharyngeal nerve disorder;10061185;LLT;20,1
2858;C143231;Guillain-Barre Syndrome, CTCAE;A disorder characterized by the body's immune system attacking the peripheral nervous system causing ascending paralysis.;Guillain-Barre syndrome;A disorder characterized by the body's immune system attacking the peripheral nervous system causing ascending paralysis.;Guillain-Barre syndrome;10018767;LLT;20,1
2859;C144136;Grade 1 Guillain-Barre Syndrome, CTCAE;Mild symptoms;Grade 1 Guillain-Barre syndrome;Mild symptoms;Guillain-Barre syndrome;10018767;LLT;20,1
2860;C144701;Grade 2 Guillain-Barre Syndrome, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Guillain-Barre syndrome;"Moderate symptoms; limiting instrumental ADL";Guillain-Barre syndrome;10018767;LLT;20,1
2861;C145321;Grade 3 Guillain-Barre Syndrome, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Guillain-Barre syndrome;"Severe symptoms; limiting self care ADL";Guillain-Barre syndrome;10018767;LLT;20,1
2862;C145880;Grade 4 Guillain-Barre Syndrome, CTCAE;"Life-threatening consequences; urgent intervention indicated; intubation";Grade 4 Guillain-Barre syndrome;"Life-threatening consequences; urgent intervention indicated; intubation";Guillain-Barre syndrome;10018767;LLT;20,1
2863;C146330;Grade 5 Guillain-Barre Syndrome, CTCAE;Death;Grade 5 Guillain-Barre syndrome;Death;Guillain-Barre syndrome;10018767;LLT;20,1
2864;C143527;Headache, CTCAE;A disorder characterized by a sensation of marked discomfort in various parts of the head, not confined to the area of distribution of any nerve.;Headache;A disorder characterized by a sensation of marked discomfort in various parts of the head, not confined to the area of distribution of any nerve.;Headache;10019211;LLT;20,1
2865;C144143;Grade 1 Headache, CTCAE;Mild pain;Grade 1 Headache;Mild pain;Headache;10019211;LLT;20,1
2866;C144704;Grade 2 Headache, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Headache;"Moderate pain; limiting instrumental ADL";Headache;10019211;LLT;20,1
2867;C145324;Grade 3 Headache, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Headache;"Severe pain; limiting self care ADL";Headache;10019211;LLT;20,1
2868;C55401;Hydrocephalus, CTCAE;A disorder characterized by an abnormal increase of cerebrospinal fluid in the ventricles of the brain.;Hydrocephalus;A disorder characterized by an abnormal increase of cerebrospinal fluid in the ventricles of the brain.;Hydrocephalus;10020508;LLT;20,1
2869;C55402;Grade 1 Hydrocephalus, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hydrocephalus;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Hydrocephalus;10020508;LLT;20,1
2870;C55403;Grade 2 Hydrocephalus, CTCAE;"Moderate symptoms; intervention not indicated";Grade 2 Hydrocephalus;"Moderate symptoms; intervention not indicated";Hydrocephalus;10020508;LLT;20,1
2871;C55404;Grade 3 Hydrocephalus, CTCAE;"Severe symptoms or neurological deficit; intervention indicated";Grade 3 Hydrocephalus;"Severe symptoms or neurological deficit; intervention indicated";Hydrocephalus;10020508;LLT;20,1
2872;C55405;Grade 4 Hydrocephalus, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hydrocephalus;"Life-threatening consequences; urgent intervention indicated";Hydrocephalus;10020508;LLT;20,1
2873;C55406;Grade 5 Hydrocephalus, CTCAE;Death;Grade 5 Hydrocephalus;Death;Hydrocephalus;10020508;LLT;20,1
2874;C143558;Hypersomnia, CTCAE;A disorder characterized by characterized by excessive sleepiness during the daytime.;Hypersomnia;A disorder characterized by characterized by excessive sleepiness during the daytime.;Hypersomnia;10020765;LLT;20,1
2875;C144170;Grade 1 Hypersomnia, CTCAE;Mild increased need for sleep;Grade 1 Hypersomnia;Mild increased need for sleep;Hypersomnia;10020765;LLT;20,1
2876;C144731;Grade 2 Hypersomnia, CTCAE;Moderate increased need for sleep;Grade 2 Hypersomnia;Moderate increased need for sleep;Hypersomnia;10020765;LLT;20,1
2877;C145353;Grade 3 Hypersomnia, CTCAE;Severe increased need for sleep;Grade 3 Hypersomnia;Severe increased need for sleep;Hypersomnia;10020765;LLT;20,1
2878;C143566;Hypoglossal Nerve Disorder, CTCAE;A disorder characterized by dysfunction of the hypoglossal nerve (twelfth cranial nerve).;Hypoglossal nerve disorder;A disorder characterized by dysfunction of the hypoglossal nerve (twelfth cranial nerve).;Hypoglossal nerve disorder;10061212;LLT;20,1
2879;C144177;Grade 1 Hypoglossal Nerve Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hypoglossal nerve disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Hypoglossal nerve disorder;10061212;LLT;20,1
2880;C144737;Grade 2 Hypoglossal Nerve Disorder, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Hypoglossal nerve disorder;"Moderate symptoms; limiting instrumental ADL";Hypoglossal nerve disorder;10061212;LLT;20,1
2881;C145359;Grade 3 Hypoglossal Nerve Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Hypoglossal nerve disorder;"Severe symptoms; limiting self care ADL";Hypoglossal nerve disorder;10061212;LLT;20,1
2882;C143596;Intracranial Hemorrhage, CTCAE;A disorder characterized by bleeding from the cranium.;Intracranial hemorrhage;A disorder characterized by bleeding from the cranium.;Intracranial hemorrhage;10022763;LLT;20,1
2883;C144204;Grade 1 Intracranial Hemorrhage, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Intracranial hemorrhage;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Intracranial hemorrhage;10022763;LLT;20,1
2884;C144771;Grade 2 Intracranial Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Intracranial hemorrhage;"Moderate symptoms; intervention indicated";Intracranial hemorrhage;10022763;LLT;20,1
2885;C145393;Grade 3 Intracranial Hemorrhage, CTCAE;"Ventriculostomy, ICP monitoring, intraventricular thrombolysis, or invasive intervention indicated; hospitalization";Grade 3 Intracranial hemorrhage;"Ventriculostomy, ICP monitoring, intraventricular thrombolysis, or invasive intervention indicated; hospitalization";Intracranial hemorrhage;10022763;LLT;20,1
2886;C145941;Grade 4 Intracranial Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Intracranial hemorrhage;"Life-threatening consequences; urgent intervention indicated";Intracranial hemorrhage;10022763;LLT;20,1
2887;C146388;Grade 5 Intracranial Hemorrhage, CTCAE;Death;Grade 5 Intracranial hemorrhage;Death;Intracranial hemorrhage;10022763;LLT;20,1
2888;C143619;Ischemia Cerebrovascular, CTCAE;A disorder characterized by a decrease or absence of blood supply to the brain caused by obstruction (thrombosis or embolism) of an artery resulting in neurological damage.;Ischemia cerebrovascular;A disorder characterized by a decrease or absence of blood supply to the brain caused by obstruction (thrombosis or embolism) of an artery resulting in neurological damage.;Ischemia cerebrovascular;10023030;LLT;20,1
2889;C144223;Grade 1 Ischemia Cerebrovascular, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Ischemia cerebrovascular;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Ischemia cerebrovascular;10023030;LLT;20,1
2890;C144791;Grade 2 Ischemia Cerebrovascular, CTCAE;Moderate symptoms;Grade 2 Ischemia cerebrovascular;Moderate symptoms;Ischemia cerebrovascular;10023030;LLT;20,1
2891;C143645;Lethargy, CTCAE;A disorder characterized by a decrease in consciousness characterized by mental and physical inertness.;Lethargy;A disorder characterized by a decrease in consciousness characterized by mental and physical inertness.;Lethargy;10024264;LLT;20,1
2892;C144244;Grade 1 Lethargy, CTCAE;"Mild symptoms; reduced alertness and awareness";Grade 1 Lethargy;"Mild symptoms; reduced alertness and awareness";Lethargy;10024264;LLT;20,1
2893;C144817;Grade 2 Lethargy, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Lethargy;"Moderate symptoms; limiting instrumental ADL";Lethargy;10024264;LLT;20,1
2894;C143648;Leukoencephalopathy, CTCAE;A disorder characterized by diffuse reactive astrocytosis with multiple areas of necrotic foci without inflammation.;Leukoencephalopathy;A disorder characterized by diffuse reactive astrocytosis with multiple areas of necrotic foci without inflammation.;Leukoencephalopathy;10024382;LLT;20,1
2895;C144245;Grade 1 Leukoencephalopathy, CTCAE;"Asymptomatic; small focal T2/FLAIR hyperintensities; involving periventricular white matter or <1/3 of susceptible areas of cerebrum +/- mild increase in subarachnoid space (SAS) and/or mild ventriculomegaly";Grade 1 Leukoencephalopathy;"Asymptomatic; small focal T2/FLAIR hyperintensities; involving periventricular white matter or <1/3 of susceptible areas of cerebrum +/- mild increase in subarachnoid space (SAS) and/or mild ventriculomegaly";Leukoencephalopathy;10024382;LLT;20,1
2896;C144818;Grade 2 Leukoencephalopathy, CTCAE;"Moderate symptoms; focal T2/FLAIR hyperintensities, involving periventricular white matter extending into centrum semiovale or involving 1/3 to 2/3 of susceptible areas of cerebrum +/- moderate increase in SAS and/or moderate ventriculomegaly";Grade 2 Leukoencephalopathy;"Moderate symptoms; focal T2/FLAIR hyperintensities, involving periventricular white matter extending into centrum semiovale or involving 1/3 to 2/3 of susceptible areas of cerebrum +/- moderate increase in SAS and/or moderate ventriculomegaly";Leukoencephalopathy;10024382;LLT;20,1
2897;C145439;Grade 3 Leukoencephalopathy, CTCAE;"Severe symptoms; extensive T2/FLAIR hyperintensities, involving periventricular white matter involving 2/3 or more of susceptible areas of cerebrum +/- moderate to severe increase in SAS and/or moderate to severe ventriculomegaly";Grade 3 Leukoencephalopathy;"Severe symptoms; extensive T2/FLAIR hyperintensities, involving periventricular white matter involving 2/3 or more of susceptible areas of cerebrum +/- moderate to severe increase in SAS and/or moderate to severe ventriculomegaly";Leukoencephalopathy;10024382;LLT;20,1
2898;C145982;Grade 4 Leukoencephalopathy, CTCAE;"Life-threatening consequences; extensive T2/FLAIR hyperintensities, involving periventricular white matter involving most of susceptible areas of cerebrum +/- moderate to severe increase in SAS and/or moderate to severe ventriculomegaly";Grade 4 Leukoencephalopathy;"Life-threatening consequences; extensive T2/FLAIR hyperintensities, involving periventricular white matter involving most of susceptible areas of cerebrum +/- moderate to severe increase in SAS and/or moderate to severe ventriculomegaly";Leukoencephalopathy;10024382;LLT;20,1
2899;C146429;Grade 5 Leukoencephalopathy, CTCAE;Death;Grade 5 Leukoencephalopathy;Death;Leukoencephalopathy;10024382;LLT;20,1
2900;C146763;Memory Impairment, CTCAE 5.0;A disorder characterized by a deterioration in memory function.;Memory impairment;A disorder characterized by a deterioration in memory function.;Memory impairment;10027175;LLT;20,1
2901;C55428;Grade 1 Memory Impairment, CTCAE;Mild memory impairment;Grade 1 Memory impairment;Mild memory impairment;Memory impairment;10027175;LLT;20,1
2902;C55429;Grade 2 Memory Impairment, CTCAE;"Moderate memory impairment; limiting instrumental ADL";Grade 2 Memory impairment;"Moderate memory impairment; limiting instrumental ADL";Memory impairment;10027175;LLT;20,1
2903;C55430;Grade 3 Memory Impairment, CTCAE;"Severe memory impairment; limiting self care ADL";Grade 3 Memory impairment;"Severe memory impairment; limiting self care ADL";Memory impairment;10027175;LLT;20,1
2904;C143669;Meningismus, CTCAE;A disorder characterized by neck stiffness, headache, and photophobia resulting from irritation of the cerebral meninges.;Meningismus;A disorder characterized by neck stiffness, headache, and photophobia resulting from irritation of the cerebral meninges.;Meningismus;10027198;LLT;20,1
2905;C144259;Grade 1 Meningismus, CTCAE;Mild symptoms;Grade 1 Meningismus;Mild symptoms;Meningismus;10027198;LLT;20,1
2906;C144835;Grade 2 Meningismus, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Meningismus;"Moderate symptoms; limiting instrumental ADL";Meningismus;10027198;LLT;20,1
2907;C145456;Grade 3 Meningismus, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Meningismus;"Severe symptoms; limiting self care ADL";Meningismus;10027198;LLT;20,1
2908;C145992;Grade 4 Meningismus, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Meningismus;"Life-threatening consequences; urgent intervention indicated";Meningismus;10027198;LLT;20,1
2909;C146437;Grade 5 Meningismus, CTCAE;Death;Grade 5 Meningismus;Death;Meningismus;10027198;LLT;20,1
2910;C143677;Movements Involuntary, CTCAE;A disorder characterized by uncontrolled and purposeless movements.;Movements involuntary;A disorder characterized by uncontrolled and purposeless movements.;Movements involuntary;10028041;LLT;20,1
2911;C144266;Grade 1 Movements Involuntary, CTCAE;Mild symptoms;Grade 1 Movements involuntary;Mild symptoms;Movements involuntary;10028041;LLT;20,1
2912;C144843;Grade 2 Movements Involuntary, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Movements involuntary;"Moderate symptoms; limiting instrumental ADL";Movements involuntary;10028041;LLT;20,1
2913;C145465;Grade 3 Movements Involuntary, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Movements involuntary;"Severe symptoms; limiting self care ADL";Movements involuntary;10028041;LLT;20,1
2914;C143681;Muscle Weakness Left-Sided, CTCAE;A disorder characterized by a reduction in the strength of the muscles on the left side of the body.;Muscle weakness left-sided;A disorder characterized by a reduction in the strength of the muscles on the left side of the body.;Muscle weakness left-sided;10065780;LLT;20,1
2915;C144270;Grade 1 Muscle Weakness Left-Sided, CTCAE;"Symptomatic; perceived by patient but not evident on physical exam";Grade 1 Muscle weakness left-sided;"Symptomatic; perceived by patient but not evident on physical exam";Muscle weakness left-sided;10065780;LLT;20,1
2916;C144847;Grade 2 Muscle Weakness Left-Sided, CTCAE;"Symptomatic; evident on physical exam; limiting instrumental ADL";Grade 2 Muscle weakness left-sided;"Symptomatic; evident on physical exam; limiting instrumental ADL";Muscle weakness left-sided;10065780;LLT;20,1
2917;C145470;Grade 3 Muscle Weakness Left-Sided, CTCAE;Limiting self care ADL;Grade 3 Muscle weakness left-sided;Limiting self care ADL;Muscle weakness left-sided;10065780;LLT;20,1
2918;C143683;Muscle Weakness Right-Sided, CTCAE;A disorder characterized by a reduction in the strength of the muscles on the right side of the body.;Muscle weakness right-sided;A disorder characterized by a reduction in the strength of the muscles on the right side of the body.;Muscle weakness right-sided;10065794;LLT;20,1
2919;C144272;Grade 1 Muscle Weakness Right-Sided, CTCAE;"Symptomatic; perceived by patient but not evident on physical exam";Grade 1 Muscle weakness right-sided;"Symptomatic; perceived by patient but not evident on physical exam";Muscle weakness right-sided;10065794;LLT;20,1
2920;C144849;Grade 2 Muscle Weakness Right-Sided, CTCAE;"Symptomatic; evident on physical exam; limiting instrumental ADL";Grade 2 Muscle weakness right-sided;"Symptomatic; evident on physical exam; limiting instrumental ADL";Muscle weakness right-sided;10065794;LLT;20,1
2921;C145472;Grade 3 Muscle Weakness Right-Sided, CTCAE;Limiting self care ADL;Grade 3 Muscle weakness right-sided;Limiting self care ADL;Muscle weakness right-sided;10065794;LLT;20,1
2922;C143232;Myasthenia Gravis, CTCAE;A disorder characterized by weakness and rapid fatigue of any of the skeletal muscles.;Myasthenia gravis;A disorder characterized by weakness and rapid fatigue of any of the skeletal muscles.;Myasthenia gravis;10028417;LLT;20,1
2923;C144278;Grade 1 Myasthenia Gravis, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Myasthenia gravis;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Myasthenia gravis;10028417;LLT;20,1
2924;C144855;Grade 2 Myasthenia Gravis, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Myasthenia gravis;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Myasthenia gravis;10028417;LLT;20,1
2925;C145478;Grade 3 Myasthenia Gravis, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Myasthenia gravis;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Myasthenia gravis;10028417;LLT;20,1
2926;C146005;Grade 4 Myasthenia Gravis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Myasthenia gravis;"Life-threatening consequences; urgent intervention indicated";Myasthenia gravis;10028417;LLT;20,1
2927;C146450;Grade 5 Myasthenia Gravis, CTCAE;Death;Grade 5 Myasthenia gravis;Death;Myasthenia gravis;10028417;LLT;20,1
2928;C143702;Nervous System Disorders - Other, Specify, CTCAE;;Nervous system disorders - Other, specify;;Nervous system disorders - Other, specify;10029205;LLT;20,1
2929;C144287;Grade 1 Nervous System Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Nervous system disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Nervous system disorders - Other, specify;10029205;LLT;20,1
2930;C144863;Grade 2 Nervous System Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Nervous system disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Nervous system disorders - Other, specify;10029205;LLT;20,1
2931;C145485;Grade 3 Nervous System Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Nervous system disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Nervous system disorders - Other, specify;10029205;LLT;20,1
2932;C146011;Grade 4 Nervous System Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Nervous system disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Nervous system disorders - Other, specify;10029205;LLT;20,1
2933;C146455;Grade 5 Nervous System Disorders - Other, Specify, CTCAE;Death;Grade 5 Nervous system disorders - Other, specify;Death;Nervous system disorders - Other, specify;10029205;LLT;20,1
2934;C143703;Neuralgia, CTCAE;A disorder characterized by intense painful sensation along a nerve or group of nerves.;Neuralgia;A disorder characterized by intense painful sensation along a nerve or group of nerves.;Neuralgia;10029223;LLT;20,1
2935;C144288;Grade 1 Neuralgia, CTCAE;Mild pain;Grade 1 Neuralgia;Mild pain;Neuralgia;10029223;LLT;20,1
2936;C144864;Grade 2 Neuralgia, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Neuralgia;"Moderate pain; limiting instrumental ADL";Neuralgia;10029223;LLT;20,1
2937;C145486;Grade 3 Neuralgia, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Neuralgia;"Severe pain; limiting self care ADL";Neuralgia;10029223;LLT;20,1
2938;C146775;Nystagmus, CTCAE 5.0;A disorder characterized by involuntary movements of the eyeballs.;Nystagmus;A disorder characterized by involuntary movements of the eyeballs.;Nystagmus;10029864;LLT;20,1
2939;C55859;Grade 2 Nystagmus, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Nystagmus;"Moderate symptoms; limiting instrumental ADL";Nystagmus;10029864;LLT;20,1
2940;C55860;Grade 3 Nystagmus, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Nystagmus;"Severe symptoms; limiting self care ADL";Nystagmus;10029864;LLT;20,1
2941;C143711;Oculomotor Nerve Disorder, CTCAE;A disorder characterized by dysfunction of the oculomotor nerve (third cranial nerve).;Oculomotor nerve disorder;A disorder characterized by dysfunction of the oculomotor nerve (third cranial nerve).;Oculomotor nerve disorder;10053661;LLT;20,1
2942;C144294;Grade 1 Oculomotor Nerve Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Oculomotor nerve disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Oculomotor nerve disorder;10053661;LLT;20,1
2943;C144870;Grade 2 Oculomotor Nerve Disorder, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Oculomotor nerve disorder;"Moderate symptoms; limiting instrumental ADL";Oculomotor nerve disorder;10053661;LLT;20,1
2944;C145491;Grade 3 Oculomotor Nerve Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Oculomotor nerve disorder;"Severe symptoms; limiting self care ADL";Oculomotor nerve disorder;10053661;LLT;20,1
2945;C143712;Olfactory Nerve Disorder, CTCAE;A disorder characterized by dysfunction of the olfactory nerve (first cranial nerve).;Olfactory nerve disorder;A disorder characterized by dysfunction of the olfactory nerve (first cranial nerve).;Olfactory nerve disorder;10056388;LLT;20,1
2946;C144871;Grade 2 Olfactory Nerve Disorder, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Olfactory nerve disorder;"Moderate symptoms; limiting instrumental ADL";Olfactory nerve disorder;10056388;LLT;20,1
2947;C145492;Grade 3 Olfactory Nerve Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Olfactory nerve disorder;"Severe symptoms; limiting self care ADL";Olfactory nerve disorder;10056388;LLT;20,1
2948;C143736;Paresthesia, CTCAE;A disorder characterized by functional disturbances of sensory neurons resulting in abnormal cutaneous sensations of tingling, numbness, pressure, cold, and/or warmth.;Paresthesia;A disorder characterized by functional disturbances of sensory neurons resulting in abnormal cutaneous sensations of tingling, numbness, pressure, cold, and/or warmth.;Paresthesia;10033987;LLT;20,1
2949;C144318;Grade 1 Paresthesia, CTCAE;Mild symptoms;Grade 1 Paresthesia;Mild symptoms;Paresthesia;10033987;LLT;20,1
2950;C144897;Grade 2 Paresthesia, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Paresthesia;"Moderate symptoms; limiting instrumental ADL";Paresthesia;10033987;LLT;20,1
2951;C145519;Grade 3 Paresthesia, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Paresthesia;"Severe symptoms; limiting self care ADL";Paresthesia;10033987;LLT;20,1
2952;C143750;Peripheral Motor Neuropathy, CTCAE;A disorder characterized by damage or dysfunction of the peripheral motor nerves.;Peripheral motor neuropathy;A disorder characterized by damage or dysfunction of the peripheral motor nerves.;Peripheral motor neuropathy;10034580;LLT;20,1
2953;C144327;Grade 1 Peripheral Motor Neuropathy, CTCAE;"Asymptomatic; clinical or diagnostic observations only";Grade 1 Peripheral motor neuropathy;"Asymptomatic; clinical or diagnostic observations only";Peripheral motor neuropathy;10034580;LLT;20,1
2954;C144910;Grade 2 Peripheral Motor Neuropathy, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Peripheral motor neuropathy;"Moderate symptoms; limiting instrumental ADL";Peripheral motor neuropathy;10034580;LLT;20,1
2955;C145533;Grade 3 Peripheral Motor Neuropathy, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Peripheral motor neuropathy;"Severe symptoms; limiting self care ADL";Peripheral motor neuropathy;10034580;LLT;20,1
2956;C146041;Grade 4 Peripheral Motor Neuropathy, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Peripheral motor neuropathy;"Life-threatening consequences; urgent intervention indicated";Peripheral motor neuropathy;10034580;LLT;20,1
2957;C146481;Grade 5 Peripheral Motor Neuropathy, CTCAE;Death;Grade 5 Peripheral motor neuropathy;Death;Peripheral motor neuropathy;10034580;LLT;20,1
2958;C143752;Peripheral Sensory Neuropathy, CTCAE;A disorder characterized by damage or dysfunction of the peripheral sensory nerves.;Peripheral sensory neuropathy;A disorder characterized by damage or dysfunction of the peripheral sensory nerves.;Peripheral sensory neuropathy;10034620;LLT;20,1
2959;C144328;Grade 1 Peripheral Sensory Neuropathy, CTCAE;Asymptomatic;Grade 1 Peripheral sensory neuropathy;Asymptomatic;Peripheral sensory neuropathy;10034620;LLT;20,1
2960;C144912;Grade 2 Peripheral Sensory Neuropathy, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Peripheral sensory neuropathy;"Moderate symptoms; limiting instrumental ADL";Peripheral sensory neuropathy;10034620;LLT;20,1
2961;C145535;Grade 3 Peripheral Sensory Neuropathy, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Peripheral sensory neuropathy;"Severe symptoms; limiting self care ADL";Peripheral sensory neuropathy;10034620;LLT;20,1
2962;C146043;Grade 4 Peripheral Sensory Neuropathy, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Peripheral sensory neuropathy;"Life-threatening consequences; urgent intervention indicated";Peripheral sensory neuropathy;10034620;LLT;20,1
2963;C146682;Phantom Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort related to a limb or an organ that is removed from or is not physically part of the body.;Phantom pain;A disorder characterized by a sensation of marked discomfort related to a limb or an organ that is removed from or is not physically part of the body.;Phantom pain;10056238;LLT;20,1
2964;C144330;Grade 1 Phantom Pain, CTCAE;Mild pain;Grade 1 Phantom pain;Mild pain;Phantom pain;10056238;LLT;20,1
2965;C144914;Grade 2 Phantom Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Phantom pain;"Moderate pain; limiting instrumental ADL";Phantom pain;10056238;LLT;20,1
2966;C145539;Grade 3 Phantom Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Phantom pain;"Severe pain; limiting self care ADL";Phantom pain;10056238;LLT;20,1
2967;C143778;Presyncope, CTCAE;A disorder characterized by an episode of lightheadedness and dizziness which may precede an episode of syncope.;Presyncope;A disorder characterized by an episode of lightheadedness and dizziness which may precede an episode of syncope.;Presyncope;10036653;LLT;20,1
2968;C144938;Grade 2 Presyncope, CTCAE;Present (e.g., near fainting);Grade 2 Presyncope;Present (e.g., near fainting);Presyncope;10036653;LLT;20,1
2969;C143795;Pyramidal Tract Syndrome, CTCAE;A disorder characterized by dysfunction of the corticospinal (pyramidal) tracts of the spinal cord. Symptoms include an increase in the muscle tone in the lower extremities, hyperreflexia, positive Babinski and a decrease in fine motor coordination.;Pyramidal tract syndrome;A disorder characterized by dysfunction of the corticospinal (pyramidal) tracts of the spinal cord. Symptoms include an increase in the muscle tone in the lower extremities, hyperreflexia, positive Babinski and a decrease in fine motor coordination.;Pyramidal tract syndrome;10063636;LLT;20,1
2970;C144361;Grade 1 Pyramidal Tract Syndrome, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Pyramidal tract syndrome;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Pyramidal tract syndrome;10063636;LLT;20,1
2971;C144953;Grade 2 Pyramidal Tract Syndrome, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Pyramidal tract syndrome;"Moderate symptoms; limiting instrumental ADL";Pyramidal tract syndrome;10063636;LLT;20,1
2972;C145575;Grade 3 Pyramidal Tract Syndrome, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Pyramidal tract syndrome;"Severe symptoms; limiting self care ADL";Pyramidal tract syndrome;10063636;LLT;20,1
2973;C146077;Grade 4 Pyramidal Tract Syndrome, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pyramidal tract syndrome;"Life-threatening consequences; urgent intervention indicated";Pyramidal tract syndrome;10063636;LLT;20,1
2974;C146512;Grade 5 Pyramidal Tract Syndrome, CTCAE;Death;Grade 5 Pyramidal tract syndrome;Death;Pyramidal tract syndrome;10063636;LLT;20,1
2975;C143797;Radiculitis, CTCAE;A disorder characterized by inflammation involving a nerve root. Patients experience marked discomfort radiating along a nerve path because of spinal pressure on the connecting nerve root.;Radiculitis;A disorder characterized by inflammation involving a nerve root. Patients experience marked discomfort radiating along a nerve path because of spinal pressure on the connecting nerve root.;Radiculitis;10061928;LLT;20,1
2976;C144363;Grade 1 Radiculitis, CTCAE;Mild symptoms;Grade 1 Radiculitis;Mild symptoms;Radiculitis;10061928;LLT;20,1
2977;C144955;Grade 2 Radiculitis, CTCAE;"Moderate symptoms; medical intervention indicated; limiting instrumental ADL";Grade 2 Radiculitis;"Moderate symptoms; medical intervention indicated; limiting instrumental ADL";Radiculitis;10061928;LLT;20,1
2978;C145577;Grade 3 Radiculitis, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Radiculitis;"Severe symptoms; limiting self care ADL";Radiculitis;10061928;LLT;20,1
2979;C146079;Grade 4 Radiculitis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Radiculitis;"Life-threatening consequences; urgent intervention indicated";Radiculitis;10061928;LLT;20,1
2980;C146514;Grade 5 Radiculitis, CTCAE;Death;Grade 5 Radiculitis;Death;Radiculitis;10061928;LLT;20,1
2981;C143804;Recurrent Laryngeal Nerve Palsy, CTCAE;A disorder characterized by paralysis of the recurrent laryngeal nerve.;Recurrent laryngeal nerve palsy;A disorder characterized by paralysis of the recurrent laryngeal nerve.;Recurrent laryngeal nerve palsy;10038130;LLT;20,1
2982;C144375;Grade 1 Recurrent Laryngeal Nerve Palsy, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Recurrent laryngeal nerve palsy;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Recurrent laryngeal nerve palsy;10038130;LLT;20,1
2983;C144969;Grade 2 Recurrent Laryngeal Nerve Palsy, CTCAE;Moderate symptoms;Grade 2 Recurrent laryngeal nerve palsy;Moderate symptoms;Recurrent laryngeal nerve palsy;10038130;LLT;20,1
2984;C145592;Grade 3 Recurrent Laryngeal Nerve Palsy, CTCAE;"Severe symptoms; medical intervention indicated (e.g., thyroplasty, vocal cord injection)";Grade 3 Recurrent laryngeal nerve palsy;"Severe symptoms; medical intervention indicated (e.g., thyroplasty, vocal cord injection)";Recurrent laryngeal nerve palsy;10038130;LLT;20,1
2985;C146090;Grade 4 Recurrent Laryngeal Nerve Palsy, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Recurrent laryngeal nerve palsy;"Life-threatening consequences; urgent intervention indicated";Recurrent laryngeal nerve palsy;10038130;LLT;20,1
2986;C146525;Grade 5 Recurrent Laryngeal Nerve Palsy, CTCAE;Death;Grade 5 Recurrent laryngeal nerve palsy;Death;Recurrent laryngeal nerve palsy;10038130;LLT;20,1
2987;C143818;Reversible Posterior Leukoencephalopathy Syndrome, CTCAE;A disorder characterized by headaches, mental status changes, visual disturbances, and/or seizures associated with imaging findings of posterior leukoencephalopathy. It has been observed in association with hypertensive encephalopathy, eclampsia, and immunosuppressive and cytotoxic drug treatment. It is an acute or subacute reversible condition. Also known as posterior reversible encephalopathy syndrome (PRES).;Reversible posterior leukoencephalopathy syndrome;A disorder characterized by headaches, mental status changes, visual disturbances, and/or seizures associated with imaging findings of posterior leukoencephalopathy. It has been observed in association with hypertensive encephalopathy, eclampsia, and immunosuppressive and cytotoxic drug treatment. It is an acute or subacute reversible condition. Also known as posterior reversible encephalopathy syndrome (PRES).;Reversible posterior leukoencephalopathy syndrome;10063761;LLT;20,1
2988;C144980;Grade 2 Reversible Posterior Leukoencephalopathy Syndrome, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Reversible posterior leukoencephalopathy syndrome;"Moderate symptoms; limiting instrumental ADL";Reversible posterior leukoencephalopathy syndrome;10063761;LLT;20,1
2989;C145602;Grade 3 Reversible Posterior Leukoencephalopathy Syndrome, CTCAE;"Severe symptoms; limiting self care ADL; hospitalization";Grade 3 Reversible posterior leukoencephalopathy syndrome;"Severe symptoms; limiting self care ADL; hospitalization";Reversible posterior leukoencephalopathy syndrome;10063761;LLT;20,1
2990;C146098;Grade 4 Reversible Posterior Leukoencephalopathy Syndrome, CTCAE;Life-threatening consequences;Grade 4 Reversible posterior leukoencephalopathy syndrome;Life-threatening consequences;Reversible posterior leukoencephalopathy syndrome;10063761;LLT;20,1
2991;C146533;Grade 5 Reversible Posterior Leukoencephalopathy Syndrome, CTCAE;Death;Grade 5 Reversible posterior leukoencephalopathy syndrome;Death;Reversible posterior leukoencephalopathy syndrome;10063761;LLT;20,1
2992;C146700;Seizure, CTCAE 5.0;A disorder characterized by a sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.;Seizure;A disorder characterized by a sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.;Seizure;10039906;LLT;20,1
2993;C144392;Grade 1 Seizure, CTCAE;Brief partial seizure and no loss of consciousness;Grade 1 Seizure;Brief partial seizure and no loss of consciousness;Seizure;10039906;LLT;20,1
2994;C55579;Grade 2 Seizure, CTCAE;Brief generalized seizure;Grade 2 Seizure;Brief generalized seizure;Seizure;10039906;LLT;20,1
2995;C55580;Grade 3 Seizure, CTCAE;"New onset seizures (partial or generalized); multiple seizures despite medical intervention";Grade 3 Seizure;"New onset seizures (partial or generalized); multiple seizures despite medical intervention";Seizure;10039906;LLT;20,1
2996;C55581;Grade 4 Seizure, CTCAE;"Life-threatening consequences; prolonged repetitive seizures";Grade 4 Seizure;"Life-threatening consequences; prolonged repetitive seizures";Seizure;10039906;LLT;20,1
2997;C55582;Grade 5 Seizure, CTCAE;Death;Grade 5 Seizure;Death;Seizure;10039906;LLT;20,1
2998;C143852;Somnolence, CTCAE;A disorder characterized by characterized by excessive sleepiness and drowsiness.;Somnolence;A disorder characterized by characterized by excessive sleepiness and drowsiness.;Somnolence;10041349;LLT;20,1
2999;C144412;Grade 1 Somnolence, CTCAE;Mild but more than usual drowsiness or sleepiness;Grade 1 Somnolence;Mild but more than usual drowsiness or sleepiness;Somnolence;10041349;LLT;20,1
3000;C145016;Grade 2 Somnolence, CTCAE;"Moderate sedation; limiting instrumental ADL";Grade 2 Somnolence;"Moderate sedation; limiting instrumental ADL";Somnolence;10041349;LLT;20,1
3001;C145634;Grade 3 Somnolence, CTCAE;Obtundation or stupor;Grade 3 Somnolence;Obtundation or stupor;Somnolence;10041349;LLT;20,1
3002;C146127;Grade 4 Somnolence, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Somnolence;"Life-threatening consequences; urgent intervention indicated";Somnolence;10041349;LLT;20,1
3003;C146559;Grade 5 Somnolence, CTCAE;Death;Grade 5 Somnolence;Death;Somnolence;10041349;LLT;20,1
3004;C143854;Spasticity, CTCAE;A disorder characterized by increased involuntary muscle tone that affects the regions interfering with voluntary movement. It results in gait, movement, and speech disturbances.;Spasticity;A disorder characterized by increased involuntary muscle tone that affects the regions interfering with voluntary movement. It results in gait, movement, and speech disturbances.;Spasticity;10041416;LLT;20,1
3005;C144414;Grade 1 Spasticity, CTCAE;Mild or slight increase in muscle tone;Grade 1 Spasticity;Mild or slight increase in muscle tone;Spasticity;10041416;LLT;20,1
3006;C145018;Grade 2 Spasticity, CTCAE;Moderate increase in muscle tone and increase in resistance through range of motion;Grade 2 Spasticity;Moderate increase in muscle tone and increase in resistance through range of motion;Spasticity;10041416;LLT;20,1
3007;C145636;Grade 3 Spasticity, CTCAE;Severe increase in muscle tone and increase in resistance through range of motion;Grade 3 Spasticity;Severe increase in muscle tone and increase in resistance through range of motion;Spasticity;10041416;LLT;20,1
3008;C146128;Grade 4 Spasticity, CTCAE;"Life-threatening consequences; unable to move active or passive range of motion";Grade 4 Spasticity;"Life-threatening consequences; unable to move active or passive range of motion";Spasticity;10041416;LLT;20,1
3009;C146560;Grade 5 Spasticity, CTCAE;Death;Grade 5 Spasticity;Death;Spasticity;10041416;LLT;20,1
3010;C143233;Spinal Cord Compression, CTCAE;A disorder characterized by pressure on the spinal cord.;Spinal cord compression;A disorder characterized by pressure on the spinal cord.;Spinal cord compression;10041549;LLT;20,1
3011;C145638;Grade 3 Spinal Cord Compression, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Spinal cord compression;"Severe symptoms; limiting self care ADL";Spinal cord compression;10041549;LLT;20,1
3012;C146130;Grade 4 Spinal Cord Compression, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Spinal cord compression;"Life-threatening consequences; urgent intervention indicated";Spinal cord compression;10041549;LLT;20,1
3013;C146562;Grade 5 Spinal Cord Compression, CTCAE;Death;Grade 5 Spinal cord compression;Death;Spinal cord compression;10041549;LLT;20,1
3014;C143862;Stroke, CTCAE;A disorder characterized by a decrease or absence of blood supply to the brain caused by obstruction (thrombosis or embolism) of an artery resulting in neurological damage.;Stroke;A disorder characterized by a decrease or absence of blood supply to the brain caused by obstruction (thrombosis or embolism) of an artery resulting in neurological damage.;Stroke;10042244;LLT;20,1
3015;C144419;Grade 1 Stroke, CTCAE;Incidental radiographic findings only;Grade 1 Stroke;Incidental radiographic findings only;Stroke;10042244;LLT;20,1
3016;C145024;Grade 2 Stroke, CTCAE;"Mild to moderate neurologic deficit; limiting instrumental ADL";Grade 2 Stroke;"Mild to moderate neurologic deficit; limiting instrumental ADL";Stroke;10042244;LLT;20,1
3017;C145646;Grade 3 Stroke, CTCAE;"Severe neurologic deficit; limiting self care ADL; hospitalization";Grade 3 Stroke;"Severe neurologic deficit; limiting self care ADL; hospitalization";Stroke;10042244;LLT;20,1
3018;C146137;Grade 4 Stroke, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Stroke;"Life-threatening consequences; urgent intervention indicated";Stroke;10042244;LLT;20,1
3019;C146569;Grade 5 Stroke, CTCAE;Death;Grade 5 Stroke;Death;Stroke;10042244;LLT;20,1
3020;C146750;Syncope, CTCAE 5.0;A disorder characterized by spontaneous loss of consciousness caused by insufficient blood supply to the brain.;Syncope;A disorder characterized by spontaneous loss of consciousness caused by insufficient blood supply to the brain.;Syncope;10042772;LLT;20,1
3021;C55593;Grade 3 Syncope, CTCAE;"Fainting; orthostatic collapse";Grade 3 Syncope;"Fainting; orthostatic collapse";Syncope;10042772;LLT;20,1
3022;C143234;Tendon Reflex Decreased, CTCAE;A disorder characterized by less than normal deep tendon reflexes.;Tendon reflex decreased;A disorder characterized by less than normal deep tendon reflexes.;Tendon reflex decreased;10043245;LLT;20,1
3023;C144425;Grade 1 Tendon Reflex Decreased, CTCAE;Ankle reflex reduced;Grade 1 Tendon reflex decreased;Ankle reflex reduced;Tendon reflex decreased;10043245;LLT;20,1
3024;C145031;Grade 2 Tendon Reflex Decreased, CTCAE;"Ankle reflex absent; other reflexes reduced";Grade 2 Tendon reflex decreased;"Ankle reflex absent; other reflexes reduced";Tendon reflex decreased;10043245;LLT;20,1
3025;C145653;Grade 3 Tendon Reflex Decreased, CTCAE;Absence of all reflexes;Grade 3 Tendon reflex decreased;Absence of all reflexes;Tendon reflex decreased;10043245;LLT;20,1
3026;C143886;Transient Ischemic Attacks, CTCAE;A disorder characterized by a brief attack (less than 24 hours) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.;Transient ischemic attacks;A disorder characterized by a brief attack (less than 24 hours) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.;Transient ischemic attacks;10044391;LLT;20,1
3027;C144443;Grade 1 Transient Ischemic Attacks, CTCAE;Mild neurologic deficit with or without imaging confirmation;Grade 1 Transient ischemic attacks;Mild neurologic deficit with or without imaging confirmation;Transient ischemic attacks;10044391;LLT;20,1
3028;C145048;Grade 2 Transient Ischemic Attacks, CTCAE;Moderate neurologic deficit with or without imaging confirmation;Grade 2 Transient ischemic attacks;Moderate neurologic deficit with or without imaging confirmation;Transient ischemic attacks;10044391;LLT;20,1
3029;C146780;Tremor, CTCAE 5.0;A disorder characterized by the uncontrolled shaking movement of the whole body or individual parts.;Tremor;A disorder characterized by the uncontrolled shaking movement of the whole body or individual parts.;Tremor;10044565;LLT;20,1
3030;C55597;Grade 1 Tremor, CTCAE;Mild symptoms;Grade 1 Tremor;Mild symptoms;Tremor;10044565;LLT;20,1
3031;C55598;Grade 2 Tremor, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Tremor;"Moderate symptoms; limiting instrumental ADL";Tremor;10044565;LLT;20,1
3032;C55599;Grade 3 Tremor, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Tremor;"Severe symptoms; limiting self care ADL";Tremor;10044565;LLT;20,1
3033;C143890;Trigeminal Nerve Disorder, CTCAE;A disorder characterized by dysfunction of the trigeminal nerve (fifth cranial nerve).;Trigeminal nerve disorder;A disorder characterized by dysfunction of the trigeminal nerve (fifth cranial nerve).;Trigeminal nerve disorder;10060890;LLT;20,1
3034;C144445;Grade 1 Trigeminal Nerve Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Trigeminal nerve disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Trigeminal nerve disorder;10060890;LLT;20,1
3035;C145050;Grade 2 Trigeminal Nerve Disorder, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Trigeminal nerve disorder;"Moderate symptoms; limiting instrumental ADL";Trigeminal nerve disorder;10060890;LLT;20,1
3036;C145672;Grade 3 Trigeminal Nerve Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Trigeminal nerve disorder;"Severe symptoms; limiting self care ADL";Trigeminal nerve disorder;10060890;LLT;20,1
3037;C143235;Trochlear Nerve Disorder, CTCAE;A disorder characterized by dysfunction of the trochlear nerve (fourth cranial nerve).;Trochlear nerve disorder;A disorder characterized by dysfunction of the trochlear nerve (fourth cranial nerve).;Trochlear nerve disorder;10074765;LLT;20,1
3038;C144446;Grade 1 Trochlear Nerve Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Trochlear nerve disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Trochlear nerve disorder;10074765;LLT;20,1
3039;C145051;Grade 2 Trochlear Nerve Disorder, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Trochlear nerve disorder;"Moderate symptoms; limiting instrumental ADL";Trochlear nerve disorder;10074765;LLT;20,1
3040;C145673;Grade 3 Trochlear Nerve Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Trochlear nerve disorder;"Severe symptoms; limiting self care ADL";Trochlear nerve disorder;10074765;LLT;20,1
3041;C143927;Vagus Nerve Disorder, CTCAE;A disorder characterized by dysfunction of the vagus nerve (tenth cranial nerve).;Vagus nerve disorder;A disorder characterized by dysfunction of the vagus nerve (tenth cranial nerve).;Vagus nerve disorder;10061403;LLT;20,1
3042;C144476;Grade 1 Vagus Nerve Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Vagus nerve disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Vagus nerve disorder;10061403;LLT;20,1
3043;C145088;Grade 2 Vagus Nerve Disorder, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Vagus nerve disorder;"Moderate symptoms; limiting instrumental ADL";Vagus nerve disorder;10061403;LLT;20,1
3044;C145708;Grade 3 Vagus Nerve Disorder, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Vagus nerve disorder;"Severe symptoms; limiting self care ADL";Vagus nerve disorder;10061403;LLT;20,1
3045;C146185;Grade 4 Vagus Nerve Disorder, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Vagus nerve disorder;"Life-threatening consequences; urgent intervention indicated";Vagus nerve disorder;10061403;LLT;20,1
3046;C146613;Grade 5 Vagus Nerve Disorder, CTCAE;Death;Grade 5 Vagus nerve disorder;Death;Vagus nerve disorder;10061403;LLT;20,1
3047;C143932;Vasovagal Reaction, CTCAE;A disorder characterized by a sudden drop of the blood pressure, bradycardia, and peripheral vasodilation that may lead to loss of consciousness. It results from an increase in the stimulation of the vagus nerve.;Vasovagal reaction;A disorder characterized by a sudden drop of the blood pressure, bradycardia, and peripheral vasodilation that may lead to loss of consciousness. It results from an increase in the stimulation of the vagus nerve.;Vasovagal reaction;10047166;LLT;20,1
3048;C145712;Grade 3 Vasovagal Reaction, CTCAE;Present;Grade 3 Vasovagal reaction;Present;Vasovagal reaction;10047166;LLT;20,1
3049;C146189;Grade 4 Vasovagal Reaction, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Vasovagal reaction;"Life-threatening consequences; urgent intervention indicated";Vasovagal reaction;10047166;LLT;20,1
3050;C146617;Grade 5 Vasovagal Reaction, CTCAE;Death;Grade 5 Vasovagal reaction;Death;Vasovagal reaction;10047166;LLT;20,1
3051;C143178;Pregnancy, Puerperium and Perinatal Conditions, CTCAE;;;;;;;
3052;C143484;Fetal Growth Retardation, CTCAE;A disorder characterized by inhibition of fetal growth resulting in the inability of the fetus to achieve its potential weight.;Fetal growth retardation;A disorder characterized by inhibition of fetal growth resulting in the inability of the fetus to achieve its potential weight.;Fetal growth retardation;10054746;LLT;20,1
3053;C144664;Grade 2 Fetal Growth Retardation, CTCAE;<10% percentile of weight for gestational age;Grade 2 Fetal growth retardation;<10% percentile of weight for gestational age;Fetal growth retardation;10054746;LLT;20,1
3054;C145284;Grade 3 Fetal Growth Retardation, CTCAE;<5% percentile of weight for gestational age;Grade 3 Fetal growth retardation;<5% percentile of weight for gestational age;Fetal growth retardation;10054746;LLT;20,1
3055;C145857;Grade 4 Fetal Growth Retardation, CTCAE;<1% percentile of weight for gestational age;Grade 4 Fetal growth retardation;<1% percentile of weight for gestational age;Fetal growth retardation;10054746;LLT;20,1
3056;C143236;Pregnancy Loss, CTCAE;Death in utero.;Pregnancy loss;Death in utero.;Pregnancy loss;10072314;LLT;20,1
3057;C146064;Grade 4 Pregnancy Loss, CTCAE;Fetal loss at any gestational age;Grade 4 Pregnancy loss;Fetal loss at any gestational age;Pregnancy loss;10072314;LLT;20,1
3058;C143775;Pregnancy, Puerperium and Perinatal Conditions - Other, Specify, CTCAE;;Pregnancy, puerperium and perinatal conditions - Other, specify;;Pregnancy, puerperium and perinatal conditions - Other, specify;10036585;LLT;20,1
3059;C144346;Grade 1 Pregnancy, Puerperium and Perinatal Conditions - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Pregnancy, puerperium and perinatal conditions - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Pregnancy, puerperium and perinatal conditions - Other, specify;10036585;LLT;20,1
3060;C144935;Grade 2 Pregnancy, Puerperium and Perinatal Conditions - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Pregnancy, puerperium and perinatal conditions - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Pregnancy, puerperium and perinatal conditions - Other, specify;10036585;LLT;20,1
3061;C145559;Grade 3 Pregnancy, Puerperium and Perinatal Conditions - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Pregnancy, puerperium and perinatal conditions - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Pregnancy, puerperium and perinatal conditions - Other, specify;10036585;LLT;20,1
3062;C146065;Grade 4 Pregnancy, Puerperium and Perinatal Conditions - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pregnancy, puerperium and perinatal conditions - Other, specify;"Life-threatening consequences; urgent intervention indicated";Pregnancy, puerperium and perinatal conditions - Other, specify;10036585;LLT;20,1
3063;C146501;Grade 5 Pregnancy, Puerperium and Perinatal Conditions - Other, Specify, CTCAE;Death;Grade 5 Pregnancy, puerperium and perinatal conditions - Other, specify;Death;Pregnancy, puerperium and perinatal conditions - Other, specify;10036585;LLT;20,1
3064;C143776;Premature Delivery, CTCAE;A disorder characterized by delivery of a viable infant before the normal end of gestation. Typically, viability is achievable between the twentieth and thirty-seventh week of gestation.;Premature delivery;A disorder characterized by delivery of a viable infant before the normal end of gestation. Typically, viability is achievable between the twentieth and thirty-seventh week of gestation.;Premature delivery;10036595;LLT;20,1
3065;C144347;Grade 1 Premature Delivery, CTCAE;Delivery of a liveborn infant at >34 to 37 weeks gestation;Grade 1 Premature delivery;Delivery of a liveborn infant at >34 to 37 weeks gestation;Premature delivery;10036595;LLT;20,1
3066;C144936;Grade 2 Premature Delivery, CTCAE;Delivery of a liveborn infant at >28 to 34 weeks gestation;Grade 2 Premature delivery;Delivery of a liveborn infant at >28 to 34 weeks gestation;Premature delivery;10036595;LLT;20,1
3067;C145560;Grade 3 Premature Delivery, CTCAE;Delivery of a liveborn infant at 24 to 28 weeks gestation;Grade 3 Premature delivery;Delivery of a liveborn infant at 24 to 28 weeks gestation;Premature delivery;10036595;LLT;20,1
3068;C146066;Grade 4 Premature Delivery, CTCAE;Delivery of a liveborn infant at 24 weeks of gestation or less;Grade 4 Premature delivery;Delivery of a liveborn infant at 24 weeks of gestation or less;Premature delivery;10036595;LLT;20,1
3069;C143187;Psychiatric Disorders, CTCAE;;;;;;;
3070;C146777;Agitation, CTCAE 5.0;A disorder characterized by a state of restlessness associated with unpleasant feelings of irritability and tension.;Agitation;A disorder characterized by a state of restlessness associated with unpleasant feelings of irritability and tension.;Agitation;10001497;LLT;20,1
3071;C55436;Grade 1 Agitation, CTCAE;Mild mood alteration;Grade 1 Agitation;Mild mood alteration;Agitation;10001497;LLT;20,1
3072;C55437;Grade 2 Agitation, CTCAE;Moderate mood alteration;Grade 2 Agitation;Moderate mood alteration;Agitation;10001497;LLT;20,1
3073;C55438;Grade 3 Agitation, CTCAE;"Severe agitation; hospitalization not indicated";Grade 3 Agitation;"Severe agitation; hospitalization not indicated";Agitation;10001497;LLT;20,1
3074;C55439;Grade 4 Agitation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Agitation;"Life-threatening consequences; urgent intervention indicated";Agitation;10001497;LLT;20,1
3075;C143287;Anorgasmia, CTCAE;A disorder characterized by an inability to achieve orgasm.;Anorgasmia;A disorder characterized by an inability to achieve orgasm.;Anorgasmia;10002652;LLT;20,1
3076;C143982;Grade 1 Anorgasmia, CTCAE;Inability to achieve orgasm not adversely affecting relationship;Grade 1 Anorgasmia;Inability to achieve orgasm not adversely affecting relationship;Anorgasmia;10002652;LLT;20,1
3077;C144520;Grade 2 Anorgasmia, CTCAE;Inability to achieve orgasm adversely affecting relationship;Grade 2 Anorgasmia;Inability to achieve orgasm adversely affecting relationship;Anorgasmia;10002652;LLT;20,1
3078;C146778;Anxiety, CTCAE 5.0;A disorder characterized by apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.;Anxiety;A disorder characterized by apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.;Anxiety;10002855;LLT;20,1
3079;C55442;Grade 1 Anxiety, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Anxiety;"Mild symptoms; intervention not indicated";Anxiety;10002855;LLT;20,1
3080;C55443;Grade 2 Anxiety, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Anxiety;"Moderate symptoms; limiting instrumental ADL";Anxiety;10002855;LLT;20,1
3081;C55444;Grade 3 Anxiety, CTCAE;"Severe symptoms; limiting self care ADL; hospitalization indicated";Grade 3 Anxiety;"Severe symptoms; limiting self care ADL; hospitalization indicated";Anxiety;10002855;LLT;20,1
3082;C55445;Grade 4 Anxiety, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Anxiety;"Life-threatening consequences; urgent intervention indicated";Anxiety;10002855;LLT;20,1
3083;C146785;Confusion, CTCAE 5.0;A disorder characterized by a lack of clear and orderly thought and behavior.;Confusion;A disorder characterized by a lack of clear and orderly thought and behavior.;Confusion;10010300;LLT;20,1
3084;C55380;Grade 1 Confusion, CTCAE;Mild disorientation;Grade 1 Confusion;Mild disorientation;Confusion;10010300;LLT;20,1
3085;C55381;Grade 2 Confusion, CTCAE;"Moderate disorientation; limiting instrumental ADL";Grade 2 Confusion;"Moderate disorientation; limiting instrumental ADL";Confusion;10010300;LLT;20,1
3086;C55382;Grade 3 Confusion, CTCAE;"Severe disorientation; limiting self care ADL";Grade 3 Confusion;"Severe disorientation; limiting self care ADL";Confusion;10010300;LLT;20,1
3087;C55383;Grade 4 Confusion, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Confusion;"Life-threatening consequences; urgent intervention indicated";Confusion;10010300;LLT;20,1
3088;C143398;Delayed Orgasm, CTCAE;A disorder characterized by sexual dysfunction characterized by a delay in climax.;Delayed orgasm;A disorder characterized by sexual dysfunction characterized by a delay in climax.;Delayed orgasm;10057066;LLT;20,1
3089;C144048;Grade 1 Delayed Orgasm, CTCAE;Delay in achieving orgasm not adversely affecting relationship;Grade 1 Delayed orgasm;Delay in achieving orgasm not adversely affecting relationship;Delayed orgasm;10057066;LLT;20,1
3090;C144600;Grade 2 Delayed Orgasm, CTCAE;Delay in achieving orgasm adversely affecting relationship;Grade 2 Delayed orgasm;Delay in achieving orgasm adversely affecting relationship;Delayed orgasm;10057066;LLT;20,1
3091;C143400;Delirium, CTCAE;A disorder characterized by the acute and sudden development of confusion, illusions, movement changes, inattentiveness, agitation, and hallucinations. Usually, it is a reversible condition.;Delirium;A disorder characterized by the acute and sudden development of confusion, illusions, movement changes, inattentiveness, agitation, and hallucinations. Usually, it is a reversible condition.;Delirium;10012218;LLT;20,1
3092;C144049;Grade 1 Delirium, CTCAE;Mild acute confusional state;Grade 1 Delirium;Mild acute confusional state;Delirium;10012218;LLT;20,1
3093;C144601;Grade 2 Delirium, CTCAE;"Moderate and acute confusional state; limiting instrumental ADL";Grade 2 Delirium;"Moderate and acute confusional state; limiting instrumental ADL";Delirium;10012218;LLT;20,1
3094;C145218;Grade 3 Delirium, CTCAE;"Severe and acute confusional state; limiting self care ADL; urgent intervention indicated; new onset";Grade 3 Delirium;"Severe and acute confusional state; limiting self care ADL; urgent intervention indicated; new onset";Delirium;10012218;LLT;20,1
3095;C145814;Grade 4 Delirium, CTCAE;"Life-threatening consequences, threats of harm to self or others; urgent intervention indicated";Grade 4 Delirium;"Life-threatening consequences, threats of harm to self or others; urgent intervention indicated";Delirium;10012218;LLT;20,1
3096;C146274;Grade 5 Delirium, CTCAE;Death;Grade 5 Delirium;Death;Delirium;10012218;LLT;20,1
3097;C143401;Delusions, CTCAE;A disorder characterized by false personal beliefs held contrary to reality, despite contradictory evidence and common sense.;Delusions;A disorder characterized by false personal beliefs held contrary to reality, despite contradictory evidence and common sense.;Delusions;10012260;LLT;20,1
3098;C144602;Grade 2 Delusions, CTCAE;Moderate delusional symptoms;Grade 2 Delusions;Moderate delusional symptoms;Delusions;10012260;LLT;20,1
3099;C145219;Grade 3 Delusions, CTCAE;"Severe delusional symptoms; hospitalization not indicated; new onset";Grade 3 Delusions;"Severe delusional symptoms; hospitalization not indicated; new onset";Delusions;10012260;LLT;20,1
3100;C145815;Grade 4 Delusions, CTCAE;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Grade 4 Delusions;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Delusions;10012260;LLT;20,1
3101;C146275;Grade 5 Delusions, CTCAE;Death;Grade 5 Delusions;Death;Delusions;10012260;LLT;20,1
3102;C55447;Depression, CTCAE;A disorder characterized by melancholic feelings of grief or unhappiness.;Depression;A disorder characterized by melancholic feelings of grief or unhappiness.;Depression;10012378;LLT;20,1
3103;C55448;Grade 1 Depression, CTCAE;Mild depressive symptoms;Grade 1 Depression;Mild depressive symptoms;Depression;10012378;LLT;20,1
3104;C55449;Grade 2 Depression, CTCAE;"Moderate depressive symptoms; limiting instrumental ADL";Grade 2 Depression;"Moderate depressive symptoms; limiting instrumental ADL";Depression;10012378;LLT;20,1
3105;C55450;Grade 3 Depression, CTCAE;"Severe depressive symptoms; limiting self care ADL; hospitalization not indicated";Grade 3 Depression;"Severe depressive symptoms; limiting self care ADL; hospitalization not indicated";Depression;10012378;LLT;20,1
3106;C55451;Grade 4 Depression, CTCAE;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Grade 4 Depression;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Depression;10012378;LLT;20,1
3107;C55452;Grade 5 Depression, CTCAE;Death;Grade 5 Depression;Death;Depression;10012378;LLT;20,1
3108;C146748;Euphoria, CTCAE 5.0;A disorder characterized by an exaggerated feeling of well-being which is disproportionate to events and stimuli.;Euphoria;A disorder characterized by an exaggerated feeling of well-being which is disproportionate to events and stimuli.;Euphoria;10015533;LLT;20,1
3109;C55454;Grade 1 Euphoria, CTCAE;Mild mood elevation;Grade 1 Euphoria;Mild mood elevation;Euphoria;10015533;LLT;20,1
3110;C55455;Grade 2 Euphoria, CTCAE;Moderate mood elevation;Grade 2 Euphoria;Moderate mood elevation;Euphoria;10015533;LLT;20,1
3111;C55456;Grade 3 Euphoria, CTCAE;Severe mood elevation (e.g., hypomania);Grade 3 Euphoria;Severe mood elevation (e.g., hypomania);Euphoria;10015533;LLT;20,1
3112;C143525;Hallucinations, CTCAE;A disorder characterized by a false sensory perception in the absence of an external stimulus.;Hallucinations;A disorder characterized by a false sensory perception in the absence of an external stimulus.;Hallucinations;10019077;LLT;20,1
3113;C144141;Grade 1 Hallucinations, CTCAE;Mild hallucinations (e.g., perceptual distortions);Grade 1 Hallucinations;Mild hallucinations (e.g., perceptual distortions);Hallucinations;10019077;LLT;20,1
3114;C144703;Grade 2 Hallucinations, CTCAE;Moderate hallucinations;Grade 2 Hallucinations;Moderate hallucinations;Hallucinations;10019077;LLT;20,1
3115;C145323;Grade 3 Hallucinations, CTCAE;"Severe hallucinations; hospitalization not indicated";Grade 3 Hallucinations;"Severe hallucinations; hospitalization not indicated";Hallucinations;10019077;LLT;20,1
3116;C145882;Grade 4 Hallucinations, CTCAE;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Grade 4 Hallucinations;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Hallucinations;10019077;LLT;20,1
3117;C146332;Grade 5 Hallucinations, CTCAE;Death;Grade 5 Hallucinations;Death;Hallucinations;10019077;LLT;20,1
3118;C146771;Insomnia, CTCAE 5.0;A disorder characterized by difficulty in falling asleep and/or remaining asleep.;Insomnia;A disorder characterized by difficulty in falling asleep and/or remaining asleep.;Insomnia;10022437;LLT;20,1
3119;C55294;Grade 1 Insomnia, CTCAE;Mild difficulty falling asleep, staying asleep or waking up early;Grade 1 Insomnia;Mild difficulty falling asleep, staying asleep or waking up early;Insomnia;10022437;LLT;20,1
3120;C55304;Grade 2 Insomnia, CTCAE;Moderate difficulty falling asleep, staying asleep or waking up early;Grade 2 Insomnia;Moderate difficulty falling asleep, staying asleep or waking up early;Insomnia;10022437;LLT;20,1
3121;C55314;Grade 3 Insomnia, CTCAE;Severe difficulty in falling asleep, staying asleep or waking up early;Grade 3 Insomnia;Severe difficulty in falling asleep, staying asleep or waking up early;Insomnia;10022437;LLT;20,1
3122;C143618;Irritability, CTCAE;"A disorder characterized by an abnormal responsiveness to stimuli or physiological arousal; may be in response to pain, fright, a drug, an emotional situation or a medical condition.";Irritability;"A disorder characterized by an abnormal responsiveness to stimuli or physiological arousal; may be in response to pain, fright, a drug, an emotional situation or a medical condition.";Irritability;10022998;LLT;20,1
3123;C144222;Grade 1 Irritability, CTCAE;"Mild; easily consolable";Grade 1 Irritability;"Mild; easily consolable";Irritability;10022998;LLT;20,1
3124;C144790;Grade 2 Irritability, CTCAE;"Moderate; limiting instrumental ADL; increased attention indicated";Grade 2 Irritability;"Moderate; limiting instrumental ADL; increased attention indicated";Irritability;10022998;LLT;20,1
3125;C145413;Grade 3 Irritability, CTCAE;"Severe abnormal or excessive response; limiting self care ADL; inconsolable; medical or psychiatric intervention indicated";Grade 3 Irritability;"Severe abnormal or excessive response; limiting self care ADL; inconsolable; medical or psychiatric intervention indicated";Irritability;10022998;LLT;20,1
3126;C143649;Libido Decreased, CTCAE;A disorder characterized by a decrease in sexual desire.;Libido decreased;A disorder characterized by a decrease in sexual desire.;Libido decreased;10024419;LLT;20,1
3127;C144246;Grade 1 Libido Decreased, CTCAE;Decrease in sexual interest not adversely affecting relationship;Grade 1 Libido decreased;Decrease in sexual interest not adversely affecting relationship;Libido decreased;10024419;LLT;20,1
3128;C144819;Grade 2 Libido Decreased, CTCAE;Decrease in sexual interest adversely affecting relationship;Grade 2 Libido decreased;Decrease in sexual interest adversely affecting relationship;Libido decreased;10024419;LLT;20,1
3129;C143650;Libido Increased, CTCAE;A disorder characterized by an increase in sexual desire.;Libido increased;A disorder characterized by an increase in sexual desire.;Libido increased;10024421;LLT;20,1
3130;C144247;Grade 1 Libido Increased, CTCAE;Present;Grade 1 Libido increased;Present;Libido increased;10024421;LLT;20,1
3131;C143666;Mania, CTCAE;A disorder characterized by excitement of psychotic proportions manifested by mental and physical hyperactivity, disorganization of behavior and elevation of mood.;Mania;A disorder characterized by excitement of psychotic proportions manifested by mental and physical hyperactivity, disorganization of behavior and elevation of mood.;Mania;10026749;LLT;20,1
3132;C144257;Grade 1 Mania, CTCAE;Mild manic symptoms (e.g., elevated mood, rapid thoughts, rapid speech, decreased need for sleep);Grade 1 Mania;Mild manic symptoms (e.g., elevated mood, rapid thoughts, rapid speech, decreased need for sleep);Mania;10026749;LLT;20,1
3133;C144833;Grade 2 Mania, CTCAE;"Moderate manic symptoms (e.g., relationship and work difficulties; poor hygiene)";Grade 2 Mania;"Moderate manic symptoms (e.g., relationship and work difficulties; poor hygiene)";Mania;10026749;LLT;20,1
3134;C145453;Grade 3 Mania, CTCAE;"Severe manic symptoms (e.g., hypomania; major sexual or financial indiscretions); hospitalization not indicated; new onset";Grade 3 Mania;"Severe manic symptoms (e.g., hypomania; major sexual or financial indiscretions); hospitalization not indicated; new onset";Mania;10026749;LLT;20,1
3135;C145989;Grade 4 Mania, CTCAE;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Grade 4 Mania;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Mania;10026749;LLT;20,1
3136;C146434;Grade 5 Mania, CTCAE;Death;Grade 5 Mania;Death;Mania;10026749;LLT;20,1
3137;C143754;Personality Change, CTCAE;A disorder characterized by a conspicuous change in a person's behavior and thinking.;Personality change;A disorder characterized by a conspicuous change in a person's behavior and thinking.;Personality change;10034719;LLT;20,1
3138;C144329;Grade 1 Personality Change, CTCAE;Mild personality change;Grade 1 Personality change;Mild personality change;Personality change;10034719;LLT;20,1
3139;C144913;Grade 2 Personality Change, CTCAE;Moderate personality change;Grade 2 Personality change;Moderate personality change;Personality change;10034719;LLT;20,1
3140;C145538;Grade 3 Personality Change, CTCAE;"Severe personality change; hospitalization not indicated";Grade 3 Personality change;"Severe personality change; hospitalization not indicated";Personality change;10034719;LLT;20,1
3141;C146046;Grade 4 Personality Change, CTCAE;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Grade 4 Personality change;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Personality change;10034719;LLT;20,1
3142;C143787;Psychiatric Disorders - Other, Specify, CTCAE;;Psychiatric disorders - Other, specify;;Psychiatric disorders - Other, specify;10037175;LLT;20,1
3143;C144354;Grade 1 Psychiatric Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Psychiatric disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Psychiatric disorders - Other, specify;10037175;LLT;20,1
3144;C144946;Grade 2 Psychiatric Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Psychiatric disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Psychiatric disorders - Other, specify;10037175;LLT;20,1
3145;C145568;Grade 3 Psychiatric Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; limiting self care ADL";Grade 3 Psychiatric disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; limiting self care ADL";Psychiatric disorders - Other, specify;10037175;LLT;20,1
3146;C146071;Grade 4 Psychiatric Disorders - Other, Specify, CTCAE;"Life-threatening consequences; hospitalization or urgent intervention indicated";Grade 4 Psychiatric disorders - Other, specify;"Life-threatening consequences; hospitalization or urgent intervention indicated";Psychiatric disorders - Other, specify;10037175;LLT;20,1
3147;C146506;Grade 5 Psychiatric Disorders - Other, Specify, CTCAE;Death;Grade 5 Psychiatric disorders - Other, specify;Death;Psychiatric disorders - Other, specify;10037175;LLT;20,1
3148;C143788;Psychosis, CTCAE;A disorder characterized by personality change, impaired functioning, and loss of touch with reality. It may be a manifestation of schizophrenia, bipolar disorder or brain tumor.;Psychosis;A disorder characterized by personality change, impaired functioning, and loss of touch with reality. It may be a manifestation of schizophrenia, bipolar disorder or brain tumor.;Psychosis;10037234;LLT;20,1
3149;C144355;Grade 1 Psychosis, CTCAE;Mild psychotic symptoms;Grade 1 Psychosis;Mild psychotic symptoms;Psychosis;10037234;LLT;20,1
3150;C144947;Grade 2 Psychosis, CTCAE;"Moderate psychotic symptoms (e.g., disorganized speech; impaired reality testing)";Grade 2 Psychosis;"Moderate psychotic symptoms (e.g., disorganized speech; impaired reality testing)";Psychosis;10037234;LLT;20,1
3151;C145569;Grade 3 Psychosis, CTCAE;"Severe psychotic symptoms (e.g., paranoid, extreme disorganization); hospitalization not indicated; new onset";Grade 3 Psychosis;"Severe psychotic symptoms (e.g., paranoid, extreme disorganization); hospitalization not indicated; new onset";Psychosis;10037234;LLT;20,1
3152;C146072;Grade 4 Psychosis, CTCAE;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Grade 4 Psychosis;"Life-threatening consequences, threats of harm to self or others; hospitalization indicated";Psychosis;10037234;LLT;20,1
3153;C146507;Grade 5 Psychosis, CTCAE;Death;Grade 5 Psychosis;Death;Psychosis;10037234;LLT;20,1
3154;C143811;Restlessness, CTCAE;A disorder characterized by an inability to rest, relax or be still.;Restlessness;A disorder characterized by an inability to rest, relax or be still.;Restlessness;10038743;LLT;20,1
3155;C144382;Grade 1 Restlessness, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Restlessness;"Mild symptoms; intervention not indicated";Restlessness;10038743;LLT;20,1
3156;C144976;Grade 2 Restlessness, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Restlessness;"Moderate symptoms; limiting instrumental ADL";Restlessness;10038743;LLT;20,1
3157;C145599;Grade 3 Restlessness, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Restlessness;"Severe symptoms; limiting self care ADL";Restlessness;10038743;LLT;20,1
3158;C143864;Suicidal Ideation, CTCAE;A disorder characterized by thoughts of taking one's own life.;Suicidal ideation;A disorder characterized by thoughts of taking one's own life.;Suicidal ideation;10042458;LLT;20,1
3159;C144421;Grade 1 Suicidal Ideation, CTCAE;Increased thoughts of death but no wish to kill oneself;Grade 1 Suicidal ideation;Increased thoughts of death but no wish to kill oneself;Suicidal ideation;10042458;LLT;20,1
3160;C145026;Grade 2 Suicidal Ideation, CTCAE;Suicidal ideation with no specific plan or intent;Grade 2 Suicidal ideation;Suicidal ideation with no specific plan or intent;Suicidal ideation;10042458;LLT;20,1
3161;C145648;Grade 3 Suicidal Ideation, CTCAE;Specific plan to commit suicide without serious intent to die which may not require hospitalization;Grade 3 Suicidal ideation;Specific plan to commit suicide without serious intent to die which may not require hospitalization;Suicidal ideation;10042458;LLT;20,1
3162;C146138;Grade 4 Suicidal Ideation, CTCAE;Specific plan to commit suicide with serious intent to die which requires hospitalization;Grade 4 Suicidal ideation;Specific plan to commit suicide with serious intent to die which requires hospitalization;Suicidal ideation;10042458;LLT;20,1
3163;C143865;Suicide Attempt, CTCAE;A disorder characterized by self-inflicted harm in an attempt to end one's own life.;Suicide attempt;A disorder characterized by self-inflicted harm in an attempt to end one's own life.;Suicide attempt;10042464;LLT;20,1
3164;C145649;Grade 3 Suicide Attempt, CTCAE;Suicide attempt or gesture without intent to die;Grade 3 Suicide attempt;Suicide attempt or gesture without intent to die;Suicide attempt;10042464;LLT;20,1
3165;C146139;Grade 4 Suicide Attempt, CTCAE;Suicide attempt with intent to die which requires hospitalization;Grade 4 Suicide attempt;Suicide attempt with intent to die which requires hospitalization;Suicide attempt;10042464;LLT;20,1
3166;C146571;Grade 5 Suicide Attempt, CTCAE;Death;Grade 5 Suicide attempt;Death;Suicide attempt;10042464;LLT;20,1
3167;C143179;Renal and Urinary Disorders, CTCAE;;;;;;;
3168;C143262;Acute Kidney Injury, CTCAE;A disorder characterized by the acute loss of renal function (within 2 weeks) and is traditionally classified as pre-renal (low blood flow into kidney), renal (kidney damage) and post-renal causes (ureteral or bladder outflow obstruction).;Acute kidney injury;A disorder characterized by the acute loss of renal function (within 2 weeks) and is traditionally classified as pre-renal (low blood flow into kidney), renal (kidney damage) and post-renal causes (ureteral or bladder outflow obstruction).;Acute kidney injury;10069339;LLT;20,1
3169;C145119;Grade 3 Acute Kidney Injury, CTCAE;Hospitalization indicated;Grade 3 Acute kidney injury;Hospitalization indicated;Acute kidney injury;10069339;LLT;20,1
3170;C145733;Grade 4 Acute Kidney Injury, CTCAE;"Life-threatening consequences; dialysis indicated";Grade 4 Acute kidney injury;"Life-threatening consequences; dialysis indicated";Acute kidney injury;10069339;LLT;20,1
3171;C146205;Grade 5 Acute Kidney Injury, CTCAE;Death;Grade 5 Acute kidney injury;Death;Acute kidney injury;10069339;LLT;20,1
3172;C146707;Bladder Perforation, CTCAE 5.0;A disorder characterized by a rupture in the bladder wall.;Bladder perforation;A disorder characterized by a rupture in the bladder wall.;Bladder perforation;10063575;LLT;20,1
3173;C56823;Grade 2 Bladder Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Bladder perforation;Invasive intervention not indicated;Bladder perforation;10063575;LLT;20,1
3174;C56883;Grade 3 Bladder Perforation, CTCAE;Invasive intervention indicated;Grade 3 Bladder perforation;Invasive intervention indicated;Bladder perforation;10063575;LLT;20,1
3175;C56944;Grade 4 Bladder Perforation, CTCAE;"Life-threatening consequences; organ failure; urgent operative intervention indicated";Grade 4 Bladder perforation;"Life-threatening consequences; organ failure; urgent operative intervention indicated";Bladder perforation;10063575;LLT;20,1
3176;C57003;Grade 5 Bladder Perforation, CTCAE;Death;Grade 5 Bladder perforation;Death;Bladder perforation;10063575;LLT;20,1
3177;C146698;Bladder Spasm, CTCAE 5.0;A disorder characterized by a sudden and involuntary contraction of the bladder wall.;Bladder spasm;A disorder characterized by a sudden and involuntary contraction of the bladder wall.;Bladder spasm;10048994;LLT;20,1
3178;C56763;Grade 1 Bladder Spasm, CTCAE;Intervention not indicated;Grade 1 Bladder spasm;Intervention not indicated;Bladder spasm;10048994;LLT;20,1
3179;C56824;Grade 2 Bladder Spasm, CTCAE;Antispasmodics indicated;Grade 2 Bladder spasm;Antispasmodics indicated;Bladder spasm;10048994;LLT;20,1
3180;C56884;Grade 3 Bladder Spasm, CTCAE;Hospitalization indicated;Grade 3 Bladder spasm;Hospitalization indicated;Bladder spasm;10048994;LLT;20,1
3181;C143369;Chronic Kidney Disease, CTCAE;A disorder characterized by gradual and usually permanent loss of kidney function resulting in renal failure.;Chronic kidney disease;A disorder characterized by gradual and usually permanent loss of kidney function resulting in renal failure.;Chronic kidney disease;10064848;LLT;20,1
3182;C144031;Grade 1 Chronic Kidney Disease, CTCAE;"eGFR (estimated Glomerular Filtration Rate) or CrCl (creatinine clearance) <LLN-60 ml/min/1.73 m2 or proteinuria 2+ present; urine protein/creatinine >0.5";Grade 1 Chronic kidney disease;"eGFR (estimated Glomerular Filtration Rate) or CrCl (creatinine clearance) <LLN-60 ml/min/1.73 m2 or proteinuria 2+ present; urine protein/creatinine >0.5";Chronic kidney disease;10064848;LLT;20,1
3183;C144579;Grade 2 Chronic Kidney Disease, CTCAE;eGFR or CrCl 59-30 ml/min/1.73 m2;Grade 2 Chronic kidney disease;eGFR or CrCl 59-30 ml/min/1.73 m2;Chronic kidney disease;10064848;LLT;20,1
3184;C145196;Grade 3 Chronic Kidney Disease, CTCAE;eGFR or CrCl 29-15 ml/min/1.73 m2;Grade 3 Chronic kidney disease;eGFR or CrCl 29-15 ml/min/1.73 m2;Chronic kidney disease;10064848;LLT;20,1
3185;C145793;Grade 4 Chronic Kidney Disease, CTCAE;"eGFR or CrCl <15 ml/min/1.73 m2; dialysis or renal transplant indicated";Grade 4 Chronic kidney disease;"eGFR or CrCl <15 ml/min/1.73 m2; dialysis or renal transplant indicated";Chronic kidney disease;10064848;LLT;20,1
3186;C146258;Grade 5 Chronic Kidney Disease, CTCAE;Death;Grade 5 Chronic kidney disease;Death;Chronic kidney disease;10064848;LLT;20,1
3187;C143393;Cystitis Noninfective, CTCAE;A disorder characterized by inflammation of the bladder which is not caused by an infection of the urinary tract.;Cystitis noninfective;A disorder characterized by inflammation of the bladder which is not caused by an infection of the urinary tract.;Cystitis noninfective;10063057;LLT;20,1
3188;C144045;Grade 1 Cystitis Noninfective, CTCAE;"Microscopic hematuria; minimal increase in frequency, urgency, dysuria, or nocturia; new onset of incontinence";Grade 1 Cystitis noninfective;"Microscopic hematuria; minimal increase in frequency, urgency, dysuria, or nocturia; new onset of incontinence";Cystitis noninfective;10063057;LLT;20,1
3189;C144597;Grade 2 Cystitis Noninfective, CTCAE;"Moderate hematuria; moderate increase in frequency, urgency, dysuria, nocturia or incontinence; urinary catheter placement or bladder irrigation indicated; limiting instrumental ADL";Grade 2 Cystitis noninfective;"Moderate hematuria; moderate increase in frequency, urgency, dysuria, nocturia or incontinence; urinary catheter placement or bladder irrigation indicated; limiting instrumental ADL";Cystitis noninfective;10063057;LLT;20,1
3190;C145215;Grade 3 Cystitis Noninfective, CTCAE;"Gross hematuria; transfusion, IV medications, or hospitalization indicated; elective invasive intervention indicated";Grade 3 Cystitis noninfective;"Gross hematuria; transfusion, IV medications, or hospitalization indicated; elective invasive intervention indicated";Cystitis noninfective;10063057;LLT;20,1
3191;C145810;Grade 4 Cystitis Noninfective, CTCAE;"Life-threatening consequences; urgent invasive intervention indicated";Grade 4 Cystitis noninfective;"Life-threatening consequences; urgent invasive intervention indicated";Cystitis noninfective;10063057;LLT;20,1
3192;C146270;Grade 5 Cystitis Noninfective, CTCAE;Death;Grade 5 Cystitis noninfective;Death;Cystitis noninfective;10063057;LLT;20,1
3193;C143237;Dysuria, CTCAE;A disorder characterized by painful urination.;Dysuria;A disorder characterized by painful urination.;Dysuria;10013990;LLT;20,1
3194;C144067;Grade 1 Dysuria, CTCAE;Present;Grade 1 Dysuria;Present;Dysuria;10013990;LLT;20,1
3195;C143238;Glucosuria, CTCAE;A disorder characterized by laboratory test results that indicate glucose in the urine.;Glucosuria;A disorder characterized by laboratory test results that indicate glucose in the urine.;Glucosuria;10068405;LLT;20,1
3196;C144133;Grade 1 Glucosuria, CTCAE;Present;Grade 1 Glucosuria;Present;Glucosuria;10068405;LLT;20,1
3197;C143532;Hematuria, CTCAE;A disorder characterized by laboratory test results that indicate blood in the urine.;Hematuria;A disorder characterized by laboratory test results that indicate blood in the urine.;Hematuria;10019450;LLT;20,1
3198;C144147;Grade 1 Hematuria, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hematuria;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Hematuria;10019450;LLT;20,1
3199;C144708;Grade 2 Hematuria, CTCAE;"Symptomatic; urinary catheter or bladder irrigation indicated; limiting instrumental ADL";Grade 2 Hematuria;"Symptomatic; urinary catheter or bladder irrigation indicated; limiting instrumental ADL";Hematuria;10019450;LLT;20,1
3200;C145328;Grade 3 Hematuria, CTCAE;"Gross hematuria; transfusion, IV medications, or hospitalization indicated; elective invasive intervention indicated; limiting self care ADL";Grade 3 Hematuria;"Gross hematuria; transfusion, IV medications, or hospitalization indicated; elective invasive intervention indicated; limiting self care ADL";Hematuria;10019450;LLT;20,1
3201;C145886;Grade 4 Hematuria, CTCAE;"Life-threatening consequences; urgent invasive intervention indicated";Grade 4 Hematuria;"Life-threatening consequences; urgent invasive intervention indicated";Hematuria;10019450;LLT;20,1
3202;C146335;Grade 5 Hematuria, CTCAE;Death;Grade 5 Hematuria;Death;Hematuria;10019450;LLT;20,1
3203;C146768;Hemoglobinuria, CTCAE 5.0;A disorder characterized by laboratory test results that indicate the presence of free hemoglobin in the urine.;Hemoglobinuria;A disorder characterized by laboratory test results that indicate the presence of free hemoglobin in the urine.;Hemoglobinuria;10019489;LLT;20,1
3204;C55178;Grade 1 Hemoglobinuria, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Hemoglobinuria;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Hemoglobinuria;10019489;LLT;20,1
3205;C56544;Renal Hemorrhage, CTCAE;A disorder characterized by bleeding from the kidney.;Renal hemorrhage;A disorder characterized by bleeding from the kidney.;Renal hemorrhage;10038463;LLT;20,1
3206;C56301;Grade 1 Renal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Renal hemorrhage;"Mild symptoms; intervention not indicated";Renal hemorrhage;10038463;LLT;20,1
3207;C56350;Grade 2 Renal Hemorrhage, CTCAE;Analgesics and hematocrit monitoring indicated;Grade 2 Renal hemorrhage;Analgesics and hematocrit monitoring indicated;Renal hemorrhage;10038463;LLT;20,1
3208;C56400;Grade 3 Renal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Renal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Renal hemorrhage;10038463;LLT;20,1
3209;C56450;Grade 4 Renal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Renal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Renal hemorrhage;10038463;LLT;20,1
3210;C56499;Grade 5 Renal Hemorrhage, CTCAE;Death;Grade 5 Renal hemorrhage;Death;Renal hemorrhage;10038463;LLT;20,1
3211;C143239;Nephrotic Syndrome, CTCAE;"A disorder characterized by symptoms that include severe edema, proteinuria, and hypoalbuminemia; it is indicative of renal dysfunction.";Nephrotic syndrome;"A disorder characterized by symptoms that include severe edema, proteinuria, and hypoalbuminemia; it is indicative of renal dysfunction.";Nephrotic syndrome;10029164;LLT;20,1
3212;C145484;Grade 3 Nephrotic Syndrome, CTCAE;"Not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Nephrotic syndrome;"Not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Nephrotic syndrome;10029164;LLT;20,1
3213;C146010;Grade 4 Nephrotic Syndrome, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Nephrotic syndrome;"Life-threatening consequences; urgent intervention indicated";Nephrotic syndrome;10029164;LLT;20,1
3214;C146454;Grade 5 Nephrotic Syndrome, CTCAE;Death;Grade 5 Nephrotic syndrome;Death;Nephrotic syndrome;10029164;LLT;20,1
3215;C146758;Proteinuria, CTCAE 5.0;A disorder characterized by laboratory test results that indicate the presence of excessive protein in the urine. It is predominantly albumin, but also globulin.;Proteinuria;A disorder characterized by laboratory test results that indicate the presence of excessive protein in the urine. It is predominantly albumin, but also globulin.;Proteinuria;10037032;LLT;20,1
3216;C55220;Grade 1 Proteinuria, CTCAE;"1+ proteinuria; urinary protein > or = to ULN-<1.0 g/24 hrs";Grade 1 Proteinuria;"1+ proteinuria; urinary protein > or = to ULN-<1.0 g/24 hrs";Proteinuria;10037032;LLT;20,1
3217;C55221;Grade 2 Proteinuria, CTCAE;"Adult: 2+ and 3+ proteinuria; urinary protein 1.0-<3.5 g/24 hrs; Pediatric: Urine P/C (Protein/Creatinine) ratio 0.5-1.9";Grade 2 Proteinuria;"Adult: 2+ and 3+ proteinuria; urinary protein 1.0-<3.5 g/24 hrs; Pediatric: Urine P/C (Protein/Creatinine) ratio 0.5-1.9";Proteinuria;10037032;LLT;20,1
3218;C55222;Grade 3 Proteinuria, CTCAE;"Adult: Urinary protein >=3.5 g/24 hrs; 4+ proteinuria; Pediatric: Urine P/C (Protein/Creatinine) ratio >1.9";Grade 3 Proteinuria;"Adult: Urinary protein >=3.5 g/24 hrs; 4+ proteinuria; Pediatric: Urine P/C (Protein/Creatinine) ratio >1.9";Proteinuria;10037032;LLT;20,1
3219;C143805;Renal and Urinary Disorders - Other, Specify, CTCAE;;Renal and urinary disorders - Other, specify;;Renal and urinary disorders - Other, specify;10038359;LLT;20,1
3220;C144376;Grade 1 Renal and Urinary Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Renal and urinary disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Renal and urinary disorders - Other, specify;10038359;LLT;20,1
3221;C144970;Grade 2 Renal and Urinary Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Renal and urinary disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Renal and urinary disorders - Other, specify;10038359;LLT;20,1
3222;C145593;Grade 3 Renal and Urinary Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Renal and urinary disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Renal and urinary disorders - Other, specify;10038359;LLT;20,1
3223;C146091;Grade 4 Renal and Urinary Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Renal and urinary disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Renal and urinary disorders - Other, specify;10038359;LLT;20,1
3224;C146526;Grade 5 Renal and Urinary Disorders - Other, Specify, CTCAE;Death;Grade 5 Renal and urinary disorders - Other, specify;Death;Renal and urinary disorders - Other, specify;10038359;LLT;20,1
3225;C143806;Renal Calculi, CTCAE;A disorder characterized by the formation of crystals/kidney stones in the pelvis of the kidney.;Renal calculi;A disorder characterized by the formation of crystals/kidney stones in the pelvis of the kidney.;Renal calculi;10038385;LLT;20,1
3226;C144377;Grade 1 Renal Calculi, CTCAE;"Asymptomatic or mild symptoms; occasional use of nonprescription analgesics indicated";Grade 1 Renal calculi;"Asymptomatic or mild symptoms; occasional use of nonprescription analgesics indicated";Renal calculi;10038385;LLT;20,1
3227;C144971;Grade 2 Renal Calculi, CTCAE;"Symptomatic; oral antiemetics indicated; around the clock nonprescription analgesics or any oral narcotic analgesics indicated";Grade 2 Renal calculi;"Symptomatic; oral antiemetics indicated; around the clock nonprescription analgesics or any oral narcotic analgesics indicated";Renal calculi;10038385;LLT;20,1
3228;C145594;Grade 3 Renal Calculi, CTCAE;"Hospitalization indicated; IV intervention (e.g., analgesics, antiemetics); elective invasive intervention indicated";Grade 3 Renal calculi;"Hospitalization indicated; IV intervention (e.g., analgesics, antiemetics); elective invasive intervention indicated";Renal calculi;10038385;LLT;20,1
3229;C146092;Grade 4 Renal Calculi, CTCAE;"Life-threatening consequences; urgent invasive intervention indicated";Grade 4 Renal calculi;"Life-threatening consequences; urgent invasive intervention indicated";Renal calculi;10038385;LLT;20,1
3230;C146527;Grade 5 Renal Calculi, CTCAE;Death;Grade 5 Renal calculi;Death;Renal calculi;10038385;LLT;20,1
3231;C143807;Renal Colic, CTCAE;A disorder characterized by paroxysmal and severe flank marked discomfort radiating to the inguinal area. Often, the cause is the passage of crystals/kidney stones.;Renal colic;A disorder characterized by paroxysmal and severe flank marked discomfort radiating to the inguinal area. Often, the cause is the passage of crystals/kidney stones.;Renal colic;10038419;LLT;20,1
3232;C144378;Grade 1 Renal Colic, CTCAE;"Mild pain not interfering with activity; nonprescription medication indicated";Grade 1 Renal colic;"Mild pain not interfering with activity; nonprescription medication indicated";Renal colic;10038419;LLT;20,1
3233;C144972;Grade 2 Renal Colic, CTCAE;"Moderate pain; limiting instrumental ADL; prescription medication indicated";Grade 2 Renal colic;"Moderate pain; limiting instrumental ADL; prescription medication indicated";Renal colic;10038419;LLT;20,1
3234;C145595;Grade 3 Renal Colic, CTCAE;"Hospitalization indicated; limiting self care ADL";Grade 3 Renal colic;"Hospitalization indicated; limiting self care ADL";Renal colic;10038419;LLT;20,1
3235;C143900;Urinary Fistula, CTCAE;A disorder characterized by an abnormal communication between any part of the urinary system and another organ or anatomic site.;Urinary fistula;A disorder characterized by an abnormal communication between any part of the urinary system and another organ or anatomic site.;Urinary fistula;10065368;LLT;20,1
3236;C145059;Grade 2 Urinary Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Urinary fistula;Symptomatic, invasive intervention not indicated;Urinary fistula;10065368;LLT;20,1
3237;C145681;Grade 3 Urinary Fistula, CTCAE;Invasive intervention indicated;Grade 3 Urinary fistula;Invasive intervention indicated;Urinary fistula;10065368;LLT;20,1
3238;C146165;Grade 4 Urinary Fistula, CTCAE;"Life-threatening consequences; urgent invasive intervention indicated";Grade 4 Urinary fistula;"Life-threatening consequences; urgent invasive intervention indicated";Urinary fistula;10065368;LLT;20,1
3239;C146595;Grade 5 Urinary Fistula, CTCAE;Death;Grade 5 Urinary fistula;Death;Urinary fistula;10065368;LLT;20,1
3240;C143901;Urinary Frequency, CTCAE;A disorder characterized by urination at short intervals.;Urinary frequency;A disorder characterized by urination at short intervals.;Urinary frequency;10046539;LLT;20,1
3241;C144452;Grade 1 Urinary Frequency, CTCAE;Present;Grade 1 Urinary frequency;Present;Urinary frequency;10046539;LLT;20,1
3242;C145060;Grade 2 Urinary Frequency, CTCAE;"Limiting instrumental ADL; medical management indicated";Grade 2 Urinary frequency;"Limiting instrumental ADL; medical management indicated";Urinary frequency;10046539;LLT;20,1
3243;C146786;Urinary Incontinence, CTCAE 5.0;A disorder characterized by inability to control the flow of urine from the bladder.;Urinary incontinence;A disorder characterized by inability to control the flow of urine from the bladder.;Urinary incontinence;10046543;LLT;20,1
3244;C56803;Grade 1 Urinary Incontinence, CTCAE;Occasional (e.g., with coughing, sneezing, etc.), pads not indicated;Grade 1 Urinary incontinence;Occasional (e.g., with coughing, sneezing, etc.), pads not indicated;Urinary incontinence;10046543;LLT;20,1
3245;C56864;Grade 2 Urinary Incontinence, CTCAE;"Spontaneous; pads indicated; limiting instrumental ADL";Grade 2 Urinary incontinence;"Spontaneous; pads indicated; limiting instrumental ADL";Urinary incontinence;10046543;LLT;20,1
3246;C56925;Grade 3 Urinary Incontinence, CTCAE;"Intervention indicated (e.g., clamp, collagen injections); operative intervention indicated; limiting self care ADL";Grade 3 Urinary incontinence;"Intervention indicated (e.g., clamp, collagen injections); operative intervention indicated; limiting self care ADL";Urinary incontinence;10046543;LLT;20,1
3247;C57097;Urinary Retention, CTCAE;A disorder characterized by accumulation of urine within the bladder because of the inability to urinate.;Urinary retention;A disorder characterized by accumulation of urine within the bladder because of the inability to urinate.;Urinary retention;10046555;LLT;20,1
3248;C56804;Grade 1 Urinary Retention, CTCAE;"Urinary, suprapubic or intermittent catheter placement not indicated; able to void with some residual";Grade 1 Urinary retention;"Urinary, suprapubic or intermittent catheter placement not indicated; able to void with some residual";Urinary retention;10046555;LLT;20,1
3249;C56865;Grade 2 Urinary Retention, CTCAE;"Placement of urinary, suprapubic or intermittent catheter placement indicated; medication indicated";Grade 2 Urinary retention;"Placement of urinary, suprapubic or intermittent catheter placement indicated; medication indicated";Urinary retention;10046555;LLT;20,1
3250;C56926;Grade 3 Urinary Retention, CTCAE;"Elective invasive intervention indicated; substantial loss of affected kidney function or mass";Grade 3 Urinary retention;"Elective invasive intervention indicated; substantial loss of affected kidney function or mass";Urinary retention;10046555;LLT;20,1
3251;C56985;Grade 4 Urinary Retention, CTCAE;"Life-threatening consequences; organ failure; urgent operative intervention indicated";Grade 4 Urinary retention;"Life-threatening consequences; organ failure; urgent operative intervention indicated";Urinary retention;10046555;LLT;20,1
3252;C57042;Grade 5 Urinary Retention, CTCAE;Death;Grade 5 Urinary retention;Death;Urinary retention;10046555;LLT;20,1
3253;C143905;Urinary Tract Obstruction, CTCAE;A disorder characterized by blockage of the normal flow of contents of the urinary tract.;Urinary tract obstruction;A disorder characterized by blockage of the normal flow of contents of the urinary tract.;Urinary tract obstruction;10061574;LLT;20,1
3254;C144453;Grade 1 Urinary Tract Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Urinary tract obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Urinary tract obstruction;10061574;LLT;20,1
3255;C145062;Grade 2 Urinary Tract Obstruction, CTCAE;"Symptomatic but no hydronephrosis, sepsis, or renal dysfunction; urethral dilation, urinary or suprapubic catheter indicated";Grade 2 Urinary tract obstruction;"Symptomatic but no hydronephrosis, sepsis, or renal dysfunction; urethral dilation, urinary or suprapubic catheter indicated";Urinary tract obstruction;10061574;LLT;20,1
3256;C145683;Grade 3 Urinary Tract Obstruction, CTCAE;"Altered organ function (e.g., hydronephrosis or renal dysfunction); invasive intervention indicated";Grade 3 Urinary tract obstruction;"Altered organ function (e.g., hydronephrosis or renal dysfunction); invasive intervention indicated";Urinary tract obstruction;10061574;LLT;20,1
3257;C146167;Grade 4 Urinary Tract Obstruction, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Urinary tract obstruction;"Life-threatening consequences; urgent intervention indicated";Urinary tract obstruction;10061574;LLT;20,1
3258;C146597;Grade 5 Urinary Tract Obstruction, CTCAE;Death;Grade 5 Urinary tract obstruction;Death;Urinary tract obstruction;10061574;LLT;20,1
3259;C143906;Urinary Tract Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the urinary tract.;Urinary tract pain;A disorder characterized by a sensation of marked discomfort in the urinary tract.;Urinary tract pain;10062225;LLT;20,1
3260;C144454;Grade 1 Urinary Tract Pain, CTCAE;Mild pain;Grade 1 Urinary tract pain;Mild pain;Urinary tract pain;10062225;LLT;20,1
3261;C145063;Grade 2 Urinary Tract Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Urinary tract pain;"Moderate pain; limiting instrumental ADL";Urinary tract pain;10062225;LLT;20,1
3262;C145684;Grade 3 Urinary Tract Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Urinary tract pain;"Severe pain; limiting self care ADL";Urinary tract pain;10062225;LLT;20,1
3263;C143907;Urinary Urgency, CTCAE;A disorder characterized by a sudden compelling urge to urinate.;Urinary urgency;A disorder characterized by a sudden compelling urge to urinate.;Urinary urgency;10046593;LLT;20,1
3264;C144455;Grade 1 Urinary Urgency, CTCAE;Present;Grade 1 Urinary urgency;Present;Urinary urgency;10046593;LLT;20,1
3265;C145064;Grade 2 Urinary Urgency, CTCAE;"Limiting instrumental ADL; medical management indicated";Grade 2 Urinary urgency;"Limiting instrumental ADL; medical management indicated";Urinary urgency;10046593;LLT;20,1
3266;C143908;Urine Discoloration, CTCAE;A disorder characterized by a change in the color of the urine.;Urine discoloration;A disorder characterized by a change in the color of the urine.;Urine discoloration;10046628;LLT;20,1
3267;C144456;Grade 1 Urine Discoloration, CTCAE;Present;Grade 1 Urine discoloration;Present;Urine discoloration;10046628;LLT;20,1
3268;C143180;Reproductive System and Breast Disorders, CTCAE;;;;;;;
3269;C143240;Amenorrhea, CTCAE;A disorder characterized by the abnormal absence of menses for at least three consecutive menstrual cycles;Amenorrhea;A disorder characterized by the abnormal absence of menses for at least three consecutive menstrual cycles;Amenorrhea;10001927;LLT;20,1
3270;C144508;Grade 2 Amenorrhea, CTCAE;Present;Grade 2 Amenorrhea;Present;Amenorrhea;10001927;LLT;20,1
3271;C143312;Azoospermia, CTCAE;A disorder characterized by laboratory test results that indicate complete absence of spermatozoa in the semen.;Azoospermia;A disorder characterized by laboratory test results that indicate complete absence of spermatozoa in the semen.;Azoospermia;10003883;LLT;20,1
3272;C144533;Grade 2 Azoospermia, CTCAE;Absence of sperm in ejaculate;Grade 2 Azoospermia;Absence of sperm in ejaculate;Azoospermia;10003883;LLT;20,1
3273;C143335;Breast Atrophy, CTCAE;A disorder characterized by underdevelopment of the breast.;Breast atrophy;A disorder characterized by underdevelopment of the breast.;Breast atrophy;10006179;LLT;20,1
3274;C144010;Grade 1 Breast Atrophy, CTCAE;"Minimal asymmetry; minimal atrophy";Grade 1 Breast atrophy;"Minimal asymmetry; minimal atrophy";Breast atrophy;10006179;LLT;20,1
3275;C144553;Grade 2 Breast Atrophy, CTCAE;"Moderate asymmetry; moderate atrophy";Grade 2 Breast atrophy;"Moderate asymmetry; moderate atrophy";Breast atrophy;10006179;LLT;20,1
3276;C145169;Grade 3 Breast Atrophy, CTCAE;"Asymmetry >1/3 of breast volume; severe atrophy";Grade 3 Breast atrophy;"Asymmetry >1/3 of breast volume; severe atrophy";Breast atrophy;10006179;LLT;20,1
3277;C146742;Breast Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the breast region.;Breast pain;A disorder characterized by a sensation of marked discomfort in the breast region.;Breast pain;10006298;LLT;20,1
3278;C56026;Grade 1 Breast Pain, CTCAE;Mild pain;Grade 1 Breast pain;Mild pain;Breast pain;10006298;LLT;20,1
3279;C56027;Grade 2 Breast Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Breast pain;"Moderate pain; limiting instrumental ADL";Breast pain;10006298;LLT;20,1
3280;C56028;Grade 3 Breast Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Breast pain;"Severe pain; limiting self care ADL";Breast pain;10006298;LLT;20,1
3281;C143423;Dysmenorrhea, CTCAE;A disorder characterized by abnormally painful abdominal cramps during menses.;Dysmenorrhea;A disorder characterized by abnormally painful abdominal cramps during menses.;Dysmenorrhea;10013934;LLT;20,1
3282;C144063;Grade 1 Dysmenorrhea, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Dysmenorrhea;"Mild symptoms; intervention not indicated";Dysmenorrhea;10013934;LLT;20,1
3283;C144619;Grade 2 Dysmenorrhea, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Dysmenorrhea;"Moderate symptoms; limiting instrumental ADL";Dysmenorrhea;10013934;LLT;20,1
3284;C145235;Grade 3 Dysmenorrhea, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Dysmenorrhea;"Severe symptoms; limiting self care ADL";Dysmenorrhea;10013934;LLT;20,1
3285;C143424;Dyspareunia, CTCAE;A disorder characterized by painful or difficult coitus.;Dyspareunia;A disorder characterized by painful or difficult coitus.;Dyspareunia;10013941;LLT;20,1
3286;C144064;Grade 1 Dyspareunia, CTCAE;"Mild discomfort or pain associated with vaginal penetration; discomfort relieved with use of vaginal lubricants or estrogen";Grade 1 Dyspareunia;"Mild discomfort or pain associated with vaginal penetration; discomfort relieved with use of vaginal lubricants or estrogen";Dyspareunia;10013941;LLT;20,1
3287;C144620;Grade 2 Dyspareunia, CTCAE;"Moderate discomfort or pain associated with vaginal penetration; discomfort or pain partially relieved with use of vaginal lubricants or estrogen";Grade 2 Dyspareunia;"Moderate discomfort or pain associated with vaginal penetration; discomfort or pain partially relieved with use of vaginal lubricants or estrogen";Dyspareunia;10013941;LLT;20,1
3288;C145236;Grade 3 Dyspareunia, CTCAE;"Severe discomfort or pain associated with vaginal penetration; discomfort or pain unrelieved by vaginal lubricants or estrogen";Grade 3 Dyspareunia;"Severe discomfort or pain associated with vaginal penetration; discomfort or pain unrelieved by vaginal lubricants or estrogen";Dyspareunia;10013941;LLT;20,1
3289;C143435;Ejaculation Disorder, CTCAE;A disorder characterized by problems related to ejaculation. This category includes premature, delayed, retrograde and painful ejaculation.;Ejaculation disorder;A disorder characterized by problems related to ejaculation. This category includes premature, delayed, retrograde and painful ejaculation.;Ejaculation disorder;10014326;LLT;20,1
3290;C144074;Grade 1 Ejaculation Disorder, CTCAE;Diminished ejaculation;Grade 1 Ejaculation disorder;Diminished ejaculation;Ejaculation disorder;10014326;LLT;20,1
3291;C144629;Grade 2 Ejaculation Disorder, CTCAE;Anejaculation or retrograde ejaculation;Grade 2 Ejaculation disorder;Anejaculation or retrograde ejaculation;Ejaculation disorder;10014326;LLT;20,1
3292;C55615;Erectile Dysfunction, CTCAE;A disorder characterized by the persistent or recurrent inability to achieve or to maintain an erection during sexual activity.;Erectile dysfunction;A disorder characterized by the persistent or recurrent inability to achieve or to maintain an erection during sexual activity.;Erectile dysfunction;10061461;LLT;20,1
3293;C55616;Grade 1 Erectile Dysfunction, CTCAE;Decrease in erectile function (frequency or rigidity of erections) but intervention not indicated (e.g., medication or use of mechanical device, penile pump);Grade 1 Erectile dysfunction;Decrease in erectile function (frequency or rigidity of erections) but intervention not indicated (e.g., medication or use of mechanical device, penile pump);Erectile dysfunction;10061461;LLT;20,1
3294;C55617;Grade 2 Erectile Dysfunction, CTCAE;Decrease in erectile function (frequency/rigidity of erections), erectile intervention indicated, (e.g., medication or mechanical devices such as penile pump);Grade 2 Erectile dysfunction;Decrease in erectile function (frequency/rigidity of erections), erectile intervention indicated, (e.g., medication or mechanical devices such as penile pump);Erectile dysfunction;10061461;LLT;20,1
3295;C55618;Grade 3 Erectile Dysfunction, CTCAE;"Decrease in erectile function (frequency/rigidity of erections) but erectile intervention not helpful (e.g., medication or mechanical devices such as penile pump); placement of a permanent penile prosthesis indicated (not previously present)";Grade 3 Erectile dysfunction;"Decrease in erectile function (frequency/rigidity of erections) but erectile intervention not helpful (e.g., medication or mechanical devices such as penile pump); placement of a permanent penile prosthesis indicated (not previously present)";Erectile dysfunction;10061461;LLT;20,1
3296;C146752;Fallopian Tube Obstruction, CTCAE 5.0;A disorder characterized by blockage of the normal flow of the contents in the fallopian tube.;Fallopian tube obstruction;A disorder characterized by blockage of the normal flow of the contents in the fallopian tube.;Fallopian tube obstruction;10065789;LLT;20,1
3297;C56767;Grade 1 Fallopian Tube Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Fallopian tube obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Fallopian tube obstruction;10065789;LLT;20,1
3298;C56828;Grade 2 Fallopian Tube Obstruction, CTCAE;"Symptomatic; elective intervention indicated";Grade 2 Fallopian tube obstruction;"Symptomatic; elective intervention indicated";Fallopian tube obstruction;10065789;LLT;20,1
3299;C56888;Grade 3 Fallopian Tube Obstruction, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Fallopian tube obstruction;"Severe symptoms; invasive intervention indicated";Fallopian tube obstruction;10065789;LLT;20,1
3300;C143483;Feminization Acquired, CTCAE;A disorder characterized by the development of secondary female sex characteristics in males due to extrinsic factors.;Feminization acquired;A disorder characterized by the development of secondary female sex characteristics in males due to extrinsic factors.;Feminization acquired;10054382;LLT;20,1
3301;C144103;Grade 1 Feminization Acquired, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Feminization acquired;"Mild symptoms; intervention not indicated";Feminization acquired;10054382;LLT;20,1
3302;C144663;Grade 2 Feminization Acquired, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Feminization acquired;"Moderate symptoms; medical intervention indicated";Feminization acquired;10054382;LLT;20,1
3303;C143515;Genital Edema, CTCAE;A disorder characterized by swelling due to an excessive accumulation of fluid in the genitals.;Genital edema;A disorder characterized by swelling due to an excessive accumulation of fluid in the genitals.;Genital edema;10018146;LLT;20,1
3304;C144128;Grade 1 Genital Edema, CTCAE;Mild swelling or obscuration of anatomic architecture on close inspection;Grade 1 Genital edema;Mild swelling or obscuration of anatomic architecture on close inspection;Genital edema;10018146;LLT;20,1
3305;C144693;Grade 2 Genital Edema, CTCAE;"Readily apparent obscuration of anatomic architecture; obliteration of skin folds; readily apparent deviation from normal anatomic contour";Grade 2 Genital edema;"Readily apparent obscuration of anatomic architecture; obliteration of skin folds; readily apparent deviation from normal anatomic contour";Genital edema;10018146;LLT;20,1
3306;C145315;Grade 3 Genital Edema, CTCAE;"Lymphorrhea; gross deviation from normal anatomic contour; limiting self care ADL";Grade 3 Genital edema;"Lymphorrhea; gross deviation from normal anatomic contour; limiting self care ADL";Genital edema;10018146;LLT;20,1
3307;C146685;Gynecomastia, CTCAE 5.0;A disorder characterized by excessive development of the breasts in males.;Gynecomastia;A disorder characterized by excessive development of the breasts in males.;Gynecomastia;10018801;LLT;20,1
3308;C144138;Grade 1 Gynecomastia, CTCAE;Asymptomatic;Grade 1 Gynecomastia;Asymptomatic;Gynecomastia;10018801;LLT;20,1
3309;C55620;Grade 2 Gynecomastia, CTCAE;Symptomatic (e.g., pain or psychosocial impact);Grade 2 Gynecomastia;Symptomatic (e.g., pain or psychosocial impact);Gynecomastia;10018801;LLT;20,1
3310;C55621;Grade 3 Gynecomastia, CTCAE;"Severe symptoms; elective operative intervention indicated";Grade 3 Gynecomastia;"Severe symptoms; elective operative intervention indicated";Gynecomastia;10018801;LLT;20,1
3311;C143531;Hematosalpinx, CTCAE;A disorder characterized by the presence of blood in a fallopian tube.;Hematosalpinx;A disorder characterized by the presence of blood in a fallopian tube.;Hematosalpinx;10060602;LLT;20,1
3312;C144146;Grade 1 Hematosalpinx, CTCAE;"Minimal bleeding identified on imaging study or laparoscopy; intervention not indicated";Grade 1 Hematosalpinx;"Minimal bleeding identified on imaging study or laparoscopy; intervention not indicated";Hematosalpinx;10060602;LLT;20,1
3313;C144707;Grade 2 Hematosalpinx, CTCAE;"Moderate bleeding; medical intervention indicated";Grade 2 Hematosalpinx;"Moderate bleeding; medical intervention indicated";Hematosalpinx;10060602;LLT;20,1
3314;C145327;Grade 3 Hematosalpinx, CTCAE;"Transfusion indicated; invasive intervention indicated";Grade 3 Hematosalpinx;"Transfusion indicated; invasive intervention indicated";Hematosalpinx;10060602;LLT;20,1
3315;C145885;Grade 4 Hematosalpinx, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Hematosalpinx;"Life-threatening consequences; urgent operative intervention indicated";Hematosalpinx;10060602;LLT;20,1
3316;C146334;Grade 5 Hematosalpinx, CTCAE;Death;Grade 5 Hematosalpinx;Death;Hematosalpinx;10060602;LLT;20,1
3317;C143617;Irregular Menstruation, CTCAE;A disorder characterized by a change in cycle or duration of menses from baseline.;Irregular menstruation;A disorder characterized by a change in cycle or duration of menses from baseline.;Irregular menstruation;10022992;LLT;20,1
3318;C144221;Grade 1 Irregular Menstruation, CTCAE;Intermittent/irregular menses for no more than 3 consecutive menstrual cycles;Grade 1 Irregular menstruation;Intermittent/irregular menses for no more than 3 consecutive menstrual cycles;Irregular menstruation;10022992;LLT;20,1
3319;C144789;Grade 2 Irregular Menstruation, CTCAE;Intermittent/irregular menses for more than 3 consecutive menstrual cycles;Grade 2 Irregular menstruation;Intermittent/irregular menses for more than 3 consecutive menstrual cycles;Irregular menstruation;10022992;LLT;20,1
3320;C143634;Lactation Disorder, CTCAE;A disorder characterized by disturbances of milk secretion. It is not necessarily related to pregnancy that is observed in females and can be observed in males.;Lactation disorder;A disorder characterized by disturbances of milk secretion. It is not necessarily related to pregnancy that is observed in females and can be observed in males.;Lactation disorder;10061261;LLT;20,1
3321;C144234;Grade 1 Lactation Disorder, CTCAE;Mild changes in lactation, not significantly affecting production or expression of breast milk;Grade 1 Lactation disorder;Mild changes in lactation, not significantly affecting production or expression of breast milk;Lactation disorder;10061261;LLT;20,1
3322;C144805;Grade 2 Lactation Disorder, CTCAE;Changes in lactation, significantly affecting breast production or expression of breast milk;Grade 2 Lactation disorder;Changes in lactation, significantly affecting breast production or expression of breast milk;Lactation disorder;10061261;LLT;20,1
3323;C143671;Menorrhagia, CTCAE;A disorder characterized by abnormally heavy vaginal bleeding during menses.;Menorrhagia;A disorder characterized by abnormally heavy vaginal bleeding during menses.;Menorrhagia;10027313;LLT;20,1
3324;C144260;Grade 1 Menorrhagia, CTCAE;"Mild; iron supplements indicated";Grade 1 Menorrhagia;"Mild; iron supplements indicated";Menorrhagia;10027313;LLT;20,1
3325;C144836;Grade 2 Menorrhagia, CTCAE;"Moderate symptoms; medical intervention indicated (e.g., hormones)";Grade 2 Menorrhagia;"Moderate symptoms; medical intervention indicated (e.g., hormones)";Menorrhagia;10027313;LLT;20,1
3326;C145458;Grade 3 Menorrhagia, CTCAE;"Severe; transfusion indicated; operative intervention indicated (e.g., hysterectomy)";Grade 3 Menorrhagia;"Severe; transfusion indicated; operative intervention indicated (e.g., hysterectomy)";Menorrhagia;10027313;LLT;20,1
3327;C145994;Grade 4 Menorrhagia, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Menorrhagia;"Life-threatening consequences; urgent intervention indicated";Menorrhagia;10027313;LLT;20,1
3328;C146439;Grade 5 Menorrhagia, CTCAE;Death;Grade 5 Menorrhagia;Death;Menorrhagia;10027313;LLT;20,1
3329;C143706;Nipple Deformity, CTCAE;A disorder characterized by a malformation of the nipple.;Nipple deformity;A disorder characterized by a malformation of the nipple.;Nipple deformity;10065823;LLT;20,1
3330;C144291;Grade 1 Nipple Deformity, CTCAE;"Asymptomatic; asymmetry with slight retraction and/or thickening of the nipple areolar complex";Grade 1 Nipple deformity;"Asymptomatic; asymmetry with slight retraction and/or thickening of the nipple areolar complex";Nipple deformity;10065823;LLT;20,1
3331;C144867;Grade 2 Nipple Deformity, CTCAE;"Symptomatic; asymmetry of nipple areolar complex with moderate retraction and/or thickening of the nipple areolar complex";Grade 2 Nipple deformity;"Symptomatic; asymmetry of nipple areolar complex with moderate retraction and/or thickening of the nipple areolar complex";Nipple deformity;10065823;LLT;20,1
3332;C143713;Oligospermia, CTCAE;A disorder characterized by a decrease in the number of spermatozoa in the semen.;Oligospermia;A disorder characterized by a decrease in the number of spermatozoa in the semen.;Oligospermia;10030300;LLT;20,1
3333;C144295;Grade 1 Oligospermia, CTCAE;Sperm concentration > 0 to < 15 million/ml;Grade 1 Oligospermia;Sperm concentration > 0 to < 15 million/ml;Oligospermia;10030300;LLT;20,1
3334;C143722;Ovarian Rupture, CTCAE;A disorder characterized by tearing or disruption of the ovarian tissue.;Ovarian rupture;A disorder characterized by tearing or disruption of the ovarian tissue.;Ovarian rupture;10033279;LLT;20,1
3335;C144306;Grade 1 Ovarian Rupture, CTCAE;"Asymptomatic clinical or diagnostic observations only; intervention not indicated";Grade 1 Ovarian rupture;"Asymptomatic clinical or diagnostic observations only; intervention not indicated";Ovarian rupture;10033279;LLT;20,1
3336;C144884;Grade 2 Ovarian Rupture, CTCAE;Symptomatic and intervention not indicated;Grade 2 Ovarian rupture;Symptomatic and intervention not indicated;Ovarian rupture;10033279;LLT;20,1
3337;C145505;Grade 3 Ovarian Rupture, CTCAE;"Transfusion; invasive intervention indicated";Grade 3 Ovarian rupture;"Transfusion; invasive intervention indicated";Ovarian rupture;10033279;LLT;20,1
3338;C146024;Grade 4 Ovarian Rupture, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Ovarian rupture;"Life-threatening consequences; urgent intervention indicated";Ovarian rupture;10033279;LLT;20,1
3339;C146465;Grade 5 Ovarian Rupture, CTCAE;Death;Grade 5 Ovarian rupture;Death;Ovarian rupture;10033279;LLT;20,1
3340;C56553;Ovarian Hemorrhage, CTCAE;A disorder characterized by bleeding from the ovary.;Ovarian hemorrhage;A disorder characterized by bleeding from the ovary.;Ovarian hemorrhage;10065763;LLT;20,1
3341;C56309;Grade 1 Ovarian Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Ovarian hemorrhage;"Mild symptoms; intervention not indicated";Ovarian hemorrhage;10065763;LLT;20,1
3342;C56358;Grade 2 Ovarian Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Ovarian hemorrhage;"Moderate symptoms; intervention indicated";Ovarian hemorrhage;10065763;LLT;20,1
3343;C56408;Grade 3 Ovarian Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Ovarian hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Ovarian hemorrhage;10065763;LLT;20,1
3344;C56458;Grade 4 Ovarian Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Ovarian hemorrhage;"Life-threatening consequences; urgent intervention indicated";Ovarian hemorrhage;10065763;LLT;20,1
3345;C56507;Grade 5 Ovarian Hemorrhage, CTCAE;Death;Grade 5 Ovarian hemorrhage;Death;Ovarian hemorrhage;10065763;LLT;20,1
3346;C146769;Ovulation Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in one side of the abdomen between menstrual cycles, around the time of the discharge of the ovum from the ovarian follicle.;Ovulation pain;A disorder characterized by a sensation of marked discomfort in one side of the abdomen between menstrual cycles, around the time of the discharge of the ovum from the ovarian follicle.;Ovulation pain;10033314;LLT;20,1
3347;C56157;Grade 2 Ovulation Pain, CTCAE;Present;Grade 2 Ovulation pain;Present;Ovulation pain;10033314;LLT;20,1
3348;C143739;Pelvic Floor Muscle Weakness, CTCAE;A disorder characterized by a reduction in the strength of the muscles of the pelvic floor.;Pelvic floor muscle weakness;A disorder characterized by a reduction in the strength of the muscles of the pelvic floor.;Pelvic floor muscle weakness;10064026;LLT;20,1
3349;C144321;Grade 1 Pelvic Floor Muscle Weakness, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Pelvic floor muscle weakness;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Pelvic floor muscle weakness;10064026;LLT;20,1
3350;C144900;Grade 2 Pelvic Floor Muscle Weakness, CTCAE;"Symptomatic, not interfering with bladder, bowel, or vaginal function; limiting instrumental ADL";Grade 2 Pelvic floor muscle weakness;"Symptomatic, not interfering with bladder, bowel, or vaginal function; limiting instrumental ADL";Pelvic floor muscle weakness;10064026;LLT;20,1
3351;C145522;Grade 3 Pelvic Floor Muscle Weakness, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Pelvic floor muscle weakness;"Severe symptoms; limiting self care ADL";Pelvic floor muscle weakness;10064026;LLT;20,1
3352;C146679;Pelvic Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the pelvis.;Pelvic pain;A disorder characterized by a sensation of marked discomfort in the pelvis.;Pelvic pain;10034263;LLT;20,1
3353;C144322;Grade 1 Pelvic Pain, CTCAE;Mild pain;Grade 1 Pelvic pain;Mild pain;Pelvic pain;10034263;LLT;20,1
3354;C144902;Grade 2 Pelvic Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Pelvic pain;"Moderate pain; limiting instrumental ADL";Pelvic pain;10034263;LLT;20,1
3355;C145524;Grade 3 Pelvic Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Pelvic pain;"Severe pain; limiting self care ADL";Pelvic pain;10034263;LLT;20,1
3356;C146680;Penile Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the penis.;Penile pain;A disorder characterized by a sensation of marked discomfort in the penis.;Penile pain;10034310;LLT;20,1
3357;C56171;Grade 1 Penile Pain, CTCAE;Mild pain;Grade 1 Penile pain;Mild pain;Penile pain;10034310;LLT;20,1
3358;C56172;Grade 2 Penile Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Penile pain;"Moderate pain; limiting instrumental ADL";Penile pain;10034310;LLT;20,1
3359;C56173;Grade 3 Penile Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Penile pain;"Severe pain; limiting self care ADL";Penile pain;10034310;LLT;20,1
3360;C146681;Perineal Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the area between the genital organs and the anus.;Perineal pain;A disorder characterized by a sensation of marked discomfort in the area between the genital organs and the anus.;Perineal pain;10061339;LLT;20,1
3361;C144325;Grade 1 Perineal Pain, CTCAE;Mild pain;Grade 1 Perineal pain;Mild pain;Perineal pain;10061339;LLT;20,1
3362;C144906;Grade 2 Perineal Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Perineal pain;"Moderate pain; limiting instrumental ADL";Perineal pain;10061339;LLT;20,1
3363;C145529;Grade 3 Perineal Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Perineal pain;"Severe pain; limiting self care ADL";Perineal pain;10061339;LLT;20,1
3364;C143777;Premature Menopause, CTCAE;A disorder characterized by premature ovarian failure. Symptoms may include hot flashes, night sweats, mood swings, and a decrease in sex drive. Laboratory findings include elevated luteinizing hormone (LH) and follicle-stimulating hormone (FSH.);Premature menopause;A disorder characterized by premature ovarian failure. Symptoms may include hot flashes, night sweats, mood swings, and a decrease in sex drive. Laboratory findings include elevated luteinizing hormone (LH) and follicle-stimulating hormone (FSH.);Premature menopause;10036601;LLT;20,1
3365;C144937;Grade 2 Premature Menopause, CTCAE;Present;Grade 2 Premature menopause;Present;Premature menopause;10036601;LLT;20,1
3366;C56552;Prostatic Hemorrhage, CTCAE;A disorder characterized by bleeding from the prostate gland.;Prostatic hemorrhage;A disorder characterized by bleeding from the prostate gland.;Prostatic hemorrhage;10055325;LLT;20,1
3367;C56315;Grade 1 Prostatic Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Prostatic hemorrhage;"Mild symptoms; intervention not indicated";Prostatic hemorrhage;10055325;LLT;20,1
3368;C56364;Grade 2 Prostatic Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Prostatic hemorrhage;"Moderate symptoms; intervention indicated";Prostatic hemorrhage;10055325;LLT;20,1
3369;C56414;Grade 3 Prostatic Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Prostatic hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Prostatic hemorrhage;10055325;LLT;20,1
3370;C56463;Grade 4 Prostatic Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Prostatic hemorrhage;"Life-threatening consequences; urgent intervention indicated";Prostatic hemorrhage;10055325;LLT;20,1
3371;C56512;Grade 5 Prostatic Hemorrhage, CTCAE;Death;Grade 5 Prostatic hemorrhage;Death;Prostatic hemorrhage;10055325;LLT;20,1
3372;C143784;Prostatic Obstruction, CTCAE;A disorder characterized by compression of the urethra secondary to enlargement of the prostate gland. This results in voiding difficulties (straining to void, slow urine stream, and incomplete emptying of the bladder).;Prostatic obstruction;A disorder characterized by compression of the urethra secondary to enlargement of the prostate gland. This results in voiding difficulties (straining to void, slow urine stream, and incomplete emptying of the bladder).;Prostatic obstruction;10055026;LLT;20,1
3373;C144352;Grade 1 Prostatic Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Prostatic obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Prostatic obstruction;10055026;LLT;20,1
3374;C144944;Grade 2 Prostatic Obstruction, CTCAE;"Symptomatic; elective intervention indicated";Grade 2 Prostatic obstruction;"Symptomatic; elective intervention indicated";Prostatic obstruction;10055026;LLT;20,1
3375;C145566;Grade 3 Prostatic Obstruction, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Prostatic obstruction;"Severe symptoms; invasive intervention indicated";Prostatic obstruction;10055026;LLT;20,1
3376;C146664;Prostatic Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the prostate gland.;Prostatic pain;A disorder characterized by a sensation of marked discomfort in the prostate gland.;Prostatic pain;10036968;LLT;20,1
3377;C144353;Grade 1 Prostatic Pain, CTCAE;Mild pain;Grade 1 Prostatic pain;Mild pain;Prostatic pain;10036968;LLT;20,1
3378;C144945;Grade 2 Prostatic Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Prostatic pain;"Moderate pain; limiting instrumental ADL";Prostatic pain;10036968;LLT;20,1
3379;C145567;Grade 3 Prostatic Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Prostatic pain;"Severe pain; limiting self care ADL";Prostatic pain;10036968;LLT;20,1
3380;C143808;Reproductive System and Breast Disorders - Other, Specify, CTCAE;;Reproductive system and breast disorders - Other, specify;;Reproductive system and breast disorders - Other, specify;10038604;LLT;20,1
3381;C144380;Grade 1 Reproductive System and Breast Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Reproductive system and breast disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Reproductive system and breast disorders - Other, specify;10038604;LLT;20,1
3382;C144974;Grade 2 Reproductive System and Breast Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Reproductive system and breast disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Reproductive system and breast disorders - Other, specify;10038604;LLT;20,1
3383;C145597;Grade 3 Reproductive System and Breast Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Reproductive system and breast disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Reproductive system and breast disorders - Other, specify;10038604;LLT;20,1
3384;C146094;Grade 4 Reproductive System and Breast Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Reproductive system and breast disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Reproductive system and breast disorders - Other, specify;10038604;LLT;20,1
3385;C146529;Grade 5 Reproductive System and Breast Disorders - Other, Specify, CTCAE;Death;Grade 5 Reproductive system and breast disorders - Other, specify;Death;Reproductive system and breast disorders - Other, specify;10038604;LLT;20,1
3386;C146665;Scrotal Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the scrotal area.;Scrotal pain;A disorder characterized by a sensation of marked discomfort in the scrotal area.;Scrotal pain;10039757;LLT;20,1
3387;C144391;Grade 1 Scrotal Pain, CTCAE;Mild pain;Grade 1 Scrotal pain;Mild pain;Scrotal pain;10039757;LLT;20,1
3388;C144989;Grade 2 Scrotal Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Scrotal pain;"Moderate pain; limiting instrumental ADL";Scrotal pain;10039757;LLT;20,1
3389;C145610;Grade 3 Scrotal Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Scrotal pain;"Severe pain; limiting self care ADL";Scrotal pain;10039757;LLT;20,1
3390;C56563;Spermatic Cord Hemorrhage, CTCAE;A disorder characterized by bleeding from the spermatic cord.;Spermatic cord hemorrhage;A disorder characterized by bleeding from the spermatic cord.;Spermatic cord hemorrhage;10065762;LLT;20,1
3391;C56320;Grade 1 Spermatic Cord Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Spermatic cord hemorrhage;"Mild symptoms; intervention not indicated";Spermatic cord hemorrhage;10065762;LLT;20,1
3392;C56369;Grade 2 Spermatic Cord Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Spermatic cord hemorrhage;"Moderate symptoms; intervention indicated";Spermatic cord hemorrhage;10065762;LLT;20,1
3393;C56419;Grade 3 Spermatic Cord Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Spermatic cord hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Spermatic cord hemorrhage;10065762;LLT;20,1
3394;C56468;Grade 4 Spermatic Cord Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Spermatic cord hemorrhage;"Life-threatening consequences; urgent intervention indicated";Spermatic cord hemorrhage;10065762;LLT;20,1
3395;C56517;Grade 5 Spermatic Cord Hemorrhage, CTCAE;Death;Grade 5 Spermatic cord hemorrhage;Death;Spermatic cord hemorrhage;10065762;LLT;20,1
3396;C146757;Spermatic Cord Obstruction, CTCAE 5.0;A disorder characterized by blockage of the normal flow of the contents of the spermatic cord.;Spermatic cord obstruction;A disorder characterized by blockage of the normal flow of the contents of the spermatic cord.;Spermatic cord obstruction;10065805;LLT;20,1
3397;C56784;Grade 1 Spermatic Cord Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Spermatic cord obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Spermatic cord obstruction;10065805;LLT;20,1
3398;C56845;Grade 2 Spermatic Cord Obstruction, CTCAE;"Symptomatic; elective intervention indicated";Grade 2 Spermatic cord obstruction;"Symptomatic; elective intervention indicated";Spermatic cord obstruction;10065805;LLT;20,1
3399;C56906;Grade 3 Spermatic Cord Obstruction, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Spermatic cord obstruction;"Severe symptoms; invasive intervention indicated";Spermatic cord obstruction;10065805;LLT;20,1
3400;C56566;Testicular Hemorrhage, CTCAE;A disorder characterized by bleeding from the testis.;Testicular hemorrhage;A disorder characterized by bleeding from the testis.;Testicular hemorrhage;10055347;LLT;20,1
3401;C56323;Grade 1 Testicular Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Testicular hemorrhage;"Mild symptoms; intervention not indicated";Testicular hemorrhage;10055347;LLT;20,1
3402;C56372;Grade 2 Testicular Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Testicular hemorrhage;"Moderate symptoms; intervention indicated";Testicular hemorrhage;10055347;LLT;20,1
3403;C56422;Grade 3 Testicular Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Testicular hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Testicular hemorrhage;10055347;LLT;20,1
3404;C56471;Grade 4 Testicular Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Testicular hemorrhage;"Life-threatening consequences; urgent intervention indicated";Testicular hemorrhage;10055347;LLT;20,1
3405;C56520;Grade 5 Testicular Hemorrhage, CTCAE;Death;Grade 5 Testicular hemorrhage;Death;Testicular hemorrhage;10055347;LLT;20,1
3406;C143872;Testicular Disorder, CTCAE;A disorder characterized by abnormal function or appearance of the testis.;Testicular disorder;A disorder characterized by abnormal function or appearance of the testis.;Testicular disorder;10043306;LLT;20,1
3407;C144426;Grade 1 Testicular Disorder, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Testicular disorder;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Testicular disorder;10043306;LLT;20,1
3408;C145032;Grade 2 Testicular Disorder, CTCAE;"Symptomatic but not interfering with sexual function; intervention not indicated; limiting instrumental ADL";Grade 2 Testicular disorder;"Symptomatic but not interfering with sexual function; intervention not indicated; limiting instrumental ADL";Testicular disorder;10043306;LLT;20,1
3409;C145654;Grade 3 Testicular Disorder, CTCAE;"Severe symptoms; interfering with sexual function; limiting self care ADL; intervention indicated";Grade 3 Testicular disorder;"Severe symptoms; interfering with sexual function; limiting self care ADL; intervention indicated";Testicular disorder;10043306;LLT;20,1
3410;C146143;Grade 4 Testicular Disorder, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Testicular disorder;"Life-threatening consequences; urgent intervention indicated";Testicular disorder;10043306;LLT;20,1
3411;C146666;Testicular Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the testis.;Testicular pain;A disorder characterized by a sensation of marked discomfort in the testis.;Testicular pain;10043345;LLT;20,1
3412;C144428;Grade 1 Testicular Pain, CTCAE;Mild pain;Grade 1 Testicular pain;Mild pain;Testicular pain;10043345;LLT;20,1
3413;C145034;Grade 2 Testicular Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Testicular pain;"Moderate pain; limiting instrumental ADL";Testicular pain;10043345;LLT;20,1
3414;C145656;Grade 3 Testicular Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Testicular pain;"Severe pain; limiting self care ADL";Testicular pain;10043345;LLT;20,1
3415;C143916;Uterine Fistula, CTCAE;A disorder characterized by an abnormal communication between the uterus and another organ or anatomic site.;Uterine fistula;A disorder characterized by an abnormal communication between the uterus and another organ or anatomic site.;Uterine fistula;10065811;LLT;20,1
3416;C144461;Grade 1 Uterine Fistula, CTCAE;Asymptomatic;Grade 1 Uterine fistula;Asymptomatic;Uterine fistula;10065811;LLT;20,1
3417;C145070;Grade 2 Uterine Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Uterine fistula;Symptomatic, invasive intervention not indicated;Uterine fistula;10065811;LLT;20,1
3418;C145691;Grade 3 Uterine Fistula, CTCAE;Invasive intervention indicated;Grade 3 Uterine fistula;Invasive intervention indicated;Uterine fistula;10065811;LLT;20,1
3419;C146174;Grade 4 Uterine Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Uterine fistula;"Life-threatening consequences; urgent intervention indicated";Uterine fistula;10065811;LLT;20,1
3420;C146603;Grade 5 Uterine Fistula, CTCAE;Death;Grade 5 Uterine fistula;Death;Uterine fistula;10065811;LLT;20,1
3421;C143918;Uterine Obstruction, CTCAE;A disorder characterized by blockage of the uterine outlet.;Uterine obstruction;A disorder characterized by blockage of the uterine outlet.;Uterine obstruction;10065928;LLT;20,1
3422;C144463;Grade 1 Uterine Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Uterine obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Uterine obstruction;10065928;LLT;20,1
3423;C145073;Grade 2 Uterine Obstruction, CTCAE;"Symptomatic; elective intervention indicated";Grade 2 Uterine obstruction;"Symptomatic; elective intervention indicated";Uterine obstruction;10065928;LLT;20,1
3424;C145694;Grade 3 Uterine Obstruction, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Uterine obstruction;"Severe symptoms; invasive intervention indicated";Uterine obstruction;10065928;LLT;20,1
3425;C146683;Uterine Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the uterus.;Uterine pain;A disorder characterized by a sensation of marked discomfort in the uterus.;Uterine pain;10046809;LLT;20,1
3426;C144464;Grade 1 Uterine Pain, CTCAE;Mild pain;Grade 1 Uterine pain;Mild pain;Uterine pain;10046809;LLT;20,1
3427;C145074;Grade 2 Uterine Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Uterine pain;"Moderate pain; limiting instrumental ADL";Uterine pain;10046809;LLT;20,1
3428;C145695;Grade 3 Uterine Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Uterine pain;"Severe pain; limiting self care ADL";Uterine pain;10046809;LLT;20,1
3429;C56572;Uterine Hemorrhage, CTCAE;A disorder characterized by bleeding from the uterus.;Uterine hemorrhage;A disorder characterized by bleeding from the uterus.;Uterine hemorrhage;10046789;LLT;20,1
3430;C56329;Grade 1 Uterine Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Uterine hemorrhage;"Mild symptoms; intervention not indicated";Uterine hemorrhage;10046789;LLT;20,1
3431;C56378;Grade 2 Uterine Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Uterine hemorrhage;"Moderate symptoms; intervention indicated";Uterine hemorrhage;10046789;LLT;20,1
3432;C56428;Grade 3 Uterine Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Uterine hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Uterine hemorrhage;10046789;LLT;20,1
3433;C56477;Grade 4 Uterine Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Uterine hemorrhage;"Life-threatening consequences; urgent intervention indicated";Uterine hemorrhage;10046789;LLT;20,1
3434;C56526;Grade 5 Uterine Hemorrhage, CTCAE;Death;Grade 5 Uterine hemorrhage;Death;Uterine hemorrhage;10046789;LLT;20,1
3435;C57104;Vaginal Fistula, CTCAE;A disorder characterized by an abnormal communication between the vagina and another organ or anatomic site.;Vaginal fistula;A disorder characterized by an abnormal communication between the vagina and another organ or anatomic site.;Vaginal fistula;10065813;LLT;20,1
3436;C56811;Grade 1 Vaginal Fistula, CTCAE;Asymptomatic;Grade 1 Vaginal fistula;Asymptomatic;Vaginal fistula;10065813;LLT;20,1
3437;C56871;Grade 2 Vaginal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Vaginal fistula;Symptomatic, invasive intervention not indicated;Vaginal fistula;10065813;LLT;20,1
3438;C56932;Grade 3 Vaginal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Vaginal fistula;Invasive intervention indicated;Vaginal fistula;10065813;LLT;20,1
3439;C56991;Grade 4 Vaginal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Vaginal fistula;"Life-threatening consequences; urgent intervention indicated";Vaginal fistula;10065813;LLT;20,1
3440;C57048;Grade 5 Vaginal Fistula, CTCAE;Death;Grade 5 Vaginal fistula;Death;Vaginal fistula;10065813;LLT;20,1
3441;C56573;Vaginal Hemorrhage, CTCAE;A disorder characterized by bleeding from the vagina.;Vaginal hemorrhage;A disorder characterized by bleeding from the vagina.;Vaginal hemorrhage;10046912;LLT;20,1
3442;C56330;Grade 1 Vaginal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Vaginal hemorrhage;"Mild symptoms; intervention not indicated";Vaginal hemorrhage;10046912;LLT;20,1
3443;C56379;Grade 2 Vaginal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Vaginal hemorrhage;"Moderate symptoms; intervention indicated";Vaginal hemorrhage;10046912;LLT;20,1
3444;C56429;Grade 3 Vaginal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Vaginal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Vaginal hemorrhage;10046912;LLT;20,1
3445;C56478;Grade 4 Vaginal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Vaginal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Vaginal hemorrhage;10046912;LLT;20,1
3446;C56527;Grade 5 Vaginal Hemorrhage, CTCAE;Death;Grade 5 Vaginal hemorrhage;Death;Vaginal hemorrhage;10046912;LLT;20,1
3447;C143922;Vaginal Discharge, CTCAE;A disorder characterized by vaginal secretions. Mucus produced by the cervical glands is discharged from the vagina naturally, especially during the childbearing years.;Vaginal discharge;A disorder characterized by vaginal secretions. Mucus produced by the cervical glands is discharged from the vagina naturally, especially during the childbearing years.;Vaginal discharge;10046901;LLT;20,1
3448;C144468;Grade 1 Vaginal Discharge, CTCAE;Mild vaginal discharge (greater than baseline for patient);Grade 1 Vaginal discharge;Mild vaginal discharge (greater than baseline for patient);Vaginal discharge;10046901;LLT;20,1
3449;C145079;Grade 2 Vaginal Discharge, CTCAE;"Moderate to heavy vaginal discharge; use of perineal pad or tampon indicated";Grade 2 Vaginal discharge;"Moderate to heavy vaginal discharge; use of perineal pad or tampon indicated";Vaginal discharge;10046901;LLT;20,1
3450;C146687;Vaginal Dryness, CTCAE 5.0;A disorder characterized by an uncomfortable feeling of itching and burning in the vagina.;Vaginal dryness;A disorder characterized by an uncomfortable feeling of itching and burning in the vagina.;Vaginal dryness;10046904;LLT;20,1
3451;C55646;Grade 1 Vaginal Dryness, CTCAE;Mild vaginal dryness not interfering with sexual function;Grade 1 Vaginal dryness;Mild vaginal dryness not interfering with sexual function;Vaginal dryness;10046904;LLT;20,1
3452;C55647;Grade 2 Vaginal Dryness, CTCAE;Moderate vaginal dryness interfering with sexual function or causing frequent discomfort;Grade 2 Vaginal dryness;Moderate vaginal dryness interfering with sexual function or causing frequent discomfort;Vaginal dryness;10046904;LLT;20,1
3453;C145699;Grade 3 Vaginal Dryness, CTCAE;Severe vaginal dryness resulting in dyspareunia or severe discomfort;Grade 3 Vaginal dryness;Severe vaginal dryness resulting in dyspareunia or severe discomfort;Vaginal dryness;10046904;LLT;20,1
3454;C143925;Vaginal Inflammation, CTCAE;A disorder characterized by inflammation involving the vagina. Symptoms may include redness, edema, marked discomfort and an increase in vaginal discharge.;Vaginal inflammation;A disorder characterized by inflammation involving the vagina. Symptoms may include redness, edema, marked discomfort and an increase in vaginal discharge.;Vaginal inflammation;10046916;LLT;20,1
3455;C144472;Grade 1 Vaginal Inflammation, CTCAE;Mild discomfort or pain, edema, or redness;Grade 1 Vaginal inflammation;Mild discomfort or pain, edema, or redness;Vaginal inflammation;10046916;LLT;20,1
3456;C145083;Grade 2 Vaginal Inflammation, CTCAE;"Moderate discomfort or pain, edema, or redness; limiting instrumental ADL";Grade 2 Vaginal inflammation;"Moderate discomfort or pain, edema, or redness; limiting instrumental ADL";Vaginal inflammation;10046916;LLT;20,1
3457;C145703;Grade 3 Vaginal Inflammation, CTCAE;"Severe discomfort or pain, edema, or redness; limiting self care ADL; small areas of mucosal ulceration";Grade 3 Vaginal inflammation;"Severe discomfort or pain, edema, or redness; limiting self care ADL; small areas of mucosal ulceration";Vaginal inflammation;10046916;LLT;20,1
3458;C146183;Grade 4 Vaginal Inflammation, CTCAE;"Life-threatening consequences; widespread areas of mucosal ulceration; urgent intervention indicated";Grade 4 Vaginal inflammation;"Life-threatening consequences; widespread areas of mucosal ulceration; urgent intervention indicated";Vaginal inflammation;10046916;LLT;20,1
3459;C146696;Vaginal Obstruction, CTCAE 5.0;A disorder characterized by blockage of vaginal canal.;Vaginal obstruction;A disorder characterized by blockage of vaginal canal.;Vaginal obstruction;10065817;LLT;20,1
3460;C144473;Grade 1 Vaginal Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Vaginal obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Vaginal obstruction;10065817;LLT;20,1
3461;C145084;Grade 2 Vaginal Obstruction, CTCAE;"Symptomatic; elective intervention indicated";Grade 2 Vaginal obstruction;"Symptomatic; elective intervention indicated";Vaginal obstruction;10065817;LLT;20,1
3462;C145704;Grade 3 Vaginal Obstruction, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Vaginal obstruction;"Severe symptoms; invasive intervention indicated";Vaginal obstruction;10065817;LLT;20,1
3463;C146684;Vaginal Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the vagina.;Vaginal pain;A disorder characterized by a sensation of marked discomfort in the vagina.;Vaginal pain;10046937;LLT;20,1
3464;C144474;Grade 1 Vaginal Pain, CTCAE;Mild pain;Grade 1 Vaginal pain;Mild pain;Vaginal pain;10046937;LLT;20,1
3465;C145085;Grade 2 Vaginal Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Vaginal pain;"Moderate pain; limiting instrumental ADL";Vaginal pain;10046937;LLT;20,1
3466;C145705;Grade 3 Vaginal Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Vaginal pain;"Severe pain; limiting self care ADL";Vaginal pain;10046937;LLT;20,1
3467;C146697;Vaginal Perforation, CTCAE 5.0;A disorder characterized by a rupture in the vaginal wall.;Vaginal perforation;A disorder characterized by a rupture in the vaginal wall.;Vaginal perforation;10065818;LLT;20,1
3468;C145086;Grade 2 Vaginal Perforation, CTCAE;Invasive intervention not indicated;Grade 2 Vaginal perforation;Invasive intervention not indicated;Vaginal perforation;10065818;LLT;20,1
3469;C145706;Grade 3 Vaginal Perforation, CTCAE;Invasive intervention indicated;Grade 3 Vaginal perforation;Invasive intervention indicated;Vaginal perforation;10065818;LLT;20,1
3470;C146184;Grade 4 Vaginal Perforation, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Vaginal perforation;"Life-threatening consequences; urgent intervention indicated";Vaginal perforation;10065818;LLT;20,1
3471;C146611;Grade 5 Vaginal Perforation, CTCAE;Death;Grade 5 Vaginal perforation;Death;Vaginal perforation;10065818;LLT;20,1
3472;C143926;Vaginal Stricture, CTCAE;A disorder characterized by a narrowing of the vaginal canal.;Vaginal stricture;A disorder characterized by a narrowing of the vaginal canal.;Vaginal stricture;10053496;LLT;20,1
3473;C144475;Grade 1 Vaginal Stricture, CTCAE;"Asymptomatic; mild vaginal shortening or narrowing";Grade 1 Vaginal stricture;"Asymptomatic; mild vaginal shortening or narrowing";Vaginal stricture;10053496;LLT;20,1
3474;C145087;Grade 2 Vaginal Stricture, CTCAE;Vaginal narrowing and/or shortening not interfering with physical examination;Grade 2 Vaginal stricture;Vaginal narrowing and/or shortening not interfering with physical examination;Vaginal stricture;10053496;LLT;20,1
3475;C145707;Grade 3 Vaginal Stricture, CTCAE;Vaginal narrowing and/or shortening interfering with the use of tampons, sexual activity or physical examination;Grade 3 Vaginal stricture;Vaginal narrowing and/or shortening interfering with the use of tampons, sexual activity or physical examination;Vaginal stricture;10053496;LLT;20,1
3476;C146612;Grade 5 Vaginal Stricture, CTCAE;Death;Grade 5 Vaginal stricture;Death;Vaginal stricture;10053496;LLT;20,1
3477;C143181;Respiratory, Thoracic and Mediastinal Disorders, CTCAE;;;;;;;
3478;C58020;Adult Respiratory Distress Syndrome, CTCAE;A disorder characterized by progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery.;Adult respiratory distress syndrome;A disorder characterized by progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery.;Adult respiratory distress syndrome;10001409;LLT;20,1
3479;C58090;Grade 3 Adult Respiratory Distress Syndrome, CTCAE;"Present with radiologic findings; intubation not indicated";Grade 3 Adult respiratory distress syndrome;"Present with radiologic findings; intubation not indicated";Adult respiratory distress syndrome;10001409;LLT;20,1
3480;C58123;Grade 4 Adult Respiratory Distress Syndrome, CTCAE;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Grade 4 Adult respiratory distress syndrome;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Adult respiratory distress syndrome;10001409;LLT;20,1
3481;C58154;Grade 5 Adult Respiratory Distress Syndrome, CTCAE;Death;Grade 5 Adult respiratory distress syndrome;Death;Adult respiratory distress syndrome;10001409;LLT;20,1
3482;C143272;Allergic Rhinitis, CTCAE;A disorder characterized by an inflammation of the nasal mucous membranes caused by an IgE-mediated response to external allergens. The inflammation may also involve the mucous membranes of the sinuses, eyes, middle ear, and pharynx. Symptoms include sneezing, nasal congestion, rhinorrhea and itching.;Allergic rhinitis;A disorder characterized by an inflammation of the nasal mucous membranes caused by an IgE-mediated response to external allergens. The inflammation may also involve the mucous membranes of the sinuses, eyes, middle ear, and pharynx. Symptoms include sneezing, nasal congestion, rhinorrhea and itching.;Allergic rhinitis;10001723;LLT;20,1
3483;C143970;Grade 1 Allergic Rhinitis, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Allergic rhinitis;"Mild symptoms; intervention not indicated";Allergic rhinitis;10001723;LLT;20,1
3484;C144507;Grade 2 Allergic Rhinitis, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Allergic rhinitis;"Moderate symptoms; medical intervention indicated";Allergic rhinitis;10001723;LLT;20,1
3485;C55340;Apnea, CTCAE;A disorder characterized by cessation of breathing.;Apnea;A disorder characterized by cessation of breathing.;Apnea;10002972;LLT;20,1
3486;C55341;Grade 3 Apnea, CTCAE;"Present; medical intervention indicated";Grade 3 Apnea;"Present; medical intervention indicated";Apnea;10002972;LLT;20,1
3487;C55342;Grade 4 Apnea, CTCAE;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Grade 4 Apnea;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Apnea;10002972;LLT;20,1
3488;C55343;Grade 5 Apnea, CTCAE;Death;Grade 5 Apnea;Death;Apnea;10002972;LLT;20,1
3489;C28245;Aspiration, CTCAE;A disorder characterized by inhalation of solids or liquids into the lungs.;Aspiration;A disorder characterized by inhalation of solids or liquids into the lungs.;Aspiration;10003504;LLT;20,1
3490;C58029;Grade 1 Aspiration, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Aspiration;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Aspiration;10003504;LLT;20,1
3491;C58058;Grade 2 Aspiration, CTCAE;"Altered eating habits; coughing or choking episodes after eating or swallowing; medical intervention indicated (e.g., suction or oxygen)";Grade 2 Aspiration;"Altered eating habits; coughing or choking episodes after eating or swallowing; medical intervention indicated (e.g., suction or oxygen)";Aspiration;10003504;LLT;20,1
3492;C58091;Grade 3 Aspiration, CTCAE;"Dyspnea and pneumonia symptoms (e.g., aspiration pneumonia); hospitalization indicated; unable to aliment orally";Grade 3 Aspiration;"Dyspnea and pneumonia symptoms (e.g., aspiration pneumonia); hospitalization indicated; unable to aliment orally";Aspiration;10003504;LLT;20,1
3493;C58124;Grade 4 Aspiration, CTCAE;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Grade 4 Aspiration;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Aspiration;10003504;LLT;20,1
3494;C58155;Grade 5 Aspiration, CTCAE;Death;Grade 5 Aspiration;Death;Aspiration;10003504;LLT;20,1
3495;C58022;Atelectasis, CTCAE;A disorder characterized by the collapse of part or the entire lung.;Atelectasis;A disorder characterized by the collapse of part or the entire lung.;Atelectasis;10003598;LLT;20,1
3496;C58030;Grade 1 Atelectasis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Atelectasis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Atelectasis;10003598;LLT;20,1
3497;C58059;Grade 2 Atelectasis, CTCAE;"Symptomatic (e.g., dyspnea, cough); medical intervention indicated (e.g., chest physiotherapy, suctioning); bronchoscopic suctioning";Grade 2 Atelectasis;"Symptomatic (e.g., dyspnea, cough); medical intervention indicated (e.g., chest physiotherapy, suctioning); bronchoscopic suctioning";Atelectasis;10003598;LLT;20,1
3498;C58092;Grade 3 Atelectasis, CTCAE;"Supplemental oxygen indicated; hospitalization or elective operative intervention indicated (e.g., stent, laser)";Grade 3 Atelectasis;"Supplemental oxygen indicated; hospitalization or elective operative intervention indicated (e.g., stent, laser)";Atelectasis;10003598;LLT;20,1
3499;C58125;Grade 4 Atelectasis, CTCAE;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Grade 4 Atelectasis;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Atelectasis;10003598;LLT;20,1
3500;C58156;Grade 5 Atelectasis, CTCAE;Death;Grade 5 Atelectasis;Death;Atelectasis;10003598;LLT;20,1
3501;C143338;Bronchial Fistula, CTCAE;A disorder characterized by an abnormal communication between the bronchus and another organ or anatomic site.;Bronchial fistula;A disorder characterized by an abnormal communication between the bronchus and another organ or anatomic site.;Bronchial fistula;10006437;LLT;20,1
3502;C144011;Grade 1 Bronchial Fistula, CTCAE;Asymptomatic;Grade 1 Bronchial fistula;Asymptomatic;Bronchial fistula;10006437;LLT;20,1
3503;C144555;Grade 2 Bronchial Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Bronchial fistula;Symptomatic, invasive intervention not indicated;Bronchial fistula;10006437;LLT;20,1
3504;C145171;Grade 3 Bronchial Fistula, CTCAE;Invasive intervention indicated;Grade 3 Bronchial fistula;Invasive intervention indicated;Bronchial fistula;10006437;LLT;20,1
3505;C145771;Grade 4 Bronchial Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Bronchial fistula;"Life-threatening consequences; urgent intervention indicated";Bronchial fistula;10006437;LLT;20,1
3506;C146239;Grade 5 Bronchial Fistula, CTCAE;Death;Grade 5 Bronchial fistula;Death;Bronchial fistula;10006437;LLT;20,1
3507;C143340;Bronchial Obstruction, CTCAE;A disorder characterized by blockage of a bronchus passage, most often by bronchial secretions and exudates.;Bronchial obstruction;A disorder characterized by blockage of a bronchus passage, most often by bronchial secretions and exudates.;Bronchial obstruction;10006440;LLT;20,1
3508;C144012;Grade 1 Bronchial Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Bronchial obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Bronchial obstruction;10006440;LLT;20,1
3509;C144557;Grade 2 Bronchial Obstruction, CTCAE;"Symptomatic (e.g., mild wheezing); endoscopic evaluation indicated; radiographic evidence of atelectasis/lobar collapse; medical management indicated (e.g., steroids, bronchodilators)";Grade 2 Bronchial obstruction;"Symptomatic (e.g., mild wheezing); endoscopic evaluation indicated; radiographic evidence of atelectasis/lobar collapse; medical management indicated (e.g., steroids, bronchodilators)";Bronchial obstruction;10006440;LLT;20,1
3510;C145173;Grade 3 Bronchial Obstruction, CTCAE;"Shortness of breath with stridor; endoscopic intervention indicated (e.g., laser, stent placement)";Grade 3 Bronchial obstruction;"Shortness of breath with stridor; endoscopic intervention indicated (e.g., laser, stent placement)";Bronchial obstruction;10006440;LLT;20,1
3511;C145773;Grade 4 Bronchial Obstruction, CTCAE;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Grade 4 Bronchial obstruction;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Bronchial obstruction;10006440;LLT;20,1
3512;C146241;Grade 5 Bronchial Obstruction, CTCAE;Death;Grade 5 Bronchial obstruction;Death;Bronchial obstruction;10006440;LLT;20,1
3513;C143341;Bronchial Stricture, CTCAE;A disorder characterized by a narrowing of the bronchial tube.;Bronchial stricture;A disorder characterized by a narrowing of the bronchial tube.;Bronchial stricture;10063524;LLT;20,1
3514;C144013;Grade 1 Bronchial Stricture, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Bronchial stricture;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Bronchial stricture;10063524;LLT;20,1
3515;C144558;Grade 2 Bronchial Stricture, CTCAE;"Symptomatic (e.g., rhonchi or wheezing) but without respiratory distress; medical intervention indicated (e.g., steroids, bronchodilators)";Grade 2 Bronchial stricture;"Symptomatic (e.g., rhonchi or wheezing) but without respiratory distress; medical intervention indicated (e.g., steroids, bronchodilators)";Bronchial stricture;10063524;LLT;20,1
3516;C145174;Grade 3 Bronchial Stricture, CTCAE;"Shortness of breath with stridor; endoscopic intervention indicated (e.g., laser, stent placement)";Grade 3 Bronchial stricture;"Shortness of breath with stridor; endoscopic intervention indicated (e.g., laser, stent placement)";Bronchial stricture;10063524;LLT;20,1
3517;C145774;Grade 4 Bronchial Stricture, CTCAE;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Grade 4 Bronchial stricture;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Bronchial stricture;10063524;LLT;20,1
3518;C146242;Grade 5 Bronchial Stricture, CTCAE;Death;Grade 5 Bronchial stricture;Death;Bronchial stricture;10063524;LLT;20,1
3519;C143342;Bronchopleural Fistula, CTCAE;A disorder characterized by an abnormal communication between a bronchus and the pleural cavity.;Bronchopleural fistula;A disorder characterized by an abnormal communication between a bronchus and the pleural cavity.;Bronchopleural fistula;10053481;LLT;20,1
3520;C144014;Grade 1 Bronchopleural Fistula, CTCAE;Asymptomatic;Grade 1 Bronchopleural fistula;Asymptomatic;Bronchopleural fistula;10053481;LLT;20,1
3521;C144559;Grade 2 Bronchopleural Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Bronchopleural fistula;Symptomatic, invasive intervention not indicated;Bronchopleural fistula;10053481;LLT;20,1
3522;C145175;Grade 3 Bronchopleural Fistula, CTCAE;"Hospitalization; invasive intervention indicated";Grade 3 Bronchopleural fistula;"Hospitalization; invasive intervention indicated";Bronchopleural fistula;10053481;LLT;20,1
3523;C145775;Grade 4 Bronchopleural Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Bronchopleural fistula;"Life-threatening consequences; urgent intervention indicated";Bronchopleural fistula;10053481;LLT;20,1
3524;C146243;Grade 5 Bronchopleural Fistula, CTCAE;Death;Grade 5 Bronchopleural fistula;Death;Bronchopleural fistula;10053481;LLT;20,1
3525;C143343;Bronchopulmonary Hemorrhage, CTCAE;A disorder characterized by bleeding from the bronchial wall and/or lung parenchyma.;Bronchopulmonary hemorrhage;A disorder characterized by bleeding from the bronchial wall and/or lung parenchyma.;Bronchopulmonary hemorrhage;10065746;LLT;20,1
3526;C144015;Grade 1 Bronchopulmonary Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Bronchopulmonary hemorrhage;"Mild symptoms; intervention not indicated";Bronchopulmonary hemorrhage;10065746;LLT;20,1
3527;C144560;Grade 2 Bronchopulmonary Hemorrhage, CTCAE;"Moderate symptoms; invasive intervention not indicated";Grade 2 Bronchopulmonary hemorrhage;"Moderate symptoms; invasive intervention not indicated";Bronchopulmonary hemorrhage;10065746;LLT;20,1
3528;C145176;Grade 3 Bronchopulmonary Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Bronchopulmonary hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Bronchopulmonary hemorrhage;10065746;LLT;20,1
3529;C145776;Grade 4 Bronchopulmonary Hemorrhage, CTCAE;"Life-threatening consequences; intubation or urgent intervention indicated";Grade 4 Bronchopulmonary hemorrhage;"Life-threatening consequences; intubation or urgent intervention indicated";Bronchopulmonary hemorrhage;10065746;LLT;20,1
3530;C146244;Grade 5 Bronchopulmonary Hemorrhage, CTCAE;Death;Grade 5 Bronchopulmonary hemorrhage;Death;Bronchopulmonary hemorrhage;10065746;LLT;20,1
3531;C143344;Bronchospasm, CTCAE;A disorder characterized by a sudden contraction of the smooth muscles of the bronchial wall.;Bronchospasm;A disorder characterized by a sudden contraction of the smooth muscles of the bronchial wall.;Bronchospasm;10006482;LLT;20,1
3532;C144016;Grade 1 Bronchospasm, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Bronchospasm;"Mild symptoms; intervention not indicated";Bronchospasm;10006482;LLT;20,1
3533;C144561;Grade 2 Bronchospasm, CTCAE;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Grade 2 Bronchospasm;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Bronchospasm;10006482;LLT;20,1
3534;C145177;Grade 3 Bronchospasm, CTCAE;"Limiting self care ADL; supplemental oxygen indicated";Grade 3 Bronchospasm;"Limiting self care ADL; supplemental oxygen indicated";Bronchospasm;10006482;LLT;20,1
3535;C145777;Grade 4 Bronchospasm, CTCAE;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Grade 4 Bronchospasm;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Bronchospasm;10006482;LLT;20,1
3536;C146245;Grade 5 Bronchospasm, CTCAE;Death;Grade 5 Bronchospasm;Death;Bronchospasm;10006482;LLT;20,1
3537;C58027;Chylothorax, CTCAE;A disorder characterized by milky pleural effusion (abnormal collection of fluid) resulting from accumulation of lymph fluid in the pleural cavity.;Chylothorax;A disorder characterized by milky pleural effusion (abnormal collection of fluid) resulting from accumulation of lymph fluid in the pleural cavity.;Chylothorax;10051228;LLT;20,1
3538;C58035;Grade 1 Chylothorax, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Chylothorax;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Chylothorax;10051228;LLT;20,1
3539;C58064;Grade 2 Chylothorax, CTCAE;"Symptomatic; medical intervention indicated (e.g., fat-restricted diet); thoracentesis or tube drainage indicated";Grade 2 Chylothorax;"Symptomatic; medical intervention indicated (e.g., fat-restricted diet); thoracentesis or tube drainage indicated";Chylothorax;10051228;LLT;20,1
3540;C58097;Grade 3 Chylothorax, CTCAE;"Severe symptoms; elective operative intervention indicated";Grade 3 Chylothorax;"Severe symptoms; elective operative intervention indicated";Chylothorax;10051228;LLT;20,1
3541;C58130;Grade 4 Chylothorax, CTCAE;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Grade 4 Chylothorax;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Chylothorax;10051228;LLT;20,1
3542;C58161;Grade 5 Chylothorax, CTCAE;Death;Grade 5 Chylothorax;Death;Chylothorax;10051228;LLT;20,1
3543;C58028;Cough, CTCAE;A disorder characterized by sudden, often repetitive, spasmodic contraction of the thoracic cavity, resulting in violent release of air from the lungs and usually accompanied by a distinctive sound.;Cough;A disorder characterized by sudden, often repetitive, spasmodic contraction of the thoracic cavity, resulting in violent release of air from the lungs and usually accompanied by a distinctive sound.;Cough;10011224;LLT;20,1
3544;C58036;Grade 1 Cough, CTCAE;"Mild symptoms; nonprescription intervention indicated";Grade 1 Cough;"Mild symptoms; nonprescription intervention indicated";Cough;10011224;LLT;20,1
3545;C58065;Grade 2 Cough, CTCAE;"Moderate symptoms, medical intervention indicated; limiting instrumental ADL";Grade 2 Cough;"Moderate symptoms, medical intervention indicated; limiting instrumental ADL";Cough;10011224;LLT;20,1
3546;C58098;Grade 3 Cough, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Cough;"Severe symptoms; limiting self care ADL";Cough;10011224;LLT;20,1
3547;C58185;Dyspnea, CTCAE;A disorder characterized by an uncomfortable sensation of difficulty breathing.;Dyspnea;A disorder characterized by an uncomfortable sensation of difficulty breathing.;Dyspnea;10013963;LLT;20,1
3548;C58037;Grade 1 Dyspnea, CTCAE;Shortness of breath with moderate exertion;Grade 1 Dyspnea;Shortness of breath with moderate exertion;Dyspnea;10013963;LLT;20,1
3549;C58066;Grade 2 Dyspnea, CTCAE;"Shortness of breath with minimal exertion; limiting instrumental ADL";Grade 2 Dyspnea;"Shortness of breath with minimal exertion; limiting instrumental ADL";Dyspnea;10013963;LLT;20,1
3550;C58099;Grade 3 Dyspnea, CTCAE;"Shortness of breath at rest; limiting self care ADL";Grade 3 Dyspnea;"Shortness of breath at rest; limiting self care ADL";Dyspnea;10013963;LLT;20,1
3551;C58131;Grade 4 Dyspnea, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Dyspnea;"Life-threatening consequences; urgent intervention indicated";Dyspnea;10013963;LLT;20,1
3552;C58162;Grade 5 Dyspnea, CTCAE;Death;Grade 5 Dyspnea;Death;Dyspnea;10013963;LLT;20,1
3553;C143447;Epistaxis, CTCAE;A disorder characterized by bleeding from the nose.;Epistaxis;A disorder characterized by bleeding from the nose.;Epistaxis;10015090;LLT;20,1
3554;C144082;Grade 1 Epistaxis, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Epistaxis;"Mild symptoms; intervention not indicated";Epistaxis;10015090;LLT;20,1
3555;C144638;Grade 2 Epistaxis, CTCAE;"Moderate symptoms; medical intervention indicated (e.g., nasal packing, cauterization; topical vasoconstrictors)";Grade 2 Epistaxis;"Moderate symptoms; medical intervention indicated (e.g., nasal packing, cauterization; topical vasoconstrictors)";Epistaxis;10015090;LLT;20,1
3556;C145257;Grade 3 Epistaxis, CTCAE;"Transfusion; invasive intervention indicated (e.g., hemostasis of bleeding site)";Grade 3 Epistaxis;"Transfusion; invasive intervention indicated (e.g., hemostasis of bleeding site)";Epistaxis;10015090;LLT;20,1
3557;C145838;Grade 4 Epistaxis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Epistaxis;"Life-threatening consequences; urgent intervention indicated";Epistaxis;10015090;LLT;20,1
3558;C146296;Grade 5 Epistaxis, CTCAE;Death;Grade 5 Epistaxis;Death;Epistaxis;10015090;LLT;20,1
3559;C143545;Hiccups, CTCAE;A disorder characterized by repeated gulp sounds that result from an involuntary opening and closing of the glottis. This is attributed to a spasm of the diaphragm.;Hiccups;A disorder characterized by repeated gulp sounds that result from an involuntary opening and closing of the glottis. This is attributed to a spasm of the diaphragm.;Hiccups;10020039;LLT;20,1
3560;C144156;Grade 1 Hiccups, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Hiccups;"Mild symptoms; intervention not indicated";Hiccups;10020039;LLT;20,1
3561;C144718;Grade 2 Hiccups, CTCAE;"Moderate symptoms; medical intervention indicated; limiting instrumental ADL";Grade 2 Hiccups;"Moderate symptoms; medical intervention indicated; limiting instrumental ADL";Hiccups;10020039;LLT;20,1
3562;C145340;Grade 3 Hiccups, CTCAE;"Severe symptoms; interfering with sleep; limiting self care ADL";Grade 3 Hiccups;"Severe symptoms; interfering with sleep; limiting self care ADL";Hiccups;10020039;LLT;20,1
3563;C143548;Hoarseness, CTCAE;A disorder characterized by harsh and raspy voice arising from or spreading to the larynx.;Hoarseness;A disorder characterized by harsh and raspy voice arising from or spreading to the larynx.;Hoarseness;10020201;LLT;20,1
3564;C144158;Grade 1 Hoarseness, CTCAE;"Mild or intermittent voice change; fully understandable; self-resolves";Grade 1 Hoarseness;"Mild or intermittent voice change; fully understandable; self-resolves";Hoarseness;10020201;LLT;20,1
3565;C144721;Grade 2 Hoarseness, CTCAE;"Moderate or persistent voice changes; may require occasional repetition but understandable on telephone; medical evaluation indicated";Grade 2 Hoarseness;"Moderate or persistent voice changes; may require occasional repetition but understandable on telephone; medical evaluation indicated";Hoarseness;10020201;LLT;20,1
3566;C145342;Grade 3 Hoarseness, CTCAE;Severe voice changes including predominantly whispered speech;Grade 3 Hoarseness;Severe voice changes including predominantly whispered speech;Hoarseness;10020201;LLT;20,1
3567;C58188;Hypoxia, CTCAE;A disorder characterized by a decrease in the level of oxygen in the body.;Hypoxia;A disorder characterized by a decrease in the level of oxygen in the body.;Hypoxia;10021143;LLT;20,1
3568;C58069;Grade 2 Hypoxia, CTCAE;"Decreased oxygen saturation with exercise (e.g., pulse oximeter <88%); intermittent supplemental oxygen";Grade 2 Hypoxia;"Decreased oxygen saturation with exercise (e.g., pulse oximeter <88%); intermittent supplemental oxygen";Hypoxia;10021143;LLT;20,1
3569;C58102;Grade 3 Hypoxia, CTCAE;Decreased oxygen saturation at rest (e.g., pulse oximeter <88% or PaO2 <=55 mm Hg);Grade 3 Hypoxia;Decreased oxygen saturation at rest (e.g., pulse oximeter <88% or PaO2 <=55 mm Hg);Hypoxia;10021143;LLT;20,1
3570;C58133;Grade 4 Hypoxia, CTCAE;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Hypoxia;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Hypoxia;10021143;LLT;20,1
3571;C58164;Grade 5 Hypoxia, CTCAE;Death;Grade 5 Hypoxia;Death;Hypoxia;10021143;LLT;20,1
3572;C143636;Laryngeal Edema, CTCAE;A disorder characterized by swelling due to an excessive accumulation of fluid in the larynx.;Laryngeal edema;A disorder characterized by swelling due to an excessive accumulation of fluid in the larynx.;Laryngeal edema;10023838;LLT;20,1
3573;C144236;Grade 1 Laryngeal Edema, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Laryngeal edema;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Laryngeal edema;10023838;LLT;20,1
3574;C144807;Grade 2 Laryngeal Edema, CTCAE;"Symptomatic; medical intervention indicated (e.g., dexamethasone, epinephrine, antihistamines)";Grade 2 Laryngeal edema;"Symptomatic; medical intervention indicated (e.g., dexamethasone, epinephrine, antihistamines)";Laryngeal edema;10023838;LLT;20,1
3575;C145428;Grade 3 Laryngeal Edema, CTCAE;"Stridor; respiratory distress; hospitalization indicated";Grade 3 Laryngeal edema;"Stridor; respiratory distress; hospitalization indicated";Laryngeal edema;10023838;LLT;20,1
3576;C145971;Grade 4 Laryngeal Edema, CTCAE;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Laryngeal edema;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Laryngeal edema;10023838;LLT;20,1
3577;C146418;Grade 5 Laryngeal Edema, CTCAE;Death;Grade 5 Laryngeal edema;Death;Laryngeal edema;10023838;LLT;20,1
3578;C143637;Laryngeal Inflammation, CTCAE;A disorder characterized by an inflammation involving the larynx.;Laryngeal inflammation;A disorder characterized by an inflammation involving the larynx.;Laryngeal inflammation;10065735;LLT;20,1
3579;C144239;Grade 1 Laryngeal Inflammation, CTCAE;"Mild sore throat; raspy voice";Grade 1 Laryngeal inflammation;"Mild sore throat; raspy voice";Laryngeal inflammation;10065735;LLT;20,1
3580;C144810;Grade 2 Laryngeal Inflammation, CTCAE;"Moderate sore throat; analgesics indicated";Grade 2 Laryngeal inflammation;"Moderate sore throat; analgesics indicated";Laryngeal inflammation;10065735;LLT;20,1
3581;C145431;Grade 3 Laryngeal Inflammation, CTCAE;"Severe throat pain; endoscopic intervention indicated";Grade 3 Laryngeal inflammation;"Severe throat pain; endoscopic intervention indicated";Laryngeal inflammation;10065735;LLT;20,1
3582;C143638;Laryngeal Mucositis, CTCAE;A disorder characterized by ulceration or inflammation involving the mucous membrane of the larynx.;Laryngeal mucositis;A disorder characterized by ulceration or inflammation involving the mucous membrane of the larynx.;Laryngeal mucositis;10065880;LLT;20,1
3583;C144240;Grade 1 Laryngeal Mucositis, CTCAE;"Endoscopic findings only; mild discomfort with normal intake";Grade 1 Laryngeal mucositis;"Endoscopic findings only; mild discomfort with normal intake";Laryngeal mucositis;10065880;LLT;20,1
3584;C144811;Grade 2 Laryngeal Mucositis, CTCAE;"Moderate pain, analgesics indicated; altered oral intake; limiting instrumental ADL";Grade 2 Laryngeal mucositis;"Moderate pain, analgesics indicated; altered oral intake; limiting instrumental ADL";Laryngeal mucositis;10065880;LLT;20,1
3585;C145432;Grade 3 Laryngeal Mucositis, CTCAE;"Severe pain; severely altered eating/swallowing; medical intervention indicated";Grade 3 Laryngeal mucositis;"Severe pain; severely altered eating/swallowing; medical intervention indicated";Laryngeal mucositis;10065880;LLT;20,1
3586;C145974;Grade 4 Laryngeal Mucositis, CTCAE;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Laryngeal mucositis;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Laryngeal mucositis;10065880;LLT;20,1
3587;C146421;Grade 5 Laryngeal Mucositis, CTCAE;Death;Grade 5 Laryngeal mucositis;Death;Laryngeal mucositis;10065880;LLT;20,1
3588;C143639;Laryngeal Obstruction, CTCAE;A disorder characterized by blockage of the laryngeal airway.;Laryngeal obstruction;A disorder characterized by blockage of the laryngeal airway.;Laryngeal obstruction;10059639;LLT;20,1
3589;C144241;Grade 1 Laryngeal Obstruction, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Laryngeal obstruction;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Laryngeal obstruction;10059639;LLT;20,1
3590;C144812;Grade 2 Laryngeal Obstruction, CTCAE;"Symptomatic (e.g., noisy airway breathing), no respiratory distress; medical intervention indicated (e.g., steroids); limiting instrumental ADL";Grade 2 Laryngeal obstruction;"Symptomatic (e.g., noisy airway breathing), no respiratory distress; medical intervention indicated (e.g., steroids); limiting instrumental ADL";Laryngeal obstruction;10059639;LLT;20,1
3591;C145433;Grade 3 Laryngeal Obstruction, CTCAE;"Limiting self care ADL; stridor; endoscopic intervention indicated (e.g., stent, laser)";Grade 3 Laryngeal obstruction;"Limiting self care ADL; stridor; endoscopic intervention indicated (e.g., stent, laser)";Laryngeal obstruction;10059639;LLT;20,1
3592;C145975;Grade 4 Laryngeal Obstruction, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Laryngeal obstruction;"Life-threatening consequences; urgent intervention indicated";Laryngeal obstruction;10059639;LLT;20,1
3593;C146422;Grade 5 Laryngeal Obstruction, CTCAE;Death;Grade 5 Laryngeal obstruction;Death;Laryngeal obstruction;10059639;LLT;20,1
3594;C143640;Laryngeal Stenosis, CTCAE;A disorder characterized by a narrowing of the laryngeal airway.;Laryngeal stenosis;A disorder characterized by a narrowing of the laryngeal airway.;Laryngeal stenosis;10023862;LLT;20,1
3595;C144242;Grade 1 Laryngeal Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Laryngeal stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Laryngeal stenosis;10023862;LLT;20,1
3596;C144813;Grade 2 Laryngeal Stenosis, CTCAE;"Symptomatic (e.g., noisy airway breathing), no respiratory distress; medical intervention indicated (e.g., steroids); limiting instrumental ADL";Grade 2 Laryngeal stenosis;"Symptomatic (e.g., noisy airway breathing), no respiratory distress; medical intervention indicated (e.g., steroids); limiting instrumental ADL";Laryngeal stenosis;10023862;LLT;20,1
3597;C145434;Grade 3 Laryngeal Stenosis, CTCAE;"Limiting self care ADL; stridor; endoscopic intervention indicated (e.g., stent, laser)";Grade 3 Laryngeal stenosis;"Limiting self care ADL; stridor; endoscopic intervention indicated (e.g., stent, laser)";Laryngeal stenosis;10023862;LLT;20,1
3598;C145976;Grade 4 Laryngeal Stenosis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Laryngeal stenosis;"Life-threatening consequences; urgent intervention indicated";Laryngeal stenosis;10023862;LLT;20,1
3599;C146423;Grade 5 Laryngeal Stenosis, CTCAE;Death;Grade 5 Laryngeal stenosis;Death;Laryngeal stenosis;10023862;LLT;20,1
3600;C143642;Laryngopharyngeal Dysesthesia, CTCAE;A disorder characterized by an uncomfortable persistent sensation in the area of the laryngopharynx.;Laryngopharyngeal dysesthesia;A disorder characterized by an uncomfortable persistent sensation in the area of the laryngopharynx.;Laryngopharyngeal dysesthesia;10062667;LLT;20,1
3601;C144243;Grade 1 Laryngopharyngeal Dysesthesia, CTCAE;"Mild symptoms; no anxiety; intervention not indicated";Grade 1 Laryngopharyngeal dysesthesia;"Mild symptoms; no anxiety; intervention not indicated";Laryngopharyngeal dysesthesia;10062667;LLT;20,1
3602;C144815;Grade 2 Laryngopharyngeal Dysesthesia, CTCAE;"Moderate symptoms; mild anxiety, but no dyspnea; short duration of observation and/or anxiolytic indicated; limiting instrumental ADL";Grade 2 Laryngopharyngeal dysesthesia;"Moderate symptoms; mild anxiety, but no dyspnea; short duration of observation and/or anxiolytic indicated; limiting instrumental ADL";Laryngopharyngeal dysesthesia;10062667;LLT;20,1
3603;C145436;Grade 3 Laryngopharyngeal Dysesthesia, CTCAE;"Severe symptoms; dyspnea and swallowing difficulty; limiting self care ADL";Grade 3 Laryngopharyngeal dysesthesia;"Severe symptoms; dyspnea and swallowing difficulty; limiting self care ADL";Laryngopharyngeal dysesthesia;10062667;LLT;20,1
3604;C145978;Grade 4 Laryngopharyngeal Dysesthesia, CTCAE;Life-threatening consequences;Grade 4 Laryngopharyngeal dysesthesia;Life-threatening consequences;Laryngopharyngeal dysesthesia;10062667;LLT;20,1
3605;C146425;Grade 5 Laryngopharyngeal Dysesthesia, CTCAE;Death;Grade 5 Laryngopharyngeal dysesthesia;Death;Laryngopharyngeal dysesthesia;10062667;LLT;20,1
3606;C143643;Laryngospasm, CTCAE;A disorder characterized by paroxysmal spasmodic muscular contraction of the vocal cords.;Laryngospasm;A disorder characterized by paroxysmal spasmodic muscular contraction of the vocal cords.;Laryngospasm;10023891;LLT;20,1
3607;C144816;Grade 2 Laryngospasm, CTCAE;"Transient episode; intervention not indicated";Grade 2 Laryngospasm;"Transient episode; intervention not indicated";Laryngospasm;10023891;LLT;20,1
3608;C145437;Grade 3 Laryngospasm, CTCAE;"Recurrent episodes; noninvasive intervention indicated (e.g., breathing technique, pressure point massage)";Grade 3 Laryngospasm;"Recurrent episodes; noninvasive intervention indicated (e.g., breathing technique, pressure point massage)";Laryngospasm;10023891;LLT;20,1
3609;C145979;Grade 4 Laryngospasm, CTCAE;"Persistent or severe episodes associated with syncope; urgent intervention indicated (e.g., fiberoptic laryngoscopy, intubation, botox injection)";Grade 4 Laryngospasm;"Persistent or severe episodes associated with syncope; urgent intervention indicated (e.g., fiberoptic laryngoscopy, intubation, botox injection)";Laryngospasm;10023891;LLT;20,1
3610;C146426;Grade 5 Laryngospasm, CTCAE;Death;Grade 5 Laryngospasm;Death;Laryngospasm;10023891;LLT;20,1
3611;C58190;Laryngeal Fistula, CTCAE;A disorder characterized by an abnormal communication between the larynx and another organ or anatomic site.;Laryngeal fistula;A disorder characterized by an abnormal communication between the larynx and another organ or anatomic site.;Laryngeal fistula;10065786;LLT;20,1
3612;C58041;Grade 1 Laryngeal Fistula, CTCAE;Asymptomatic;Grade 1 Laryngeal fistula;Asymptomatic;Laryngeal fistula;10065786;LLT;20,1
3613;C58071;Grade 2 Laryngeal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Laryngeal fistula;Symptomatic, invasive intervention not indicated;Laryngeal fistula;10065786;LLT;20,1
3614;C58104;Grade 3 Laryngeal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Laryngeal fistula;Invasive intervention indicated;Laryngeal fistula;10065786;LLT;20,1
3615;C58135;Grade 4 Laryngeal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Laryngeal fistula;"Life-threatening consequences; urgent intervention indicated";Laryngeal fistula;10065786;LLT;20,1
3616;C58166;Grade 5 Laryngeal Fistula, CTCAE;Death;Grade 5 Laryngeal fistula;Death;Laryngeal fistula;10065786;LLT;20,1
3617;C56545;Laryngeal Hemorrhage, CTCAE;A disorder characterized by bleeding from the larynx.;Laryngeal hemorrhage;A disorder characterized by bleeding from the larynx.;Laryngeal hemorrhage;10065759;LLT;20,1
3618;C56302;Grade 1 Laryngeal Hemorrhage, CTCAE;"Mild cough or trace hemoptysis; laryngoscopic findings";Grade 1 Laryngeal hemorrhage;"Mild cough or trace hemoptysis; laryngoscopic findings";Laryngeal hemorrhage;10065759;LLT;20,1
3619;C56351;Grade 2 Laryngeal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Laryngeal hemorrhage;"Moderate symptoms; intervention indicated";Laryngeal hemorrhage;10065759;LLT;20,1
3620;C56401;Grade 3 Laryngeal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Laryngeal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Laryngeal hemorrhage;10065759;LLT;20,1
3621;C56451;Grade 4 Laryngeal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Laryngeal hemorrhage;"Life-threatening consequences; urgent intervention indicated (e.g., tracheotomy or intubation)";Laryngeal hemorrhage;10065759;LLT;20,1
3622;C56500;Grade 5 Laryngeal Hemorrhage, CTCAE;Death;Grade 5 Laryngeal hemorrhage;Death;Laryngeal hemorrhage;10065759;LLT;20,1
3623;C56549;Mediastinal Hemorrhage, CTCAE;A disorder characterized by bleeding from the mediastinum.;Mediastinal hemorrhage;A disorder characterized by bleeding from the mediastinum.;Mediastinal hemorrhage;10056356;LLT;20,1
3624;C56306;Grade 1 Mediastinal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated; radiologic evidence only";Grade 1 Mediastinal hemorrhage;"Mild symptoms; intervention not indicated; radiologic evidence only";Mediastinal hemorrhage;10056356;LLT;20,1
3625;C56355;Grade 2 Mediastinal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Mediastinal hemorrhage;"Moderate symptoms; intervention indicated";Mediastinal hemorrhage;10056356;LLT;20,1
3626;C56405;Grade 3 Mediastinal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Mediastinal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Mediastinal hemorrhage;10056356;LLT;20,1
3627;C56455;Grade 4 Mediastinal Hemorrhage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Mediastinal hemorrhage;"Life-threatening consequences; urgent intervention indicated";Mediastinal hemorrhage;10056356;LLT;20,1
3628;C56504;Grade 5 Mediastinal Hemorrhage, CTCAE;Death;Grade 5 Mediastinal hemorrhage;Death;Mediastinal hemorrhage;10056356;LLT;20,1
3629;C143698;Nasal Congestion, CTCAE;A disorder characterized by obstruction of the nasal passage due to mucosal edema.;Nasal congestion;A disorder characterized by obstruction of the nasal passage due to mucosal edema.;Nasal congestion;10028735;LLT;20,1
3630;C144284;Grade 1 Nasal Congestion, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Nasal congestion;"Mild symptoms; intervention not indicated";Nasal congestion;10028735;LLT;20,1
3631;C144860;Grade 2 Nasal Congestion, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Nasal congestion;"Moderate symptoms; medical intervention indicated";Nasal congestion;10028735;LLT;20,1
3632;C145481;Grade 3 Nasal Congestion, CTCAE;Associated with bloody nasal discharge or epistaxis;Grade 3 Nasal congestion;Associated with bloody nasal discharge or epistaxis;Nasal congestion;10028735;LLT;20,1
3633;C143241;Oropharyngeal Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the oropharynx.;Oropharyngeal pain;A disorder characterized by a sensation of marked discomfort in the oropharynx.;Oropharyngeal pain;10068319;LLT;20,1
3634;C144301;Grade 1 Oropharyngeal Pain, CTCAE;Mild pain;Grade 1 Oropharyngeal pain;Mild pain;Oropharyngeal pain;10068319;LLT;20,1
3635;C144877;Grade 2 Oropharyngeal Pain, CTCAE;"Moderate pain; altered oral intake; non-narcotics initiated; topical analgesics initiated";Grade 2 Oropharyngeal pain;"Moderate pain; altered oral intake; non-narcotics initiated; topical analgesics initiated";Oropharyngeal pain;10068319;LLT;20,1
3636;C145498;Grade 3 Oropharyngeal Pain, CTCAE;"Severe pain; severely altered eating/swallowing; narcotics initiated; requires parenteral nutrition";Grade 3 Oropharyngeal pain;"Severe pain; severely altered eating/swallowing; narcotics initiated; requires parenteral nutrition";Oropharyngeal pain;10068319;LLT;20,1
3637;C143756;Pharyngeal Mucositis, CTCAE;A disorder characterized by ulceration or inflammation involving the mucous membrane of the pharynx.;Pharyngeal mucositis;A disorder characterized by ulceration or inflammation involving the mucous membrane of the pharynx.;Pharyngeal mucositis;10065881;LLT;20,1
3638;C144334;Grade 1 Pharyngeal Mucositis, CTCAE;"Endoscopic findings only; minimal symptoms with normal oral intake; mild pain but analgesics not indicated";Grade 1 Pharyngeal mucositis;"Endoscopic findings only; minimal symptoms with normal oral intake; mild pain but analgesics not indicated";Pharyngeal mucositis;10065881;LLT;20,1
3639;C144918;Grade 2 Pharyngeal Mucositis, CTCAE;"Moderate pain, analgesics indicated; altered oral intake; limiting instrumental ADL";Grade 2 Pharyngeal mucositis;"Moderate pain, analgesics indicated; altered oral intake; limiting instrumental ADL";Pharyngeal mucositis;10065881;LLT;20,1
3640;C145543;Grade 3 Pharyngeal Mucositis, CTCAE;"Severe pain; unable to adequately aliment or hydrate orally; limiting self care ADL";Grade 3 Pharyngeal mucositis;"Severe pain; unable to adequately aliment or hydrate orally; limiting self care ADL";Pharyngeal mucositis;10065881;LLT;20,1
3641;C146050;Grade 4 Pharyngeal Mucositis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pharyngeal mucositis;"Life-threatening consequences; urgent intervention indicated";Pharyngeal mucositis;10065881;LLT;20,1
3642;C146488;Grade 5 Pharyngeal Mucositis, CTCAE;Death;Grade 5 Pharyngeal mucositis;Death;Pharyngeal mucositis;10065881;LLT;20,1
3643;C143757;Pharyngeal Stenosis, CTCAE;A disorder characterized by a narrowing of the pharyngeal airway.;Pharyngeal stenosis;A disorder characterized by a narrowing of the pharyngeal airway.;Pharyngeal stenosis;10050028;LLT;20,1
3644;C144335;Grade 1 Pharyngeal Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Pharyngeal stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Pharyngeal stenosis;10050028;LLT;20,1
3645;C144919;Grade 2 Pharyngeal Stenosis, CTCAE;"Symptomatic (e.g., noisy airway breathing), no respiratory distress; medical intervention indicated (e.g., steroids); limiting instrumental ADL";Grade 2 Pharyngeal stenosis;"Symptomatic (e.g., noisy airway breathing), no respiratory distress; medical intervention indicated (e.g., steroids); limiting instrumental ADL";Pharyngeal stenosis;10050028;LLT;20,1
3646;C145545;Grade 3 Pharyngeal Stenosis, CTCAE;"Limiting self care ADL; stridor; endoscopic intervention indicated (e.g., stent, laser)";Grade 3 Pharyngeal stenosis;"Limiting self care ADL; stridor; endoscopic intervention indicated (e.g., stent, laser)";Pharyngeal stenosis;10050028;LLT;20,1
3647;C146052;Grade 4 Pharyngeal Stenosis, CTCAE;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Pharyngeal stenosis;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Pharyngeal stenosis;10050028;LLT;20,1
3648;C146490;Grade 5 Pharyngeal Stenosis, CTCAE;Death;Grade 5 Pharyngeal stenosis;Death;Pharyngeal stenosis;10050028;LLT;20,1
3649;C143759;Pharyngolaryngeal Pain, CTCAE;A disorder characterized by a sensation of marked discomfort in the pharyngolaryngeal region.;Pharyngolaryngeal pain;A disorder characterized by a sensation of marked discomfort in the pharyngolaryngeal region.;Pharyngolaryngeal pain;10034844;LLT;20,1
3650;C144336;Grade 1 Pharyngolaryngeal Pain, CTCAE;Mild pain;Grade 1 Pharyngolaryngeal pain;Mild pain;Pharyngolaryngeal pain;10034844;LLT;20,1
3651;C144921;Grade 2 Pharyngolaryngeal Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Pharyngolaryngeal pain;"Moderate pain; limiting instrumental ADL";Pharyngolaryngeal pain;10034844;LLT;20,1
3652;C145547;Grade 3 Pharyngolaryngeal Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Pharyngolaryngeal pain;"Severe pain; limiting self care ADL";Pharyngolaryngeal pain;10034844;LLT;20,1
3653;C57851;Pharyngeal Fistula, CTCAE;A disorder characterized by an abnormal communication between the pharynx and another organ or anatomic site.;Pharyngeal fistula;A disorder characterized by an abnormal communication between the pharynx and another organ or anatomic site.;Pharyngeal fistula;10034825;LLT;20,1
3654;C57222;Grade 1 Pharyngeal Fistula, CTCAE;Asymptomatic;Grade 1 Pharyngeal fistula;Asymptomatic;Pharyngeal fistula;10034825;LLT;20,1
3655;C57345;Grade 2 Pharyngeal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Pharyngeal fistula;Symptomatic, invasive intervention not indicated;Pharyngeal fistula;10034825;LLT;20,1
3656;C57479;Grade 3 Pharyngeal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Pharyngeal fistula;Invasive intervention indicated;Pharyngeal fistula;10034825;LLT;20,1
3657;C57612;Grade 4 Pharyngeal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pharyngeal fistula;"Life-threatening consequences; urgent intervention indicated";Pharyngeal fistula;10034825;LLT;20,1
3658;C57743;Grade 5 Pharyngeal Fistula, CTCAE;Death;Grade 5 Pharyngeal fistula;Death;Pharyngeal fistula;10034825;LLT;20,1
3659;C56557;Pharyngeal Hemorrhage, CTCAE;A disorder characterized by bleeding from the pharynx.;Pharyngeal hemorrhage;A disorder characterized by bleeding from the pharynx.;Pharyngeal hemorrhage;10055315;LLT;20,1
3660;C56313;Grade 1 Pharyngeal Hemorrhage, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Pharyngeal hemorrhage;"Mild symptoms; intervention not indicated";Pharyngeal hemorrhage;10055315;LLT;20,1
3661;C56362;Grade 2 Pharyngeal Hemorrhage, CTCAE;"Moderate symptoms; intervention indicated";Grade 2 Pharyngeal hemorrhage;"Moderate symptoms; intervention indicated";Pharyngeal hemorrhage;10055315;LLT;20,1
3662;C56412;Grade 3 Pharyngeal Hemorrhage, CTCAE;"Transfusion indicated; invasive intervention indicated; hospitalization";Grade 3 Pharyngeal hemorrhage;"Transfusion indicated; invasive intervention indicated; hospitalization";Pharyngeal hemorrhage;10055315;LLT;20,1
3663;C56461;Grade 4 Pharyngeal Hemorrhage, CTCAE;"Life-threatening consequences; intubation or urgent intervention indicated";Grade 4 Pharyngeal hemorrhage;"Life-threatening consequences; intubation or urgent intervention indicated";Pharyngeal hemorrhage;10055315;LLT;20,1
3664;C56510;Grade 5 Pharyngeal Hemorrhage, CTCAE;Death;Grade 5 Pharyngeal hemorrhage;Death;Pharyngeal hemorrhage;10055315;LLT;20,1
3665;C57855;Pharyngeal Necrosis, CTCAE;A disorder characterized by a necrotic process occurring in the pharynx.;Pharyngeal necrosis;A disorder characterized by a necrotic process occurring in the pharynx.;Pharyngeal necrosis;10065706;LLT;20,1
3666;C57483;Grade 3 Pharyngeal Necrosis, CTCAE;"Inability to aliment adequately by GI tract; invasive intervention indicated; tube feeding or TPN indicated";Grade 3 Pharyngeal necrosis;"Inability to aliment adequately by GI tract; invasive intervention indicated; tube feeding or TPN indicated";Pharyngeal necrosis;10065706;LLT;20,1
3667;C57616;Grade 4 Pharyngeal Necrosis, CTCAE;"Life-threatening consequences; urgent operative intervention indicated";Grade 4 Pharyngeal necrosis;"Life-threatening consequences; urgent operative intervention indicated";Pharyngeal necrosis;10065706;LLT;20,1
3668;C57747;Grade 5 Pharyngeal Necrosis, CTCAE;Death;Grade 5 Pharyngeal necrosis;Death;Pharyngeal necrosis;10065706;LLT;20,1
3669;C56558;Pleural Hemorrhage, CTCAE;A disorder characterized by bleeding from the pleural cavity.;Pleural hemorrhage;A disorder characterized by bleeding from the pleural cavity.;Pleural hemorrhage;10055319;LLT;20,1
3670;C56314;Grade 1 Pleural Hemorrhage, CTCAE;"Asymptomatic; mild hemorrhage confirmed by thoracentesis";Grade 1 Pleural hemorrhage;"Asymptomatic; mild hemorrhage confirmed by thoracentesis";Pleural hemorrhage;10055319;LLT;20,1
3671;C56363;Grade 2 Pleural Hemorrhage, CTCAE;"Symptomatic or associated with pneumothorax; chest tube drainage indicated";Grade 2 Pleural hemorrhage;"Symptomatic or associated with pneumothorax; chest tube drainage indicated";Pleural hemorrhage;10055319;LLT;20,1
3672;C56413;Grade 3 Pleural Hemorrhage, CTCAE;">1000 ml of blood evacuated; persistent bleeding (150-200 ml/hr for 2-4 hr); persistent transfusion indicated; elective operative intervention indicated; hospitalization";Grade 3 Pleural hemorrhage;">1000 ml of blood evacuated; persistent bleeding (150-200 ml/hr for 2-4 hr); persistent transfusion indicated; elective operative intervention indicated; hospitalization";Pleural hemorrhage;10055319;LLT;20,1
3673;C56462;Grade 4 Pleural Hemorrhage, CTCAE;"Life-threatening consequences; intubation or urgent intervention indicated";Grade 4 Pleural hemorrhage;"Life-threatening consequences; intubation or urgent intervention indicated";Pleural hemorrhage;10055319;LLT;20,1
3674;C56511;Grade 5 Pleural Hemorrhage, CTCAE;Death;Grade 5 Pleural hemorrhage;Death;Pleural hemorrhage;10055319;LLT;20,1
3675;C143765;Pleural Effusion, CTCAE;A disorder characterized by an increase in amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough and marked chest discomfort.;Pleural effusion;A disorder characterized by an increase in amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough and marked chest discomfort.;Pleural effusion;10035598;LLT;20,1
3676;C144339;Grade 1 Pleural Effusion, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Pleural effusion;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Pleural effusion;10035598;LLT;20,1
3677;C144925;Grade 2 Pleural Effusion, CTCAE;"Symptomatic; intervention indicated (e.g., diuretics or therapeutic thoracentesis)";Grade 2 Pleural effusion;"Symptomatic; intervention indicated (e.g., diuretics or therapeutic thoracentesis)";Pleural effusion;10035598;LLT;20,1
3678;C145550;Grade 3 Pleural Effusion, CTCAE;"Symptomatic with respiratory distress and hypoxia; operative intervention including chest tube or pleurodesis indicated";Grade 3 Pleural effusion;"Symptomatic with respiratory distress and hypoxia; operative intervention including chest tube or pleurodesis indicated";Pleural effusion;10035598;LLT;20,1
3679;C146056;Grade 4 Pleural Effusion, CTCAE;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Grade 4 Pleural effusion;"Life-threatening respiratory or hemodynamic compromise; intubation or urgent intervention indicated";Pleural effusion;10035598;LLT;20,1
3680;C146493;Grade 5 Pleural Effusion, CTCAE;Death;Grade 5 Pleural effusion;Death;Pleural effusion;10035598;LLT;20,1
3681;C146663;Pleuritic Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the pleura.;Pleuritic pain;A disorder characterized by a sensation of marked discomfort in the pleura.;Pleuritic pain;10035623;LLT;20,1
3682;C144341;Grade 1 Pleuritic Pain, CTCAE;Mild pain;Grade 1 Pleuritic pain;Mild pain;Pleuritic pain;10035623;LLT;20,1
3683;C144928;Grade 2 Pleuritic Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Pleuritic pain;"Moderate pain; limiting instrumental ADL";Pleuritic pain;10035623;LLT;20,1
3684;C145553;Grade 3 Pleuritic Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Pleuritic pain;"Severe pain; limiting self care ADL";Pleuritic pain;10035623;LLT;20,1
3685;C143767;Pneumonitis, CTCAE;A disorder characterized by inflammation focally or diffusely affecting the lung parenchyma.;Pneumonitis;A disorder characterized by inflammation focally or diffusely affecting the lung parenchyma.;Pneumonitis;10035742;LLT;20,1
3686;C144342;Grade 1 Pneumonitis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Pneumonitis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Pneumonitis;10035742;LLT;20,1
3687;C144929;Grade 2 Pneumonitis, CTCAE;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Grade 2 Pneumonitis;"Symptomatic; medical intervention indicated; limiting instrumental ADL";Pneumonitis;10035742;LLT;20,1
3688;C145554;Grade 3 Pneumonitis, CTCAE;"Severe symptoms; limiting self care ADL; oxygen indicated";Grade 3 Pneumonitis;"Severe symptoms; limiting self care ADL; oxygen indicated";Pneumonitis;10035742;LLT;20,1
3689;C146059;Grade 4 Pneumonitis, CTCAE;"Life-threatening respiratory compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Pneumonitis;"Life-threatening respiratory compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Pneumonitis;10035742;LLT;20,1
3690;C146496;Grade 5 Pneumonitis, CTCAE;Death;Grade 5 Pneumonitis;Death;Pneumonitis;10035742;LLT;20,1
3691;C58201;Pneumothorax, CTCAE;A disorder characterized by abnormal presence of air in the pleural cavity resulting in the collapse of the lung.;Pneumothorax;A disorder characterized by abnormal presence of air in the pleural cavity resulting in the collapse of the lung.;Pneumothorax;10035759;LLT;20,1
3692;C58052;Grade 1 Pneumothorax, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Pneumothorax;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Pneumothorax;10035759;LLT;20,1
3693;C58082;Grade 2 Pneumothorax, CTCAE;"Symptomatic; intervention indicated";Grade 2 Pneumothorax;"Symptomatic; intervention indicated";Pneumothorax;10035759;LLT;20,1
3694;C58115;Grade 3 Pneumothorax, CTCAE;"Sclerosis and/or operative intervention indicated; hospitalization indicated";Grade 3 Pneumothorax;"Sclerosis and/or operative intervention indicated; hospitalization indicated";Pneumothorax;10035759;LLT;20,1
3695;C58146;Grade 4 Pneumothorax, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pneumothorax;"Life-threatening consequences; urgent intervention indicated";Pneumothorax;10035759;LLT;20,1
3696;C58177;Grade 5 Pneumothorax, CTCAE;Death;Grade 5 Pneumothorax;Death;Pneumothorax;10035759;LLT;20,1
3697;C143771;Postnasal Drip, CTCAE;A disorder characterized by excessive mucous secretion in the back of the nasal cavity or throat, causing sore throat and/or coughing.;Postnasal drip;A disorder characterized by excessive mucous secretion in the back of the nasal cavity or throat, causing sore throat and/or coughing.;Postnasal drip;10036402;LLT;20,1
3698;C144343;Grade 1 Postnasal Drip, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Postnasal drip;"Mild symptoms; intervention not indicated";Postnasal drip;10036402;LLT;20,1
3699;C144932;Grade 2 Postnasal Drip, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Postnasal drip;"Moderate symptoms; medical intervention indicated";Postnasal drip;10036402;LLT;20,1
3700;C143780;Productive Cough, CTCAE;A disorder characterized by expectorated secretions upon coughing.;Productive cough;A disorder characterized by expectorated secretions upon coughing.;Productive cough;10036790;LLT;20,1
3701;C144348;Grade 1 Productive Cough, CTCAE;Occasional/minimal production of sputum with cough;Grade 1 Productive cough;Occasional/minimal production of sputum with cough;Productive cough;10036790;LLT;20,1
3702;C144939;Grade 2 Productive Cough, CTCAE;"Moderate sputum production; limiting instrumental ADL";Grade 2 Productive cough;"Moderate sputum production; limiting instrumental ADL";Productive cough;10036790;LLT;20,1
3703;C145561;Grade 3 Productive Cough, CTCAE;"Persistent or copious production of sputum; limiting self care ADL";Grade 3 Productive cough;"Persistent or copious production of sputum; limiting self care ADL";Productive cough;10036790;LLT;20,1
3704;C143789;Pulmonary Edema, CTCAE;A disorder characterized by accumulation of fluid in the lung tissues that causes a disturbance of the gas exchange that may lead to respiratory failure.;Pulmonary edema;A disorder characterized by accumulation of fluid in the lung tissues that causes a disturbance of the gas exchange that may lead to respiratory failure.;Pulmonary edema;10037375;LLT;20,1
3705;C144356;Grade 1 Pulmonary Edema, CTCAE;"Radiologic findings only; minimal dyspnea on exertion";Grade 1 Pulmonary edema;"Radiologic findings only; minimal dyspnea on exertion";Pulmonary edema;10037375;LLT;20,1
3706;C144948;Grade 2 Pulmonary Edema, CTCAE;"Moderate dyspnea on exertion; medical intervention indicated; limiting instrumental ADL";Grade 2 Pulmonary edema;"Moderate dyspnea on exertion; medical intervention indicated; limiting instrumental ADL";Pulmonary edema;10037375;LLT;20,1
3707;C145570;Grade 3 Pulmonary Edema, CTCAE;"Severe dyspnea or dyspnea at rest; oxygen indicated; limiting self care ADL";Grade 3 Pulmonary edema;"Severe dyspnea or dyspnea at rest; oxygen indicated; limiting self care ADL";Pulmonary edema;10037375;LLT;20,1
3708;C146073;Grade 4 Pulmonary Edema, CTCAE;"Life-threatening respiratory compromise; urgent intervention or intubation with ventilatory support indicated";Grade 4 Pulmonary edema;"Life-threatening respiratory compromise; urgent intervention or intubation with ventilatory support indicated";Pulmonary edema;10037375;LLT;20,1
3709;C146508;Grade 5 Pulmonary Edema, CTCAE;Death;Grade 5 Pulmonary edema;Death;Pulmonary edema;10037375;LLT;20,1
3710;C143790;Pulmonary Fibrosis, CTCAE;A disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure or right heart failure.;Pulmonary fibrosis;A disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure or right heart failure.;Pulmonary fibrosis;10037383;LLT;20,1
3711;C144357;Grade 1 Pulmonary Fibrosis, CTCAE;Radiologic pulmonary fibrosis <25% of lung volume associated with hypoxia;Grade 1 Pulmonary fibrosis;Radiologic pulmonary fibrosis <25% of lung volume associated with hypoxia;Pulmonary fibrosis;10037383;LLT;20,1
3712;C144949;Grade 2 Pulmonary Fibrosis, CTCAE;"Evidence of pulmonary hypertension; radiographic pulmonary fibrosis 25-50% associated with hypoxia";Grade 2 Pulmonary fibrosis;"Evidence of pulmonary hypertension; radiographic pulmonary fibrosis 25-50% associated with hypoxia";Pulmonary fibrosis;10037383;LLT;20,1
3713;C145571;Grade 3 Pulmonary Fibrosis, CTCAE;"Severe hypoxia; evidence of right-sided heart failure; radiographic pulmonary fibrosis >50-75%";Grade 3 Pulmonary fibrosis;"Severe hypoxia; evidence of right-sided heart failure; radiographic pulmonary fibrosis >50-75%";Pulmonary fibrosis;10037383;LLT;20,1
3714;C146074;Grade 4 Pulmonary Fibrosis, CTCAE;"Life-threatening consequences (e.g., hemodynamic/pulmonary complications); intubation with ventilatory support indicated; radiographic pulmonary fibrosis >75% with severe honeycombing";Grade 4 Pulmonary fibrosis;"Life-threatening consequences (e.g., hemodynamic/pulmonary complications); intubation with ventilatory support indicated; radiographic pulmonary fibrosis >75% with severe honeycombing";Pulmonary fibrosis;10037383;LLT;20,1
3715;C146509;Grade 5 Pulmonary Fibrosis, CTCAE;Death;Grade 5 Pulmonary fibrosis;Death;Pulmonary fibrosis;10037383;LLT;20,1
3716;C143791;Pulmonary Fistula, CTCAE;A disorder characterized by an abnormal communication between the lung and another organ or anatomic site.;Pulmonary fistula;A disorder characterized by an abnormal communication between the lung and another organ or anatomic site.;Pulmonary fistula;10065873;LLT;20,1
3717;C144358;Grade 1 Pulmonary Fistula, CTCAE;Asymptomatic;Grade 1 Pulmonary fistula;Asymptomatic;Pulmonary fistula;10065873;LLT;20,1
3718;C144950;Grade 2 Pulmonary Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Pulmonary fistula;Symptomatic, invasive intervention not indicated;Pulmonary fistula;10065873;LLT;20,1
3719;C145572;Grade 3 Pulmonary Fistula, CTCAE;Invasive intervention indicated;Grade 3 Pulmonary fistula;Invasive intervention indicated;Pulmonary fistula;10065873;LLT;20,1
3720;C146075;Grade 4 Pulmonary Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Pulmonary fistula;"Life-threatening consequences; urgent intervention indicated";Pulmonary fistula;10065873;LLT;20,1
3721;C146510;Grade 5 Pulmonary Fistula, CTCAE;Death;Grade 5 Pulmonary fistula;Death;Pulmonary fistula;10065873;LLT;20,1
3722;C55068;Pulmonary Hypertension, CTCAE;A disorder characterized by an increase in pressure within the pulmonary circulation due to lung or heart disorder.;Pulmonary hypertension;A disorder characterized by an increase in pressure within the pulmonary circulation due to lung or heart disorder.;Pulmonary hypertension;10037400;LLT;20,1
3723;C55002;Grade 1 Pulmonary Hypertension, CTCAE;"Minimal dyspnea; findings on physical exam or other evaluation";Grade 1 Pulmonary hypertension;"Minimal dyspnea; findings on physical exam or other evaluation";Pulmonary hypertension;10037400;LLT;20,1
3724;C55013;Grade 2 Pulmonary Hypertension, CTCAE;"Moderate dyspnea, cough; requiring evaluation by cardiac catheterization and medical intervention";Grade 2 Pulmonary hypertension;"Moderate dyspnea, cough; requiring evaluation by cardiac catheterization and medical intervention";Pulmonary hypertension;10037400;LLT;20,1
3725;C55027;Grade 3 Pulmonary Hypertension, CTCAE;"Severe symptoms, associated with hypoxia, right heart failure; oxygen indicated";Grade 3 Pulmonary hypertension;"Severe symptoms, associated with hypoxia, right heart failure; oxygen indicated";Pulmonary hypertension;10037400;LLT;20,1
3726;C55041;Grade 4 Pulmonary Hypertension, CTCAE;"Life-threatening airway consequences; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Pulmonary hypertension;"Life-threatening airway consequences; urgent intervention indicated (e.g., tracheotomy or intubation)";Pulmonary hypertension;10037400;LLT;20,1
3727;C55055;Grade 5 Pulmonary Hypertension, CTCAE;Death;Grade 5 Pulmonary hypertension;Death;Pulmonary hypertension;10037400;LLT;20,1
3728;C143809;Respiratory Failure, CTCAE;A disorder characterized by impaired gas exchange by the respiratory system resulting in hypoxia and a decrease in oxygenation of the tissues that may be associated with an increase in arterial levels of carbon dioxide.;Respiratory failure;A disorder characterized by impaired gas exchange by the respiratory system resulting in hypoxia and a decrease in oxygenation of the tissues that may be associated with an increase in arterial levels of carbon dioxide.;Respiratory failure;10038695;LLT;20,1
3729;C146095;Grade 4 Respiratory Failure, CTCAE;"Life-threatening consequences; urgent intervention, intubation, or ventilatory support indicated";Grade 4 Respiratory failure;"Life-threatening consequences; urgent intervention, intubation, or ventilatory support indicated";Respiratory failure;10038695;LLT;20,1
3730;C146530;Grade 5 Respiratory Failure, CTCAE;Death;Grade 5 Respiratory failure;Death;Respiratory failure;10038695;LLT;20,1
3731;C143810;Respiratory, Thoracic and Mediastinal Disorders - Other, Specify, CTCAE;;Respiratory, thoracic and mediastinal disorders - Other, specify;;Respiratory, thoracic and mediastinal disorders - Other, specify;10038738;LLT;20,1
3732;C144381;Grade 1 Respiratory, Thoracic and Mediastinal Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Respiratory, thoracic and mediastinal disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Respiratory, thoracic and mediastinal disorders - Other, specify;10038738;LLT;20,1
3733;C144975;Grade 2 Respiratory, Thoracic and Mediastinal Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Respiratory, thoracic and mediastinal disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Respiratory, thoracic and mediastinal disorders - Other, specify;10038738;LLT;20,1
3734;C145598;Grade 3 Respiratory, Thoracic and Mediastinal Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Respiratory, thoracic and mediastinal disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Respiratory, thoracic and mediastinal disorders - Other, specify;10038738;LLT;20,1
3735;C146096;Grade 4 Respiratory, Thoracic and Mediastinal Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Respiratory, thoracic and mediastinal disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Respiratory, thoracic and mediastinal disorders - Other, specify;10038738;LLT;20,1
3736;C146531;Grade 5 Respiratory, Thoracic and Mediastinal Disorders - Other, Specify, CTCAE;Death;Grade 5 Respiratory, thoracic and mediastinal disorders - Other, specify;Death;Respiratory, thoracic and mediastinal disorders - Other, specify;10038738;LLT;20,1
3737;C56635;Retinoic Acid Syndrome, CTCAE;A disorder characterized by weight gain, dyspnea, pleural and pericardial effusions, leukocytosis and/or renal failure originally described in patients treated with all-trans retinoic acid.;Retinoic acid syndrome;A disorder characterized by weight gain, dyspnea, pleural and pericardial effusions, leukocytosis and/or renal failure originally described in patients treated with all-trans retinoic acid.;Retinoic acid syndrome;10038921;LLT;20,1
3738;C56606;Grade 1 Retinoic Acid Syndrome, CTCAE;"Fluid retention; <3 kg of weight gain; intervention with fluid restriction and/or diuretics indicated";Grade 1 Retinoic acid syndrome;"Fluid retention; <3 kg of weight gain; intervention with fluid restriction and/or diuretics indicated";Retinoic acid syndrome;10038921;LLT;20,1
3739;C56611;Grade 2 Retinoic Acid Syndrome, CTCAE;"Moderate signs or symptoms; steroids indicated";Grade 2 Retinoic acid syndrome;"Moderate signs or symptoms; steroids indicated";Retinoic acid syndrome;10038921;LLT;20,1
3740;C56617;Grade 3 Retinoic Acid Syndrome, CTCAE;"Severe symptoms; hospitalization indicated";Grade 3 Retinoic acid syndrome;"Severe symptoms; hospitalization indicated";Retinoic acid syndrome;10038921;LLT;20,1
3741;C56623;Grade 4 Retinoic Acid Syndrome, CTCAE;"Life-threatening consequences; ventilatory support indicated";Grade 4 Retinoic acid syndrome;"Life-threatening consequences; ventilatory support indicated";Retinoic acid syndrome;10038921;LLT;20,1
3742;C56629;Grade 5 Retinoic Acid Syndrome, CTCAE;Death;Grade 5 Retinoic acid syndrome;Death;Retinoic acid syndrome;10038921;LLT;20,1
3743;C143242;Rhinorrhea, CTCAE;A disorder characterized by excessive mucous secretions draining from the nose.;Rhinorrhea;A disorder characterized by excessive mucous secretions draining from the nose.;Rhinorrhea;10039100;LLT;20,1
3744;C144385;Grade 1 Rhinorrhea, CTCAE;Present;Grade 1 Rhinorrhea;Present;Rhinorrhea;10039100;LLT;20,1
3745;C143831;Sinus Disorder, CTCAE;A disorder characterized by involvement of the paranasal sinuses.;Sinus disorder;A disorder characterized by involvement of the paranasal sinuses.;Sinus disorder;10062244;LLT;20,1
3746;C144396;Grade 1 Sinus Disorder, CTCAE;"Asymptomatic mucosal crusting; blood-tinged secretions";Grade 1 Sinus disorder;"Asymptomatic mucosal crusting; blood-tinged secretions";Sinus disorder;10062244;LLT;20,1
3747;C144993;Grade 2 Sinus Disorder, CTCAE;"Symptomatic stenosis or edema/narrowing interfering with airflow; limiting instrumental ADL";Grade 2 Sinus disorder;"Symptomatic stenosis or edema/narrowing interfering with airflow; limiting instrumental ADL";Sinus disorder;10062244;LLT;20,1
3748;C145614;Grade 3 Sinus Disorder, CTCAE;"Stenosis with significant nasal obstruction; limiting self care ADL";Grade 3 Sinus disorder;"Stenosis with significant nasal obstruction; limiting self care ADL";Sinus disorder;10062244;LLT;20,1
3749;C146108;Grade 4 Sinus Disorder, CTCAE;"Necrosis of soft tissue or bone; urgent operative intervention indicated";Grade 4 Sinus disorder;"Necrosis of soft tissue or bone; urgent operative intervention indicated";Sinus disorder;10062244;LLT;20,1
3750;C146540;Grade 5 Sinus Disorder, CTCAE;Death;Grade 5 Sinus disorder;Death;Sinus disorder;10062244;LLT;20,1
3751;C146783;Sinus Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the face, between the eyes, or upper teeth originating from the sinuses.;Sinus pain;A disorder characterized by a sensation of marked discomfort in the face, between the eyes, or upper teeth originating from the sinuses.;Sinus pain;10040747;LLT;20,1
3752;C56221;Grade 1 Sinus Pain, CTCAE;Mild pain;Grade 1 Sinus pain;Mild pain;Sinus pain;10040747;LLT;20,1
3753;C56222;Grade 2 Sinus Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Sinus pain;"Moderate pain; limiting instrumental ADL";Sinus pain;10040747;LLT;20,1
3754;C56223;Grade 3 Sinus Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Sinus pain;"Severe pain; limiting self care ADL";Sinus pain;10040747;LLT;20,1
3755;C143840;Sleep Apnea, CTCAE;A disorder characterized by cessation of breathing for short periods during sleep.;Sleep apnea;A disorder characterized by cessation of breathing for short periods during sleep.;Sleep apnea;10040975;LLT;20,1
3756;C144404;Grade 1 Sleep Apnea, CTCAE;Snoring and nocturnal sleep arousal without apneic periods;Grade 1 Sleep apnea;Snoring and nocturnal sleep arousal without apneic periods;Sleep apnea;10040975;LLT;20,1
3757;C145003;Grade 2 Sleep Apnea, CTCAE;"Moderate apnea and oxygen desaturation; excessive daytime sleepiness; medical evaluation indicated; limiting instrumental ADL";Grade 2 Sleep apnea;"Moderate apnea and oxygen desaturation; excessive daytime sleepiness; medical evaluation indicated; limiting instrumental ADL";Sleep apnea;10040975;LLT;20,1
3758;C145622;Grade 3 Sleep Apnea, CTCAE;"Oxygen desaturation; associated with pulmonary hypertension; medical intervention indicated; limiting self care ADL";Grade 3 Sleep apnea;"Oxygen desaturation; associated with pulmonary hypertension; medical intervention indicated; limiting self care ADL";Sleep apnea;10040975;LLT;20,1
3759;C146115;Grade 4 Sleep Apnea, CTCAE;"Cardiovascular or neuropsychiatric symptoms; urgent operative intervention indicated";Grade 4 Sleep apnea;"Cardiovascular or neuropsychiatric symptoms; urgent operative intervention indicated";Sleep apnea;10040975;LLT;20,1
3760;C146547;Grade 5 Sleep Apnea, CTCAE;Death;Grade 5 Sleep apnea;Death;Sleep apnea;10040975;LLT;20,1
3761;C143847;Sneezing, CTCAE;A disorder characterized by the involuntary expulsion of air from the nose.;Sneezing;A disorder characterized by the involuntary expulsion of air from the nose.;Sneezing;10041232;LLT;20,1
3762;C144410;Grade 1 Sneezing, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Sneezing;"Mild symptoms; intervention not indicated";Sneezing;10041232;LLT;20,1
3763;C145011;Grade 2 Sneezing, CTCAE;"Moderate symptoms; medical intervention indicated";Grade 2 Sneezing;"Moderate symptoms; medical intervention indicated";Sneezing;10041232;LLT;20,1
3764;C143853;Sore Throat, CTCAE;A disorder characterized by marked discomfort in the throat;Sore throat;A disorder characterized by marked discomfort in the throat;Sore throat;10041367;LLT;20,1
3765;C144413;Grade 1 Sore Throat, CTCAE;Mild pain;Grade 1 Sore throat;Mild pain;Sore throat;10041367;LLT;20,1
3766;C145017;Grade 2 Sore Throat, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Sore throat;"Moderate pain; limiting instrumental ADL";Sore throat;10041367;LLT;20,1
3767;C145635;Grade 3 Sore Throat, CTCAE;"Severe pain; limiting self care ADL; limiting ability to swallow";Grade 3 Sore throat;"Severe pain; limiting self care ADL; limiting ability to swallow";Sore throat;10041367;LLT;20,1
3768;C143861;Stridor, CTCAE;A disorder characterized by a high pitched breathing sound due to laryngeal or upper airway obstruction.;Stridor;A disorder characterized by a high pitched breathing sound due to laryngeal or upper airway obstruction.;Stridor;10042241;LLT;20,1
3769;C145645;Grade 3 Stridor, CTCAE;"Respiratory distress limiting self care ADL; medical intervention indicated";Grade 3 Stridor;"Respiratory distress limiting self care ADL; medical intervention indicated";Stridor;10042241;LLT;20,1
3770;C146136;Grade 4 Stridor, CTCAE;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Stridor;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Stridor;10042241;LLT;20,1
3771;C146568;Grade 5 Stridor, CTCAE;Death;Grade 5 Stridor;Death;Stridor;10042241;LLT;20,1
3772;C58205;Tracheal Fistula, CTCAE;A disorder characterized by an abnormal communication between the trachea and another organ or anatomic site.;Tracheal fistula;A disorder characterized by an abnormal communication between the trachea and another organ or anatomic site.;Tracheal fistula;10065787;LLT;20,1
3773;C58054;Grade 1 Tracheal Fistula, CTCAE;Asymptomatic;Grade 1 Tracheal fistula;Asymptomatic;Tracheal fistula;10065787;LLT;20,1
3774;C58086;Grade 2 Tracheal Fistula, CTCAE;Symptomatic, invasive intervention not indicated;Grade 2 Tracheal fistula;Symptomatic, invasive intervention not indicated;Tracheal fistula;10065787;LLT;20,1
3775;C58119;Grade 3 Tracheal Fistula, CTCAE;Invasive intervention indicated;Grade 3 Tracheal fistula;Invasive intervention indicated;Tracheal fistula;10065787;LLT;20,1
3776;C58150;Grade 4 Tracheal Fistula, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Tracheal fistula;"Life-threatening consequences; urgent intervention indicated";Tracheal fistula;10065787;LLT;20,1
3777;C58181;Grade 5 Tracheal Fistula, CTCAE;Death;Grade 5 Tracheal fistula;Death;Tracheal fistula;10065787;LLT;20,1
3778;C143881;Tracheal Mucositis, CTCAE;A disorder characterized by an inflammation or ulceration involving the mucous membrane of the trachea.;Tracheal mucositis;A disorder characterized by an inflammation or ulceration involving the mucous membrane of the trachea.;Tracheal mucositis;10065900;LLT;20,1
3779;C144439;Grade 1 Tracheal Mucositis, CTCAE;"Endoscopic findings only; minimal hemoptysis, pain, or respiratory symptoms";Grade 1 Tracheal mucositis;"Endoscopic findings only; minimal hemoptysis, pain, or respiratory symptoms";Tracheal mucositis;10065900;LLT;20,1
3780;C145043;Grade 2 Tracheal Mucositis, CTCAE;"Moderate symptoms; medical intervention indicated; limiting instrumental ADL";Grade 2 Tracheal mucositis;"Moderate symptoms; medical intervention indicated; limiting instrumental ADL";Tracheal mucositis;10065900;LLT;20,1
3781;C145665;Grade 3 Tracheal Mucositis, CTCAE;"Severe pain; hemorrhage or respiratory symptoms; limiting self care ADL";Grade 3 Tracheal mucositis;"Severe pain; hemorrhage or respiratory symptoms; limiting self care ADL";Tracheal mucositis;10065900;LLT;20,1
3782;C146151;Grade 4 Tracheal Mucositis, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Tracheal mucositis;"Life-threatening consequences; urgent intervention indicated";Tracheal mucositis;10065900;LLT;20,1
3783;C146582;Grade 5 Tracheal Mucositis, CTCAE;Death;Grade 5 Tracheal mucositis;Death;Tracheal mucositis;10065900;LLT;20,1
3784;C143883;Tracheal Stenosis, CTCAE;A disorder characterized by a narrowing of the trachea.;Tracheal stenosis;A disorder characterized by a narrowing of the trachea.;Tracheal stenosis;10050816;LLT;20,1
3785;C144441;Grade 1 Tracheal Stenosis, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Tracheal stenosis;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Tracheal stenosis;10050816;LLT;20,1
3786;C145045;Grade 2 Tracheal Stenosis, CTCAE;"Symptomatic (e.g., noisy airway breathing), no respiratory distress; medical intervention indicated (e.g., steroids); limiting instrumental ADL";Grade 2 Tracheal stenosis;"Symptomatic (e.g., noisy airway breathing), no respiratory distress; medical intervention indicated (e.g., steroids); limiting instrumental ADL";Tracheal stenosis;10050816;LLT;20,1
3787;C145667;Grade 3 Tracheal Stenosis, CTCAE;"Stridor or respiratory distress limiting self care ADL; invasive intervention indicated (e.g., stent, laser)";Grade 3 Tracheal stenosis;"Stridor or respiratory distress limiting self care ADL; invasive intervention indicated (e.g., stent, laser)";Tracheal stenosis;10050816;LLT;20,1
3788;C146153;Grade 4 Tracheal Stenosis, CTCAE;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Grade 4 Tracheal stenosis;"Life-threatening airway compromise; urgent intervention indicated (e.g., tracheotomy or intubation)";Tracheal stenosis;10050816;LLT;20,1
3789;C146584;Grade 5 Tracheal Stenosis, CTCAE;Death;Grade 5 Tracheal stenosis;Death;Tracheal stenosis;10050816;LLT;20,1
3790;C143941;Voice Alteration, CTCAE;A disorder characterized by a change in the sound and/or speed of the voice.;Voice alteration;A disorder characterized by a change in the sound and/or speed of the voice.;Voice alteration;10047681;LLT;20,1
3791;C144485;Grade 1 Voice Alteration, CTCAE;Mild or intermittent change from normal voice;Grade 1 Voice alteration;Mild or intermittent change from normal voice;Voice alteration;10047681;LLT;20,1
3792;C145101;Grade 2 Voice Alteration, CTCAE;"Moderate or persistent change from normal voice; still understandable";Grade 2 Voice alteration;"Moderate or persistent change from normal voice; still understandable";Voice alteration;10047681;LLT;20,1
3793;C145721;Grade 3 Voice Alteration, CTCAE;"Severe voice changes including predominantly whispered speech; may require frequent repetition or face-to-face contact for understandability; may require assistive technology";Grade 3 Voice alteration;"Severe voice changes including predominantly whispered speech; may require frequent repetition or face-to-face contact for understandability; may require assistive technology";Voice alteration;10047681;LLT;20,1
3794;C143947;Wheezing, CTCAE;A disorder characterized by a high-pitched, whistling sound during breathing. It results from the narrowing or obstruction of the respiratory airways.;Wheezing;A disorder characterized by a high-pitched, whistling sound during breathing. It results from the narrowing or obstruction of the respiratory airways.;Wheezing;10047924;LLT;20,1
3795;C144488;Grade 1 Wheezing, CTCAE;Detectable airway noise with minimal symptoms;Grade 1 Wheezing;Detectable airway noise with minimal symptoms;Wheezing;10047924;LLT;20,1
3796;C145104;Grade 2 Wheezing, CTCAE;"Moderate symptoms; medical intervention indicated; limiting instrumental ADL";Grade 2 Wheezing;"Moderate symptoms; medical intervention indicated; limiting instrumental ADL";Wheezing;10047924;LLT;20,1
3797;C145724;Grade 3 Wheezing, CTCAE;"Severe respiratory symptoms limiting self care ADL; oxygen therapy or hospitalization indicated";Grade 3 Wheezing;"Severe respiratory symptoms limiting self care ADL; oxygen therapy or hospitalization indicated";Wheezing;10047924;LLT;20,1
3798;C146197;Grade 4 Wheezing, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Wheezing;"Life-threatening consequences; urgent intervention indicated";Wheezing;10047924;LLT;20,1
3799;C146622;Grade 5 Wheezing, CTCAE;Death;Grade 5 Wheezing;Death;Wheezing;10047924;LLT;20,1
3800;C143182;Skin and Subcutaneous Tissue Disorders, CTCAE;;;;;;;
3801;C57898;Alopecia, CTCAE;A disorder characterized by a decrease in density of hair compared to normal for a given individual at a given age and body location.;Alopecia;A disorder characterized by a decrease in density of hair compared to normal for a given individual at a given age and body location.;Alopecia;10001760;LLT;20,1
3802;C57902;Grade 1 Alopecia, CTCAE;"Hair loss of <50% of normal for that individual that is not obvious from a distance but only on close inspection; a different hair style may be required to cover the hair loss but it does not require a wig or hair piece to camouflage";Grade 1 Alopecia;"Hair loss of <50% of normal for that individual that is not obvious from a distance but only on close inspection; a different hair style may be required to cover the hair loss but it does not require a wig or hair piece to camouflage";Alopecia;10001760;LLT;20,1
3803;C57927;Grade 2 Alopecia, CTCAE;"Hair loss of >=50% normal for that individual that is readily apparent to others; a wig or hair piece is necessary if the patient desires to completely camouflage the hair loss; associated with psychosocial impact";Grade 2 Alopecia;"Hair loss of >=50% normal for that individual that is readily apparent to others; a wig or hair piece is necessary if the patient desires to completely camouflage the hair loss; associated with psychosocial impact";Alopecia;10001760;LLT;20,1
3804;C143330;Body Odor, CTCAE;A disorder characterized by an abnormal body smell resulting from the growth of bacteria on the body.;Body odor;A disorder characterized by an abnormal body smell resulting from the growth of bacteria on the body.;Body odor;10005901;LLT;20,1
3805;C144008;Grade 1 Body Odor, CTCAE;"Mild odor; physician intervention not indicated; self care interventions";Grade 1 Body odor;"Mild odor; physician intervention not indicated; self care interventions";Body odor;10005901;LLT;20,1
3806;C144550;Grade 2 Body Odor, CTCAE;"Pronounced odor; psychosocial impact; patient seeks medical intervention";Grade 2 Body odor;"Pronounced odor; psychosocial impact; patient seeks medical intervention";Body odor;10005901;LLT;20,1
3807;C143346;Bullous Dermatitis, CTCAE;A disorder characterized by inflammation of the skin characterized by the presence of bullae which are filled with fluid.;Bullous dermatitis;A disorder characterized by inflammation of the skin characterized by the presence of bullae which are filled with fluid.;Bullous dermatitis;10006556;LLT;20,1
3808;C144018;Grade 1 Bullous Dermatitis, CTCAE;"Asymptomatic; blisters covering <10% BSA";Grade 1 Bullous dermatitis;"Asymptomatic; blisters covering <10% BSA";Bullous dermatitis;10006556;LLT;20,1
3809;C144564;Grade 2 Bullous Dermatitis, CTCAE;"Blisters covering 10-30% BSA; painful blisters; limiting instrumental ADL";Grade 2 Bullous dermatitis;"Blisters covering 10-30% BSA; painful blisters; limiting instrumental ADL";Bullous dermatitis;10006556;LLT;20,1
3810;C145179;Grade 3 Bullous Dermatitis, CTCAE;"Blisters covering >30% BSA; limiting self care ADL";Grade 3 Bullous dermatitis;"Blisters covering >30% BSA; limiting self care ADL";Bullous dermatitis;10006556;LLT;20,1
3811;C145779;Grade 4 Bullous Dermatitis, CTCAE;"Blisters covering >30% BSA; associated with fluid or electrolyte abnormalities; ICU care or burn unit indicated";Grade 4 Bullous dermatitis;"Blisters covering >30% BSA; associated with fluid or electrolyte abnormalities; ICU care or burn unit indicated";Bullous dermatitis;10006556;LLT;20,1
3812;C146247;Grade 5 Bullous Dermatitis, CTCAE;Death;Grade 5 Bullous dermatitis;Death;Bullous dermatitis;10006556;LLT;20,1
3813;C57996;Dry Skin, CTCAE;"A disorder characterized by flaky and dull skin; the pores are generally fine, the texture is a papery thin texture.";Dry skin;"A disorder characterized by flaky and dull skin; the pores are generally fine, the texture is a papery thin texture.";Dry skin;10013786;LLT;20,1
3814;C57907;Grade 1 Dry Skin, CTCAE;Covering <10% BSA and no associated erythema or pruritus;Grade 1 Dry skin;Covering <10% BSA and no associated erythema or pruritus;Dry skin;10013786;LLT;20,1
3815;C57932;Grade 2 Dry Skin, CTCAE;"Covering 10-30% BSA and associated with erythema or pruritus; limiting instrumental ADL";Grade 2 Dry skin;"Covering 10-30% BSA and associated with erythema or pruritus; limiting instrumental ADL";Dry skin;10013786;LLT;20,1
3816;C57958;Grade 3 Dry Skin, CTCAE;"Covering >30% BSA and associated with pruritus; limiting self care ADL";Grade 3 Dry skin;"Covering >30% BSA and associated with pruritus; limiting self care ADL";Dry skin;10013786;LLT;20,1
3817;C143243;Eczema, CTCAE;A disorder characterized by skin which becomes itchy, red, inflamed, crusty, thick, scaly, and/or forms blisters.;Eczema;A disorder characterized by skin which becomes itchy, red, inflamed, crusty, thick, scaly, and/or forms blisters.;Eczema;10014184;LLT;20,1
3818;C144070;Grade 1 Eczema, CTCAE;"Asymptomatic or mild symptoms;??additional medical intervention over baseline not indicated";Grade 1 Eczema;"Asymptomatic or mild symptoms;??additional medical intervention over baseline not indicated";Eczema;10014184;LLT;20,1
3819;C144625;Grade 2 Eczema, CTCAE;"Moderate; topical or oral intervention indicated; additional medical intervention over baseline indicated";Grade 2 Eczema;"Moderate; topical or oral intervention indicated; additional medical intervention over baseline indicated";Eczema;10014184;LLT;20,1
3820;C145241;Grade 3 Eczema, CTCAE;"Severe or medically significant but not immediately life-threatening; IV intervention indicated";Grade 3 Eczema;"Severe or medically significant but not immediately life-threatening; IV intervention indicated";Eczema;10014184;LLT;20,1
3821;C143449;Erythema Multiforme, CTCAE;A disorder characterized by target lesions (a pink-red ring around a pale center).;Erythema multiforme;A disorder characterized by target lesions (a pink-red ring around a pale center).;Erythema multiforme;10015218;LLT;20,1
3822;C144084;Grade 1 Erythema Multiforme, CTCAE;Target lesions covering <10% BSA and not associated with skin tenderness;Grade 1 Erythema multiforme;Target lesions covering <10% BSA and not associated with skin tenderness;Erythema multiforme;10015218;LLT;20,1
3823;C144640;Grade 2 Erythema Multiforme, CTCAE;Target lesions covering 10-30% BSA and associated with skin tenderness;Grade 2 Erythema multiforme;Target lesions covering 10-30% BSA and associated with skin tenderness;Erythema multiforme;10015218;LLT;20,1
3824;C145259;Grade 3 Erythema Multiforme, CTCAE;Target lesions covering >30% BSA and associated with oral or genital erosions;Grade 3 Erythema multiforme;Target lesions covering >30% BSA and associated with oral or genital erosions;Erythema multiforme;10015218;LLT;20,1
3825;C145840;Grade 4 Erythema Multiforme, CTCAE;"Target lesions covering >30% BSA; associated with fluid or electrolyte abnormalities; ICU care or burn unit indicated";Grade 4 Erythema multiforme;"Target lesions covering >30% BSA; associated with fluid or electrolyte abnormalities; ICU care or burn unit indicated";Erythema multiforme;10015218;LLT;20,1
3826;C146298;Grade 5 Erythema Multiforme, CTCAE;Death;Grade 5 Erythema multiforme;Death;Erythema multiforme;10015218;LLT;20,1
3827;C143450;Erythroderma, CTCAE;A disorder characterized by generalized inflammatory erythema and exfoliation. The inflammatory process involves > 90% of the body surface area.;Erythroderma;A disorder characterized by generalized inflammatory erythema and exfoliation. The inflammatory process involves > 90% of the body surface area.;Erythroderma;10015277;LLT;20,1
3828;C144641;Grade 2 Erythroderma, CTCAE;"Erythema covering >90% BSA without associated symptoms; limiting instrumental ADL";Grade 2 Erythroderma;"Erythema covering >90% BSA without associated symptoms; limiting instrumental ADL";Erythroderma;10015277;LLT;20,1
3829;C145260;Grade 3 Erythroderma, CTCAE;"Erythema covering >90% BSA with associated symptoms (e.g., pruritus or tenderness); limiting self care ADL";Grade 3 Erythroderma;"Erythema covering >90% BSA with associated symptoms (e.g., pruritus or tenderness); limiting self care ADL";Erythroderma;10015277;LLT;20,1
3830;C145841;Grade 4 Erythroderma, CTCAE;"Erythema covering >90% BSA with associated fluid or electrolyte abnormalities; ICU care or burn unit indicated";Grade 4 Erythroderma;"Erythema covering >90% BSA with associated fluid or electrolyte abnormalities; ICU care or burn unit indicated";Erythroderma;10015277;LLT;20,1
3831;C146299;Grade 5 Erythroderma, CTCAE;Death;Grade 5 Erythroderma;Death;Erythroderma;10015277;LLT;20,1
3832;C143479;Fat Atrophy, CTCAE;A disorder characterized by shrinking of adipose tissue.;Fat atrophy;A disorder characterized by shrinking of adipose tissue.;Fat atrophy;10016241;LLT;20,1
3833;C144101;Grade 1 Fat Atrophy, CTCAE;Covering <10% BSA and asymptomatic;Grade 1 Fat atrophy;Covering <10% BSA and asymptomatic;Fat atrophy;10016241;LLT;20,1
3834;C144661;Grade 2 Fat Atrophy, CTCAE;"Covering 10-30% BSA and associated with erythema or tenderness; limiting instrumental ADL";Grade 2 Fat atrophy;"Covering 10-30% BSA and associated with erythema or tenderness; limiting instrumental ADL";Fat atrophy;10016241;LLT;20,1
3835;C145281;Grade 3 Fat Atrophy, CTCAE;"Covering >30% BSA; associated with erythema or tenderness; limiting self-care ADL";Grade 3 Fat atrophy;"Covering >30% BSA; associated with erythema or tenderness; limiting self-care ADL";Fat atrophy;10016241;LLT;20,1
3836;C143244;Hair Color Changes, CTCAE;A disorder characterized by change in hair color or loss of normal pigmentation.;Hair color changes;A disorder characterized by change in hair color or loss of normal pigmentation.;Hair color changes;10055525;LLT;20,1
3837;C144139;Grade 1 Hair Color Changes, CTCAE;Present;Grade 1 Hair color changes;Present;Hair color changes;10055525;LLT;20,1
3838;C143245;Hair Texture Abnormal, CTCAE;A disorder characterized by a change in the way the hair feels.;Hair texture abnormal;A disorder characterized by a change in the way the hair feels.;Hair texture abnormal;10019049;LLT;20,1
3839;C144140;Grade 1 Hair Texture Abnormal, CTCAE;Present;Grade 1 Hair texture abnormal;Present;Hair texture abnormal;10019049;LLT;20,1
3840;C143547;Hirsutism, CTCAE;A disorder characterized by the presence of excess hair growth in women in anatomic sites where growth is considered to be a secondary male characteristic and under androgen control (beard, moustache, chest, abdomen).;Hirsutism;A disorder characterized by the presence of excess hair growth in women in anatomic sites where growth is considered to be a secondary male characteristic and under androgen control (beard, moustache, chest, abdomen).;Hirsutism;10020112;LLT;20,1
3841;C144157;Grade 1 Hirsutism, CTCAE;In women, increase in length, thickness or density of hair in a male distribution that the patient is able to camouflage by periodic shaving, bleaching, or removal of hair;Grade 1 Hirsutism;In women, increase in length, thickness or density of hair in a male distribution that the patient is able to camouflage by periodic shaving, bleaching, or removal of hair;Hirsutism;10020112;LLT;20,1
3842;C144720;Grade 2 Hirsutism, CTCAE;"In women, increase in length, thickness or density of hair in a male distribution that requires daily shaving or consistent destructive means of hair removal to camouflage; associated with psychosocial impact";Grade 2 Hirsutism;"In women, increase in length, thickness or density of hair in a male distribution that requires daily shaving or consistent destructive means of hair removal to camouflage; associated with psychosocial impact";Hirsutism;10020112;LLT;20,1
3843;C143553;Hyperhidrosis, CTCAE;A disorder characterized by excessive sweating.;Hyperhidrosis;A disorder characterized by excessive sweating.;Hyperhidrosis;10020642;LLT;20,1
3844;C144162;Grade 1 Hyperhidrosis, CTCAE;"Limited to one site (palms, soles, or axillae); self care interventions";Grade 1 Hyperhidrosis;"Limited to one site (palms, soles, or axillae); self care interventions";Hyperhidrosis;10020642;LLT;20,1
3845;C144725;Grade 2 Hyperhidrosis, CTCAE;"Involving >1 site; patient seeks medical intervention; associated with psychosocial impact";Grade 2 Hyperhidrosis;"Involving >1 site; patient seeks medical intervention; associated with psychosocial impact";Hyperhidrosis;10020642;LLT;20,1
3846;C145346;Grade 3 Hyperhidrosis, CTCAE;Associated with electrolyte/hemodynamic imbalance;Grade 3 Hyperhidrosis;Associated with electrolyte/hemodynamic imbalance;Hyperhidrosis;10020642;LLT;20,1
3847;C143246;Hyperkeratosis, CTCAE;A disorder characterized by a thickening of the outer layer of the skin.;Hyperkeratosis;A disorder characterized by a thickening of the outer layer of the skin.;Hyperkeratosis;10020649;LLT;20,1
3848;C144164;Grade 1 Hyperkeratosis, CTCAE;Present;Grade 1 Hyperkeratosis;Present;Hyperkeratosis;10020649;LLT;20,1
3849;C145348;Grade 3 Hyperkeratosis, CTCAE;Limiting self-care ADLs;Grade 3 Hyperkeratosis;Limiting self-care ADLs;Hyperkeratosis;10020649;LLT;20,1
3850;C143561;Hypertrichosis, CTCAE;A disorder characterized by hair density or length beyond the accepted limits of normal in a particular body region, for a particular age or race.;Hypertrichosis;A disorder characterized by hair density or length beyond the accepted limits of normal in a particular body region, for a particular age or race.;Hypertrichosis;10020864;LLT;20,1
3851;C144172;Grade 1 Hypertrichosis, CTCAE;Increase in length, thickness or density of hair that the patient is either able to camouflage by periodic shaving or removal of hairs or is not concerned enough about the overgrowth to use any form of hair removal;Grade 1 Hypertrichosis;Increase in length, thickness or density of hair that the patient is either able to camouflage by periodic shaving or removal of hairs or is not concerned enough about the overgrowth to use any form of hair removal;Hypertrichosis;10020864;LLT;20,1
3852;C144733;Grade 2 Hypertrichosis, CTCAE;"Increase in length, thickness or density of hair at least on the usual exposed areas of the body [face (not limited to beard/moustache area) plus/minus arms] that requires frequent shaving or use of destructive means of hair removal to camouflage; associated with psychosocial impact";Grade 2 Hypertrichosis;"Increase in length, thickness or density of hair at least on the usual exposed areas of the body [face (not limited to beard/moustache area) plus/minus arms] that requires frequent shaving or use of destructive means of hair removal to camouflage; associated with psychosocial impact";Hypertrichosis;10020864;LLT;20,1
3853;C143568;Hypohidrosis, CTCAE;A disorder characterized by reduced sweating.;Hypohidrosis;A disorder characterized by reduced sweating.;Hypohidrosis;10021013;LLT;20,1
3854;C144739;Grade 2 Hypohidrosis, CTCAE;"Symptomatic; limiting instrumental ADL";Grade 2 Hypohidrosis;"Symptomatic; limiting instrumental ADL";Hypohidrosis;10021013;LLT;20,1
3855;C145361;Grade 3 Hypohidrosis, CTCAE;"Increase in body temperature; limiting self care ADL";Grade 3 Hypohidrosis;"Increase in body temperature; limiting self care ADL";Hypohidrosis;10021013;LLT;20,1
3856;C145910;Grade 4 Hypohidrosis, CTCAE;Heat stroke;Grade 4 Hypohidrosis;Heat stroke;Hypohidrosis;10021013;LLT;20,1
3857;C146357;Grade 5 Hypohidrosis, CTCAE;Death;Grade 5 Hypohidrosis;Death;Hypohidrosis;10021013;LLT;20,1
3858;C143653;Lipohypertrophy, CTCAE;A disorder characterized by hypertrophy of the subcutaneous adipose tissue at the site of multiple subcutaneous injections of insulin.;Lipohypertrophy;A disorder characterized by hypertrophy of the subcutaneous adipose tissue at the site of multiple subcutaneous injections of insulin.;Lipohypertrophy;10062315;LLT;20,1
3859;C144250;Grade 1 Lipohypertrophy, CTCAE;Asymptomatic and covering <10% BSA;Grade 1 Lipohypertrophy;Asymptomatic and covering <10% BSA;Lipohypertrophy;10062315;LLT;20,1
3860;C144822;Grade 2 Lipohypertrophy, CTCAE;"Covering 10-30% BSA and associated tenderness; limiting instrumental ADL";Grade 2 Lipohypertrophy;"Covering 10-30% BSA and associated tenderness; limiting instrumental ADL";Lipohypertrophy;10062315;LLT;20,1
3861;C145442;Grade 3 Lipohypertrophy, CTCAE;"Covering >30% BSA and associated tenderness and narcotics or NSAIDs indicated; lipohypertrophy; limiting self care ADL";Grade 3 Lipohypertrophy;"Covering >30% BSA and associated tenderness and narcotics or NSAIDs indicated; lipohypertrophy; limiting self care ADL";Lipohypertrophy;10062315;LLT;20,1
3862;C143247;Nail Changes, CTCAE 5.0;A disorder characterized by a change in the nails.;Nail changes;A disorder characterized by a change in the nails.;Nail changes;10028689;LLT;20,1
3863;C57913;Grade 1 Nail Changes, CTCAE;Present;Grade 1 Nail changes;Present;Nail changes;10028689;LLT;20,1
3864;C143694;Nail Discoloration, CTCAE;A disorder characterized by a change in the color of the nail plate.;Nail discoloration;A disorder characterized by a change in the color of the nail plate.;Nail discoloration;10028691;LLT;20,1
3865;C144280;Grade 1 Nail Discoloration, CTCAE;"Asymptomatic; clinical or diagnostic observations only";Grade 1 Nail discoloration;"Asymptomatic; clinical or diagnostic observations only";Nail discoloration;10028691;LLT;20,1
3866;C143696;Nail Loss, CTCAE;A disorder characterized by loss of all or a portion of the nail.;Nail loss;A disorder characterized by loss of all or a portion of the nail.;Nail loss;10049281;LLT;20,1
3867;C144282;Grade 1 Nail Loss, CTCAE;Asymptomatic separation of the nail bed from the nail plate or nail loss;Grade 1 Nail loss;Asymptomatic separation of the nail bed from the nail plate or nail loss;Nail loss;10049281;LLT;20,1
3868;C144859;Grade 2 Nail Loss, CTCAE;"Symptomatic separation of the nail bed from the nail plate or nail loss; limiting instrumental ADL";Grade 2 Nail loss;"Symptomatic separation of the nail bed from the nail plate or nail loss; limiting instrumental ADL";Nail loss;10049281;LLT;20,1
3869;C143697;Nail Ridging, CTCAE;A disorder characterized by vertical or horizontal ridges on the nails.;Nail ridging;A disorder characterized by vertical or horizontal ridges on the nails.;Nail ridging;10062283;LLT;20,1
3870;C144283;Grade 1 Nail Ridging, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Nail ridging;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Nail ridging;10062283;LLT;20,1
3871;C143724;Pain of Skin, CTCAE;A disorder characterized by a sensation of marked discomfort in the skin.;Pain of skin;A disorder characterized by a sensation of marked discomfort in the skin.;Pain of skin;10033474;LLT;20,1
3872;C144308;Grade 1 Pain of Skin, CTCAE;Mild pain;Grade 1 Pain of skin;Mild pain;Pain of skin;10033474;LLT;20,1
3873;C144887;Grade 2 Pain of Skin, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Pain of skin;"Moderate pain; limiting instrumental ADL";Pain of skin;10033474;LLT;20,1
3874;C145507;Grade 3 Pain of Skin, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Pain of skin;"Severe pain; limiting self care ADL";Pain of skin;10033474;LLT;20,1
3875;C143726;Palmar-Plantar Erythrodysesthesia Syndrome, CTCAE;A disorder characterized by redness, marked discomfort, swelling, and tingling in the palms of the hands or the soles of the feet. Also known as Hand-Foot Syndrome.;Palmar-plantar erythrodysesthesia syndrome;A disorder characterized by redness, marked discomfort, swelling, and tingling in the palms of the hands or the soles of the feet. Also known as Hand-Foot Syndrome.;Palmar-plantar erythrodysesthesia syndrome;10054524;LLT;20,1
3876;C144310;Grade 1 Palmar-Plantar Erythrodysesthesia Syndrome, CTCAE;Minimal skin changes or dermatitis (e.g., erythema, edema, or hyperkeratosis) without pain;Grade 1 Palmar-plantar erythrodysesthesia syndrome;Minimal skin changes or dermatitis (e.g., erythema, edema, or hyperkeratosis) without pain;Palmar-plantar erythrodysesthesia syndrome;10054524;LLT;20,1
3877;C144889;Grade 2 Palmar-Plantar Erythrodysesthesia Syndrome, CTCAE;"Skin changes (e.g., peeling, blisters, bleeding, fissures, edema, or hyperkeratosis) with pain; limiting instrumental ADL";Grade 2 Palmar-plantar erythrodysesthesia syndrome;"Skin changes (e.g., peeling, blisters, bleeding, fissures, edema, or hyperkeratosis) with pain; limiting instrumental ADL";Palmar-plantar erythrodysesthesia syndrome;10054524;LLT;20,1
3878;C145509;Grade 3 Palmar-Plantar Erythrodysesthesia Syndrome, CTCAE;"Severe skin changes (e.g., peeling, blisters, bleeding, fissures, edema, or hyperkeratosis) with pain; limiting self care ADL";Grade 3 Palmar-plantar erythrodysesthesia syndrome;"Severe skin changes (e.g., peeling, blisters, bleeding, fissures, edema, or hyperkeratosis) with pain; limiting self care ADL";Palmar-plantar erythrodysesthesia syndrome;10054524;LLT;20,1
3879;C58005;Photosensitivity, CTCAE;A disorder characterized by an increase in sensitivity of the skin to light.;Photosensitivity;A disorder characterized by an increase in sensitivity of the skin to light.;Photosensitivity;10034966;LLT;20,1
3880;C57916;Grade 1 Photosensitivity, CTCAE;Painless erythema and erythema covering <10% BSA;Grade 1 Photosensitivity;Painless erythema and erythema covering <10% BSA;Photosensitivity;10034966;LLT;20,1
3881;C57941;Grade 2 Photosensitivity, CTCAE;Tender erythema covering 10-30% BSA;Grade 2 Photosensitivity;Tender erythema covering 10-30% BSA;Photosensitivity;10034966;LLT;20,1
3882;C57964;Grade 3 Photosensitivity, CTCAE;"Erythema covering >30% BSA and erythema with blistering; photosensitivity; oral corticosteroid therapy indicated; pain control indicated (e.g., narcotics or NSAIDs)";Grade 3 Photosensitivity;"Erythema covering >30% BSA and erythema with blistering; photosensitivity; oral corticosteroid therapy indicated; pain control indicated (e.g., narcotics or NSAIDs)";Photosensitivity;10034966;LLT;20,1
3883;C57979;Grade 4 Photosensitivity, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Photosensitivity;"Life-threatening consequences; urgent intervention indicated";Photosensitivity;10034966;LLT;20,1
3884;C57989;Grade 5 Photosensitivity, CTCAE;Death;Grade 5 Photosensitivity;Death;Photosensitivity;10034966;LLT;20,1
3885;C58006;Pruritus, CTCAE;A disorder characterized by an intense itching sensation.;Pruritus;A disorder characterized by an intense itching sensation.;Pruritus;10037087;LLT;20,1
3886;C57917;Grade 1 Pruritus, CTCAE;"Mild or localized; topical intervention indicated";Grade 1 Pruritus;"Mild or localized; topical intervention indicated";Pruritus;10037087;LLT;20,1
3887;C57942;Grade 2 Pruritus, CTCAE;"Widespread and intermittent; skin changes from scratching (e.g., edema, papulation, excoriations, lichenification, oozing/crusts); oral intervention indicated; limiting instrumental ADL";Grade 2 Pruritus;"Widespread and intermittent; skin changes from scratching (e.g., edema, papulation, excoriations, lichenification, oozing/crusts); oral intervention indicated; limiting instrumental ADL";Pruritus;10037087;LLT;20,1
3888;C57965;Grade 3 Pruritus, CTCAE;"Widespread and constant; limiting self care ADL or sleep; systemic corticosteroid or immunosuppressive therapy indicated";Grade 3 Pruritus;"Widespread and constant; limiting self care ADL or sleep; systemic corticosteroid or immunosuppressive therapy indicated";Pruritus;10037087;LLT;20,1
3889;C143794;Purpura, CTCAE;A disorder characterized by hemorrhagic areas of the skin and mucous membrane. Newer lesions appear reddish in color. Older lesions are usually a darker purple color and eventually become a brownish-yellow color.;Purpura;A disorder characterized by hemorrhagic areas of the skin and mucous membrane. Newer lesions appear reddish in color. Older lesions are usually a darker purple color and eventually become a brownish-yellow color.;Purpura;10037549;LLT;20,1
3890;C144360;Grade 1 Purpura, CTCAE;Combined area of lesions covering <10% BSA;Grade 1 Purpura;Combined area of lesions covering <10% BSA;Purpura;10037549;LLT;20,1
3891;C144952;Grade 2 Purpura, CTCAE;"Combined area of lesions covering 10-30% BSA; bleeding with trauma";Grade 2 Purpura;"Combined area of lesions covering 10-30% BSA; bleeding with trauma";Purpura;10037549;LLT;20,1
3892;C145574;Grade 3 Purpura, CTCAE;"Combined area of lesions covering >30% BSA; spontaneous bleeding";Grade 3 Purpura;"Combined area of lesions covering >30% BSA; spontaneous bleeding";Purpura;10037549;LLT;20,1
3893;C143798;Rash Acneiform, CTCAE;A disorder characterized by an eruption of papules and pustules, typically appearing in face, scalp, upper chest and back.;Rash acneiform;A disorder characterized by an eruption of papules and pustules, typically appearing in face, scalp, upper chest and back.;Rash acneiform;10037847;LLT;20,1
3894;C144364;Grade 1 Rash Acneiform, CTCAE;Papules and/or pustules covering <10% BSA, which may or may not be associated with symptoms of pruritus or tenderness;Grade 1 Rash acneiform;Papules and/or pustules covering <10% BSA, which may or may not be associated with symptoms of pruritus or tenderness;Rash acneiform;10037847;LLT;20,1
3895;C144956;Grade 2 Rash Acneiform, CTCAE;"Papules and/or pustules covering 10-30% BSA, which may or may not be associated with symptoms of pruritus or tenderness; associated with psychosocial impact; limiting instrumental ADL; papules and/or pustules covering > 30% BSA with or without mild symptoms";Grade 2 Rash acneiform;"Papules and/or pustules covering 10-30% BSA, which may or may not be associated with symptoms of pruritus or tenderness; associated with psychosocial impact; limiting instrumental ADL; papules and/or pustules covering > 30% BSA with or without mild symptoms";Rash acneiform;10037847;LLT;20,1
3896;C145578;Grade 3 Rash Acneiform, CTCAE;"Papules and/or pustules covering >30% BSA with moderate or severe symptoms; limiting self-care ADL; associated with local superinfection with oral antibiotics indicated";Grade 3 Rash acneiform;"Papules and/or pustules covering >30% BSA with moderate or severe symptoms; limiting self-care ADL; associated with local superinfection with oral antibiotics indicated";Rash acneiform;10037847;LLT;20,1
3897;C146080;Grade 4 Rash Acneiform, CTCAE;"Life-threatening consequences; papules and/or pustules covering any % BSA, which may or may not be associated with symptoms of pruritus or tenderness and are associated with extensive superinfection with IV antibiotics indicated";Grade 4 Rash acneiform;"Life-threatening consequences; papules and/or pustules covering any % BSA, which may or may not be associated with symptoms of pruritus or tenderness and are associated with extensive superinfection with IV antibiotics indicated";Rash acneiform;10037847;LLT;20,1
3898;C146515;Grade 5 Rash Acneiform, CTCAE;Death;Grade 5 Rash acneiform;Death;Rash acneiform;10037847;LLT;20,1
3899;C143799;Rash Maculo-Papular, CTCAE;A disorder characterized by the presence of macules (flat) and papules (elevated). Also known as morbillform rash, it is one of the most common cutaneous adverse events, frequently affecting the upper trunk, spreading centripetally and associated with pruritis.;Rash maculo-papular;A disorder characterized by the presence of macules (flat) and papules (elevated). Also known as morbillform rash, it is one of the most common cutaneous adverse events, frequently affecting the upper trunk, spreading centripetally and associated with pruritis.;Rash maculo-papular;10037868;LLT;20,1
3900;C144365;Grade 1 Rash Maculo-Papular, CTCAE;Macules/papules covering <10% BSA with or without symptoms (e.g., pruritus, burning, tightness);Grade 1 Rash maculo-papular;Macules/papules covering <10% BSA with or without symptoms (e.g., pruritus, burning, tightness);Rash maculo-papular;10037868;LLT;20,1
3901;C144957;Grade 2 Rash Maculo-Papular, CTCAE;"Macules/papules covering 10-30% BSA with or without symptoms (e.g., pruritus, burning, tightness); limiting instrumental ADL; rash covering > 30% BSA with or without mild symptoms";Grade 2 Rash maculo-papular;"Macules/papules covering 10-30% BSA with or without symptoms (e.g., pruritus, burning, tightness); limiting instrumental ADL; rash covering > 30% BSA with or without mild symptoms";Rash maculo-papular;10037868;LLT;20,1
3902;C145579;Grade 3 Rash Maculo-Papular, CTCAE;"Macules/papules covering >30% BSA with moderate or severe symptoms; limiting self care ADL";Grade 3 Rash maculo-papular;"Macules/papules covering >30% BSA with moderate or severe symptoms; limiting self care ADL";Rash maculo-papular;10037868;LLT;20,1
3903;C146772;Scalp Pain, CTCAE 5.0;A disorder characterized by a sensation of marked discomfort in the skin covering the top and the back of the head.;Scalp pain;A disorder characterized by a sensation of marked discomfort in the skin covering the top and the back of the head.;Scalp pain;10049120;LLT;20,1
3904;C56211;Grade 1 Scalp Pain, CTCAE;Mild pain;Grade 1 Scalp pain;Mild pain;Scalp pain;10049120;LLT;20,1
3905;C56212;Grade 2 Scalp Pain, CTCAE;"Moderate pain; limiting instrumental ADL";Grade 2 Scalp pain;"Moderate pain; limiting instrumental ADL";Scalp pain;10049120;LLT;20,1
3906;C56213;Grade 3 Scalp Pain, CTCAE;"Severe pain; limiting self care ADL";Grade 3 Scalp pain;"Severe pain; limiting self care ADL";Scalp pain;10049120;LLT;20,1
3907;C143833;Skin and Subcutaneous Tissue Disorders - Other, Specify, CTCAE;;Skin and subcutaneous tissue disorders - Other, specify;;Skin and subcutaneous tissue disorders - Other, specify;10040785;LLT;20,1
3908;C144397;Grade 1 Skin and Subcutaneous Tissue Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Skin and subcutaneous tissue disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Skin and subcutaneous tissue disorders - Other, specify;10040785;LLT;20,1
3909;C144996;Grade 2 Skin and Subcutaneous Tissue Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Skin and subcutaneous tissue disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Skin and subcutaneous tissue disorders - Other, specify;10040785;LLT;20,1
3910;C145617;Grade 3 Skin and Subcutaneous Tissue Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Skin and subcutaneous tissue disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Skin and subcutaneous tissue disorders - Other, specify;10040785;LLT;20,1
3911;C146111;Grade 4 Skin and Subcutaneous Tissue Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Skin and subcutaneous tissue disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Skin and subcutaneous tissue disorders - Other, specify;10040785;LLT;20,1
3912;C146543;Grade 5 Skin and Subcutaneous Tissue Disorders - Other, Specify, CTCAE;Death;Grade 5 Skin and subcutaneous tissue disorders - Other, specify;Death;Skin and subcutaneous tissue disorders - Other, specify;10040785;LLT;20,1
3913;C146644;Skin Atrophy, CTCAE 5.0;A disorder characterized by the degeneration and thinning of the epidermis and dermis.;Skin atrophy;A disorder characterized by the degeneration and thinning of the epidermis and dermis.;Skin atrophy;10040799;LLT;20,1
3914;C57922;Grade 1 Skin Atrophy, CTCAE;"Covering <10% BSA; associated with telangiectasias or changes in skin color";Grade 1 Skin atrophy;"Covering <10% BSA; associated with telangiectasias or changes in skin color";Skin atrophy;10040799;LLT;20,1
3915;C57948;Grade 2 Skin Atrophy, CTCAE;"Covering 10-30% BSA; associated with striae or adnexal structure loss";Grade 2 Skin atrophy;"Covering 10-30% BSA; associated with striae or adnexal structure loss";Skin atrophy;10040799;LLT;20,1
3916;C145618;Grade 3 Skin Atrophy, CTCAE;"Covering >30% BSA; associated with ulceration";Grade 3 Skin atrophy;"Covering >30% BSA; associated with ulceration";Skin atrophy;10040799;LLT;20,1
3917;C143835;Skin Hyperpigmentation, CTCAE;A disorder characterized by darkening of the skin due to excessive melanin deposition.;Skin hyperpigmentation;A disorder characterized by darkening of the skin due to excessive melanin deposition.;Skin hyperpigmentation;10040865;LLT;20,1
3918;C144398;Grade 1 Skin Hyperpigmentation, CTCAE;"Hyperpigmentation covering <10% BSA; no psychosocial impact";Grade 1 Skin hyperpigmentation;"Hyperpigmentation covering <10% BSA; no psychosocial impact";Skin hyperpigmentation;10040865;LLT;20,1
3919;C144997;Grade 2 Skin Hyperpigmentation, CTCAE;"Hyperpigmentation covering >10% BSA; associated psychosocial impact";Grade 2 Skin hyperpigmentation;"Hyperpigmentation covering >10% BSA; associated psychosocial impact";Skin hyperpigmentation;10040865;LLT;20,1
3920;C143836;Skin Hypopigmentation, CTCAE;A disorder characterized by loss of skin pigment (e.g., vitiligo).;Skin hypopigmentation;A disorder characterized by loss of skin pigment (e.g., vitiligo).;Skin hypopigmentation;10040868;LLT;20,1
3921;C144399;Grade 1 Skin Hypopigmentation, CTCAE;"Hypopigmentation or depigmentation covering <10% BSA; no psychosocial impact";Grade 1 Skin hypopigmentation;"Hypopigmentation or depigmentation covering <10% BSA; no psychosocial impact";Skin hypopigmentation;10040868;LLT;20,1
3922;C144998;Grade 2 Skin Hypopigmentation, CTCAE;"Hypopigmentation or depigmentation covering >10% BSA; associated psychosocial impact";Grade 2 Skin hypopigmentation;"Hypopigmentation or depigmentation covering >10% BSA; associated psychosocial impact";Skin hypopigmentation;10040868;LLT;20,1
3923;C143837;Skin Induration, CTCAE;A disorder characterized by an area of hardness in the skin.;Skin induration;A disorder characterized by an area of hardness in the skin.;Skin induration;10051837;LLT;20,1
3924;C144400;Grade 1 Skin Induration, CTCAE;Mild induration, able to move skin parallel to plane (sliding) and perpendicular to skin (pinching up);Grade 1 Skin induration;Mild induration, able to move skin parallel to plane (sliding) and perpendicular to skin (pinching up);Skin induration;10051837;LLT;20,1
3925;C144999;Grade 2 Skin Induration, CTCAE;"Moderate induration, able to slide skin, unable to pinch skin; limiting instrumental ADL";Grade 2 Skin induration;"Moderate induration, able to slide skin, unable to pinch skin; limiting instrumental ADL";Skin induration;10051837;LLT;20,1
3926;C145619;Grade 3 Skin Induration, CTCAE;"Severe induration; unable to slide or pinch skin; limiting joint or orifice movement (e.g., mouth, anus); limiting self care ADL";Grade 3 Skin induration;"Severe induration; unable to slide or pinch skin; limiting joint or orifice movement (e.g., mouth, anus); limiting self care ADL";Skin induration;10051837;LLT;20,1
3927;C146112;Grade 4 Skin Induration, CTCAE;"Generalized; associated with signs or symptoms of impaired breathing or feeding";Grade 4 Skin induration;"Generalized; associated with signs or symptoms of impaired breathing or feeding";Skin induration;10051837;LLT;20,1
3928;C146544;Grade 5 Skin Induration, CTCAE;Death;Grade 5 Skin induration;Death;Skin induration;10051837;LLT;20,1
3929;C143839;Skin Ulceration, CTCAE;A disorder characterized by a circumscribed, erosive lesion on the skin.;Skin ulceration;A disorder characterized by a circumscribed, erosive lesion on the skin.;Skin ulceration;10040947;LLT;20,1
3930;C144403;Grade 1 Skin Ulceration, CTCAE;"Combined area of ulcers <1 cm; nonblanchable erythema of intact skin with associated warmth or edema";Grade 1 Skin ulceration;"Combined area of ulcers <1 cm; nonblanchable erythema of intact skin with associated warmth or edema";Skin ulceration;10040947;LLT;20,1
3931;C145002;Grade 2 Skin Ulceration, CTCAE;"Combined area of ulcers 1-2 cm; partial thickness skin loss involving skin or subcutaneous fat";Grade 2 Skin ulceration;"Combined area of ulcers 1-2 cm; partial thickness skin loss involving skin or subcutaneous fat";Skin ulceration;10040947;LLT;20,1
3932;C145621;Grade 3 Skin Ulceration, CTCAE;"Combined area of ulcers >2 cm; full-thickness skin loss involving damage to or necrosis of subcutaneous tissue that may extend down to fascia";Grade 3 Skin ulceration;"Combined area of ulcers >2 cm; full-thickness skin loss involving damage to or necrosis of subcutaneous tissue that may extend down to fascia";Skin ulceration;10040947;LLT;20,1
3933;C146114;Grade 4 Skin Ulceration, CTCAE;Any size ulcer with extensive destruction, tissue necrosis, or damage to muscle, bone, or supporting structures with or without full thickness skin loss;Grade 4 Skin ulceration;Any size ulcer with extensive destruction, tissue necrosis, or damage to muscle, bone, or supporting structures with or without full thickness skin loss;Skin ulceration;10040947;LLT;20,1
3934;C146546;Grade 5 Skin Ulceration, CTCAE;Death;Grade 5 Skin ulceration;Death;Skin ulceration;10040947;LLT;20,1
3935;C143859;Stevens-Johnson Syndrome, CTCAE;A disorder characterized by less than 10% total body skin area separation of dermis. The syndrome is thought to be a hypersensitivity complex affecting the skin and the mucous membranes.;Stevens-Johnson syndrome;A disorder characterized by less than 10% total body skin area separation of dermis. The syndrome is thought to be a hypersensitivity complex affecting the skin and the mucous membranes.;Stevens-Johnson syndrome;10042033;LLT;20,1
3936;C145642;Grade 3 Stevens-Johnson Syndrome, CTCAE;Skin sloughing covering <10% BSA with associated signs (e.g., erythema, purpura, epidermal detachment, and mucous membrane detachment);Grade 3 Stevens-Johnson syndrome;Skin sloughing covering <10% BSA with associated signs (e.g., erythema, purpura, epidermal detachment, and mucous membrane detachment);Stevens-Johnson syndrome;10042033;LLT;20,1
3937;C146134;Grade 4 Stevens-Johnson Syndrome, CTCAE;Skin sloughing covering 10-30% BSA with associated signs (e.g., erythema, purpura, epidermal detachment and mucous membrane detachment);Grade 4 Stevens-Johnson syndrome;Skin sloughing covering 10-30% BSA with associated signs (e.g., erythema, purpura, epidermal detachment and mucous membrane detachment);Stevens-Johnson syndrome;10042033;LLT;20,1
3938;C146566;Grade 5 Stevens-Johnson Syndrome, CTCAE;Death;Grade 5 Stevens-Johnson syndrome;Death;Stevens-Johnson syndrome;10042033;LLT;20,1
3939;C143248;Subcutaneous Emphysema, CTCAE;A disorder characterized by air in the subcutaneous tissue.;Subcutaneous emphysema;A disorder characterized by air in the subcutaneous tissue.;Subcutaneous emphysema;10042344;LLT;20,1
3940;C144420;Grade 1 Subcutaneous Emphysema, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Subcutaneous emphysema;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Subcutaneous emphysema;10042344;LLT;20,1
3941;C145025;Grade 2 Subcutaneous Emphysema, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated";Grade 2 Subcutaneous emphysema;"Moderate; minimal, local or noninvasive intervention indicated";Subcutaneous emphysema;10042344;LLT;20,1
3942;C145647;Grade 3 Subcutaneous Emphysema, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Subcutaneous emphysema;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Subcutaneous emphysema;10042344;LLT;20,1
3943;C146740;Telangiectasia, CTCAE 5.0;A disorder characterized by local dilatation of small vessels resulting in red discoloration of the skin or mucous membranes.;Telangiectasia;A disorder characterized by local dilatation of small vessels resulting in red discoloration of the skin or mucous membranes.;Telangiectasia;10043189;LLT;20,1
3944;C57925;Grade 1 Telangiectasia, CTCAE;Telangiectasias covering <10% BSA;Grade 1 Telangiectasia;Telangiectasias covering <10% BSA;Telangiectasia;10043189;LLT;20,1
3945;C57952;Grade 2 Telangiectasia, CTCAE;"Telangiectasias covering >=10% BSA; associated with psychosocial impact";Grade 2 Telangiectasia;"Telangiectasias covering >=10% BSA; associated with psychosocial impact";Telangiectasia;10043189;LLT;20,1
3946;C143880;Toxic Epidermal Necrolysis, CTCAE;A disorder characterized by greater than 30% total body skin area separation of dermis. The syndrome is thought to be a hypersensitivity complex affecting the skin and the mucous membranes.;Toxic epidermal necrolysis;A disorder characterized by greater than 30% total body skin area separation of dermis. The syndrome is thought to be a hypersensitivity complex affecting the skin and the mucous membranes.;Toxic epidermal necrolysis;10044223;LLT;20,1
3947;C146148;Grade 4 Toxic Epidermal Necrolysis, CTCAE;Skin sloughing covering >=30% BSA with associated symptoms (e.g., erythema, purpura, or epidermal detachment);Grade 4 Toxic epidermal necrolysis;Skin sloughing covering >=30% BSA with associated symptoms (e.g., erythema, purpura, or epidermal detachment);Toxic epidermal necrolysis;10044223;LLT;20,1
3948;C146579;Grade 5 Toxic Epidermal Necrolysis, CTCAE;Death;Grade 5 Toxic epidermal necrolysis;Death;Toxic epidermal necrolysis;10044223;LLT;20,1
3949;C58019;Urticaria, CTCAE;A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins.;Urticaria;A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins.;Urticaria;10046735;LLT;20,1
3950;C57926;Grade 1 Urticaria, CTCAE;"Urticarial lesions covering <10% BSA; topical intervention indicated";Grade 1 Urticaria;"Urticarial lesions covering <10% BSA; topical intervention indicated";Urticaria;10046735;LLT;20,1
3951;C57954;Grade 2 Urticaria, CTCAE;"Urticarial lesions covering 10-30% BSA; oral intervention indicated";Grade 2 Urticaria;"Urticarial lesions covering 10-30% BSA; oral intervention indicated";Urticaria;10046735;LLT;20,1
3952;C57974;Grade 3 Urticaria, CTCAE;"Urticarial lesions covering >30% BSA; IV intervention indicated";Grade 3 Urticaria;"Urticarial lesions covering >30% BSA; IV intervention indicated";Urticaria;10046735;LLT;20,1
3953;C143188;Social Circumstances, CTCAE;;;;;;;
3954;C143848;Social Circumstances - Other, Specify, CTCAE;;Social circumstances - Other, specify;;Social circumstances - Other, specify;10041244;LLT;20,1
3955;C144411;Grade 1 Social Circumstances - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Social circumstances - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Social circumstances - Other, specify;10041244;LLT;20,1
3956;C145012;Grade 2 Social Circumstances - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Social circumstances - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Social circumstances - Other, specify;10041244;LLT;20,1
3957;C145630;Grade 3 Social Circumstances - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Social circumstances - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Social circumstances - Other, specify;10041244;LLT;20,1
3958;C146123;Grade 4 Social Circumstances - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Social circumstances - Other, specify;"Life-threatening consequences; urgent intervention indicated";Social circumstances - Other, specify;10041244;LLT;20,1
3959;C146555;Grade 5 Social Circumstances - Other, Specify, CTCAE;Death;Grade 5 Social circumstances - Other, specify;Death;Social circumstances - Other, specify;10041244;LLT;20,1
3960;C143189;Surgical and Medical Procedures, CTCAE;;;;;;;
3961;C143869;Surgical and Medical Procedures - Other, Specify, CTCAE;;Surgical and medical procedures - Other, specify;;Surgical and medical procedures - Other, specify;10042613;LLT;20,1
3962;C144424;Grade 1 Surgical and Medical Procedures - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Surgical and medical procedures - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Surgical and medical procedures - Other, specify;10042613;LLT;20,1
3963;C145030;Grade 2 Surgical and Medical Procedures - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Surgical and medical procedures - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Surgical and medical procedures - Other, specify;10042613;LLT;20,1
3964;C145652;Grade 3 Surgical and Medical Procedures - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Surgical and medical procedures - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Surgical and medical procedures - Other, specify;10042613;LLT;20,1
3965;C146142;Grade 4 Surgical and Medical Procedures - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Surgical and medical procedures - Other, specify;"Life-threatening consequences; urgent intervention indicated";Surgical and medical procedures - Other, specify;10042613;LLT;20,1
3966;C146574;Grade 5 Surgical and Medical Procedures - Other, Specify, CTCAE;Death;Grade 5 Surgical and medical procedures - Other, specify;Death;Surgical and medical procedures - Other, specify;10042613;LLT;20,1
3967;C143183;Vascular Disorders, CTCAE;;;;;;;
3968;C143249;Arterial Thromboembolism, CTCAE;A disorder characterized by occlusion of an arterial vessel by a blood clot that develops in an artery.;Arterial thromboembolism;A disorder characterized by occlusion of an arterial vessel by a blood clot that develops in an artery.;Arterial thromboembolism;10073529;LLT;20,1
3969;C145146;Grade 3 Arterial Thromboembolism, CTCAE;Urgent intervention indicated;Grade 3 Arterial thromboembolism;Urgent intervention indicated;Arterial thromboembolism;10073529;LLT;20,1
3970;C145753;Grade 4 Arterial Thromboembolism, CTCAE;"Life-threatening consequences; hemodynamic or neurologic instability; organ damage; loss of extremity(ies)";Grade 4 Arterial thromboembolism;"Life-threatening consequences; hemodynamic or neurologic instability; organ damage; loss of extremity(ies)";Arterial thromboembolism;10073529;LLT;20,1
3971;C146223;Grade 5 Arterial Thromboembolism, CTCAE;Death;Grade 5 Arterial thromboembolism;Death;Arterial thromboembolism;10073529;LLT;20,1
3972;C143349;Capillary Leak Syndrome, CTCAE;A disorder characterized by leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, medications, or poisoning. It can lead to generalized edema and multiple organ failure.;Capillary leak syndrome;A disorder characterized by leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, medications, or poisoning. It can lead to generalized edema and multiple organ failure.;Capillary leak syndrome;10007196;LLT;20,1
3973;C144019;Grade 1 Capillary Leak Syndrome, CTCAE;Asymptomatic;Grade 1 Capillary leak syndrome;Asymptomatic;Capillary leak syndrome;10007196;LLT;20,1
3974;C144565;Grade 2 Capillary Leak Syndrome, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Capillary leak syndrome;"Symptomatic; medical intervention indicated";Capillary leak syndrome;10007196;LLT;20,1
3975;C145180;Grade 3 Capillary Leak Syndrome, CTCAE;"Severe symptoms; intervention indicated";Grade 3 Capillary leak syndrome;"Severe symptoms; intervention indicated";Capillary leak syndrome;10007196;LLT;20,1
3976;C145780;Grade 4 Capillary Leak Syndrome, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Capillary leak syndrome;"Life-threatening consequences; urgent intervention indicated";Capillary leak syndrome;10007196;LLT;20,1
3977;C146248;Grade 5 Capillary Leak Syndrome, CTCAE;Death;Grade 5 Capillary leak syndrome;Death;Capillary leak syndrome;10007196;LLT;20,1
3978;C146643;Flushing, CTCAE 5.0;A disorder characterized by episodic reddening of the skin, especially face, neck, or chest.;Flushing;A disorder characterized by episodic reddening of the skin, especially face, neck, or chest.;Flushing;10016825;LLT;20,1
3979;C57908;Grade 1 Flushing, CTCAE;"Asymptomatic; clinical or diagnostic observations only";Grade 1 Flushing;"Asymptomatic; clinical or diagnostic observations only";Flushing;10016825;LLT;20,1
3980;C57933;Grade 2 Flushing, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Flushing;"Moderate symptoms; limiting instrumental ADL";Flushing;10016825;LLT;20,1
3981;C145292;Grade 3 Flushing, CTCAE;"Symptomatic, associated with hypotension and/or tachycardia; limiting self care ADL";Grade 3 Flushing;"Symptomatic, associated with hypotension and/or tachycardia; limiting self care ADL";Flushing;10016825;LLT;20,1
3982;C56539;Hematoma, CTCAE;A disorder characterized by a localized collection of blood, usually clotted, in an organ, space, or tissue, due to a break in the wall of a blood vessel.;Hematoma;A disorder characterized by a localized collection of blood, usually clotted, in an organ, space, or tissue, due to a break in the wall of a blood vessel.;Hematoma;10019428;LLT;20,1
3983;C56298;Grade 1 Hematoma, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Hematoma;"Mild symptoms; intervention not indicated";Hematoma;10019428;LLT;20,1
3984;C56347;Grade 2 Hematoma, CTCAE;Minimally invasive evacuation or aspiration indicated;Grade 2 Hematoma;Minimally invasive evacuation or aspiration indicated;Hematoma;10019428;LLT;20,1
3985;C56396;Grade 3 Hematoma, CTCAE;"Transfusion; invasive intervention indicated";Grade 3 Hematoma;"Transfusion; invasive intervention indicated";Hematoma;10019428;LLT;20,1
3986;C56446;Grade 4 Hematoma, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Hematoma;"Life-threatening consequences; urgent intervention indicated";Hematoma;10019428;LLT;20,1
3987;C56495;Grade 5 Hematoma, CTCAE;Death;Grade 5 Hematoma;Death;Hematoma;10019428;LLT;20,1
3988;C143549;Hot Flashes, CTCAE;A disorder characterized by an uncomfortable and temporary sensation of intense body warmth, flushing, sometimes accompanied by sweating upon cooling.;Hot flashes;A disorder characterized by an uncomfortable and temporary sensation of intense body warmth, flushing, sometimes accompanied by sweating upon cooling.;Hot flashes;10020407;LLT;20,1
3989;C144159;Grade 1 Hot Flashes, CTCAE;"Mild symptoms; intervention not indicated";Grade 1 Hot flashes;"Mild symptoms; intervention not indicated";Hot flashes;10020407;LLT;20,1
3990;C144722;Grade 2 Hot Flashes, CTCAE;"Moderate symptoms; limiting instrumental ADL";Grade 2 Hot flashes;"Moderate symptoms; limiting instrumental ADL";Hot flashes;10020407;LLT;20,1
3991;C145343;Grade 3 Hot Flashes, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Hot flashes;"Severe symptoms; limiting self care ADL";Hot flashes;10020407;LLT;20,1
3992;C55060;Hypertension, CTCAE;A disorder characterized by a pathological increase in blood pressure.;Hypertension;A disorder characterized by a pathological increase in blood pressure.;Hypertension;10020772;LLT;20,1
3993;C54996;Grade 1 Hypertension, CTCAE;"Adult: Systolic BP 120-139 mm Hg or diastolic BP 80-89 mm Hg; Pediatric: Systolic/diastolic BP >90th percentile but< 95th percentile; Adolescent: BP >= 120/80 even if < 95th percentile";Grade 1 Hypertension;"Adult: Systolic BP 120-139 mm Hg or diastolic BP 80-89 mm Hg; Pediatric: Systolic/diastolic BP >90th percentile but< 95th percentile; Adolescent: BP >= 120/80 even if < 95th percentile";Hypertension;10020772;LLT;20,1
3994;C55008;Grade 2 Hypertension, CTCAE;"Adult: Systolic BP 140-159 mm Hg or diastolic BP 90-99 mm Hg if previously WNL; change in baseline medical intervention indicated; recurrent or persistent (>=24 hrs); symptomatic increase by >20 mm Hg (diastolic) or to >140/90 mm Hg; monotherapy indicated initiated; Pediatric and adolescent: Recurrent or persistent (>=24 hrs) BP >ULN; monotherapy indicated; systolic and /or diastolic BP between the 95th percentile and 5 mmHg above the 99th percentile; Adolescent: Systolic between 130-139 or diastolic between 80-89 even if < 95th percentile";Grade 2 Hypertension;"Adult: Systolic BP 140-159 mm Hg or diastolic BP 90-99 mm Hg if previously WNL; change in baseline medical intervention indicated; recurrent or persistent (>=24 hrs); symptomatic increase by >20 mm Hg (diastolic) or to >140/90 mm Hg; monotherapy indicated initiated; Pediatric and adolescent: Recurrent or persistent (>=24 hrs) BP >ULN; monotherapy indicated; systolic and /or diastolic BP between the 95th percentile and 5 mmHg above the 99th percentile; Adolescent: Systolic between 130-139 or diastolic between 80-89 even if < 95th percentile";Hypertension;10020772;LLT;20,1
3995;C55020;Grade 3 Hypertension, CTCAE;"Adult: Systolic BP >=160 mm Hg or diastolic BP >=100 mm Hg; medical intervention indicated; more than one drug or more intensive therapy than previously used indicated; Pediatric and adolescent: Systolic and/or diastolic > 5 mmHg above the 99th percentile";Grade 3 Hypertension;"Adult: Systolic BP >=160 mm Hg or diastolic BP >=100 mm Hg; medical intervention indicated; more than one drug or more intensive therapy than previously used indicated; Pediatric and adolescent: Systolic and/or diastolic > 5 mmHg above the 99th percentile";Hypertension;10020772;LLT;20,1
3996;C55034;Grade 4 Hypertension, CTCAE;"Adult and Pediatric: Life-threatening consequences (e.g., malignant hypertension, transient or permanent neurologic deficit, hypertensive crisis); urgent intervention indicated";Grade 4 Hypertension;"Adult and Pediatric: Life-threatening consequences (e.g., malignant hypertension, transient or permanent neurologic deficit, hypertensive crisis); urgent intervention indicated";Hypertension;10020772;LLT;20,1
3997;C55048;Grade 5 Hypertension, CTCAE;Death;Grade 5 Hypertension;Death;Hypertension;10020772;LLT;20,1
3998;C55061;Hypotension, CTCAE;A disorder characterized by a blood pressure that is below the normal expected for an individual in a given environment.;Hypotension;A disorder characterized by a blood pressure that is below the normal expected for an individual in a given environment.;Hypotension;10021097;LLT;20,1
3999;C54997;Grade 1 Hypotension, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Hypotension;Asymptomatic, intervention not indicated;Hypotension;10021097;LLT;20,1
4000;C55009;Grade 2 Hypotension, CTCAE;Non-urgent medical intervention indicated;Grade 2 Hypotension;Non-urgent medical intervention indicated;Hypotension;10021097;LLT;20,1
4001;C55021;Grade 3 Hypotension, CTCAE;"Medical intervention indicated; hospitalization indicated";Grade 3 Hypotension;"Medical intervention indicated; hospitalization indicated";Hypotension;10021097;LLT;20,1
4002;C55035;Grade 4 Hypotension, CTCAE;Life-threatening consequences and urgent intervention indicated;Grade 4 Hypotension;Life-threatening consequences and urgent intervention indicated;Hypotension;10021097;LLT;20,1
4003;C55049;Grade 5 Hypotension, CTCAE;Death;Grade 5 Hypotension;Death;Hypotension;10021097;LLT;20,1
4004;C143659;Lymph Leakage, CTCAE;A disorder characterized by the loss of lymph fluid into the surrounding tissue or body cavity.;Lymph leakage;A disorder characterized by the loss of lymph fluid into the surrounding tissue or body cavity.;Lymph leakage;10065773;LLT;20,1
4005;C144828;Grade 2 Lymph Leakage, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Lymph leakage;"Symptomatic; medical intervention indicated";Lymph leakage;10065773;LLT;20,1
4006;C145448;Grade 3 Lymph Leakage, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Lymph leakage;"Severe symptoms; invasive intervention indicated";Lymph leakage;10065773;LLT;20,1
4007;C145987;Grade 4 Lymph Leakage, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Lymph leakage;"Life-threatening consequences; urgent intervention indicated";Lymph leakage;10065773;LLT;20,1
4008;C146433;Grade 5 Lymph Leakage, CTCAE;Death;Grade 5 Lymph leakage;Death;Lymph leakage;10065773;LLT;20,1
4009;C143660;Lymphedema, CTCAE;A disorder characterized by excessive fluid collection in tissues that causes swelling.;Lymphedema;A disorder characterized by excessive fluid collection in tissues that causes swelling.;Lymphedema;10025233;LLT;20,1
4010;C144254;Grade 1 Lymphedema, CTCAE;Trace thickening or faint discoloration;Grade 1 Lymphedema;Trace thickening or faint discoloration;Lymphedema;10025233;LLT;20,1
4011;C144829;Grade 2 Lymphedema, CTCAE;"Marked discoloration; leathery skin texture; papillary formation; limiting instrumental ADL";Grade 2 Lymphedema;"Marked discoloration; leathery skin texture; papillary formation; limiting instrumental ADL";Lymphedema;10025233;LLT;20,1
4012;C145449;Grade 3 Lymphedema, CTCAE;"Severe symptoms; limiting self care ADL";Grade 3 Lymphedema;"Severe symptoms; limiting self care ADL";Lymphedema;10025233;LLT;20,1
4013;C55705;Lymphocele, CTCAE;A disorder characterized by a cystic lesion containing lymph.;Lymphocele;A disorder characterized by a cystic lesion containing lymph.;Lymphocele;10048642;LLT;20,1
4014;C55706;Grade 1 Lymphocele, CTCAE;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Grade 1 Lymphocele;"Asymptomatic; clinical or diagnostic observations only; intervention not indicated";Lymphocele;10048642;LLT;20,1
4015;C55707;Grade 2 Lymphocele, CTCAE;"Symptomatic; medical intervention indicated";Grade 2 Lymphocele;"Symptomatic; medical intervention indicated";Lymphocele;10048642;LLT;20,1
4016;C55708;Grade 3 Lymphocele, CTCAE;"Severe symptoms; invasive intervention indicated";Grade 3 Lymphocele;"Severe symptoms; invasive intervention indicated";Lymphocele;10048642;LLT;20,1
4017;C143749;Peripheral Ischemia, CTCAE;A disorder characterized by impaired circulation to an extremity.;Peripheral ischemia;A disorder characterized by impaired circulation to an extremity.;Peripheral ischemia;10034578;LLT;20,1
4018;C144909;Grade 2 Peripheral Ischemia, CTCAE;Brief (<24 hrs) episode of ischemia managed medically and without permanent deficit;Grade 2 Peripheral ischemia;Brief (<24 hrs) episode of ischemia managed medically and without permanent deficit;Peripheral ischemia;10034578;LLT;20,1
4019;C145532;Grade 3 Peripheral Ischemia, CTCAE;Prolonged (>=24 hrs) or recurring symptoms and/or invasive intervention indicated;Grade 3 Peripheral ischemia;Prolonged (>=24 hrs) or recurring symptoms and/or invasive intervention indicated;Peripheral ischemia;10034578;LLT;20,1
4020;C146040;Grade 4 Peripheral Ischemia, CTCAE;"Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated";Grade 4 Peripheral ischemia;"Life-threatening consequences; evidence of end organ damage; urgent operative intervention indicated";Peripheral ischemia;10034578;LLT;20,1
4021;C146480;Grade 5 Peripheral Ischemia, CTCAE;Death;Grade 5 Peripheral ischemia;Death;Peripheral ischemia;10034578;LLT;20,1
4022;C143761;Phlebitis, CTCAE;A disorder characterized by inflammation of the wall of a vein.;Phlebitis;A disorder characterized by inflammation of the wall of a vein.;Phlebitis;10034879;LLT;20,1
4023;C144923;Grade 2 Phlebitis, CTCAE;Present;Grade 2 Phlebitis;Present;Phlebitis;10034879;LLT;20,1
4024;C143867;Superficial Thrombophlebitis, CTCAE;A disorder characterized by a blood clot and inflammation involving a superficial vein of the extremities.;Superficial thrombophlebitis;A disorder characterized by a blood clot and inflammation involving a superficial vein of the extremities.;Superficial thrombophlebitis;10042554;LLT;20,1
4025;C145028;Grade 2 Superficial Thrombophlebitis, CTCAE;Present;Grade 2 Superficial thrombophlebitis;Present;Superficial thrombophlebitis;10042554;LLT;20,1
4026;C143868;Superior Vena Cava Syndrome, CTCAE;A disorder characterized by obstruction of the blood flow in the superior vena cava. Signs and symptoms include swelling and cyanosis of the face, neck, and upper arms, cough, orthopnea and headache.;Superior vena cava syndrome;A disorder characterized by obstruction of the blood flow in the superior vena cava. Signs and symptoms include swelling and cyanosis of the face, neck, and upper arms, cough, orthopnea and headache.;Superior vena cava syndrome;10042569;LLT;20,1
4027;C144423;Grade 1 Superior Vena Cava Syndrome, CTCAE;"Asymptomatic; incidental finding of SVC thrombosis";Grade 1 Superior vena cava syndrome;"Asymptomatic; incidental finding of SVC thrombosis";Superior vena cava syndrome;10042569;LLT;20,1
4028;C145029;Grade 2 Superior Vena Cava Syndrome, CTCAE;"Symptomatic; medical intervention indicated (e.g., anticoagulation, radiation or chemotherapy)";Grade 2 Superior vena cava syndrome;"Symptomatic; medical intervention indicated (e.g., anticoagulation, radiation or chemotherapy)";Superior vena cava syndrome;10042569;LLT;20,1
4029;C145651;Grade 3 Superior Vena Cava Syndrome, CTCAE;"Severe symptoms; multi-modality intervention indicated (e.g., anticoagulation, chemotherapy, radiation, stenting)";Grade 3 Superior vena cava syndrome;"Severe symptoms; multi-modality intervention indicated (e.g., anticoagulation, chemotherapy, radiation, stenting)";Superior vena cava syndrome;10042569;LLT;20,1
4030;C146141;Grade 4 Superior Vena Cava Syndrome, CTCAE;"Life-threatening consequences; urgent multi-modality intervention indicated (e.g., lysis, thrombectomy, surgery)";Grade 4 Superior vena cava syndrome;"Life-threatening consequences; urgent multi-modality intervention indicated (e.g., lysis, thrombectomy, surgery)";Superior vena cava syndrome;10042569;LLT;20,1
4031;C146573;Grade 5 Superior Vena Cava Syndrome, CTCAE;Death;Grade 5 Superior vena cava syndrome;Death;Superior vena cava syndrome;10042569;LLT;20,1
4032;C143873;Thromboembolic Event, CTCAE;A disorder characterized by occlusion of a vessel by a thrombus that has migrated from a distal site via the blood stream.;Thromboembolic event;A disorder characterized by occlusion of a vessel by a thrombus that has migrated from a distal site via the blood stream.;Thromboembolic event;10043565;LLT;20,1
4033;C144430;Grade 1 Thromboembolic Event, CTCAE;Medical intervention not indicated (e.g., superficial thrombosis);Grade 1 Thromboembolic event;Medical intervention not indicated (e.g., superficial thrombosis);Thromboembolic event;10043565;LLT;20,1
4034;C145036;Grade 2 Thromboembolic Event, CTCAE;Medical intervention indicated;Grade 2 Thromboembolic event;Medical intervention indicated;Thromboembolic event;10043565;LLT;20,1
4035;C145657;Grade 3 Thromboembolic Event, CTCAE;Urgent medical intervention indicated (e.g., pulmonary embolism or intracardiac thrombus);Grade 3 Thromboembolic event;Urgent medical intervention indicated (e.g., pulmonary embolism or intracardiac thrombus);Thromboembolic event;10043565;LLT;20,1
4036;C146145;Grade 4 Thromboembolic Event, CTCAE;Life-threatening consequences with hemodynamic or neurologic instability;Grade 4 Thromboembolic event;Life-threatening consequences with hemodynamic or neurologic instability;Thromboembolic event;10043565;LLT;20,1
4037;C146576;Grade 5 Thromboembolic Event, CTCAE;Death;Grade 5 Thromboembolic event;Death;Thromboembolic event;10043565;LLT;20,1
4038;C143930;Vascular Disorders - Other, Specify, CTCAE;;Vascular disorders - Other, specify;;Vascular disorders - Other, specify;10047065;LLT;20,1
4039;C144479;Grade 1 Vascular Disorders - Other, Specify, CTCAE;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Grade 1 Vascular disorders - Other, specify;"Asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated";Vascular disorders - Other, specify;10047065;LLT;20,1
4040;C145091;Grade 2 Vascular Disorders - Other, Specify, CTCAE;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Grade 2 Vascular disorders - Other, specify;"Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental ADL";Vascular disorders - Other, specify;10047065;LLT;20,1
4041;C145711;Grade 3 Vascular Disorders - Other, Specify, CTCAE;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Grade 3 Vascular disorders - Other, specify;"Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of existing hospitalization indicated; limiting self care ADL";Vascular disorders - Other, specify;10047065;LLT;20,1
4042;C146188;Grade 4 Vascular Disorders - Other, Specify, CTCAE;"Life-threatening consequences; urgent intervention indicated";Grade 4 Vascular disorders - Other, specify;"Life-threatening consequences; urgent intervention indicated";Vascular disorders - Other, specify;10047065;LLT;20,1
4043;C146616;Grade 5 Vascular Disorders - Other, Specify, CTCAE;Death;Grade 5 Vascular disorders - Other, specify;Death;Vascular disorders - Other, specify;10047065;LLT;20,1
4044;C54741;Vasculitis, CTCAE;A disorder characterized by inflammation involving the wall of a vessel.;Vasculitis;A disorder characterized by inflammation involving the wall of a vessel.;Vasculitis;10047115;LLT;20,1
4045;C54746;Grade 1 Vasculitis, CTCAE;Asymptomatic, intervention not indicated;Grade 1 Vasculitis;Asymptomatic, intervention not indicated;Vasculitis;10047115;LLT;20,1
4046;C54751;Grade 2 Vasculitis, CTCAE;Moderate symptoms, medical intervention indicated;Grade 2 Vasculitis;Moderate symptoms, medical intervention indicated;Vasculitis;10047115;LLT;20,1
4047;C54756;Grade 3 Vasculitis, CTCAE;Severe symptoms, medical intervention indicated (e.g., steroids);Grade 3 Vasculitis;Severe symptoms, medical intervention indicated (e.g., steroids);Vasculitis;10047115;LLT;20,1
4048;C54760;Grade 4 Vasculitis, CTCAE;"Life-threatening consequences; evidence of peripheral or visceral ischemia; urgent intervention indicated";Grade 4 Vasculitis;"Life-threatening consequences; evidence of peripheral or visceral ischemia; urgent intervention indicated";Vasculitis;10047115;LLT;20,1
4049;C54765;Grade 5 Vasculitis, CTCAE;Death;Grade 5 Vasculitis;Death;Vasculitis;10047115;LLT;20,1
